Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - GAMG [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - hTERT-RPE1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - JURKAT [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - OE19 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - SuSa [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"	"Single Cell Type RNA - Alveolar cells type 1 [NX]"	"Single Cell Type RNA - Alveolar cells type 2 [NX]"	"Single Cell Type RNA - B-cells [NX]"	"Single Cell Type RNA - Basal glandular cells [NX]"	"Single Cell Type RNA - Basal keratinocytes [NX]"	"Single Cell Type RNA - Bipolar cells [NX]"	"Single Cell Type RNA - Cardiomyocytes [NX]"	"Single Cell Type RNA - Cholangiocytes [NX]"	"Single Cell Type RNA - Ciliated cells [NX]"	"Single Cell Type RNA - Club cells [NX]"	"Single Cell Type RNA - Collecting duct cells [NX]"	"Single Cell Type RNA - Cone photoreceptor cells [NX]"	"Single Cell Type RNA - Cytotrophoblasts [NX]"	"Single Cell Type RNA - Distal tubular cells [NX]"	"Single Cell Type RNA - Ductal cells [NX]"	"Single Cell Type RNA - Early spermatids [NX]"	"Single Cell Type RNA - Endothelial cells [NX]"	"Single Cell Type RNA - Enterocytes [NX]"	"Single Cell Type RNA - Erythroid cells [NX]"	"Single Cell Type RNA - Exocrine glandular cells [NX]"	"Single Cell Type RNA - Extravillous trophoblasts [NX]"	"Single Cell Type RNA - Fibroblasts [NX]"	"Single Cell Type RNA - Glandular cells [NX]"	"Single Cell Type RNA - granulocytes [NX]"	"Single Cell Type RNA - Hepatocytes [NX]"	"Single Cell Type RNA - Hofbauer cells [NX]"	"Single Cell Type RNA - Horizontal cells [NX]"	"Single Cell Type RNA - Intestinal endocrine cells [NX]"	"Single Cell Type RNA - Ito cells [NX]"	"Single Cell Type RNA - Kupffer cells [NX]"	"Single Cell Type RNA - Late spermatids [NX]"	"Single Cell Type RNA - Leydig cells [NX]"	"Single Cell Type RNA - Macrophages [NX]"	"Single Cell Type RNA - Melanocytes [NX]"	"Single Cell Type RNA - monocytes [NX]"	"Single Cell Type RNA - Mucus-secreting cells [NX]"	"Single Cell Type RNA - Muller glia cells [NX]"	"Single Cell Type RNA - Pancreatic endocrine cells [NX]"	"Single Cell Type RNA - Paneth cells [NX]"	"Single Cell Type RNA - Peritubular cells [NX]"	"Single Cell Type RNA - Proximal tubular cells [NX]"	"Single Cell Type RNA - Rod photoreceptor cells [NX]"	"Single Cell Type RNA - Sertoli cells [NX]"	"Single Cell Type RNA - Smooth muscle cells [NX]"	"Single Cell Type RNA - Spermatocytes [NX]"	"Single Cell Type RNA - Spermatogonia [NX]"	"Single Cell Type RNA - Suprabasal keratinocytes [NX]"	"Single Cell Type RNA - Syncytiotrophoblasts [NX]"	"Single Cell Type RNA - T-cells [NX]"	"Single Cell Type RNA - Undifferentiated cells [NX]"	"Single Cell Type RNA - Urothelial cells [NX]"
ABCA7	ABCX	ENSG00000064687	"ATP binding cassette subfamily A member 7"	Q8IZY2	19	1040101-1065572	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Phagocytosis, Transport"	Translocase	"Alzheimer disease, Amyloidosis, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 35.2"	"Group enriched"	"Detected in many"	4	"Alveolar cells type 1: 68.5;Bipolar cells: 64.0;Cone photoreceptor cells: 164.9;Extravillous trophoblasts: 217.5;Rod photoreceptor cells: 151.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HeLa: 26.7;HMC-1: 32.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041564	Enhanced		Supported	"Golgi apparatus,Plasma membrane,Cell Junctions"		NA	NA			"Golgi apparatus, Plasma membrane"	"Cell Junctions"	"HPA041564: AB_2677550"	"unprognostic (1.52e-1)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (7.26e-4)"	"prognostic favorable (1.12e-4)"	"unprognostic (8.88e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.51e-3)"	"unprognostic (3.68e-2)"	"unprognostic (8.99e-3)"	"unprognostic (2.08e-2)"	"unprognostic (3.66e-1)"	"unprognostic (7.88e-2)"	"unprognostic (7.85e-2)"	6.0	3.5	6.2	20.2	4.8	35.2	7.6	13.6	11.1	5.0	5.8	1.9	4.7	4.9	2.1	3.9	7.5	2.8	5.5	2.3	5.3	6.5	5.3	3.6	9.5	17.7	5.2	5.1	1.0	7.0	5.6	34.5	3.1	7.7	4.9	4.2	34.7	9.9	6.5	5.5	11.1	11.1	1.8	6.7	26.6	7.9	1.6	4.3	19.8	7.0	3.9	14.5	5.1	4.9	1.5	9.9	10.8	2.5	1.9	2.6	1.2	5.7	5.4	1.1	3.4	6.7	3.0	5.6	0.8	0.8	0.3	0.6	4.1	2.2	11.2	3.8	0.8	0.4	5.7	2.3	5.1	0.3	7.4	2.1	8.6	26.7	4.1	2.6	3.2	32.2	2.8	1.8	1.5	2.9	5.5	1.9	6.1	8.7	7.0	1.0	1.4	3.1	2.3	0.6	4.2	2.5	2.9	0.6	8.0	2.8	10.8	0.7	2.2	6.3	1.9	0.6	2.5	3.7	5.2	2.8	0.6	1.4	2.9	0.8	8.1	7.9	6.1	1.4	7.7	1.3	4.3	2.5	7.0	2.6	1.7	1.6	1.0	1.5	1.8	2.8	1.5	1.4	2.1	10.8	1.9	1.6	9.9	0.6	1.2	6.2	4.8	13.6	11.1	5.3	6.5	5.2	5.1	7.7	4.3	68.5	31.1	10.2	0.6	3.0	64.0	5.6	2.5	5.3	9.1	5.2	164.9	2.4	1.7	2.7	6.0	2.9	9.0	0.0	2.1	217.5	2.8	1.4	9.3	3.2	6.9	14.3	3.4	3.1	14.8	2.9	0.0	7.0	0.0	10.0	3.8	13.0	5.9	10.5	0.0	1.3	151.3	0.0	3.1	0.7	1.9	3.0	21.5	10.2	2.9	1.7
ABCC1	"GS-X, MRP, MRP1"	ENSG00000103222	"ATP binding cassette subfamily C member 1"	P33527	16	15949577-16143074	"Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters"	Transport	"Hydrolase, Translocase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"basophil: 7.5;eosinophil: 3.1;T-reg: 2.1"	"Group enriched"	"Detected in many"	7	"granulocytes: 7.5;T-cells: 2.1"	"Cell line enhanced"	"Detected in many"		"EFO-21: 39.0"	"Low region specificity"	"Detected in all"							"HPA002380, HPA076011"	Uncertain		Supported	"Plasma membrane,Cell Junctions"		NA	NA			"Plasma membrane"	"Cell Junctions"	"HPA002380: AB_1844432, HPA076011: "	"unprognostic (9.97e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.05e-2)"	"unprognostic (2.94e-1)"	"unprognostic (4.89e-2)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (5.42e-5)"	"unprognostic (3.42e-1)"	"unprognostic (3.31e-1)"	"unprognostic (4.07e-2)"	"unprognostic (9.78e-3)"	"unprognostic (7.19e-2)"	"prognostic unfavorable (1.55e-6)"	"unprognostic (1.84e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.80e-2)"	8.9	8.2	2.4	8.3	3.1	8.4	9.6	4.4	5.0	8.3	10.7	2.6	15.5	3.5	10.5	12.7	14.7	5.6	9.6	8.0	2.1	2.4	4.5	1.6	10.9	12.2	3.0	2.1	6.8	5.8	18.4	4.2	5.2	4.1	9.6	4.1	12.0	16.9	10.9	20.8	6.6	8.2	16.4	4.0	9.2	10.9	15.1	2.3	26.8	15.7	12.6	15.6	15.3	11.8	0.7	0.5	7.5	0.5	0.4	2.1	0.2	2.3	24.7	0.1	6.5	5.7	3.5	1.3	7.3	8.9	6.3	6.6	3.9	17.8	6.7	39.0	14.0	5.9	6.7	2.0	7.1	4.8	11.8	2.3	8.3	14.4	14.3	17.1	3.0	21.5	7.5	4.8	1.8	1.0	5.4	6.9	12.9	8.4	3.4	1.9	4.6	5.3	2.8	3.9	3.3	3.6	18.9	3.7	3.3	2.3	8.3	3.6	5.9	9.2	10.0	2.4	6.6	3.5	1.6	0.7	0.4	1.5	5.2	5.8	6.4	3.2	2.3	3.3	3.1	0.7	7.5	0.1	3.1	0.6	0.4	0.6	0.7	0.5	0.6	0.5	0.3	0.6	0.6	0.0	0.4	0.5	0.3	2.1	0.2	2.4	3.1	4.4	5.0	2.1	2.4	3.0	2.1	4.1	2.3	23.8	6.4	10.4	6.8	7.8	3.1	5.3	5.1	2.7	12.5	5.2	21.6	0.6	3.3	8.7	7.2	6.2	1.1	0.0	5.5	2.2	3.3	13.8	20.9	0.2	7.2	4.8	17.9	8.6	15.5	11.0	6.9	10.2	3.3	6.4	7.2	1.2	8.5	3.5	6.3	1.4	8.3	0.0	3.1	2.4	5.9	4.4	0.5	9.6	3.1	8.4
ABCC5	"EST277145, MOAT-C, MRP5, SMRP"	ENSG00000114770	"ATP binding cassette subfamily C member 5"	O15440	3	183919934-184018015	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Cone photoreceptor cells: 184.6;Rod photoreceptor cells: 122.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RT4: 48.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044067, HPA052295"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA			"Plasma membrane, Cell Junctions"	Nucleoplasm	"HPA044067: AB_2678797, HPA052295: AB_2681789"	"unprognostic (9.39e-2)"	"unprognostic (6.23e-3)"	"unprognostic (3.83e-2)"	"unprognostic (1.10e-3)"	"unprognostic (2.28e-2)"	"unprognostic (2.07e-1)"	"prognostic unfavorable (6.78e-8)"	"unprognostic (4.46e-2)"	"unprognostic (6.07e-3)"	"unprognostic (1.02e-1)"	"unprognostic (5.91e-3)"	"prognostic unfavorable (3.40e-4)"	"unprognostic (1.10e-1)"	"unprognostic (9.05e-3)"	"unprognostic (1.64e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.24e-2)"	7.9	11.2	24.7	9.6	26.2	12.0	6.7	42.8	28.6	7.7	11.4	12.0	13.4	6.8	14.1	7.0	17.1	6.1	11.6	16.0	19.1	13.7	12.8	3.6	9.4	7.3	20.5	18.5	11.8	4.9	22.4	20.5	10.8	21.7	10.6	14.4	31.1	7.4	9.3	41.0	14.5	8.5	10.5	12.9	16.3	48.5	9.4	20.9	9.3	5.5	7.3	7.4	18.1	12.7	4.2	3.5	15.8	4.5	5.0	7.0	4.5	7.3	4.1	9.4	11.2	9.4	10.7	14.6	6.0	4.7	5.4	5.9	6.3	5.7	8.0	14.1	5.7	8.2	29.9	11.6	6.6	7.1	8.7	11.2	16.9	10.3	5.7	3.9	5.1	13.2	17.0	6.7	5.8	3.8	11.1	6.3	23.7	15.7	11.1	9.2	19.5	14.1	5.9	9.7	13.4	7.9	9.8	3.1	4.7	19.6	48.0	17.2	10.2	6.1	33.9	10.1	12.7	20.5	1.6	7.2	6.3	6.2	8.0	8.2	4.3	8.3	7.4	4.6	10.3	6.4	10.7	4.5	7.7	7.0	2.1	4.5	3.2	4.0	3.1	3.5	4.2	4.6	6.3	15.8	5.0	3.5	1.3	5.0	4.5	24.7	26.2	42.8	28.6	19.1	13.7	20.5	18.5	21.7	20.9	8.9	4.0	1.9	12.9	7.9	34.3	31.9	2.5	56.2	46.6	41.8	184.6	2.7	6.6	5.0	4.8	6.7	9.5	0.0	4.0	3.9	8.0	10.9	4.7	2.4	39.9	31.8	56.9	5.5	27.9	2.2	7.5	11.2	11.8	6.4	6.3	9.4	6.1	9.3	7.4	2.7	122.3	0.0	8.6	3.1	14.7	10.7	3.8	5.0	7.2	50.3
ABLIM3	KIAA0843	ENSG00000173210	"Actin binding LIM protein family member 3"	O94929	5	149141483-149260542	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 58.4"	"Cell type enhanced"	"Detected in many"	12	"Cardiomyocytes: 57.0;Hepatocytes: 97.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"neutrophil: 2.2"	"Lineage enhanced"	"Detected in single"		"granulocytes: 2.2"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 25.1;HHSteC: 25.7;HSkMC: 29.6;hTERT-HME1: 29.6;hTERT-RPE1: 24.8;TIME: 32.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003245	Approved		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA			"Nucleoplasm, Plasma membrane"	"Cell Junctions"	"HPA003245: AB_1078083"	"unprognostic (1.07e-1)"	"unprognostic (1.31e-1)"	"unprognostic (9.87e-2)"	"unprognostic (1.75e-1)"	"unprognostic (8.74e-2)"	"unprognostic (4.19e-2)"	"unprognostic (9.48e-3)"	"unprognostic (4.37e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.09e-2)"	"unprognostic (4.17e-3)"	"unprognostic (2.42e-1)"	"prognostic unfavorable (1.28e-4)"	"unprognostic (3.12e-2)"	"unprognostic (8.10e-2)"	"unprognostic (2.45e-3)"	"unprognostic (1.20e-1)"	45.9	6.0	7.9	3.5	9.8	1.2	35.0	29.7	12.5	9.1	4.7	11.6	7.0	2.9	4.9	8.9	15.6	5.8	6.1	58.4	8.5	10.2	17.0	48.1	9.1	4.8	9.9	5.9	2.6	2.4	39.3	3.1	26.1	14.3	6.5	4.7	7.7	3.0	9.9	24.3	3.5	3.7	8.7	14.0	5.0	2.7	2.3	3.3	0.1	4.2	8.9	4.5	8.8	14.6	0.0	0.6	2.2	0.3	0.0	0.0	6.8	7.2	1.5	0.0	0.0	13.1	25.1	0.0	5.1	14.3	2.9	5.1	0.0	5.1	0.0	0.8	6.4	15.6	0.1	0.0	5.9	5.8	0.0	0.0	0.0	0.3	0.1	25.7	0.0	0.0	29.6	1.6	10.5	29.6	24.8	13.1	0.0	0.0	2.3	17.0	2.8	0.0	0.0	0.0	0.4	20.1	0.0	0.0	0.0	16.4	5.0	2.0	0.0	1.0	0.3	2.7	0.4	0.4	0.0	32.8	6.2	1.4	6.4	8.6	0.0	0.0	0.0	10.8	0.0	17.6	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.6	0.0	6.8	7.9	9.8	29.7	12.5	8.5	10.2	9.9	5.9	14.3	3.3	0.0	3.0	4.7	1.0	1.3	1.1	57.0	28.1	4.0	1.2	0.0	0.0	0.1	5.0	6.8	1.8	20.2	0.0	0.0	3.0	0.6	2.1	2.2	1.1	97.0	9.3	27.0	0.0	20.3	11.9	0.0	0.3	0.8	5.0	0.0	0.0	19.7	14.9	0.0	0.7	18.3	21.8	0.0	2.3	1.7	2.3	1.4	0.3	0.0	0.0	4.9
AC004922.1		ENSG00000284292			7	99325879-99394653	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	25	"Club cells: 4.5;Exocrine glandular cells: 1.3;granulocytes: 1.1"									"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA004334	Uncertain		Approved	"Cell Junctions,Cytosol"		NA	NA			"Cell Junctions"	Cytosol	"HPA004334: AB_1078215"																		6.0	5.2	4.2	9.4	6.2	6.9	7.8	3.2	9.1	5.3	6.6	4.6	5.6	13.8	5.8	3.8	5.3	5.0	4.5	4.9	7.1		4.1	6.3	4.6	8.1	3.2	6.0	3.9	6.4	3.0	4.1	5.2	6.2	5.0	3.1	4.9	3.3	5.4	4.6	2.4	9.6	4.2	3.0	6.5	7.0	3.9	3.2	2.9	6.0	6.4	4.4	4.6	4.1	7.9	13.0	18.1	16.3	5.1	11.9	18.0	4.2	4.0	0.4	1.0	0.6	2.8	5.1	3.3	1.8	3.0	3.2	7.2	5.9	4.4	10.9	3.5	3.8	2.8	1.2	3.8	0.6	2.2	7.5	2.5	2.9	1.9	0.9	2.7	3.1	2.7	1.1	3.1	1.2	0.7	4.4	2.3	3.9	4.0	2.1	7.9	4.9	1.2	2.6	1.7	11.9	2.1	1.1	1.5	0.6	2.0	1.1	1.0	2.8	4.6	8.4	0.7	2.2	1.7	2.9	4.9	2.6	7.2	4.3	0.0	2.3	4.7	3.0	4.2	5.7	9.2	15.5	18.1	7.1	16.3	5.1	7.3	7.0	6.9	13.0	7.9	6.1	6.1	13.9	5.1	15.0	8.9	11.9	18.0											0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ACOT13	"HT012, THEM2"	ENSG00000112304	"Acyl-CoA thioesterase 13"	Q9NPJ3	6	24667035-24705065	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 41.7"	"Cell type enhanced"	"Detected in many"	12	"Early spermatids: 754.9;Proximal tubular cells: 372.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019881, HPA057134"	Enhanced		Approved	"Cell Junctions"		NA	NA			"Cell Junctions"		"HPA019881: AB_1857978, HPA057134: "	"unprognostic (3.61e-1)"	"unprognostic (1.62e-1)"	"unprognostic (6.02e-2)"	"unprognostic (1.80e-2)"	"unprognostic (9.57e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.71e-1)"	"prognostic favorable (2.53e-6)"	"unprognostic (3.67e-2)"	"unprognostic (1.64e-2)"	"unprognostic (7.16e-2)"	"unprognostic (5.97e-2)"	"unprognostic (4.86e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.13e-2)"	10.0	9.7	13.5	7.0	14.5	4.7	7.9	8.2	13.1	5.8	12.8	5.6	5.9	9.4	5.2	6.2	5.4	5.9	9.9	24.2	11.1	11.6	26.3	41.7	7.0	7.1	13.8	10.6	6.4	9.7	8.9	12.2	6.3	12.3	9.8	11.0	4.0	7.4	6.4	15.7	8.2	8.6	5.5	10.1	6.8	8.1	19.8	8.8	10.5	8.7	8.5	5.2	6.9	4.7	12.8	8.7	11.5	10.5	7.8	12.0	8.8	4.3	5.6	5.7	10.3	8.2	10.3	3.2	3.6	4.3	2.6	4.2	7.5	5.6	8.1	12.3	4.1	14.0	4.8	5.0	7.3	4.1	12.7	4.6	7.6	5.8	5.2	4.1	4.8	3.5	5.9	7.2	3.5	7.0	6.5	6.2	8.4	12.1	4.3	5.2	4.5	8.7	9.4	3.9	8.6	4.5	7.5	5.1	10.2	8.8	4.1	11.5	4.0	4.2	14.4	10.1	7.0	9.9	4.0	7.2	4.8	2.7	1.3	3.4	8.2	20.8	8.2	5.0	17.6	14.3	6.9	10.2	6.4	8.8	10.5	12.0	12.8	9.9	10.0	8.7	8.7	11.7	10.2	11.5	7.8	9.9	7.0	9.5	8.8	13.5	14.5	8.2	13.1	11.1	11.6	13.8	10.6	12.3	8.8	62.5	32.4	18.2	21.9	15.2	15.6	80.7	43.3	40.2	25.0	29.6	15.7	46.4	134.3	36.6	754.9	21.5	50.1	0.0	35.3	23.9	19.9	21.9	13.9	199.8	79.5	4.8	52.6	21.5	21.2	100.1	18.1	27.8	25.3	112.8	85.9	34.6	30.9	101.7	22.6	372.2	30.4	25.8	15.5	41.9	20.4	20.6	33.4	16.2	62.8	21.7
ADAM22	MDC2	ENSG00000008277	"ADAM metallopeptidase domain 22"	Q9P0K1	7	87934143-88202889	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	Receptor	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 46.9"	"Cell type enhanced"	"Detected in many"	14	"Bipolar cells: 30.7;Cone photoreceptor cells: 21.6;Horizontal cells: 14.3;Rod photoreceptor cells: 10.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 36.3;SH-SY5Y: 34.6;U-266/84: 13.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050325, CAB079064"		Supported	Approved	"Cell Junctions"	"Intracellular and membrane"	NA	NA		78000	"Cell Junctions"		"CAB079064: , HPA050325: AB_2681087"	"unprognostic (1.20e-2)"	"unprognostic (8.61e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.94e-2)"	"unprognostic (2.89e-2)"	"unprognostic (3.09e-1)"	"unprognostic (7.84e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.71e-3)"	"unprognostic (1.69e-1)"	"unprognostic (3.47e-2)"	"unprognostic (4.13e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.61e-4)"	"unprognostic (4.70e-2)"	2.9	11.7	10.9	1.5	15.7	1.5	2.1	46.9	36.4	8.6	2.3	6.2	1.6	1.3	6.3	11.2	1.6	3.7	3.7	3.0	14.0	10.6	5.5	0.8	2.0	2.9	8.8	14.4	5.6	1.8	4.5	3.7	0.9	17.0	14.5	2.3	2.9	1.5	7.1	3.3	1.8	1.9	5.0	8.2	2.9	1.4	2.7	5.7	2.8	4.5	0.0	1.9	2.1	2.9	0.4	1.2	1.9	0.0	0.5	1.6	0.1	1.1	0.3	2.1	2.6	0.6	0.1	1.6	0.0	0.2	0.1	0.2	2.2	3.6	3.2	0.9	0.0	1.5	0.0	3.0	0.0	0.0	8.7	4.0	2.4	2.3	0.6	0.0	2.9	0.0	0.3	0.0	0.0	0.1	2.8	0.2	3.5	0.1	36.3	0.1	2.8	3.7	0.6	5.1	0.2	1.1	2.2	8.4	4.6	0.0	1.7	11.6	34.6	1.8	0.0	0.3	1.7	1.5	0.3	0.0	2.2	1.5	0.4	1.5	8.4	13.9	2.5	1.8	6.1	3.1	1.9	0.0	0.0	1.0	0.0	0.1	0.4	0.3	1.0	0.0	0.3	1.6	1.2	0.2	0.5	0.0	1.2	0.0	0.1	10.9	15.7	46.9	21.8	14.0	10.6	8.8	14.4	17.0	5.7	0.0	1.3	0.0	1.8	0.5	30.7	2.9	0.0	1.4	1.2	1.8	21.6	0.3	1.7	0.0	5.9	0.7	0.0	0.0	0.0	0.1	1.0	0.3	0.0	0.0	0.1	14.3	1.2	0.0	0.0	1.1	2.3	0.0	1.7	0.0	0.8	1.4	0.0	1.5	2.5	0.8	10.6	0.0	0.9	0.5	1.1	0.4	0.0	0.5	1.0	0.1
ADGRL2	"KIAA0786, LEC1, LPHH1, LPHN2"	ENSG00000117114	"Adhesion G protein-coupled receptor L2"	O95490	1	81306160-81992436	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Bipolar cells: 51.9;Cardiomyocytes: 43.9;Hepatocytes: 33.8;Horizontal cells: 31.8;Ito cells: 40.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 63.8;hTEC/SVTERT24-B: 31.7;NTERA-2: 26.8;SH-SY5Y: 42.7;U-2197: 29.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043447			Approved	"Plasma membrane,Cell Junctions"		NA	NA		280000	"Plasma membrane, Cell Junctions"		"HPA043447: AB_2678486"	"unprognostic (2.54e-2)"	"unprognostic (6.29e-3)"	"unprognostic (2.57e-1)"	"prognostic unfavorable (1.33e-4)"	"unprognostic (3.22e-1)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (9.92e-4)"	"unprognostic (3.55e-2)"	"unprognostic (9.84e-2)"	"unprognostic (2.42e-1)"	"unprognostic (7.81e-2)"	"unprognostic (8.01e-2)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (3.00e-4)"	"unprognostic (2.76e-1)"	"unprognostic (3.38e-3)"	"unprognostic (1.41e-2)"	8.9	10.5	21.1	3.6	20.9	0.0	8.8	1.5	45.8	7.5	7.0	1.4	1.2	2.7	6.1	8.6	12.0	12.0	11.5	17.6	12.2	6.6	10.9	18.7	32.7	3.5	3.5	22.8	18.8	4.9	20.3	11.8	24.4	6.2	15.6	5.4	9.4	19.1	10.1	2.0	6.3	6.1	6.0	3.2	10.0	7.6	2.0	3.3	0.6	22.4	15.0	5.0	6.5	11.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	2.4	63.8	0.0	7.9	9.1	0.8	1.5	3.5	0.6	0.7	0.0	0.0	0.0	17.5	8.1	1.8	2.5	5.0	6.7	0.5	0.1	10.4	0.0	1.8	4.4	3.0	0.0	0.1	7.7	0.4	31.7	3.2	4.4	10.4	0.0	0.0	0.0	0.8	0.0	0.0	0.0	26.8	0.0	1.9	0.0	8.8	0.0	14.5	0.9	3.2	42.7	0.0	1.8	0.0	18.9	0.1	18.8	6.8	6.5	7.4	29.2	2.2	0.0	0.0	0.0	3.7	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.1	20.9	1.5	45.8	12.2	6.6	3.5	22.8	6.2	3.3	3.0	2.1	0.0	6.5	0.0	51.9	43.9	10.2	0.0	5.7	5.2	5.9	0.3	0.0	3.7	1.0	27.2	0.0	0.0	1.5	0.2	9.1	8.9	0.0	33.8	0.7	31.8	0.0	40.5	6.0	1.3	21.6	0.9	0.0	0.0	1.1	20.6	1.0	0.0	16.6	7.0	2.4	19.4	3.7	0.5	3.0	0.0	0.3	0.0	0.7	2.4
AFDN	"AF-6, AF6, MLLT4"	ENSG00000130396	"Afadin, adherens junction formation factor"	P55196	6	167826922-167972023	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Cell adhesion"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Alveolar cells type 1: 157.8;Alveolar cells type 2: 72.9;Ciliated cells: 85.6;Club cells: 75.1;Collecting duct cells: 90.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013496, HPA030212, HPA030213, HPA030214, HPA030215, HPA049868"	Approved		Enhanced	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA			"Plasma membrane, Cell Junctions"	Nucleoplasm	"CAB013496: , HPA030212: AB_10599291, HPA030213: AB_10601340, HPA030214: AB_10601005, HPA030215: AB_10601556, HPA049868: AB_2680924"	"prognostic unfavorable (7.43e-5)"	"unprognostic (2.66e-3)"	"unprognostic (2.07e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.13e-1)"	"unprognostic (9.06e-2)"	"unprognostic (4.12e-1)"	"unprognostic (3.12e-2)"	"unprognostic (4.12e-1)"	"unprognostic (1.09e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.73e-2)"	"unprognostic (5.56e-2)"	"unprognostic (5.43e-3)"	"unprognostic (1.59e-1)"	"unprognostic (4.72e-2)"	"unprognostic (5.68e-2)"	17.0	7.4	14.9	13.0	17.2	1.8	23.5	17.8	19.3	19.6	26.3	16.1	25.5	22.2	15.8	17.7	59.5	27.9	18.2	13.9	15.6	7.2	20.6	29.3	26.3	5.1	17.1	12.5	16.2	29.7	16.4	27.4	18.7	16.1	20.9	27.2	15.3	38.6	18.6	12.7	24.8	42.3	17.4	13.0	13.5	21.1	16.3	15.2	2.1	25.7	13.7	24.5	16.3	27.9	3.5	0.6	2.9	0.5	0.0	1.2	0.0	18.9	5.9	41.5	14.8	4.0	3.4	30.9	7.7	4.0	6.7	8.3	25.3	11.9	3.4	14.3	4.6	10.5	9.1	17.2	15.8	12.0	21.4	17.8	0.1	2.5	19.1	6.1	2.1	9.1	2.4	10.7	11.2	26.5	10.7	12.3	7.4	38.0	13.3	4.3	8.1	0.2	0.1	10.1	27.1	2.7	12.3	10.9	14.4	12.2	9.3	19.2	11.7	7.8	29.8	11.8	40.5	3.5	0.8	18.0	3.1	15.1	13.4	12.7	0.2	16.1	6.9	9.3	4.4	27.2	0.0	0.5	0.0	1.0	0.5	0.6	3.5	1.2	0.4	0.6	2.7	0.0	0.5	2.9	0.0	0.3	0.0	0.6	0.0	14.9	17.2	17.8	19.3	15.6	7.2	17.1	12.5	16.1	15.2	157.8	72.9	0.0	0.0	0.0	0.0	0.0	0.0	85.6	75.1	90.7	0.0	27.0	18.3	58.2	0.0	0.0	0.0	0.0	34.2	28.5	0.0	0.0	8.1	0.0	16.2	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	19.0	0.0	0.0	52.1	0.0	0.0	23.8	0.0	0.0	0.0	0.0	0.0	0.0	35.2	0.0	0.0	0.0
AGER	"RAGE, SCARJ1"	ENSG00000204305	"Advanced glycosylation end-product specific receptor"	Q15109	6	32180968-32184324	"Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Inflammatory response"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"lung: 178.6"	"Cell type enriched"	"Detected in many"	18	"Alveolar cells type 1: 2224.3"	"Cancer enhanced"	"Detected in all"		"lung cancer: 27.2"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HEK 293: 4.9;JURKAT: 8.1;MCF7: 4.2;RPTEC TERT1: 5.1;U-266/70: 6.1"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"CAB011682, HPA064436, HPA069474"	Enhanced		Approved	"Nucleoli fibrillar center,Plasma membrane,Cell Junctions"	"Secreted in other tissues"	NA	NA	5360000	140000	"Plasma membrane, Cell Junctions"	"Nucleoli fibrillar center"	"CAB011682: AB_2258049, HPA064436: AB_2685264, HPA069474: "	"unprognostic (9.37e-2)"	"unprognostic (3.70e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.55e-2)"	"unprognostic (1.59e-3)"	"unprognostic (4.36e-2)"	"unprognostic (1.00e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.27e-1)"	"prognostic favorable (3.41e-4)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (9.01e-7)"	"unprognostic (3.57e-1)"	"unprognostic (3.70e-2)"	"unprognostic (4.44e-2)"	"prognostic favorable (2.74e-6)"	0.2	0.3	0.2	0.3	0.2	0.2	0.2	0.9	0.2	0.3	0.3	0.2	0.2	0.2	0.3	0.6	0.4	0.4	0.2	0.2	0.2	0.0	0.5	0.2	178.6	0.2	0.2	0.2	0.5	0.3	0.1	0.7	0.4	0.4	0.5	0.3	0.2	0.2	0.2	0.3	0.2	0.2	0.2	0.2	1.0	0.2	0.2	0.2	0.2	22.6	0.2	0.2	0.2	0.3	0.7	0.7	1.0	0.3	0.1	0.5	0.1	0.2	0.2	0.0	0.6	0.2	1.9	2.7	0.1	0.2	0.1	0.2	0.1	0.4	0.2	2.1	0.5	0.0	2.2	0.2	1.1	0.3	0.4	4.9	1.3	0.1	0.0	0.0	0.6	2.2	0.3	0.3	0.1	0.2	0.3	0.3	8.1	0.0	0.8	0.2	4.2	0.3	1.5	0.0	0.2	0.0	0.1	0.2	0.3	5.1	0.1	0.1	0.5	0.1	0.0	1.9	0.1	1.2	0.1	0.2	0.0	1.5	1.5	0.1	6.1	3.2	2.2	2.2	0.5	0.5	0.0	0.3	0.0	0.5	0.0	0.1	0.0	0.3	0.2	0.0	0.7	0.4	0.3	1.0	0.1	0.2	0.7	0.0	0.1	0.2	0.2	0.9	0.2	0.2	0.0	0.2	0.2	0.4	0.2	2224.3	120.3	1.7	1.1	0.8	4.8	3.4	5.1	8.1	37.5	1.8	0.0	0.9	0.0	1.5	0.0	2.6	0.5	0.0	0.8	0.8	1.6	2.3	16.3	1.8	1.2	6.4	0.0	2.5	9.0	0.2	1.7	4.9	1.7	2.8	1.4	7.4	0.8	2.9	1.1	0.2	4.1	6.5	1.7	0.0	0.7	1.6	1.8	5.0	0.9	0.8
AL358113.1		ENSG00000285130			9	69035750-69255187	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	13	"Alveolar cells type 1: 3.0;Alveolar cells type 2: 2.9;Ciliated cells: 2.7;Club cells: 1.2"									"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	11	"dendritic cells: 1.3;monocytes: 2.8;T-cells: 2.6"	"Cell line enhanced"	"Detected in some"		"HaCaT: 2.9;HUVEC TERT2: 2.2;REH: 9.8;U-2 OS: 2.2"									"HPA001813, HPA068304, HPA070714"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA			"Nucleoplasm, Plasma membrane, Cell Junctions"		"HPA001813: AB_1080764, HPA068304: AB_2685970, HPA070714: AB_2732161"																		1.6	4.3	2.5	1.9	2.1	2.6	2.8	3.6	2.5	1.6	2.8	3.0	2.7	1.6	2.2	1.6	1.6	3.4	1.6	5.8	1.3		2.1	8.8	2.1	3.2	2.8	1.7	3.7	9.4	1.6	1.7	1.6	2.4	4.0	1.6	2.9	2.8	3.2	7.5	1.6	3.0	4.5	1.6	3.1	3.1	3.4	2.1	0.0	2.6	2.0	2.1	2.4	1.3	0.1	1.3	0.1	2.8	0.0	2.6	0.4	0.4	0.0	0.9	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	1.7	0.3	0.0	2.9	0.2	1.3	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.6	0.9	0.0	0.0	0.0	0.0	2.2	1.5	0.1	0.0	0.2	0.0	1.2	0.2	0.8	0.0	0.1	9.8	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.1	0.0	2.2	0.0	0.4	0.0	0.4	0.6	0.0	0.0	0.0	0.0	1.0	0.0	0.2	2.6	0.2	0.1	1.3	0.1	1.0	0.1	0.6	0.3	0.1	0.0	2.8	1.3	2.6	0.4											3.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	2.7	1.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
AL645922.1		ENSG00000244255			6	31927698-31952048	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enriched"	"Detected in many"	7	"liver: 115.5"	"Group enriched"	"Detected in some"	8	"Ciliated cells: 9.4;Club cells: 5.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 1.3;Hep G2: 1.6;Karpas-707: 2.4;U-266/84: 1.0"									"HPA000951, HPA001817, HPA001832"	Approved		Approved	"Endoplasmic reticulum,Vesicles,Cell Junctions"		NA	NA			"Endoplasmic reticulum, Vesicles"	"Cell Junctions"	"HPA000951: AB_2797216, HPA001817: AB_1078779, HPA001832: AB_1078778"							"unprognostic (7.68e-2)"							"unprognostic (1.86e-2)"				5.3	0.9	0.6	2.9	0.7	0.3	3.9	0.6	0.7	0.7	3.7	0.3	0.0	0.8	0.9	3.0	0.9	1.1	0.8	4.4	0.7	0.6	10.8	115.5	15.8	9.7	0.7	0.0	1.5	0.7	0.3	0.7	5.0	0.6	0.8	0.6	1.1	0.8	0.3	0.8	0.7	4.3	1.5	0.8	9.7	1.3	1.3	0.0	0.3	0.7	0.0	1.3	1.5	0.8	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.6	0.7	0.6	0.7	0.7	0.6	0.7	0.0	0.6	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AMOT	KIAA1071	ENSG00000126016	Angiomotin	Q4VCS5	X	112774503-112840815	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ductus deferens: 40.0;epididymis: 102.0"	"Cell type enhanced"	"Detected in many"	8	"Collecting duct cells: 27.9;Cytotrophoblasts: 35.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 15.6;HAP1: 16.7;OE19: 13.4;SuSa: 24.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA067290, HPA067853"	Enhanced		Supported	"Nucleoplasm,Cell Junctions"		NA	NA			"Cell Junctions"	Nucleoplasm	"HPA067290: AB_2685819, HPA067853: AB_2732773"	"unprognostic (1.08e-2)"	"unprognostic (5.51e-2)"	"unprognostic (2.38e-2)"	"unprognostic (3.36e-1)"	"unprognostic (3.20e-1)"	"unprognostic (8.95e-2)"	"unprognostic (3.82e-2)"	"prognostic favorable (3.94e-4)"	"unprognostic (4.46e-2)"	"unprognostic (3.79e-1)"	"unprognostic (2.17e-1)"	"unprognostic (5.60e-2)"	"prognostic favorable (4.21e-9)"	"unprognostic (9.54e-2)"	"unprognostic (2.59e-2)"	"unprognostic (4.50e-2)"	"unprognostic (6.44e-2)"	3.7	2.3	18.4	2.0	17.9	1.3	5.5	3.0	14.0	8.1	3.5	13.9	40.0	3.1	4.7	102.0	3.8	9.7	3.1	3.7	15.4	10.9	8.2	2.5	3.0	1.6	14.4	10.3	5.4	2.7	8.4	7.0	14.9	18.0	5.6	4.3	1.2	6.9	27.6	25.2	2.7	3.6	3.5	15.7	2.1	3.3	2.7	13.5	0.1	3.8	9.3	1.8	3.2	4.3	0.5	0.2	0.0	0.6	1.9	1.5	0.2	2.7	0.0	15.6	0.6	0.3	0.3	5.7	0.5	0.0	0.0	0.0	6.5	0.5	0.3	3.2	2.4	0.0	5.6	16.7	0.0	0.0	0.0	4.0	0.0	0.0	0.1	0.1	0.0	0.7	0.1	0.0	3.5	0.4	3.2	0.1	0.3	0.0	0.0	0.3	0.2	4.2	0.2	6.9	13.4	0.1	5.4	4.8	0.1	7.2	7.1	0.0	5.3	0.0	0.0	6.0	24.5	0.5	0.1	0.1	1.9	4.6	0.0	6.2	0.4	0.0	0.0	0.7	0.0	4.0	0.0	0.0	0.0	1.1	0.4	1.5	0.5	0.7	1.0	0.2	0.2	0.7	0.6	0.0	1.9	0.6	0.2	1.0	0.2	18.4	17.9	3.0	14.0	15.4	10.9	14.4	10.3	18.0	13.5	3.0	1.3	0.0	2.1	1.5	1.0	1.2	0.0	8.1	6.8	27.9	0.0	35.2	1.7	3.4	0.1	3.0	4.6	0.0	1.8	2.6	3.8	8.2	0.0	3.6	5.2	0.0	15.2	3.7	1.5	0.0	6.4	0.6	3.3	2.8	9.2	4.5	2.2	3.5	6.0	14.4	0.4	6.5	3.1	0.5	2.1	1.0	13.3	0.0	6.3	2.2
AMOTL1	JEAP	ENSG00000166025	"Angiomotin like 1"	Q8IY63	11	94706431-94876753	"Predicted intracellular proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 78.2"	"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 104.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 2.3;NK-cell: 2.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 36.6;WM-115: 35.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001196	Approved		Approved	"Cell Junctions,Cytosol"		NA	NA		11000	Cytosol	"Cell Junctions"	"HPA001196: AB_1078147"	"unprognostic (2.21e-1)"	"unprognostic (5.25e-2)"	"unprognostic (4.23e-2)"	"unprognostic (5.43e-2)"	"unprognostic (7.58e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.09e-1)"	"unprognostic (7.97e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.95e-2)"	"prognostic favorable (5.03e-6)"	"unprognostic (7.47e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.68e-2)"	"unprognostic (1.29e-2)"	14.4	5.7	3.3	6.9	4.0	0.6	9.2	3.7	4.8	12.8	15.4	2.7	9.1	2.2	16.4	11.4	19.3	7.5	10.9	10.1	3.1	3.9	4.4	4.8	10.0	2.5	3.2	2.5	7.3	10.8	13.5	13.9	25.4	3.5	18.7	4.0	11.3	8.9	13.6	78.2	11.7	4.8	32.8	2.6	6.2	8.1	7.1	1.8	12.9	8.6	21.9	10.1	24.4	9.5	2.3	1.0	0.0	0.7	2.3	0.1	0.5	18.3	5.2	14.0	0.0	15.1	13.2	6.7	10.2	17.8	4.7	5.5	9.6	0.5	0.8	5.0	13.8	3.8	23.9	6.6	36.6	4.9	1.4	5.1	9.9	5.4	0.0	3.5	2.1	0.0	7.8	22.7	16.0	26.8	12.1	9.7	3.9	24.9	0.9	11.0	5.3	6.7	1.3	2.1	0.0	3.5	0.0	25.5	1.5	6.6	7.7	10.7	12.9	0.6	14.1	3.6	9.9	0.7	3.1	8.9	12.9	9.5	0.2	7.0	0.5	0.0	5.2	3.6	0.0	35.0	0.0	0.6	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.6	2.3	0.0	0.0	0.0	2.3	0.2	1.0	0.0	0.5	3.3	4.0	3.7	3.0	3.1	3.9	3.2	2.5	3.5	1.8	32.8	28.3	0.9	15.3	31.5	1.9	39.3	7.6	5.3	13.6	7.0	3.9	25.5	0.0	14.1	104.0	28.1	0.0	0.0	14.6	12.7	38.7	10.8	2.3	15.3	4.3	14.3	0.0	28.8	4.3	25.4	7.5	4.7	10.1	1.8	0.0	15.0	12.1	0.0	11.7	2.9	1.1	12.9	26.7	17.0	12.7	23.5	23.3	1.5	0.0	6.4
AMOTL2	LCCP	ENSG00000114019	"Angiomotin like 2"	Q9Y2J4	3	134355874-134375479	"Predicted intracellular proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Suprabasal keratinocytes: 113.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 68.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063027			Approved	"Cell Junctions"		NA	NA			"Cell Junctions"		"HPA063027: AB_2684924"	"unprognostic (2.23e-1)"	"unprognostic (2.55e-2)"	"unprognostic (7.01e-3)"	"prognostic unfavorable (1.94e-4)"	"unprognostic (6.09e-2)"	"unprognostic (1.57e-2)"	"unprognostic (9.84e-2)"	"unprognostic (4.40e-2)"	"unprognostic (2.32e-1)"	"unprognostic (3.02e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.49e-1)"	"unprognostic (8.09e-2)"	"unprognostic (3.59e-1)"	"unprognostic (7.67e-2)"	"unprognostic (3.85e-1)"	"unprognostic (1.17e-2)"	49.4	9.5	9.2	8.8	22.6	0.6	29.0	6.1	19.3	25.7	13.5	47.7	7.9	6.9	24.2	10.2	19.4	19.1	18.2	14.0	13.1	7.6	21.4	10.4	20.4	8.5	25.5	15.1	12.6	21.3	11.1	3.4	27.6	16.6	21.0	4.9	20.3	13.8	14.8	11.5	19.8	8.2	27.8	17.7	15.9	12.6	7.6	28.1	0.1	18.6	15.9	8.6	15.1	31.8	0.0	0.0	0.2	0.0	0.0	0.2	0.0	25.4	10.9	7.8	8.3	8.0	10.5	68.8	25.8	15.1	25.0	12.3	34.3	7.7	0.0	33.8	17.6	13.2	19.5	5.0	6.9	10.2	0.0	0.5	0.0	6.0	3.5	16.2	0.0	0.0	14.7	21.8	9.3	10.1	9.0	11.6	0.2	0.2	0.0	15.4	8.0	0.0	0.0	10.0	5.3	4.4	0.0	10.4	0.1	14.9	5.9	1.2	3.2	20.9	24.6	17.3	17.5	23.4	0.2	19.6	16.4	14.5	10.9	15.9	0.0	0.0	0.0	5.9	0.0	17.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	9.2	22.6	6.1	19.3	13.1	7.6	25.5	15.1	16.6	28.1	56.6	15.9	0.0	14.9	64.8	9.5	13.0	58.6	10.7	5.7	17.4	17.7	17.7	14.9	22.7	3.6	24.3	7.3	0.0	11.3	28.9	30.5	20.3	1.1	21.5	2.6	1.6	12.0	54.6	1.6	8.0	33.1	3.3	13.5	0.0	3.9	10.0	35.7	3.5	18.7	15.1	4.1	12.9	23.6	0.3	0.4	113.8	20.7	0.0	3.7	21.4
ANKRA2		ENSG00000164331	"Ankyrin repeat family A member 2"	Q9H9E1	5	73552335-73565686	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003968, HPA065263"	Approved		Enhanced	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA			"Plasma membrane"	"Nucleoplasm, Cell Junctions"	"HPA003968: , HPA065263: AB_2685449"	"unprognostic (1.75e-1)"	"unprognostic (5.78e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.31e-1)"	"unprognostic (3.89e-2)"	"unprognostic (5.68e-2)"	"unprognostic (6.19e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.79e-1)"	"unprognostic (9.80e-3)"	"unprognostic (3.36e-1)"	"unprognostic (3.31e-1)"	"unprognostic (6.65e-2)"	"unprognostic (1.13e-3)"	13.0	19.4	11.9	9.2	17.1	18.7	20.9	22.8	18.3	15.7	13.5	16.6	13.1	15.0	20.0	21.0	13.3	18.5	15.0	12.2	18.1	15.8	9.6	15.9	20.7	13.9	20.6	12.3	23.3	19.7	11.4	30.2	15.4	23.1	19.8	16.4	17.5	19.0	14.3	14.5	13.4	15.3	17.8	30.7	13.0	16.2	10.3	15.8	18.1	22.2	4.5	14.7	14.9	13.3	10.7	5.9	16.9	7.4	7.0	15.5	7.3	5.1	3.9	5.8	6.1	10.6	16.2	17.7	7.1	10.6	6.2	9.3	1.2	8.0	4.8	5.7	7.0	7.0	3.7	2.7	12.6	8.9	10.1	4.8	4.2	3.0	5.5	8.3	2.5	8.3	16.7	17.1	7.4	7.7	11.6	6.9	6.4	4.1	8.1	7.1	3.1	4.3	6.5	3.1	1.9	2.9	2.6	6.2	6.6	4.8	6.4	7.8	6.1	5.4	4.3	8.4	9.3	6.5	4.2	8.6	2.5	3.0	4.0	5.1	16.0	11.5	4.1	6.2	4.1	7.2	16.9	5.7	11.3	8.7	4.6	10.5	10.7	10.2	12.1	4.9	8.4	15.5	14.2	9.0	7.0	7.4	5.9	11.7	7.3	11.9	17.1	22.8	18.3	18.1	15.8	20.6	12.3	23.1	15.8	3.0	8.6	26.7	25.9	14.1	25.6	7.7	35.7	16.0	12.5	17.4	9.8	22.6	23.2	10.6	0.9	12.1	16.1	23.3	14.6	18.8	13.1	25.9	18.5	19.5	9.2	22.3	23.2	16.0	16.2	1.7	30.2	11.1	11.8	12.6	19.4	15.6	14.7	18.4	27.3	14.0	21.5	25.8	14.4	23.0	15.1	10.8	40.8	18.1	16.2	31.3
APOC3		ENSG00000110245	"Apolipoprotein C3"	P02656	11	116829706-116833072	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism, Lipid transport, Transport"		"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"liver: 714.1"	"Cell type enriched"	"Detected in some"	60	"Hepatocytes: 64257.6"	"Cancer enriched"	"Detected in many"	643	"liver cancer: 4021.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	19	"CACO-2: 28.5;Hep G2: 77.0"					"Not detected"	"Not detected"			"HPA065365, HPA073918"	Supported		Approved	"Nucleoplasm,Nucleoli,Cell Junctions"	"Secreted to blood"	NA	NA	106000000000	97000000000	Nucleoplasm	"Nucleoli, Cell Junctions"	"HPA065365: AB_2732733, HPA073918: "							"prognostic favorable (3.77e-4)"				"unprognostic (2.33e-1)"		"prognostic unfavorable (6.87e-5)"	"unprognostic (1.60e-2)"	"unprognostic (5.21e-2)"			0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.1	38.7	0.1	0.1	31.7	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.0	0.4	714.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.0	91.3	0.1	0.1	0.3	0.0	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	28.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	77.0	0.0	2.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.7	0.9	0.0	0.0	0.3	1.0	1.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.2	0.1	0.0	0.0	100.1	0.0	0.0	0.0	0.0	858.6	0.0	0.0	0.0	0.0	0.0	3.3	0.0	3.8	0.0	0.0	1074.6	0.4	0.3	0.0	0.0	0.0	64257.6	1.0	0.0	0.0	825.6	1072.7	10.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	3.2	0.0	0.0
AQP4	MIWC	ENSG00000171885	"Aquaporin 4"	P55087	18	26852038-26865818	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 185.1;lung: 53.5"	"Cell type enriched"	"Detected in some"	4	"Alveolar cells type 1: 1024.3"	"Cancer enriched"	"Detected in some"	22	"glioma: 223.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 6.9;Karpas-707: 2.0;RPTEC TERT1: 3.9;SCLC-21H: 1.3;U-87 MG: 1.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005079, HPA014784, CAB058689"	Enhanced	Supported	Supported	"Plasma membrane,Cell Junctions"		NA	NA			"Plasma membrane"	"Cell Junctions"	"CAB005079: AB_2274338, CAB058689: AB_2665579, HPA014784: AB_1844967"	"unprognostic (7.23e-5)"	"unprognostic (1.55e-1)"		"unprognostic (3.19e-8)"	"unprognostic (3.68e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.34e-1)"	"unprognostic (5.38e-3)"	"unprognostic (1.64e-3)"	"unprognostic (8.98e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.10e-2)"		1.7	1.7	60.7	1.6	57.1	1.6	1.8	21.8	185.1	1.9	1.6	41.3	0.0	1.6	1.6	2.0	1.9	2.1	1.6	2.7	64.3	27.1	2.7	2.0	53.5	1.7	39.8	36.4	2.8	1.7	2.9	0.8	1.6	39.1	1.8	1.6	0.0	1.8	1.7	25.4	1.6	1.6	1.6	67.2	1.8	6.1	1.7	42.2	0.0	8.4	0.1	1.6	1.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.5	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.5	0.2	0.9	0.0	0.0	0.0	0.0	0.0	3.9	0.0	1.3	0.3	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.8	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	60.7	57.1	21.8	31.7	64.3	27.1	39.8	36.4	39.1	42.2	1024.3	245.1	0.0	0.6	0.0	2.1	8.5	0.0	37.5	138.8	3.5	5.9	0.0	3.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	3.5	0.5	0.0	1.6	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	224.7	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.6
ARHGAP21	"ARHGAP10, KIAA1424"	ENSG00000107863	"Rho GTPase activating protein 21"	Q5T5U3	10	24583609-24723668	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 54.8"	"Cell type enhanced"	"Detected in all"	7	"Muller glia cells: 217.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036610, HPA057861"	Approved		Supported	"Plasma membrane,Cell Junctions,Actin filaments"		NA	NA			"Cell Junctions, Actin filaments"	"Plasma membrane"	"HPA036610: AB_10669910, HPA057861: AB_2683546"	"unprognostic (7.65e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.88e-1)"	"unprognostic (5.84e-2)"	"unprognostic (2.69e-1)"	"unprognostic (3.59e-1)"	"unprognostic (1.12e-3)"	"unprognostic (5.35e-2)"	"unprognostic (9.75e-2)"	"unprognostic (3.34e-2)"	"unprognostic (2.65e-3)"	"unprognostic (3.23e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.32e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.61e-2)"	19.6	13.6	34.5	7.1	38.5	4.7	15.6	37.9	39.3	16.2	12.0	39.1	4.4	9.4	14.8	6.0	8.4	14.0	13.5	15.0	43.1	25.2	8.5	9.8	15.7	3.5	42.3	24.0	25.5	11.0	12.4	9.7	12.1	27.3	8.2	14.1	6.7	16.0	9.1	10.9	4.7	11.5	13.7	54.8	6.0	19.5	10.4	43.7	2.7	9.8	3.7	4.2	9.2	9.3	0.2	1.6	3.6	1.9	1.0	2.0	1.0	23.0	10.2	25.1	21.3	17.7	25.6	8.6	16.6	11.0	10.2	14.4	7.4	14.7	4.3	5.7	26.3	15.8	15.3	13.2	16.6	15.0	14.1	8.4	25.3	22.0	5.3	10.6	0.0	3.9	10.4	18.2	13.3	14.5	15.2	17.5	6.5	10.7	38.8	20.0	4.5	12.0	0.8	3.8	8.3	5.5	2.6	8.9	2.4	6.9	4.1	4.3	4.4	11.3	6.3	13.5	7.7	6.6	3.6	19.3	14.7	9.4	16.0	11.9	4.3	7.6	3.0	15.1	4.4	9.8	3.6	0.8	1.6	0.5	1.9	0.4	0.2	0.6	1.6	1.3	0.0	2.0	1.2	0.1	1.0	0.9	1.6	1.0	1.0	34.5	38.5	37.9	36.1	43.1	25.2	42.3	24.0	27.3	43.7	80.4	22.0	5.2	10.4	26.3	127.8	32.7	20.4	34.8	61.4	5.2	64.8	19.4	1.7	18.9	4.3	25.3	34.0	23.3	23.9	15.9	47.4	17.6	16.2	18.7	12.1	125.5	15.5	20.9	25.3	5.3	86.0	24.4	18.6	7.2	26.8	217.5	27.9	26.0	55.9	5.7	53.2	25.8	19.4	25.1	33.0	17.7	10.5	10.0	23.4	24.0
ARHGAP28	"FLJ10312, KIAA1314"	ENSG00000088756	"Rho GTPase activating protein 28"	Q9P2N2	18	6729718-6915716	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 39.4"	"Group enriched"	"Detected in many"	21	"Early spermatids: 446.0;Late spermatids: 371.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in some"	4	"neutrophil: 7.1"	"Lineage enriched"	"Detected in single"	11	"granulocytes: 7.1"	"Cell line enhanced"	"Detected in many"		"AF22: 22.0;CACO-2: 22.9;SuSa: 16.2;U-2 OS: 10.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA030413, HPA030414, HPA030415"	Enhanced		Supported	"Cell Junctions"		NA	NA			"Cell Junctions"		"HPA030413: AB_10601455, HPA030414: AB_10670042, HPA030415: AB_10669598"	"unprognostic (8.33e-2)"	"unprognostic (8.79e-3)"	"unprognostic (3.15e-3)"	"unprognostic (6.94e-5)"	"unprognostic (1.49e-1)"	"unprognostic (2.92e-2)"	"unprognostic (1.11e-3)"	"unprognostic (1.10e-1)"	"unprognostic (7.56e-3)"	"unprognostic (9.52e-4)"	"unprognostic (1.43e-2)"	"unprognostic (3.12e-1)"	"unprognostic (4.53e-3)"	"unprognostic (3.59e-3)"	"unprognostic (6.00e-2)"	"unprognostic (3.61e-2)"	"unprognostic (2.76e-2)"	8.6	1.9	0.9	4.4	0.9	0.3	12.7	0.8	1.0	13.5	5.1	0.1	2.8	1.0	5.7	8.5	1.3	2.1	7.3	4.2	0.9	1.0	6.9	0.7	9.3	2.8	0.8	0.5	9.9	7.4	4.9	1.3	16.1	0.6	9.1	1.3	3.9	1.7	4.2	16.0	2.2	3.4	4.3	1.5	21.5	1.5	39.4	0.0	3.5	5.0	4.2	0.4	4.8	3.9	0.6	0.6	7.1	0.5	0.4	0.3	0.1	0.1	0.1	22.0	2.1	4.3	7.5	3.7	1.8	3.8	1.6	3.6	22.9	0.1	0.1	0.7	0.2	1.1	0.9	0.0	0.5	2.7	0.6	1.2	0.0	1.8	0.1	0.7	0.1	0.1	9.4	0.4	1.9	0.1	0.2	5.1	0.3	0.6	1.8	2.5	0.3	0.3	0.2	6.9	0.2	1.1	0.1	1.5	0.1	0.0	1.8	2.2	9.2	0.1	1.8	0.3	16.2	0.1	0.0	0.7	0.3	10.3	7.3	0.2	0.1	0.0	0.1	3.5	0.2	0.7	1.5	0.5	0.7	0.3	0.2	0.2	0.2	0.2	0.3	0.1	0.6	0.2	0.3	7.1	0.4	0.1	0.6	0.1	0.1	0.9	0.9	0.8	1.0	0.9	1.0	0.8	0.5	0.6	0.0	0.0	3.4	0.0	1.0	1.6	1.3	1.4	0.0	0.0	1.2	1.8	19.6	10.8	0.0	0.5	446.0	4.1	0.0	0.0	2.4	2.1	6.6	5.1	0.0	0.0	1.8	0.0	0.0	3.1	0.3	371.7	17.0	0.2	0.0	0.0	0.0	0.1	1.1	0.0	13.4	2.7	0.8	0.0	1.4	9.3	2.5	1.3	5.5	0.0	0.0	1.2
ARHGAP9	"10C, MGC1295"	ENSG00000123329	"Rho GTPase activating protein 9"	Q9BRR9	12	57472255-57488814	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 76.9;bone marrow: 48.1;lymphoid tissue: 50.4"	"Cell type enhanced"	"Detected in many"	13	"Early spermatids: 56.4;Hofbauer cells: 36.3;Kupffer cells: 39.0;Macrophages: 34.2;T-cells: 110.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"neutrophil: 76.9"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 76.9"	"Cell line enhanced"	"Detected in some"		"HEL: 11.2;HMC-1: 50.1;THP-1: 14.4;U-937: 11.4"					"Low region specificity"	"Detected in some"			HPA078822			Approved	"Plasma membrane,Cell Junctions"		NA	NA			"Plasma membrane"	"Cell Junctions"	"HPA078822: "	"unprognostic (1.02e-2)"	"unprognostic (4.01e-3)"	"unprognostic (1.91e-2)"	"prognostic favorable (6.61e-5)"	"unprognostic (1.24e-1)"	"unprognostic (2.38e-3)"	"unprognostic (4.79e-2)"	"unprognostic (5.56e-3)"	"unprognostic (1.28e-2)"	"unprognostic (2.80e-1)"	"unprognostic (3.05e-2)"	"unprognostic (3.64e-1)"	"prognostic unfavorable (7.90e-9)"	"unprognostic (1.60e-1)"	"unprognostic (6.32e-2)"	"unprognostic (9.13e-2)"	"unprognostic (6.91e-2)"	5.1	2.5	5.1	33.0	8.0	48.1	4.4	3.7	4.8	1.8	5.4	2.5	0.5	3.6	1.6	1.7	2.7	4.4	4.8	2.4	4.2	1.8	3.5	3.8	11.2	24.1	8.1	0.6	1.2	2.2	0.3	1.5	2.3	5.8	2.5	5.1	2.4	6.0	1.3	0.9	1.4	18.6	2.6	8.5	50.4	3.9	8.8	6.4	19.0	2.6	3.2	28.5	4.7	2.2	8.9	18.9	76.9	17.0	13.1	13.3	11.8	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	5.9	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.3	0.0	11.2	0.0	0.0	0.4	6.5	50.1	0.3	0.0	0.0	0.1	0.0	0.0	5.9	0.2	3.3	0.0	0.0	8.9	8.9	0.4	0.0	0.0	3.7	4.3	1.8	0.0	0.0	1.6	1.4	0.0	0.0	0.1	0.2	0.0	14.4	0.3	0.0	0.1	0.0	0.0	4.0	2.7	5.4	0.1	11.4	0.2	8.4	16.6	45.1	9.0	17.0	6.2	7.1	9.9	8.1	13.9	8.9	13.3	9.6	76.9	13.1	12.8	18.9	12.1	11.8	5.1	8.0	3.7	4.8	4.2	1.8	8.1	0.6	5.8	6.4	0.0	23.5	22.6	0.0	1.3	0.0	1.2	0.0	4.0	2.3	0.0	2.0	0.3	0.0	0.0	56.4	1.8	0.0	0.0	0.0	0.4	1.3	0.2	11.5	1.1	36.3	0.0	0.0	4.3	39.0	28.4	1.7	34.2	0.0	10.0	0.0	0.0	0.2	0.0	0.0	0.3	0.7	0.0	0.5	28.8	8.5	1.3	0.2	110.8	0.1	0.1
ARL15	"ARFRP2, FLJ20051"	ENSG00000185305	"ADP ribosylation factor like GTPase 15"	Q9NXU5	5	53883945-54310582	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cytotrophoblasts: 46.4;Syncytiotrophoblasts: 35.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044604, HPA063820"	Uncertain		Approved	"Golgi apparatus,Plasma membrane,Cell Junctions"		NA	NA			"Golgi apparatus"	"Plasma membrane, Cell Junctions"	"HPA044604: AB_10960542, HPA063820: AB_2685131"	"unprognostic (2.18e-1)"	"unprognostic (4.32e-2)"	"unprognostic (1.82e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.70e-1)"	"unprognostic (8.52e-3)"	"unprognostic (1.16e-2)"	"unprognostic (3.05e-2)"	"unprognostic (6.56e-2)"	"unprognostic (4.26e-3)"	"unprognostic (3.86e-1)"	"unprognostic (2.48e-3)"	"unprognostic (1.35e-1)"	"unprognostic (9.15e-2)"	"unprognostic (5.60e-2)"	"unprognostic (1.08e-1)"	22.0	19.9	13.4	13.1	10.5	2.2	20.1	15.7	22.4	29.9	15.6	5.9	8.7	13.9	32.2	9.9	13.2	12.7	20.5	20.1	19.7	13.2	23.9	12.8	14.4	13.9	11.3	11.2	9.8	7.8	3.5	28.0	31.4	12.3	14.3	15.4	15.3	19.6	12.1	5.2	16.9	12.7	26.7	15.1	15.2	11.1	14.2	10.5	17.4	13.4	13.9	10.8	19.1	13.6	2.0	5.0	7.4	3.5	1.4	4.8	2.3	1.9	3.9	6.0	10.1	6.0	5.3	7.5	6.3	9.5	6.3	13.5	14.9	4.9	17.4	10.3	6.1	7.1	4.8	9.0	10.3	8.9	2.3	9.4	24.0	5.5	1.3	1.5	2.3	28.1	7.5	7.1	10.4	7.2	10.1	15.2	4.5	21.5	2.8	4.1	4.2	4.4	2.2	2.0	0.8	2.5	4.0	6.4	0.4	8.9	21.0	7.6	3.9	8.0	4.4	5.0	12.1	4.8	2.9	7.7	3.9	6.1	2.9	4.5	1.1	1.1	19.9	6.0	6.4	6.4	2.7	3.5	4.6	2.9	3.2	1.7	2.0	2.0	2.1	5.0	1.6	2.1	1.7	7.4	1.4	2.3	0.7	4.8	2.3	13.4	10.5	15.7	22.4	19.7	13.2	11.3	11.2	12.3	10.5	3.0	7.7	0.9	6.9	8.7	5.0	6.3	7.6	4.0	3.4	12.2	13.7	46.4	18.3	2.8	1.8	27.5	4.9	0.0	4.2	2.6	5.0	4.8	2.3	4.0	7.5	1.6	20.1	17.8	7.6	1.1	4.0	7.4	1.7	0.0	6.7	2.8	5.6	8.2	3.5	5.7	2.8	6.5	3.5	0.7	2.8	8.8	35.7	4.3	6.6	6.0
ARPC1A	"Arc40, SOP2Hs, SOP2L"	ENSG00000241685	"Actin related protein 2/3 complex subunit 1A"	Q92747	7	99325910-99366262	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA004334	Approved		Approved	"Cell Junctions,Cytosol"		NA	NA		2400000	"Cell Junctions"	Cytosol	"HPA004334: AB_1078215"	"unprognostic (1.31e-1)"	"unprognostic (1.58e-1)"	"unprognostic (6.22e-3)"	"unprognostic (1.93e-2)"	"unprognostic (8.38e-3)"	"unprognostic (1.95e-2)"	"prognostic unfavorable (4.70e-4)"	"unprognostic (2.52e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.73e-2)"	"unprognostic (3.89e-2)"	"unprognostic (7.88e-2)"	"unprognostic (4.45e-2)"	"unprognostic (9.15e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.83e-1)"	36.6	39.8	40.2	25.2	41.0	18.7	49.1	32.3	55.9	40.0	43.6	32.3	37.9	50.1	30.4	45.9	58.3	43.3	32.1	65.3	45.9	43.5	30.6	41.2	29.6	32.2	38.6	39.7	47.2	41.9	30.9	31.4	31.8	40.6	28.2	44.2	33.9	31.7	36.7	20.9	46.1	55.0	31.9	27.9	26.8	53.1	28.6	25.1	23.7	44.4	41.8	31.6	31.5	33.9	11.1	16.1	33.2	29.1	10.9	12.6	9.9	45.5	24.8	28.2	12.9	26.3	44.9	24.0	32.8	38.5	33.4	33.4	27.8	52.6	16.0	48.5	39.7	49.5	19.4	37.0	47.5	40.5	7.9	31.1	8.5	18.5	22.4	29.0	10.0	11.2	41.7	26.6	43.1	46.0	39.7	54.7	13.2	21.3	18.5	51.3	66.6	16.8	13.4	26.5	51.0	56.2	9.9	19.5	19.5	24.8	27.7	29.2	24.9	32.1	46.1	43.6	49.9	23.0	14.8	42.4	42.9	38.4	75.5	52.2	7.2	13.3	22.7	37.0	22.6	56.2	33.2	18.9	31.9	9.8	28.6	7.6	11.0	9.3	12.6	16.1	11.1	12.1	9.1	23.8	10.9	29.1	11.7	12.1	9.9	40.2	41.0	32.3	55.9	45.9	43.5	38.6	39.7	40.6	25.1	47.6	40.3	44.7	107.8	36.9	36.8	41.2	86.6	64.3	34.2	55.8	17.7	167.1	114.4	166.9	15.6	83.7	206.9	116.8	242.7	281.6	45.8	130.5	12.7	70.0	73.9	31.8	71.2	92.1	68.9	20.6	61.9	41.2	75.9	60.5	155.3	53.9	324.8	150.8	63.3	116.3	29.0	181.1	159.3	117.8	120.8	41.9	108.5	26.7	144.4	216.4
ARPC5	"ARC16, dJ127C7.3, p16-Arc"	ENSG00000162704	"Actin related protein 2/3 complex subunit 5"	O15511	1	183620846-183635757	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 154.0"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022013, HPA031972"	Approved		Approved	"Vesicles,Plasma membrane,Cell Junctions,Cytosol"		NA	NA		15000000	"Vesicles, Plasma membrane, Cell Junctions, Cytosol"		"HPA022013: AB_1845045, HPA031972: "	"unprognostic (3.82e-1)"	"unprognostic (8.78e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.36e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.85e-2)"	"prognostic unfavorable (3.63e-4)"	"unprognostic (5.90e-3)"	"unprognostic (3.84e-2)"	"unprognostic (3.17e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.29e-1)"	"prognostic unfavorable (1.21e-10)"	"unprognostic (3.03e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.48e-1)"	46.6	25.1	24.9	57.5	24.3	25.2	28.9	13.8	24.8	26.6	42.3	26.5	18.6	40.8	39.0	26.7	44.5	29.3	24.6	36.8	28.2	22.3	28.8	29.7	52.3	58.3	28.4	18.7	27.3	21.5	12.4	18.2	84.8	20.0	23.2	29.2	17.0	25.4	16.5	16.4	25.2	47.3	32.8	46.0	79.9	35.6	21.7	23.5	61.2	27.5	22.7	52.8	30.6	30.8	27.4	68.9	154.0	96.6	30.7	40.7	124.3	51.8	28.8	24.8	17.0	20.5	29.3	59.3	71.3	55.0	31.1	25.4	26.0	36.8	47.7	81.2	41.0	20.1	36.1	17.4	24.3	16.5	68.7	15.6	28.8	39.2	22.4	33.4	41.8	56.3	35.4	25.9	37.6	29.9	35.7	36.4	33.8	21.9	39.6	40.2	21.3	39.0	11.3	23.6	40.3	11.1	36.3	22.0	46.0	17.4	26.9	10.8	28.9	74.3	32.1	27.6	27.1	32.2	37.4	81.1	45.4	23.6	50.8	68.6	47.2	52.1	32.7	35.8	30.2	34.9	79.3	80.0	124.1	34.8	89.8	27.7	27.4	34.2	35.5	68.9	24.4	37.1	37.6	154.0	30.7	96.6	32.5	40.7	124.3	24.9	24.3	13.8	21.1	28.2	22.3	28.4	18.7	20.0	23.5	348.4	174.9	170.6	139.1	221.2	29.2	25.0	142.7	81.7	120.6	78.5	13.7	419.1	140.9	316.3	26.2	168.2	202.4	0.0	245.8	625.6	206.8	137.2	247.7	72.7	547.8	36.5	193.8	182.3	533.2	18.6	116.5	649.2	241.3	607.8	124.2	50.0	287.4	192.9	172.5	110.5	24.5	239.3	277.9	83.0	95.6	214.0	166.8	309.6	117.5	206.4
ARVCF		ENSG00000099889	"ARVCF, delta catenin family member"	O00192	22	19969896-20016808	"Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 30.8"	"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 21.6;Muller glia cells: 18.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"naive CD8 T-cell: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"K-562: 15.7;SCLC-21H: 15.0;SH-SY5Y: 11.5;U-2 OS: 13.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016162, HPA055264, HPA063675"	Enhanced		Enhanced	"Plasma membrane,Cell Junctions"		NA	NA			"Plasma membrane, Cell Junctions"		"CAB016162: AB_2058690, HPA055264: AB_2682766, HPA063675: AB_2685085"	"unprognostic (1.66e-1)"	"unprognostic (1.48e-2)"	"unprognostic (4.00e-2)"	"unprognostic (4.28e-2)"	"unprognostic (3.35e-1)"	"unprognostic (3.18e-2)"	"unprognostic (4.79e-3)"	"unprognostic (1.67e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.09e-3)"	"unprognostic (5.77e-2)"	"unprognostic (4.00e-3)"	"unprognostic (9.84e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.15e-1)"	"prognostic favorable (5.76e-6)"	3.4	6.6	9.0	1.8	6.1	6.0	3.2	30.8	11.1	3.4	3.2	7.7	3.5	2.7	4.2	14.6	3.1	2.6	8.0	6.2	8.1	8.1	5.0	4.9	3.9	1.4	3.8	6.8	2.9	8.7	4.9	7.3	2.7	5.9	6.1	1.1	6.4	8.7	4.6	13.4	5.3	3.7	3.6	4.0	13.4	5.2	5.2	2.8	0.5	12.1	1.6	1.5	2.8	1.8	0.0	0.6	0.0	0.2	0.7	1.2	0.8	3.3	0.3	4.5	5.9	0.0	0.0	4.7	0.8	0.3	0.2	0.5	0.9	0.7	1.4	3.7	0.4	0.4	3.1	0.7	1.4	0.0	0.4	5.6	0.4	0.3	3.5	1.3	0.5	1.1	0.1	0.6	0.2	0.2	0.3	3.7	1.0	15.7	0.4	0.0	3.0	0.2	2.1	4.6	1.0	1.8	8.3	0.2	0.4	0.8	0.7	15.0	11.5	0.9	1.4	2.2	0.8	1.2	0.4	1.3	0.1	13.1	0.5	0.3	1.8	0.5	0.4	0.2	0.2	0.2	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.4	1.2	0.0	0.7	0.0	0.6	0.0	0.8	9.0	6.1	30.8	8.9	8.1	8.1	3.8	6.8	5.9	2.8	3.0	1.6	0.0	2.6	1.8	8.5	5.0	5.1	1.4	0.0	1.8	21.6	3.8	0.0	7.0	2.1	1.6	1.2	0.0	4.6	1.7	1.9	4.2	0.0	3.2	1.2	4.8	8.6	4.3	1.0	1.3	3.7	0.9	3.3	0.0	6.2	18.8	9.7	0.0	3.2	5.0	7.6	0.0	3.1	2.2	9.2	1.6	3.7	0.0	1.8	0.9
ASGR1	CLEC4H1	ENSG00000141505	"Asialoglycoprotein receptor 1"	P07306	17	7173431-7179564	"Predicted intracellular proteins"	"Endocytosis, Host-virus interaction"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"liver: 171.0"	"Cell type enriched"	"Detected in many"	5	"Hepatocytes: 1020.7"	"Cancer enriched"	"Detected in many"	90	"liver cancer: 131.6"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	5	"classical monocyte: 39.1;intermediate monocyte: 17.9;myeloid DC: 13.7"	"Group enriched"	"Detected in many"	13	"dendritic cells: 13.7;monocytes: 39.1"	"Cell line enriched"	"Detected in some"	30	"Hep G2: 104.5"	"Region enriched"	"Detected in many"	9	"cerebellum: 49.4"	"Not detected"	"Not detected"			"HPA011954, HPA012852"	Enhanced		Supported	"Vesicles,Cell Junctions"	"Intracellular and membrane"	NA	NA			Vesicles	"Cell Junctions"	"HPA011954: AB_1845079, HPA012852: AB_1845080"	"unprognostic (3.56e-3)"	"unprognostic (3.57e-1)"	"unprognostic (8.76e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.86e-2)"	"unprognostic (5.37e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.39e-1)"	"unprognostic (8.55e-5)"	"unprognostic (1.55e-1)"	"unprognostic (8.33e-11)"	"unprognostic (1.45e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.73e-3)"	"unprognostic (4.46e-3)"	0.2	0.1	0.8	0.9	0.6	0.6	0.2	2.8	1.8	0.1	0.2	0.2	0.2	0.5	0.2	0.1	0.1	0.1	0.7	0.1	0.8	0.8	0.1	171.0	0.7	0.3	0.4	1.2	0.1	0.3	0.9	0.2	0.1	0.7	0.1	0.1	0.1	0.1	0.1	0.3	0.7	0.3	0.3	0.3	0.5	0.2	2.9	0.2	0.1	1.4	0.1	0.1	0.3	0.1	0.2	13.7	2.1	39.1	0.1	0.3	10.1	0.0	0.1	2.0	0.9	0.0	0.0	0.1	0.1	0.2	0.2	0.3	3.5	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.3	104.5	0.0	0.1	0.4	0.2	0.0	0.1	0.0	0.1	1.8	1.6	0.2	0.1	0.1	0.0	0.1	0.2	0.3	0.0	0.1	0.1	0.8	0.0	0.0	0.1	0.1	0.8	0.1	0.0	0.1	0.3	0.1	0.0	0.2	0.2	0.7	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	2.1	39.1	0.1	0.1	17.9	0.3	0.1	0.0	0.0	13.7	0.2	0.1	0.1	1.1	0.1	4.5	0.6	0.1	10.1	0.8	0.6	2.8	1.8	0.8	0.8	0.4	1.2	0.7	0.2	0.0	6.6	13.0	1.0	2.9	31.7	1.2	73.9	1.4	2.3	3.5	151.2	3.2	3.3	0.8	212.5	12.7	0.3	23.3	0.2	3.6	2.0	0.8	0.0	1020.7	41.3	14.3	15.0	23.9	110.6	80.2	2.3	18.3	0.0	0.0	0.7	2.6	0.4	0.6	1.1	1.6	39.8	0.0	0.4	4.5	7.8	4.3	10.4	0.7	1.0	2.4
ATP23	"KUB3, XRCC6BP1"	ENSG00000166896	"ATP23 metallopeptidase and ATP synthase assembly factor homolog"	Q9Y6H3	12	57941541-57957269	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 39.5"	"Cell type enhanced"	"Detected in many"	8	"Cytotrophoblasts: 11.7;Distal tubular cells: 14.9;Extravillous trophoblasts: 11.6;granulocytes: 10.5;Hofbauer cells: 9.7;Proximal tubular cells: 18.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 15.2;RH-30: 49.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035804, HPA043204"	Uncertain		Enhanced	"Vesicles,Plasma membrane,Cell Junctions,Cytosol"		NA	NA			"Vesicles, Plasma membrane"	"Cell Junctions, Cytosol"	"HPA035804: AB_10601026, HPA043204: AB_2678361"	"unprognostic (2.56e-1)"	"unprognostic (1.31e-2)"	"unprognostic (8.82e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.30e-2)"	"unprognostic (6.16e-2)"	"unprognostic (1.20e-1)"	"unprognostic (5.28e-2)"	"unprognostic (5.41e-3)"	"unprognostic (1.03e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (1.44e-5)"	"unprognostic (4.36e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.27e-1)"	6.7	4.9	4.3	5.2	5.3	11.3	4.8	6.1	4.8	5.6	8.2	1.3	2.5	3.9	3.2	4.2	7.3	3.1	2.4	6.4	4.2	3.6	5.4	6.2	2.7	6.8	2.7	3.8	4.2	5.8	3.2	3.0	3.5	2.9	5.1	8.2	2.3	3.4	3.3	11.7	5.6	4.3	6.5	3.4	3.7	3.8	39.5	2.0	20.8	4.7	5.9	4.7	6.3	6.2	3.0	4.5	12.0	4.5	2.6	5.6	3.0	2.0	1.5	1.9	2.2	2.8	2.7	1.0	1.9	2.0	2.2	2.1	1.2	2.5	6.9	2.5	1.5	2.2	1.9	1.8	2.0	3.8	3.5	1.8	4.5	1.3	2.0	1.2	9.1	3.1	1.4	1.5	1.3	0.6	2.2	1.5	5.0	4.7	5.0	1.8	3.1	4.9	15.2	1.7	3.4	3.7	3.2	49.9	2.9	1.8	2.6	1.2	1.8	3.1	2.9	1.6	0.9	5.0	8.6	0.8	1.7	2.9	2.2	1.9	4.1	2.1	3.6	1.8	9.8	2.7	7.6	4.5	12.0	3.5	2.4	2.6	3.0	4.0	3.3	4.5	3.0	4.3	4.0	1.9	2.6	4.2	2.1	5.6	3.0	4.3	5.3	6.1	4.8	4.2	3.6	2.7	3.8	2.9	2.0	0.0	8.6	0.0	0.0	0.0	0.0	0.0	0.0	1.4	3.4	3.5	0.0	11.7	14.9	5.1	0.0	0.0	0.0	0.0	9.4	11.6	0.0	0.0	10.5	0.0	9.7	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	1.8	0.0	0.0	4.0	0.0	0.0	18.5	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0
BORCS8-MEF2B	MEF2BNB-MEF2B	ENSG00000064489	"BORCS8-MEF2B readthrough"		19	19145567-19192158	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"	19	"Club cells: 1.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"PC-3: 11.1;U-266/70: 11.2"									HPA004734	Uncertain		Approved	"Nucleoplasm,Cell Junctions,Cytosol"		NA	NA			"Nucleoplasm, Cytosol"	"Cell Junctions"	"HPA004734: AB_10963939"	"unprognostic (2.74e-1)"	"unprognostic (5.77e-3)"	"unprognostic (8.67e-2)"	"unprognostic (3.88e-1)"	"unprognostic (1.46e-4)"	"unprognostic (1.88e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.66e-1)"	"unprognostic (7.20e-2)"	"unprognostic (6.23e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.33e-1)"	"unprognostic (7.78e-2)"	"unprognostic (5.29e-2)"	4.8	3.5	7.0	5.8	7.4	7.4	4.6	5.6	8.6	5.4	5.4	8.1	6.7	3.2	6.7	7.4	5.4	10.5	7.2	3.4	6.8	6.2	7.5	5.9	4.8	7.1	8.0	5.5	9.8	7.8	5.5	4.9	5.0	7.3	5.7	5.5	6.2	5.6	7.2	5.3	8.8	4.0	8.9	5.9	5.8	5.0	5.5	5.8	5.6	5.9	4.9	7.5	5.8	5.8	0.0	0.4	0.6	0.1	0.0	0.3	0.0	1.6	0.0	0.7	1.2	1.0	2.5	1.3	1.1	1.0	1.5	1.5	0.0	3.1	3.4	0.5	0.0	0.5	0.6	0.7	0.6	0.3	0.5	2.5	1.1	0.1	0.3	2.3	0.0	0.2	0.0	2.3	0.7	3.7	0.6	0.4	3.2	0.2	2.0	0.6	3.1	0.7	0.4	0.0	0.0	11.1	3.3	0.9	0.9	0.0	0.2	0.0	1.1	2.0	0.0	0.9	0.1	0.3	0.6	0.3	0.7	1.2	5.7	0.4	11.2	1.7	5.6	2.4	2.7	0.2	0.0	0.1	0.4	0.0	0.1	0.0	0.0	0.3	0.1	0.4	0.0	0.0	0.0	0.6	0.0	0.1	0.2	0.1	0.0	7.0	7.4	5.6	8.6	6.8	6.2	8.0	5.5	7.3	5.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0
BRK1	"C3orf10, HSPC300, MDS027"	ENSG00000254999	"BRICK1, SCAR/WAVE actin nucleating complex subunit"	Q8WUW1	3	10115592-10127190	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"Late spermatids: 1965.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA060391			Approved	"Nuclear speckles,Cell Junctions"		NA	NA		130000	"Nuclear speckles"	"Cell Junctions"	"HPA060391: AB_2684272"	"unprognostic (4.99e-2)"	"unprognostic (3.48e-2)"	"unprognostic (2.64e-1)"	"unprognostic (3.83e-2)"	"unprognostic (2.91e-1)"	"unprognostic (9.60e-2)"	"prognostic unfavorable (5.76e-5)"	"unprognostic (2.49e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.37e-1)"	"unprognostic (7.14e-3)"	"unprognostic (1.12e-1)"	"unprognostic (9.40e-2)"	"unprognostic (4.35e-2)"	"unprognostic (7.75e-3)"	67.1	47.6	53.4	40.4	57.1	52.4	62.9	33.4	69.5	52.8	58.6	36.1	47.3	37.9	63.2	68.3	73.0	59.4	70.8	54.4	42.6	45.3	66.8	57.3	49.3	53.2	43.3	53.6	62.7	57.8	38.8	39.2	44.4	40.7	60.8	51.8	41.5	84.2	53.1	62.7	57.0	46.5	74.3	37.2	47.0	57.2	65.2	34.2	50.2	83.3	62.4	64.8	63.0	61.0	67.4	89.7	76.1	75.4	47.2	61.0	89.1	30.6	36.8	39.2	20.4	65.7	71.8	93.0	45.7	45.6	42.9	42.7	25.2	36.1	35.4	21.8	52.5	37.7	16.1	28.2	46.3	47.1	39.0	39.0	48.8	42.5	37.6	37.4	46.4	37.0	47.1	44.8	48.0	35.0	56.6	59.9	29.9	31.6	41.5	64.7	67.4	30.0	37.2	45.2	43.7	46.7	29.1	40.4	38.4	56.4	50.9	15.2	26.5	36.7	32.1	36.9	40.8	52.1	40.7	54.0	43.3	33.1	50.5	40.6	23.9	64.1	79.8	62.6	63.8	35.5	54.1	75.4	75.9	56.5	72.4	50.3	67.4	55.0	53.1	84.3	67.4	50.1	54.4	76.1	47.2	70.9	89.7	61.0	89.1	53.4	57.1	33.4	69.5	42.6	45.3	43.3	53.6	40.7	34.2	59.6	65.2	192.9	249.1	234.3	35.8	112.3	242.0	80.3	80.8	193.7	19.6	217.7	417.8	328.3	849.5	294.2	166.8	93.5	317.6	231.0	237.3	296.5	172.8	204.5	385.0	44.5	286.9	207.5	335.1	1965.9	229.0	331.9	335.8	527.6	186.8	106.0	371.4	168.4	238.6	736.5	29.7	232.8	294.2	162.6	168.0	275.8	178.3	223.7	210.0	344.6
BRSK1	KIAA1811	ENSG00000160469	"BR serine/threonine kinase 1"	Q8TDC3	19	55282072-55312533	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, DNA damage, Neurogenesis"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 65.0"	"Cell type enhanced"	"Detected in many"	13	"Bipolar cells: 30.8;Enterocytes: 12.3;Horizontal cells: 36.5"	"Cancer enhanced"	"Detected in all"		"glioma: 12.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 26.2;SH-SY5Y: 23.6;WM-115: 21.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021212, HPA061719"	Enhanced		Supported	"Nucleoplasm,Cell Junctions"		NA	NA			Nucleoplasm	"Cell Junctions"	"HPA021212: AB_1845455, HPA061719: AB_2684593"	"unprognostic (1.42e-3)"	"unprognostic (2.92e-2)"	"unprognostic (1.20e-1)"	"unprognostic (6.69e-3)"	"unprognostic (2.71e-1)"	"unprognostic (4.21e-2)"	"unprognostic (3.06e-6)"	"unprognostic (4.24e-1)"	"unprognostic (2.06e-2)"	"unprognostic (3.04e-1)"	"prognostic favorable (1.02e-4)"	"unprognostic (3.00e-1)"	"prognostic unfavorable (7.98e-6)"	"unprognostic (1.16e-1)"	"unprognostic (6.61e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.09e-1)"	1.4	9.8	28.6	3.2	23.6	1.0	1.6	26.7	65.0	1.8	2.2	7.9	0.1	3.3	5.4	3.7	3.0	2.3	3.9	6.5	33.4	20.0	1.4	0.8	1.7	2.4	20.4	14.8	2.4	2.6	12.4	11.0	1.5	13.3	3.8	1.9	2.8	2.5	4.6	1.0	1.1	2.6	4.9	9.2	1.5	1.9	4.4	7.2	0.0	3.0	0.0	1.6	3.2	0.7	0.0	0.3	0.0	0.9	0.1	0.8	0.2	0.3	1.3	15.5	8.2	0.0	0.6	0.1	2.4	3.4	3.3	4.9	5.9	2.7	3.1	1.7	2.8	3.1	0.1	3.2	0.1	3.1	14.6	12.8	2.0	1.6	0.6	3.3	0.6	6.0	2.2	0.3	3.4	0.0	12.9	0.1	8.2	2.8	19.1	3.0	0.8	3.7	0.7	11.2	0.3	1.0	8.5	3.9	0.5	0.2	0.0	26.2	23.6	0.0	0.4	5.7	4.6	1.3	1.7	0.0	6.4	6.8	3.5	4.6	15.8	11.6	7.1	6.5	1.4	21.4	0.0	0.9	0.0	0.1	0.4	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.3	0.0	0.2	28.6	23.6	26.7	40.2	33.4	20.0	20.4	14.8	13.3	7.2	0.0	2.2	0.0	1.0	0.1	30.8	0.8	0.0	0.0	1.2	1.8	2.0	0.0	0.0	0.3	0.8	0.3	12.3	0.0	0.0	0.0	0.5	0.8	0.0	0.0	1.4	36.5	3.4	0.0	7.8	0.0	0.6	0.4	0.0	0.0	1.0	3.2	0.2	0.0	4.6	0.8	10.2	0.0	1.0	3.9	6.5	0.0	0.0	0.8	1.2	0.1
BUB1B-PAK6		ENSG00000259288	"BUB1B-PAK6 readthrough"		15	40217428-40276396	"Predicted intracellular proteins, RAS pathway related proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in single"		"brain: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA031124	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cell Junctions"		NA	NA			"Nucleoplasm, Nucleoli fibrillar center"	"Cell Junctions"	"HPA031124: AB_10601044"		"unprognostic (1.83e-1)"				"unprognostic (1.29e-3)"		"unprognostic (1.32e-1)"		"unprognostic (9.23e-2)"				"unprognostic (1.12e-1)"		"unprognostic (1.88e-1)"	"unprognostic (9.48e-2)"	0.0	0.0		0.0		0.0	0.0		1.5	0.0	0.0			0.0	0.6	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
BVES	"HBVES, POP1, POPDC1"	ENSG00000112276	"Blood vessel epicardial substance"	Q8NE79	6	105096822-105137174	"Disease related genes, Predicted membrane proteins"	"Cell adhesion"	"Developmental protein"	"Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 29.3;skeletal muscle: 37.1"	"Group enriched"	"Detected in some"	5	"Cardiomyocytes: 31.1;Early spermatids: 24.1;Late spermatids: 42.6;Sertoli cells: 12.9;Spermatocytes: 12.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"basophil: 2.9"	"Group enriched"	"Detected in many"	4	"dendritic cells: 1.2;granulocytes: 2.9"	"Cell line enhanced"	"Detected in many"		"RH-30: 18.7;WM-115: 18.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA014788, HPA018176"	Enhanced		Supported	"Plasma membrane,Cell Junctions"		Yes	NA			"Plasma membrane, Cell Junctions"		"HPA014788: AB_1845504, HPA018176: AB_1845503"	"unprognostic (2.91e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.73e-2)"	"unprognostic (5.46e-2)"	"unprognostic (3.66e-2)"	"unprognostic (5.21e-2)"	"unprognostic (2.22e-2)"	"unprognostic (8.37e-2)"	"unprognostic (4.49e-2)"	"unprognostic (2.29e-2)"	"unprognostic (8.92e-2)"	"unprognostic (5.84e-3)"	"unprognostic (3.77e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.02e-2)"	"unprognostic (3.24e-4)"	2.9	1.0	2.3	2.4	7.6	0.6	8.9	0.7	4.1	2.6	11.5	6.7	6.7	1.7	5.3	2.8	5.3	2.5	2.1	29.3	2.8	2.5	1.5	0.7	2.3	0.9	10.4	1.3	1.2	1.0	0.8	3.5	3.5	6.1	5.4	3.5	3.6	1.6	10.0	37.1	0.8	2.7	19.4	10.7	0.7	5.9	10.0	6.3	0.0	1.6	8.6	0.8	10.3	8.6	0.5	1.2	2.9	0.3	0.4	0.4	0.1	0.8	1.2	4.8	0.8	7.0	9.7	2.1	3.6	2.5	5.6	7.4	0.3	0.0	0.0	0.0	6.7	9.3	0.0	2.0	1.2	5.2	0.0	1.7	0.0	0.6	0.2	1.5	0.0	0.4	5.6	4.3	8.6	0.7	4.2	2.4	2.0	0.1	12.1	12.2	0.1	0.1	0.6	1.0	0.0	0.0	3.4	18.7	0.0	0.0	0.0	6.2	10.8	2.3	0.0	4.8	3.6	0.0	12.2	5.5	8.9	0.0	0.0	9.3	1.1	0.5	0.0	5.3	0.0	18.8	2.9	0.3	0.3	0.2	0.1	0.2	0.3	0.2	0.4	0.0	0.5	0.3	0.3	1.7	0.4	0.1	1.2	0.1	0.1	2.3	7.6	0.7	4.1	2.8	2.5	10.4	1.3	6.1	6.3	0.0	0.0	0.0	0.2	0.2	0.0	31.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.1	1.9	0.0	0.0	0.0	0.1	1.5	0.6	0.0	0.0	1.7	0.0	0.0	2.5	0.0	42.6	1.1	0.5	0.0	1.8	0.0	0.0	0.2	0.0	3.2	0.0	0.0	12.9	3.9	12.5	5.1	0.6	0.1	0.0	0.0	0.1
C11orf52	"FLJ25219, MGC14839"	ENSG00000149300	"Chromosome 11 open reading frame 52"	Q96A22	11	111918032-111926872	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	18	"Alveolar cells type 1: 6.0;Alveolar cells type 2: 3.2;Ciliated cells: 10.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 8.5;CAPAN-2: 11.1;Hep G2: 9.4;MCF7: 8.4;RPTEC TERT1: 13.7;SK-BR-3: 11.7;T-47d: 38.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA038387, HPA038388"	Uncertain		Enhanced	"Cell Junctions"		NA	NA			"Cell Junctions"		"HPA038387: AB_10670167, HPA038388: AB_2675987"	"unprognostic (1.30e-2)"	"unprognostic (1.13e-1)"	"unprognostic (5.84e-4)"	"unprognostic (1.48e-4)"	"unprognostic (2.57e-1)"	"unprognostic (8.04e-2)"	"unprognostic (6.77e-2)"	"unprognostic (2.07e-2)"		"unprognostic (2.26e-1)"	"unprognostic (2.77e-1)"	"unprognostic (3.80e-1)"	"unprognostic (5.38e-4)"	"unprognostic (1.44e-1)"		"unprognostic (1.84e-1)"	"unprognostic (3.03e-1)"	1.8	0.5	0.7	1.0	1.9	0.0	13.8	3.2	0.8	1.7	7.6	0.9	25.9	4.9	2.1	12.8	3.9	8.9	11.3	2.0	1.0	0.6	38.7	12.9	12.7	0.3	2.9	0.3	2.2	38.0	12.6	12.8	25.8	2.2	9.1	2.9	1.6	23.8	33.9	5.3	5.5	12.4	1.0	2.5	0.6	10.9	0.8	1.0	0.8	22.9	2.1	3.0	4.6	3.6	0.0	0.0	0.0	0.1	0.0	0.7	0.0	2.1	0.0	0.0	0.0	1.4	0.2	8.5	0.5	0.4	0.1	0.0	3.2	11.1	0.0	5.2	1.2	0.0	2.6	0.0	0.7	0.0	0.0	0.3	0.0	0.2	9.4	0.0	0.0	0.0	0.3	2.6	0.0	0.1	0.1	0.5	0.0	0.0	0.0	0.7	8.4	0.0	0.0	0.0	5.8	0.9	0.0	0.7	0.0	13.7	7.5	0.5	0.0	0.0	11.7	0.0	1.2	38.4	0.7	0.9	0.7	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.9	3.2	0.8	1.0	0.6	2.9	0.3	2.2	1.0	6.0	3.2	0.0	0.7	0.1	0.0	0.4	0.0	10.7	0.0	0.0	0.0	0.4	0.0	1.0	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.1	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.5	0.0	0.1	0.3	1.1	0.0	0.0	0.5
C17orf62	"FLJ90469, MGC4368"	ENSG00000178927	"Chromosome 17 open reading frame 62"	Q9BQA9	17	82442589-82450829	"Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Innate immunity"	Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"B-cells: 93.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045696	Uncertain		Approved	"Plasma membrane,Cell Junctions"		NA	NA			"Plasma membrane"	"Cell Junctions"	"HPA045696: AB_2679421"	"unprognostic (1.87e-2)"	"unprognostic (6.92e-3)"	"unprognostic (2.25e-1)"	"unprognostic (2.15e-3)"	"unprognostic (5.75e-2)"	"unprognostic (2.05e-3)"	"unprognostic (3.81e-3)"	"unprognostic (4.86e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.49e-3)"	"unprognostic (7.99e-2)"	"prognostic unfavorable (6.83e-11)"	"unprognostic (1.47e-1)"	"unprognostic (5.51e-2)"	"unprognostic (7.78e-2)"	"unprognostic (9.14e-3)"	19.9	17.3	16.8	35.8	25.2	16.4	20.0	8.6	20.4	16.2	16.2	20.8	10.5	12.1	16.5	13.1	17.1	16.0	22.9	12.1	15.2	12.1	17.5	29.1	20.2	48.3	26.8	12.4	17.6	21.3	12.9	15.7	14.9	20.6	19.5	13.6	12.2	14.7	12.7	6.5	13.9	21.1	20.2	19.0	53.7	16.4	8.3	20.9	26.0	13.8	8.2	42.3	29.2	13.3	30.6	33.0	74.9	44.2	24.2	25.9	34.6	14.2	20.9	11.5	19.0	18.2	19.2	11.2	12.9	15.7	19.0	22.7	7.8	14.5	36.4	11.9	18.3	23.9	14.5	7.9	9.7	13.1	25.9	6.4	9.9	6.9	9.0	18.9	11.1	29.2	22.1	14.1	16.3	9.2	18.4	24.6	28.2	8.3	27.3	16.0	15.9	46.1	9.3	8.7	19.8	11.2	35.2	6.9	27.9	14.0	18.2	9.9	18.7	23.3	27.2	16.6	21.7	28.0	44.7	8.4	14.8	14.5	24.3	13.7	49.9	16.6	26.7	19.4	18.1	13.1	43.8	34.1	44.0	25.9	44.2	20.0	30.2	23.9	25.0	31.4	30.6	20.2	19.6	74.9	24.2	39.6	33.0	24.8	34.6	16.8	25.2	8.6	20.4	15.2	12.1	26.8	12.4	20.6	20.9	29.8	24.8	93.2	8.2	9.8	16.7	0.0	17.8	9.4	13.6	0.0	9.8	23.8	0.0	0.0	1.1	17.6	29.5	23.3	0.0	27.8	22.4	13.1	32.4	21.3	69.8	25.4	24.9	19.0	53.5	1.5	24.7	43.5	18.6	0.0	20.3	22.1	0.0	28.1	17.0	0.0	12.0	0.0	11.4	10.4	7.3	7.8	23.1	58.6	15.2	7.1
C4orf19	FLJ11017	ENSG00000154274	"Chromosome 4 open reading frame 19"	Q8IY42	4	37453941-37623495	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 37.7;placenta: 38.3"	"Cell type enhanced"	"Detected in many"	6	"Enterocytes: 45.7;Exocrine glandular cells: 45.6;Pancreatic endocrine cells: 48.4;Paneth cells: 37.4;Syncytiotrophoblasts: 39.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"neutrophil: 11.4"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 11.4"	"Group enriched"	"Detected in some"	5	"OE19: 25.1;RT4: 32.3;SK-BR-3: 13.0;T-47d: 46.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043458, HPA052894"	Enhanced		Supported	"Cell Junctions"		No	No			"Cell Junctions"		"HPA043458: AB_10960696, HPA052894: AB_2681982"	"unprognostic (8.83e-2)"	"unprognostic (7.86e-2)"	"unprognostic (3.00e-3)"	"unprognostic (2.04e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.59e-3)"	"unprognostic (5.55e-2)"	"unprognostic (2.29e-1)"	"unprognostic (6.66e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.38e-2)"	"prognostic favorable (1.49e-11)"	"unprognostic (1.33e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.63e-3)"	"unprognostic (8.19e-3)"	2.0	0.5	2.6	1.5	2.7	1.6	2.2	2.8	5.4	6.5	14.6	2.5	2.3	10.3	4.2	1.9	2.1	1.7	7.4	0.7	4.4	1.7	11.9	26.2	2.8	0.0	3.1	2.5	0.6	37.7	5.8	6.1	38.3	6.2	1.9	14.0	1.9	22.2	9.8	0.6	1.7	11.0	2.3	3.8	0.6	12.4	1.5	2.2	0.0	1.3	1.0	3.3	5.9	2.9	0.9	2.2	11.4	2.1	1.2	1.2	0.3	0.0	0.0	1.3	0.1	0.0	0.0	1.7	0.3	0.0	0.0	0.0	5.2	2.0	0.0	1.3	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	3.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	5.6	0.0	0.0	0.2	25.1	0.7	0.0	3.2	0.0	5.1	32.3	0.4	0.1	0.2	13.0	0.4	1.7	46.3	0.2	0.2	0.1	1.9	0.0	0.6	0.0	0.0	0.2	0.0	2.6	2.2	0.9	2.1	2.5	0.8	0.3	0.5	0.3	0.5	0.5	0.3	0.9	0.8	1.2	11.4	1.2	0.2	2.2	0.9	0.3	2.6	2.7	2.8	5.4	4.4	1.7	3.1	2.5	6.2	2.2	0.0	13.0	1.3	4.9	0.2	0.2	0.2	22.9	6.7	0.0	10.4	0.0	5.1	10.0	18.9	1.0	0.1	45.7	0.0	45.6	4.6	0.2	5.3	0.0	11.5	0.6	0.0	9.2	0.0	0.0	1.3	0.0	0.0	3.3	1.0	28.4	4.3	48.4	37.4	0.0	7.9	1.0	0.0	0.1	0.1	0.0	0.0	39.7	0.0	28.5	13.7
C8orf37	"BBS21, CORD16, FLJ30600, RP64"	ENSG00000156172	"Chromosome 8 open reading frame 37"	Q96NL8	8	95244919-95269201	"Disease related genes, Predicted intracellular proteins"			"Bardet-Biedl syndrome, Ciliopathy, Cone-rod dystrophy, Disease mutation, Obesity, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024198	Approved		Approved	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA			Cytosol	"Plasma membrane, Cell Junctions"	"HPA024198: AB_1845775"	"unprognostic (7.90e-2)"	"unprognostic (1.98e-2)"	"unprognostic (5.68e-2)"	"prognostic unfavorable (4.63e-4)"	"unprognostic (2.72e-3)"	"unprognostic (4.20e-3)"	"unprognostic (2.04e-2)"	"unprognostic (8.94e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.76e-1)"	"unprognostic (6.11e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.09e-1)"	"unprognostic (6.72e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.33e-2)"	"unprognostic (3.29e-1)"	4.8	5.6	7.9	5.8	9.9	2.4	6.4	9.8	8.0	6.7	3.1	10.5	2.9	2.6	6.5	8.6	3.3	10.5	4.0	7.0	8.7	7.1	6.6	4.9	4.3	5.6	7.4	6.9	13.0	3.8	10.1	9.9	4.9	7.9	5.6	2.8	4.6	4.3	7.1	2.9	4.2	3.3	6.2	9.2	4.4	3.2	4.5	9.5	3.8	6.7	1.6	5.1	4.0	4.4	3.9	1.9	2.3	1.4	2.7	2.3	0.8	4.0	6.7	5.5	2.9	1.9	5.2	1.6	1.8	4.1	2.3	3.1	1.0	9.0	8.2	4.3	3.0	5.8	3.4	2.3	4.6	5.1	2.6	2.1	6.4	4.0	3.0	2.2	1.3	3.6	5.2	2.2	2.7	7.7	6.0	3.5	4.9	3.3	4.8	3.0	3.1	6.8	1.6	1.7	8.3	4.6	3.6	2.9	2.1	5.1	1.8	5.4	5.2	3.7	0.7	3.1	4.3	6.4	1.2	2.9	2.9	3.7	2.5	1.8	4.4	4.2	5.5	5.6	3.1	3.6	1.3	1.4	0.6	1.2	0.9	2.1	1.9	1.4	1.3	1.9	3.9	1.4	2.3	2.3	2.7	0.7	0.9	0.5	0.8	7.9	9.9	9.8	8.0	8.7	7.1	7.4	6.9	7.9	9.5	3.0	1.6	0.8	3.1	0.8	1.6	3.9	0.0	9.4	4.5	7.0	2.0	2.0	6.6	1.5	8.2	1.0	0.0	0.0	2.4	2.4	2.2	1.7	0.0	3.2	1.2	3.2	0.0	1.3	1.6	8.0	2.8	1.1	1.7	2.8	0.0	5.7	1.0	0.0	2.8	3.7	3.6	0.0	2.1	4.4	3.6	1.6	0.7	0.0	0.4	1.0
C9orf3	"AOPEP, AP-O, APO, C90RF3, FLJ14675"	ENSG00000148120	"Chromosome 9 open reading frame 3"	Q8N6M6	9	94726701-95087218	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Melanocytes: 187.3;Smooth muscle cells: 202.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A549: 20.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004633, HPA072729"	Approved		Approved	"Cell Junctions"		NA	NA			"Cell Junctions"		"HPA004633: AB_1078362, HPA072729: AB_2686553"	"unprognostic (4.25e-2)"	"unprognostic (1.07e-3)"	"unprognostic (6.29e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.75e-2)"	"unprognostic (9.59e-2)"	"unprognostic (4.24e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.80e-1)"	"prognostic favorable (6.33e-5)"	"unprognostic (2.31e-1)"	"unprognostic (2.56e-1)"	"unprognostic (3.29e-2)"	"unprognostic (3.37e-2)"	6.2	8.5	6.8	9.1	12.7	2.4	11.3	10.5	10.3	14.0	17.8	24.6	24.1	5.1	28.8	15.0	20.2	16.0	17.9	29.9	8.9	5.9	12.7	28.1	10.9	3.1	11.3	6.1	11.7	24.7	25.0	11.1	24.4	11.3	22.1	6.8	11.4	13.1	17.6	29.8	39.1	8.1	32.2	11.6	6.8	10.8	6.4	11.4	3.3	11.6	23.7	7.8	12.9	25.1	5.4	5.8	2.1	3.6	3.4	3.6	1.8	4.6	20.6	2.2	3.9	2.3	3.0	8.8	4.4	2.0	4.7	2.8	4.4	6.0	1.4	3.8	7.4	6.6	18.2	4.1	4.2	2.3	9.6	3.2	1.3	18.7	3.9	4.8	1.2	1.0	3.1	17.6	4.1	2.7	12.6	2.6	2.2	2.1	1.9	8.5	6.7	1.7	1.5	2.9	5.5	8.6	2.7	7.2	1.7	8.1	4.1	4.6	6.9	7.5	7.0	1.6	6.3	7.7	0.9	2.0	2.0	2.0	8.3	2.3	1.7	2.2	0.7	7.0	1.1	3.6	0.3	3.6	2.1	3.6	2.5	2.3	2.4	3.0	3.3	5.8	5.4	2.3	2.7	1.3	3.4	1.7	5.2	1.9	1.8	6.8	12.7	10.5	10.3	8.9	5.9	11.3	6.1	11.3	11.4	20.8	26.6	2.0	151.6	128.8	21.9	142.0	61.1	30.8	31.8	12.2	17.7	55.1	38.1	34.9	33.0	58.5	10.1	0.0	83.2	34.0	56.4	54.9	3.5	70.1	8.0	11.1	10.9	21.5	6.2	19.5	17.5	5.9	187.3	1.8	8.5	71.9	51.7	14.4	100.0	32.7	12.4	12.9	202.8	14.3	20.0	131.6	73.8	3.5	9.5	61.6
CABLES2	"C20orf150, dJ908M14.2, ik3-2"	ENSG00000149679	"Cdk5 and Abl enzyme substrate 2"	Q9BTV7	20	62388632-62407285	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Cell division"	Cyclin		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 34.9"	"Cell type enhanced"	"Detected in many"	10	"Early spermatids: 33.1;Late spermatids: 16.4;Spermatocytes: 16.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052138			Approved	"Nucleoplasm,Nuclear bodies,Cell Junctions"		NA	NA			"Nuclear bodies"	"Nucleoplasm, Cell Junctions"	"HPA052138: AB_2681743"	"unprognostic (1.08e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.25e-1)"	"prognostic unfavorable (5.26e-5)"	"unprognostic (1.45e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.71e-2)"	"unprognostic (5.07e-2)"	"unprognostic (5.37e-3)"	"unprognostic (6.05e-2)"	"unprognostic (1.40e-3)"	"unprognostic (3.09e-2)"	"prognostic unfavorable (1.24e-6)"	"unprognostic (1.99e-2)"	"unprognostic (3.87e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.94e-2)"	2.3	3.3	5.9	5.6	5.6	8.3	2.8	15.1	10.2	3.4	4.4	3.6	1.3	3.6	3.7	3.6	3.7	4.7	3.0	10.5	4.3	5.5	2.6	3.6	2.9	5.7	4.9	5.3	4.3	3.7	4.1	5.8	4.3	7.2	4.1	4.1	3.1	3.6	4.2	5.4	5.2	4.9	4.3	3.5	4.1	3.8	34.9	5.4	5.1	5.7	2.6	5.2	4.1	3.2	1.4	1.1	1.0	1.1	1.5	4.1	0.5	9.3	7.0	12.2	12.4	1.9	2.7	1.7	5.3	5.3	14.9	6.9	25.4	5.4	9.4	4.6	3.4	20.4	6.0	7.4	3.5	5.8	4.2	4.1	11.0	3.7	6.1	3.4	4.4	5.7	1.7	4.0	4.3	1.6	2.6	3.4	12.3	2.8	8.3	3.3	11.5	11.6	3.5	4.0	9.4	8.1	16.1	10.3	4.1	2.2	6.2	6.6	10.2	7.8	10.4	2.1	4.8	7.0	6.8	3.5	13.8	4.2	18.1	5.5	8.0	6.5	11.2	12.4	5.1	7.2	0.0	0.9	0.2	2.7	1.1	1.5	1.4	1.9	2.1	1.1	1.1	1.0	1.2	1.0	1.5	1.1	0.9	4.1	0.5	5.9	5.6	15.1	10.2	4.3	5.5	4.9	5.3	7.2	5.4	3.0	1.7	2.2	0.5	0.8	6.4	6.7	0.0	0.0	3.4	0.0	3.9	0.9	1.7	1.7	33.1	1.5	1.5	0.0	2.0	0.5	2.1	0.9	0.0	1.5	1.7	12.7	3.4	1.8	2.4	16.4	1.7	1.5	0.0	0.0	3.3	1.6	1.9	2.9	3.2	0.7	2.9	0.0	0.9	16.7	7.3	1.8	1.9	0.0	2.5	0.5
CADM1	"BL2, IGSF4, IGSF4A, Necl-2, NECL2, RA175, ST17, SYNCAM, SYNCAM1, TSLC1"	ENSG00000182985	"Cell adhesion molecule 1"	Q9BY67	11	115169218-115504957	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Cell adhesion, Differentiation, Host-virus interaction, Immunity, Spermatogenesis"	"Developmental protein"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	9	"Alveolar cells type 1: 431.7;Bipolar cells: 552.1;Cone photoreceptor cells: 329.9;Muller glia cells: 546.2;Rod photoreceptor cells: 707.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"gdT-cell: 10.6;myeloid DC: 10.2"	"Group enriched"	"Detected in many"	6	"dendritic cells: 10.2;T-cells: 10.6"	"Cell line enhanced"	"Detected in many"		"CACO-2: 69.8;WM-115: 45.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB037266	Enhanced		Supported	"Cell Junctions"		NA	NA		200000000	"Cell Junctions"		"CAB037266: AB_532287"	"unprognostic (1.50e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.92e-2)"	"prognostic favorable (1.32e-4)"	"unprognostic (4.11e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.75e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.67e-1)"	"unprognostic (6.61e-3)"	"unprognostic (9.22e-2)"	"unprognostic (2.92e-3)"	"unprognostic (1.77e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.67e-2)"	"unprognostic (5.40e-2)"	3.5	15.2	31.3	3.0	33.7	0.5	8.3	53.7	24.8	11.5	7.1	16.9	22.9	4.0	9.1	53.1	6.5	11.4	6.2	12.2	21.5	26.5	15.2	31.3	34.3	6.3	14.2	19.0	6.6	8.0	47.6	24.0	18.1	27.8	7.9	4.4	32.9	17.8	15.1	3.9	5.5	4.4	4.5	11.5	3.9	6.6	23.3	17.1	1.0	34.5	1.3	6.9	6.6	3.6	1.8	10.2	0.1	0.0	0.5	10.6	1.8	0.0	5.5	6.2	0.0	0.0	0.0	0.0	5.7	9.9	0.7	0.0	69.8	6.3	0.0	18.6	8.7	6.2	1.2	1.1	6.5	0.4	0.2	9.6	0.0	2.0	26.6	0.0	0.0	13.8	0.0	9.4	0.0	15.6	4.0	0.2	4.1	0.0	0.6	1.0	4.7	4.6	0.1	5.8	0.0	0.0	0.0	0.1	14.2	11.0	0.2	12.2	26.4	0.0	6.1	5.0	26.2	22.3	0.3	0.0	0.5	11.3	5.6	3.0	15.8	22.7	4.4	8.9	0.0	45.0	0.1	0.0	0.0	10.6	0.0	4.7	1.8	3.9	2.8	10.2	0.3	0.1	2.7	0.0	0.5	0.0	0.0	6.3	1.8	31.3	33.7	53.7	24.8	21.5	26.5	14.2	19.0	27.8	17.1	431.7	161.3	9.3	23.5	18.3	552.1	52.3	25.5	13.4	48.9	34.9	329.9	63.6	10.0	33.2	149.6	5.5	0.5	0.0	1.7	3.0	20.1	31.5	23.1	39.0	37.8	28.6	7.5	1.8	4.1	155.9	5.5	11.9	42.2	22.6	1.3	546.2	8.1	0.0	3.9	8.7	707.7	0.0	5.9	52.0	22.1	20.6	26.9	6.7	3.8	10.4
CAMK2A	"CAMKA, CaMKIINalpha, KIAA0968"	ENSG00000070808	"Calcium/calmodulin dependent protein kinase II alpha"	Q9UQM7	5	150219491-150290291	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	21	"brain: 105.7;skeletal muscle: 50.1"	"Cell type enhanced"	"Detected in some"	20	"Basal keratinocytes: 3.1;Cardiomyocytes: 11.0;Fibroblasts: 2.8;Melanocytes: 3.3"	"Cancer enriched"	"Detected in single"	13	"glioma: 6.0"	"Group enriched"	"Detected in all"	6	"amygdala: 60.7;basal ganglia: 50.6;cerebral cortex: 99.6;hippocampal formation: 74.6;olfactory region: 39.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 2.7;SCLC-21H: 9.6;SuSa: 2.6;U-87 MG: 8.1"	"Group enriched"	"Detected in all"	4	"amygdala: 1311.6;basal ganglia: 698.1;cerebral cortex: 1576.4;hippocampal formation: 1569.1"	"Low region specificity"	"Detected in all"			"CAB004330, HPA051783, HPA051785, HPA053973"	Supported		Approved	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA		21000	"Plasma membrane"	"Cell Junctions, Cytosol"	"CAB004330: AB_626788, HPA051783: AB_2681608, HPA051785: AB_2681609, HPA053973: AB_2682328"	"unprognostic (7.20e-3)"	"unprognostic (6.47e-3)"	"unprognostic (6.16e-3)"	"unprognostic (4.85e-2)"	"unprognostic (4.25e-2)"	"unprognostic (1.06e-3)"	"unprognostic (1.13e-1)"	"unprognostic (6.19e-3)"	"unprognostic (3.07e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.49e-2)"	"unprognostic (1.41e-2)"	"unprognostic (2.00e-8)"	"unprognostic (2.71e-4)"	"unprognostic (1.68e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.36e-3)"	1.3	1.7	60.7	1.3	50.6	1.3	1.1	1.4	105.7	1.8	1.3	3.7	0.0	1.2	2.1	1.4	1.9	1.7	1.3	3.7	74.6	10.5	1.6	1.2	1.5	1.2	5.1	39.8	1.3	1.1	1.1	0.4	1.3	2.4	1.6	1.3	0.0	1.2	1.4	50.1	1.6	1.3	2.5	1.7	1.2	1.3	1.2	2.3	0.0	1.2	0.0	1.1	1.4	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.5	0.0	0.0	0.6	0.0	0.5	1.3	0.8	0.7	0.0	0.1	0.0	0.2	0.6	0.1	2.7	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.2	0.5	0.2	1.7	0.0	1.1	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.2	0.0	0.0	9.6	0.0	0.1	0.2	0.3	2.6	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.2	0.1	0.0	8.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	60.7	50.6	1.4	99.6	74.6	10.5	5.1	39.8	2.4	2.3	0.0	0.0	0.0	0.0	3.1	0.1	11.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.3	0.0	0.0	0.4	0.8	0.0	0.0	1.1	0.0	0.2	1.3	0.2	0.0	0.0	0.0
CAMK2B	"CAM2, CAMK2, CAMKB"	ENSG00000058404	"Calcium/calmodulin dependent protein kinase II beta"	Q13554	7	44217150-44334577	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Actin-binding, Calmodulin-binding, Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 81.9;heart muscle: 39.2;skeletal muscle: 70.7"	"Cell type enriched"	"Detected in many"	11	"Bipolar cells: 838.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in some"	8	"SCLC-21H: 42.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006849, HPA026307, HPA051783, HPA051785, HPA053973"	Enhanced	Supported	Supported	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA		680000	"Plasma membrane"	"Cell Junctions, Cytosol"	"CAB006849: , HPA026307: AB_1845941, HPA051783: AB_2681608, HPA051785: AB_2681609, HPA053973: AB_2682328"	"unprognostic (1.88e-3)"	"unprognostic (4.49e-2)"	"unprognostic (3.55e-3)"	"unprognostic (1.36e-2)"	"unprognostic (5.25e-2)"	"unprognostic (2.90e-2)"	"unprognostic (8.78e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.60e-2)"	"unprognostic (5.23e-7)"	"unprognostic (7.04e-2)"	"unprognostic (2.34e-1)"	"unprognostic (3.15e-2)"	"unprognostic (3.95e-2)"	1.4	8.1	20.6	1.4	46.7	1.2	2.0	60.1	81.9	1.2	1.4	4.0	0.7	1.7	1.3	18.8	2.0	1.8	1.2	39.2	36.5	18.0	1.7	3.5	1.2	1.8	10.3	21.3	1.1	3.3	5.6	9.9	1.1	13.4	3.0	1.4	2.7	1.8	2.2	70.7	1.8	1.6	1.2	4.1	1.3	2.4	2.3	4.8	0.0	7.7	2.4	2.0	1.1	0.0	1.3	1.0	3.2	1.2	3.2	1.2	0.8	0.0	0.3	0.2	0.3	0.0	0.2	0.2	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.9	0.2	0.1	0.1	0.2	0.8	0.0	1.1	2.4	0.0	0.1	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.4	0.0	5.3	0.0	0.2	0.1	0.0	2.4	0.1	0.9	0.1	0.0	0.0	42.0	2.2	0.2	0.0	0.0	0.1	1.9	0.2	0.2	0.2	0.4	0.2	0.0	0.5	0.4	0.1	0.2	0.0	0.2	3.2	0.7	1.0	0.8	0.9	1.2	1.1	1.0	0.5	0.5	1.3	1.2	1.1	2.0	3.2	1.2	1.0	0.9	0.8	20.6	46.7	60.1	42.4	36.5	18.0	10.3	21.3	13.4	4.8	0.0	0.0	0.0	27.8	1.0	838.1	74.9	2.5	0.0	0.0	0.0	43.2	0.0	8.3	0.0	0.8	0.6	0.0	0.0	0.0	0.1	0.4	2.6	4.6	4.4	0.2	57.2	39.0	0.0	1.2	2.1	1.7	0.0	1.7	0.0	0.0	14.1	0.1	0.0	0.0	0.8	46.7	0.0	0.9	0.0	1.7	0.4	0.2	0.0	0.0	0.7
CAMK2D	CAMKD	ENSG00000145349	"Calcium/calmodulin dependent protein kinase II delta"	Q13557	4	113451032-113761927	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Cardiomyocytes: 243.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 67.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026281, HPA051783, HPA051785, HPA053973"	Approved		Approved	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA		140000	"Plasma membrane"	"Cell Junctions, Cytosol"	"HPA026281: AB_1845944, HPA051783: AB_2681608, HPA051785: AB_2681609, HPA053973: AB_2682328"	"unprognostic (2.14e-2)"	"unprognostic (3.17e-1)"	"unprognostic (2.13e-1)"	"unprognostic (7.49e-2)"	"unprognostic (2.19e-1)"	"unprognostic (5.09e-1)"	"unprognostic (4.26e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.62e-1)"	"unprognostic (7.81e-2)"	"unprognostic (7.91e-3)"	"unprognostic (2.62e-2)"	"unprognostic (1.46e-1)"	"unprognostic (9.68e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.90e-2)"	22.8	12.9	47.7	18.3	13.0	2.8	23.5	50.2	30.6	11.0	18.2	7.4	28.6	13.6	11.6	9.4	15.6	9.6	14.8	77.1	17.9	21.4	9.6	17.6	14.7	17.5	14.0	23.8	12.9	7.4	33.7	7.0	9.3	12.5	16.3	19.0	9.9	9.4	48.3	48.5	10.8	19.2	26.2	16.0	8.4	17.6	9.4	8.5	11.2	11.6	9.8	14.5	21.5	22.6	18.5	11.2	0.6	8.8	6.4	9.7	5.2	1.0	14.5	16.1	5.4	35.2	67.4	5.7	34.1	22.8	13.4	11.6	9.8	4.1	20.9	5.0	23.7	17.0	0.5	10.0	5.3	13.7	8.0	2.5	0.0	5.3	11.2	17.9	0.0	0.0	43.0	7.3	10.4	25.8	21.3	11.9	2.6	0.8	9.3	25.3	3.9	2.1	0.8	2.3	13.9	5.4	4.0	18.9	0.1	13.7	9.9	4.3	4.4	4.6	6.9	4.6	14.0	0.1	5.6	7.1	35.5	8.4	15.1	6.7	7.3	3.6	17.9	18.3	1.3	16.7	0.0	8.8	0.0	5.1	5.1	9.7	8.0	5.0	5.6	11.2	18.5	5.8	4.9	0.6	6.4	1.7	0.0	9.3	5.2	47.7	13.0	50.2	25.6	17.9	21.4	14.0	23.8	12.5	8.5	38.7	29.9	22.6	16.0	16.4	72.0	243.3	58.6	20.1	28.4	27.9	82.5	0.4	5.0	6.4	2.9	29.8	57.0	0.0	17.5	0.4	34.7	31.3	9.3	49.4	15.8	68.3	99.5	19.6	16.8	4.5	18.7	21.0	5.0	2.8	82.1	41.3	11.4	45.6	18.7	17.7	71.5	6.5	33.3	2.9	4.4	27.9	0.9	17.5	41.1	16.3
CAMK2G	CAMKG	ENSG00000148660	"Calcium/calmodulin dependent protein kinase II gamma"	Q13555	10	73812501-73874591	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Calmodulin-binding, Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 73.0"	"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 94.2;Cytotrophoblasts: 130.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Lineage enriched"	"Detected in all"	4	"granulocytes: 39.8"	"Cell line enhanced"	"Detected in all"		"PC-3: 46.3;SK-BR-3: 58.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040656, HPA051783, HPA051785, HPA053973"	Approved		Approved	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA		170000	"Plasma membrane"	"Cell Junctions, Cytosol"	"HPA040656: AB_2677065, HPA051783: AB_2681608, HPA051785: AB_2681609, HPA053973: AB_2682328"	"unprognostic (8.63e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.46e-3)"	"unprognostic (4.27e-2)"	"unprognostic (1.82e-2)"	"unprognostic (2.19e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.48e-1)"	"unprognostic (6.25e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.48e-1)"	"unprognostic (8.28e-2)"	"unprognostic (9.64e-2)"	"unprognostic (4.62e-2)"	9.1	8.8	27.4	9.4	20.7	17.4	6.8	22.2	53.8	9.0	37.3	13.3	9.7	19.7	20.1	9.1	20.6	13.2	10.6	6.7	22.8	24.4	11.6	5.9	10.7	8.9	26.8	31.2	6.4	5.7	8.0	6.0	15.8	38.6	18.5	15.5	8.5	12.4	29.8	73.0	9.1	18.1	29.6	29.8	11.0	14.2	3.8	13.4	4.4	6.4	7.6	8.7	26.5	10.8	4.2	7.1	39.8	5.6	9.8	9.2	5.0	11.1	8.0	7.3	13.9	5.3	8.7	8.6	7.6	13.2	10.6	8.7	12.5	12.0	8.2	8.1	9.8	4.1	17.4	5.7	6.5	8.4	7.5	6.8	5.6	6.2	5.6	2.6	7.6	9.5	4.6	5.9	10.5	7.3	16.3	9.0	10.6	6.1	12.4	5.8	7.8	12.7	11.4	5.3	6.8	46.3	11.6	7.6	4.3	5.5	16.2	3.8	8.8	4.4	58.3	3.7	5.6	10.9	4.8	11.0	7.9	12.7	4.2	10.3	3.8	4.5	7.7	8.4	21.9	2.8	8.5	5.6	39.8	7.5	2.3	9.2	4.2	8.4	8.0	7.1	3.9	8.1	7.9	36.4	9.8	4.0	2.4	8.1	5.0	27.4	20.7	22.2	53.8	22.8	24.4	26.8	31.2	38.6	13.4	14.9	9.4	11.5	7.6	8.4	55.8	6.1	15.3	6.7	9.1	7.0	94.2	130.5	11.6	10.6	1.9	18.0	50.5	0.0	17.2	36.6	11.5	7.3	16.1	7.8	22.8	25.4	23.0	12.3	13.6	2.3	11.8	10.5	11.8	5.4	20.0	16.3	16.9	51.8	17.7	27.0	74.1	45.3	50.6	0.5	10.6	11.0	67.9	22.4	26.2	10.7
CCDC107	MGC31967	ENSG00000159884	"Coiled-coil domain containing 107"	Q8WV48	9	35658290-35661511	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016857, HPA050442"			Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA			"Plasma membrane, Cell Junctions"	Nucleoplasm	"HPA016857: AB_10669751, HPA050442: AB_2681128"	"unprognostic (3.70e-3)"	"unprognostic (7.07e-3)"	"unprognostic (3.60e-2)"	"unprognostic (2.63e-2)"	"unprognostic (7.77e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.86e-1)"	"unprognostic (4.09e-2)"	"unprognostic (4.13e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.26e-1)"	"unprognostic (8.33e-2)"	"unprognostic (1.89e-1)"	"unprognostic (5.15e-1)"	"unprognostic (1.96e-1)"	"unprognostic (5.75e-2)"	42.1	23.4	11.1	15.4	10.3	5.4	50.3	17.2	12.9	17.5	35.2	8.5	18.1	15.0	24.9	28.6	22.4	18.2	31.5	31.3	10.2	11.0	13.0	15.0	14.0	14.1	9.7	7.9	15.3	80.2	7.6	10.5	10.8	8.4	22.8	13.7	11.5	14.6	24.5	29.3	9.6	16.0	44.8	9.7	13.5	24.2	9.2	8.8	19.3	14.0	8.8	10.9	38.9	24.1	20.7	32.5	7.6	11.0	16.4	46.9	18.3	7.9	7.2	6.0	7.5	30.2	19.4	3.5	13.4	12.2	8.6	8.1	3.3	2.4	5.2	6.0	17.6	22.3	2.6	4.4	6.5	6.4	15.3	7.1	2.4	10.9	8.1	7.1	3.7	9.5	11.4	7.7	9.2	7.2	16.1	6.0	8.8	3.2	10.0	10.8	5.1	4.2	5.6	4.4	5.7	22.2	6.1	1.4	4.1	28.6	4.3	3.9	6.5	6.9	9.7	6.6	4.7	5.1	4.7	7.5	13.9	7.7	10.0	12.2	4.5	6.6	10.3	25.6	6.0	12.1	7.6	10.6	5.1	36.1	11.0	46.9	20.7	31.7	31.4	11.8	20.1	15.5	21.3	2.1	16.4	6.4	32.5	35.2	18.3	11.1	10.3	17.2	12.9	10.2	11.0	9.7	7.9	8.4	8.8	62.5	23.5	48.4	32.4	62.4	31.1	0.6	61.1	25.4	15.9	78.5	7.9	12.3	14.9	64.0	5.7	40.2	115.3	0.0	122.5	55.2	43.7	39.9	34.5	68.4	86.5	30.2	84.6	43.0	48.7	20.1	55.0	66.1	108.0	39.7	73.5	46.8	82.6	80.7	96.2	54.7	32.0	116.4	97.8	27.9	59.2	58.5	11.6	95.8	40.0	23.7
CCDC170	"bA282P11.1, C6orf97, FLJ23305"	ENSG00000120262	"Coiled-coil domain containing 170"	Q8IYT3	6	151494030-151621193	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 19.4;fallopian tube: 33.0"	"Cell type enriched"	"Detected in many"	8	"Ciliated cells: 481.8"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"pons and medulla: 16.1"	"Cell type enhanced"	"Detected in many"		"eosinophil: 8.6"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"MCF7: 14.2;T-47d: 8.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA027114, HPA027185"	Enhanced		Approved	"Golgi apparatus,Cell Junctions"		NA	NA			"Golgi apparatus"	"Cell Junctions"	"HPA027114: AB_2732435, HPA027185: AB_2672151"	"unprognostic (7.46e-2)"	"unprognostic (3.54e-2)"	"unprognostic (6.93e-2)"	"prognostic favorable (3.64e-4)"	"unprognostic (2.13e-1)"	"unprognostic (8.79e-3)"	"unprognostic (2.74e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.18e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.40e-2)"	"unprognostic (3.93e-2)"	"unprognostic (2.17e-1)"	"unprognostic (5.21e-2)"	3.0	6.2	2.1	1.4	6.7	0.3	4.0	0.4	2.4	3.9	0.9	6.5	0.3	2.6	5.2	19.4	0.6	33.0	1.5	3.3	3.7	3.6	1.6	1.5	9.7	3.6	1.3	1.4	14.4	0.5	0.3	1.5	1.6	16.1	1.2	0.7	3.9	0.5	0.6	0.8	0.6	1.2	1.5	1.2	2.9	1.8	5.9	1.5	0.7	5.7	0.6	0.8	1.7	1.2	0.1	1.8	8.6	4.1	0.1	0.1	0.9	0.0	0.2	0.5	0.0	0.5	0.4	0.0	0.1	0.5	0.0	0.0	0.3	0.4	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.1	0.0	0.1	0.1	1.5	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.1	0.1	14.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.0	0.1	0.0	0.0	0.1	8.3	0.1	0.9	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.5	3.1	8.6	0.1	4.1	0.1	0.1	0.0	0.0	1.8	0.1	0.1	0.1	2.9	0.1	3.7	0.1	0.1	0.9	2.1	6.7	0.4	2.4	3.7	3.6	1.3	1.4	16.1	1.5	3.0	1.0	0.5	0.2	0.6	0.3	0.8	0.0	481.8	62.6	0.0	21.6	0.1	0.0	0.2	38.6	0.3	0.4	0.0	1.0	0.1	1.7	1.0	3.5	1.1	9.6	0.0	0.0	1.3	14.3	64.1	6.6	18.9	0.0	1.8	0.0	2.5	1.7	2.9	0.0	3.5	0.7	0.0	1.2	2.4	1.0	0.9	0.0	0.0	0.0	0.4
CCDC66	DKFZp686C0433	ENSG00000180376	"Coiled-coil domain containing 66"	A2RUB6	3	56557161-56621818	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Early spermatids: 158.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044185, HPA051937"	Approved		Supported	"Cell Junctions,Midbody ring,Centriolar satellite,Cytosol"		Yes	No			"Centriolar satellite"	"Cell Junctions, Midbody ring, Cytosol"	"HPA044185: AB_10965852, HPA051937: "	"unprognostic (2.28e-2)"	"unprognostic (7.74e-2)"	"unprognostic (7.37e-2)"	"unprognostic (2.90e-1)"	"unprognostic (5.28e-2)"	"unprognostic (1.72e-2)"	"unprognostic (7.26e-3)"	"unprognostic (1.68e-3)"	"unprognostic (2.05e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.05e-3)"	"unprognostic (5.48e-3)"	"unprognostic (6.85e-3)"	"unprognostic (1.81e-1)"	"unprognostic (6.57e-2)"	"unprognostic (3.24e-1)"	"unprognostic (6.81e-3)"	8.4	7.5	9.3	7.6	11.7	6.5	12.0	31.0	15.1	11.7	11.0	9.6	7.6	5.9	12.7	12.7	6.7	12.9	7.6	8.4	9.8	6.4	9.2	4.6	7.7	10.1	10.8	10.6	14.7	7.1	10.1	32.9	7.6	11.0	9.7	9.4	7.8	9.1	10.9	11.9	5.7	7.7	11.1	11.2	8.7	8.0	8.6	12.9	11.9	12.1	5.7	10.2	11.0	9.7	2.6	1.1	7.0	2.2	5.0	14.1	2.7	5.5	1.9	6.2	3.7	9.3	5.6	4.9	7.1	6.5	9.4	8.3	4.3	4.4	15.5	1.6	3.8	6.1	3.1	3.4	6.5	10.5	5.5	4.2	9.7	8.6	4.9	6.6	12.4	3.6	5.4	9.4	7.8	5.5	8.3	5.9	7.9	9.0	2.4	7.2	4.5	9.9	7.9	10.1	4.7	7.7	3.3	5.3	8.3	5.6	1.9	2.3	4.3	8.6	5.5	5.3	5.5	1.9	5.4	3.2	7.0	5.5	6.5	9.6	5.0	5.3	8.3	5.2	14.2	5.5	7.0	1.5	3.3	4.3	1.9	5.6	2.6	7.4	5.3	1.1	1.7	8.6	6.2	0.3	5.0	2.2	1.0	14.1	2.7	9.3	11.7	31.0	15.1	9.8	6.4	10.8	10.6	11.0	12.9	20.8	19.9	24.5	21.3	25.0	66.8	26.9	25.5	57.6	35.2	21.0	102.1	17.7	24.9	17.3	158.6	28.7	8.0	23.3	9.1	11.3	30.0	13.3	33.5	7.5	16.2	49.3	20.2	27.0	26.2	74.4	50.0	20.8	25.3	43.3	9.4	34.0	13.6	10.2	44.9	16.5	99.9	32.3	30.2	49.7	45.4	25.7	13.7	47.3	13.6	9.5
CCDC85C		ENSG00000205476	"Coiled-coil domain containing 85C"	A6NKD9	14	99500180-99604026	"Predicted intracellular proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Cone photoreceptor cells: 58.9;Rod photoreceptor cells: 47.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058346, HPA061922"	Uncertain		Approved	"Nucleoplasm,Nucleoli rim,Nuclear bodies,Mitotic chromosome,Cell Junctions"		Yes	No			"Nucleoli rim, Cell Junctions"	"Nucleoplasm, Nuclear bodies, Mitotic chromosome"	"HPA058346: AB_2683686, HPA061922: "	"unprognostic (7.17e-2)"	"unprognostic (2.23e-2)"	"unprognostic (3.64e-1)"	"prognostic unfavorable (1.44e-4)"	"unprognostic (5.70e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.68e-3)"	"unprognostic (4.80e-2)"	"unprognostic (1.45e-2)"	"unprognostic (8.75e-2)"	"unprognostic (3.30e-1)"	"unprognostic (1.68e-3)"	"prognostic favorable (2.60e-5)"	"unprognostic (4.14e-2)"	"unprognostic (1.95e-1)"	"unprognostic (8.74e-3)"	"unprognostic (9.81e-3)"	3.5	12.0	13.9	3.3	15.5	7.2	6.1	45.2	11.8	11.3	15.3	11.7	16.6	15.4	8.7	12.6	24.0	10.0	13.9	11.4	11.6	7.6	7.8	32.3	6.7	1.9	10.3	5.9	6.9	15.3	10.4	10.0	7.1	9.1	15.8	9.5	19.9	20.8	14.8	15.2	13.6	27.0	15.4	8.4	3.0	10.5	8.1	8.1	2.7	9.5	9.3	8.7	13.7	17.9	0.3	0.1	0.7	0.0	0.4	2.0	0.6	17.5	16.1	20.0	12.0	0.2	0.0	18.6	5.9	6.1	12.0	7.0	19.5	18.7	0.1	23.7	6.7	3.3	23.7	14.7	14.3	7.5	28.8	8.7	0.9	16.0	13.1	1.6	0.2	1.9	0.0	7.6	3.4	9.9	7.1	3.7	10.5	4.2	2.7	1.4	29.4	7.8	2.4	7.3	20.3	16.8	11.7	8.4	3.9	8.5	7.0	9.9	12.5	15.2	8.1	3.7	8.0	17.7	3.6	8.4	2.3	20.0	8.5	5.9	4.2	5.5	0.1	0.4	1.5	1.6	0.7	0.0	0.0	0.6	0.0	0.8	0.2	1.9	1.3	0.0	0.3	2.0	1.1	0.6	0.4	0.0	0.1	2.0	0.6	13.9	15.5	45.2	11.8	11.6	7.6	10.3	5.9	9.1	8.1	20.8	6.4	0.9	7.8	7.8	31.0	2.2	7.6	2.7	9.1	1.8	58.9	5.4	0.0	7.3	2.3	4.2	14.2	0.0	8.1	3.5	2.3	8.5	5.8	15.3	1.6	1.6	9.2	6.2	1.2	0.9	0.6	0.6	8.5	0.0	9.6	28.9	11.9	14.0	0.7	5.1	47.8	0.0	2.3	0.9	1.6	12.3	4.1	0.7	10.9	10.3
CD34		ENSG00000174059	"CD34 molecule"	P28906	1	207880972-207911402	"CD markers, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"Endothelial cells: 214.1;Ito cells: 81.0;Leydig cells: 135.4;Peritubular cells: 115.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"HUVEC TERT2: 32.6;MOLT-4: 32.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000018, HPA036722, HPA036723"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA		69000000	"Plasma membrane, Cell Junctions"	Nucleoplasm	"CAB000018: AB_2063006, HPA036722: AB_2675271, HPA036723: AB_2675272"	"unprognostic (3.82e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.24e-1)"	"prognostic favorable (5.93e-5)"	"unprognostic (1.25e-2)"	"unprognostic (7.74e-2)"	"unprognostic (7.65e-2)"	"unprognostic (3.53e-1)"	"unprognostic (1.37e-3)"	"unprognostic (6.95e-2)"	"prognostic unfavorable (8.47e-4)"	"unprognostic (1.51e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.01e-2)"	61.9	8.8	4.6	12.8	7.6	1.9	37.5	3.1	6.7	38.3	15.9	5.2	20.5	5.0	41.4	40.3	33.8	22.3	20.6	51.2	5.4	4.9	18.8	2.2	25.0	11.9	8.1	6.7	20.7	8.6	7.8	3.6	78.9	6.3	21.0	7.4	12.8	12.4	20.5	39.7	21.2	12.1	42.3	4.7	9.2	11.3	23.1	4.7	3.5	25.8	35.9	11.0	33.6	33.1	0.6	1.7	1.6	0.3	0.6	0.5	1.5	0.0	0.0	0.1	0.0	1.6	0.1	0.1	0.2	1.2	0.3	0.9	0.0	0.0	0.0	3.2	0.3	0.1	0.0	0.0	0.0	0.3	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.4	32.6	0.5	0.0	0.0	0.8	0.0	32.1	0.1	0.2	0.0	0.0	0.0	1.9	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.0	0.2	1.1	0.0	4.9	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	1.6	0.2	0.3	0.5	0.2	0.5	0.3	0.3	0.2	0.2	0.6	0.3	0.3	1.1	0.6	0.3	1.7	0.2	1.5	4.6	7.6	3.1	6.7	5.4	4.9	8.1	6.7	6.3	4.7	3.0	8.5	0.0	0.1	14.8	0.4	12.3	2.5	0.0	0.0	3.5	2.0	0.2	0.0	0.2	10.9	214.1	0.0	0.0	0.2	0.3	22.6	0.2	1.1	0.5	0.3	0.0	0.0	81.0	0.3	4.2	135.4	2.2	16.9	0.0	0.0	0.3	0.2	0.0	115.6	0.0	0.0	6.5	4.1	0.7	0.5	11.3	0.1	0.0	0.0	0.3
CDC42SE1	"SCIP1, SPEC1"	ENSG00000197622	"CDC42 small effector 1"	Q9NRR8	1	151050971-151070325	"Predicted intracellular proteins"	"Cell shape, Phagocytosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 102.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027634	Approved		Supported	"Cell Junctions"		NA	NA			"Cell Junctions"		"HPA027634: AB_10600861"	"unprognostic (1.59e-2)"	"unprognostic (5.76e-2)"	"unprognostic (8.93e-3)"	"unprognostic (4.61e-3)"	"unprognostic (1.63e-1)"	"unprognostic (5.76e-2)"	"unprognostic (2.85e-2)"	"unprognostic (1.71e-1)"	"unprognostic (6.96e-3)"	"unprognostic (2.19e-1)"	"unprognostic (2.59e-2)"	"unprognostic (3.04e-1)"	"prognostic unfavorable (2.19e-6)"	"unprognostic (9.94e-2)"	"unprognostic (4.89e-2)"	"unprognostic (2.86e-3)"	"unprognostic (4.12e-2)"	26.8	21.7	15.7	33.8	21.6	39.2	22.1	13.8	19.7	18.7	17.5	23.9	25.0	11.4	18.5	20.1	45.2	20.2	25.0	21.5	15.8	13.9	21.2	15.9	34.0	42.6	30.0	14.8	22.2	18.1	45.5	19.1	46.6	21.5	27.1	20.0	14.7	33.5	32.1	12.0	27.4	27.5	21.4	21.6	60.3	21.3	6.0	23.3	29.3	23.3	27.7	47.7	24.5	29.2	10.0	11.7	74.8	16.1	17.7	24.2	6.2	13.3	6.4	11.0	6.9	8.6	8.3	16.8	10.2	10.6	11.7	10.0	6.1	14.3	9.7	8.2	11.3	6.2	16.7	11.6	17.8	10.2	15.2	6.2	15.6	6.6	2.9	11.5	13.8	25.1	9.3	28.7	14.6	11.4	16.5	14.5	9.8	24.5	22.8	13.0	19.9	10.0	10.0	12.3	12.3	6.9	8.9	9.3	10.8	14.7	21.4	4.7	11.2	8.7	18.9	17.8	18.1	21.0	24.9	13.7	11.4	8.4	8.7	18.4	15.0	11.9	102.2	8.2	10.5	25.1	20.7	9.0	44.1	19.1	16.1	15.2	9.4	16.4	17.2	11.7	10.0	13.8	16.9	74.8	17.7	15.6	4.4	24.2	6.2	15.7	21.6	13.8	19.7	15.8	13.9	30.0	14.8	21.5	23.3	35.7	61.2	84.9	51.4	58.7	26.6	7.3	22.9	21.4	43.3	52.4	23.6	47.7	18.3	37.4	77.5	39.4	18.7	23.3	32.4	57.4	43.5	39.5	70.4	28.7	65.9	25.4	33.9	65.7	136.0	13.8	10.6	97.0	52.3	161.5	27.8	19.2	50.5	35.1	22.6	17.2	21.8	32.3	46.7	10.8	16.6	81.9	96.0	121.6	15.0	70.6
CDH1	"CD324, UVO, uvomorulin"	ENSG00000039068	"Cadherin 1"	P12830	16	68737225-68835548	"Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"Cancer-related genes, Disease mutation, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 125.5"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	12	"myeloid DC: 2.8;plasmacytoid DC: 8.5"	"Lineage enriched"	"Detected in single"	18	"dendritic cells: 8.5"	"Cell line enhanced"	"Detected in some"		"BEWO: 107.1;CACO-2: 36.0;CAPAN-2: 50.3;HaCaT: 48.6;hTCEpi: 34.3;MCF7: 29.7;OE19: 31.7;RT4: 37.0;T-47d: 32.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB000087, HPA004812, CAB028364, CAB072855, CAB072856, CAB072857"	Enhanced		Supported	"Golgi apparatus,Plasma membrane,Cell Junctions"		NA	NA		22000000	"Plasma membrane, Cell Junctions"	"Golgi apparatus"	"CAB000087: AB_2533003, CAB028364: AB_2076812, CAB072855: AB_2665698, CAB072856: AB_2665699, CAB072857: AB_2665700, HPA004812: AB_1078369"	"unprognostic (3.95e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.12e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.78e-1)"	"unprognostic (5.04e-3)"	"unprognostic (1.63e-1)"	"unprognostic (5.47e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.19e-2)"	"unprognostic (3.61e-1)"	"prognostic favorable (2.06e-4)"	"unprognostic (1.21e-1)"	"unprognostic (2.62e-1)"	"unprognostic (2.51e-1)"	"unprognostic (5.92e-2)"	1.1	0.7	1.3	14.8	1.5	0.5	15.3	0.8	1.1	14.4	63.8	1.8	42.4	25.5	4.7	18.6	48.5	9.7	48.9	0.8	1.5	1.0	24.2	64.9	24.4	0.5	1.8	0.9	5.6	71.5	62.2	13.2	55.2	2.8	28.9	25.9	11.8	66.6	43.7	0.8	30.5	125.5	1.5	1.1	3.5	21.6	2.1	1.8	11.7	83.0	26.2	32.6	16.8	21.7	0.0	8.5	0.0	0.0	0.3	0.4	0.1	21.6	2.2	0.0	0.0	0.0	0.0	107.1	0.0	0.0	0.0	0.0	36.0	50.3	0.0	0.4	0.0	0.0	48.6	0.0	24.1	0.0	4.2	0.6	0.0	0.1	7.7	0.0	0.0	0.2	0.0	34.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.7	0.0	0.1	0.8	31.7	0.1	0.0	0.0	0.3	8.8	37.0	1.3	0.1	0.2	0.0	9.1	15.2	32.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	2.8	0.0	0.0	0.0	0.0	0.3	0.0	8.5	0.1	0.1	1.3	1.5	0.8	1.1	1.5	1.0	1.8	0.9	2.8	1.8	122.1	58.7	0.9	101.9	83.6	0.0	0.8	152.8	73.6	64.8	155.3	0.0	97.3	1.7	107.7	0.0	1.2	202.1	0.0	98.3	22.3	4.1	170.0	1.1	44.7	10.1	0.0	83.2	0.6	1.5	0.0	0.3	6.3	50.6	5.4	180.9	0.0	193.9	160.9	0.4	3.3	0.0	0.0	4.7	0.0	0.1	114.9	42.2	0.0	125.1	204.2
CDH17	"cadherin, HPT-1"	ENSG00000079112	"Cadherin 17"	Q12864	8	94127171-94217303	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"intestine: 184.4"	"Group enriched"	"Detected in some"	51	"Enterocytes: 404.8;Intestinal endocrine cells: 104.0;Mucus-secreting cells: 149.4;Paneth cells: 316.3;Undifferentiated cells: 191.5"	"Group enriched"	"Detected in many"	6	"colorectal cancer: 156.4;stomach cancer: 54.9"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in many"	5	"neutrophil: 12.1"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 12.1"	"Cell line enhanced"	"Detected in some"		"CACO-2: 21.9;OE19: 94.0;U-266/70: 36.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA023614, HPA023616, CAB025143, HPA026556"	Enhanced		Supported	"Nucleoplasm,Cell Junctions"		NA	NA		3400000	"Cell Junctions"	Nucleoplasm	"CAB025143: , HPA023614: AB_1845896, HPA023616: AB_1845895, HPA026556: AB_1845897"	"unprognostic (2.08e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.02e-1)"	"unprognostic (3.06e-2)"	"unprognostic (5.60e-2)"	"unprognostic (3.38e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.74e-1)"	"unprognostic (5.47e-2)"	"unprognostic (3.74e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.31e-1)"	"unprognostic (7.33e-2)"	"unprognostic (1.46e-2)"	0.3	0.2	0.2	17.6	0.3	0.3	0.3	0.2	0.2	0.3	88.9	0.2	0.2	54.5	0.4	0.3	0.4	0.4	7.0	0.6	0.2	0.3	0.3	0.3	0.3	0.5	0.2	0.2	0.3	0.4	0.0	0.3	0.2	0.2	0.4	44.0	0.2	0.3	0.2	0.3	0.2	184.4	1.4	0.2	0.6	0.3	0.3	0.2	0.3	0.2	0.2	0.5	0.4	0.3	1.5	0.8	12.1	1.0	1.4	0.6	0.1	0.0	4.0	0.2	0.2	0.0	0.1	0.3	0.1	0.0	0.0	0.0	21.9	1.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.3	0.1	0.3	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.4	0.0	0.3	0.1	0.3	0.1	94.0	0.1	0.2	0.0	0.7	0.1	0.0	0.4	0.2	0.1	0.1	0.1	0.1	0.2	0.2	0.1	0.2	0.2	0.3	0.1	36.3	0.0	0.1	0.1	0.1	0.2	2.5	1.0	1.2	0.5	0.8	0.3	0.6	0.5	0.4	0.8	1.5	0.5	0.6	12.1	1.4	0.5	0.7	0.5	0.1	0.2	0.3	0.2	0.2	0.2	0.3	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.6	0.0	404.8	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	104.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	149.4	0.0	0.0	316.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	191.5	0.0
CDH2	"CD325, CDHN, NCAD"	ENSG00000170558	"Cadherin 2"	P19022	18	27950966-28177446	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 77.6;parathyroid gland: 35.4"	"Cell type enhanced"	"Detected in many"	15	"Cardiomyocytes: 330.4;Cone photoreceptor cells: 141.4;Hepatocytes: 98.3;Muller glia cells: 175.2;Rod photoreceptor cells: 92.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"basophil: 4.4;neutrophil: 4.1"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 4.4"	"Cell line enhanced"	"Detected in many"		"AF22: 56.7;BJ: 40.9;fHDF/TERT166: 84.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000141, CAB018580, HPA058574, CAB078686"	Enhanced		Supported	"Plasma membrane,Cell Junctions"		NA	NA		160000000	"Plasma membrane, Cell Junctions"		"CAB000141: , CAB018580: AB_626778, CAB078686: AB_2665849, HPA058574: AB_2683760"	"unprognostic (9.42e-2)"	"unprognostic (2.69e-3)"	"unprognostic (9.07e-3)"	"unprognostic (5.45e-2)"	"unprognostic (1.14e-1)"	"unprognostic (9.30e-2)"	"unprognostic (3.97e-2)"	"unprognostic (2.53e-3)"	"unprognostic (6.70e-3)"	"unprognostic (1.00e-2)"	"unprognostic (7.53e-2)"	"unprognostic (3.51e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.93e-3)"	"unprognostic (6.69e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.59e-3)"	0.6	29.6	9.8	1.5	9.4	0.5	0.5	5.7	16.1	3.2	2.0	8.0	0.2	0.8	3.1	1.9	0.6	4.7	1.7	77.6	9.9	9.6	9.2	23.3	0.7	1.1	6.0	9.1	3.4	0.7	35.4	5.4	0.5	5.9	1.4	0.8	6.8	0.5	4.6	0.4	0.5	0.9	3.2	6.7	5.9	2.5	19.6	7.4	0.9	2.8	0.0	1.0	1.0	1.3	0.0	0.0	4.4	0.0	0.7	0.9	0.0	0.0	4.5	56.7	0.0	9.0	1.8	0.0	40.9	12.4	16.7	15.3	0.0	0.0	0.0	22.0	84.6	8.0	6.0	9.3	0.0	23.7	0.1	5.9	0.0	15.3	14.0	8.6	0.0	0.0	0.8	0.1	38.3	6.7	38.6	14.6	2.5	0.0	0.0	13.0	0.0	10.3	0.0	7.6	0.0	4.9	0.0	6.7	7.8	0.0	1.8	14.8	25.6	0.0	0.0	4.5	23.2	0.0	0.0	2.3	36.2	11.5	0.5	29.6	0.0	0.0	0.0	6.9	0.0	27.8	4.4	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.1	0.7	0.0	0.0	0.0	0.0	9.8	9.4	5.7	10.1	9.9	9.6	6.0	9.1	5.9	7.4	0.0	1.1	5.0	0.0	0.2	23.9	330.4	58.6	2.7	1.2	10.4	141.4	0.2	0.0	5.6	31.9	3.6	0.0	0.0	0.3	0.0	1.2	0.0	0.0	98.3	0.3	3.2	0.0	18.4	1.9	11.0	2.0	0.4	3.3	0.0	0.0	175.2	12.4	0.0	12.0	40.6	92.8	6.5	5.3	3.3	28.8	0.0	0.2	0.0	0.0	0.1
CDH3	"CDHP, PCAD"	ENSG00000062038	"Cadherin 3"	P22223	16	68636189-68722616	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Sensory transduction, Vision"		"Disease mutation, Ectodermal dysplasia, Hypotrichosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 44.0;retina: 40.5"	"Cell type enhanced"	"Detected in many"	6	"Basal glandular cells: 49.5;Basal keratinocytes: 54.0;Melanocytes: 57.3;Pancreatic endocrine cells: 60.0;Urothelial cells: 48.9"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	10	"pons and medulla: 16.0"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"A-431: 24.9;HaCaT: 69.1;HBEC3-KT: 33.3;hTCEpi: 26.6;hTERT-HME1: 20.3;RPTEC TERT1: 29.9"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA001767, CAB002487"	Enhanced		Supported	"Plasma membrane,Cell Junctions"		NA	NA			"Plasma membrane"	"Cell Junctions"	"CAB002487: AB_563446, HPA001767: AB_1078376"	"unprognostic (1.55e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.38e-3)"	"unprognostic (6.73e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.85e-2)"	"prognostic unfavorable (8.53e-4)"	"unprognostic (1.22e-1)"	"unprognostic (3.45e-2)"	"prognostic unfavorable (8.43e-4)"	"unprognostic (4.30e-2)"	"unprognostic (2.41e-5)"	"unprognostic (2.11e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.33e-3)"	"unprognostic (8.56e-2)"	2.2	0.1	1.0	2.5	1.2	0.0	8.7	1.5	1.1	10.5	1.0	2.2	3.0	0.3	9.4	10.3	23.5	8.9	1.4	0.4	1.1	0.8	8.3	0.2	3.6	2.1	0.6	0.4	32.6	0.4	0.5	3.6	6.4	16.0	11.7	0.5	40.5	9.3	4.4	0.1	21.2	0.4	4.1	1.5	10.0	0.7	2.2	0.1	44.0	2.0	26.1	20.1	2.5	6.7	0.9	0.6	1.4	0.5	0.6	0.8	0.2	24.9	0.0	0.1	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	14.9	9.3	0.0	0.1	0.0	0.0	69.1	0.6	33.3	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	26.6	0.0	20.3	0.0	0.0	0.0	0.0	0.0	0.0	13.0	0.0	0.0	1.3	0.2	2.1	0.0	0.0	0.0	29.9	11.3	0.1	0.0	0.2	0.0	11.8	12.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.5	0.2	0.4	0.2	0.3	0.6	0.5	0.4	0.1	0.9	0.6	0.8	1.4	0.6	0.2	0.6	0.2	0.2	1.0	1.2	1.5	1.1	1.1	0.8	0.6	0.4	16.0	0.1	14.9	2.9	0.0	49.5	54.0	0.8	1.2	0.0	4.0	13.6	14.0	2.0	21.3	0.0	31.6	0.2	0.5	0.0	0.0	28.5	1.2	3.3	13.1	1.1	0.0	2.5	0.0	1.2	0.0	0.0	0.0	0.6	1.2	57.3	1.8	1.4	0.2	60.0	0.0	8.9	0.0	0.4	0.0	1.9	0.2	0.7	26.8	5.3	0.0	0.4	48.9
CDH6		ENSG00000113361	"Cadherin 6"	P55285	5	31193750-31329146	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 73.8"	"Cell type enhanced"	"Detected in some"	14	"Ductal cells: 30.0;Pancreatic endocrine cells: 38.4;Proximal tubular cells: 100.9;Sertoli cells: 45.3;Smooth muscle cells: 69.4"	"Group enriched"	"Detected in many"	5	"ovarian cancer: 15.0;renal cancer: 28.6"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	8	"EFO-21: 106.5"	"Low region specificity"	"Detected in many"							"HPA007047, HPA007403, HPA007456, CAB025274"	Enhanced		Supported	"Plasma membrane,Cell Junctions"		NA	NA		1200000	"Plasma membrane, Cell Junctions"		"CAB025274: , HPA007047: AB_1078374, HPA007403: , HPA007456: AB_1078373"	"unprognostic (3.87e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.92e-3)"	"unprognostic (1.58e-2)"	"unprognostic (7.61e-3)"	"unprognostic (9.04e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.74e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.19e-2)"	"unprognostic (8.29e-3)"	"unprognostic (1.22e-3)"	"unprognostic (2.67e-1)"	"unprognostic (6.22e-2)"	"unprognostic (2.09e-2)"	6.7	1.9	3.4	2.2	7.5	0.6	3.9	1.1	8.4	7.0	2.1	2.4	1.0	2.1	4.5	8.4	3.8	10.0	13.4	3.0	3.3	4.3	73.8	1.4	6.5	1.1	5.0	4.8	3.5	1.3	2.5	2.1	5.3	5.6	2.4	1.7	20.4	1.4	2.9	1.9	1.8	2.0	4.0	6.3	1.4	1.8	0.9	5.5	0.0	3.5	3.3	1.3	4.4	3.4	0.6	0.5	1.7	0.5	0.7	0.4	0.3	0.0	0.4	13.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	106.5	0.0	0.0	0.0	10.6	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	2.4	0.0	3.1	0.0	0.3	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.4	1.3	0.3	0.0	0.0	0.2	0.0	0.0	0.3	1.5	0.4	0.4	0.4	0.3	0.3	0.4	0.3	0.3	0.2	0.6	0.3	0.4	1.7	0.7	0.5	0.5	0.3	0.3	3.4	7.5	1.1	6.7	3.3	4.3	5.0	4.8	5.6	5.5	0.0	0.3	0.0	0.0	0.8	7.9	1.7	25.5	0.0	3.4	10.4	0.0	0.0	23.2	30.0	0.2	1.4	0.0	0.0	2.5	0.0	0.9	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	1.8	0.0	0.3	38.4	0.0	0.4	100.9	0.7	45.3	69.4	0.0	0.2	0.9	0.0	0.0	0.0	0.0
CDK5	PSSALRE	ENSG00000164885	"Cyclin dependent kinase 5"	Q00535	7	151053812-151058530	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Biological rhythms, Cell cycle, Cell division, Neurogenesis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Lissencephaly, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 36.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008909, HPA064535"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA			"Nucleoplasm, Plasma membrane"	"Cell Junctions"	"CAB008909: , HPA064535: AB_2685280"	"unprognostic (1.21e-1)"	"unprognostic (3.23e-2)"	"unprognostic (4.22e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.48e-1)"	"unprognostic (5.67e-3)"	"unprognostic (1.05e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.78e-3)"	"unprognostic (6.25e-3)"	"unprognostic (3.35e-1)"	"unprognostic (4.47e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.11e-1)"	4.5	11.3	24.4	6.9	30.4	6.1	5.3	13.6	36.1	5.3	6.1	6.7	4.5	7.9	4.5	17.4	6.5	5.0	6.2	5.8	25.0	19.7	9.0	7.7	5.3	6.0	15.4	15.4	3.2	5.8	8.9	7.9	5.3	20.8	5.8	6.3	3.2	6.0	6.3	5.7	6.5	6.2	6.0	8.6	5.2	5.7	3.1	7.7	6.8	6.0	3.6	6.9	6.7	3.1	6.6	21.5	9.0	21.7	9.5	14.9	10.6	11.7	14.1	13.2	21.5	14.6	10.7	6.6	7.8	12.8	15.3	12.6	10.0	11.0	11.6	27.9	9.6	22.8	8.4	21.2	11.8	7.0	9.1	12.6	12.7	12.4	9.9	9.6	10.2	23.9	11.6	8.9	12.6	3.9	21.4	10.3	18.2	12.9	8.5	15.3	22.7	27.6	21.0	14.5	18.9	22.3	13.5	5.4	12.9	13.3	8.9	8.4	35.9	11.2	13.8	14.7	12.6	6.4	9.0	8.7	15.1	3.9	11.3	14.5	19.7	21.5	4.5	23.7	14.8	27.0	7.8	19.0	9.0	6.9	21.7	5.4	6.6	6.8	6.8	21.5	5.9	5.1	6.2	2.8	9.5	16.4	12.8	14.9	10.6	24.4	30.4	13.6	36.1	25.0	19.7	15.4	15.4	20.8	7.7	0.0	5.9	11.5	6.4	3.2	11.5	3.2	7.6	8.1	7.9	10.4	2.0	20.0	33.2	19.0	0.6	6.3	7.1	0.0	16.6	10.2	6.6	5.0	31.0	9.6	37.8	0.0	8.6	6.2	21.6	0.9	4.4	14.3	10.1	20.8	9.1	11.5	18.7	14.4	10.6	24.0	4.7	6.5	5.0	2.6	9.7	5.5	7.6	8.5	9.6	7.6
CDK5RAP2	"C48, CEP215, FLJ10867, MCPH3"	ENSG00000136861	"CDK5 regulatory subunit associated protein 2"	Q96SN8	9	120388869-120580170	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		Calmodulin-binding	"Mental retardation, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA035820, HPA035821, HPA046529, CAB079753"	Approved		Enhanced	"Cell Junctions,Centrosome"		NA	NA			Centrosome	"Cell Junctions"	"CAB079753: AB_2665827, HPA035820: AB_10671939, HPA035821: , HPA046529: AB_2679688"	"unprognostic (7.72e-2)"	"unprognostic (2.04e-2)"	"unprognostic (2.84e-2)"	"unprognostic (4.48e-2)"	"unprognostic (6.63e-2)"	"unprognostic (6.88e-2)"	"unprognostic (6.70e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.00e-1)"	"unprognostic (7.36e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.88e-1)"	"unprognostic (4.94e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.33e-2)"	"unprognostic (7.41e-2)"	10.3	12.0	12.3	13.0	23.2	21.3	15.2	20.0	19.9	15.7	13.0	22.0	9.1	5.8	11.9	8.4	12.8	11.2	10.2	18.3	14.9	7.9	7.8	20.1	10.9	14.0	21.6	9.8	18.6	9.3	17.0	20.3	8.8	15.1	14.5	9.2	10.6	21.3	11.6	41.7	16.0	10.2	15.6	14.2	11.2	12.3	19.8	25.7	23.4	11.9	8.5	14.9	12.8	16.5	7.4	2.7	13.7	5.2	4.7	4.5	1.9	9.5	16.9	23.5	14.1	10.1	15.0	12.6	12.4	9.5	14.1	13.2	13.2	12.7	17.9	5.7	12.1	9.6	21.2	18.5	14.2	13.6	14.3	7.4	15.3	30.9	23.5	9.5	18.9	10.2	27.0	9.5	12.4	16.5	10.6	12.2	21.7	14.1	15.6	18.4	21.6	20.2	12.1	21.7	20.5	12.8	19.8	28.1	8.4	10.0	7.7	15.4	17.7	21.5	11.8	14.3	10.6	27.8	13.0	8.1	12.2	13.4	14.3	14.0	11.4	15.8	20.1	12.7	12.1	25.7	13.7	2.2	3.5	4.5	2.1	4.4	5.7	4.2	4.1	1.3	7.4	3.5	3.5	2.9	4.7	5.2	2.7	3.3	1.9	12.3	23.2	20.0	19.9	14.9	7.9	21.6	9.8	15.1	25.7	26.8	36.1	14.1	10.3	6.3	24.3	48.4	15.3	41.5	20.5	1.8	15.7	9.3	6.6	10.8	27.1	10.3	5.9	23.3	12.4	10.0	11.9	11.1	16.2	18.8	9.3	17.5	8.1	6.7	10.0	25.6	20.4	12.9	11.8	13.6	10.2	23.9	9.9	5.9	21.9	3.6	28.0	32.3	13.2	57.4	36.8	5.9	6.1	13.8	6.7	7.3
CERCAM	"CEECAM1, CerCAM, GLT25D3"	ENSG00000167123	"Cerebral endothelial cell adhesion molecule"	Q5T4B2	9	128411751-128437351	"Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 78.1"	"Cell type enhanced"	"Detected in many"	8	"Extravillous trophoblasts: 48.9;Fibroblasts: 70.1;Melanocytes: 38.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD8 T-cell: 5.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 55.6;ASC TERT1: 59.3;fHDF/TERT166: 50.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021657, HPA051595"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Cell Junctions"	"Intracellular and membrane"	NA	NA			"Nucleoplasm, Nucleoli"	"Cell Junctions"	"HPA021657: AB_1846507, HPA051595: AB_2681545"	"unprognostic (2.87e-2)"	"unprognostic (1.37e-3)"	"unprognostic (1.89e-3)"	"unprognostic (2.19e-1)"	"unprognostic (4.68e-3)"	"unprognostic (7.79e-3)"	"unprognostic (3.29e-3)"	"unprognostic (5.68e-2)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (5.22e-4)"	"unprognostic (1.59e-1)"	"unprognostic (5.93e-2)"	"prognostic unfavorable (3.33e-16)"	"unprognostic (1.34e-2)"	"unprognostic (1.04e-1)"	"unprognostic (6.05e-3)"	"prognostic unfavorable (3.30e-5)"	12.7	5.1	40.0	7.2	65.5	1.6	9.0	10.0	62.1	19.1	6.9	61.2	5.0	4.8	11.4	10.9	8.2	6.0	17.3	8.8	72.8	34.7	4.9	1.8	5.3	2.3	59.5	28.1	14.1	18.8	15.8	21.6	27.4	31.4	11.1	5.2	3.5	13.2	13.6	4.3	8.9	6.0	27.7	78.1	3.3	5.4	5.2	62.1	0.0	6.7	2.4	2.7	15.1	6.6	0.3	2.0	0.3	1.6	1.1	5.3	2.2	9.5	6.1	6.9	7.3	55.6	59.3	5.9	30.9	29.2	8.1	6.1	2.2	0.4	0.0	12.7	50.4	6.9	6.5	3.0	4.1	3.1	2.4	4.9	0.5	5.6	3.3	17.0	1.1	17.3	32.8	2.2	8.8	2.1	33.5	9.1	0.6	2.8	7.6	10.5	18.1	0.4	11.7	0.4	0.4	4.7	0.9	4.8	1.3	3.8	3.6	1.0	1.9	6.9	8.4	3.5	2.3	6.8	2.3	10.1	21.6	5.9	29.6	4.7	8.9	6.9	0.1	20.4	3.4	4.2	0.3	1.1	0.1	3.8	1.6	0.3	0.3	0.3	4.7	1.5	0.1	0.1	5.3	0.3	1.1	0.1	2.0	0.0	2.2	40.0	65.5	10.0	24.5	72.8	34.7	59.5	28.1	31.4	62.1	6.0	13.0	0.0	6.2	7.9	1.1	3.2	0.0	6.7	21.6	10.4	0.0	14.3	0.0	10.7	2.0	7.1	0.0	0.0	2.9	48.9	70.1	3.9	8.1	0.0	5.9	6.4	0.0	18.4	0.6	1.5	22.5	4.7	38.8	1.0	0.0	0.1	6.9	0.0	24.8	0.5	0.7	6.5	15.6	1.0	19.0	3.6	16.4	2.5	0.0	2.0
CFAP206	"C6orf165, dJ382I10.1, FLJ25974"	ENSG00000272514	"Cilia and flagella associated protein 206"	Q8IYR0	6	87407983-87464465	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"fallopian tube: 17.7;testis: 60.5"	"Cell type enhanced"	"Detected in some"	29	"Ciliated cells: 80.3;Early spermatids: 214.5;Spermatocytes: 42.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.2"	"Lineage enhanced"	"Detected in single"		"granulocytes: 1.2"	"Cell line enhanced"	"Detected in some"		"MCF7: 4.5;RPTEC TERT1: 5.4;T-47d: 9.1"									"HPA044891, HPA072261"	Approved		Approved	"Nucleoplasm,Cell Junctions"		NA	NA			Nucleoplasm	"Cell Junctions"	"HPA044891: AB_10960832, HPA072261: AB_2686501"	"unprognostic (4.31e-1)"	"unprognostic (8.75e-3)"		"unprognostic (2.40e-1)"	"unprognostic (2.31e-1)"	"unprognostic (5.51e-2)"		"unprognostic (1.68e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.68e-3)"	"unprognostic (3.13e-2)"	"unprognostic (3.99e-3)"	"unprognostic (9.08e-3)"	"unprognostic (4.22e-2)"	"unprognostic (1.46e-1)"	"unprognostic (8.54e-2)"	"unprognostic (2.26e-2)"	0.2	0.5	1.3	0.3	3.0	0.2	0.5	0.3	2.2	0.9	0.3	3.0	0.2	0.3	0.7	3.4	0.2	17.7	0.4	0.3	2.1	2.0	1.5	0.3	2.4	0.2	0.7	1.4	2.7	0.3	0.8	2.6	0.4	8.1	0.5	0.2	0.3	0.3	0.5	0.2	0.3	0.2	0.3	0.5	0.2	0.2	60.5	0.6	0.0	1.4	0.0	0.2	0.4	0.1	0.0	0.0	1.2	0.0	0.0	0.6	0.0	0.0	1.0	0.5	2.0	0.0	0.7	0.0	0.0	0.0	0.6	0.0	0.2	1.0	0.0	0.0	0.0	2.1	1.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.3	0.9	0.0	0.0	0.2	0.0	0.0	0.1	0.9	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	5.4	1.2	1.1	0.6	0.4	0.5	0.3	0.1	9.1	0.2	0.0	0.5	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	1.3	3.0	0.3	2.2	2.1	2.0	0.7	1.4	8.1	0.6	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	80.3	13.6	0.0	0.0	0.1	1.7	0.1	214.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	12.5	2.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	1.1	0.7	0.4	0.0	0.0	42.3	2.0	0.0	0.0	0.0	0.0	0.0
CFB	"BF, BFD, H2-Bf"	ENSG00000243649	"Complement factor B"	P00751	6	31945650-31952084	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Complement alternate pathway, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"	"Age-related macular degeneration, Disease mutation, Hemolytic uremic syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	29	"liver: 461.5"	"Group enriched"	"Detected in many"	8	"Ductal cells: 523.0;Exocrine glandular cells: 173.6;Hepatocytes: 158.3;Pancreatic endocrine cells: 492.1"	"Cancer enhanced"	"Detected in all"		"liver cancer: 78.3"	"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"ASC diff: 6.1;ASC TERT1: 6.0;CAPAN-2: 7.1;EFO-21: 5.3;fHDF/TERT166: 11.6;HSkMC: 19.1"									"HPA000951, HPA001817, HPA001832, CAB016381"	Supported		Approved	"Endoplasmic reticulum,Vesicles,Cell Junctions"	"Secreted to blood"	NA	NA	879000000	180000000000	"Endoplasmic reticulum, Vesicles"	"Cell Junctions"	"CAB016381: AB_627562, HPA000951: AB_2797216, HPA001817: AB_1078779, HPA001832: AB_1078778"	"prognostic favorable (2.76e-5)"	"unprognostic (1.02e-1)"	"unprognostic (1.44e-1)"	"unprognostic (7.94e-2)"	"unprognostic (1.82e-2)"	"unprognostic (8.56e-2)"	"unprognostic (8.08e-3)"	"unprognostic (8.81e-2)"	"unprognostic (3.51e-1)"	"unprognostic (2.26e-2)"	"unprognostic (1.32e-2)"	"unprognostic (6.57e-2)"	"prognostic unfavorable (1.53e-5)"	"unprognostic (1.36e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.68e-2)"	9.3	1.0	0.3	4.1	0.4	0.3	2.4	0.2	0.4	1.3	9.0	0.4	0.9	3.2	0.5	3.7	2.2	4.0	8.9	3.3	0.2	0.0	16.1	461.5	2.5	2.1	0.7	0.1	2.8	5.8	0.4	1.0	4.0	1.0	4.0	1.6	2.6	3.1	0.3	0.5	0.5	4.7	2.6	0.6	0.8	4.1	1.4	0.3	0.3	1.8	0.5	1.7	1.6	0.4	0.1	1.6	0.0	0.8	0.0	0.2	0.0	0.0	1.8	0.1	0.1	6.1	6.0	0.0	0.0	0.3	1.6	0.6	0.0	7.1	0.1	5.3	11.6	0.3	0.0	0.0	1.9	1.4	0.4	0.3	0.4	0.3	0.6	0.0	0.7	0.1	19.1	0.1	0.9	0.6	0.6	0.2	0.1	0.2	0.7	0.1	0.1	0.1	0.4	0.3	0.0	0.1	0.2	0.4	0.2	1.7	0.0	0.0	0.0	0.6	1.2	0.2	0.0	0.0	0.2	0.0	0.2	0.5	0.3	0.4	0.6	1.9	0.5	3.2	0.6	0.5	0.0	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	1.6	0.0	0.0	0.3	0.4	0.2	0.3	0.2	0.0	0.7	0.1	1.0	0.3	0.0	20.0	14.0	0.7	0.7	0.1	0.4	20.4	24.1	40.9	5.2	0.0	0.0	3.3	523.0	0.0	2.4	5.0	0.0	173.6	0.1	6.0	9.0	0.0	158.3	0.8	0.0	2.4	11.6	13.2	0.0	2.6	1.2	0.0	31.5	6.7	0.8	492.1	11.8	0.0	11.2	0.7	0.0	3.8	0.1	0.0	1.6	1.4	1.9	11.2	1.8
CGN	KIAA1319	ENSG00000143375	Cingulin	Q9P2M7	1	151510510-151538692	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 44.1"	"Cell type enhanced"	"Detected in many"	10	"Alveolar cells type 1: 110.2;Ciliated cells: 50.9;Enterocytes: 85.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 36.9;CAPAN-2: 24.3;OE19: 23.6;RT4: 17.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB017193, HPA027586, HPA027587, HPA027657"	Enhanced		Supported	"Plasma membrane,Cell Junctions"		NA	NA		24000000	"Plasma membrane, Cell Junctions"		"CAB017193: , HPA027586: AB_10600208, HPA027587: AB_10601884, HPA027657: AB_10611527"	"unprognostic (1.57e-1)"	"unprognostic (4.30e-2)"	"unprognostic (1.12e-1)"	"unprognostic (8.74e-3)"	"unprognostic (1.02e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.98e-1)"	"unprognostic (8.38e-2)"	"unprognostic (4.61e-1)"	"unprognostic (2.11e-2)"	"unprognostic (2.96e-3)"	"unprognostic (7.10e-2)"	"prognostic favorable (5.84e-10)"	"unprognostic (2.66e-1)"	"unprognostic (3.00e-1)"	"unprognostic (8.28e-2)"	"unprognostic (2.10e-2)"	3.9	0.3	2.1	8.5	5.1	0.0	4.1	11.9	3.5	2.2	18.0	3.7	15.5	23.9	1.0	3.5	5.9	6.1	11.9	0.5	1.4	1.4	10.7	15.0	12.4	0.2	5.0	1.0	1.4	25.3	22.1	4.7	1.9	4.8	4.6	11.6	1.8	19.8	14.4	0.2	11.6	44.1	1.8	1.9	0.2	13.6	6.4	4.3	0.9	3.6	2.3	4.3	6.9	3.8	1.2	0.9	2.6	1.0	1.6	2.4	0.1	11.5	1.3	1.1	1.9	0.0	0.0	14.8	0.0	0.0	0.3	0.4	36.9	24.3	0.5	4.0	0.0	2.0	11.1	3.6	2.0	0.2	6.9	2.4	1.0	0.5	0.7	0.0	0.2	1.6	0.0	0.4	0.5	0.3	0.0	0.1	3.3	0.5	3.5	0.0	10.7	2.0	0.2	9.5	23.6	1.0	2.2	1.2	1.7	7.8	17.9	3.7	1.9	0.7	11.3	0.4	4.5	13.9	0.1	0.2	0.1	3.6	0.2	0.5	3.3	3.2	2.0	0.1	1.3	0.9	1.1	1.0	0.4	2.4	0.4	0.7	0.7	0.7	0.5	0.1	1.2	0.8	1.4	2.6	1.6	0.5	0.9	0.7	0.1	2.1	5.1	11.9	3.5	1.4	1.4	5.0	1.0	4.8	4.3	110.2	25.7	0.0	3.7	0.2	2.7	0.4	15.3	50.9	26.1	3.5	0.0	2.1	0.0	19.2	0.0	0.0	85.9	0.0	22.2	0.2	0.3	9.6	0.0	25.2	0.2	0.0	9.9	0.0	0.0	0.5	0.6	0.7	3.3	3.6	26.7	16.6	34.9	40.1	0.7	2.6	1.4	0.0	0.3	0.7	7.1	1.6	0.3	0.0	21.4	13.9
CGNL1	"FLJ14957, JACOP, KIAA1749, PCING"	ENSG00000128849	"Cingulin like 1"	Q0VF96	15	57375967-57550727	"Disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 54.8"	"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 2: 81.1;Hepatocytes: 49.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 29.4;SuSa: 22.4;TIME: 18.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013500, HPA056911, HPA069214"	Enhanced		Supported	"Nuclear bodies,Cell Junctions"		No	No			"Cell Junctions"	"Nuclear bodies"	"CAB013500: , HPA056911: AB_2683274, HPA069214: AB_2686102"	"unprognostic (1.04e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.52e-2)"	"prognostic favorable (3.55e-4)"	"unprognostic (3.22e-1)"	"unprognostic (1.51e-3)"	"prognostic favorable (5.58e-4)"	"unprognostic (4.32e-2)"	"unprognostic (2.34e-1)"	"unprognostic (4.86e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.91e-2)"	"prognostic favorable (1.37e-6)"	"unprognostic (2.26e-2)"	"unprognostic (3.39e-1)"	"unprognostic (1.88e-3)"	"unprognostic (1.18e-2)"	3.1	8.7	10.8	1.7	9.8	0.6	14.6	3.2	12.2	25.7	2.0	7.3	8.9	1.4	14.9	4.9	7.7	7.0	2.7	13.6	11.2	7.8	54.8	26.2	15.3	1.3	8.3	5.9	8.1	13.6	12.5	2.9	20.8	10.9	27.6	2.3	11.1	32.0	12.7	1.0	7.4	1.7	10.6	5.3	0.8	9.0	5.2	9.7	1.3	15.0	4.2	8.0	10.0	14.6	0.5	0.2	1.1	0.1	0.3	0.2	0.0	0.0	0.7	7.4	0.0	0.0	0.0	0.1	0.1	1.6	0.6	1.4	4.6	0.0	0.0	6.5	0.9	1.1	0.0	3.5	0.0	1.0	0.0	0.5	0.0	0.0	3.1	0.1	0.0	0.0	0.2	0.2	0.7	0.0	2.5	29.4	0.3	0.0	0.0	1.1	1.3	0.0	0.1	3.6	2.0	0.3	0.0	3.7	0.1	2.5	0.0	0.1	0.4	0.0	2.8	0.0	22.4	0.3	0.3	18.0	0.0	1.9	0.0	1.0	0.0	0.0	0.0	0.1	3.3	0.0	0.9	0.1	0.2	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.5	0.2	0.2	1.1	0.3	0.0	0.2	0.1	0.0	10.8	9.8	3.2	12.2	11.2	7.8	8.3	5.9	10.9	9.7	47.6	81.1	0.0	10.9	4.0	0.4	19.4	17.8	2.7	18.2	21.0	0.0	0.8	34.9	6.9	2.5	13.5	0.2	23.3	11.6	0.7	19.3	30.4	1.1	49.7	0.3	0.0	12.6	22.1	1.0	11.5	18.4	2.4	6.8	1.0	3.2	37.1	5.1	0.0	26.2	32.9	1.3	0.0	2.8	0.5	0.4	2.0	1.1	0.5	2.9	7.6
CHCHD7	"COX23, MGC2217"	ENSG00000170791	"Coiled-coil-helix-coiled-coil-helix domain containing 7"	Q9BUK0	8	56211686-56218798	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA050783	Approved		Approved	"Cell Junctions,Aggresome"		NA	NA			"Cell Junctions"	Aggresome	"HPA050783: AB_2681236"	"unprognostic (1.64e-2)"	"unprognostic (3.23e-2)"	"unprognostic (3.18e-2)"	"prognostic unfavorable (1.39e-6)"	"unprognostic (4.46e-2)"	"unprognostic (2.43e-1)"	"unprognostic (5.04e-2)"	"unprognostic (8.38e-3)"	"unprognostic (1.62e-1)"	"unprognostic (9.03e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.15e-1)"	"prognostic favorable (9.47e-5)"	"unprognostic (1.94e-1)"	"unprognostic (5.07e-1)"	"unprognostic (1.77e-2)"	"unprognostic (2.50e-1)"	16.6	14.8	24.1	19.6	29.4	17.6	18.9	27.1	23.3	17.6	20.7	18.3	22.8	22.5	13.1	34.3	15.7	17.6	12.3	27.0	21.0	19.5	23.4	18.0	19.4	24.4	27.0	16.0	36.3	20.0	22.5	48.3	13.3	26.7	19.2	21.3	19.2	34.5	18.0	23.2	14.6	26.2	14.8	32.0	33.0	17.7	7.6	24.8	27.4	19.8	18.3	24.9	15.5	16.4	31.0	33.6	26.2	20.6	24.2	31.1	17.3	18.7	6.0	13.5	4.4	35.9	25.5	13.9	13.4	12.7	10.7	8.0	15.4	23.0	17.8	11.9	7.9	14.8	10.6	13.9	20.7	13.3	7.7	26.8	27.1	14.3	21.2	18.2	23.1	17.4	30.4	19.1	7.6	34.1	15.2	11.1	33.4	13.2	11.7	25.3	9.4	23.1	34.3	11.8	30.0	8.7	26.5	4.1	14.8	19.8	20.3	3.5	2.3	7.0	11.0	9.9	16.9	11.5	13.0	16.1	5.7	12.1	18.3	12.6	12.3	12.6	29.6	15.9	34.4	9.7	21.5	20.6	26.2	23.2	19.0	22.5	31.0	26.0	23.6	22.8	26.4	31.1	27.8	7.9	24.2	16.6	33.6	29.7	17.3	24.1	29.4	27.1	23.3	21.0	19.5	27.0	16.0	26.7	24.8	17.9	68.8	75.2	36.1	18.4	31.3	84.5	48.4	44.2	40.9	47.1	13.7	38.6	106.1	35.3	16.9	29.6	88.5	23.3	65.0	72.3	25.3	33.7	52.0	63.7	129.2	12.7	38.1	46.6	72.1	9.6	34.2	55.9	50.6	69.5	53.7	38.5	58.7	54.7	29.0	49.6	34.8	12.9	36.3	52.6	37.9	20.8	35.2	57.5	63.2	39.1
CHRNB4		ENSG00000117971	"Cholinergic receptor nicotinic beta 4 subunit"	P30926	15	78624119-78727754	"FDA approved drug targets, Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	4	"adrenal gland: 6.6;lymphoid tissue: 18.5;retina: 10.6;testis: 10.7"	"Group enriched"	"Detected in some"	21	"Early spermatids: 41.7;Late spermatids: 39.8"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.0"	"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	16	"SCLC-21H: 20.7;SH-SY5Y: 26.9"	"Group enriched"	"Detected in some"	5	"olfactory region: 6.5;pons and medulla: 1.4;thalamus: 4.6"	"Low region specificity"	"Detected in many"			HPA059484			Approved	"Endoplasmic reticulum,Cell Junctions"		NA	NA			"Endoplasmic reticulum"	"Cell Junctions"	"HPA059484: "	"unprognostic (4.74e-2)"	"unprognostic (4.54e-1)"	"unprognostic (1.26e-2)"	"unprognostic (8.77e-5)"	"unprognostic (8.15e-2)"	"unprognostic (6.43e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.19e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.45e-4)"	"unprognostic (7.00e-3)"	"unprognostic (2.58e-1)"	"unprognostic (8.50e-2)"	"unprognostic (7.76e-2)"	0.2	6.6	2.7	3.9	0.8	0.7	0.2	0.5	0.4	0.6	2.3	0.2	0.0	0.2	0.8	0.7	1.4	0.1	0.1	0.8	1.0	0.3	0.5	0.1	0.1	2.9	0.2	0.0	0.3	0.2	0.0	1.6	0.0	1.3	0.2	1.1	10.6	2.2	2.4	0.6	0.3	1.0	0.9	1.0	1.0	0.8	10.7	0.1	18.5	0.4	0.3	1.1	0.5	0.5	1.5	0.4	1.4	0.8	1.0	0.8	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.4	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.7	26.9	0.1	0.3	0.1	0.2	0.0	0.0	0.0	0.1	0.3	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	1.4	0.8	0.3	0.5	0.2	0.6	0.9	0.5	0.6	0.2	1.5	0.8	0.8	1.4	1.0	0.4	0.4	0.3	0.0	2.7	0.8	0.5	0.4	1.0	0.3	0.2	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	41.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	39.8	0.0	0.0	0.0	1.0	0.0	0.3	0.2	0.0	0.4	0.1	0.0	0.0	0.0	1.6	1.9	0.0	0.0	0.0	0.0	0.1
CLCA2	CLCRG2	ENSG00000137975	"Chloride channel accessory 2"	Q9UQC9	1	86424086-86456558	"Predicted membrane proteins"	"Cell adhesion, Ion transport, Transport"	"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 105.2;lymphoid tissue: 33.9;skin 1: 36.4;tongue: 42.1"	"Cell type enhanced"	"Detected in some"	13	"Basal keratinocytes: 42.1;Club cells: 22.7;Early spermatids: 20.6;Suprabasal keratinocytes: 47.9;Urothelial cells: 35.8"	"Group enriched"	"Detected in many"	6	"cervical cancer: 68.3;head and neck cancer: 146.1;lung cancer: 35.2;urothelial cancer: 31.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"hTCEpi: 68.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA047192	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cell Junctions"	"Intracellular and membrane"	NA	NA		66000	"Plasma membrane, Cell Junctions"	Nucleoplasm	"HPA047192: AB_2679977"	"unprognostic (1.04e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.96e-3)"	"unprognostic (6.99e-2)"	"unprognostic (6.33e-2)"	"unprognostic (1.40e-1)"		"unprognostic (6.15e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.73e-1)"	"unprognostic (9.99e-3)"	"unprognostic (1.97e-8)"	"unprognostic (3.88e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.72e-1)"	0.4	0.0	0.1	0.1	0.1	0.0	2.0	0.1	0.1	27.7	0.2	0.1	0.4	0.1	1.1	0.7	105.2	0.1	0.2	0.1	0.1	0.0	0.1	0.1	1.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	1.2	0.1	1.4	0.3	0.1	5.1	0.1	0.1	36.4	0.3	0.1	0.2	0.1	0.0	0.2	0.1	0.7	0.1	42.1	33.9	6.1	17.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.0	12.6	0.5	0.8	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	10.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	68.6	0.3	3.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	6.0	42.1	0.0	0.3	0.0	10.7	22.7	0.0	0.0	0.2	0.0	0.0	20.6	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	2.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	47.9	0.1	0.0	0.0	35.8
CLDN11	"OSP, OTM"	ENSG00000013297	"Claudin 11"	O75508	3	170418865-170454733	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 85.9;ovary: 47.7;testis: 86.1"	"Cell type enhanced"	"Detected in many"	13	"Fibroblasts: 37.5;Ito cells: 49.1;Leydig cells: 97.5;Peritubular cells: 63.6"	"Cancer enhanced"	"Detected in many"		"glioma: 11.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 57.6;ASC TERT1: 72.7;EFO-21: 43.2;HSkMC: 26.6;HUVEC TERT2: 62.3;TIME: 98.4"									"CAB009789, HPA013166, HPA013657"	Enhanced		Supported	"Lipid droplets,Cell Junctions"		NA	NA			"Cell Junctions"	"Lipid droplets"	"CAB009789: AB_639330, HPA013166: AB_1854821, HPA013657: "	"prognostic favorable (6.31e-4)"	"unprognostic (3.18e-1)"	"unprognostic (2.32e-2)"	"unprognostic (5.28e-4)"	"unprognostic (3.45e-2)"	"unprognostic (4.60e-1)"	"unprognostic (5.25e-2)"	"unprognostic (5.40e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.48e-2)"	"unprognostic (8.70e-11)"	"unprognostic (2.50e-3)"	"unprognostic (1.93e-1)"	"unprognostic (6.68e-3)"	"unprognostic (2.29e-1)"	8.2	1.9	14.1	2.0	40.6	1.7	6.3	3.5	50.3	1.9	3.4	85.9	0.5	2.2	2.7	4.6	4.6	4.2	18.9	4.0	28.7	13.0	3.2	2.8	2.8	2.1	59.5	17.1	47.7	2.1	1.8	5.5	4.2	37.3	5.1	2.5	0.6	4.7	4.2	1.7	3.6	2.6	2.8	80.6	2.6	2.5	86.1	47.9	0.0	2.0	0.9	2.0	6.3	3.4	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	57.6	72.7	0.0	0.7	3.7	4.7	7.9	0.0	9.7	0.0	43.2	5.8	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.0	3.3	17.8	0.0	0.0	26.6	0.0	25.9	0.0	0.2	62.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	1.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	98.4	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	14.1	40.6	3.5	25.0	28.7	13.0	59.5	17.1	37.3	47.9	0.0	1.1	0.0	12.0	12.8	0.4	1.4	0.0	0.0	0.0	1.8	0.0	1.0	0.0	0.0	6.5	21.9	0.0	0.0	0.0	1.7	37.5	1.3	0.0	0.8	0.8	0.0	0.0	49.1	0.0	16.0	97.5	1.7	13.5	0.0	0.0	0.3	0.5	0.0	63.6	0.0	0.0	0.0	5.9	7.2	2.6	8.9	0.7	0.0	0.0	1.0
CLDN18	SFTPJ	ENSG00000066405	"Claudin 18"	P56856	3	137998735-138033655	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	41	"gallbladder: 37.4;lung: 91.9;stomach 1: 126.9"	"Cell type enriched"	"Detected in some"	5	"Alveolar cells type 1: 1488.8"	"Group enriched"	"Detected in some"	11	"pancreatic cancer: 113.7;stomach cancer: 186.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	20	"OE19: 18.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB013010, CAB013243, HPA018446"	Enhanced		Approved	"Cell Junctions"		NA	NA			"Cell Junctions"		"CAB013010: AB_2533382, CAB013243: AB_2533383, HPA018446: AB_2669866"	"unprognostic (1.03e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.41e-1)"	"unprognostic (8.51e-2)"	"unprognostic (5.14e-4)"	"unprognostic (2.00e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.60e-1)"	"unprognostic (9.54e-2)"	"unprognostic (1.38e-2)"	"unprognostic (4.42e-5)"	"unprognostic (1.66e-1)"	"unprognostic (2.26e-1)"	"unprognostic (8.26e-2)"	"unprognostic (2.95e-1)"	0.1	0.0	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.7	0.8	0.1	0.1	0.1	0.1	0.3	0.1	37.4	2.0	0.1	0.0	0.1	0.1	91.9	0.1	0.1	0.1	0.1	0.2	0.0	0.1	0.1	0.5	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.5	0.2	0.1	0.1	126.9	0.3	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.1	0.2	0.0	0.4	0.1	0.0	0.1	0.1	0.2	0.1	0.4	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.5	0.0	0.3	0.1	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.9	0.3	0.1	0.1	0.2	0.5	0.0	0.0	0.0	0.1	0.0	0.1	0.5	0.1	0.6	18.9	0.1	0.4	0.0	0.0	0.0	0.3	0.1	0.1	0.1	0.0	0.0	0.1	0.2	0.1	0.1	0.3	0.5	0.3	0.1	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.5	0.1	1488.8	318.5	0.0	0.0	0.0	0.8	18.9	0.0	1.4	20.5	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	9.9	0.0	0.0	0.1	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.0	257.5	0.0	0.0	0.0	1.4	0.0	0.0	6.6	3.8	0.0	0.0	0.0	0.0	0.0
CLDN2		ENSG00000165376	"Claudin 2"	P57739	X	106900164-106930861	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 31.7;gallbladder: 28.4;kidney: 46.1;liver: 25.2;seminal vesicle: 27.7"	"Cell type enhanced"	"Detected in some"	21	"Ductal cells: 67.3;Exocrine glandular cells: 42.5;Pancreatic endocrine cells: 28.7;Proximal tubular cells: 138.0"	"Group enriched"	"Detected in many"	5	"colorectal cancer: 53.3;liver cancer: 24.6;pancreatic cancer: 48.5;renal cancer: 87.2;stomach cancer: 30.5"	"Region enriched"	"Detected in some"	6	"pons and medulla: 31.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"OE19: 81.0"	"Group enriched"	"Detected in many"	5	"basal ganglia: 4.6;hippocampal formation: 10.6;pons and medulla: 10.8;thalamus: 9.5"	"Not detected"	"Not detected"			"CAB002609, HPA051548"	Enhanced		Supported	"Nucleoplasm,Cell Junctions"		NA	NA			"Nucleoplasm, Cell Junctions"		"CAB002609: , HPA051548: AB_2681530"	"unprognostic (2.31e-1)"	"unprognostic (2.62e-1)"	"unprognostic (3.99e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.42e-2)"	"unprognostic (6.07e-2)"	"unprognostic (7.47e-3)"	"unprognostic (2.24e-1)"	"unprognostic (8.67e-2)"	"unprognostic (8.83e-2)"	"unprognostic (8.15e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.12e-1)"	"prognostic favorable (1.70e-4)"	"unprognostic (9.76e-2)"	0.4	1.2	0.4	0.4	0.6	0.0	0.4	0.4	3.4	0.4	0.4	19.4	0.4	5.3	0.4	9.6	0.4	0.1	28.4	0.4	5.0	0.1	46.1	25.2	0.4	0.4	0.4	0.4	0.4	7.8	0.0	0.4	0.4	31.7	0.6	1.0	11.0	0.4	27.7	0.4	0.2	11.3	0.4	0.4	0.4	2.1	0.4	0.5	0.4	0.4	0.4	0.4	0.4	0.4	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	81.0	0.0	0.0	0.0	0.0	13.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.6	0.4	3.4	5.0	0.1	0.4	0.4	31.7	0.5	0.0	0.0	0.9	0.0	0.0	0.0	0.2	15.3	0.0	0.0	1.8	0.0	0.0	13.3	67.3	0.0	0.0	1.0	0.0	42.5	0.0	0.0	0.0	0.0	15.7	0.0	0.0	0.0	0.0	0.6	0.7	0.0	0.0	0.0	2.8	0.1	0.9	28.7	2.9	0.0	138.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0
CLDN3	"C7orf1, CPE-R2, CPETR2, HRVP1, RVP1"	ENSG00000165215	"Claudin 3"	O15551	7	73768997-73770270	"Cancer-related genes, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Cancer-related genes, Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 100.4;thyroid gland: 91.6"	"Cell type enhanced"	"Detected in many"	12	"Enterocytes: 2133.6;Mucus-secreting cells: 1109.4;Paneth cells: 1932.3;Undifferentiated cells: 955.0"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"cerebellum: 3.1;pons and medulla: 3.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 10.6;MCF7: 66.5;PC-3: 14.2;RPMI-8226: 11.4;SCLC-21H: 17.6;T-47d: 31.6"	"Not detected"	"Not detected"							HPA014361	Enhanced		Supported	"Cell Junctions"		NA	NA		15000	"Cell Junctions"		"HPA014361: AB_2668982"	"unprognostic (1.84e-1)"	"unprognostic (4.83e-2)"	"unprognostic (2.05e-1)"	"unprognostic (5.27e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.79e-2)"	"unprognostic (8.26e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.28e-3)"	"unprognostic (1.42e-1)"	"prognostic favorable (3.39e-5)"	"unprognostic (1.46e-2)"	"unprognostic (1.87e-1)"	"unprognostic (5.18e-2)"	"unprognostic (6.72e-2)"	0.3	0.1	0.1	11.5	0.1	0.2	7.1	3.1	0.2	3.8	77.9	1.6	21.8	24.3	2.8	8.8	0.3	9.4	11.3	0.1	0.2	0.4	20.7	16.0	6.0	0.2	0.0	0.0	4.3	38.0	0.2	7.4	3.1	3.0	14.6	8.0	1.9	31.1	32.1	0.1	2.1	100.4	0.5	0.0	0.1	0.7	1.2	0.0	2.2	91.6	0.9	3.6	0.8	0.4	0.2	0.0	0.1	0.0	0.0	0.1	0.5	0.7	1.0	0.0	0.1	0.0	0.0	5.3	0.0	0.0	0.0	0.0	1.2	10.6	0.0	3.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	1.4	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	66.5	0.1	0.3	0.6	2.6	14.2	0.0	0.0	11.4	0.6	0.0	17.6	0.2	0.0	10.1	0.0	0.0	31.6	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.1	0.1	3.1	0.2	0.2	0.4	0.0	0.0	3.0	0.0	35.7	34.4	4.2	34.2	0.1	0.7	0.5	206.4	104.4	48.9	120.4	3.9	47.1	8.3	212.5	0.0	0.0	2133.6	23.3	15.9	8.6	0.5	498.9	28.7	32.7	4.3	0.0	581.8	0.0	0.0	0.0	2.3	0.9	10.1	3.6	1109.4	10.8	59.3	1932.3	0.0	42.3	8.5	0.0	0.4	0.0	0.0	0.0	60.5	2.9	955.0	455.4
CLDN7	"CEPTRL2, CPETRL2, Hs.84359"	ENSG00000181885	"Claudin 7"	O95471	17	7259903-7263983	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 166.7"	"Cell type enhanced"	"Detected in many"	7	"Enterocytes: 1175.0;Paneth cells: 985.5;Urothelial cells: 711.9"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BEWO: 26.8;CACO-2: 27.9;CAPAN-2: 54.3;HaCaT: 114.0;MCF7: 39.7;OE19: 42.8;SK-BR-3: 47.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB013063, HPA014703, HPA073662"	Enhanced		Approved	"Vesicles,Cell Junctions"		NA	NA			Vesicles	"Cell Junctions"	"CAB013063: , HPA014703: AB_1846873, HPA073662: "	"unprognostic (5.47e-2)"	"unprognostic (2.22e-1)"	"unprognostic (4.12e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.67e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.98e-2)"	"unprognostic (5.64e-3)"	"unprognostic (8.34e-2)"	"unprognostic (4.89e-3)"	"unprognostic (1.62e-2)"	"prognostic favorable (8.96e-11)"	"prognostic favorable (4.09e-4)"	"unprognostic (1.87e-1)"	"prognostic favorable (1.85e-4)"	"unprognostic (1.62e-1)"	1.6	2.0	0.4	28.0	0.4	0.0	9.5	0.4	0.4	9.9	71.4	0.4	47.6	47.2	2.4	49.3	73.4	13.4	47.2	0.7	0.4	0.3	30.0	12.1	32.3	0.8	0.4	0.4	3.4	70.9	12.3	7.3	25.0	0.4	9.8	42.5	0.7	40.9	42.2	0.9	2.9	166.7	1.8	0.5	1.4	1.2	1.8	0.4	1.5	40.5	28.3	45.6	12.2	19.3	3.8	1.6	0.0	3.0	2.2	6.7	2.3	3.2	0.3	0.0	0.0	0.0	0.2	26.8	0.0	0.1	0.0	0.0	27.9	54.3	0.0	1.0	0.1	0.1	114.0	0.0	3.5	0.0	0.0	0.6	0.0	0.7	0.0	2.1	0.0	0.2	0.5	5.4	0.0	0.2	0.0	2.5	0.0	0.3	0.1	0.0	39.7	0.0	0.3	0.2	42.8	1.0	0.0	0.0	0.7	0.0	0.0	6.5	0.1	0.3	47.5	0.0	2.2	17.3	0.4	5.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.0	0.0	2.2	3.0	4.8	0.5	1.5	3.3	1.6	3.8	3.7	6.7	0.0	2.2	0.1	0.2	0.9	2.3	0.4	0.4	0.4	0.4	0.4	0.3	0.4	0.4	0.4	0.4	104.2	43.9	5.4	188.2	1.8	0.8	0.5	226.7	123.1	91.0	305.4	7.9	231.4	33.2	701.7	0.0	3.8	1175.0	0.0	684.7	284.5	5.1	310.2	5.7	34.7	29.8	0.0	313.6	3.7	3.1	0.0	1.1	9.1	23.6	18.0	591.9	0.4	632.6	985.5	0.0	47.8	6.8	0.0	2.1	0.2	3.0	2.3	492.5	5.9	501.5	711.9
CLDN9		ENSG00000213937	"Claudin 9"	O95484	16	3012456-3014505	"Predicted membrane proteins"	"Host-virus interaction"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 16.5;pancreas: 9.6;pituitary gland: 15.9;placenta: 10.2"	"Cell type enhanced"	"Detected in some"	12	"Cholangiocytes: 10.2;Ductal cells: 8.3;Pancreatic endocrine cells: 5.9"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	8	"cerebellum: 16.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"CAPAN-2: 5.7;MCF7: 19.5;SCLC-21H: 15.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA076613			Supported	"Vesicles,Cell Junctions"		NA	NA			"Cell Junctions"	Vesicles	"HPA076613: AB_2686808"	"unprognostic (7.93e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.43e-2)"	"prognostic unfavorable (2.24e-6)"	"unprognostic (4.91e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.64e-2)"	"unprognostic (5.06e-2)"	"unprognostic (8.97e-3)"	"unprognostic (4.51e-2)"	"unprognostic (2.89e-2)"	"prognostic unfavorable (4.67e-4)"	"unprognostic (1.29e-1)"	"unprognostic (7.71e-3)"	"unprognostic (5.55e-2)"	0.3	0.4	0.4	0.5	2.1	5.2	0.3	16.5	1.4	0.6	1.0	0.3	0.3	1.8	0.3	0.9	0.3	2.3	1.1	0.4	0.8	0.8	0.6	2.6	1.5	0.3	1.4	0.3	0.3	9.6	4.8	15.9	10.2	0.5	0.3	0.1	0.3	1.7	0.3	1.5	0.4	1.2	0.3	2.2	1.0	0.3	0.3	0.3	1.2	0.3	0.3	0.3	0.3	0.3	0.0	0.0	0.7	0.0	0.0	0.0	0.0	3.3	0.1	0.0	2.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.4	5.7	0.0	0.1	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	19.5	0.0	1.6	0.0	0.2	0.1	0.0	0.0	0.2	0.2	0.1	15.3	0.1	0.8	0.8	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.2	0.0	0.3	0.2	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.4	2.1	16.5	1.4	0.8	0.8	1.4	0.3	0.5	0.3	0.0	0.0	0.0	1.8	0.1	1.4	0.3	10.2	2.7	0.0	0.0	0.0	0.2	0.0	8.3	0.0	0.0	0.0	0.0	1.6	0.7	0.0	0.7	0.0	0.0	0.1	0.0	1.7	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.2	5.9	1.1	0.0	0.0	0.7	0.0	0.0	0.1	0.2	0.4	0.9	0.0	0.2	1.7
CMTR2	"AFT, FLJ11171, FTSJD1, MTr2"	ENSG00000180917	"Cap methyltransferase 2"	Q8IYT2	16	71281389-71289715	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"mRNA capping, mRNA processing"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 75.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041700, HPA048265"	Uncertain		Approved	"Nuclear speckles,Cell Junctions"		NA	NA			"Cell Junctions"	"Nuclear speckles"	"HPA041700: AB_2677623, HPA048265: AB_2680334"	"unprognostic (1.27e-1)"	"unprognostic (2.49e-2)"	"unprognostic (2.94e-3)"	"unprognostic (1.43e-1)"	"unprognostic (6.30e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.93e-3)"	"unprognostic (2.86e-2)"	"unprognostic (7.93e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.85e-2)"	"unprognostic (7.39e-2)"	"prognostic favorable (4.97e-5)"	"unprognostic (9.55e-2)"	"unprognostic (5.99e-2)"	"unprognostic (1.54e-1)"	"unprognostic (5.34e-2)"	10.4	14.9	7.1	11.7	9.0	5.4	15.9	5.3	9.1	10.6	13.4	11.5	15.6	14.1	12.5	16.4	20.4	8.8	11.0	9.0	8.5	6.9	13.5	18.2	10.7	14.7	12.4	3.4	16.2	12.2	12.7	24.3	17.4	9.0	11.9	10.5	10.6	13.6	14.1	8.4	9.9	16.1	9.4	9.5	17.5	8.9	16.0	9.3	20.9	14.3	7.6	15.4	9.6	14.2	11.2	10.3	11.0	8.0	13.1	11.2	8.6	11.5	8.1	11.6	11.5	13.1	11.4	6.5	9.4	9.2	10.7	10.3	4.8	16.0	6.2	11.4	7.4	12.0	11.4	7.1	8.5	13.1	6.5	4.8	17.2	4.7	6.0	16.3	10.2	23.7	8.2	16.2	7.8	10.6	7.8	12.1	12.3	7.5	4.7	17.7	10.3	12.3	17.2	7.2	9.6	4.8	16.6	7.4	13.5	13.2	7.8	7.7	8.6	10.6	9.3	10.4	6.7	13.9	7.4	11.6	12.1	11.2	12.3	7.3	8.7	9.0	11.1	9.1	10.4	10.4	11.0	7.2	7.1	9.8	8.0	11.2	11.2	9.2	10.3	10.3	10.2	10.5	10.3	0.4	13.1	5.2	3.6	8.0	8.6	7.1	9.0	5.3	9.1	8.5	6.9	12.4	3.4	9.0	9.3	3.0	10.2	29.3	13.2	12.6	20.9	6.7	10.2	0.0	6.8	15.7	29.5	18.6	6.6	10.2	75.3	15.7	25.5	0.0	8.3	10.6	10.4	12.0	8.1	23.6	13.9	14.3	17.9	18.4	15.4	21.7	15.5	13.0	1.7	8.2	17.2	17.1	10.3	15.2	11.7	12.9	27.8	6.5	7.4	23.0	11.7	21.2	22.1	25.4	15.5	15.2
COBL	KIAA0633	ENSG00000106078	"Cordon-bleu WH2 repeat protein"	O75128	7	51016212-51316818	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 68.7"	"Cell type enhanced"	"Detected in many"	7	"Muller glia cells: 114.1;Rod photoreceptor cells: 71.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	46	"plasmacytoid DC: 4.6"	"Lineage enriched"	"Detected in single"	46	"dendritic cells: 4.6"	"Cell line enhanced"	"Detected in many"		"BEWO: 15.1;HeLa: 27.0;OE19: 23.9;RPMI-8226: 20.7;SuSa: 16.0;U-266/84: 15.3"	"Low region specificity"	"Detected in many"							"HPA019033, HPA019167"	Enhanced		Approved	"Plasma membrane,Cell Junctions"		NA	NA			"Plasma membrane, Cell Junctions"		"HPA019033: AB_2083648, HPA019167: AB_1847070"	"unprognostic (8.09e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.62e-3)"	"unprognostic (3.13e-1)"	"unprognostic (5.33e-3)"	"unprognostic (2.90e-1)"	"unprognostic (5.29e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.51e-2)"	"unprognostic (3.92e-2)"	"prognostic favorable (5.21e-12)"	"unprognostic (7.64e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.08e-1)"	"unprognostic (5.41e-3)"	1.8	1.3	27.5	1.8	26.1	0.7	9.5	12.5	23.8	3.9	11.6	27.9	2.2	11.6	2.0	4.4	9.5	12.7	5.8	32.8	27.7	14.5	8.3	12.3	8.8	0.7	23.8	13.8	2.6	11.4	24.7	5.2	3.4	10.8	9.4	7.3	2.8	26.9	3.7	68.7	10.7	20.7	2.2	25.0	0.8	7.4	2.5	16.8	0.0	5.5	12.2	3.1	1.0	2.3	0.0	4.6	0.0	0.0	0.0	0.0	0.0	5.5	4.1	0.0	0.1	0.0	0.0	15.1	0.0	0.0	0.0	0.0	9.9	8.9	0.0	0.4	0.0	0.6	10.4	5.7	0.0	0.0	0.0	4.4	0.0	27.0	2.1	0.0	0.0	0.0	0.7	1.3	0.0	0.0	0.0	0.0	0.8	2.8	0.1	0.0	3.5	0.0	0.0	4.0	23.9	3.4	0.0	0.2	20.7	8.1	0.0	5.4	0.1	1.9	12.1	1.7	16.0	8.7	0.0	0.0	0.0	4.9	0.1	0.4	0.0	15.3	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	27.5	26.1	12.5	19.0	27.7	14.5	23.8	13.8	10.8	16.8	35.7	15.8	2.2	2.5	15.9	1.6	66.3	17.8	37.5	19.4	8.7	55.0	16.7	0.0	19.8	2.6	1.4	61.6	0.0	8.3	8.0	1.8	28.8	9.3	24.7	1.8	0.0	17.9	0.6	0.6	2.7	0.6	1.8	15.1	1.8	27.0	114.1	19.3	28.1	0.4	14.7	71.8	0.0	1.0	0.5	5.5	31.1	33.6	1.3	11.7	6.4
COBLL1	KIAA0977	ENSG00000082438	"Cordon-bleu WH2 repeat protein like 1"	Q53SF7	2	164653624-164843679	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 154.2"	"Cell type enhanced"	"Detected in many"	6	"Collecting duct cells: 207.6;Cone photoreceptor cells: 235.6;Rod photoreceptor cells: 204.2;Syncytiotrophoblasts: 277.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	17	"memory B-cell: 15.5;naive B-cell: 9.2;plasmacytoid DC: 5.5"	"Group enriched"	"Detected in many"	18	"B-cells: 15.5;dendritic cells: 5.5"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 29.3;RPTEC TERT1: 29.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044933, HPA053344"	Enhanced		Approved	"Cell Junctions"		NA	NA			"Cell Junctions"		"HPA044933: AB_2679148, HPA053344: AB_2682123"	"unprognostic (1.20e-1)"	"unprognostic (3.13e-1)"	"unprognostic (6.82e-2)"	"unprognostic (2.38e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.49e-3)"	"unprognostic (1.10e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.76e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.77e-1)"	"prognostic favorable (5.27e-13)"	"unprognostic (1.56e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.42e-1)"	14.3	35.7	3.3	4.1	4.0	1.1	9.3	1.4	4.0	8.1	7.0	3.3	17.7	4.3	5.3	11.2	16.3	2.9	9.7	3.7	4.1	3.2	35.6	43.4	10.8	4.7	4.5	2.9	7.1	23.4	4.9	8.9	154.2	5.2	11.9	3.1	8.8	8.0	22.6	2.6	8.2	5.8	9.7	3.9	4.6	12.6	3.0	2.6	1.2	7.6	9.6	6.9	13.0	11.1	15.5	5.5	0.0	0.0	0.5	0.0	0.3	4.7	1.1	3.0	0.0	3.4	0.6	5.4	16.1	6.5	2.8	2.6	3.9	2.0	0.4	3.1	1.5	2.4	17.3	12.0	10.0	2.9	1.3	4.6	4.5	4.7	16.2	4.9	0.0	0.0	0.8	9.4	0.4	13.2	2.8	10.0	0.6	0.0	29.3	3.5	5.3	0.1	0.0	1.4	11.7	5.4	0.6	11.6	4.8	29.5	16.3	6.6	2.5	7.0	6.8	2.2	5.7	5.1	0.0	4.3	5.2	4.4	2.0	3.7	11.0	4.1	1.5	2.1	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	15.5	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.5	0.0	5.5	0.0	0.3	3.3	4.0	1.4	4.0	4.1	3.2	4.5	2.9	5.2	2.6	65.5	51.4	43.3	40.0	86.4	11.5	10.1	22.9	12.0	29.6	207.6	235.6	40.1	53.0	22.3	0.0	41.7	10.7	0.0	28.9	56.5	18.0	52.9	32.4	126.9	7.6	3.2	21.4	6.2	3.7	0.4	13.6	3.0	18.6	0.0	10.3	171.4	30.8	3.5	7.4	27.0	204.2	45.3	41.9	0.5	0.9	61.5	277.1	1.9	9.2	67.1
COLEC12	"CL-P1, SCARA4, SRCL"	ENSG00000158270	"Collectin subfamily member 12"	Q5KU26	18	316740-500722	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"cervix, uterine: 40.8"	"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 2: 109.4;Cytotrophoblasts: 115.8;Hofbauer cells: 118.9;Syncytiotrophoblasts: 93.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 3.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 17.7;BJ: 8.6;HSkMC: 14.6;U-2197: 22.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047917, HPA071056"	Enhanced		Approved	"Golgi apparatus,Vesicles,Cell Junctions"		NA	NA		550000	"Golgi apparatus, Vesicles"	"Cell Junctions"	"HPA047917: AB_2680208, HPA071056: AB_2686338"	"unprognostic (8.67e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.51e-2)"	"unprognostic (3.60e-2)"	"unprognostic (6.94e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.14e-4)"	"unprognostic (2.21e-1)"	"unprognostic (1.21e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.61e-1)"	"unprognostic (2.24e-3)"	"unprognostic (1.52e-2)"	"prognostic unfavorable (8.10e-4)"	"unprognostic (3.01e-3)"	14.2	3.7	6.9	4.6	9.7	1.2	9.4	3.5	6.4	40.8	8.0	7.7	5.1	3.4	13.1	9.9	7.5	6.6	8.1	13.5	7.0	6.3	2.7	1.4	18.7	13.9	8.1	5.8	6.8	2.4	1.5	1.5	32.0	10.5	9.6	5.0	23.5	4.8	3.5	6.3	4.4	5.0	14.3	5.2	1.2	5.0	5.0	4.7	0.7	7.6	3.8	4.9	15.0	7.3	0.9	0.9	3.3	0.8	0.7	0.5	0.3	0.0	0.0	1.5	0.0	1.7	17.7	0.6	8.6	3.0	1.2	2.2	0.0	0.0	0.0	0.1	1.4	0.1	0.0	0.2	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	14.6	0.0	0.8	0.0	0.5	3.3	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.5	0.0	4.6	0.0	0.0	0.0	0.2	0.0	0.1	0.0	1.5	0.0	0.0	0.1	2.2	0.3	22.4	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.8	0.8	0.4	0.5	0.3	0.3	0.5	0.5	0.4	0.2	0.9	0.4	0.4	3.3	0.7	0.5	0.9	0.3	0.3	6.9	9.7	3.5	6.4	7.0	6.3	8.1	5.8	10.5	4.7	3.0	109.4	0.0	2.9	3.7	6.1	3.6	0.0	2.7	19.4	3.5	9.8	115.8	0.0	0.1	7.2	3.1	0.0	0.0	0.0	4.3	47.7	8.6	12.8	0.2	118.9	6.4	15.1	1.8	4.1	16.7	57.0	17.9	1.7	27.1	0.2	63.6	0.3	0.0	6.7	0.0	10.8	0.0	1.9	1.1	1.2	3.3	93.0	1.3	0.7	1.6
COLQ	EAD	ENSG00000206561	"Collagen like tail subunit of asymmetric acetylcholinesterase"	Q9Y215	3	15450133-15521751	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Neurotransmitter degradation"		"Congenital myasthenic syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"blood: 31.8;lymphoid tissue: 19.6"	"Cell type enhanced"	"Detected in some"	11	"Ciliated cells: 6.7;Early spermatids: 4.2;Horizontal cells: 6.4;Late spermatids: 11.3;Peritubular cells: 4.2"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	5	"cerebellum: 11.4"	"Cell type enriched"	"Detected in some"	6	"MAIT T-cell: 31.8"	"Lineage enriched"	"Detected in single"	35	"T-cells: 31.8"	"Group enriched"	"Detected in some"	5	"BEWO: 17.3;HDLM-2: 5.6;U-937: 8.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA045876			Approved	"Plasma membrane,Cell Junctions"	"Secreted to blood"	NA	NA			"Plasma membrane"	"Cell Junctions"	"HPA045876: AB_2679479"	"unprognostic (4.08e-3)"	"unprognostic (2.61e-2)"	"unprognostic (2.13e-3)"	"unprognostic (2.37e-1)"	"unprognostic (2.11e-1)"	"unprognostic (4.62e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.28e-3)"	"unprognostic (4.68e-1)"	"unprognostic (7.00e-5)"	"unprognostic (6.58e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.30e-4)"	2.7	0.7	0.9	0.7	1.1	1.3	0.9	11.4	2.1	2.4	2.3	0.4	0.2	0.8	3.2	2.7	1.3	8.8	1.8	15.9	1.5	1.2	0.5	0.9	2.1	19.6	0.9	1.1	2.3	0.6	10.0	1.1	0.5	2.1	2.0	0.5	2.0	1.1	1.4	14.3	0.9	1.4	1.1	1.5	3.8	1.5	2.0	0.4	3.8	1.0	0.6	3.3	1.3	1.4	0.0	0.2	0.0	0.4	0.9	31.8	1.7	0.1	0.5	2.0	1.2	1.5	1.0	17.3	0.3	0.5	0.4	0.6	0.0	0.3	0.1	0.7	0.3	0.1	0.2	0.3	0.4	0.5	5.6	1.2	0.6	0.7	0.2	0.2	0.4	1.2	0.8	0.4	0.8	0.3	0.8	0.3	1.5	0.0	0.6	0.8	0.3	0.6	1.8	0.2	0.0	0.6	0.8	0.2	0.4	0.4	0.4	0.6	1.8	0.2	0.1	0.4	1.9	1.2	0.8	0.1	0.2	1.1	1.9	0.6	1.7	1.5	0.1	0.1	8.7	0.1	0.0	0.4	0.0	5.5	0.0	31.8	0.0	2.7	3.9	0.0	0.0	0.3	0.3	0.0	0.9	0.0	0.2	0.1	1.7	0.9	1.1	11.4	2.1	1.5	1.2	0.9	1.1	2.1	0.4	0.0	1.1	0.0	0.1	0.2	0.3	0.7	0.0	6.7	2.3	0.0	0.0	0.2	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.1	0.4	0.2	0.0	0.8	0.2	6.4	1.2	2.5	0.0	11.3	1.7	0.0	0.0	0.0	0.0	0.4	0.2	0.0	4.2	0.0	0.6	0.0	0.2	0.7	0.2	0.1	1.9	1.3	0.0	0.0
CRB3	MGC17303	ENSG00000130545	"Crumbs 3, cell polarity complex component"	Q9BUF7	19	6463777-6467221	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Pancreatic endocrine cells: 118.0;Suprabasal keratinocytes: 122.0;Urothelial cells: 233.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 11.3"	"Group enriched"	"Detected in many"	17	"B-cells: 3.8;T-cells: 11.3"	"Cell line enhanced"	"Detected in some"		"A-431: 26.3;BEWO: 16.9;CACO-2: 17.7;HaCaT: 17.3;hTCEpi: 13.3;OE19: 15.2;SK-BR-3: 14.0;T-47d: 12.2"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA013835	Enhanced		Supported	"Cell Junctions"		NA	NA			"Cell Junctions"		"HPA013835: AB_1847214"	"unprognostic (3.25e-1)"	"unprognostic (4.41e-2)"	"unprognostic (9.69e-2)"	"prognostic favorable (4.54e-4)"	"unprognostic (1.24e-1)"	"unprognostic (1.95e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.57e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.11e-1)"	"prognostic favorable (0.00e+0)"	"unprognostic (8.42e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.12e-2)"	"prognostic favorable (8.06e-5)"	0.4	0.1	0.4	5.9	0.5	0.0	2.6	0.4	0.4	4.1	24.4	0.6	20.7	19.8	2.2	12.6	24.2	4.3	14.8	0.4	0.5	0.1	24.8	28.5	11.7	1.4	0.4	0.5	1.4	37.2	7.0	7.7	6.5	1.8	5.0	5.5	4.1	19.3	16.9	0.4	18.3	33.6	0.9	0.4	0.6	16.1	1.6	0.4	0.8	19.4	7.7	10.6	5.2	7.0	3.8	0.0	0.4	0.0	0.0	11.3	2.7	26.3	3.3	0.0	0.1	0.0	0.0	16.9	0.0	0.0	0.0	0.0	17.7	11.2	0.1	10.6	0.0	0.1	17.3	0.2	5.8	0.0	0.0	0.2	0.0	0.1	9.7	0.0	0.0	0.0	0.0	13.3	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	6.9	0.0	0.2	0.6	15.2	0.0	0.0	0.0	0.3	7.9	11.2	0.0	0.0	0.1	14.0	0.0	0.8	12.2	0.1	0.0	0.0	0.2	0.1	0.0	0.3	0.1	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.4	0.0	1.7	3.8	5.6	2.6	0.0	1.3	11.3	4.5	0.4	0.0	0.0	0.0	3.6	2.7	0.4	0.5	0.4	0.4	0.5	0.1	0.4	0.5	1.8	0.4	32.8	29.4	0.8	51.0	64.1	0.0	0.3	58.6	14.7	23.9	29.6	0.0	23.3	39.7	102.1	0.0	0.5	81.0	0.0	88.0	9.0	3.1	85.4	1.1	29.8	2.1	0.0	16.1	0.6	0.6	0.0	0.0	4.1	6.8	4.6	35.2	1.1	118.0	63.1	0.0	33.6	0.6	0.0	2.3	0.7	0.2	122.0	47.0	2.9	39.7	233.8
CTNNA1	CAP102	ENSG00000044115	"Catenin alpha 1"	P35221	5	138610967-138935034	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB021089, HPA046119, HPA063535"	Approved		Enhanced	"Plasma membrane,Cell Junctions"		NA	NA		5400	"Plasma membrane, Cell Junctions"		"CAB021089: AB_10123543, HPA046119: AB_2679547, HPA063535: AB_2685033"	"unprognostic (2.25e-3)"	"unprognostic (3.32e-2)"	"unprognostic (2.82e-3)"	"unprognostic (1.80e-1)"	"unprognostic (8.40e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.66e-3)"	"unprognostic (4.83e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.48e-1)"	"prognostic unfavorable (8.02e-4)"	"unprognostic (6.18e-2)"	"prognostic favorable (7.34e-7)"	"unprognostic (1.54e-1)"	"unprognostic (2.31e-1)"	"unprognostic (7.62e-2)"	"unprognostic (1.04e-1)"	55.9	54.0	39.6	24.4	50.2	10.9	55.1	16.5	39.5	43.4	58.9	68.5	33.9	44.2	53.0	47.5	76.9	45.8	41.1	68.6	38.8	32.3	62.2	37.7	49.8	27.0	57.3	29.3	42.7	38.1	55.5	25.6	54.0	45.5	39.4	49.0	35.6	48.8	43.5	30.5	49.8	53.9	59.6	49.7	30.9	48.2	18.7	56.6	8.1	51.2	46.4	44.1	48.4	45.1	3.8	15.2	9.8	21.8	0.3	5.0	7.1	32.2	23.5	35.7	52.8	31.1	34.2	54.4	32.7	41.2	31.3	39.7	49.0	43.9	0.1	27.7	48.8	34.4	24.7	24.5	53.8	36.5	18.5	21.3	13.6	38.8	29.7	37.5	0.2	13.3	21.5	43.1	37.4	41.1	34.9	59.0	9.8	7.4	14.0	33.7	28.5	0.3	4.1	14.3	34.4	0.5	12.7	20.8	19.4	66.1	43.2	14.3	18.8	60.4	84.9	49.4	79.5	30.0	9.3	50.0	33.0	17.9	20.4	22.6	5.1	9.5	1.9	31.4	5.9	42.5	2.2	17.1	1.5	2.9	21.8	1.9	3.8	2.1	2.1	15.2	3.2	0.1	1.1	9.8	0.3	20.2	3.7	5.0	7.1	39.6	50.2	16.5	39.5	38.8	32.3	57.3	29.3	45.5	56.6	241.2	121.7	23.1	99.7	69.7	8.7	202.9	84.1	172.6	201.3	115.1	19.6	101.5	58.0	167.3	13.9	111.5	204.4	23.3	152.7	117.7	74.1	118.0	39.3	51.3	79.8	3.2	49.0	92.7	73.9	18.8	72.2	73.0	74.2	212.8	129.6	45.5	232.1	131.5	79.5	116.5	23.0	97.0	108.1	17.0	21.1	67.5	158.8	17.0	92.7	143.6
CTNNBIP1	"ICAT, MGC15093"	ENSG00000178585	"Catenin beta interacting protein 1"	Q9NSA3	1	9848276-9910336	"Predicted intracellular proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 116.5"	"Cell type enhanced"	"Detected in many"	7	"Suprabasal keratinocytes: 254.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042617, HPA067089"	Enhanced		Approved	"Plasma membrane,Cell Junctions,Mitochondria"		NA	NA			"Plasma membrane, Cell Junctions, Mitochondria"		"HPA042617: AB_2678081, HPA067089: "	"unprognostic (2.71e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.94e-1)"	"prognostic favorable (5.68e-6)"	"unprognostic (3.08e-1)"	"unprognostic (2.63e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.23e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.24e-3)"	"unprognostic (3.62e-2)"	"unprognostic (3.22e-2)"	"unprognostic (8.63e-2)"	"unprognostic (4.37e-2)"	12.6	4.0	10.1	4.3	8.1	7.7	18.3	21.4	14.8	16.6	5.8	10.1	10.9	7.4	4.8	31.3	49.0	5.2	4.8	13.7	10.1	9.5	5.6	4.8	15.2	4.0	8.4	11.3	5.5	14.1	4.0	6.6	11.0	13.7	9.9	4.2	13.3	15.5	16.5	13.1	116.5	5.8	4.5	9.2	3.3	8.8	11.8	6.5	4.8	7.9	33.9	13.5	5.6	21.7	1.9	6.8	12.9	5.4	8.8	2.9	2.3	26.2	3.9	24.2	18.4	3.6	6.1	7.7	5.2	9.2	7.7	4.9	1.9	33.5	8.1	15.1	6.7	7.9	13.4	2.8	30.9	3.5	20.4	4.3	5.2	1.2	24.4	7.6	3.9	3.1	6.8	30.6	9.8	10.0	6.6	20.7	15.3	9.2	3.8	4.7	16.1	8.7	14.6	12.8	21.2	6.8	10.0	7.1	5.2	3.9	9.0	26.6	16.8	11.8	10.8	15.7	8.6	13.2	9.7	13.5	5.0	6.1	7.5	11.4	8.4	10.9	9.5	1.8	20.0	19.7	2.7	5.4	12.9	2.9	1.9	1.7	1.9	1.5	2.4	6.8	1.6	1.4	1.4	4.0	8.8	1.2	2.1	1.2	2.3	10.1	8.1	21.4	14.8	10.1	9.5	8.4	11.3	13.7	6.5	26.8	11.5	11.8	34.8	91.7	8.4	11.6	22.9	1.4	7.9	17.4	7.9	61.2	28.2	16.0	101.0	18.1	20.6	23.3	16.2	34.6	26.7	52.4	0.0	22.9	49.6	15.9	47.1	16.0	32.6	19.5	13.8	30.5	45.5	5.4	34.9	106.1	27.9	25.8	21.5	23.0	12.2	45.3	22.1	72.3	36.2	254.8	40.5	18.1	24.3	54.7
CTNND2	"GT24, NPRAP"	ENSG00000169862	"Catenin delta 2"	Q9UQB3	5	10971840-11904043	"Disease related genes, Predicted intracellular proteins"	"Cell adhesion, Transcription, Transcription regulation, Wnt signaling pathway"	"Developmental protein"	"Autism, Autism spectrum disorder, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 74.3"	"Cell type enhanced"	"Detected in many"	10	"Bipolar cells: 18.0;Cholangiocytes: 38.2;Early spermatids: 21.0;Late spermatids: 23.3;Muller glia cells: 39.5"	"Cancer enriched"	"Detected in many"	16	"glioma: 44.2"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 18.1;MCF7: 8.2;SK-BR-3: 5.4;U-266/84: 15.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015077, CAB037339, HPA071124"	Enhanced		Approved	"Nucleoplasm,Cell Junctions,Cytosol"		NA	NA			"Nucleoplasm, Cell Junctions"	Cytosol	"CAB037339: , HPA015077: AB_2669150, HPA071124: "	"unprognostic (7.32e-2)"	"unprognostic (1.51e-3)"	"unprognostic (2.23e-1)"	"unprognostic (5.16e-2)"	"unprognostic (5.66e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.74e-2)"	"unprognostic (9.13e-2)"	"unprognostic (9.86e-2)"	"unprognostic (8.95e-3)"	"unprognostic (2.66e-1)"	"unprognostic (9.55e-4)"	"unprognostic (5.87e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.76e-2)"	1.7	2.4	30.9	1.8	26.3	1.4	2.8	21.6	74.3	1.7	1.8	16.6	0.0	1.7	1.6	1.9	1.6	1.7	4.8	6.0	26.0	17.7	1.5	1.7	2.4	1.6	22.8	20.2	2.1	12.5	1.5	5.7	1.9	11.0	2.6	1.9	2.6	1.7	1.7	1.6	1.5	2.0	1.6	13.3	5.7	1.9	4.2	14.7	0.0	1.7	0.0	1.5	1.6	0.1	0.0	0.0	0.8	0.4	0.0	0.3	0.6	0.0	0.1	18.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	8.2	0.0	0.0	2.7	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.1	0.0	0.0	5.4	0.0	0.6	0.0	0.0	0.0	0.0	0.9	0.0	3.3	0.0	15.4	0.0	1.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.4	0.0	0.0	0.6	30.9	26.3	21.6	29.1	26.0	17.7	22.8	20.2	11.0	14.7	0.0	0.0	0.0	0.0	0.0	18.0	8.4	38.2	0.0	0.0	1.8	0.0	0.0	3.3	5.4	21.0	0.3	0.0	0.0	5.4	0.0	0.0	3.6	0.0	0.0	0.1	7.9	4.7	0.0	0.0	23.3	1.4	0.0	0.0	0.0	0.0	39.5	3.5	0.0	0.0	0.3	2.6	0.0	0.0	1.4	3.1	0.0	0.0	0.0	0.0	0.1
CTXN1	FLJ25968	ENSG00000178531	"Cortexin 1"	P60606	19	7924485-7926166	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	5	"brain: 91.1"	"Cell type enhanced"	"Detected in many"	7	"Glandular cells: 14.7;Late spermatids: 13.4;Spermatogonia: 10.4"	"Cancer enhanced"	"Detected in all"		"ovarian cancer: 138.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 33.9;HEK 293: 23.6;NTERA-2: 25.7;REH: 19.5;SCLC-21H: 20.0;SH-SY5Y: 33.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA016669	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA			Nucleoplasm	"Plasma membrane, Cell Junctions"	"HPA016669: AB_1847330"	"unprognostic (1.49e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.79e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.82e-2)"	"unprognostic (5.42e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.69e-3)"	"unprognostic (3.31e-2)"	"unprognostic (1.56e-3)"	"unprognostic (4.84e-2)"	"unprognostic (3.09e-2)"	"unprognostic (3.76e-2)"	"unprognostic (9.41e-2)"	2.1	4.8	47.7	2.5	91.1	1.6	2.1	0.0	74.2	5.2	6.1	5.0	3.6	2.6	17.5	5.1	2.4	16.4	1.8	1.6	49.4	16.8	3.1	1.5	3.0	1.6	15.7	20.1	2.7	2.1	2.3	6.5	2.0	4.0	5.5	2.1	0.0	2.1	16.5	1.6	2.8	2.1	7.1	1.5	2.0	2.2	6.1	8.3	0.0	1.8	0.0	1.6	2.9	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.3	2.8	7.3	33.9	0.0	0.1	1.7	2.9	0.8	1.4	0.8	0.8	1.7	0.0	5.8	0.7	0.8	12.3	1.6	0.3	0.0	1.0	23.6	0.2	1.9	0.5	0.3	0.6	0.6	0.0	0.9	0.5	0.3	3.5	1.9	3.2	7.1	0.1	0.1	13.7	6.2	4.6	25.7	0.8	11.9	19.5	0.0	2.2	5.2	0.5	20.0	33.6	1.8	0.9	3.1	0.6	7.4	0.2	2.8	0.7	11.9	1.3	1.6	0.2	0.3	1.6	2.8	1.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.7	91.1	0.0	63.8	49.4	16.8	15.7	20.1	4.0	8.3	0.0	0.0	0.0	3.6	1.0	0.2	0.2	0.0	0.0	0.0	8.7	3.9	0.1	3.3	5.0	7.3	0.5	0.0	0.0	0.3	0.4	0.9	14.7	0.0	0.0	0.2	0.0	8.7	0.6	0.0	13.4	1.1	0.1	1.7	0.0	0.0	0.1	2.0	0.2	1.8	7.2	0.4	0.0	4.2	3.6	10.4	1.8	0.2	0.0	0.0	5.9
CXADR	CAR	ENSG00000154639	"CXADR, Ig-like cell adhesion molecule"	P78310	21	17512382-17593579	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 41.4"	"Cell type enhanced"	"Detected in many"	5	"Basal keratinocytes: 287.2;Suprabasal keratinocytes: 300.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 32.2;Hep G2: 20.8;NTERA-2: 37.3;RT4: 36.0"									"HPA003342, CAB005103, HPA030411, HPA030412"	Enhanced		Enhanced	"Plasma membrane,Cell Junctions"	"Intracellular and membrane"	NA	NA		11000	"Plasma membrane, Cell Junctions"		"CAB005103: AB_2087557, HPA003342: AB_1078588, HPA030411: AB_10599620, HPA030412: AB_10601992"	"unprognostic (3.75e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.45e-3)"	"unprognostic (2.10e-1)"	"unprognostic (1.56e-1)"	"prognostic favorable (3.50e-4)"	"unprognostic (1.32e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.15e-1)"	"unprognostic (3.48e-3)"	"unprognostic (1.04e-1)"	"unprognostic (9.35e-2)"	"unprognostic (3.89e-3)"	"unprognostic (2.20e-1)"	"unprognostic (8.27e-2)"	"unprognostic (5.71e-3)"	4.0	3.1	6.4	3.2	9.4	1.3	5.8	2.0	15.4	6.3	27.1	12.5	9.0	24.9	3.3	9.3	15.0	6.5	17.2	10.8	7.9	5.5	5.1	28.6	9.9	4.2	9.2	5.6	1.1	12.0	5.2	11.1	0.3	11.6	9.2	15.4	3.7	16.3	15.8	0.6	30.0	41.4	2.1	13.0	1.4	17.6	8.5	6.9	0.9	13.1	4.9	3.8	14.7	10.0	0.8	0.4	2.6	0.5	0.9	2.7	0.9	5.6	3.1	15.4	0.0	0.0	0.0	9.3	0.0	0.0	0.2	0.9	32.2	4.9	2.0	6.9	0.0	4.6	9.8	7.8	2.0	0.3	3.1	6.6	0.0	9.2	20.8	1.0	0.6	0.0	0.0	8.5	0.4	0.1	3.7	3.0	1.9	0.1	0.1	0.0	0.3	1.2	0.0	37.3	5.0	0.0	0.0	5.2	4.0	12.9	36.0	6.2	4.2	3.6	4.1	2.1	16.5	8.6	0.1	0.1	0.0	9.3	0.1	2.2	1.5	2.5	0.1	1.2	0.0	0.2	2.6	0.5	0.4	0.5	0.2	1.0	0.3	2.6	0.6	0.1	0.8	2.7	0.8	1.4	0.9	0.2	0.4	0.5	0.9	6.4	9.4	2.0	15.4	7.9	5.5	9.2	5.6	11.6	6.9	131.0	63.6	1.5	156.7	287.2	15.2	27.4	137.6	50.9	55.7	97.7	25.5	1.0	5.0	109.2	4.3	2.0	199.0	0.0	81.3	0.2	6.8	133.1	5.7	114.1	0.6	0.0	77.6	70.6	23.6	4.0	2.0	5.3	21.9	1.0	96.0	11.6	81.7	112.0	0.0	4.4	10.0	6.5	3.8	4.2	22.3	300.5	0.6	3.8	81.0	165.3
CYP20A1	CYP-M	ENSG00000119004	"Cytochrome P450 family 20 subfamily A member 1"	Q6UW02	2	203238940-203305611	"Predicted intracellular proteins, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA055872, HPA058461"	Uncertain		Uncertain	"Nucleoplasm,Plasma membrane,Cell Junctions,Actin filaments"		No	No			"Plasma membrane, Cell Junctions, Actin filaments"	Nucleoplasm	"HPA055872: AB_2682951, HPA058461: AB_2683725"	"unprognostic (4.72e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.20e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.06e-2)"	"unprognostic (5.21e-2)"	"unprognostic (2.58e-2)"	"unprognostic (4.21e-2)"	"unprognostic (2.62e-2)"	"unprognostic (4.53e-2)"	"unprognostic (4.42e-2)"	"unprognostic (7.64e-3)"	"unprognostic (9.39e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.95e-3)"	11.1	14.9	5.0	9.1	6.4	2.8	7.6	6.8	6.1	9.3	8.6	8.6	9.2	6.0	10.8	7.1	8.0	8.0	9.1	7.0	4.5	4.8	13.5	12.5	8.4	7.8	8.1	2.1	13.4	17.3	9.1	13.6	9.4	6.5	9.0	7.8	10.9	9.8	8.8	5.3	6.3	10.5	9.0	6.5	10.1	8.8	10.8	8.1	13.8	16.9	4.3	9.1	7.7	9.7	13.0	13.6	6.8	11.3	8.8	15.5	9.1	5.2	4.9	2.5	4.9	14.6	3.1	5.2	8.9	4.5	3.8	3.9	14.1	7.6	3.8	7.3	5.6	6.4	5.8	3.2	4.0	5.3	5.1	3.8	8.2	3.1	6.4	11.3	9.0	5.2	6.9	3.1	6.1	6.4	2.8	7.5	7.0	12.7	13.1	6.9	7.1	7.5	4.7	9.7	3.8	10.9	5.1	5.7	7.4	4.5	10.4	3.7	5.1	0.3	4.6	7.3	4.6	2.8	4.9	8.5	12.3	4.8	6.1	5.6	8.9	9.7	4.6	7.6	3.6	5.7	5.2	10.4	6.8	14.4	11.3	15.5	11.1	14.9	12.7	7.8	13.0	12.5	9.2	2.2	8.8	10.5	13.6	13.4	9.1	5.0	6.4	6.8	6.1	4.5	4.8	8.1	2.1	6.5	8.1	14.9	28.6	32.8	34.8	11.0	38.9	22.7	35.7	28.1	43.3	15.7	55.0	28.0	10.0	15.4	79.1	37.9	32.7	23.3	17.9	19.0	33.8	32.0	27.8	42.9	33.5	47.7	43.6	74.3	32.1	14.0	113.9	25.8	6.8	21.6	29.9	37.0	13.8	28.1	78.8	22.1	69.0	64.7	26.8	43.2	28.1	11.7	34.1	33.1	28.6	27.5
DCAF13	"DKFZP564O0463, Gm83, HSPC064, Sof1, WDSOF1"	ENSG00000164934	"DDB1 and CUL4 associated factor 13"	Q9NV06	8	103414714-103443453	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing, Ubl conjugation pathway"	Ribonucleoprotein		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044504	Uncertain		Supported	"Nucleoplasm,Nucleoli,Cell Junctions,Centrosome,Cytosol"		NA	NA			"Nucleoplasm, Nucleoli"	"Cell Junctions, Centrosome, Cytosol"	"HPA044504: AB_2678963"	"prognostic unfavorable (4.06e-4)"	"unprognostic (4.39e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.46e-3)"	"unprognostic (3.57e-2)"	"unprognostic (7.86e-3)"	"prognostic unfavorable (8.05e-6)"	"unprognostic (5.92e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.27e-2)"	"unprognostic (5.54e-3)"	"unprognostic (2.31e-2)"	"prognostic unfavorable (2.85e-4)"	"unprognostic (1.53e-1)"	"unprognostic (1.55e-1)"	"unprognostic (6.42e-2)"	"unprognostic (8.63e-2)"	18.4	20.5	13.8	18.1	15.7	10.6	20.2	11.3	14.3	16.0	16.7	13.0	12.9	13.1	18.1	16.7	24.0	15.3	10.7	15.9	12.4	11.8	35.2	26.5	12.4	18.4	16.5	12.1	20.9	28.9	15.7	34.6	21.2	16.2	16.4	18.5	7.4	15.9	11.3	21.1	13.7	16.8	15.3	13.9	20.4	14.7	25.3	15.0	26.4	17.1	22.6	24.3	16.9	15.5	28.6	26.4	10.3	22.1	24.0	27.2	20.2	25.3	22.8	21.3	21.7	15.5	18.0	16.0	18.9	14.5	18.0	18.5	22.4	24.8	35.3	32.4	19.8	17.8	19.1	28.8	24.2	34.9	33.6	20.5	48.7	13.7	25.4	17.7	19.9	21.0	14.6	16.7	26.5	44.1	11.3	24.9	24.3	32.7	15.5	27.3	20.6	37.8	21.0	32.6	71.8	35.6	24.6	25.9	36.3	26.2	21.2	27.2	25.8	11.8	18.5	21.4	19.6	28.6	13.7	16.4	18.3	29.5	23.6	25.3	17.1	29.8	49.9	24.7	43.6	23.4	8.6	18.6	10.3	18.4	22.1	25.2	28.6	19.8	19.7	26.4	22.1	19.8	20.2	2.0	24.0	16.0	13.7	27.2	20.2	13.8	15.7	11.3	14.3	12.4	11.8	16.5	12.1	16.2	15.0	14.9	14.2	31.8	57.7	70.6	19.2	17.3	7.6	14.7	31.8	31.4	23.6	50.1	33.2	41.0	33.6	28.9	16.1	0.0	42.0	61.5	36.1	25.3	40.3	14.7	39.5	15.9	13.9	17.2	15.4	10.8	22.5	25.0	25.3	30.7	16.0	25.8	34.4	10.5	16.6	66.3	19.8	12.9	36.3	85.0	87.9	67.2	28.4	26.3	25.4	52.2
DCP2	NUDT20	ENSG00000172795	"Decapping mRNA 2"	Q8IU60	5	112976702-113020970	"Enzymes, Predicted intracellular proteins"	"Nonsense-mediated mRNA decay"	"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 52.9"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011677, HPA057676"	Approved		Approved	"Nucleoplasm,Cell Junctions,Cytoplasmic bodies"		NA	NA			"Nucleoplasm, Cytoplasmic bodies"	"Cell Junctions"	"CAB011677: AB_731858, HPA057676: AB_2683500"	"unprognostic (2.76e-1)"	"unprognostic (3.27e-1)"	"unprognostic (2.79e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.86e-3)"	"prognostic unfavorable (4.84e-4)"	"unprognostic (1.87e-1)"	"unprognostic (3.64e-2)"	"unprognostic (6.26e-2)"	"unprognostic (1.15e-1)"	"unprognostic (9.30e-2)"	"prognostic unfavorable (2.66e-5)"	"unprognostic (8.39e-2)"	"unprognostic (2.84e-1)"	"unprognostic (3.25e-2)"	"unprognostic (5.75e-2)"	8.0	7.5	8.1	16.3	9.5	22.9	15.0	16.8	10.9	9.1	6.6	6.4	6.6	6.3	10.5	6.8	7.4	8.0	6.5	6.1	8.1	8.9	8.1	8.1	13.2	19.8	6.9	6.1	12.8	6.2	7.0	12.2	40.2	8.3	8.1	7.3	6.5	9.6	8.6	8.3	9.8	8.7	7.3	7.4	19.9	6.7	6.8	6.5	52.9	7.0	4.1	20.0	8.7	9.1	5.1	6.5	16.3	8.3	3.9	5.9	3.2	3.6	3.1	14.1	11.3	2.8	3.1	22.8	3.3	2.7	4.2	6.1	14.6	7.8	19.1	5.3	1.9	3.4	4.5	16.2	4.5	5.1	5.1	7.0	17.9	2.7	5.8	3.2	10.9	9.3	2.9	3.1	5.1	5.1	4.0	7.1	14.7	13.2	7.5	3.8	4.6	16.0	11.6	12.2	2.2	1.9	15.7	13.4	7.1	6.5	9.3	3.3	7.0	4.6	5.2	6.7	15.3	15.4	14.6	4.6	4.7	8.4	2.4	5.0	5.1	11.2	14.6	2.7	15.3	3.6	12.2	7.2	5.5	4.0	7.1	5.5	5.1	4.9	4.2	6.5	3.6	4.6	4.7	16.3	3.9	8.3	3.5	5.9	3.2	8.1	9.5	16.8	10.9	8.1	8.9	6.9	6.1	8.3	6.5	17.9	15.6	38.9	16.7	24.6	21.6	11.4	5.1	18.7	22.7	19.2	74.6	53.4	16.6	8.9	23.5	21.8	10.0	0.0	10.3	41.1	27.2	25.6	18.5	5.9	27.7	27.0	15.5	27.6	71.2	42.2	17.5	46.5	25.3	36.9	9.1	34.4	12.8	10.5	10.3	11.2	35.2	6.5	17.9	29.3	19.0	23.2	53.9	38.8	11.3	37.6
DDB2	"DDBB, FLJ34321, UV-DDB2, XPE"	ENSG00000134574	"Damage specific DNA binding protein 2"	Q92466	11	47214465-47239240	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	DNA-binding	"Cancer-related genes, Disease mutation, Xeroderma pigmentosum"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"monocytes: 221.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025912, HPA058406"	Enhanced		Supported	"Nucleoplasm,Cell Junctions"		NA	NA			"Nucleoplasm, Cell Junctions"		"CAB025912: , HPA058406: AB_2683708"	"prognostic favorable (7.29e-4)"	"prognostic favorable (1.58e-4)"	"unprognostic (1.49e-1)"	"prognostic favorable (1.20e-4)"	"unprognostic (4.29e-2)"	"unprognostic (2.04e-2)"	"unprognostic (2.96e-2)"	"unprognostic (6.18e-2)"	"unprognostic (2.25e-1)"	"unprognostic (3.58e-3)"	"unprognostic (3.53e-1)"	"unprognostic (1.94e-1)"	"unprognostic (4.57e-3)"	"unprognostic (1.21e-2)"	"unprognostic (4.25e-2)"	"unprognostic (9.82e-3)"	"unprognostic (1.07e-1)"	12.2	22.2	5.3	13.3	8.6	8.1	11.3	11.0	8.2	16.8	13.5	7.3	13.4	6.0	18.2	14.1	25.4	14.3	13.0	6.1	4.7	2.9	6.6	20.8	11.3	16.1	15.0	5.0	9.8	15.6	6.1	8.6	5.5	6.3	20.9	12.3	8.1	17.6	14.8	6.3	36.9	11.0	19.0	17.6	15.1	9.1	7.6	7.6	23.3	6.6	16.7	26.0	17.3	15.2	11.4	6.1	11.5	11.0	7.4	27.0	9.0	8.4	22.7	9.5	7.1	6.1	12.4	11.2	9.2	21.7	11.9	14.0	3.7	4.9	20.3	1.9	8.4	8.9	14.8	5.4	18.8	5.9	5.0	10.2	4.7	21.7	16.8	6.0	5.5	12.7	16.6	21.4	5.9	13.2	3.8	34.6	5.3	1.2	9.9	19.4	15.9	21.1	2.6	3.0	11.1	8.2	10.6	2.4	10.9	5.0	8.3	5.0	6.2	11.3	3.3	3.0	11.9	20.8	1.8	14.9	36.4	16.6	7.9	4.3	10.4	7.9	4.5	13.7	7.0	13.0	5.9	8.1	11.5	12.1	11.0	11.7	11.4	12.7	11.7	6.1	7.4	9.4	10.1	2.2	7.4	9.2	0.1	27.0	9.0	5.3	8.6	11.0	8.2	4.7	2.9	15.0	5.0	6.3	7.6	14.9	20.3	19.2	35.4	34.6	4.6	7.2	12.7	10.7	13.6	5.2	9.8	2.1	8.3	9.6	1.1	17.8	7.9	0.0	12.0	7.7	14.1	9.5	22.0	12.4	15.9	1.6	7.5	14.1	16.5	1.6	17.5	16.5	18.6	221.8	13.6	14.2	15.3	7.0	9.9	6.2	11.6	0.0	15.5	0.7	9.9	26.5	1.3	38.8	14.0	21.3
DDR1	"CAK, CD167, EDDR1, NEP, NTRK4, PTK3A, RTK6"	ENSG00000204580	"Discoidin domain receptor tyrosine kinase 1"	Q08345	6	30876421-30900156	"CD markers, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Lactation, Pregnancy"	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Muller glia cells: 145.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HaCaT: 31.8;HBEC3-KT: 24.5;RT4: 32.5;T-47d: 36.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010162, CAB025656, HPA057194"	Approved		Approved	"Nucleoplasm,Cell Junctions"	"Intracellular and membrane"	NA	NA		2100000	"Nucleoplasm, Cell Junctions"		"CAB010162: AB_2092090, CAB025656: , HPA057194: "	"unprognostic (2.11e-2)"	"unprognostic (9.31e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.07e-1)"	"unprognostic (7.75e-3)"	"unprognostic (6.43e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.41e-2)"	"prognostic favorable (3.31e-10)"	"unprognostic (1.42e-1)"	"unprognostic (2.53e-1)"	"unprognostic (5.49e-3)"	"unprognostic (4.09e-2)"	6.7	11.3	23.5	7.9	36.2	2.2	12.5	6.8	42.2	9.7	25.2	57.4	17.6	16.8	7.7	10.5	30.5	31.7	18.9	8.7	27.8	20.8	19.8	3.5	13.2	3.1	55.7	19.8	11.3	20.9	28.2	14.6	13.3	34.7	17.7	14.9	4.0	28.3	20.5	9.1	41.3	32.1	3.1	43.2	5.1	52.2	5.1	37.0	8.7	20.9	10.5	7.6	16.3	16.6	1.8	0.4	0.0	0.2	0.0	1.8	0.9	19.7	6.5	9.2	1.9	0.6	0.9	5.7	0.5	0.1	0.3	0.0	8.7	10.5	0.1	11.0	1.7	9.6	31.8	2.0	24.5	0.1	10.9	3.5	0.0	6.0	2.3	1.8	0.0	0.4	1.2	12.7	0.1	0.2	5.8	0.7	0.5	5.7	0.2	1.4	12.5	0.7	0.0	1.6	10.9	1.3	1.3	6.9	0.7	4.7	32.5	1.6	0.9	1.8	14.7	7.1	3.2	36.5	0.2	1.5	4.6	4.3	0.4	4.6	0.2	0.0	0.8	3.0	0.0	4.0	0.0	0.2	0.0	1.1	0.0	0.8	0.4	0.2	0.7	0.4	1.8	1.2	1.8	0.0	0.0	0.0	0.4	0.0	0.9	23.5	36.2	6.8	25.0	27.8	20.8	55.7	19.8	34.7	37.0	32.8	24.0	2.2	62.3	47.2	5.2	19.9	38.2	33.5	31.8	85.5	0.0	53.4	5.0	115.9	10.8	4.9	88.3	23.3	66.9	19.7	6.5	54.7	1.1	0.4	5.4	6.4	44.4	1.8	0.8	16.6	7.8	2.2	15.1	22.6	55.1	145.4	62.4	74.8	4.9	5.6	7.4	6.5	8.9	0.7	4.5	45.4	38.9	0.0	54.4	76.8
DHRS7B	"CGI-93, DKFZp566O084, MGC8916, SDR32C1"	ENSG00000109016	"Dehydrogenase/reductase 7B"	Q6IAN0	17	21123364-21193265	"Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012132, HPA016873"	Uncertain		Approved	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA			"Plasma membrane, Cell Junctions, Cytosol"		"HPA012132: AB_1847658, HPA016873: AB_1847657"	"unprognostic (1.90e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.71e-1)"	"prognostic favorable (1.98e-8)"	"unprognostic (9.83e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.45e-1)"	"unprognostic (5.02e-3)"	"unprognostic (2.76e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.81e-1)"	"prognostic favorable (3.95e-5)"	"unprognostic (1.20e-2)"	"unprognostic (6.26e-2)"	"unprognostic (9.20e-2)"	"unprognostic (3.97e-1)"	15.9	17.8	14.0	10.3	14.5	2.5	16.2	11.1	15.2	17.6	14.2	11.9	16.7	14.4	13.5	25.3	12.8	15.4	16.3	17.9	11.8	13.2	23.1	18.4	13.9	14.0	14.5	14.8	11.8	18.9	31.2	11.4	14.2	12.9	14.8	15.2	16.5	17.5	10.5	23.7	15.7	18.3	12.7	11.1	11.5	14.7	30.5	9.1	8.0	19.7	15.8	10.9	10.7	12.8	4.2	11.7	15.0	20.4	4.1	5.7	7.5	8.6	10.2	3.7	8.1	10.0	6.8	6.5	8.2	4.6	6.0	11.0	12.8	9.1	3.6	12.6	7.0	4.7	12.2	5.4	13.5	8.5	6.9	17.6	5.0	7.5	11.0	5.5	2.7	3.7	5.3	9.0	7.7	11.7	3.0	5.8	6.4	3.0	4.5	7.0	17.7	3.0	10.8	5.2	28.1	4.4	5.0	9.9	6.3	20.0	10.5	2.0	4.4	10.2	9.1	8.8	31.4	6.1	5.7	2.9	5.0	3.5	15.1	9.3	2.5	3.8	6.7	7.9	10.3	7.5	9.7	18.9	15.0	3.8	17.9	3.4	4.2	3.8	2.5	11.7	3.6	4.1	3.6	13.5	4.1	20.4	5.0	5.7	7.5	14.0	14.5	11.1	15.2	11.8	13.2	14.5	14.8	12.9	9.1	14.9	14.9	16.4	24.6	14.4	20.5	12.2	25.5	28.1	14.8	27.9	29.5	44.8	14.9	40.1	48.5	21.9	30.7	23.3	34.3	26.4	19.3	22.8	8.1	16.3	25.9	17.5	6.9	28.8	12.3	16.2	20.8	11.7	18.6	19.8	19.0	29.9	27.5	22.4	32.9	21.4	35.7	6.5	16.9	44.2	20.3	16.3	43.1	16.6	21.2	17.9
DLG5	"KIAA0583, P-dlg"	ENSG00000151208	"Discs large MAGUK scaffold protein 5"	Q8TDM6	10	77790791-77926526	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Cytotrophoblasts: 83.0;Horizontal cells: 176.4;Muller glia cells: 59.7;Syncytiotrophoblasts: 143.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 2.0;NK-cell: 1.5"	"Group enriched"	"Detected in many"	6	"NK-cells: 1.5;T-cells: 2.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001746			Supported	"Cell Junctions"		NA	NA			"Cell Junctions"		"HPA001746: AB_2666418"	"unprognostic (1.36e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.07e-1)"	"unprognostic (6.48e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.94e-2)"	"prognostic unfavorable (5.38e-4)"	"unprognostic (8.48e-2)"	"unprognostic (6.41e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.02e-2)"	"unprognostic (2.60e-1)"	"unprognostic (8.00e-2)"	"unprognostic (3.06e-1)"	"unprognostic (5.13e-1)"	"unprognostic (6.00e-2)"	"unprognostic (2.74e-2)"	5.3	24.3	9.2	3.4	9.2	0.9	14.5	9.8	7.9	11.6	12.4	8.0	21.8	4.3	12.6	28.2	9.5	7.8	11.2	3.4	8.2	4.9	4.7	1.9	3.7	1.4	7.5	3.0	9.8	9.4	22.2	19.4	18.2	8.9	15.5	4.9	8.6	9.4	19.5	11.8	24.9	7.7	13.1	8.3	2.0	8.5	4.4	8.0	2.1	11.4	5.2	6.0	11.6	16.1	0.0	0.1	0.3	0.0	1.5	2.0	0.0	11.5	9.2	13.9	10.8	9.3	6.8	17.0	6.7	13.4	6.5	6.2	9.0	13.3	0.0	6.4	10.0	4.9	15.1	6.8	13.8	5.7	1.4	5.6	1.5	6.2	8.8	9.9	1.5	2.4	9.5	13.8	8.5	17.1	13.8	2.5	1.4	2.7	0.2	6.1	8.8	1.1	2.2	6.2	9.0	21.7	4.1	4.3	0.7	4.6	10.3	4.6	9.6	7.2	22.3	3.3	9.5	15.8	2.1	4.6	7.1	11.2	5.7	9.2	0.0	1.8	0.7	6.7	2.5	3.3	0.3	0.0	0.1	2.0	0.0	1.1	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.0	1.5	0.0	0.1	0.0	0.0	9.2	9.2	9.8	5.8	8.2	4.9	7.5	3.0	8.9	8.0	6.0	4.8	0.0	20.4	26.3	14.5	2.2	15.3	12.0	6.8	19.2	15.7	83.0	0.0	6.1	14.2	4.5	11.3	0.0	5.1	18.3	13.9	25.5	1.1	2.1	11.3	176.4	2.4	2.5	0.0	7.5	17.3	1.2	8.5	1.0	9.7	59.7	9.0	5.8	17.3	1.9	14.1	25.8	11.3	1.4	6.4	21.1	143.5	2.9	10.2	18.6
DNAJC18	MGC29463	ENSG00000170464	"DnaJ heat shock protein family (Hsp40) member C18"	Q9H819	5	139408588-139444491	"Predicted intracellular proteins, Predicted membrane proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 51.4"	"Group enriched"	"Detected in many"	20	"Early spermatids: 425.4;Late spermatids: 1065.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036538, HPA060154"	Approved		Approved	"Cell Junctions,Cytosol"		NA	NA			"Cell Junctions"	Cytosol	"HPA036538: AB_10670802, HPA060154: AB_2684212"	"unprognostic (2.03e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.19e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.73e-3)"	"unprognostic (8.76e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.90e-1)"	"prognostic favorable (5.89e-4)"	"unprognostic (8.09e-2)"	"unprognostic (1.69e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.81e-1)"	"unprognostic (6.96e-2)"	"unprognostic (1.97e-2)"	4.1	4.0	8.2	2.9	15.7	1.9	4.3	10.7	19.5	4.7	3.3	12.4	0.7	1.8	7.6	4.9	3.9	4.9	4.2	6.3	8.7	8.7	4.5	1.2	4.5	3.3	8.8	11.7	10.7	2.3	6.5	7.1	4.1	16.2	4.9	3.0	3.4	2.1	5.9	8.4	2.2	2.4	6.8	9.0	2.9	2.4	51.4	7.5	1.2	5.1	1.7	2.6	3.4	3.3	3.5	2.0	2.1	2.0	6.0	6.7	1.4	1.6	1.8	11.3	10.4	6.3	6.7	1.2	3.4	7.5	6.0	11.0	4.0	1.3	7.5	9.3	5.3	13.3	2.9	6.3	10.2	6.3	17.0	8.4	5.1	3.8	1.9	5.0	0.6	2.5	9.0	1.3	10.0	6.1	10.2	8.2	2.9	2.2	7.3	8.9	0.9	2.2	2.4	7.8	0.6	2.5	6.2	12.3	1.2	3.6	1.8	10.5	11.0	3.5	1.4	7.7	15.2	1.6	3.8	10.5	8.0	0.0	2.4	7.2	8.7	11.4	4.0	4.3	3.8	3.4	1.9	2.0	2.1	2.2	1.3	3.2	3.5	3.2	4.1	1.5	3.5	3.2	2.0	0.6	6.0	0.7	2.0	6.7	1.4	8.2	15.7	10.7	19.5	8.7	8.7	8.8	11.7	16.2	7.5	3.0	4.6	2.2	8.0	1.3	29.0	8.8	0.0	2.7	7.9	1.8	9.8	3.8	1.7	4.8	425.4	11.3	0.5	0.0	0.9	3.3	5.4	2.7	9.2	0.0	2.4	15.9	12.1	12.9	3.1	1065.4	13.0	2.6	5.0	4.6	2.5	14.5	2.5	1.4	17.7	2.9	18.4	19.4	8.5	37.2	4.9	1.0	3.9	3.2	1.2	2.6
DOC2A		ENSG00000149927	"Double C2 domain alpha"	Q14183	16	30005509-30023270	"Predicted intracellular proteins"	Exocytosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 49.0;testis: 12.6"	"Group enriched"	"Detected in many"	6	"Ciliated cells: 72.3;Early spermatids: 196.5;Late spermatids: 146.0"	"Cancer enhanced"	"Detected in many"		"renal cancer: 5.0"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 9.8;SCLC-21H: 26.6;U-937: 12.8"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in all"	4	"amygdala: 13.5;cerebral cortex: 30.8;hippocampal formation: 24.4"	HPA065676			Uncertain	"Nucleoplasm,Nucleoli,Cell Junctions"		NA	NA			"Cell Junctions"	"Nucleoplasm, Nucleoli"	"HPA065676: AB_2685528"	"unprognostic (1.46e-3)"	"unprognostic (3.39e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.26e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.66e-2)"	"unprognostic (9.14e-2)"	"unprognostic (3.90e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.28e-3)"	"unprognostic (5.13e-2)"	"unprognostic (8.29e-3)"	"unprognostic (1.71e-1)"	"unprognostic (2.74e-1)"	"unprognostic (2.68e-1)"	"unprognostic (2.61e-1)"	1.2	2.7	18.5	1.0	17.5	3.9	2.3	24.0	49.0	1.3	3.1	0.9	0.3	1.7	1.6	2.4	1.1	3.3	1.8	1.0	15.3	8.3	1.6	1.4	3.5	1.4	2.8	27.4	5.7	1.0	1.3	3.2	1.2	13.1	2.5	2.4	0.0	1.6	1.4	1.1	2.0	2.3	1.8	4.2	3.1	1.7	12.6	1.8	0.0	1.6	0.0	1.2	1.4	0.6	0.6	1.1	1.0	0.4	0.2	0.5	0.3	0.7	1.5	1.1	0.8	0.3	0.0	9.8	0.4	0.7	0.5	0.3	4.0	2.7	0.0	0.9	0.4	1.4	0.2	5.0	2.0	0.2	0.1	0.5	0.8	0.5	0.3	0.7	0.9	2.9	1.2	0.8	0.1	1.1	5.0	0.0	3.3	0.3	0.0	0.0	7.8	2.1	3.6	1.5	3.1	4.2	8.0	0.1	0.4	0.5	0.8	26.6	2.1	0.6	2.8	0.2	2.4	2.7	1.7	0.8	0.3	1.5	0.3	0.3	0.5	0.1	0.1	0.3	12.8	0.3	0.8	0.4	0.0	0.0	0.3	0.1	0.5	0.1	0.3	1.1	0.6	0.5	0.5	1.0	0.2	0.0	0.0	0.1	0.3	18.5	17.5	24.0	36.2	15.3	8.3	2.8	27.4	13.1	1.8	0.0	5.8	0.5	3.1	0.6	1.2	0.6	2.5	72.3	12.5	1.8	21.6	0.3	1.7	0.0	196.5	0.7	0.9	0.0	0.0	0.9	0.7	1.8	0.0	0.0	0.4	0.0	1.2	1.8	1.3	146.0	0.6	1.3	1.7	0.0	2.2	3.1	0.0	0.0	1.8	0.0	1.8	0.0	0.3	1.7	4.1	0.6	0.1	0.0	4.1	0.7
DONSON	"B17, C21orf60, C2TA, DKFZP434M035"	ENSG00000159147	"Downstream neighbor of SON"	Q9NYP3	21	33559542-33588708	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Developmental protein"	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 44.4;Spermatocytes: 53.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039558, HPA049033"	Uncertain		Approved	"Nucleoplasm,Cell Junctions,Cytosol"		NA	NA			"Nucleoplasm, Cell Junctions"	Cytosol	"HPA039558: AB_2676570, HPA049033: AB_2680608"	"unprognostic (9.90e-3)"	"unprognostic (1.01e-3)"	"unprognostic (6.58e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.93e-2)"	"prognostic unfavorable (8.22e-4)"	"unprognostic (4.00e-2)"	"unprognostic (5.93e-3)"	"prognostic favorable (2.17e-4)"	"unprognostic (1.25e-1)"	"unprognostic (4.10e-3)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.77e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.07e-1)"	"unprognostic (8.83e-2)"	6.4	3.5	4.1	9.2	8.0	9.4	10.2	7.8	5.6	6.8	7.1	3.3	3.5	6.1	6.7	5.8	8.3	6.3	5.9	7.5	5.5	4.4	5.6	16.2	5.2	11.1	4.7	4.0	13.5	5.7	11.7	6.9	12.2	8.1	5.7	7.4	4.4	4.8	4.3	5.9	9.1	9.3	5.4	5.2	8.2	5.8	24.0	3.0	26.4	5.0	8.1	10.7	4.5	9.7	0.7	0.5	0.1	0.9	0.4	1.4	0.3	27.4	6.4	13.5	11.8	4.2	7.8	10.5	21.9	9.5	16.8	19.1	18.0	7.5	14.9	5.7	10.9	12.7	8.2	18.2	7.8	18.5	14.9	15.7	27.9	14.1	16.3	3.1	14.8	6.8	5.5	2.5	19.0	4.6	5.0	10.7	7.8	26.6	26.0	14.4	5.6	13.5	5.3	14.0	13.1	7.9	12.1	27.9	15.9	7.5	7.4	14.7	6.1	32.9	10.5	9.6	7.0	13.8	7.5	6.2	16.0	11.2	11.7	15.4	23.6	23.2	24.5	8.9	19.8	18.0	0.0	0.3	0.1	1.4	0.9	0.7	0.2	1.4	0.6	0.2	0.7	0.8	0.1	0.0	0.4	0.0	0.5	0.6	0.3	4.1	8.0	7.8	5.6	5.5	4.4	4.7	4.0	8.1	3.0	3.0	3.4	0.8	7.7	7.2	3.5	3.4	7.6	0.0	1.2	3.5	9.8	8.0	1.7	3.0	44.4	4.5	2.7	0.0	4.0	22.1	6.4	4.6	8.1	5.5	7.6	6.4	1.2	8.6	2.7	16.6	9.5	5.1	6.8	3.6	3.8	2.4	3.7	2.9	13.1	4.2	2.7	0.0	8.1	53.1	21.1	8.5	13.8	5.7	5.1	8.1
DPEP1		ENSG00000015413	"Dipeptidase 1"	P16444	16	89613308-89638456	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Lipid metabolism"	"Dipeptidase, Hydrolase, Metalloprotease, Protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"intestine: 161.7;kidney: 52.2;pancreas: 100.5"	"Cell type enhanced"	"Detected in many"	26	"Leydig cells: 268.4;Peritubular cells: 1144.5;Proximal tubular cells: 391.6"	"Cancer enriched"	"Detected in many"	8	"colorectal cancer: 107.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 5.2;Hep G2: 20.3;HHSteC: 9.2;U-937: 28.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA009426, HPA012783"	Enhanced		Approved	"Nucleoplasm,Cell Junctions"	"Intracellular and membrane"	NA	NA		270000	"Nucleoplasm, Cell Junctions"		"HPA009426: AB_1847842, HPA012783: AB_1847843"	"unprognostic (3.31e-2)"	"unprognostic (3.86e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.91e-2)"	"unprognostic (4.93e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.45e-2)"	"unprognostic (5.18e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.27e-1)"	"prognostic favorable (6.84e-4)"	"unprognostic (6.12e-3)"	"unprognostic (1.92e-1)"	"unprognostic (5.23e-2)"	"unprognostic (3.93e-2)"	0.1	0.4	0.1	0.9	0.1	0.0	0.1	0.1	0.1	1.5	53.6	0.1	0.4	16.1	0.2	3.4	0.3	0.1	0.9	0.1	0.1	0.1	52.2	0.1	0.3	0.9	0.1	0.1	0.2	100.5	0.0	0.2	0.1	0.2	0.1	0.0	0.2	0.3	0.4	0.1	0.4	161.7	0.1	0.1	0.9	0.2	9.8	0.1	0.2	0.1	0.1	0.5	0.6	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.1	0.0	1.1	0.1	2.8	0.0	0.0	0.0	0.0	5.2	0.1	0.0	1.9	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.4	0.0	0.0	20.3	9.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.6	0.7	2.1	0.0	0.0	0.0	1.8	0.0	0.0	0.6	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.9	0.0	0.0	0.1	0.1	0.0	28.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	3.0	2.6	14.9	0.0	0.5	3.3	0.3	0.0	0.0	1.2	22.7	0.0	0.1	48.0	0.3	10.3	0.1	4.2	0.0	171.7	0.3	4.5	0.0	1.1	0.0	0.5	0.0	8.5	1.8	0.0	29.1	268.4	1.7	5.0	1.8	1.9	0.0	43.8	11.5	1144.5	391.6	0.1	6.5	0.3	15.6	2.9	0.3	0.3	0.5	1.2	0.0
DPH1	"DPH2L, DPH2L1, OVCA1"	ENSG00000108963	"Diphthamide biosynthesis 1"	Q9BZG8	17	2030110-2043430	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Transferase	"Disease mutation, Dwarfism, Ectodermal dysplasia, Hypotrichosis, Mental retardation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	9	"Alveolar cells type 2: 8.6;Club cells: 4.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA069750, HPA073864"	Approved		Approved	"Nucleoplasm,Cell Junctions"		NA	NA			Nucleoplasm	"Cell Junctions"	"HPA069750: AB_2686188, HPA073864: "	"unprognostic (5.54e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.93e-2)"	"unprognostic (2.30e-1)"	"prognostic favorable (1.78e-5)"	"unprognostic (2.74e-3)"	"unprognostic (2.10e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.40e-1)"	"unprognostic (7.30e-2)"	"unprognostic (1.41e-1)"	16.6	22.9	17.6	19.0	22.7	10.3	17.0	38.6	26.5	17.8	17.1	17.2	21.1	17.0	22.2	17.0	17.9	29.0	22.6	20.2	14.1	13.1	21.4	32.7	15.7	22.7	17.0	21.6	25.2	29.4	28.4	42.9	17.3	15.4	26.1	13.3	21.3	25.7	23.9	33.3	29.0	17.3	18.9	11.4	17.8	18.4	19.5	19.9	17.5	21.0	25.8	19.0	17.2	16.0	11.3	9.3	0.7	6.8	5.6	12.0	5.5	9.1	16.1	4.4	10.7	13.8	10.1	12.2	12.1	18.2	20.6	13.4	15.4	7.5	17.9	15.7	35.8	7.9	7.3	14.8	13.6	11.2	4.6	33.9	4.1	7.6	9.2	13.1	5.2	6.8	15.1	13.9	16.5	13.4	14.7	9.3	10.4	14.0	7.4	8.1	12.1	9.1	3.4	4.1	11.2	16.5	10.6	3.1	13.9	9.2	5.7	8.3	9.7	10.9	12.5	12.1	4.3	18.1	4.3	6.4	14.4	6.6	17.7	10.9	7.3	5.0	4.4	14.2	7.1	5.0	0.0	4.6	0.7	9.5	6.8	10.4	11.3	7.8	8.6	9.3	9.5	12.0	8.7	0.3	5.6	4.6	6.7	10.4	5.5	17.6	22.7	38.6	26.5	14.1	13.1	17.0	21.6	15.4	19.9	3.0	8.6	0.0	0.8	0.3	1.9	1.3	0.0	2.7	4.5	0.0	2.0	1.2	0.0	0.4	0.9	0.6	0.4	0.0	0.5	0.7	1.3	0.5	2.3	0.0	0.5	1.6	0.0	0.6	0.0	1.0	0.6	1.0	0.0	0.0	0.3	1.0	0.0	0.0	0.4	0.4	3.0	0.0	1.2	0.7	0.3	0.3	1.1	0.7	0.4	0.6
DPPA5	Esg1	ENSG00000203909	"Developmental pluripotency associated 5"	A6NC42	6	73353062-73354295	"Predicted intracellular proteins"		"Developmental protein, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"lung: 2.0;testis: 6.8"	"Cell type enhanced"	"Detected in single"	35	"Spermatocytes: 1.4"	"Cancer enriched"	"Detected in single"	2209	"testis cancer: 347.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	49	"SuSa: 12.7"					"Not detected"	"Not detected"			"HPA055016, HPA064505"	Uncertain		Approved	"Cell Junctions"		NA	NA			"Cell Junctions"		"HPA055016: , HPA064505: AB_2685275"															"unprognostic (1.85e-1)"			0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.4	0.1	6.8	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0
DSC3	"CDHF3, DSC, DSC1, DSC2, DSC4"	ENSG00000134762	"Desmocollin 3"	Q14574	18	30990008-31042815	"Disease related genes, Plasma proteins, Predicted membrane proteins"	"Cell adhesion"		Hypotrichosis	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"esophagus: 73.2;lymphoid tissue: 28.4;skin 1: 99.1;tongue: 92.4"	"Group enriched"	"Detected in many"	5	"Basal keratinocytes: 444.8;Suprabasal keratinocytes: 602.1"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 78.6;head and neck cancer: 107.7"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HaCaT: 71.0;HBEC3-KT: 16.3;hTCEpi: 42.0;hTERT-HME1: 30.9;REH: 11.9"	"Group enriched"	"Detected in some"	4	"basal ganglia: 1.3;hippocampal formation: 3.6"	"Low region specificity"	"Detected in some"			"CAB037328, HPA049265, HPA073937"	Enhanced		Enhanced	"Plasma membrane,Cell Junctions"		NA	NA		2700000	"Plasma membrane, Cell Junctions"		"CAB037328: , HPA049265: AB_2680695, HPA073937: AB_2686645"	"unprognostic (4.44e-3)"	"unprognostic (6.28e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.02e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.32e-2)"	"unprognostic (6.38e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.41e-1)"	"unprognostic (3.48e-2)"	"unprognostic (3.92e-3)"	"unprognostic (3.13e-1)"	"unprognostic (4.13e-4)"	"unprognostic (1.22e-2)"	"unprognostic (7.85e-2)"	"unprognostic (3.47e-1)"	"prognostic unfavorable (1.04e-5)"	1.5	0.0	0.0	0.6	0.0	0.0	10.4	0.0	0.0	11.9	1.0	0.0	0.4	0.1	2.1	1.4	73.2	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.4	0.0	2.4	0.1	16.0	0.1	4.5	0.0	0.0	7.2	0.3	0.2	99.1	0.2	0.1	0.0	0.0	0.0	0.5	0.0	2.2	0.0	92.4	28.4	1.0	14.4	0.7	0.2	1.0	0.5	0.4	0.4	0.1	4.5	0.5	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	71.0	0.0	16.3	0.0	0.0	3.9	0.2	1.4	0.1	2.7	0.0	0.0	2.8	42.0	0.0	30.9	5.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	5.8	11.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.2	0.3	0.2	0.2	0.4	0.3	0.2	0.0	0.7	0.3	0.4	1.0	0.4	0.5	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.0	1.4	0.0	43.5	444.8	0.0	1.2	0.0	2.7	19.4	0.0	0.0	62.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	10.1	7.5	19.6	0.0	0.0	4.6	0.0	2.4	0.0	0.0	0.0	0.0	0.6	37.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	602.1	20.9	0.0	0.0	96.7
DSG2	CDHF5	ENSG00000046604	"Desmoglein 2"	Q14126	18	31498043-31549008	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 70.7"	"Cell type enhanced"	"Detected in many"	5	"Enterocytes: 208.8;Mucus-secreting cells: 176.4;Pancreatic endocrine cells: 177.3"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in single"	7	"pons and medulla: 6.9"	"Cell type enriched"	"Detected in single"	10	"basophil: 9.5"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 9.5"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 36.3;HaCaT: 56.6;HBEC3-KT: 42.0;hTERT-HME1: 45.7;OE19: 47.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA004896, CAB025122"	Enhanced		Supported	"Cell Junctions"		NA	NA		94000000	"Cell Junctions"		"CAB025122: , HPA004896: AB_1078643"	"unprognostic (1.56e-3)"	"prognostic unfavorable (8.22e-4)"	"prognostic favorable (7.81e-4)"	"unprognostic (8.77e-3)"	"unprognostic (3.53e-4)"	"prognostic unfavorable (5.63e-4)"	"unprognostic (2.86e-3)"	"prognostic unfavorable (2.43e-4)"	"unprognostic (5.21e-2)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (4.94e-5)"	"unprognostic (3.40e-1)"	"prognostic favorable (3.14e-10)"	"unprognostic (1.76e-1)"	"unprognostic (1.51e-1)"	"unprognostic (3.72e-1)"	"unprognostic (8.57e-3)"	17.3	1.1	0.6	11.6	0.7	0.0	21.1	0.7	0.7	3.9	50.2	1.3	4.0	18.1	3.8	5.6	6.3	4.9	14.2	15.7	0.7	0.6	22.4	10.8	7.0	2.4	0.6	0.9	8.8	15.5	39.9	2.7	39.8	6.9	10.4	23.8	4.5	27.3	1.5	2.2	5.3	70.7	3.1	0.5	0.6	17.3	2.3	0.5	13.6	20.8	3.2	5.8	18.5	7.7	0.1	0.9	9.5	0.0	0.0	0.3	0.0	24.2	9.4	0.8	0.0	0.1	1.5	30.5	0.0	0.0	0.0	0.0	6.5	36.3	0.0	13.8	0.0	11.6	56.6	11.5	42.0	0.0	0.0	7.1	0.0	10.8	7.3	4.4	3.0	0.0	2.1	29.2	0.9	45.7	22.0	0.0	7.2	9.6	0.0	0.0	6.4	6.4	0.4	11.7	47.1	4.8	10.8	0.0	15.5	14.1	12.1	5.1	0.0	18.4	13.1	0.0	26.3	9.3	2.6	0.0	0.0	5.4	0.0	6.0	1.2	0.0	0.0	4.3	0.0	5.3	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.2	0.0	0.0	0.9	0.0	0.0	0.6	0.7	0.7	0.7	0.7	0.6	0.6	0.9	6.9	0.5	50.6	38.4	0.5	64.3	11.9	0.2	51.1	89.2	42.8	50.0	12.2	0.0	70.4	3.3	82.4	0.6	8.7	208.8	23.3	65.2	91.9	9.5	96.7	4.6	22.1	9.0	1.6	76.9	2.5	1.5	1.6	1.4	1.8	16.9	10.8	176.4	4.2	177.3	149.7	0.4	10.0	0.2	0.0	9.5	3.0	8.1	5.3	50.1	1.3	168.5	163.4
DSP	"DPI, DPII, KPPS2, PPKS2"	ENSG00000096696	Desmoplakin	P15924	6	7541575-7586717	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cardiomyopathy, Disease mutation, Epidermolysis bullosa, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 138.3;skin 1: 136.5;tongue: 189.6"	"Cell type enhanced"	"Detected in many"	13	"Basal keratinocytes: 801.2;Cardiomyocytes: 699.5;Suprabasal keratinocytes: 1763.9"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 314.1"	"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	19	"naive B-cell: 5.8"	"Lineage enriched"	"Detected in single"	59	"B-cells: 5.8"	"Cell line enhanced"	"Detected in many"		"BEWO: 46.0;HaCaT: 49.6;HBEC3-KT: 35.7;hTCEpi: 112.8;SuSa: 35.9"	"Region enriched"	"Detected in single"	23	"hippocampal formation: 12.8"	"Low region specificity"	"Detected in all"			"CAB037324, HPA045840, HPA054950"	Enhanced		Supported	"Cell Junctions"		NA	NA		110000000	"Cell Junctions"		"CAB037324: , HPA045840: AB_2679468, HPA054950: AB_2682645"	"unprognostic (1.65e-1)"	"unprognostic (3.09e-1)"	"unprognostic (6.13e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.05e-2)"	"unprognostic (3.82e-2)"	"unprognostic (7.03e-3)"	"unprognostic (1.28e-1)"	"unprognostic (2.64e-2)"	"unprognostic (5.02e-2)"	"unprognostic (2.94e-2)"	"prognostic favorable (1.53e-9)"	"unprognostic (2.45e-1)"	"unprognostic (2.88e-1)"	"unprognostic (8.38e-2)"	"prognostic unfavorable (1.82e-4)"	1.3	2.7	0.9	9.6	0.7	0.0	12.5	0.6	0.8	27.5	19.4	0.2	9.1	8.1	2.8	11.2	138.3	2.5	8.7	71.8	0.7	0.6	8.7	21.9	8.0	1.4	0.6	0.9	1.4	23.0	8.1	2.7	25.7	2.5	9.0	7.0	3.4	25.6	8.5	0.6	136.5	28.2	1.1	1.4	1.0	7.4	0.8	0.1	15.0	17.1	189.6	48.7	3.1	46.9	5.8	0.0	0.0	0.0	0.0	0.0	0.0	20.8	6.3	0.0	0.0	0.9	1.4	46.0	4.1	3.6	2.0	2.0	18.0	5.5	0.0	5.9	6.6	1.6	49.6	7.6	35.7	0.3	0.0	8.8	0.0	3.6	24.1	0.0	0.1	0.1	0.3	112.8	1.8	20.6	5.0	0.0	0.1	0.0	0.0	3.6	9.8	0.0	0.1	0.9	10.1	3.1	0.0	0.0	5.3	7.6	5.6	2.1	0.0	4.6	9.9	0.0	35.9	11.7	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.7	0.6	0.8	0.7	0.6	0.6	0.9	2.5	0.1	47.6	14.2	5.1	114.0	801.2	2.1	699.5	132.5	179.3	220.6	57.6	13.7	231.6	1.7	136.3	1.3	28.8	238.5	0.0	97.9	229.6	43.4	178.6	3.5	162.5	23.9	0.0	167.6	3.1	1.6	0.5	0.9	5.6	96.2	4.6	145.6	14.8	137.3	200.0	0.0	11.0	27.9	0.0	22.7	1.4	2.5	1763.9	322.6	2.9	145.6	184.4
DTNA	"D18S892E, DRP3, DTN, DTN-1, DTN-2, DTN-3"	ENSG00000134769	"Dystrobrevin alpha"	Q9Y4J8	18	34493290-34891844	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 106.3;heart muscle: 82.8;skeletal muscle: 90.2"	"Cell type enhanced"	"Detected in many"	18	"Cardiomyocytes: 121.0;Muller glia cells: 42.7"	"Cancer enriched"	"Detected in many"	9	"glioma: 28.2"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"dendritic cells: 7.0;T-cells: 6.7"	"Cell line enhanced"	"Detected in many"		"MCF7: 17.7;NTERA-2: 19.8;SCLC-21H: 27.8;U-87 MG: 28.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015196, HPA071177"	Enhanced		Approved	"Nucleoplasm,Cell Junctions,Intermediate filaments"		NA	NA			"Cell Junctions, Intermediate filaments"	Nucleoplasm	"CAB015196: AB_2261797, HPA071177: "	"unprognostic (1.57e-1)"	"unprognostic (4.57e-2)"	"unprognostic (3.13e-3)"	"unprognostic (7.82e-6)"	"unprognostic (5.03e-1)"	"unprognostic (2.43e-3)"	"unprognostic (2.73e-1)"	"unprognostic (7.42e-2)"	"unprognostic (1.23e-1)"	"unprognostic (6.27e-2)"	"unprognostic (1.35e-4)"	"unprognostic (6.89e-2)"	"prognostic favorable (2.64e-7)"	"unprognostic (6.08e-3)"	"unprognostic (3.93e-2)"	"unprognostic (1.12e-1)"	"unprognostic (7.27e-5)"	9.3	5.3	51.5	4.0	47.6	1.6	7.3	37.7	69.1	4.5	5.4	38.7	0.9	3.4	4.3	13.9	13.9	7.6	7.1	82.8	42.3	46.5	2.7	2.5	4.8	2.3	44.7	21.0	5.4	12.3	1.4	6.1	3.6	51.0	14.6	5.6	3.4	5.7	15.9	90.2	1.8	3.9	15.2	106.3	3.9	3.6	4.7	39.5	0.0	9.3	6.5	2.4	12.8	1.7	1.4	7.0	0.4	1.3	1.0	6.7	1.7	0.3	0.1	7.6	0.0	4.9	13.6	1.2	2.0	7.4	0.3	0.9	1.7	0.0	0.0	4.5	0.8	7.0	0.6	0.9	3.9	0.7	0.0	5.3	0.0	0.4	3.5	3.9	0.1	0.1	10.3	0.8	6.4	2.2	7.3	3.3	0.0	1.1	1.0	2.1	17.7	0.1	0.0	19.8	0.3	4.0	0.0	3.7	12.1	0.3	0.1	27.8	3.2	0.0	0.7	2.0	12.5	10.9	2.6	0.1	8.8	4.8	0.1	2.7	0.6	0.9	0.4	28.4	0.0	3.8	0.4	1.3	0.0	1.4	0.0	1.9	1.4	2.7	1.9	7.0	1.1	2.8	2.0	0.1	1.0	0.0	0.2	6.7	1.7	51.5	47.6	37.7	35.7	42.3	46.5	44.7	21.0	51.0	39.5	0.0	1.4	0.0	0.0	1.3	10.2	121.0	22.9	4.0	1.2	0.0	5.9	0.0	5.0	9.9	3.1	0.7	0.0	0.0	21.8	0.1	2.8	0.9	0.0	0.0	7.1	1.6	0.0	0.0	4.1	1.9	5.5	8.8	5.0	0.0	0.0	42.7	12.5	0.0	0.4	1.5	4.2	12.9	22.8	0.5	1.5	0.9	0.0	0.0	0.0	0.1
EDA2R	"EDA-A2R, EDAA2R, TNFRSF27, XEDAR"	ENSG00000131080	"Ectodysplasin A2 receptor"	Q9HAV5	X	66595637-66639298	"Predicted membrane proteins"	Differentiation	"Developmental protein, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	6	"Alveolar cells type 1: 3.0;Cholangiocytes: 2.5;Muller glia cells: 2.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 1.1;naive B-cell: 1.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 14.0;HSkMC: 19.1;LHCN-M2: 17.6;SuSa: 14.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA054522			Approved	"Cell Junctions"		NA	NA			"Cell Junctions"		"HPA054522: AB_2682516"	"unprognostic (1.31e-3)"	"unprognostic (3.17e-3)"	"unprognostic (2.19e-1)"	"unprognostic (8.49e-3)"	"unprognostic (4.15e-3)"	"unprognostic (3.63e-3)"	"unprognostic (2.48e-2)"	"unprognostic (3.37e-2)"	"unprognostic (2.82e-1)"	"unprognostic (7.17e-2)"	"unprognostic (6.04e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.12e-2)"	"unprognostic (8.23e-2)"	"unprognostic (4.92e-2)"	"unprognostic (3.08e-1)"	4.7	9.4	2.3	1.9	3.2	0.0	5.6	1.2	3.0	9.7	3.7	5.7	4.6	0.4	13.5	6.3	3.6	6.5	4.8	2.8	2.9	1.2	3.0	1.2	3.7	0.6	5.7	1.1	12.9	4.9	7.4	16.0	4.8	4.5	14.5	7.6	5.5	6.1	8.3	11.0	2.5	1.8	7.5	8.2	2.0	1.6	2.7	4.0	1.5	8.2	1.9	1.2	6.3	7.4	1.1	0.3	0.0	0.5	0.0	1.1	0.0	0.0	9.0	8.3	0.0	12.0	14.0	0.1	12.3	13.4	1.2	1.8	0.0	0.0	4.4	0.0	8.0	0.0	0.0	0.0	4.7	4.1	0.0	4.3	0.0	0.2	5.9	2.1	0.0	0.0	19.1	11.2	9.3	8.5	11.4	0.3	0.2	0.4	4.6	17.6	1.0	0.2	0.0	3.1	0.0	0.0	0.0	1.1	0.0	0.8	0.0	0.0	1.5	0.0	0.0	0.0	14.8	0.2	0.1	9.4	0.0	6.8	0.0	0.1	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.1	0.0	0.3	1.1	0.2	0.2	0.0	0.0	0.5	0.0	0.0	0.0	2.3	3.2	1.2	2.6	2.9	1.2	5.7	1.1	4.5	4.0	3.0	0.0	0.0	1.0	0.2	0.0	0.5	2.5	0.0	0.0	1.8	0.0	1.0	0.0	0.1	0.0	0.3	0.0	0.0	0.5	1.1	1.0	0.8	0.0	0.0	0.2	0.0	1.2	0.6	0.0	0.0	1.7	0.0	1.7	0.0	0.3	2.3	0.7	0.0	0.4	0.2	0.0	0.0	1.9	0.0	0.1	0.5	0.6	0.0	0.4	0.6
EFCAB11	C14orf143	ENSG00000140025	"EF-hand calcium binding domain 11"	Q9BUY7	14	89794669-89954777	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 36.9"	"Group enriched"	"Detected in many"	7	"Early spermatids: 451.2;Late spermatids: 287.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 12.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA051209			Approved	"Cell Junctions,Cytosol"		NA	NA			"Cell Junctions, Cytosol"		"HPA051209: AB_2681389"	"unprognostic (1.03e-1)"	"unprognostic (6.10e-3)"	"unprognostic (2.36e-2)"	"unprognostic (2.00e-3)"	"unprognostic (2.39e-1)"	"unprognostic (3.74e-3)"	"unprognostic (1.38e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.00e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.84e-7)"	"unprognostic (4.16e-2)"	"unprognostic (1.95e-1)"	"unprognostic (9.82e-2)"	"unprognostic (8.45e-2)"	4.7	5.8	10.2	6.2	8.1	5.3	9.3	5.7	7.6	5.6	5.2	10.4	6.7	5.1	4.9	6.9	6.2	11.0	4.9	3.7	7.8	6.6	7.6	5.8	3.2	3.3	8.6	5.7	5.2	4.8	8.3	8.2	8.4	7.7	5.4	5.6	6.1	5.6	5.4	2.4	3.7	3.6	6.3	8.4	6.7	4.4	36.9	6.2	2.5	7.9	3.3	6.3	5.2	4.1	2.6	2.1	12.8	5.3	3.3	1.6	0.8	4.8	7.5	6.5	8.2	4.0	4.4	18.5	7.2	6.5	9.8	6.9	8.8	17.4	7.6	13.7	4.8	7.0	10.7	5.6	14.3	14.2	8.6	3.6	5.5	6.4	14.3	0.9	7.0	13.3	3.0	3.5	6.4	7.3	5.6	8.1	8.2	5.7	7.6	11.6	25.3	5.2	9.4	2.8	19.9	13.6	6.0	10.4	5.5	9.0	13.6	2.8	4.6	9.1	16.9	8.4	14.2	13.7	5.0	6.9	5.3	7.4	5.6	7.0	4.5	13.0	13.2	7.7	3.3	9.7	12.8	1.3	3.4	0.6	3.0	0.3	2.6	1.0	1.0	2.1	2.6	1.6	1.4	4.0	3.3	5.3	1.8	1.3	0.8	10.2	8.1	5.7	7.6	7.8	6.6	8.6	5.7	7.7	6.2	0.0	0.6	12.8	5.3	4.5	8.4	3.5	17.8	49.5	6.8	17.4	2.0	13.9	8.3	10.8	451.2	6.0	2.7	0.0	14.8	23.8	8.0	3.2	4.7	5.8	10.3	3.2	0.0	4.3	3.7	287.7	5.2	6.4	3.3	12.6	3.3	4.2	5.4	6.2	7.1	13.3	10.8	0.0	3.1	26.2	12.8	2.9	6.4	2.9	9.5	4.6
EGFR	"ERBB, ERBB1"	ENSG00000146648	"Epidermal growth factor receptor"	P00533	7	55019021-55211628	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	"Host-virus interaction"	"Developmental protein, Host cell receptor for virus entry, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 102.3"	"Cell type enhanced"	"Detected in many"	8	"Cytotrophoblasts: 207.2;Syncytiotrophoblasts: 315.1"	"Cancer enhanced"	"Detected in all"		"glioma: 136.0"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	12	"A-431: 345.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB000035, HPA001200, HPA018530, CAB068186, CAB073534"	Enhanced		Enhanced	"Plasma membrane,Cell Junctions"	"Secreted to blood"	NA	NA	4740000	93000000	"Plasma membrane, Cell Junctions"		"CAB000035: , CAB068186: AB_2665679, CAB073534: , HPA001200: AB_1078723, HPA018530: AB_1848044"	"unprognostic (2.62e-2)"	"unprognostic (9.56e-3)"	"unprognostic (1.59e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.27e-2)"	"unprognostic (6.11e-2)"	"unprognostic (4.88e-2)"	"unprognostic (2.85e-2)"	"unprognostic (3.30e-3)"	"unprognostic (1.78e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.93e-3)"	"unprognostic (6.98e-3)"	"unprognostic (1.72e-1)"	"unprognostic (6.62e-2)"	"prognostic unfavorable (2.04e-5)"	16.2	8.4	4.9	7.5	6.8	0.1	39.8	5.1	8.5	13.8	7.8	3.3	10.7	3.6	8.2	11.7	15.6	8.8	8.5	4.8	6.8	2.7	7.6	23.5	14.2	2.3	4.1	3.9	10.4	10.1	1.8	2.1	102.3	5.6	10.9	6.7	9.2	15.4	12.9	10.7	32.5	6.3	15.5	3.5	3.3	7.8	5.5	5.9	3.2	12.8	15.5	8.0	10.2	28.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	345.9	4.4	1.1	1.5	7.1	4.4	1.2	3.4	4.6	2.1	1.6	0.8	3.7	0.2	0.8	2.9	9.0	13.9	0.0	15.3	2.5	0.1	0.2	0.0	1.9	0.2	1.8	0.0	0.0	2.1	14.0	5.3	28.6	3.1	0.2	0.0	0.0	0.0	4.5	0.2	0.0	0.0	0.3	1.3	2.2	0.0	0.6	0.0	2.6	3.7	0.0	1.3	2.9	3.5	0.7	1.2	0.3	0.8	1.0	1.9	0.5	14.9	3.2	0.0	0.3	0.2	2.6	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	6.8	5.1	6.6	6.8	2.7	4.1	3.9	5.6	5.9	89.3	37.5	4.2	67.7	76.2	1.5	7.3	53.5	16.0	59.1	21.0	5.9	207.2	0.0	30.6	4.6	10.9	15.9	23.3	21.0	36.6	45.3	37.8	0.0	77.4	24.2	0.0	4.1	6.7	7.0	2.2	118.8	1.3	16.9	2.8	25.3	106.1	41.7	17.3	125.5	14.0	2.3	77.6	23.1	1.6	2.7	78.5	315.1	0.0	20.0	46.4
ELFN1	PPP1R28	ENSG00000225968	"Extracellular leucine rich repeat and fibronectin type III domain containing 1"	P0C7U0	7	1688119-1747954	"Predicted membrane proteins"		"Protein phosphatase inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"liver: 13.3"	"Cell type enhanced"	"Detected in some"	10	"Cone photoreceptor cells: 5.9;Hepatocytes: 7.8;Ito cells: 9.8;Rod photoreceptor cells: 6.7"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"REH: 19.5;U-138 MG: 12.3;U-2 OS: 18.0;U-2197: 20.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA066382			Approved	"Nucleoplasm,Cell Junctions"		NA	NA		11000	"Nucleoplasm, Cell Junctions"		"HPA066382: AB_2732744"	"unprognostic (8.45e-2)"	"unprognostic (3.39e-3)"	"unprognostic (6.54e-4)"	"unprognostic (1.64e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.44e-1)"	"prognostic favorable (9.68e-4)"	"unprognostic (4.60e-3)"	"unprognostic (1.63e-3)"	"unprognostic (6.60e-2)"	"unprognostic (4.14e-3)"	"unprognostic (1.11e-2)"	"unprognostic (2.31e-2)"	"unprognostic (7.47e-3)"	"unprognostic (8.63e-2)"	"unprognostic (2.78e-1)"	"unprognostic (4.07e-1)"	1.8	0.8	2.2	0.6	1.4	0.0	0.6	0.0	4.2	3.2	0.3			0.2	2.2	0.3	0.3	0.8	0.8	3.3	1.8	2.2	2.8	13.3	0.3	0.1	2.7		0.0	0.2	0.2	0.2	0.7		0.6	0.0		0.5	0.2	1.2	0.6	0.3	0.5	1.7	1.7	0.2	0.7			0.2		0.0	0.5	0.9	0.5	0.0	0.7	0.0	0.0	0.2	0.0	0.1	0.0	3.0	6.3	0.0	1.0	0.0	1.0	0.0	0.0	0.0	0.1	0.3	0.0	3.0	1.3	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	3.5	0.0	2.9	1.2	0.0	0.7	19.5	0.0	1.9	0.0	0.0	2.8	1.3	0.1	0.1	0.0	0.3	0.0	0.2	0.0	12.3	18.0	20.9	0.0	0.0	0.2	5.3	0.0	0.0	1.5	0.1	0.0	0.2	0.1	0.0	0.1	0.1	0.2	0.1	0.0	0.5	0.1	0.1	0.7	0.0	0.0	0.0	0.1	0.0											0.0	1.1	0.0	0.4	0.1	1.0	1.6	0.0	0.0	0.0	0.0	5.9	0.0	3.3	0.0	0.0	3.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	7.8	0.1	0.0	0.0	9.8	0.6	0.0	0.9	0.0	1.7	0.0	0.0	0.9	0.0	0.0	0.0	0.0	6.7	0.0	0.9	0.0	2.7	0.0	0.0	0.0	0.0	0.0
ELMO3	"CED-12, CED12, ELMO-3, FLJ13824"	ENSG00000102890	"Engulfment and cell motility 3"	Q96BJ8	16	67199111-67204029	"Predicted intracellular proteins"	"Apoptosis, Phagocytosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Enterocytes: 67.1;Paneth cells: 44.1;Undifferentiated cells: 45.7"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"cerebellum: 6.7"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 17.0;CAPAN-2: 24.9;HaCaT: 23.6;T-47d: 23.3"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA021484	Approved		Approved	"Plasma membrane,Cell Junctions"		NA	NA			"Plasma membrane, Cell Junctions"		"HPA021484: AB_1848129"	"unprognostic (4.49e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.10e-2)"	"unprognostic (8.08e-2)"	"unprognostic (1.39e-1)"	"unprognostic (6.16e-3)"	"unprognostic (3.14e-1)"	"unprognostic (8.17e-3)"	"unprognostic (1.73e-1)"	"unprognostic (8.06e-2)"	"unprognostic (3.40e-2)"	"unprognostic (6.95e-3)"	"prognostic favorable (2.77e-5)"	"unprognostic (3.47e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.97e-2)"	1.1	0.8	0.6	7.8	1.8	2.5	4.6	6.7	1.4	2.8	30.3	0.5	32.0	18.9	2.6	9.8	13.1	4.8	16.0	0.9	0.7	0.8	13.3	3.9	6.9	1.4	0.5	0.5	1.2	26.6	6.5	28.7	13.7	1.0	13.2	5.1	0.9	25.1	28.8	0.5	19.1	37.7	1.7	0.5	2.8	12.8	8.7	0.6	1.1	18.2	9.7	9.2	6.8	6.0	1.2	0.8	2.1	0.4	0.4	1.0	0.1	10.8	1.2	1.2	1.5	0.2	0.3	17.0	0.6	0.3	0.8	0.7	7.1	24.9	1.5	0.8	0.3	0.3	23.6	1.1	10.9	0.2	0.7	1.4	1.5	2.0	2.3	0.5	0.9	3.9	0.2	8.0	0.6	0.6	0.8	0.8	1.3	1.5	0.8	0.4	9.0	0.9	4.5	1.6	10.2	1.0	2.2	1.2	2.4	1.0	1.5	8.3	1.9	1.6	7.4	0.7	0.7	23.3	1.7	1.4	1.9	2.3	1.2	1.1	2.5	0.8	2.8	1.0	2.1	0.9	0.0	0.4	1.0	1.0	0.0	0.1	1.2	0.8	0.1	0.5	1.1	0.6	0.2	2.1	0.4	0.1	0.8	0.5	0.1	0.6	1.8	6.7	1.4	0.7	0.8	0.5	0.5	1.0	0.6	0.0	12.5	2.4	11.4	7.8	0.8	1.1	12.7	1.4	2.3	19.2	0.0	26.3	14.9	16.5	19.0	1.4	67.1	0.0	20.8	12.4	1.0	6.3	4.6	3.9	3.1	0.0	12.6	1.3	1.3	26.2	0.9	1.4	3.3	2.8	31.8	0.4	23.9	44.1	0.7	23.7	1.3	0.0	0.4	7.9	2.5	11.8	14.1	0.0	45.7	8.1
ELOC	"SIII, TCEB1"	ENSG00000154582	"Elongin C"	Q15369	8	73939169-73972287	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Extravillous trophoblasts: 271.8;Hofbauer cells: 287.3;Pancreatic endocrine cells: 255.4;Proximal tubular cells: 236.7;Syncytiotrophoblasts: 278.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA078113			Approved	"Nucleoli,Vesicles,Cell Junctions"		NA	NA		250000	Vesicles	"Nucleoli, Cell Junctions"	"HPA078113: AB_2686877"	"prognostic unfavorable (6.48e-4)"	"unprognostic (1.60e-1)"	"unprognostic (3.14e-1)"	"unprognostic (2.83e-2)"	"unprognostic (2.46e-2)"	"unprognostic (8.02e-3)"	"unprognostic (5.84e-3)"	"unprognostic (2.19e-2)"	"unprognostic (1.77e-1)"	"unprognostic (6.99e-3)"	"unprognostic (4.02e-3)"	"unprognostic (3.33e-2)"	"unprognostic (2.77e-3)"	"unprognostic (3.84e-2)"	"unprognostic (5.33e-2)"	"unprognostic (1.67e-1)"	"unprognostic (8.95e-2)"	27.0	29.5	39.1	19.2	37.6	35.4	24.2	25.6	43.3	17.5	19.6	12.2	21.0	13.4	18.2	31.7	24.5	17.2	17.9	50.1	33.9	29.5	28.2	36.1	21.2	35.2	32.5	28.4	17.9	25.5	17.6	20.0	25.7	27.3	19.2	20.6	12.1	16.3	21.0	62.5	16.6	14.5	24.4	33.9	18.7	18.5	51.0	18.8	19.7	19.6	31.9	27.9	19.3	16.7	38.9	55.3	51.7	35.4	32.5	44.9	26.4	43.9	36.0	33.0	23.9	25.3	33.1	23.7	43.7	35.7	42.9	44.1	32.0	38.4	22.4	35.4	38.7	58.0	31.5	36.4	43.6	56.8	25.8	30.2	39.0	38.5	50.6	33.0	25.0	29.3	33.4	35.0	38.8	50.2	31.9	39.8	38.8	34.4	30.1	56.3	32.5	64.3	44.9	30.0	72.1	58.4	23.5	20.8	21.3	46.8	38.6	31.2	29.6	18.3	99.9	40.8	35.8	36.8	27.0	30.4	31.2	35.3	34.1	43.7	34.2	41.8	41.3	37.5	27.4	37.8	51.7	32.2	38.2	31.2	35.4	34.0	38.9	37.5	34.8	34.2	34.0	34.3	34.4	37.7	32.5	33.8	55.3	44.9	26.4	39.1	37.6	25.6	43.3	33.9	29.5	32.5	28.4	27.3	18.8	62.5	90.6	0.0	0.0	0.0	0.0	0.0	0.0	116.4	91.0	113.4	0.0	190.4	225.5	210.9	0.0	0.0	0.0	0.0	197.5	271.8	0.0	0.0	64.0	0.0	287.3	0.0	0.0	0.0	0.0	0.0	0.0	68.7	0.0	196.6	0.0	0.0	255.4	0.0	0.0	236.7	0.0	0.0	0.0	0.0	0.0	0.0	278.0	0.0	0.0	0.0
EPB41	"4.1R, EL1"	ENSG00000159023	"Erythrocyte membrane protein band 4.1"	P11171	1	28887091-29120046	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell cycle, Cell division, Mitosis, Transport"	"Actin-binding, Calmodulin-binding"	"Elliptocytosis, Hereditary hemolytic anemia, Pyropoikilocytosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 59.7"	"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 129.6;Erythroid cells: 116.8;Rod photoreceptor cells: 166.4"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 59.7"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 39.5"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in all"	11	"cerebellum: 375.3"	"HPA028076, HPA028096, HPA028412, HPA028414"	Supported		Supported	"Nuclear bodies,Plasma membrane,Cell Junctions,Cytokinetic bridge,Mitotic spindle,Cytosol"		Yes	No		3400000	"Plasma membrane, Cell Junctions"	"Nuclear bodies, Cytokinetic bridge, Mitotic spindle, Cytosol"	"HPA028076: AB_2672476, HPA028096: , HPA028412: AB_2672592, HPA028414: AB_10601366"	"unprognostic (2.16e-1)"	"unprognostic (1.96e-1)"	"unprognostic (8.92e-3)"	"prognostic unfavorable (4.58e-4)"	"unprognostic (5.00e-2)"	"prognostic favorable (5.87e-4)"	"unprognostic (5.01e-3)"	"unprognostic (5.40e-3)"	"unprognostic (2.52e-2)"	"unprognostic (6.65e-2)"	"unprognostic (7.81e-2)"	"unprognostic (1.42e-2)"	"prognostic unfavorable (1.75e-6)"	"unprognostic (2.66e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.22e-1)"	"unprognostic (6.67e-2)"	9.2	9.6	3.3	19.4	10.2	28.0	9.6	59.7	11.6	8.2	12.4	2.0	9.8	9.3	10.5	5.7	10.8	5.5	7.9	7.5	3.3	4.8	10.0	13.2	11.0	25.4	3.9	3.0	12.3	10.4	9.1	9.0	8.7	10.3	8.3	12.5	14.6	10.1	10.8	15.0	8.9	14.6	9.2	5.8	13.5	14.0	7.9	6.9	42.2	8.1	8.8	19.8	11.3	12.4	9.9	3.0	30.1	2.1	5.7	15.9	7.7	7.4	1.8	18.6	8.8	1.5	0.2	6.2	1.9	2.8	2.3	2.9	4.9	9.0	13.8	5.0	2.5	3.8	3.4	23.2	1.8	2.5	24.8	7.1	39.5	5.6	8.0	2.9	13.4	26.4	0.5	5.4	2.2	4.0	5.7	4.1	22.1	37.2	11.0	0.0	2.5	21.7	8.8	19.5	12.3	2.9	33.4	8.2	19.8	2.2	9.5	25.1	18.6	5.8	5.5	12.6	6.6	4.2	5.2	0.4	0.1	3.9	3.6	3.8	16.5	21.4	24.7	3.5	13.8	2.1	17.2	2.1	12.6	8.5	0.7	9.6	9.9	12.4	9.3	2.4	9.3	14.8	8.9	30.1	5.7	0.8	3.0	15.9	7.7	3.3	10.2	59.7	11.6	3.3	4.8	3.9	3.0	10.3	6.9	17.9	64.9	30.6	6.3	9.3	105.3	20.1	30.6	22.7	21.6	15.7	129.6	2.3	14.9	15.8	13.9	14.5	25.2	116.8	16.1	3.2	3.3	11.2	23.1	28.8	6.5	20.6	40.0	20.3	22.1	13.3	2.0	11.5	0.0	11.8	25.9	13.2	25.6	22.4	2.1	10.5	166.4	12.9	4.7	8.6	53.0	14.6	3.4	42.8	28.3	11.5
EPB41L2	4.1-G	ENSG00000079819	"Erythrocyte membrane protein band 4.1 like 2"	O43491	6	130839347-131063322	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Cell division, Mitosis, Transport"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	18	"Muller glia cells: 499.6;Rod photoreceptor cells: 1331.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005730, HPA006642"	Supported		Enhanced	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA		170000	"Plasma membrane"	"Nucleoplasm, Cell Junctions"	"HPA005730: AB_1848195, HPA006642: AB_1848194"	"unprognostic (3.18e-2)"	"unprognostic (1.04e-1)"	"unprognostic (8.34e-3)"	"unprognostic (3.40e-3)"	"unprognostic (1.41e-1)"	"unprognostic (5.17e-2)"	"prognostic unfavorable (2.41e-5)"	"unprognostic (1.25e-1)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (2.16e-4)"	"unprognostic (3.24e-1)"	"unprognostic (1.63e-1)"	"unprognostic (5.63e-2)"	"unprognostic (3.64e-2)"	"unprognostic (3.82e-1)"	"unprognostic (3.48e-2)"	"unprognostic (9.19e-2)"	50.2	16.5	29.6	17.3	42.8	3.9	21.1	6.5	40.1	20.5	23.1	32.3	7.2	12.3	23.0	13.7	13.2	25.6	18.0	22.8	33.4	24.6	11.5	12.1	24.4	15.4	50.5	33.1	44.4	9.1	8.2	8.4	26.2	34.8	11.2	23.2	52.0	10.1	15.8	16.0	7.1	21.4	20.6	59.5	25.3	11.7	32.2	51.9	6.8	15.2	14.6	11.6	15.2	16.6	10.5	8.6	0.5	8.8	1.0	2.5	1.3	8.3	8.8	20.0	27.4	13.9	22.3	6.1	14.2	18.0	14.5	20.3	16.8	11.9	10.2	26.7	19.5	11.8	4.3	7.6	13.1	29.0	43.3	17.7	18.3	10.5	9.6	8.2	0.0	22.3	10.9	0.2	25.6	9.9	23.5	22.3	15.6	49.5	29.3	9.2	2.1	14.3	3.1	18.5	35.8	9.6	22.3	24.0	0.9	24.4	8.0	2.1	0.0	5.9	0.1	11.5	21.4	3.0	19.1	27.0	17.1	32.3	28.9	42.7	24.3	0.4	9.5	11.7	0.1	26.0	0.1	3.1	0.5	1.0	8.8	0.9	2.9	1.0	1.2	8.6	10.5	1.7	0.7	0.0	1.0	3.3	2.3	2.5	1.3	29.6	42.8	6.5	39.6	33.4	24.6	50.5	33.1	34.8	51.9	6.0	11.8	15.4	12.1	13.7	52.8	12.6	22.9	20.1	28.4	1.8	212.1	2.8	0.0	28.2	273.7	47.2	31.6	0.0	14.3	5.1	74.8	3.3	42.8	3.4	29.8	27.0	9.8	39.3	104.6	245.3	67.6	61.1	10.1	17.2	36.8	499.6	37.8	21.0	43.5	9.8	1331.8	116.4	56.7	54.3	79.8	8.9	2.1	5.0	21.6	6.8
EPB41L3	"4.1B, DAL1, KIAA0987"	ENSG00000082397	"Erythrocyte membrane protein band 4.1 like 3"	Q9Y2J2	18	5392381-5630700	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis	Actin-binding	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 46.8"	"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 163.9;Late spermatids: 207.6;Syncytiotrophoblasts: 179.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 7.7;non-classical monocyte: 11.6"	"Lineage enriched"	"Detected in many"	4	"monocytes: 11.6"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 20.9;HUVEC TERT2: 18.9;SCLC-21H: 21.2;TIME: 51.8;U-2 OS: 18.9;U-2197: 18.4;U-251 MG: 22.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028605	Enhanced		Enhanced	"Plasma membrane,Cell Junctions"		NA	NA		140000	"Plasma membrane, Cell Junctions"		"HPA028605: AB_10611963"	"unprognostic (3.58e-3)"	"unprognostic (1.17e-2)"	"unprognostic (3.61e-1)"	"unprognostic (7.97e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.44e-2)"	"unprognostic (2.60e-1)"	"unprognostic (9.73e-2)"	"unprognostic (3.40e-1)"	"unprognostic (3.63e-3)"	"unprognostic (1.07e-3)"	"unprognostic (5.81e-2)"	"unprognostic (5.96e-2)"	"unprognostic (5.65e-3)"	"unprognostic (8.99e-2)"	"unprognostic (2.72e-2)"	"unprognostic (6.59e-3)"	17.1	19.4	12.0	16.4	32.1	2.5	8.9	35.9	36.3	5.1	10.6	36.2	1.4	29.8	5.8	7.1	6.8	8.8	6.0	6.0	11.3	16.6	21.0	3.1	8.8	8.8	46.4	15.9	7.8	4.4	14.7	9.0	12.7	46.8	4.0	8.4	3.8	3.6	5.0	4.6	3.5	27.9	8.3	27.2	10.5	3.2	35.9	36.6	0.9	4.0	1.5	2.6	5.6	5.8	0.0	2.5	0.7	11.6	0.0	0.6	0.7	0.1	0.3	1.2	0.0	17.9	20.9	14.1	4.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	12.4	7.5	0.0	12.2	0.0	0.0	0.0	10.9	0.0	0.1	0.0	0.0	0.0	1.4	10.9	0.0	3.9	0.0	5.2	18.9	0.0	0.1	0.1	0.0	0.0	0.1	0.2	2.5	0.0	4.0	0.0	0.0	0.0	0.1	1.5	21.2	0.1	0.0	0.1	8.3	10.5	0.2	1.5	51.8	0.1	18.9	18.4	22.2	0.0	0.0	0.0	0.0	1.7	2.1	0.0	4.5	0.0	0.0	7.7	0.0	0.0	0.0	0.0	2.5	0.0	0.6	0.0	0.7	0.0	11.6	0.0	0.0	0.7	12.0	32.1	35.9	27.7	11.3	16.6	46.4	15.9	46.8	36.6	17.9	8.3	0.0	3.7	14.2	75.0	2.0	5.1	2.7	3.4	7.0	72.6	84.0	13.3	0.3	163.9	11.1	47.9	0.0	0.6	44.2	10.4	3.0	0.0	0.5	50.4	3.2	8.7	3.7	66.5	207.6	20.8	56.6	10.1	55.9	6.1	2.9	1.2	7.0	7.4	56.6	13.2	0.0	5.0	1.9	3.0	7.3	179.0	2.2	7.2	1.3
EPHA2	ECK	ENSG00000142627	"EPH receptor A2"	P29317	1	16124337-16156087	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins, RAS pathway related proteins"	"Angiogenesis, Apoptosis, Cell adhesion, Differentiation, Host-virus interaction"	"Host cell receptor for virus entry, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Cataract, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 51.2"	"Cell type enhanced"	"Detected in many"	8	"Basal keratinocytes: 179.7;Suprabasal keratinocytes: 217.2;Urothelial cells: 155.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	115	"plasmacytoid DC: 11.4"	"Lineage enriched"	"Detected in single"	115	"dendritic cells: 11.4"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 42.4;EFO-21: 40.9;PC-3: 48.6;U-251 MG: 49.8;WM-115: 54.6"					"Low region specificity"	"Detected in all"			CAB010464			Supported	"Nuclear speckles,Golgi apparatus,Plasma membrane,Cell Junctions"		NA	NA			"Plasma membrane, Cell Junctions"	"Nuclear speckles, Golgi apparatus"	"CAB010464: AB_631436"	"unprognostic (9.41e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.13e-2)"	"unprognostic (1.67e-2)"	"unprognostic (6.22e-2)"	"unprognostic (9.12e-2)"	"unprognostic (5.24e-2)"	"unprognostic (1.29e-3)"	"unprognostic (2.52e-2)"	"unprognostic (7.05e-3)"	"unprognostic (1.52e-3)"	"unprognostic (2.77e-1)"	"unprognostic (2.65e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.77e-3)"	"unprognostic (4.40e-2)"	6.7	3.4	1.3	3.1	2.6	0.0	5.2	0.5	2.1	12.1	4.9	1.6	1.9	4.3	7.8	3.8	51.2	4.6	16.7	6.4	1.1	0.8	5.7	8.2	6.6	4.7	2.7	1.3	4.5	10.2	2.2	2.8	8.9	3.4	5.8	2.6	5.4	31.0	2.8	3.4	12.7	13.1	2.7	3.0	2.8	6.8	2.4	1.2	1.2	5.7	21.8	25.5	15.2	18.5	0.0	11.4	0.0	0.0	0.0	0.0	0.0	15.6	31.7	8.8	4.2	0.6	0.7	5.2	9.5	13.4	17.2	10.9	13.2	42.4	0.0	40.9	5.4	21.3	6.4	2.1	21.9	6.0	0.0	1.4	0.0	9.2	8.4	11.3	0.0	0.0	1.0	8.2	9.3	20.7	27.0	18.3	0.0	0.0	0.0	10.9	5.0	0.0	0.0	4.2	11.8	48.6	0.0	8.0	0.0	18.2	8.1	0.0	1.3	18.4	4.5	1.2	4.8	0.6	0.1	22.6	6.1	16.5	0.4	49.8	0.0	0.1	0.1	4.7	0.0	54.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	0.0	0.0	1.3	2.6	0.5	2.1	1.1	0.8	2.7	1.3	3.4	1.2	50.6	28.9	0.5	100.5	179.7	0.6	5.8	40.8	37.5	33.0	8.7	3.9	8.1	0.0	31.3	5.4	17.5	57.1	0.0	12.5	0.9	7.0	56.8	5.7	19.8	1.6	0.0	2.9	32.5	2.8	0.0	3.1	4.6	25.3	1.8	19.6	5.8	62.9	20.1	0.0	1.4	2.0	32.3	17.6	0.0	0.7	217.2	6.3	0.0	17.7	155.0
ESCO2	"EFO2, RBS"	ENSG00000171320	"Establishment of sister chromatid cohesion N-acetyltransferase 2"	Q56NI9	8	27771949-27812640	"Disease related genes, Predicted intracellular proteins"	"Cell cycle"	"Acyltransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"intestine: 23.2;lymphoid tissue: 39.8;testis: 10.3"	"Group enriched"	"Detected in many"	9	"Erythroid cells: 70.0;Spermatocytes: 30.1;Spermatogonia: 77.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"T-reg: 4.6"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA027243, HPA053679"			Supported	"Nucleoplasm,Golgi apparatus,Cell Junctions"		Yes	Yes			"Nucleoplasm, Golgi apparatus"	"Cell Junctions"	"HPA027243: AB_2672175, HPA053679: AB_2682227"	"unprognostic (7.86e-2)"	"unprognostic (1.50e-2)"	"prognostic favorable (1.04e-4)"	"unprognostic (5.13e-3)"	"unprognostic (9.50e-2)"	"unprognostic (8.67e-3)"	"unprognostic (7.30e-4)"	"unprognostic (5.24e-3)"	"unprognostic (2.24e-2)"	"unprognostic (2.54e-2)"	"unprognostic (7.51e-4)"	"unprognostic (2.23e-1)"	"unprognostic (1.65e-14)"	"unprognostic (6.65e-3)"	"unprognostic (5.32e-1)"	"unprognostic (5.85e-2)"	"unprognostic (4.06e-1)"	1.0	1.7	0.5	7.1	0.5	5.5	1.0	0.4	0.6	1.2	9.6	0.1	0.5	11.9	0.6	1.0	5.0	0.3	1.8	1.1	0.7	0.5	1.6	1.4	1.1	4.2	0.5	0.6	0.6	1.0	0.3	0.3	1.5	0.5	0.5	4.5	0.1	1.4	1.4	0.4	1.1	23.2	0.4	0.8	4.7	2.4	10.3	0.2	39.8	0.5	5.3	5.7	1.0	1.8	1.3	1.9	0.8	1.5	0.9	4.6	0.8	25.1	19.1	8.6	10.4	1.1	1.8	4.8	15.1	6.4	14.1	16.1	6.7	5.0	9.3	8.0	3.9	11.8	13.9	10.4	4.1	21.4	7.2	4.4	11.0	8.6	7.1	0.1	5.6	10.3	0.3	0.4	8.2	2.1	1.4	5.2	7.2	8.8	14.2	8.1	4.9	22.6	2.5	5.8	13.8	6.4	10.0	25.7	6.8	4.6	15.2	3.7	5.5	7.6	9.2	3.8	3.3	6.3	6.2	2.3	8.7	18.0	17.5	11.8	1.9	5.0	11.5	4.8	9.4	12.0	0.1	0.7	0.4	0.3	1.5	0.1	1.3	0.7	1.0	1.9	0.1	0.5	0.4	0.8	0.9	0.4	0.2	4.6	0.8	0.5	0.5	0.4	0.6	0.7	0.5	0.5	0.6	0.5	0.2	0.0	6.6	2.2	0.7	2.1	1.5	1.1	0.0	2.7	5.7	0.0	3.9	1.0	0.0	0.3	3.9	0.1	5.3	70.0	0.0	5.5	0.9	0.2	1.1	1.1	4.5	0.0	1.2	0.6	4.1	0.4	1.7	3.5	0.0	0.0	2.3	0.0	0.1	0.8	0.0	0.0	1.8	6.5	0.3	30.1	77.3	0.5	0.8	2.9	4.0	0.9
F11R	"CD321, JAM-1, JAM-A, JAM1, JAMA, JCAM, PAM-1"	ENSG00000158769	"F11 receptor"	Q9Y624	1	160995211-161021348	"CD markers, Plasma proteins, Predicted membrane proteins"	"Host-virus interaction"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 1: 235.2;Urothelial cells: 227.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"eosinophil: 44.5;neutrophil: 32.2"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 44.5"	"Cell line enhanced"	"Detected in many"		"HaCaT: 45.8;OE19: 44.1;SuSa: 54.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB004671, HPA043616, HPA061700"	Enhanced		Supported	"Cell Junctions,Microtubules"		NA	NA		41000000	Microtubules	"Cell Junctions"	"CAB004671: AB_425964, HPA043616: , HPA061700: AB_2684589"	"unprognostic (1.60e-2)"	"unprognostic (5.78e-3)"	"unprognostic (1.78e-3)"	"unprognostic (2.24e-1)"	"unprognostic (4.99e-2)"	"unprognostic (4.89e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.55e-1)"	"unprognostic (6.35e-2)"	"unprognostic (1.98e-3)"	"unprognostic (1.87e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.59e-1)"	"unprognostic (9.72e-3)"	"unprognostic (5.01e-2)"	20.7	13.3	3.0	9.6	3.6	6.4	11.8	2.0	3.5	14.5	36.3	3.9	21.4	20.5	8.6	11.2	41.5	12.3	30.5	10.0	3.4	3.2	35.9	69.8	55.0	10.4	3.6	1.8	10.9	37.9	18.5	16.3	61.8	5.3	17.8	19.5	5.7	59.3	23.7	9.0	22.0	59.8	4.9	4.0	27.0	18.8	11.0	3.3	8.1	52.2	25.8	29.9	16.8	19.7	1.3	7.0	44.5	8.9	2.2	3.8	6.6	26.4	3.4	1.0	0.3	0.7	0.0	21.5	0.1	0.0	0.9	0.9	24.5	35.0	1.9	18.0	0.0	5.2	45.8	5.4	22.7	1.4	1.5	4.0	5.5	1.4	11.1	1.1	5.1	16.5	0.3	28.7	0.1	7.6	5.5	21.5	4.2	7.5	0.5	0.1	11.4	1.6	2.9	18.2	44.1	4.9	2.4	0.0	8.5	15.4	20.1	7.6	2.0	6.4	27.5	5.7	54.5	29.9	9.2	12.9	0.0	0.6	0.1	0.2	6.4	12.6	0.6	4.1	5.1	1.7	7.6	8.9	44.5	3.8	4.5	2.0	1.3	3.5	2.3	7.0	0.9	3.4	2.7	32.2	2.2	3.4	5.3	1.5	6.6	3.0	3.6	2.0	3.5	3.4	3.2	3.6	1.8	5.3	3.3	235.2	115.8	3.7	97.8	31.3	0.8	3.0	61.1	163.3	161.5	73.3	2.0	64.9	6.6	66.4	6.8	40.7	78.8	0.0	61.9	148.6	11.0	102.0	17.4	55.2	27.9	0.0	59.7	24.5	14.6	1.5	2.0	22.4	8.5	63.1	64.1	1.4	68.6	75.0	0.7	11.9	2.5	0.0	3.1	12.9	1.2	44.3	52.7	8.7	42.7	227.3
FAAP20	"C1orf86, FLJ31031"	ENSG00000162585	"Fanconi anemia core complex associated protein 20"	Q6NZ36	1	2184461-2212720	"Predicted intracellular proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA038829	Uncertain		Supported	"Nucleoplasm,Nuclear bodies,Cell Junctions"		NA	NA			Nucleoplasm	"Nuclear bodies, Cell Junctions"	"HPA038829: AB_10673476"	"unprognostic (1.36e-2)"	"unprognostic (2.86e-2)"	"unprognostic (2.69e-3)"	"unprognostic (1.65e-1)"	"unprognostic (2.64e-1)"	"unprognostic (6.11e-2)"	"prognostic unfavorable (4.57e-4)"	"unprognostic (2.81e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.80e-1)"	"prognostic favorable (2.88e-4)"	"unprognostic (1.59e-1)"	"unprognostic (1.96e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.67e-1)"	"unprognostic (4.93e-2)"	"unprognostic (8.55e-2)"	33.1	18.8	15.4	14.3	12.1	15.2	20.5	15.4	16.4	17.8	19.1	13.8	19.1	14.6	17.8	17.7	20.3	12.6	14.2	17.0	15.4	14.8	27.7	20.9	15.0	22.5	14.9	10.3	16.9	17.2	8.0	26.4	11.7	13.3	21.8	7.3	20.9	21.4	23.9	27.3	28.1	14.9	15.0	14.3	24.4	30.5	20.2	11.5	35.1	30.5	11.4	16.5	17.1	19.3	13.2	22.0	31.0	8.7	5.1	12.6	5.6	10.4	1.6	2.3	2.8	1.4	1.9	13.8	11.8	4.4	3.9	5.1	2.5	6.9	12.2	17.5	1.8	3.5	5.1	1.6	1.7	1.9	26.0	24.0	10.1	2.7	5.3	5.4	7.0	9.8	3.3	3.9	2.3	2.5	2.4	4.7	9.7	13.9	2.9	2.6	4.3	10.2	21.9	8.2	2.0	21.9	13.7	7.2	11.4	1.8	1.6	18.9	25.3	7.7	3.3	20.2	2.2	3.3	2.9	9.9	6.0	14.3	7.4	6.7	27.5	14.6	17.8	11.2	4.4	2.5	3.6	8.7	31.0	10.1	8.1	10.0	13.2	9.2	10.9	8.8	13.1	12.6	10.4	11.2	5.1	7.5	22.0	7.8	5.6	15.4	12.1	15.4	14.1	15.4	14.8	14.9	10.3	13.3	11.5	6.0	11.0	59.7	76.1	0.0	25.1	17.1	50.9	14.7	12.5	92.5	3.9	105.4	144.2	110.3	81.6	33.1	20.8	23.3	96.1	118.9	7.2	104.6	7.0	78.0	115.2	14.3	42.1	73.1	106.0	249.7	79.7	47.3	0.0	185.8	72.9	43.5	131.8	46.3	77.8	221.5	25.4	64.7	14.6	118.4	32.4	0.0	75.1	55.3	55.7	99.4
FAM126B	"HYCC2, MGC39518"	ENSG00000155744	"Family with sequence similarity 126 member B"	Q8IXS8	2	200973718-201071671	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Cone photoreceptor cells: 155.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 20.3"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 20.3"	"Cell line enhanced"	"Detected in all"		"U-266/84: 35.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036166, HPA036167, HPA067307"	Uncertain		Supported	"Nucleoplasm,Cell Junctions"		NA	NA			"Cell Junctions"	Nucleoplasm	"HPA036166: AB_10696651, HPA036167: AB_2674982, HPA067307: AB_2685821"	"unprognostic (7.47e-3)"	"unprognostic (5.54e-2)"	"unprognostic (2.52e-1)"	"unprognostic (9.08e-2)"	"unprognostic (8.96e-2)"	"unprognostic (3.01e-3)"	"unprognostic (1.11e-2)"	"unprognostic (2.61e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.10e-2)"	10.5	6.9	9.8	8.7	17.2	22.1	7.3	28.7	21.1	5.9	10.3	6.5	5.9	9.8	6.8	6.3	12.1	5.8	6.4	6.5	9.3	9.2	12.0	10.9	9.4	7.9	7.3	11.6	7.8	7.1	9.8	16.6	7.2	15.1	5.8	9.6	8.8	7.0	4.9	5.6	10.2	9.3	5.8	8.1	10.6	11.0	6.3	6.4	8.3	10.3	2.9	8.7	5.5	8.1	2.1	1.2	20.3	1.9	2.3	3.4	1.5	3.3	1.8	2.5	2.7	2.7	3.6	5.5	3.2	1.9	2.5	2.5	4.5	4.0	3.1	3.1	3.2	2.4	4.1	5.1	2.0	4.0	4.4	3.2	8.9	4.7	4.1	2.2	10.7	7.8	1.5	2.5	3.5	2.1	2.0	2.5	3.3	8.2	11.4	2.6	2.0	6.4	7.1	1.7	2.2	3.0	3.8	3.8	2.7	2.4	3.7	5.0	2.5	3.4	3.9	2.8	3.4	2.7	4.7	4.9	4.8	3.5	2.4	2.9	8.5	35.4	6.6	2.8	4.2	3.3	1.7	1.4	5.1	3.1	1.8	3.4	2.1	2.6	2.4	1.2	2.0	2.6	3.1	20.3	2.3	1.9	0.9	1.7	1.5	9.8	17.2	28.7	21.1	9.3	9.2	7.3	11.6	15.1	6.4	26.8	19.2	18.5	8.9	46.8	48.4	13.4	20.4	14.7	14.8	19.2	155.1	13.2	14.9	8.8	4.8	18.0	46.6	23.3	9.3	7.9	12.8	13.1	24.3	17.7	10.4	25.4	35.6	34.4	29.2	2.5	29.4	26.5	28.7	13.6	19.0	21.4	15.0	26.6	24.1	13.5	38.9	19.4	17.6	30.8	20.3	64.7	14.5	30.5	16.5	16.1
FAM13A	"ARHGAP48, FAM13A1, KIAA0914"	ENSG00000138640	"Family with sequence similarity 13 member A"	O94988	4	88725955-89111398	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Hepatocytes: 111.2;Syncytiotrophoblasts: 233.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"dendritic cells: 5.7;monocytes: 6.5;T-cells: 5.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 32.6"	"Low region specificity"	"Detected in all"							"HPA038108, HPA038109"	Uncertain		Approved	"Nucleoli,Cell Junctions,Cytosol"		NA	NA			"Cell Junctions, Cytosol"	Nucleoli	"HPA038108: AB_2675837, HPA038109: AB_10672619"	"unprognostic (1.14e-1)"	"unprognostic (1.53e-2)"	"unprognostic (6.29e-2)"	"unprognostic (2.53e-1)"	"unprognostic (3.20e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.79e-1)"	"unprognostic (2.81e-1)"	"unprognostic (8.20e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.46e-3)"	"unprognostic (6.36e-2)"	"unprognostic (4.71e-1)"	"unprognostic (3.49e-3)"	"unprognostic (1.90e-2)"	"unprognostic (7.44e-2)"	"prognostic favorable (4.28e-4)"	58.6	10.8	9.1	11.0	9.3	6.5	19.0	17.9	18.5	15.5	41.0	3.7	7.4	30.5	10.9	12.0	9.3	14.8	10.7	8.8	9.6	5.7	14.0	22.9	13.3	5.3	10.0	6.8	17.8	23.5	45.5	11.2	20.7	11.4	15.9	9.3	11.5	13.3	8.0	8.4	17.5	30.5	15.6	19.4	4.9	13.4	11.1	12.9	3.2	20.4	16.1	4.0	30.4	23.8	0.1	5.7	1.4	6.5	0.7	5.2	2.6	2.4	3.7	5.6	7.3	32.6	13.5	9.2	5.8	7.0	2.3	2.1	3.1	5.8	0.1	2.3	4.1	3.6	1.5	8.2	4.1	5.2	0.3	5.7	4.1	5.2	0.4	9.6	3.4	0.5	12.9	3.4	5.8	2.1	10.1	3.9	1.4	10.6	0.4	4.9	0.1	0.3	1.5	6.9	0.4	3.9	5.6	9.5	2.2	4.2	12.2	14.2	3.8	1.4	4.5	5.4	5.8	3.1	0.1	1.4	6.5	3.6	3.1	3.3	2.0	1.1	0.0	9.6	0.3	3.3	0.1	6.5	0.1	1.8	3.2	1.3	0.1	4.7	0.6	5.7	0.1	5.2	1.3	1.4	0.7	1.0	1.9	2.5	2.6	9.1	9.3	17.9	18.5	9.6	5.7	10.0	6.8	11.4	12.9	11.9	27.5	3.7	19.8	9.0	19.2	22.7	22.9	81.7	46.6	10.4	33.4	57.4	24.9	8.6	2.3	12.5	34.9	0.0	14.6	29.6	23.6	13.3	1.1	111.2	17.5	0.0	4.7	8.0	29.1	2.4	41.7	12.6	18.6	4.6	37.9	26.9	31.2	63.3	31.5	34.7	10.7	0.0	24.2	4.8	6.1	6.8	233.8	6.4	14.6	16.6
FBLIM1	"CAL, FBLP-1, migfilin"	ENSG00000162458	"Filamin binding LIM protein 1"	Q8WUP2	1	15756607-15786594	"Predicted intracellular proteins"	"Cell adhesion, Cell shape"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Peritubular cells: 180.0;Sertoli cells: 142.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 54.1;TIME: 84.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA025287, HPA072750"	Approved		Enhanced	"Nucleoli fibrillar center,Cell Junctions,Focal adhesion sites"		NA	NA			"Cell Junctions, Focal adhesion sites"	"Nucleoli fibrillar center"	"HPA025287: AB_1848443, HPA072750: AB_2686554"	"unprognostic (4.10e-2)"	"prognostic unfavorable (4.07e-4)"	"unprognostic (2.26e-1)"	"unprognostic (5.33e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.52e-1)"	"unprognostic (9.33e-2)"	"unprognostic (8.77e-3)"	"prognostic unfavorable (6.15e-4)"	"unprognostic (2.02e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (8.64e-4)"	"unprognostic (8.33e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.08e-1)"	"unprognostic (8.21e-2)"	11.6	6.0	1.7	12.8	1.4	0.0	10.1	0.8	1.3	21.5	36.6	1.4	26.8	24.6	30.3	15.8	17.8	16.5	60.2	21.7	1.2	1.0	18.2	3.0	14.7	16.1	1.8	1.6	36.0	13.0	13.9	3.8	21.5	2.3	26.7	15.7	9.0	13.0	26.5	4.1	6.2	62.8	18.7	1.3	22.7	18.9	22.3	0.9	1.3	10.3	7.4	6.3	24.7	16.9	1.8	1.3	4.6	1.2	1.6	1.2	0.3	6.5	3.7	3.3	0.1	0.8	1.7	4.5	11.2	17.9	8.3	6.7	1.2	9.9	0.0	24.3	18.0	14.4	12.7	2.4	25.7	4.1	0.0	1.2	0.0	0.9	6.3	21.6	0.0	0.1	8.5	17.2	6.9	16.5	17.2	54.1	0.4	0.2	1.6	2.8	0.1	0.1	0.1	3.4	10.3	4.8	0.0	0.0	0.2	10.4	4.5	0.0	8.0	5.9	0.7	1.3	7.2	1.4	0.1	84.4	11.0	1.5	0.1	5.1	0.1	0.2	0.1	1.6	0.0	0.1	4.6	1.2	1.0	0.7	0.5	0.6	1.0	0.7	0.7	0.4	1.8	1.1	1.2	3.5	1.6	0.7	1.3	0.4	0.3	1.7	1.4	0.8	1.3	1.2	1.0	1.8	1.6	2.3	0.9	11.9	21.5	5.2	54.8	76.6	3.5	30.9	45.9	12.0	29.6	15.7	5.9	5.8	0.0	80.2	2.4	18.4	138.3	0.0	46.9	102.1	26.9	24.2	17.4	1.8	5.3	1.6	44.1	38.1	0.6	1.8	74.2	10.4	13.5	3.6	47.1	10.0	88.8	84.2	180.0	1.2	5.1	142.3	66.2	2.3	1.8	54.8	16.2	6.1	40.4	47.2
FBLN7	"FLJ37440, TM14"	ENSG00000144152	"Fibulin 7"	Q53RD9	2	112138385-112188216	"Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"	Heparin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Melanocytes: 16.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	25	"memory CD4 T-cell: 18.5;naive CD4 T-cell: 16.2;T-reg: 17.4"	"Lineage enriched"	"Detected in single"	36	"T-cells: 18.5"	"Cell line enhanced"	"Detected in some"		"AF22: 17.5;BJ hTERT+: 12.5;hTERT-RPE1: 9.2;SCLC-21H: 11.3;SH-SY5Y: 9.0;U-2197: 18.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA034992			Approved	"Plasma membrane,Cell Junctions"	"Secreted to extracellular matrix"	NA	NA		27000	"Plasma membrane"	"Cell Junctions"	"HPA034992: AB_10601469"	"unprognostic (1.72e-1)"	"unprognostic (1.47e-1)"	"unprognostic (5.88e-2)"	"unprognostic (4.88e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.70e-3)"	"unprognostic (4.34e-2)"	"unprognostic (4.80e-2)"	"unprognostic (5.77e-2)"	"unprognostic (2.01e-1)"	"unprognostic (7.91e-2)"	"unprognostic (2.02e-2)"	"unprognostic (2.35e-2)"	"unprognostic (3.11e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.21e-2)"	"unprognostic (9.33e-2)"	7.5	5.8	2.9	9.0	3.4	1.1	10.4	10.3	16.4	12.4	2.3	1.6	4.1	1.7	6.5	8.2	2.9	10.5	7.1	3.3	4.0	3.8	2.5	6.6	3.7	11.8	6.9	4.2	2.8	3.4	16.7	27.4	13.6	10.5	4.7	2.0	14.7	3.9	9.0	1.9	7.1	3.8	3.2	2.2	7.3	4.1	2.0	1.1	8.7	14.9	5.5	9.5	3.6	10.4	0.0	0.5	0.0	0.0	0.0	18.5	3.5	0.0	0.1	17.5	0.0	1.9	1.4	0.0	3.8	12.5	4.2	6.6	0.0	0.1	0.0	0.1	5.7	0.7	0.0	0.0	0.0	2.0	0.0	0.0	0.0	1.3	0.8	0.9	0.0	0.0	1.3	0.1	7.0	0.0	9.2	1.0	0.2	0.0	0.0	1.4	0.0	0.4	0.0	0.4	0.0	0.3	0.0	0.0	4.4	0.2	0.0	11.3	9.0	0.0	0.0	0.5	0.1	0.5	0.1	3.6	0.6	0.5	18.1	0.5	0.0	0.0	0.0	0.5	0.0	1.5	0.0	0.0	0.0	0.2	0.0	0.7	0.0	18.5	0.2	0.0	0.0	16.2	0.5	0.0	0.0	0.0	0.5	17.4	3.5	2.9	3.4	10.3	16.4	4.0	3.8	6.9	4.2	10.5	1.1	3.0	0.3	0.0	0.7	3.9	3.7	0.8	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.3	1.9	2.1	0.0	0.0	0.2	5.9	4.7	0.4	1.1	1.0	0.4	3.2	0.0	0.6	0.0	1.7	0.3	0.0	16.9	0.0	0.0	2.2	0.4	0.0	4.9	0.5	7.2	6.5	4.7	0.1	0.2	3.3	1.3	4.4	0.0	0.3
FGFR2	"BEK, CD332, CEK3, CFD1, ECT1, JWS, K-SAM, KGFR, TK14, TK25"	ENSG00000066468	"Fibroblast growth factor receptor 2"	P21802	10	121478334-121598458	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	Apoptosis	"Heparin-binding, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Craniosynostosis, Disease mutation, Ectodermal dysplasia, FDA approved drug targets, Lacrimo-auriculo-dento-digital syndrome, Mental retardation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 74.8"	"Cell type enhanced"	"Detected in many"	16	"Cholangiocytes: 191.1;Club cells: 52.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	15	"basophil: 10.8;eosinophil: 4.6"	"Lineage enriched"	"Detected in single"	35	"granulocytes: 10.8"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 58.9;BEWO: 19.8;CACO-2: 15.4;HaCaT: 17.8;HAP1: 19.1;NTERA-2: 18.9;T-47d: 15.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010886, HPA035305"	Uncertain		Supported	"Nucleoplasm,Vesicles,Cell Junctions"	"Secreted - unknown location"	NA	NA		500000	"Cell Junctions"	"Nucleoplasm, Vesicles"	"CAB010886: AB_259379, HPA035305: AB_10672862"	"unprognostic (5.53e-2)"	"prognostic favorable (8.79e-4)"	"unprognostic (1.08e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.73e-1)"	"prognostic favorable (9.32e-4)"	"unprognostic (1.53e-1)"	"unprognostic (4.96e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.74e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.11e-2)"	"unprognostic (2.54e-1)"	"unprognostic (6.93e-2)"	"unprognostic (2.25e-1)"	2.1	8.8	16.4	3.0	30.3	0.0	9.9	15.8	21.3	6.8	14.1	55.7	5.6	4.2	22.0	6.6	10.2	12.5	12.5	1.4	20.6	11.1	11.4	16.1	13.1	1.0	41.2	13.3	7.4	12.8	25.5	2.5	6.2	30.2	11.7	8.7	16.4	23.8	24.3	0.4	45.4	4.7	18.3	74.8	0.5	9.3	2.9	32.1	0.8	23.4	1.6	3.4	6.9	8.5	0.1	0.1	10.8	0.1	0.1	0.3	0.0	2.2	0.1	9.2	58.9	0.0	0.0	19.8	0.1	0.0	0.0	0.0	15.4	0.3	0.0	4.2	0.9	0.0	17.8	19.1	4.0	0.0	0.0	4.1	0.0	0.0	0.3	0.4	0.0	3.8	0.0	8.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	18.9	2.7	0.0	0.0	0.0	2.3	5.7	5.0	0.1	0.1	0.1	10.8	0.0	11.5	15.8	0.0	0.0	0.1	2.9	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	10.8	0.1	4.6	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.5	0.1	0.0	0.1	0.0	0.0	16.4	30.3	15.8	21.3	20.6	11.1	41.2	13.3	30.2	32.1	17.9	31.8	0.0	29.5	35.6	0.0	2.7	191.1	18.7	52.4	34.9	0.0	12.6	0.0	4.0	2.9	0.5	2.6	0.0	0.2	2.7	17.5	9.8	0.0	4.3	2.0	0.0	2.4	3.1	0.3	6.5	1.1	1.3	5.0	1.0	32.0	1.6	0.6	1.4	5.6	11.5	0.1	0.0	2.1	0.9	7.7	24.2	3.3	1.5	3.0	27.7
FIBCD1	FLJ14810	ENSG00000130720	"Fibrinogen C domain containing 1"	Q8N539	9	130902438-130939286	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.2;parathyroid gland: 10.7;testis: 9.5"	"Cell type enhanced"	"Detected in many"	9	"Early spermatids: 14.5;Exocrine glandular cells: 27.4;Late spermatids: 25.9;Mucus-secreting cells: 12.2;Pancreatic endocrine cells: 16.7;Spermatogonia: 15.1"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	11	"hippocampal formation: 19.2"	"Cell type enriched"	"Detected in single"	6	"non-classical monocyte: 5.7"	"Lineage enriched"	"Detected in single"	11	"monocytes: 5.7"	"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 9.4;MCF7: 21.2;OE19: 15.0;RPTEC TERT1: 16.5;THP-1: 8.2;U-2 OS: 11.3;U-251 MG: 9.2"	"Group enriched"	"Detected in many"	4	"basal ganglia: 18.2;hippocampal formation: 75.0"	"Region enriched"	"Detected in many"	4	"hippocampal formation: 81.5"	HPA055353	Approved		Approved	"Cell Junctions"		NA	NA			"Cell Junctions"		"HPA055353: AB_2682791"	"unprognostic (1.18e-3)"	"unprognostic (2.70e-1)"	"unprognostic (4.69e-2)"	"unprognostic (5.63e-2)"	"unprognostic (9.11e-2)"	"unprognostic (1.62e-1)"	"unprognostic (4.16e-5)"	"unprognostic (1.83e-3)"	"unprognostic (3.14e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.05e-2)"	"unprognostic (4.45e-2)"	"unprognostic (1.42e-6)"	"unprognostic (1.66e-1)"	"unprognostic (5.53e-2)"	"unprognostic (6.68e-3)"	"unprognostic (2.77e-1)"	0.0	8.5	1.7	0.1	1.1	0.0	1.1	0.1	3.0	0.0	1.8	0.3	0.0	0.5	0.0	1.4	0.4	0.0	5.0	2.0	19.2	1.2	0.0	0.0	5.3	0.0	0.6	0.0	0.4	0.0	10.7	0.0	1.7	1.5	1.0	1.4	1.1	1.6	0.0	0.0	0.0	1.6	2.1	0.0	0.8	0.1	9.5	0.8	0.0	0.3	0.0	0.0	2.9	0.0	0.0	0.5	0.0	5.7	0.0	0.0	0.2	0.2	2.3	0.8	0.0	0.0	0.0	0.0	5.0	5.9	0.3	0.8	0.0	2.5	0.0	1.8	0.2	4.3	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.2	0.2	0.2	0.0	0.1	2.7	0.0	9.4	0.0	0.0	0.6	0.0	0.0	21.2	0.0	2.2	1.5	15.0	0.5	0.0	4.4	0.3	16.5	0.0	0.1	0.0	0.7	0.0	0.5	0.7	1.3	8.2	0.0	0.9	11.3	0.1	9.2	0.0	0.0	0.0	3.1	0.2	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.2	1.7	1.1	0.1	1.0	19.2	1.2	0.6	0.0	1.5	0.8	0.0	0.0	0.0	0.5	0.0	0.0	1.3	0.0	0.0	0.0	1.8	0.0	7.7	0.0	0.3	14.5	0.1	4.7	0.0	27.4	0.4	1.8	0.7	0.0	0.0	0.9	3.2	0.0	0.0	0.0	25.9	0.6	0.0	0.0	0.0	12.2	0.8	16.7	3.5	3.2	0.0	0.1	0.0	0.3	1.1	15.1	0.0	3.3	0.0	4.7	1.7
FIGN		ENSG00000182263	"Fidgetin, microtubule severing factor"	Q5HY92	2	163593396-163736012	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Leydig cells: 48.1;Peritubular cells: 32.2;Sertoli cells: 71.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	54	"basophil: 5.4"	"Lineage enriched"	"Detected in single"	54	"granulocytes: 5.4"	"Cell line enhanced"	"Detected in many"		"AF22: 17.2;SuSa: 10.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA034987, HPA057919"	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cell Junctions,Cytosol"		NA	NA			"Nucleoplasm, Plasma membrane, Cytosol"	"Vesicles, Cell Junctions"	"HPA034987: AB_10669681, HPA057919: "	"unprognostic (3.93e-2)"	"unprognostic (8.30e-3)"	"unprognostic (1.48e-1)"	"unprognostic (7.68e-5)"	"unprognostic (3.45e-2)"	"unprognostic (8.98e-4)"	"unprognostic (5.23e-3)"	"unprognostic (7.65e-3)"	"unprognostic (2.33e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.07e-2)"	"unprognostic (3.24e-2)"	"unprognostic (3.85e-3)"	"unprognostic (3.22e-2)"	"unprognostic (2.69e-1)"	"unprognostic (4.10e-2)"	"unprognostic (3.78e-2)"	8.5	7.6	9.6	2.9	13.7	2.8	5.2	5.1	11.9	6.8	5.9	5.5	3.7	2.1	3.3	5.0	2.9	4.5	4.4	10.1	8.8	4.3	7.2	7.9	4.3	2.5	8.7	4.7	14.3	7.2	1.8	12.1	4.4	7.7	4.8	3.4	4.3	8.4	9.9	3.6	3.2	3.6	5.6	9.1	8.7	4.5	4.4	10.5	0.0	3.1	3.0	1.6	4.1	6.3	0.0	0.0	5.4	0.0	0.0	0.0	0.0	5.6	2.0	17.2	0.0	0.0	0.0	6.3	2.2	1.5	1.6	3.0	0.0	2.0	0.0	6.2	2.4	3.2	0.8	5.7	2.4	1.3	0.0	4.2	0.0	3.9	4.1	1.4	0.0	0.0	0.8	2.1	3.1	8.4	2.5	3.7	0.0	0.0	0.0	4.7	1.4	0.0	0.0	7.3	0.4	2.7	0.0	5.8	0.0	4.0	1.9	2.7	2.3	0.0	1.6	1.5	10.1	1.8	0.0	0.3	7.1	6.5	0.0	4.6	1.0	0.0	0.0	2.1	0.0	3.9	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	13.7	5.1	11.9	8.8	4.3	8.7	4.7	7.7	10.5	6.0	5.3	1.4	0.1	1.6	15.3	16.8	10.2	6.7	3.4	12.2	0.0	18.1	1.7	2.5	2.7	0.7	0.0	0.0	1.3	5.9	6.3	0.9	0.0	11.3	1.2	6.4	0.0	7.4	0.0	4.2	48.1	0.2	16.9	0.0	0.0	6.5	1.7	0.0	32.2	6.3	1.9	71.1	13.9	0.2	0.6	0.4	14.1	0.0	0.0	0.0
FLRT3		ENSG00000125848	"Fibronectin leucine rich transmembrane protein 3"	Q9NZU0	20	14322988-14337616	"Disease related genes, Predicted membrane proteins"	"Cell adhesion"	"Developmental protein"	"Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 43.1"	"Cell type enhanced"	"Detected in many"	12	"Alveolar cells type 1: 202.5;Alveolar cells type 2: 116.8;Basal glandular cells: 129.3;Club cells: 126.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 15.6;hTCEpi: 29.4;RPTEC TERT1: 9.9;WM-115: 35.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056033	Enhanced		Supported	"Plasma membrane,Cell Junctions,Cytosol"	"Intracellular and membrane"	NA	NA		240000	"Plasma membrane"	"Cell Junctions, Cytosol"	"HPA056033: AB_2683016"	"unprognostic (2.14e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.14e-3)"	"unprognostic (2.30e-1)"	"unprognostic (6.00e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (9.85e-5)"	"unprognostic (1.24e-1)"	"unprognostic (1.81e-1)"	"prognostic unfavorable (1.54e-4)"	"unprognostic (3.05e-1)"	"prognostic favorable (1.49e-7)"	"unprognostic (1.54e-2)"	"unprognostic (2.48e-1)"	"unprognostic (3.07e-3)"	"unprognostic (3.65e-1)"	7.3	4.3	3.4	2.2	7.4	0.1	2.7	27.5	18.9	3.8	5.0	0.7	3.2	12.4	2.6	5.5	2.5	2.7	5.6	1.6	9.3	4.1	43.1	28.9	26.2	0.2	2.3	5.3	11.9	2.3	4.6	2.1	2.0	2.9	12.7	1.0	1.9	1.5	16.4	2.1	6.9	6.0	3.9	2.3	0.8	9.7	1.7	0.7	4.8	8.5	1.8	0.4	12.0	3.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	15.6	0.0	0.0	0.0	0.0	1.5	0.4	0.1	0.0	8.5	3.1	0.0	0.5	0.3	0.0	4.4	0.0	4.6	0.1	0.0	1.0	0.0	0.2	0.1	1.3	0.0	0.0	2.7	29.4	0.0	5.5	0.0	0.0	0.1	0.0	0.1	3.0	0.2	1.9	0.0	5.1	3.4	0.0	0.0	0.1	0.0	9.9	1.9	0.3	3.2	0.0	0.0	4.9	9.2	0.2	0.0	0.0	0.0	1.1	0.0	0.4	0.0	0.0	0.0	0.1	0.0	35.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	7.4	27.5	18.9	9.3	4.1	2.3	5.3	2.9	0.7	202.5	116.8	0.0	129.3	7.7	13.3	0.9	17.8	22.7	126.3	21.0	5.9	0.3	11.6	18.8	0.0	1.6	2.0	0.0	13.0	0.0	5.4	11.3	4.7	7.8	0.2	6.4	10.9	1.8	0.0	0.2	3.4	0.9	5.0	2.8	1.0	0.5	9.4	2.9	0.4	41.7	2.9	0.0	0.1	0.0	0.0	14.4	0.0	0.5	1.5	9.0
FLT4	"PCL, VEGFR3"	ENSG00000037280	"Fms related tyrosine kinase 4"	P35916	5	180601506-180649624	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	Angiogenesis	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 56.3"	"Group enriched"	"Detected in some"	5	"Extravillous trophoblasts: 31.7;Ito cells: 65.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	5	"MAIT T-cell: 7.7"	"Lineage enriched"	"Detected in single"	35	"T-cells: 7.7"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 8.3;BEWO: 10.1;HEK 293: 12.5;HUVEC TERT2: 8.1;JURKAT: 10.0;T-47d: 11.9;TIME: 12.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"CAB000099, HPA046519, HPA067906, HPA074389"	Approved		Supported	"Nuclear speckles,Plasma membrane,Cell Junctions"	"Secreted to blood"	NA	NA		270000000	"Nuclear speckles, Plasma membrane"	"Cell Junctions"	"CAB000099: , HPA046519: AB_2732527, HPA067906: AB_2732775, HPA074389: "	"unprognostic (7.35e-2)"	"unprognostic (1.63e-1)"	"unprognostic (9.45e-3)"	"unprognostic (3.81e-1)"	"unprognostic (9.26e-2)"	"unprognostic (3.20e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.13e-2)"	"unprognostic (3.69e-1)"	"unprognostic (1.88e-2)"	"unprognostic (9.41e-3)"	"unprognostic (1.83e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.32e-1)"	14.8	7.1	1.6	4.9	6.0	0.7	28.5	1.3	2.7	6.3	7.3	1.9	2.1	3.1	7.3	6.2	5.7	9.2	5.3	6.4	1.7	0.9	11.7	10.2	14.1	23.6	2.0	0.8	5.8	2.3	2.3	6.2	56.3	2.1	4.9	1.4	6.7	3.3	4.4	4.8	2.8	4.7	4.7	1.5	14.5	2.4	3.5	2.0	0.3	19.4	4.4	2.3	6.1	14.7	0.0	0.1	0.2	0.0	0.0	7.7	0.2	0.1	2.0	2.7	8.3	0.0	0.0	10.1	0.2	0.1	0.0	0.0	0.3	0.3	0.2	0.8	0.1	0.5	0.3	2.8	0.1	0.2	0.1	12.5	1.0	0.4	0.4	0.1	7.4	0.2	0.2	0.0	0.1	0.3	0.3	8.1	10.0	0.3	0.3	1.7	4.5	0.1	0.4	5.8	0.2	0.5	6.5	0.0	0.1	0.1	0.2	0.2	0.9	0.1	0.2	0.0	2.7	11.9	0.2	12.6	0.1	5.9	0.2	0.1	0.2	0.1	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.9	0.0	7.7	0.0	0.4	1.6	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.1	0.0	0.2	1.6	6.0	1.3	2.7	1.7	0.9	2.0	0.8	2.1	2.0	0.0	1.7	0.9	0.2	0.8	0.0	4.5	0.0	0.0	1.2	0.0	0.0	0.3	0.0	0.0	0.2	9.2	0.0	0.0	0.0	31.7	0.6	0.2	2.3	0.4	1.1	0.0	0.0	65.1	5.7	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	4.3	1.0	0.8	0.7	0.0	0.1
FLVCR1	"AXPC1, FLVCR, MFSD7B, PCA"	ENSG00000162769	"Feline leukemia virus subgroup C cellular receptor 1"	Q9Y5Y0	1	212858255-212899363	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Erythrocyte maturation, Transport"	Receptor	"Disease mutation, Neurodegeneration, Neuropathy, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 40.6"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"NTERA-2: 33.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046646	Approved		Approved	"Cell Junctions"		NA	NA			"Cell Junctions"		"HPA046646: AB_2679735"	"unprognostic (2.09e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.83e-2)"	"unprognostic (2.48e-1)"	"prognostic unfavorable (2.52e-5)"	"unprognostic (1.03e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.88e-2)"	"prognostic favorable (3.50e-4)"	"unprognostic (1.89e-1)"	"prognostic unfavorable (1.06e-5)"	"unprognostic (7.15e-2)"	"unprognostic (2.25e-1)"	"unprognostic (3.91e-2)"	"unprognostic (7.29e-3)"	3.2	3.8	4.6	4.5	7.2	7.8	4.8	11.3	5.9	4.4	12.9	4.7	3.3	13.5	4.0	7.5	3.2	3.6	3.6	2.5	5.0	7.5	3.5	3.1	3.7	4.1	5.3	5.9	4.0	5.1	7.0	16.8	3.5	7.2	5.3	4.4	4.0	2.9	4.3	1.6	4.3	40.6	3.8	4.8	4.2	7.1	4.0	5.5	5.4	3.6	2.1	3.3	4.0	5.0	1.2	1.6	4.7	0.8	0.7	1.4	0.2	4.8	6.4	10.0	3.0	1.7	2.1	18.9	1.4	1.1	2.9	1.8	9.4	9.0	5.3	2.7	1.0	6.2	7.4	10.8	3.2	2.9	3.1	4.7	3.1	6.3	8.5	2.0	8.3	5.1	1.6	2.1	3.1	4.0	1.5	2.2	3.7	8.3	4.4	1.9	1.8	2.3	4.1	33.1	6.4	4.6	5.2	9.2	6.1	3.6	4.7	10.9	7.7	6.6	6.6	6.0	8.7	10.8	3.9	1.3	1.4	3.4	4.6	6.5	2.7	5.5	6.3	2.1	4.8	1.7	1.6	0.8	4.7	0.8	0.6	0.9	0.9	1.2	1.0	0.5	1.2	1.2	1.1	2.6	0.7	0.8	1.6	1.4	0.2	4.6	7.2	11.3	5.9	5.0	7.5	5.3	5.9	7.2	5.5	11.9	13.6	12.6	8.8	12.7	22.7	3.3	7.6	9.4	15.9	19.2	33.4	3.0	1.7	3.8	3.2	7.7	17.9	0.0	11.7	5.3	7.8	10.1	6.9	4.9	5.5	15.9	31.2	10.4	10.3	5.3	5.8	9.0	5.0	8.2	8.6	6.3	7.3	10.5	2.5	4.1	31.2	6.5	7.2	10.1	5.9	8.2	2.1	8.9	6.5	3.7
FOXA2	HNF3B	ENSG00000125798	"Forkhead box A2"	Q9Y261	20	22581005-22585455	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 44.4;pancreas: 47.9;stomach 1: 20.7"	"Cell type enhanced"	"Detected in many"	9	"Alveolar cells type 1: 89.3;Alveolar cells type 2: 60.1;Cholangiocytes: 48.4;Hepatocytes: 51.3;Mucus-secreting cells: 82.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 10.2;HBEC3-KT: 11.7;Hep G2: 16.2;hTERT-HME1: 7.9;OE19: 13.2;PC-3: 15.1;SCLC-21H: 26.2"	"Region enhanced"	"Detected in single"		"midbrain: 1.1"	"Region enriched"	"Detected in single"	7	"midbrain: 4.9"	"CAB001388, HPA066846"	Enhanced		Supported	"Nucleoplasm,Cell Junctions"		NA	NA			"Nucleoplasm, Cell Junctions"		"CAB001388: AB_2262810, HPA066846: AB_2685736"		"unprognostic (1.19e-1)"	"unprognostic (1.99e-1)"	"prognostic favorable (7.57e-6)"	"unprognostic (6.82e-2)"	"unprognostic (1.50e-6)"	"unprognostic (1.38e-1)"	"unprognostic (8.17e-2)"		"prognostic favorable (6.28e-4)"	"prognostic favorable (2.34e-4)"	"unprognostic (3.18e-1)"	"unprognostic (2.55e-15)"	"unprognostic (2.50e-2)"	"unprognostic (1.68e-1)"	"unprognostic (7.12e-2)"	"unprognostic (3.93e-3)"	0.2	0.0	0.2	1.3	0.2	0.0	0.2	0.2	0.3	9.7	4.5	0.2	0.2	2.2	1.8	0.2	0.2	3.8	13.1	0.2	0.2	0.1	0.2	44.4	15.9	0.2	1.4	0.2	3.4	47.9	0.0	0.4	0.3	0.4	0.5	6.0	0.2	0.2	0.2	0.2	0.0	1.8	0.2	0.2	0.2	20.7	0.3	0.2	0.2	2.2	0.2	0.9	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.3	0.0	0.1	0.0	0.0	0.0	0.0	11.7	0.0	0.0	0.7	0.0	0.0	16.2	0.0	0.0	0.0	0.0	6.3	0.0	7.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	13.2	15.1	0.0	0.0	0.0	0.5	0.0	26.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.3	0.2	0.1	1.4	0.2	0.4	0.2	89.3	60.1	0.0	1.0	0.0	0.0	0.3	48.4	17.4	22.7	0.0	0.0	0.0	0.0	21.4	0.0	0.0	4.9	0.0	31.8	0.0	0.0	0.6	4.6	51.3	0.0	0.0	27.0	0.6	0.3	0.0	0.0	0.0	0.0	1.0	82.6	0.0	24.8	2.9	0.0	0.0	0.0	0.0	0.0	3.7	0.1	0.0	0.0	0.0	33.6	0.0
FRS2	"FRS2A, FRS2alpha, SNT-1, SNT1"	ENSG00000166225	"Fibroblast growth factor receptor substrate 2"	Q8WU20	12	69470349-69579789	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038323			Approved	"Cell Junctions"		NA	NA			"Cell Junctions"		"HPA038323: "	"unprognostic (9.15e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.28e-1)"	"unprognostic (8.50e-2)"	"unprognostic (9.29e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.33e-1)"	"unprognostic (8.97e-2)"	"unprognostic (2.34e-2)"	"unprognostic (5.70e-3)"	"unprognostic (3.80e-2)"	"unprognostic (8.22e-2)"	"unprognostic (6.66e-2)"	13.4	11.9	18.4	6.9	21.9	23.1	16.3	23.4	19.5	16.3	10.3	20.7	10.0	7.8	16.4	15.8	10.5	13.0	15.6	10.2	19.3	12.0	10.3	14.3	10.2	7.2	18.3	16.8	20.2	8.7	18.4	16.0	14.2	15.4	10.9	10.0	10.7	10.4	9.9	11.0	10.0	9.6	14.7	21.2	8.1	9.4	10.0	22.7	6.9	16.4	7.0	8.7	11.2	10.2	8.8	4.1	6.8	10.3	3.6	7.4	2.9	10.4	8.2	13.9	6.7	8.6	10.6	27.8	11.2	13.1	10.8	9.3	16.4	4.3	5.0	7.7	15.0	5.1	8.8	7.1	11.8	12.4	7.2	7.4	7.5	7.0	6.2	9.0	7.3	5.9	10.0	14.9	12.1	10.5	13.4	4.8	4.7	5.4	9.4	9.7	12.6	5.6	3.7	17.1	5.5	7.8	4.7	12.0	4.0	8.1	21.9	7.7	14.5	19.3	7.7	10.9	17.5	21.8	4.3	8.2	8.5	8.6	11.4	8.5	8.3	13.2	3.9	7.0	3.8	7.7	1.2	5.6	3.0	4.1	5.6	4.4	4.2	4.3	3.3	4.1	8.8	7.4	4.7	6.8	3.6	10.3	3.9	2.2	2.9	18.4	21.9	23.4	19.5	19.3	12.0	18.3	16.8	15.4	22.7	6.0	10.1	3.0	8.4	18.0	11.2	19.7	2.5	10.7	19.4	10.4	15.7	6.2	3.3	7.3	4.3	9.5	5.6	0.0	6.2	9.0	17.0	10.2	13.8	13.9	6.0	6.4	9.8	6.7	14.0	6.7	17.5	6.5	6.8	10.8	11.5	18.6	9.9	3.5	12.4	5.5	9.5	6.5	12.3	9.8	11.9	11.0	5.3	2.5	8.1	10.1
FZD2		ENSG00000180340	"Frizzled class receptor 2"	Q14332	17	44557459-44559570	"Cancer-related genes, G-protein coupled receptors, Predicted membrane proteins"	"Wnt signaling pathway"	"Developmental protein, G-protein coupled receptor, Receptor, Transducer"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	10	"Alveolar cells type 1: 17.9;Kupffer cells: 11.1;Leydig cells: 21.6;Peritubular cells: 17.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"classical monocyte: 3.5;myeloid DC: 5.6;plasmacytoid DC: 2.6"	"Group enriched"	"Detected in many"	6	"dendritic cells: 5.6;monocytes: 3.5"	"Cell line enhanced"	"Detected in many"		"A549: 25.9;BJ hTERT+ SV40 Large T+: 25.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA057667	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Cell Junctions"		NA	NA			"Nucleoplasm, Nuclear bodies"	"Cell Junctions"	"HPA057667: AB_2683497"	"unprognostic (6.94e-2)"	"unprognostic (1.12e-2)"	"unprognostic (3.04e-2)"	"unprognostic (8.83e-3)"	"unprognostic (2.04e-1)"	"unprognostic (5.29e-3)"	"unprognostic (1.44e-2)"	"unprognostic (2.29e-1)"	"unprognostic (9.45e-2)"	"unprognostic (5.61e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.86e-1)"	"unprognostic (5.10e-3)"	"unprognostic (1.19e-2)"	"unprognostic (6.35e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.17e-3)"	2.3	2.8	2.3	3.9	5.8	0.9	3.2	0.7	3.1	16.1	2.9	2.1	3.0	2.9	10.8	7.6	2.4	6.6	7.7	5.8	3.2	1.5	5.0	0.5	6.9	3.1	2.1	2.9	12.1	2.7	1.6	1.9	8.4	4.9	4.2	0.8	14.3	2.9	7.9	1.8	1.1	3.6	3.3	2.0	3.7	2.1	6.5	1.8	1.1	5.3	2.4	3.1	3.8	4.3	0.2	5.6	0.0	3.5	0.0	0.8	0.6	7.6	25.9	14.9	8.5	3.3	2.9	0.3	21.5	13.1	25.8	18.6	20.0	4.4	0.0	6.8	5.3	7.8	3.6	1.7	1.8	6.2	1.9	5.0	0.8	4.2	0.1	4.3	0.1	4.4	5.5	1.4	6.2	4.2	15.2	1.1	2.7	1.6	0.2	6.5	4.0	3.4	2.0	16.3	0.0	4.8	9.9	4.5	1.3	3.3	0.3	1.9	6.4	2.7	0.7	1.6	9.7	8.3	3.6	0.4	13.9	12.4	2.6	12.6	0.6	0.4	1.9	2.6	1.4	6.3	0.0	3.5	0.0	0.1	0.2	0.0	0.0	0.0	0.8	5.6	0.2	0.0	0.2	0.0	0.0	0.2	2.6	0.0	0.6	2.3	5.8	0.7	2.1	3.2	1.5	2.1	2.9	4.9	1.8	17.9	0.0	0.0	0.2	0.6	0.0	1.7	0.0	0.0	0.0	1.8	0.0	1.4	0.0	0.3	0.4	0.6	0.0	0.0	1.6	0.4	5.1	0.1	0.0	0.0	4.5	0.0	1.2	1.3	11.1	0.0	21.6	4.2	0.0	2.8	0.0	6.4	0.5	0.0	17.0	0.1	0.2	0.0	1.0	0.3	0.9	0.4	1.9	0.0	0.0	0.0
GAS2L1	GAR22	ENSG00000185340	"Growth arrest specific 2 like 1"	Q99501	22	29306582-29312785	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ductus deferens: 40.5"	"Cell type enhanced"	"Detected in many"	6	"Ito cells: 77.3;Late spermatids: 73.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 2.0;eosinophil: 3.1"	"Group enriched"	"Detected in many"	10	"dendritic cells: 1.1;granulocytes: 3.1;monocytes: 2.0"	"Cell line enhanced"	"Detected in many"		"U-138 MG: 33.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019858	Approved		Approved	"Plasma membrane,Cell Junctions"		NA	NA			"Plasma membrane"	"Cell Junctions"	"HPA019858: AB_1849486"	"unprognostic (3.66e-1)"	"unprognostic (5.22e-2)"	"unprognostic (1.38e-1)"	"unprognostic (4.95e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.84e-3)"	"unprognostic (8.99e-2)"	"unprognostic (1.28e-1)"	"unprognostic (6.05e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.21e-1)"	"prognostic favorable (8.44e-4)"	"unprognostic (4.23e-2)"	"unprognostic (9.04e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.19e-2)"	15.1	10.7	15.2	5.3	13.4	5.4	7.6	10.5	19.8	4.5	5.6	6.8	40.5	17.9	5.1	8.4	8.6	4.6	4.3	7.0	12.9	8.1	6.0	6.6	7.5	2.2	11.3	10.2	2.9	10.0	4.6	6.8	4.3	9.5	7.1	2.2	3.2	12.7	22.9	4.9	22.4	13.0	4.5	10.0	11.5	8.3	16.6	8.8	0.0	4.5	9.2	3.5	3.9	4.7	0.0	1.1	3.1	2.0	0.0	0.2	1.2	8.3	9.8	1.5	6.2	2.4	2.3	9.8	12.6	3.8	5.4	2.8	4.4	6.0	0.0	5.7	6.7	5.6	25.6	2.6	7.1	1.0	11.4	1.2	11.0	7.8	3.1	3.1	0.1	7.7	2.5	4.9	5.1	2.0	3.9	7.1	11.2	5.2	1.7	3.8	7.1	0.2	6.1	2.2	5.6	22.1	0.2	4.4	0.7	3.2	5.4	0.5	8.3	9.7	13.0	7.0	2.0	13.0	1.7	15.0	33.7	23.2	15.0	12.6	0.1	0.1	0.1	14.9	0.4	8.2	0.0	2.0	3.1	0.0	0.3	0.0	0.0	0.1	0.0	1.1	0.0	0.2	0.0	0.5	0.0	1.4	0.0	0.0	1.2	15.2	13.4	10.5	19.8	12.9	8.1	11.3	10.2	9.5	8.8	6.0	1.7	0.8	5.7	25.0	2.6	3.5	7.6	1.4	9.1	1.8	5.9	19.1	6.6	10.8	26.3	19.3	19.0	23.3	6.0	10.4	10.8	6.1	1.1	10.5	13.1	12.7	1.7	77.3	12.6	73.5	8.9	10.7	11.8	4.6	5.4	4.5	8.3	9.3	11.0	7.0	19.2	38.8	14.1	2.3	10.8	28.2	5.6	0.7	9.0	2.2
GID8	"bA305P22.1, C20orf11, FLJ20602, TWA1"	ENSG00000101193	"GID complex subunit 8 homolog"	Q9NWU2	20	62938119-62948475	"Predicted intracellular proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049929, HPA055047"	Approved		Supported	"Nucleoplasm,Cell Junctions"		NA	NA			Nucleoplasm	"Cell Junctions"	"HPA049929: AB_2680957, HPA055047: AB_2682682"	"unprognostic (1.35e-1)"	"unprognostic (4.06e-2)"	"unprognostic (5.90e-2)"	"prognostic unfavorable (4.78e-4)"	"unprognostic (1.19e-1)"	"unprognostic (8.25e-2)"	"unprognostic (3.88e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.43e-1)"	"prognostic favorable (3.22e-4)"	"unprognostic (3.97e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.01e-1)"	"unprognostic (6.87e-2)"	14.0	14.1	23.0	15.4	18.7	35.5	21.5	20.7	23.5	20.8	18.6	14.3	21.0	15.1	18.2	19.5	55.9	23.0	19.0	15.9	17.4	10.9	15.6	29.6	15.2	24.2	15.5	22.9	30.6	30.0	22.2	15.7	15.1	14.7	17.8	16.1	17.7	21.2	17.7	19.7	34.0	17.1	19.8	14.1	19.6	20.1	22.4	17.2	23.6	20.6	26.0	24.6	22.8	28.7	9.3	9.8	16.0	10.4	12.9	15.0	8.3	15.7	10.1	15.1	13.6	12.5	9.8	14.8	8.8	7.4	25.3	11.5	48.5	15.4	19.8	15.2	11.4	10.4	18.3	13.8	18.3	15.4	5.2	6.8	18.4	13.1	23.2	9.8	21.4	15.6	10.8	20.4	10.9	12.7	9.2	12.3	13.2	14.1	8.6	8.7	22.1	25.4	19.1	15.2	26.3	15.1	20.2	28.4	11.8	9.3	22.3	15.7	12.9	20.8	20.5	12.8	11.7	28.5	20.7	12.3	15.2	19.1	11.9	11.9	9.1	10.4	20.6	10.2	10.5	9.6	5.8	10.4	16.0	11.7	8.7	13.7	8.4	12.3	13.0	9.8	9.3	13.6	15.0	15.2	12.9	8.1	7.4	10.6	8.3	23.0	18.7	20.7	23.5	17.4	10.9	15.5	22.9	14.7	17.2	17.9	27.2	31.3	42.8	45.8	21.3	25.4	43.3	17.4	20.5	38.4	5.9	83.9	34.9	39.5	12.5	33.3	40.2	46.7	35.2	85.8	31.3	46.5	26.5	68.6	45.9	15.9	43.3	38.6	41.2	13.8	30.5	33.4	23.6	50.5	43.5	27.0	35.3	31.6	39.6	32.0	15.2	12.9	28.3	38.7	59.5	69.8	131.2	40.8	49.4	46.5
GIPC1	"C19orf3, GIPC, GLUT1CBP, Hs.6454, NIP, RGS19IP1, SEMCAP, SYNECTIN, TIP-2"	ENSG00000123159	"GIPC PDZ domain containing family member 1"	O14908	19	14477760-14496149	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Enterocytes: 262.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043958, HPA061786"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA			"Plasma membrane, Cell Junctions"	Nucleoplasm	"HPA043958: AB_10963436, HPA061786: AB_2756319"	"unprognostic (2.80e-1)"	"unprognostic (1.16e-1)"	"unprognostic (8.21e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.19e-1)"	"unprognostic (4.82e-2)"	"unprognostic (3.53e-2)"	"unprognostic (7.72e-2)"	"unprognostic (1.04e-2)"	"unprognostic (7.17e-3)"	"unprognostic (1.70e-1)"	"unprognostic (1.16e-1)"	"unprognostic (8.82e-2)"	16.4	15.1	17.4	12.0	21.0	2.0	11.2	12.1	28.8	19.4	51.0	29.7	15.3	14.2	11.9	14.9	71.2	14.4	21.2	17.9	16.9	14.8	18.7	16.9	20.5	7.9	18.3	23.0	10.2	15.1	6.5	12.4	24.0	23.0	14.0	23.9	15.2	22.1	19.6	26.8	40.4	13.3	15.8	21.8	10.8	35.7	6.5	16.6	11.1	18.2	26.0	24.7	17.1	26.3	2.0	4.0	2.4	1.2	1.5	12.1	1.9	66.0	30.7	9.4	14.7	8.7	8.8	7.4	24.8	12.6	20.5	18.6	16.4	25.1	0.9	46.8	17.5	13.7	38.0	8.0	20.8	7.0	6.8	14.4	12.9	21.0	16.0	26.8	1.3	16.0	10.1	20.8	12.4	10.9	12.2	13.8	9.8	6.0	11.4	10.4	49.3	4.2	2.6	10.2	37.0	30.8	4.4	7.9	8.8	25.2	57.9	8.8	9.8	13.9	34.3	31.8	5.1	21.5	7.2	23.8	29.0	16.0	40.4	26.5	10.7	13.6	3.3	24.3	10.5	30.4	2.4	0.8	0.1	5.8	1.2	5.4	2.0	5.9	5.9	1.2	1.0	4.9	3.9	0.3	1.5	0.5	4.0	12.1	1.9	17.4	21.0	12.1	28.8	16.9	14.8	18.3	23.0	23.0	16.6	26.8	14.6	11.5	47.9	101.2	65.6	12.9	17.8	4.0	15.9	78.5	33.4	29.4	44.7	162.1	0.8	27.0	262.4	0.0	146.8	55.5	40.6	96.5	10.3	16.4	46.4	71.5	41.3	19.0	9.5	1.9	19.0	13.8	55.6	37.9	62.6	60.8	195.2	130.6	23.7	38.4	38.1	19.4	38.2	7.4	20.6	148.3	21.5	13.8	65.5	154.2
GJA1	"CX43, GJAL, ODD, ODDD, ODOD, SDTY3"	ENSG00000152661	"Gap junction protein alpha 1"	P17302	6	121435692-121449727	"Cancer-related genes, Disease related genes, Predicted membrane proteins"			"Cancer-related genes, Cataract, Disease mutation, Hypotrichosis, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	10	"Alveolar cells type 1: 232.3;Basal keratinocytes: 208.6;Cardiomyocytes: 174.1;Fibroblasts: 139.5;Suprabasal keratinocytes: 330.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 73.4;HUVEC TERT2: 56.2;NTERA-2: 57.2;SuSa: 74.9;U-87 MG: 55.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010753, HPA035097, HPA047551, HPA069245"	Enhanced	Supported	Supported	"Nucleoplasm,Vesicles,Cell Junctions"		NA	NA			"Vesicles, Cell Junctions"	Nucleoplasm	"CAB010753: AB_476857, HPA035097: AB_2674460, HPA047551: AB_2732540, HPA069245: "	"unprognostic (3.37e-2)"	"unprognostic (3.41e-3)"	"unprognostic (2.95e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.78e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.56e-1)"	"unprognostic (5.47e-2)"	"unprognostic (1.00e-1)"	"unprognostic (4.88e-2)"	"prognostic unfavorable (4.99e-5)"	"unprognostic (2.39e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.00e-3)"	19.7	65.2	78.6	5.5	69.7	0.4	14.2	32.4	44.4	64.5	4.0	23.8	6.1	4.2	23.5	5.5	17.3	7.8	23.0	36.0	87.3	25.5	3.6	2.5	15.2	4.4	42.9	39.9	10.5	4.5	94.7	5.7	63.8	53.7	20.0	4.8	26.3	7.1	35.7	3.4	86.3	4.4	25.6	38.7	1.1	6.4	8.3	64.3	0.5	38.9	9.9	7.6	14.8	32.2	0.5	0.5	0.4	0.5	0.0	0.4	0.0	0.0	6.6	29.3	0.0	16.0	9.9	0.0	21.9	44.6	7.4	18.1	0.1	0.0	0.0	2.4	8.5	6.3	2.8	0.7	13.4	24.1	0.0	8.0	0.3	2.7	0.0	20.0	0.0	0.0	26.4	14.5	27.1	9.8	73.4	56.2	0.0	0.0	0.6	1.4	1.2	0.0	11.7	57.2	0.0	7.3	0.0	0.0	0.5	29.6	3.2	0.0	0.4	0.0	0.0	0.0	74.9	2.3	0.0	41.3	22.8	6.3	19.2	14.1	0.0	0.0	0.0	55.7	0.0	3.2	0.4	0.5	0.0	0.2	0.0	0.2	0.0	0.3	0.0	0.2	0.5	0.4	0.4	0.0	0.0	0.1	0.5	0.1	0.0	78.6	69.7	32.4	42.8	87.3	25.5	42.9	39.9	53.7	64.3	232.3	73.8	0.0	121.0	208.6	0.2	174.1	0.0	5.3	14.8	1.8	2.0	46.7	0.0	69.9	0.3	111.0	0.0	0.0	3.5	8.1	139.5	19.9	8.1	0.0	7.5	0.0	0.0	22.7	0.3	1.1	2.3	2.8	42.2	1.0	0.0	0.1	17.0	0.0	3.9	0.0	0.2	0.0	27.8	0.3	0.1	330.6	16.7	0.0	0.0	45.0
GJB3	"CX31, DFNA2, EKV"	ENSG00000188910	"Gap junction protein beta 3"	O75712	1	34781189-34786369	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Deafness, Disease mutation, Non-syndromic deafness, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 40.1;lymphoid tissue: 25.0;skin 1: 49.3;tongue: 32.1"	"Group enriched"	"Detected in many"	7	"Basal glandular cells: 49.4;Basal keratinocytes: 123.0;Pancreatic endocrine cells: 70.6;Suprabasal keratinocytes: 149.2;Urothelial cells: 169.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 26.3;CAPAN-2: 37.4;HaCaT: 30.4;HBEC3-KT: 26.0;hTCEpi: 42.7;OE19: 16.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA074472			Supported	"Vesicles,Cell Junctions"		NA	NA			"Vesicles, Cell Junctions"		"HPA074472: AB_2686694"	"unprognostic (1.34e-3)"	"unprognostic (2.30e-1)"	"unprognostic (2.84e-2)"	"unprognostic (5.22e-3)"	"unprognostic (3.82e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.21e-4)"	"prognostic unfavorable (4.56e-4)"	"unprognostic (2.30e-1)"	"unprognostic (1.29e-1)"	"prognostic unfavorable (7.56e-5)"	"unprognostic (4.50e-2)"	"unprognostic (5.74e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.27e-2)"	"unprognostic (2.46e-2)"	0.1	0.1	1.0	2.4	0.4	0.0	3.4	1.4	1.2	6.3	2.2	0.0	0.6	0.0	0.7	3.0	40.1	0.5	4.1	0.1	0.2	0.1	0.5	0.8	0.6	0.4	0.1	0.1	0.2	0.2	0.0	0.1	11.3	0.0	3.7	2.8	0.0	3.7	0.9	0.2	49.3	0.6	0.2	0.1	0.1	3.2	0.5	0.0	0.7	0.2	32.1	25.0	4.7	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.4	0.0	3.6	0.0	0.0	30.4	0.0	26.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	42.7	0.0	11.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.1	16.3	6.8	0.0	0.0	0.0	12.7	10.0	0.0	0.0	4.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	1.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.4	1.4	1.2	0.2	0.1	0.1	0.1	0.0	0.0	3.0	0.0	0.0	49.4	123.0	0.0	0.3	2.5	1.4	2.3	5.2	0.0	0.0	0.0	15.7	0.0	0.1	3.1	0.0	6.3	0.1	3.1	16.8	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	13.5	0.0	1.9	0.0	70.6	7.0	0.0	0.0	0.0	0.0	3.1	0.0	0.2	149.2	0.1	0.0	16.1	169.4
GJB4	CX30.3	ENSG00000189433	"Gap junction protein beta 4"	Q9NTQ9	1	34759741-34763724	"Disease related genes, Predicted membrane proteins"			"Disease mutation, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"epididymis: 11.1;skin 1: 26.2"	"Cell type enriched"	"Detected in some"	4	"Urothelial cells: 91.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 6.7;HaCaT: 9.9;HBEC3-KT: 6.4;hTCEpi: 4.2;OE19: 3.7;RPTEC TERT1: 3.9;RT4: 4.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA055112, HPA073904"	Enhanced		Supported	"Cell Junctions"		NA	NA			"Cell Junctions"		"HPA055112: AB_2682699, HPA073904: "	"unprognostic (3.30e-2)"	"prognostic favorable (5.48e-4)"	"unprognostic (1.57e-1)"	"unprognostic (2.70e-2)"	"unprognostic (4.21e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.16e-2)"	"unprognostic (2.18e-2)"	"unprognostic (5.40e-2)"	"unprognostic (3.65e-1)"	"prognostic unfavorable (3.24e-5)"	"unprognostic (3.73e-2)"	"unprognostic (5.81e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.52e-4)"	"unprognostic (5.42e-2)"	0.1	0.1	0.1	1.2	0.1	0.0	1.5	0.1	0.1	1.7	0.3	0.0	2.9	0.0	0.1	11.1	2.9	0.1	8.3	0.1	0.1	0.1	0.5	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	3.4	0.0	2.0	0.2	0.0	0.8	2.0	0.1	26.2	0.3	1.2	0.1	0.1	0.2	0.7	0.0	0.1	0.1	1.6	2.4	3.2	6.3	0.0	0.0	0.0	0.0	0.0	0.3	0.2	6.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	1.0	0.0	0.1	9.9	0.0	6.4	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	3.9	4.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	22.7	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	6.5	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	21.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.2	0.0	0.0	91.2
GJB6	"CX30, DFNA3, ED2, EDH, HED"	ENSG00000121742	"Gap junction protein beta 6"	O95452	13	20221962-20232395	"Disease related genes, Predicted membrane proteins"	Hearing		"Deafness, Disease mutation, Ectodermal dysplasia, Non-syndromic deafness, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 50.5;esophagus: 97.1;tongue: 43.6"	"Cell type enhanced"	"Detected in some"	21	"Basal keratinocytes: 10.9;Early spermatids: 3.4;Late spermatids: 4.4;Suprabasal keratinocytes: 3.3"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 145.0"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"T-reg: 5.7"	"Lineage enhanced"	"Detected in many"		"T-cells: 5.7"	"Cell line enriched"	"Detected in some"	9	"RT4: 64.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014846			Supported	"Cell Junctions"		NA	NA			"Cell Junctions"		"HPA014846: AB_1847135"	"unprognostic (5.57e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.90e-4)"	"unprognostic (7.90e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.83e-1)"	"unprognostic (8.96e-2)"	"unprognostic (9.64e-2)"	"unprognostic (2.82e-2)"	"unprognostic (2.82e-2)"	"unprognostic (3.54e-2)"	"unprognostic (1.14e-11)"	"unprognostic (8.99e-2)"	"unprognostic (1.16e-1)"	"unprognostic (6.35e-3)"	"unprognostic (5.04e-2)"	1.2	1.0	15.3	1.1	17.0	50.5	3.3	9.0	15.9	16.9	1.0	1.9	0.0	1.0	1.6	1.1	97.1	1.2	1.8	1.0	16.3	7.9	1.0	1.0	1.1	1.4	11.1	11.3	1.0	1.0	1.0	0.7	1.0	9.2	1.1	1.1	0.0	8.7	1.0	1.0	18.7	1.0	1.0	3.7	1.1	1.2	1.7	6.0	7.9	4.1	43.6	15.7	6.3	30.9	1.4	0.0	1.2	0.0	0.0	5.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	1.3	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	64.8	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.0	0.0	1.4	2.7	1.5	1.2	0.0	0.0	0.0	5.7	0.6	15.3	17.0	9.0	15.9	16.3	7.9	11.1	11.3	9.2	6.0	0.0	0.0	0.0	1.0	10.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.1	0.2	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	3.3	0.0	0.0	0.0	2.0
GJC1	"CX45, GJA7"	ENSG00000182963	"Gap junction protein gamma 1"	P36383	17	44798448-44830816	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	23	"Sertoli cells: 155.2;Smooth muscle cells: 65.3;Spermatogonia: 32.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA071788			Uncertain	"Nucleoli,Cell Junctions,Cytosol"		NA	NA			Nucleoli	"Cell Junctions, Cytosol"	"HPA071788: "	"unprognostic (1.84e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.22e-1)"	"unprognostic (7.02e-2)"	"unprognostic (4.01e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.02e-1)"	"unprognostic (1.64e-1)"	"prognostic unfavorable (3.55e-8)"	"unprognostic (5.18e-2)"	"unprognostic (2.20e-1)"	"unprognostic (8.52e-2)"	"prognostic unfavorable (7.83e-4)"	7.3	0.8	2.2	4.1	3.4	1.0	4.7	8.2	4.2	14.8	23.0	2.8	7.0	1.6	24.2	3.1	3.2	5.0	5.4	10.0	3.3	1.8	1.5	0.9	6.5	2.3	2.5	4.0	2.2	1.3	2.6	0.7	28.5	3.4	8.2	2.8	3.7	1.7	17.0	5.4	1.9	4.8	27.5	2.2	0.9	7.8	8.0	2.9	1.4	5.3	2.9	1.7	12.6	10.4	1.2	1.0	4.7	1.0	1.9	1.0	0.4	17.4	9.0	22.7	7.8	3.0	4.7	8.9	19.4	15.3	20.9	22.5	5.2	9.7	0.1	1.0	18.1	28.6	4.5	11.8	6.0	29.4	0.1	8.8	0.1	4.8	0.5	1.8	0.1	0.7	3.2	0.6	15.9	5.3	7.8	7.1	3.9	0.8	0.2	12.1	0.1	2.8	1.7	10.2	0.0	7.7	16.5	28.8	0.1	5.0	7.3	4.3	9.9	2.2	0.1	6.5	15.3	4.7	2.7	5.9	18.5	17.9	8.4	16.5	0.1	4.5	12.9	6.4	0.1	17.3	4.7	1.0	1.1	0.9	0.6	0.8	0.9	0.7	0.6	0.3	1.2	0.9	1.0	3.9	1.9	0.7	1.0	0.6	0.4	2.2	3.4	8.2	4.2	3.3	1.8	2.5	4.0	3.4	2.9	0.0	0.0	0.0	1.6	1.8	1.0	18.1	0.0	0.0	0.0	1.8	2.0	0.3	0.0	1.3	1.3	11.7	0.0	0.0	0.0	2.1	5.7	1.2	0.0	0.0	1.2	12.7	0.0	6.2	0.8	0.0	1.4	0.0	3.3	1.0	0.0	0.4	0.6	0.0	2.1	0.3	1.0	155.2	65.3	10.2	32.0	2.6	0.5	0.0	0.0	1.4
GPATCH1	"ECGP, FLJ10206, FLJ38686, GPATC1"	ENSG00000076650	"G-patch domain containing 1"	Q9BRR8	19	33080880-33130542	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043430, HPA043604"	Approved		Uncertain	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA			"Nucleoplasm, Plasma membrane, Cell Junctions"		"HPA043430: AB_10960493, HPA043604: AB_10960499"	"unprognostic (2.38e-2)"	"unprognostic (1.71e-2)"	"unprognostic (9.95e-2)"	"prognostic unfavorable (8.20e-4)"	"unprognostic (2.41e-1)"	"unprognostic (1.28e-2)"	"unprognostic (4.60e-3)"	"unprognostic (3.54e-2)"	"unprognostic (5.17e-2)"	"unprognostic (3.56e-2)"	"unprognostic (6.53e-2)"	"unprognostic (5.37e-3)"	"unprognostic (8.10e-2)"	"unprognostic (4.57e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.45e-2)"	"unprognostic (6.88e-3)"	8.8	8.0	11.0	10.0	12.2	6.9	9.8	21.2	15.7	9.7	9.9	13.8	8.3	11.0	13.0	9.6	9.1	8.9	8.2	7.8	11.1	7.9	9.6	7.3	7.1	9.4	10.5	7.1	15.9	8.8	13.5	11.8	12.9	10.3	10.1	9.7	8.6	9.6	10.8	10.3	11.4	10.6	9.7	7.5	9.6	10.2	8.9	11.1	13.6	10.0	5.6	13.1	10.3	11.4	6.5	5.7	17.4	6.4	3.0	9.7	4.4	7.4	15.8	7.5	7.9	5.0	5.7	6.2	6.8	4.8	10.5	8.8	11.2	7.0	10.6	8.8	5.4	4.9	6.6	9.4	5.6	9.1	18.3	5.8	10.0	5.9	8.2	6.5	17.3	6.7	4.9	6.6	7.1	6.5	5.0	5.8	8.4	10.5	6.7	5.1	9.6	9.9	5.7	5.2	9.9	6.7	10.1	9.5	4.7	4.8	4.6	8.3	5.6	10.8	6.8	3.8	6.8	5.6	12.5	6.5	9.1	6.8	5.0	9.7	5.7	9.2	9.2	5.7	8.8	8.3	17.4	6.0	6.5	6.1	6.4	4.2	6.2	5.7	7.6	5.7	6.5	9.7	6.1	4.4	3.0	3.3	5.0	8.4	4.4	11.0	12.2	21.2	15.7	11.1	7.9	10.5	7.1	10.3	11.1	8.9	6.4	5.7	4.7	5.5	9.4	8.5	2.5	5.3	11.4	7.0	13.7	9.0	13.3	6.2	2.0	4.5	8.1	0.0	3.9	4.6	5.2	3.1	16.1	4.5	3.5	3.2	4.1	8.6	8.2	1.5	9.5	4.8	8.5	5.4	6.5	7.4	6.6	5.7	7.8	4.8	11.2	0.0	4.9	14.4	11.6	3.1	4.6	7.4	5.6	2.6
GPR142	PGR2	ENSG00000257008	"G protein-coupled receptor 142"	Q7Z601	17	74367407-74372622	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 1.3;lymphoid tissue: 1.3"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"pancreatic cancer: 1.0"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"U-937: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA031392	Uncertain		Uncertain	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	"Cell Junctions"	"HPA031392: AB_10601935"	"unprognostic (6.81e-2)"		"unprognostic (1.75e-1)"			"unprognostic (1.98e-1)"		"unprognostic (1.34e-1)"		"unprognostic (1.36e-1)"	"unprognostic (6.54e-5)"	"unprognostic (4.16e-2)"	"unprognostic (4.85e-7)"	"unprognostic (3.95e-2)"	"unprognostic (7.72e-4)"	"unprognostic (1.93e-1)"	"unprognostic (1.68e-3)"	0.2	0.0	0.0	1.3	0.1	0.0	0.1	1.3	0.2	0.3	0.1			0.8	0.6	0.0	0.5	0.3	0.0	0.0	0.2	0.0	0.0	0.2	0.3	0.2	0.0		0.1	0.8	0.0	0.0	0.1		0.2	0.1		0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.2	0.1			0.2		0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.4	1.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GPR157	FLJ12132	ENSG00000180758	"G protein-coupled receptor 157"	Q5UAW9	1	9100305-9129170	"G-protein coupled receptors, Predicted membrane proteins"	Differentiation	"Developmental protein, G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 32.2"	"Cell type enriched"	"Detected in many"	5	"monocytes: 184.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 17.3;SK-BR-3: 34.0;U-266/70: 16.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA028697	Uncertain		Uncertain	"Nucleoli,Nucleoli rim,Plasma membrane,Cell Junctions"		NA	NA			"Nucleoli, Nucleoli rim"	"Plasma membrane, Cell Junctions"	"HPA028697: AB_10601810"	"unprognostic (2.83e-3)"	"unprognostic (1.13e-2)"	"unprognostic (5.91e-2)"	"unprognostic (5.42e-2)"	"unprognostic (2.13e-4)"	"unprognostic (7.11e-2)"	"unprognostic (7.52e-3)"	"unprognostic (3.60e-2)"	"unprognostic (9.20e-2)"	"unprognostic (1.26e-1)"	"unprognostic (9.13e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.21e-1)"	"unprognostic (4.30e-2)"	"unprognostic (3.04e-3)"	3.5	3.1	0.3	3.7	0.6	0.5	3.5	0.5	0.4	6.2	2.8	0.9	3.9	2.2	2.1	2.1	23.4	2.1	6.9	10.7	0.8	0.4	2.9	6.9	5.5	3.1	0.3	0.1	4.5	4.3	9.8	1.2	19.0	1.4	2.9	1.2	5.2	14.7	7.1	32.2	14.2	3.3	4.0	0.4	2.4	2.2	2.1	0.8	3.6	4.8	25.2	16.2	4.4	8.3	2.4	1.1	4.6	1.5	1.2	2.6	0.7	4.7	2.7	0.8	2.2	0.7	0.7	4.4	1.5	1.0	1.2	1.7	2.1	1.8	0.6	1.9	1.5	1.6	10.1	2.4	1.0	1.8	13.1	4.0	0.0	7.8	3.2	2.7	0.0	1.1	0.7	2.1	2.1	1.3	1.2	1.0	2.0	0.7	17.3	0.5	3.4	1.9	1.0	0.9	2.3	3.4	0.3	0.7	2.3	0.8	3.2	1.2	3.3	5.8	34.0	2.8	1.7	4.8	0.6	7.1	4.3	1.1	11.1	0.7	16.7	2.7	0.0	3.2	6.7	1.8	1.9	1.5	0.4	2.6	1.2	2.0	1.5	1.9	2.3	0.8	2.4	1.9	2.2	4.6	1.2	0.6	1.1	0.8	0.7	0.3	0.6	0.5	0.4	0.8	0.4	0.3	0.1	1.4	0.8	6.0	9.9	0.5	6.4	12.0	0.2	12.1	5.1	2.7	6.8	5.2	2.0	25.6	0.0	3.0	0.0	2.9	5.6	0.0	3.3	9.1	3.8	4.4	0.0	12.9	3.8	1.6	0.0	0.0	1.2	0.0	1.7	4.5	6.8	184.0	4.3	1.4	9.2	4.8	4.9	1.4	1.5	0.0	3.9	0.5	2.5	21.2	40.3	2.1	4.3	13.7
GTF2F1	"BTF4, RAP74, TF2F1, TFIIF"	ENSG00000125651	"General transcription factor IIF subunit 1"	P35269	19	6379569-6393981	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Early spermatids: 199.3;Late spermatids: 301.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022793, HPA028707, HPA070752"	Supported		Enhanced	"Nucleoplasm,Cell Junctions"		NA	NA			Nucleoplasm	"Cell Junctions"	"HPA022793: AB_1857946, HPA028707: AB_2672745, HPA070752: AB_2732163"	"unprognostic (1.30e-2)"	"unprognostic (6.05e-3)"	"unprognostic (2.00e-1)"	"prognostic favorable (8.39e-4)"	"unprognostic (3.18e-1)"	"unprognostic (8.46e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.99e-2)"	"unprognostic (6.45e-3)"	"unprognostic (6.96e-2)"	"prognostic favorable (9.80e-4)"	"unprognostic (1.34e-2)"	"unprognostic (7.02e-2)"	"unprognostic (9.92e-2)"	"unprognostic (4.25e-1)"	24.9	26.0	32.5	26.6	33.1	41.1	22.6	60.7	47.3	25.5	24.7	18.8	26.1	35.2	31.7	22.6	30.8	29.9	26.5	22.9	28.9	25.9	24.4	21.7	19.8	34.9	23.9	36.3	59.8	40.7	31.8	33.4	19.9	26.6	24.6	16.3	22.3	33.9	24.4	25.6	21.8	31.9	27.6	26.4	26.7	26.4	39.4	23.1	23.6	36.4	19.7	22.2	26.0	39.8	24.4	21.5	28.4	21.4	19.0	23.8	14.1	38.3	28.3	20.6	32.7	13.9	22.6	16.3	27.0	25.3	33.7	32.2	29.6	15.2	23.4	38.0	17.7	24.2	35.0	19.3	17.1	16.6	35.7	24.6	32.5	21.1	26.3	24.2	37.6	26.4	23.7	22.9	24.0	18.4	28.6	19.8	23.2	39.6	31.8	18.6	26.7	37.3	21.4	37.3	17.8	36.1	34.6	22.8	29.9	18.8	22.0	25.3	34.8	27.9	21.4	29.8	13.0	27.2	30.0	28.0	26.5	22.3	45.7	38.0	56.5	63.4	25.3	33.0	39.5	29.6	7.0	21.4	14.0	20.5	20.6	23.8	24.4	18.4	19.5	16.9	23.3	21.7	18.8	28.4	19.0	19.1	21.5	17.6	14.1	32.5	33.1	60.7	47.3	28.9	25.9	23.9	36.3	26.6	23.1	44.7	44.6	45.7	42.2	21.6	25.9	26.2	20.4	115.1	78.5	24.4	7.9	38.5	18.3	42.3	199.3	33.5	64.5	23.3	44.2	36.6	30.1	27.3	60.3	23.7	51.8	23.8	29.2	52.8	50.9	301.8	41.1	31.9	32.1	62.3	38.4	32.6	42.6	35.9	46.7	29.3	28.8	32.3	43.2	51.5	36.8	18.3	45.2	56.5	40.9	36.7
HCAR2	"GPR109A, HCA2, HM74A, NIACR1, Puma-g, PUMAG"	ENSG00000182782	"Hydroxycarboxylic acid receptor 2"	Q8TDS4	12	122701293-122703343	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"	Apoptosis	"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"blood: 50.9"	"Cell type enhanced"	"Detected in many"	11	"Basal glandular cells: 69.6;Basal keratinocytes: 83.9;Suprabasal keratinocytes: 92.8"	"Group enriched"	"Detected in many"	8	"cervical cancer: 12.6;head and neck cancer: 16.1;lung cancer: 6.4;urothelial cancer: 9.2"	"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in some"	6	"neutrophil: 50.9"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 50.9"	"Cell line enriched"	"Detected in some"	6	"HaCaT: 52.0"									HPA028660	Approved		Supported	"Cell Junctions"		NA	NA			"Cell Junctions"		"HPA028660: AB_10602139"	"unprognostic (5.43e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.05e-1)"	"unprognostic (6.65e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.33e-3)"	"unprognostic (7.26e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.77e-2)"	"unprognostic (7.10e-2)"	"unprognostic (7.33e-2)"	"unprognostic (4.83e-4)"	"unprognostic (5.76e-2)"	"unprognostic (5.07e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.63e-2)"	16.1	0.2	0.4	6.4	0.5	13.2	8.3	0.2	0.7	5.8	3.6	0.3	6.2	0.4	0.8	1.6	26.0	0.4	1.1	1.2	0.8	0.2	1.9	1.8	11.3	0.7	3.3	0.2	1.2	0.2	4.4	0.9	8.2	1.0	8.6	0.0	0.3	9.7	10.7	0.7	17.8	0.7	0.4	0.9	16.5	0.8	2.8	1.1	1.1	0.4	13.5	21.5	3.5	8.3	0.0	0.5	50.9	6.6	0.0	0.0	0.3	1.9	0.1	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	52.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	1.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	8.5	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	9.0	0.6	0.6	0.0	1.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	50.9	0.0	6.6	0.0	0.0	0.3	0.4	0.5	0.2	0.7	0.8	0.2	3.3	0.2	1.0	1.1	0.0	7.0	0.0	69.6	83.9	0.4	0.0	0.0	6.7	33.0	0.0	0.0	0.4	0.0	0.0	21.5	0.4	0.0	0.0	0.0	22.6	2.3	8.9	2.3	0.0	3.8	0.0	0.0	0.0	4.1	2.3	0.0	30.0	8.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	92.8	2.2	0.0	0.0	18.6
HCAR3	"GPR109B, HCA3, HM74"	ENSG00000255398	"Hydroxycarboxylic acid receptor 3"	P49019	12	122714756-122716892	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"blood: 47.7"	"Cell type enhanced"	"Detected in many"	11	"Basal glandular cells: 75.5;Basal keratinocytes: 83.9;Suprabasal keratinocytes: 93.0;Urothelial cells: 41.6"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	5	"midbrain: 3.5"	"Group enriched"	"Detected in some"	6	"basophil: 12.1;neutrophil: 47.7;non-classical monocyte: 21.3"	"Group enriched"	"Detected in many"	49	"granulocytes: 47.7;monocytes: 21.3"	"Group enriched"	"Detected in some"	5	"HaCaT: 7.2;RT4: 27.9"									HPA028660	Approved		Approved	"Cell Junctions"		NA	NA			"Cell Junctions"		"HPA028660: AB_10602139"	"unprognostic (2.32e-1)"	"unprognostic (5.82e-2)"	"unprognostic (8.23e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.17e-1)"	"unprognostic (9.17e-2)"	"unprognostic (1.64e-3)"	"unprognostic (1.60e-1)"	"unprognostic (6.29e-2)"	"unprognostic (9.87e-2)"	"unprognostic (1.50e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.30e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.16e-1)"	"unprognostic (9.28e-2)"	4.8	0.2	0.6	7.9	0.3	20.8	4.0	0.4	0.5	2.3	0.9	0.2	2.2	0.1	0.4	0.4	18.2	0.5	0.5	1.0	0.3	0.3	0.9	2.5	10.2	3.5	3.5	0.0	1.6	0.2	6.6	1.1	3.0	0.7	4.2	0.0	0.3	2.9	4.3	0.6	13.9	0.3	0.4	1.2	21.6	0.5	1.6	0.4	0.3	0.5	12.0	14.9	5.7	7.2	0.0	0.7	47.7	21.3	0.0	0.0	0.6	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	7.2	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.9	0.1	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.1	12.1	0.5	0.2	0.0	4.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	47.7	0.0	21.3	0.0	0.0	0.6	0.6	0.3	0.4	0.5	0.3	0.3	3.5	0.0	0.7	0.4	3.0	10.7	0.0	75.5	83.9	0.0	0.0	0.0	0.0	19.4	0.0	0.0	0.6	0.0	0.0	0.7	0.0	0.0	0.0	0.0	19.1	2.0	5.3	3.5	0.0	6.1	0.0	0.0	0.0	7.3	0.0	0.0	22.1	8.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	93.0	11.6	0.0	0.0	41.6
HLA-DPB1	HLA-DP1B	ENSG00000223865	"Major histocompatibility complex, class II, DP beta 1"	P04440	6	33075926-33087201	"Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 99.4"	"Cell type enhanced"	"Detected in many"	19	"B-cells: 1312.2;Hofbauer cells: 1159.7;Kupffer cells: 1265.6;Macrophages: 2334.4;monocytes: 5192.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 90.1"	"Group enriched"	"Detected in all"	8	"B-cells: 57.8;dendritic cells: 90.1;monocytes: 40.6"	"Group enriched"	"Detected in some"	6	"HDLM-2: 47.2;REH: 22.5"									"HPA011078, HPA058509"	Enhanced		Approved	"Nucleoplasm,Cell Junctions"		NA	NA		730000	"Cell Junctions"	Nucleoplasm	"HPA011078: AB_1079378, HPA058509: AB_2683737"	"unprognostic (5.44e-3)"	"unprognostic (7.03e-3)"	"unprognostic (9.84e-2)"	"prognostic favorable (3.38e-4)"	"unprognostic (9.43e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.77e-2)"	"unprognostic (5.64e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.34e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.80e-1)"	"unprognostic (4.17e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.85e-1)"	29.6	31.9	9.8	52.8	15.1	6.9	22.0	6.1	7.7	15.5	11.8	14.9	6.9	14.4	15.3	23.4	9.8	11.0	26.6	29.6	9.7	10.4	25.5	12.4	79.9	99.4	23.5	6.0	10.8	10.5	4.3	11.5	6.2	19.6	19.4	6.6	22.2	25.0	15.4	6.1	14.8	33.7	8.9	35.3	88.8	15.8	4.3	16.2	51.9	14.2	20.7	69.3	35.5	11.9	57.8	90.1	1.1	40.6	2.8	7.6	23.5	0.0	0.0	0.0	0.0	0.0	0.2	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.4	0.2	0.1	0.0	0.0	0.0	0.0	47.2	2.2	1.3	0.0	0.0	0.0	0.0	0.1	1.2	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	3.6	0.0	0.0	22.5	0.0	0.1	0.1	0.0	0.5	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.7	0.0	0.2	0.0	0.0	6.0	0.1	3.9	0.0	0.0	0.0	0.2	18.7	1.1	5.3	40.6	0.7	57.8	1.9	7.6	90.1	56.9	0.7	4.2	0.4	2.8	17.0	25.7	7.2	23.5	9.8	15.1	6.1	7.7	9.7	10.4	23.5	6.0	19.6	16.2	62.5	286.9	1312.2	21.4	267.0	12.2	9.3	73.9	46.8	77.3	27.9	15.7	5.1	3.3	33.6	3.2	238.9	10.6	0.0	13.0	4.7	50.0	41.9	61.1	5.5	1159.7	7.9	9.2	88.4	1265.6	4.0	25.3	2334.4	307.1	5192.2	12.2	24.1	8.0	4.0	19.8	36.3	19.2	45.3	33.2	1.2	5.9	203.9	7.6	173.0	6.5	13.9
HOXC5	"HOX3, HOX3D"	ENSG00000172789	"Homeobox C5"	Q00444	12	54032853-54035358	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 8.8;ovary: 13.4"	"Cell type enhanced"	"Detected in some"	8	"Collecting duct cells: 1.8;Distal tubular cells: 1.7;Fibroblasts: 2.4;Leydig cells: 2.3;Peritubular cells: 2.5;Smooth muscle cells: 2.1;Spermatocytes: 3.2"	"Cancer enhanced"	"Detected in single"		"ovarian cancer: 0.7"	"Region enriched"	"Detected in single"	14	"pons and medulla: 8.8"	"Group enriched"	"Detected in some"	5	"gdT-cell: 5.9;naive CD8 T-cell: 1.9"	"Lineage enriched"	"Detected in single"	59	"T-cells: 5.9"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 8.5;ASC diff: 5.1;ASC TERT1: 6.2;HSkMC: 5.8;SH-SY5Y: 9.3"	"Region enriched"	"Detected in single"	40	"pons and medulla: 4.8"	"Region enriched"	"Detected in single"	7	"pons and medulla: 1.0"	HPA026794	Uncertain		Supported	"Nucleoplasm,Cell Junctions"		NA	NA			Nucleoplasm	"Cell Junctions"	"HPA026794: AB_10612118"	"unprognostic (1.57e-1)"	"unprognostic (7.73e-3)"		"unprognostic (1.70e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.16e-3)"		"unprognostic (2.87e-3)"	"unprognostic (6.89e-2)"	"unprognostic (9.53e-3)"	"unprognostic (1.86e-2)"	"unprognostic (2.69e-2)"	"unprognostic (2.01e-3)"	"unprognostic (1.17e-2)"	"unprognostic (7.53e-3)"	"unprognostic (2.19e-3)"	"unprognostic (1.08e-2)"	1.8	1.6	0.2	1.0	0.2	0.0	1.8	0.2	0.6	0.2	1.6	0.2	0.2	0.3	0.5	5.3	1.7	8.0	1.5	0.2	0.2	0.0	1.5	0.2	0.2	0.3	0.4	0.2	13.4	0.2	0.0	0.2	1.4	8.8	0.2	0.0	0.8	0.2	0.2	4.2	2.1	4.6	2.5	2.6	0.2	3.9	2.4	0.2	0.2	0.4	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	5.9	0.3	0.9	2.2	0.0	8.5	5.1	6.2	0.0	0.5	0.4	1.0	0.7	3.6	0.5	0.0	0.6	2.5	0.0	1.4	0.2	0.0	0.3	2.7	3.0	0.0	1.0	0.1	0.2	0.0	0.1	5.8	0.6	4.1	0.4	0.0	0.0	0.0	0.0	0.0	1.8	1.3	0.0	0.1	0.0	1.5	0.3	0.0	0.0	0.0	1.2	0.0	0.0	9.3	0.6	0.2	4.4	1.2	1.7	0.1	0.0	1.5	0.9	3.2	0.3	0.0	0.0	0.0	0.2	0.2	3.2	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.2	0.2	0.6	0.2	0.0	0.4	0.2	8.8	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.1	1.7	0.0	0.2	0.0	0.0	0.0	0.2	0.1	2.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.9	0.0	0.0	2.1	3.2	0.6	0.6	0.2	0.0	0.0	0.0
HOXD4	"HOX4, HOX4B"	ENSG00000170166	"Homeobox D4"	P09016	2	176151222-176153226	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 21.0;seminal vesicle: 26.2"	"Cell type enhanced"	"Detected in some"	17	"Collecting duct cells: 15.7;Leydig cells: 4.4;Proximal tubular cells: 5.3;Sertoli cells: 6.5"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 5.3"	"Region enriched"	"Detected in some"	7	"pons and medulla: 7.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 9.3;HEK 293: 22.1;RPTEC TERT1: 16.4;SK-MEL-30: 6.1"					"Region enriched"	"Detected in single"	28	"pons and medulla: 8.2"	"HPA054383, HPA070349"	Approved		Supported	"Nucleoplasm,Cell Junctions"		NA	NA			Nucleoplasm	"Cell Junctions"	"HPA054383: AB_2682470, HPA070349: AB_2686258"	"unprognostic (9.37e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.03e-3)"	"unprognostic (1.10e-3)"	"unprognostic (9.21e-2)"	"unprognostic (5.17e-3)"	"unprognostic (5.19e-2)"	"unprognostic (6.69e-3)"	"unprognostic (1.66e-1)"	"unprognostic (3.47e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.50e-1)"	"unprognostic (7.78e-2)"	"unprognostic (1.12e-2)"	"unprognostic (9.93e-2)"	"unprognostic (5.81e-2)"	"unprognostic (1.61e-1)"	3.4	4.9	0.5	0.5	0.5	0.0	4.0	0.5	0.7	2.8	3.4	0.5	13.8	0.2	15.6	21.0	0.5	7.9	0.5	0.5	0.5	0.0	10.2	0.5	0.5	0.6	1.1	0.5	9.7	0.5	0.0	0.5	0.5	7.6	1.5	0.8	0.5	0.5	26.2	1.3	1.0	3.5	5.3	3.7	4.4	0.4	1.5	0.5	0.5	0.8	0.5	0.5	2.2	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	1.1	1.8	0.0	0.1	0.4	0.0	0.6	0.5	0.0	0.0	9.3	1.6	0.4	0.1	1.5	0.0	0.2	0.0	22.1	0.2	0.0	0.0	0.3	0.0	0.0	5.0	1.5	0.0	0.2	0.1	3.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	16.4	2.6	1.3	2.2	0.3	0.0	6.1	0.4	0.0	0.0	2.8	0.2	0.1	1.4	1.2	0.0	0.0	0.0	1.1	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.5	0.7	0.5	0.0	1.1	0.5	7.6	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	15.7	0.0	0.0	0.0	0.0	3.7	2.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.5	4.4	0.0	1.7	0.0	0.6	0.0	0.1	0.0	2.8	5.3	0.0	6.5	0.5	0.2	0.2	0.5	0.0	0.0	1.2	0.0
IGSF11	"BT-IgSF, CT119, Igsf13, MGC35227, VSIG3"	ENSG00000144847	"Immunoglobulin superfamily member 11"	Q5DX21	3	118900557-119146068	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Growth regulation"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.8;ovary: 21.1;testis: 39.9"	"Group enriched"	"Detected in some"	7	"Cone photoreceptor cells: 70.7;Early spermatids: 226.0;Late spermatids: 237.3"	"Group enriched"	"Detected in many"	9	"glioma: 9.2;melanoma: 10.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 6.0;HEL: 4.4;SK-MEL-30: 26.2;U-266/70: 9.1;U-266/84: 10.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046377	Uncertain		Approved	"Nucleoplasm,Cell Junctions,Cytosol"		NA	NA			"Cell Junctions"	"Nucleoplasm, Cytosol"	"HPA046377: AB_10966195"	"unprognostic (2.05e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.89e-3)"	"unprognostic (2.51e-2)"	"unprognostic (3.56e-2)"	"unprognostic (3.91e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.20e-1)"	"unprognostic (8.70e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.03e-4)"	"unprognostic (1.39e-1)"	"unprognostic (3.42e-2)"	"unprognostic (7.57e-2)"	1.1	10.5	12.5	1.4	14.6	0.9	1.2	3.4	23.9	1.3	2.6	27.8	0.0	1.1	1.6	2.3	2.0	1.6	1.9	2.2	12.3	6.0	10.6	0.9	1.0	1.0	25.2	8.9	21.1	5.1	3.8	1.4	1.1	15.3	1.3	1.8	7.0	1.4	2.0	2.9	2.6	1.6	1.5	20.5	1.0	1.4	39.9	20.7	0.0	5.0	0.0	1.1	1.1	0.7	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	6.0	0.2	0.1	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.7	2.0	0.0	0.0	0.0	0.1	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.1	0.0	2.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.5	0.4	0.0	0.0	26.2	1.7	0.5	0.1	0.0	0.0	1.0	0.0	0.0	9.1	10.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	12.5	14.6	3.4	13.6	12.3	6.0	25.2	8.9	15.3	20.7	0.0	0.0	0.0	0.1	0.3	5.1	1.1	0.0	0.0	0.0	0.0	70.7	0.1	0.0	0.3	226.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	15.9	0.0	0.0	0.0	237.3	3.4	0.2	3.3	0.0	0.0	24.3	0.2	0.0	1.8	5.1	24.8	0.0	0.0	11.7	5.9	0.0	0.1	0.0	0.0	0.2
IGSF23		ENSG00000216588	"Immunoglobulin superfamily member 23"	A1L1A6	19	44613630-44636781	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"blood: 6.0;intestine: 19.9;liver: 20.6"	"Group enriched"	"Detected in some"	8	"Cholangiocytes: 7.6;Early spermatids: 7.7;Hepatocytes: 9.2;Late spermatids: 8.1"	"Cancer enriched"	"Detected in some"	10	"liver cancer: 12.4"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	5	"neutrophil: 6.0"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 6.0"	"Cell line enhanced"	"Detected in some"		"CACO-2: 14.0;Hep G2: 8.3;SiHa: 6.4"									"HPA051811, HPA054591"	Uncertain		Approved	"Nucleoplasm,Cell Junctions"		NA	NA			Nucleoplasm	"Cell Junctions"	"HPA051811: AB_2681621, HPA054591: AB_2682535"	"unprognostic (1.54e-1)"	"unprognostic (1.84e-3)"	"unprognostic (5.74e-2)"	"unprognostic (1.53e-3)"	"unprognostic (4.58e-2)"	"unprognostic (1.11e-1)"	"prognostic favorable (7.20e-6)"	"unprognostic (7.35e-3)"	"unprognostic (2.71e-1)"	"unprognostic (3.27e-2)"	"unprognostic (2.93e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.19e-8)"	"unprognostic (1.26e-1)"	"unprognostic (6.38e-2)"	"unprognostic (9.17e-2)"	"unprognostic (2.85e-1)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	10.8	0.1	0.1	12.2	0.1	0.5	0.1	0.1	0.1	0.6	0.1	0.1	0.4	20.6	0.1	0.1	0.1	0.1	0.1	3.0	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.9	0.1	0.1	0.0	19.9	0.1	0.6	0.1	0.0	1.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	6.0	1.2	0.0	0.0	0.2	0.4	0.8	0.0	0.5	0.0	0.0	0.7	0.5	0.7	0.0	0.6	14.0	0.5	0.0	1.0	0.4	0.3	0.3	0.0	0.0	0.3	0.3	0.0	0.0	0.3	8.3	0.0	0.0	0.1	0.4	0.0	0.8	0.0	0.3	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	6.4	2.3	0.0	0.0	0.3	0.0	2.6	0.5	0.5	0.6	0.0	1.2	0.0	0.0	0.1	0.3	0.0	0.0	1.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.9	7.7	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.6	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0
IL13RA2	"CD213a2, CT19, IL-13R, IL13BP"	ENSG00000123496	"Interleukin 13 receptor subunit alpha 2"	Q14627	X	115003975-115019977	"Cancer-related genes, CD markers, Predicted membrane proteins"		Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 16.1;testis: 31.5"	"Cell type enhanced"	"Detected in some"	28	"Early spermatids: 253.7;Ito cells: 63.3;Late spermatids: 36.6;Spermatocytes: 64.6"	"Cancer enhanced"	"Detected in many"		"glioma: 17.2"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"PC-3: 27.0;U-2197: 86.8;U-251 MG: 58.3;U-87 MG: 34.6"	"Region enhanced"	"Detected in some"		"olfactory region: 8.7"	"Low region specificity"	"Detected in many"			"HPA045831, HPA067363"			Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cell Junctions"		NA	NA			"Plasma membrane, Cell Junctions"	"Nucleoplasm, Vesicles"	"HPA045831: , HPA067363: "	"unprognostic (1.97e-1)"	"unprognostic (2.83e-1)"	"unprognostic (6.62e-4)"	"unprognostic (7.39e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.80e-1)"	"prognostic favorable (3.55e-4)"	"unprognostic (3.54e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.92e-2)"	"unprognostic (2.20e-3)"	"unprognostic (2.19e-2)"	"unprognostic (1.53e-5)"	"unprognostic (1.58e-1)"	"unprognostic (1.63e-1)"	"unprognostic (9.70e-3)"	"unprognostic (1.20e-1)"	0.5	4.8	3.7	3.9	11.3	0.0	0.8	0.3	3.1	1.2	0.4	2.1	5.7	0.3	0.9	4.4	0.5	0.1	0.8	0.6	5.1	11.2	3.5	9.6	1.0	0.1	1.2	2.6	0.1	0.1	0.5	16.1	2.1	3.9	4.3	0.7	1.6	0.8	3.7	0.0	0.1	0.3	0.4	0.6	0.2	0.1	31.5	1.4	0.0	1.3	0.2	0.2	1.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.7	0.0	5.9	5.7	0.0	0.0	0.0	0.0	0.0	0.1	2.9	9.6	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.0	0.1	0.9	5.5	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	27.0	0.0	0.0	0.0	0.5	0.0	0.0	1.4	0.4	0.0	0.1	0.0	0.0	0.0	0.0	3.1	0.0	86.8	58.3	0.0	0.0	0.0	34.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	11.3	0.3	3.1	5.1	11.2	1.2	2.6	3.9	1.4	0.0	0.0	0.0	2.6	0.1	0.0	0.2	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	253.7	1.0	0.0	0.0	0.0	0.0	0.4	2.3	0.0	0.4	0.0	0.0	4.1	63.3	4.8	36.6	2.6	0.0	0.0	1.0	0.0	0.0	5.5	0.0	4.6	0.0	0.0	0.0	0.2	64.6	2.1	0.0	0.0	0.0	0.0	2.5
IP6K2	IHPK2	ENSG00000068745	"Inositol hexakisphosphate kinase 2"	Q9UHH9	3	48688003-48740353	"Enzymes, Predicted intracellular proteins"	"Lipid metabolism, Phospholipid metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007532, HPA070811"	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cell Junctions"		NA	NA			"Nucleoplasm, Nucleoli fibrillar center"	"Cell Junctions"	"HPA007532: AB_1851542, HPA070811: AB_2732165"	"prognostic favorable (1.25e-4)"	"unprognostic (2.55e-2)"	"unprognostic (8.86e-2)"	"unprognostic (6.69e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.76e-3)"	"prognostic favorable (2.95e-4)"	"unprognostic (6.57e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.92e-3)"	"unprognostic (1.99e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.50e-2)"	"prognostic favorable (1.83e-4)"	18.3	31.1	40.4	20.0	55.9	51.7	28.2	74.1	37.3	29.5	32.5	23.7	34.0	36.9	34.6	56.1	30.0	28.1	24.0	19.0	30.7	19.2	32.4	24.3	18.4	22.5	35.4	27.6	33.9	28.1	23.5	42.3	20.7	29.4	34.9	41.9	22.2	28.3	32.1	19.1	50.0	31.6	21.1	28.3	25.5	27.6	26.0	37.4	31.7	35.7	21.6	19.5	24.1	34.0	27.3	22.8	50.7	25.7	27.9	35.1	19.0	8.5	16.7	34.7	24.4	19.6	24.5	25.1	16.3	18.3	18.7	21.7	13.8	22.9	15.1	13.4	15.2	23.5	22.3	17.3	24.4	17.5	17.8	15.2	17.3	51.7	29.6	15.9	16.4	16.9	23.2	35.6	25.4	21.0	24.9	25.9	49.1	12.9	19.0	21.7	19.0	35.0	22.5	26.6	16.7	31.0	14.7	11.5	16.5	25.4	41.0	21.7	32.8	35.3	24.0	17.3	28.8	23.2	27.7	18.4	20.4	20.3	12.8	16.1	17.6	20.8	21.3	18.5	19.2	17.8	50.7	22.5	38.5	29.7	21.6	26.5	27.3	25.8	27.7	21.7	25.7	24.2	24.9	35.3	27.9	25.7	22.8	35.1	19.0	40.4	55.9	74.1	37.3	30.7	19.2	35.4	27.6	29.4	37.4	65.5	38.7	24.2	78.6	73.7	63.9	10.1	33.1	69.6	69.4	94.2	37.3	101.3	64.6	51.7	30.9	42.0	85.6	0.0	41.6	64.1	64.4	60.2	53.1	20.7	35.7	19.1	105.7	35.0	15.3	14.2	75.1	31.2	25.3	34.3	96.2	28.0	50.1	90.2	64.3	55.6	50.0	51.8	35.7	56.7	54.0	72.5	103.7	47.2	78.7	75.6
IQGAP1	"HUMORFA01, KIAA0051, p195, SAR1"	ENSG00000140575	"IQ motif containing GTPase activating protein 1"	P46940	15	90388218-90502243	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013302, HPA014055"	Enhanced		Supported	"Plasma membrane,Cell Junctions"		NA	NA		890000	"Plasma membrane, Cell Junctions"		"CAB013302: AB_2533146, HPA014055: AB_1851856"	"unprognostic (2.83e-1)"	"unprognostic (7.73e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.02e-2)"	"unprognostic (5.95e-2)"	"unprognostic (4.24e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (5.67e-5)"	"unprognostic (2.01e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.25e-3)"	46.2	23.2	9.9	27.8	17.1	23.7	31.7	5.9	11.2	41.8	26.7	18.1	19.7	12.3	50.8	28.8	41.3	27.4	22.0	17.6	12.0	9.1	25.9	9.8	38.3	45.3	17.5	6.6	31.3	16.4	27.6	19.1	53.7	15.5	28.9	27.1	12.0	37.8	22.0	23.1	32.7	25.8	37.6	17.4	48.0	20.3	11.4	15.4	39.5	32.7	29.6	34.9	43.0	40.8	5.9	9.9	39.3	12.4	11.5	9.9	6.3	31.5	17.5	8.7	10.3	22.7	29.6	51.2	30.2	28.0	27.8	30.0	20.0	33.0	17.6	14.8	50.4	24.8	57.0	17.5	33.7	33.8	22.4	12.4	11.8	33.8	7.3	27.5	21.5	25.3	17.4	31.2	32.7	46.8	34.5	38.1	11.6	10.1	24.9	42.4	16.4	11.6	6.5	11.4	51.0	10.0	14.3	23.6	15.4	28.7	50.2	11.1	8.3	42.0	21.6	22.4	38.3	18.8	18.6	48.3	31.8	16.5	26.6	31.1	9.7	13.8	17.9	28.9	21.2	17.0	10.5	11.6	8.1	9.9	10.9	8.9	5.6	6.2	8.5	9.9	5.9	3.8	6.6	39.3	11.5	12.4	6.0	6.7	6.3	9.9	17.1	5.9	11.2	12.0	9.1	17.5	6.6	15.5	15.4	247.1	255.8	85.7	86.1	91.5	2.3	11.8	40.8	176.7	226.3	73.3	15.7	77.6	6.6	78.9	6.5	111.9	155.2	23.3	85.6	126.0	70.8	89.0	199.2	6.8	130.4	1.6	58.3	93.3	343.0	9.3	44.3	168.0	67.4	158.7	118.3	14.0	97.0	121.4	45.3	15.9	25.3	77.6	70.3	11.5	32.6	99.1	80.0	132.1	104.7	126.4
IREB2	IRP2	ENSG00000136381	"Iron responsive element binding protein 2"	P48200	15	78437431-78501456	"Plasma proteins, Predicted intracellular proteins"		RNA-binding	"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032885, HPA040371, HPA068982"	Uncertain		Approved	"Cell Junctions,Cytosol"		NA	NA			"Cell Junctions"	Cytosol	"CAB032885: AB_2126703, HPA040371: AB_2676945, HPA068982: AB_2686064"	"unprognostic (1.00e-2)"	"unprognostic (1.30e-1)"	"unprognostic (6.54e-2)"	"unprognostic (3.44e-2)"	"unprognostic (3.39e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.06e-1)"	"unprognostic (7.30e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.38e-1)"	"unprognostic (6.51e-2)"	"unprognostic (3.85e-3)"	"unprognostic (4.09e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.47e-2)"	"unprognostic (9.40e-2)"	18.9	42.4	12.0	16.2	22.0	22.6	18.3	22.3	24.9	19.0	16.2	14.8	14.3	16.6	20.4	17.9	19.7	17.6	14.4	13.6	10.7	11.8	18.2	21.1	22.4	31.1	10.3	16.7	23.1	17.0	20.3	23.6	23.2	21.7	16.5	19.7	19.2	17.1	15.8	27.3	18.6	25.3	15.5	13.7	25.5	15.7	18.0	12.3	39.6	27.8	14.0	20.3	17.8	18.4	7.1	9.5	7.1	7.8	7.2	8.8	3.4	7.5	13.4	20.8	13.0	18.4	12.1	14.0	12.9	10.0	11.7	10.7	13.2	13.1	27.9	8.8	10.7	8.0	14.7	48.4	13.0	10.4	8.8	16.8	24.1	14.0	9.2	9.6	26.0	26.1	12.7	8.9	9.0	11.0	12.0	13.7	16.5	25.2	10.0	10.0	11.3	15.8	13.3	27.2	9.2	4.9	18.7	20.9	7.9	12.9	20.8	12.5	18.8	17.4	12.4	13.5	24.5	11.6	22.8	11.1	12.1	8.3	6.6	11.1	12.5	27.3	15.9	8.7	24.2	8.6	7.1	5.8	4.4	6.0	7.8	7.7	6.5	6.6	5.9	8.0	7.1	6.5	8.8	6.8	7.2	6.0	9.5	5.3	3.4	12.0	22.0	22.3	24.9	10.7	11.8	10.3	16.7	21.7	12.3	20.8	35.5	37.4	16.1	12.6	53.7	19.9	22.9	14.7	23.9	22.7	62.8	28.6	0.0	17.5	10.0	22.9	41.8	46.7	16.9	20.4	21.6	26.3	17.3	36.2	22.5	74.7	30.7	51.5	44.9	8.1	30.5	32.9	13.5	16.2	28.6	31.2	21.7	38.4	28.7	15.8	44.1	6.5	13.9	30.7	26.0	16.3	25.6	34.5	28.3	19.3
IRF2		ENSG00000168310	"Interferon regulatory factor 2"	P14316	4	184387713-184474580	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"monocytes: 173.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 50.9;Karpas-707: 53.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030813, CAB032306, HPA057327"	Supported		Enhanced	"Nucleoplasm,Cell Junctions,Cytosol"		NA	NA			Nucleoplasm	"Cell Junctions, Cytosol"	"CAB032306: AB_2249157, HPA030813: AB_10600718, HPA057327: AB_2683410"	"prognostic favorable (6.95e-5)"	"unprognostic (1.69e-3)"	"unprognostic (5.43e-2)"	"unprognostic (1.59e-3)"	"unprognostic (2.70e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.48e-2)"	"unprognostic (4.05e-2)"	"unprognostic (8.37e-3)"	"unprognostic (2.90e-2)"	"unprognostic (4.00e-2)"	"unprognostic (2.35e-1)"	"unprognostic (6.87e-3)"	"unprognostic (8.55e-3)"	"unprognostic (5.25e-2)"	"prognostic favorable (8.34e-5)"	"unprognostic (1.31e-3)"	27.5	30.6	15.2	31.0	19.3	11.3	21.0	21.5	16.4	21.5	23.7	28.8	16.6	21.2	19.8	16.5	20.5	18.1	17.3	16.1	15.3	12.1	15.3	26.1	24.0	38.7	22.8	9.7	28.0	14.9	12.4	24.5	19.7	17.8	20.5	20.4	16.8	22.1	16.1	21.9	18.1	27.7	21.2	22.4	39.4	21.3	8.4	22.0	36.1	24.0	12.6	34.5	28.8	26.4	22.2	16.2	83.9	27.5	18.1	21.9	17.2	6.1	4.5	5.6	3.7	12.3	12.7	3.3	4.5	14.2	11.1	11.7	1.3	11.9	3.8	2.4	6.7	9.1	5.7	3.8	8.6	7.2	50.9	2.1	10.5	2.5	8.2	12.2	6.4	8.9	13.6	7.9	6.3	16.5	9.6	8.4	4.6	2.0	53.1	4.6	4.3	12.3	7.8	1.2	5.6	3.3	16.2	2.1	16.9	8.5	9.5	2.4	3.7	6.4	5.3	9.3	2.4	4.1	5.8	6.9	3.2	3.5	3.6	3.9	15.2	12.1	3.3	6.7	6.3	5.6	17.7	19.4	34.5	16.4	25.3	16.9	21.2	16.3	17.6	16.2	22.2	17.5	17.3	83.9	18.1	27.5	4.1	21.9	17.2	15.2	19.3	21.5	16.4	15.3	12.1	22.8	9.7	17.8	22.0	35.7	23.2	51.9	43.4	43.6	11.8	19.6	28.1	64.3	26.1	24.4	5.9	27.6	31.5	24.5	0.1	35.9	32.5	23.3	26.4	13.4	30.4	57.1	26.5	32.6	42.8	19.1	29.4	37.4	73.6	1.3	34.5	47.6	18.6	173.1	25.9	25.5	27.3	37.4	49.8	23.7	7.8	38.8	24.7	0.2	1.1	38.9	22.3	58.6	20.9	59.3
ITGA9	"ALPHA-RLC, ITGA4L, RLC"	ENSG00000144668	"Integrin subunit alpha 9"	Q13797	3	37452115-37823514	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Integrin, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	13	"Ito cells: 62.0;Kupffer cells: 24.9;Leydig cells: 38.3;Peritubular cells: 70.4"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 23.6"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"basophil: 2.1"	"Lineage enhanced"	"Detected in single"		"granulocytes: 2.1"	"Cell line enhanced"	"Detected in some"		"CACO-2: 9.4;HEL: 7.5;SH-SY5Y: 11.2;SuSa: 17.0;WM-115: 5.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA030609	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cell Junctions"	"Intracellular and membrane"	NA	NA		250000	Vesicles	"Nucleoplasm, Plasma membrane, Cell Junctions"	"HPA030609: AB_10600815"	"unprognostic (2.35e-2)"	"unprognostic (3.36e-2)"	"unprognostic (5.58e-2)"	"unprognostic (3.94e-2)"	"unprognostic (4.48e-2)"	"unprognostic (2.85e-2)"	"unprognostic (3.10e-1)"	"unprognostic (8.87e-3)"	"unprognostic (3.23e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.72e-2)"	"unprognostic (3.16e-2)"	8.5	15.5	3.1	5.3	3.7	5.8	9.6	1.6	5.7	17.9	11.1	2.9	5.8	4.6	17.3	7.5	12.3	6.9	17.8	25.0	4.5	2.0	4.6	13.6	8.3	16.8	3.4	2.7	7.5	2.1	2.4	3.0	7.3	2.6	10.0	5.3	8.4	4.7	8.7	3.7	3.5	8.7	16.2	4.0	30.5	10.9	10.2	2.7	1.0	35.4	7.2	3.6	7.4	8.4	0.0	0.7	2.1	0.2	0.0	0.0	0.4	0.2	0.0	4.1	0.3	0.0	0.2	0.1	0.1	0.0	0.0	0.0	9.4	0.0	3.0	1.3	0.0	0.1	0.2	3.6	0.0	0.0	0.0	0.6	7.5	0.1	0.2	0.2	0.0	4.5	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.2	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.4	0.2	0.0	0.2	0.5	11.2	0.1	0.5	0.6	17.0	0.0	2.9	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.1	0.2	5.8	2.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.4	3.1	3.7	1.6	5.7	4.5	2.0	3.4	2.7	2.6	2.7	0.0	14.3	0.0	1.0	2.3	0.8	13.2	2.5	0.0	5.7	1.8	0.0	0.2	0.0	0.1	0.9	18.0	0.0	0.0	0.0	0.2	3.2	0.2	5.8	0.2	2.2	0.0	0.0	62.0	24.9	3.1	38.3	1.3	3.3	0.0	0.0	0.5	0.0	0.0	70.4	0.0	0.0	0.0	3.3	0.5	0.9	1.5	0.2	0.0	0.0	0.3
ITGB4	CD104	ENSG00000132470	"Integrin subunit beta 4"	P16144	17	75721328-75757818	"Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Integrin, Receptor"	"Cancer-related genes, Disease mutation, Epidermolysis bullosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Enterocytes: 84.6;Pancreatic endocrine cells: 175.0;Syncytiotrophoblasts: 92.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 8.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 120.2;HaCaT: 46.0;HBEC3-KT: 102.5;hTCEpi: 35.1;RT4: 33.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB002422, CAB005258, HPA036348, HPA036349"	Enhanced		Supported	"Plasma membrane,Cell Junctions"		NA	NA		79000	"Plasma membrane, Cell Junctions"		"CAB002422: AB_563480, CAB005258: AB_2129021, HPA036348: AB_2675077, HPA036349: AB_2675078"	"unprognostic (3.17e-3)"	"unprognostic (3.52e-1)"	"unprognostic (4.19e-1)"	"unprognostic (2.27e-1)"	"unprognostic (5.75e-2)"	"unprognostic (6.11e-3)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (7.18e-4)"	"unprognostic (1.05e-1)"	"unprognostic (4.14e-2)"	"prognostic unfavorable (6.39e-4)"	"unprognostic (1.02e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.43e-1)"	6.3	3.4	9.7	10.9	9.7	1.4	13.7	4.7	7.7	14.3	32.1	15.6	10.0	35.3	9.7	8.8	24.0	13.7	47.8	4.3	9.4	7.9	4.8	1.5	7.4	3.7	10.1	9.1	4.7	6.7	3.1	5.7	50.0	17.2	19.7	10.4	9.8	52.3	13.2	2.4	47.0	58.5	7.4	10.7	17.0	41.0	3.9	9.8	1.8	3.2	22.1	15.9	17.2	20.5	2.4	8.2	1.3	0.7	0.0	2.2	0.8	22.3	19.7	0.0	0.2	0.0	0.1	27.2	0.1	0.0	0.0	0.1	2.1	120.2	0.0	4.3	0.0	0.1	46.0	0.1	102.5	0.0	0.1	0.0	0.1	5.0	2.2	0.1	0.0	0.2	0.1	35.1	0.0	21.9	2.4	0.7	0.0	0.0	2.1	0.0	12.5	0.2	0.2	0.1	12.1	17.2	0.3	0.6	0.2	27.5	33.8	0.0	0.2	0.6	2.0	0.3	0.7	8.6	0.2	2.2	0.6	1.1	0.0	0.2	0.7	0.2	0.0	0.2	0.1	0.3	0.0	0.4	0.0	0.7	0.7	2.2	1.4	0.3	1.0	0.1	2.4	0.9	0.6	1.3	0.0	0.0	8.2	1.4	0.8	9.7	9.7	4.7	7.7	9.4	7.9	10.1	9.1	17.2	9.8	11.9	2.1	0.5	35.9	44.0	0.2	5.9	20.4	12.0	14.8	22.7	2.0	70.7	1.7	26.1	0.3	15.7	84.6	0.0	25.5	15.4	4.9	5.9	2.3	0.0	8.2	0.0	9.2	9.8	0.0	0.0	3.4	2.5	11.8	0.0	49.0	40.4	175.0	66.4	1.4	2.0	0.4	0.0	2.5	0.1	5.9	11.4	92.9	2.2	50.4	34.6
ITGB6		ENSG00000115221	"Integrin subunit beta 6"	P18564	2	160099666-160200313	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Integrin, Receptor"	"Amelogenesis imperfecta, Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 62.1"	"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 1: 142.9;Alveolar cells type 2: 159.2;Pancreatic endocrine cells: 133.9;Spermatocytes: 219.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"CAPAN-2: 37.5;RPTEC TERT1: 74.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA023626, CAB073536"	Approved		Approved	"Nucleoplasm,Cell Junctions,Centrosome"		NA	NA			"Nucleoplasm, Cell Junctions"	Centrosome	"CAB073536: , HPA023626: AB_2671267"	"unprognostic (1.27e-1)"	"unprognostic (1.57e-2)"	"unprognostic (6.90e-2)"	"unprognostic (8.22e-3)"	"unprognostic (3.61e-3)"	"unprognostic (1.50e-2)"	"unprognostic (1.72e-3)"	"unprognostic (2.04e-2)"	"unprognostic (1.72e-1)"	"unprognostic (7.06e-2)"	"prognostic unfavorable (5.03e-6)"	"unprognostic (1.04e-1)"	"unprognostic (2.73e-1)"	"unprognostic (4.97e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.00e-1)"	0.3	0.3	0.3	3.1	0.3	0.0	8.7	0.3	0.3	4.1	8.3	0.1	4.5	3.5	2.1	2.5	18.7	1.2	12.0	0.7	0.3	0.3	62.1	0.3	28.8	0.1	0.3	0.1	1.5	3.8	7.0	2.2	18.7	0.2	7.5	3.0	0.1	3.8	4.8	31.5	1.9	11.7	2.0	0.3	0.3	7.9	0.6	0.1	0.1	4.9	6.8	5.9	12.8	8.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	37.5	0.0	0.2	0.0	0.0	7.7	0.0	12.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	8.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	1.1	0.0	0.0	0.0	2.4	0.0	0.0	2.9	0.0	74.9	12.4	0.0	0.0	0.0	11.8	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.1	0.2	0.1	142.9	159.2	0.0	106.9	9.3	0.0	37.4	10.2	8.1	77.3	68.0	0.0	6.6	0.0	51.3	71.2	2.2	10.3	0.0	92.6	5.2	3.3	42.3	3.5	0.8	2.0	0.0	0.0	1.8	0.8	24.4	2.6	2.5	1.7	3.6	14.1	0.8	133.9	21.0	1.1	0.2	0.0	0.0	2.7	219.5	2.4	7.4	3.9	0.0	11.2	104.4
JCAD	KIAA1462	ENSG00000165757	"Junctional cadherin 5 associated"	Q9P266	10	30012800-30115494	"Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	23	"Alveolar cells type 2: 5.6;Ciliated cells: 5.3;Ductal cells: 15.6;Syncytiotrophoblasts: 2.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 15.1;HUVEC TERT2: 15.7;LHCN-M2: 13.0;TIME: 35.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017956	Enhanced		Approved	"Vesicles,Cell Junctions"		NA	NA			"Vesicles, Cell Junctions"		"HPA017956: AB_1852408"	"unprognostic (1.78e-1)"	"unprognostic (8.33e-2)"	"unprognostic (5.37e-2)"	"unprognostic (8.07e-2)"	"unprognostic (6.32e-2)"	"unprognostic (7.09e-2)"	"unprognostic (9.36e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.16e-1)"	"unprognostic (4.93e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.08e-2)"	"prognostic unfavorable (2.54e-4)"	"prognostic unfavorable (2.01e-4)"	"unprognostic (1.41e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.34e-2)"	27.0	7.5	6.2	9.1	12.4	0.5	18.0	2.2	8.8	10.1	29.4	3.2	5.4	1.7	16.5	8.1	5.9	10.8	9.9	16.3	6.2	4.7	6.0	2.0	22.3	3.2	6.7	8.9	11.3	15.7	4.7	4.8	30.5	8.9	14.1	4.1	24.4	2.5	9.7	9.2	3.7	3.7	27.8	6.8	1.2	5.0	13.0	4.4	1.4	13.0	3.9	2.0	18.3	22.8	0.2	0.1	0.8	0.0	0.3	0.2	0.0	7.7	3.4	3.1	0.0	2.0	0.4	4.6	4.2	4.4	0.6	1.0	1.3	0.0	0.0	0.3	15.1	0.9	0.1	0.8	0.3	1.8	0.8	1.9	0.0	0.0	0.0	8.7	0.0	0.5	4.9	0.1	10.6	0.8	0.2	15.7	0.2	0.0	0.0	13.0	0.3	0.0	0.3	0.6	0.4	5.3	0.0	1.7	0.0	0.6	0.2	0.4	0.1	0.1	0.0	0.0	4.7	0.0	0.7	35.1	8.0	2.0	2.5	0.4	3.3	0.4	0.0	1.8	5.4	0.0	0.1	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.5	0.3	0.0	0.1	0.0	0.0	6.2	12.4	2.2	8.7	6.2	4.7	6.7	8.9	8.9	4.4	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	1.2	0.0	15.6	0.0	0.0	0.0	0.0	0.3	0.8	0.0	0.0	1.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0
JUP	"CTNNG, DP3, DPIII, PDGB, PKGB"	ENSG00000173801	"Junction plakoglobin"	P14923	17	41754604-41786931	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"		"Cancer-related genes, Cardiomyopathy, Disease mutation, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 146.3;skin 1: 126.1;tongue: 122.8"	"Cell type enhanced"	"Detected in many"	5	"Suprabasal keratinocytes: 335.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 7.6;eosinophil: 14.8;intermediate monocyte: 12.8;memory B-cell: 7.9;myeloid DC: 7.8;naive B-cell: 7.4;non-classical monocyte: 20.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HaCaT: 81.5;OE19: 288.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002139, HPA032047"	Supported		Supported	"Vesicles,Plasma membrane,Cell Junctions"		NA	NA		61000000	"Plasma membrane, Cell Junctions"	Vesicles	"CAB002139: AB_563468, HPA032047: AB_2674124"	"unprognostic (3.96e-3)"	"unprognostic (3.40e-1)"	"unprognostic (2.32e-1)"	"unprognostic (4.71e-3)"	"unprognostic (2.49e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.02e-1)"	"unprognostic (8.11e-3)"	"unprognostic (1.41e-2)"	"unprognostic (9.85e-3)"	"unprognostic (2.29e-3)"	"unprognostic (9.60e-2)"	"prognostic favorable (2.06e-10)"	"unprognostic (2.50e-1)"	"unprognostic (9.49e-2)"	"unprognostic (9.05e-2)"	"unprognostic (1.51e-2)"	12.5	2.6	2.8	9.5	4.5	3.3	13.0	6.5	3.7	34.5	17.9	8.7	12.3	15.6	12.2	9.6	146.3	13.0	19.0	34.5	3.3	1.6	31.6	11.7	13.2	4.0	5.3	2.2	12.5	12.8	3.6	5.8	42.4	4.0	14.0	8.8	8.3	34.3	14.3	17.6	126.1	36.1	4.3	3.2	4.5	15.4	3.6	4.6	10.8	27.9	122.8	84.8	12.5	55.4	7.9	7.8	14.8	20.6	0.3	0.1	2.9	19.5	16.2	1.6	1.4	0.0	0.0	25.4	1.1	6.7	0.4	0.4	24.6	21.7	0.3	12.1	0.7	0.5	81.5	2.3	18.1	0.0	0.0	5.8	0.8	12.9	5.4	2.7	0.5	8.7	0.0	41.2	0.0	3.3	4.9	7.2	0.5	7.2	7.1	0.0	25.1	0.1	7.0	3.2	288.5	2.7	22.9	0.0	14.6	12.6	50.1	4.0	2.9	2.5	49.5	0.1	7.9	41.3	0.5	11.4	0.0	1.1	0.5	0.3	0.6	2.2	0.3	0.1	0.9	0.1	1.7	7.6	14.8	0.0	12.8	0.0	7.9	0.0	0.1	7.8	7.4	0.1	0.1	0.3	0.3	20.6	2.5	0.0	2.9	2.8	4.5	6.5	3.7	3.3	1.6	5.3	2.2	4.0	4.6	56.6	33.7	8.4	158.6	174.9	1.1	80.3	53.5	18.7	43.3	125.6	3.9	81.5	23.2	189.4	28.7	23.2	158.5	0.0	119.3	141.0	19.6	196.2	10.5	29.3	12.8	0.0	64.1	28.3	5.6	6.4	4.6	9.8	11.8	6.4	91.0	16.2	237.1	128.7	0.0	33.8	4.3	6.5	14.0	2.1	4.2	335.0	155.3	5.1	94.4	236.4
KCNK13	"K2p13.1, THIK-1, THIK1"	ENSG00000152315	"Potassium two pore domain channel subfamily K member 13"	Q9HB14	14	90061765-90185857	"Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 8.3;parathyroid gland: 14.3;testis: 13.2"	"Cell type enhanced"	"Detected in some"	24	"Hofbauer cells: 5.6;Kupffer cells: 2.5;Macrophages: 5.3;monocytes: 14.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"classical monocyte: 1.5;intermediate monocyte: 1.3;myeloid DC: 3.8"	"Group enriched"	"Detected in many"	7	"dendritic cells: 3.8;monocytes: 1.5"	"Cell line enhanced"	"Detected in some"		"GAMG: 2.4;RT4: 4.2;SuSa: 7.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA003514	Approved		Approved	"Nuclear speckles,Cell Junctions"		NA	NA			"Nuclear speckles, Cell Junctions"		"HPA003514: AB_2666978"	"unprognostic (1.40e-1)"	"unprognostic (1.73e-1)"	"unprognostic (6.17e-2)"	"unprognostic (6.31e-2)"	"unprognostic (2.56e-1)"	"unprognostic (5.55e-2)"	"unprognostic (3.56e-2)"	"unprognostic (3.98e-2)"	"unprognostic (2.40e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.45e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.04e-2)"	"unprognostic (6.32e-2)"	"unprognostic (1.46e-1)"	"unprognostic (5.65e-2)"	0.8	1.1	2.9	2.2	3.5	0.1	0.4	0.2	4.2	0.4	0.6	4.0	0.0	0.6	0.3	1.5	0.3	0.4	0.5	2.7	2.9	2.4	4.8	0.7	0.7	1.6	6.3	1.4	0.4	2.7	14.3	0.6	1.2	3.6	0.4	0.7	0.1	1.1	0.7	0.1	0.1	0.7	0.4	8.3	1.1	0.5	13.2	5.4	0.7	2.7	0.0	0.6	0.8	0.1	0.0	3.8	0.0	1.5	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.4	0.0	0.9	0.0	0.0	0.8	1.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.6	0.0	0.2	0.0	0.0	0.0	1.9	0.0	0.0	0.7	0.0	1.0	0.0	0.0	0.0	0.4	4.2	1.8	0.5	0.0	1.8	1.2	7.1	0.0	1.6	0.0	0.0	2.1	0.0	0.6	0.6	1.8	0.0	0.2	0.0	0.1	0.0	1.5	0.0	0.0	1.3	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.3	2.9	3.5	0.2	4.2	2.9	2.4	6.3	1.4	3.6	5.4	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	2.5	0.6	0.0	5.3	0.0	14.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.3	0.1	0.0	0.0	0.1
KDF1	"C1orf172, FLJ34633, RP11-344H11.3"	ENSG00000175707	"Keratinocyte differentiation factor 1"	Q8NAX2	1	26949562-26960406	"Disease related genes, Predicted intracellular proteins"	Differentiation	"Developmental protein"	"Disease mutation, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 8.6"	"Group enriched"	"Detected in many"	36	"B-cells: 3.7;T-cells: 8.6"	"Cell line enhanced"	"Detected in some"		"A-431: 13.3;BEWO: 11.7;CAPAN-2: 12.5;HaCaT: 11.8;HBEC3-KT: 16.2;hTCEpi: 21.3;OE19: 20.5;SK-BR-3: 13.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA028639, HPA068312"	Uncertain		Supported	"Nucleoplasm,Cell Junctions,Mitotic spindle"		NA	NA			"Cell Junctions"	"Nucleoplasm, Mitotic spindle"	"HPA028639: AB_10599191, HPA068312: AB_2685972"	"unprognostic (2.58e-1)"	"unprognostic (1.23e-1)"	"unprognostic (6.46e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.64e-1)"	"unprognostic (8.45e-2)"	"unprognostic (9.09e-2)"	"unprognostic (9.01e-2)"	"unprognostic (2.73e-1)"	"unprognostic (3.91e-1)"	"prognostic favorable (3.04e-13)"	"unprognostic (1.38e-3)"	"unprognostic (7.83e-2)"	"unprognostic (8.03e-2)"	"prognostic favorable (4.40e-4)"	0.2	1.1	0.6	3.8	0.7	0.0	7.9	1.5	3.6	2.9	11.9	0.4	13.6	9.3	1.0	17.3	16.1	5.5	4.2	0.5	0.8	0.1	7.9	3.5	7.5	6.7	0.2	0.6	1.0	23.8	6.6	9.0	12.4	0.8	6.0	5.1	2.0	14.3	11.5	0.2	13.3	12.5	0.2	0.2	1.0	7.7	5.8	0.5	1.6	14.5	7.2	8.6	5.2	6.0	3.7	0.1	0.0	0.0	0.0	8.6	2.4	13.3	0.0	0.0	0.0	0.0	0.0	11.7	0.0	0.0	0.0	0.0	6.6	12.5	0.0	0.5	0.0	0.0	11.8	0.0	16.2	0.0	0.0	0.2	0.0	0.0	2.3	0.1	0.0	0.0	0.0	21.3	0.0	1.7	0.0	0.0	0.0	0.7	0.0	0.0	7.9	0.0	0.0	0.9	20.5	0.1	0.0	0.0	1.9	2.9	6.3	8.2	0.0	0.1	13.9	0.0	1.5	9.0	0.2	0.1	0.0	0.0	0.0	0.0	1.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	4.5	3.5	5.9	4.2	0.1	3.7	8.6	5.1	0.0	0.0	0.0	0.0	0.3	2.4	0.6	0.7	1.5	3.6	0.8	0.1	0.2	0.6	0.8	0.5	11.9	9.1	0.5	10.7	0.0	0.4	0.3	12.7	9.4	4.5	14.0	0.0	28.2	21.6	24.5	0.3	0.1	17.1	0.0	20.6	20.1	0.8	11.8	0.0	2.9	2.4	0.0	7.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	14.1	1.0	18.2	22.9	0.0	7.3	2.1	0.0	0.2	5.8	7.0	0.0	24.8	1.5	17.2	16.2
KIAA0895		ENSG00000164542	KIAA0895	Q8NCT3	7	36324221-36390125	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Early spermatids: 69.3;Late spermatids: 54.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 28.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021036, HPA061066"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions,Cytosol"		NA	NA			Nucleoplasm	"Plasma membrane, Cell Junctions, Cytosol"	"HPA021036: AB_2670571, HPA061066: AB_2684423"	"unprognostic (4.94e-2)"	"unprognostic (9.59e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.39e-1)"	"unprognostic (8.85e-2)"	"unprognostic (1.15e-3)"	"unprognostic (3.79e-3)"	"unprognostic (3.43e-1)"	"unprognostic (3.74e-1)"	"unprognostic (4.71e-3)"	"unprognostic (1.46e-1)"	"unprognostic (3.49e-1)"	"unprognostic (4.51e-2)"	"unprognostic (6.68e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.35e-2)"	"unprognostic (5.24e-2)"	1.5	9.9	8.1	1.3	11.0	2.8	5.2	28.9	13.5	3.7	3.0	5.8	6.0	3.0	4.6	9.1	3.6	8.6	4.6	2.6	6.2	8.1	13.1	10.4	4.2	0.7	4.2	8.2	12.7	12.4	18.6	14.7	2.0	8.0	4.6	2.1	6.6	4.1	4.7	2.1	7.8	1.7	4.4	4.7	1.2	14.3	27.1	4.9	2.1	5.5	1.5	0.9	2.3	2.7	0.6	0.5	1.3	0.1	0.5	1.5	0.4	7.3	4.5	9.3	9.1	0.2	0.2	2.1	2.0	2.3	4.4	5.4	1.9	3.8	0.0	2.0	0.4	7.7	4.2	12.0	3.9	3.9	0.6	7.6	0.1	7.0	1.7	1.6	1.2	0.2	1.0	7.1	3.9	5.0	5.4	0.1	4.0	2.9	0.1	0.5	2.4	3.6	2.6	0.4	1.9	1.1	1.4	0.4	0.0	10.1	0.8	28.4	9.9	3.6	8.6	2.6	6.6	8.6	1.3	0.0	0.6	2.2	1.3	2.9	4.2	9.4	0.0	1.8	0.3	2.1	0.8	0.1	0.3	0.1	0.1	1.3	0.3	0.9	0.2	0.1	0.6	1.4	0.6	1.3	0.5	0.1	0.5	1.5	0.4	8.1	11.0	28.9	13.5	6.2	8.1	4.2	8.2	8.0	4.9	6.0	2.4	0.0	4.2	8.7	17.4	2.6	5.1	16.0	3.4	3.5	25.5	1.9	5.0	4.7	69.3	1.1	0.4	0.0	2.5	1.3	0.9	3.6	1.1	5.0	0.4	11.1	8.1	0.0	0.0	54.0	2.6	0.2	3.3	0.0	1.0	5.0	3.7	1.4	0.4	9.4	15.7	6.5	1.0	21.6	12.4	7.5	0.6	0.0	1.0	1.4
KIAA1522		ENSG00000162522	KIAA1522	Q9P206	1	32741885-32774970	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	4	"Enterocytes: 90.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 2.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 38.4;hTCEpi: 32.0;RT4: 35.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA032050, HPA032051, HPA064839"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA			"Plasma membrane, Cell Junctions"	Nucleoplasm	"HPA032050: AB_10601764, HPA032051: AB_2674126, HPA064839: AB_2685366"	"unprognostic (7.98e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.44e-2)"	"unprognostic (3.09e-2)"	"unprognostic (6.41e-2)"	"unprognostic (3.63e-3)"	"prognostic unfavorable (6.29e-7)"	"unprognostic (1.58e-1)"	"unprognostic (1.13e-1)"	"unprognostic (5.06e-2)"	"prognostic unfavorable (8.25e-5)"	"unprognostic (4.55e-2)"	"prognostic favorable (1.29e-5)"	"unprognostic (1.35e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.98e-1)"	"unprognostic (2.12e-1)"	3.7	39.4	12.1	8.6	8.7	0.7	14.1	1.6	15.8	8.7	25.9	2.7	27.8	28.1	5.4	8.7	33.8	13.5	28.8	2.3	6.4	4.5	23.1	5.9	13.4	0.8	2.4	6.6	18.0	32.8	21.7	4.8	19.3	7.3	18.5	17.4	10.0	36.9	44.6	1.8	33.4	36.0	6.8	1.6	1.1	25.5	2.9	3.0	3.1	19.2	17.9	20.3	15.0	22.3	0.0	2.1	0.0	1.0	0.0	0.4	0.2	19.4	10.2	1.6	2.8	0.7	1.5	7.6	2.4	4.7	2.8	2.7	11.1	38.4	0.0	10.1	3.5	8.2	29.0	3.1	20.6	1.4	0.0	4.1	4.0	14.5	9.0	1.2	0.0	10.4	0.5	32.0	7.3	8.8	12.5	5.7	0.8	5.8	0.1	1.3	16.1	0.1	0.1	3.4	16.8	6.4	2.6	2.1	4.9	26.5	35.5	1.4	1.4	15.0	21.6	2.9	10.9	23.0	1.3	5.3	4.6	12.6	4.2	5.1	0.2	0.1	0.1	4.7	0.7	5.3	0.0	0.6	0.0	0.0	1.0	0.4	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.2	12.1	8.7	1.6	15.8	6.4	4.5	2.4	6.6	7.3	3.0	11.9	49.9	0.5	31.7	65.7	0.5	3.3	76.5	20.1	23.9	26.2	2.0	12.1	8.3	38.3	3.6	6.7	90.1	0.0	57.6	3.7	5.6	56.0	26.6	8.6	2.5	0.0	27.9	1.3	0.3	3.6	8.1	2.5	6.8	3.6	55.5	0.8	52.7	49.1	4.6	12.5	0.0	6.5	5.0	1.8	2.5	72.6	6.6	1.9	54.5	60.9
LDLRAD3	LRAD3	ENSG00000179241	"Low density lipoprotein receptor class A domain containing 3"	Q86YD5	11	35943981-36232136	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 32.5"	"Cell type enhanced"	"Detected in many"	5	"Glandular cells: 19.0;Peritubular cells: 23.3;Suprabasal keratinocytes: 22.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 6.1;non-classical monocyte: 7.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 28.5;RH-30: 26.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038251	Approved		Approved	"Cell Junctions"		NA	NA			"Cell Junctions"		"HPA038251: AB_10675790"	"unprognostic (1.59e-3)"	"prognostic unfavorable (2.24e-4)"	"unprognostic (3.25e-2)"	"unprognostic (4.08e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.29e-2)"	"prognostic unfavorable (9.34e-6)"	"unprognostic (2.17e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.68e-2)"	"unprognostic (6.93e-2)"	"prognostic unfavorable (5.05e-8)"	"unprognostic (3.32e-2)"	"unprognostic (9.21e-3)"	"unprognostic (9.33e-2)"	"prognostic unfavorable (2.14e-5)"	12.0	5.0	9.5	6.0	13.7	2.0	23.4	32.5	17.9	9.3	2.8	20.7	1.7	2.9	8.2	4.7	8.8	5.0	6.5	3.6	10.8	7.2	3.0	2.6	3.3	4.4	18.0	4.0	15.0	5.1	1.5	9.2	3.4	18.1	14.8	3.2	5.3	23.9	6.0	5.5	17.0	3.3	7.2	24.4	2.9	3.4	4.8	13.5	0.1	3.0	2.6	4.8	5.3	6.5	0.0	4.1	1.9	7.7	0.0	0.0	2.0	4.8	4.6	14.4	8.7	11.5	12.6	11.0	2.8	2.5	6.4	5.7	3.4	3.0	0.0	2.1	3.0	9.6	2.5	4.4	6.3	9.0	0.4	9.3	15.7	3.0	1.0	15.2	3.4	1.9	15.1	28.5	2.9	25.2	2.6	10.7	0.0	4.0	0.6	11.7	2.7	0.0	0.8	5.9	0.5	8.1	0.0	26.9	1.5	1.1	0.7	4.9	11.1	4.9	5.4	15.8	5.8	7.5	4.6	10.7	7.7	6.9	0.6	9.3	0.3	0.0	0.0	3.8	4.2	13.7	1.9	6.1	0.6	0.0	6.1	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.1	0.0	7.7	0.3	0.0	2.0	9.5	13.7	32.5	9.1	10.8	7.2	18.0	4.0	18.1	13.5	0.0	5.6	0.5	6.7	13.7	0.2	0.4	0.0	0.0	1.2	0.0	0.0	2.1	0.0	3.6	12.5	5.5	0.0	0.0	0.9	11.4	4.4	19.0	0.0	0.6	3.8	0.0	0.0	9.8	13.5	11.9	8.9	5.1	6.8	1.0	0.0	0.5	1.2	0.0	23.3	1.6	0.0	12.9	8.2	0.5	3.0	22.7	1.1	0.0	0.4	2.2
LMCD1		ENSG00000071282	"LIM and cysteine rich domains 1"	Q9NZU5	3	8501707-8574673	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 189.9"	"Cell type enhanced"	"Detected in many"	8	"Ductal cells: 99.6;Horizontal cells: 92.2;Smooth muscle cells: 171.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"T-reg: 17.0"	"Lineage enriched"	"Detected in many"	6	"T-cells: 17.0"	"Cell line enhanced"	"Detected in many"		"HHSteC: 30.4;HSkMC: 42.6;hTEC/SVTERT24-B: 31.3;U-2197: 27.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA024059	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cell Junctions,Cytosol"		No	No			"Nucleoplasm, Cytosol"	"Plasma membrane, Cell Junctions"	"HPA024059: AB_1852950"	"unprognostic (2.46e-1)"	"unprognostic (1.79e-1)"	"unprognostic (5.13e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.96e-1)"	"unprognostic (8.21e-3)"	"unprognostic (4.29e-1)"	"unprognostic (2.54e-2)"	"prognostic unfavorable (8.66e-5)"	"unprognostic (3.80e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.01e-3)"	"unprognostic (3.68e-3)"	38.6	3.3	1.6	10.1	1.8	0.0	36.4	3.9	1.9	11.7	4.4	3.8	5.2	1.9	22.3	20.8	8.3	11.9	15.4	15.9	2.3	1.7	5.5	2.2	25.9	3.8	2.4	1.7	17.9	8.5	5.8	2.0	14.1	4.5	16.1	1.6	4.6	19.2	7.0	189.9	5.7	3.3	72.9	3.7	14.3	10.6	9.3	1.3	0.8	4.6	34.3	7.1	29.4	15.7	1.8	2.7	0.0	0.3	0.0	17.0	0.2	2.9	16.9	2.8	2.1	21.1	11.9	2.9	12.4	6.4	6.8	16.9	12.5	3.8	0.0	1.4	14.3	2.9	0.2	1.6	3.2	2.8	5.1	1.1	3.7	1.1	2.4	30.4	0.0	0.3	42.6	0.0	31.3	0.2	4.0	3.3	0.0	0.0	0.0	8.8	2.1	0.0	0.0	5.5	3.8	0.7	0.0	9.4	0.0	6.3	1.1	0.1	7.1	2.0	10.3	6.4	8.4	13.4	0.0	1.6	6.9	13.8	27.6	8.3	1.7	1.9	0.8	1.4	0.9	8.8	0.0	0.0	0.0	0.0	0.3	0.1	1.8	2.6	0.5	2.7	0.3	0.0	0.0	0.0	0.0	0.0	0.9	17.0	0.2	1.6	1.8	3.9	1.9	2.3	1.7	2.4	1.7	4.5	1.3	8.9	15.4	0.0	47.6	28.0	13.3	13.7	20.4	20.1	15.9	5.2	9.8	2.6	3.3	99.6	0.9	70.2	0.5	0.0	42.3	3.5	58.2	6.1	10.3	11.3	3.1	92.2	11.6	36.2	0.6	1.5	10.6	4.0	50.6	15.4	2.2	34.8	83.3	0.0	30.4	29.2	7.9	0.0	171.0	5.0	7.0	23.7	3.7	2.2	3.3	5.2
LMTK3	"KIAA1883, LMR3, PPP1R101, TYKLM3"	ENSG00000142235	"Lemur tyrosine kinase 3"	Q96Q04	19	48485271-48513189	"Enzymes, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 38.1"	"Cell type enhanced"	"Detected in many"	10	"Distal tubular cells: 21.6;Ductal cells: 19.4;Horizontal cells: 17.5;Urothelial cells: 44.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HMC-1: 8.6;SK-BR-3: 10.2;U-266/70: 9.5;U-266/84: 7.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040203, HPA077070"	Enhanced	Supported	Uncertain	"Nucleoplasm,Cell Junctions"		NA	NA			Nucleoplasm	"Cell Junctions"	"HPA040203: AB_10671690, HPA077070: AB_2732330"	"unprognostic (2.41e-1)"	"unprognostic (1.48e-1)"	"unprognostic (5.37e-2)"	"unprognostic (5.45e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.71e-2)"	"unprognostic (5.67e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.51e-3)"	"unprognostic (5.71e-2)"	"unprognostic (1.47e-1)"	"prognostic favorable (3.18e-8)"	"unprognostic (1.38e-1)"	"unprognostic (3.22e-2)"	"unprognostic (3.24e-1)"	"unprognostic (6.11e-2)"	1.3	4.4	19.8	2.3	28.6	2.0	2.0	20.0	38.1	2.0	1.5	6.0	0.2	6.2	1.4	1.5	2.3	1.6	1.9	1.7	17.2	11.1	2.5	1.3	3.2	2.2	6.5	23.8	1.3	2.1	8.5	6.1	2.1	12.5	3.5	1.2	1.6	5.2	3.1	1.2	2.4	4.0	1.2	6.6	1.8	2.9	1.5	10.3	0.0	2.3	0.0	2.2	1.6	1.2	0.0	0.0	0.0	0.2	0.0	0.4	0.1	4.6	3.1	0.4	0.0	0.0	0.0	4.5	0.0	0.3	0.0	0.1	2.2	3.7	1.7	1.3	0.0	1.2	2.2	0.3	1.6	0.0	0.0	1.2	0.2	0.3	0.7	0.0	0.0	8.6	0.2	0.9	0.0	0.0	2.0	0.1	2.8	1.4	2.9	0.0	3.1	0.6	0.8	1.1	2.4	0.9	3.9	0.0	1.3	1.1	0.8	0.7	2.9	0.1	10.2	0.0	0.6	3.9	0.2	0.1	0.0	0.8	0.1	0.0	9.5	7.7	0.4	0.2	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	19.8	28.6	20.0	38.1	17.2	11.1	6.5	23.8	12.5	10.3	3.0	1.7	0.8	9.2	0.5	16.4	2.2	2.5	4.0	4.5	7.0	0.0	4.3	21.6	19.4	0.1	0.0	0.7	0.0	0.4	2.5	0.9	15.7	0.0	0.0	1.0	17.5	0.0	1.3	0.3	0.0	0.6	0.3	3.3	0.0	1.0	7.3	10.7	0.0	0.0	0.6	1.9	0.0	0.7	2.4	1.3	1.6	5.7	0.0	0.6	44.3
LNX1	"LNX, MPDZ, PDZRN2"	ENSG00000072201	"Ligand of numb-protein X 1"	Q8TBB1	4	53459301-53701405	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	11	"Early spermatids: 114.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"OE19: 13.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002235, HPA071091"	Approved		Supported	"Cell Junctions,Cytosol"	"Intracellular and membrane"	NA	NA			"Cell Junctions"	Cytosol	"HPA002235: AB_1079261, HPA071091: AB_2686344"	"unprognostic (4.95e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.00e-2)"	"unprognostic (3.16e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.31e-1)"	"unprognostic (5.62e-2)"	"unprognostic (8.14e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.18e-2)"	"unprognostic (8.56e-2)"	"prognostic favorable (3.08e-7)"	"unprognostic (2.67e-1)"	"unprognostic (5.49e-2)"	"unprognostic (6.81e-2)"	"unprognostic (3.05e-2)"	16.9	2.5	11.8	1.7	24.6	0.8	13.2	4.4	33.3	5.9	7.2	1.5	11.2	8.3	4.5	3.2	21.7	5.6	4.8	6.9	6.1	5.5	10.0	3.7	2.5	1.8	3.8	11.6	2.1	12.9	10.8	5.0	21.6	4.8	5.1	5.6	2.0	22.1	10.0	5.1	10.0	8.2	2.8	1.3	0.9	8.0	4.1	2.0	0.7	15.0	5.7	7.8	5.8	7.7	1.4	1.1	1.5	1.9	3.8	1.6	0.6	1.5	0.5	1.8	0.9	3.3	6.9	8.7	1.4	0.7	0.0	0.0	2.5	7.9	1.9	1.1	3.9	0.5	1.5	0.0	0.2	0.0	0.5	4.4	2.8	1.6	1.5	1.4	2.6	0.8	5.1	0.2	0.4	0.0	2.1	2.7	0.9	1.6	0.9	6.2	4.4	2.2	1.7	4.5	13.4	0.9	1.4	0.7	0.8	6.0	8.3	2.2	2.4	0.7	9.2	1.0	9.8	4.9	1.3	7.6	9.9	2.9	3.2	1.7	3.7	0.5	1.3	9.1	2.2	1.7	1.5	0.5	0.3	1.0	0.5	1.5	1.4	1.5	1.5	0.8	0.9	1.6	1.2	0.4	3.8	1.9	1.1	1.3	0.6	11.8	24.6	4.4	33.3	6.1	5.5	3.8	11.6	4.8	2.0	0.0	3.8	0.8	15.3	7.2	5.9	1.3	7.6	17.4	7.9	7.0	5.9	25.0	16.6	10.0	114.3	7.1	13.2	0.0	10.3	17.0	4.1	9.4	2.3	4.4	2.2	39.7	13.3	2.5	0.3	33.7	4.0	0.6	5.0	0.0	12.2	2.0	9.9	21.0	8.1	2.6	5.0	0.0	1.7	0.9	1.5	10.5	12.5	0.0	12.3	13.6
LRRC34	MGC27085	ENSG00000171757	"Leucine rich repeat containing 34"	Q8IZ02	3	169793428-169812986	"Predicted intracellular proteins"	Differentiation			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 13.7;testis: 23.8"	"Cell type enhanced"	"Detected in many"	16	"Ciliated cells: 144.6;Cone photoreceptor cells: 35.3;Early spermatids: 74.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"memory B-cell: 2.2;myeloid DC: 1.4;naive B-cell: 1.5;plasmacytoid DC: 4.6"	"Group enriched"	"Detected in many"	7	"B-cells: 2.2;dendritic cells: 4.6"	"Cell line enhanced"	"Detected in many"		"HEK 293: 7.4;HEL: 9.3;HL-60: 9.8;JURKAT: 8.1;NTERA-2: 9.9"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA035747	Approved		Approved	"Cell Junctions,Microtubules,Cytokinetic bridge,Mitotic spindle"		NA	NA			"Cell Junctions, Microtubules"	"Cytokinetic bridge, Mitotic spindle"	"HPA035747: AB_10670120"	"unprognostic (1.04e-2)"	"unprognostic (5.71e-2)"	"unprognostic (5.67e-2)"	"unprognostic (5.64e-2)"	"unprognostic (9.74e-3)"	"unprognostic (5.46e-2)"	"unprognostic (9.74e-2)"	"unprognostic (8.24e-2)"	"unprognostic (6.39e-3)"	"unprognostic (2.57e-1)"	"unprognostic (6.05e-2)"	"unprognostic (1.23e-1)"	"unprognostic (8.39e-2)"	"unprognostic (1.16e-2)"	"unprognostic (3.48e-1)"	"unprognostic (3.37e-1)"	"unprognostic (2.79e-1)"	2.8	1.1	4.8	1.2	9.6	2.7	2.3	1.1	4.0	2.3	0.9	4.2	1.4	1.0	1.9	3.9	1.0	13.7	1.1	2.0	4.1	3.8	2.1	0.9	3.4	1.9	3.5	5.6	2.2	0.5	1.0	7.9	0.9	11.8	2.0	0.7	2.6	1.3	2.4	0.9	1.0	1.1	2.0	3.6	1.8	1.1	23.8	4.8	1.7	2.7	0.5	1.2	1.0	0.9	2.2	4.6	0.1	0.3	0.0	0.5	0.4	2.7	0.4	0.8	0.0	1.1	4.1	0.0	1.2	2.4	2.8	2.7	0.1	0.0	1.6	0.0	0.7	3.8	0.0	2.5	0.0	1.0	0.4	7.4	9.3	0.1	0.0	0.7	9.8	2.4	1.4	0.4	1.1	0.0	0.1	1.7	8.1	0.2	0.0	1.0	0.0	0.9	1.9	9.9	0.0	3.1	4.9	0.0	0.5	2.3	0.2	4.9	3.8	0.8	0.1	0.0	0.3	0.0	4.7	0.4	0.6	0.0	0.3	0.0	0.0	0.0	2.3	4.5	0.1	2.6	0.0	0.2	0.0	0.0	0.3	0.2	2.2	0.0	0.0	1.4	1.5	0.0	0.0	0.1	0.0	0.0	4.6	0.5	0.4	4.8	9.6	1.1	4.0	4.1	3.8	3.5	5.6	11.8	4.8	3.0	1.6	0.0	0.9	0.3	5.3	2.8	0.0	144.6	15.9	5.2	35.3	0.2	1.7	0.5	74.2	1.5	0.0	0.0	0.2	0.2	3.2	0.7	1.1	0.0	2.2	11.1	4.1	11.1	0.3	23.5	9.8	1.7	0.0	6.4	0.5	6.0	0.2	0.0	9.9	3.2	18.6	0.0	1.7	29.6	8.6	0.3	0.5	0.7	0.1	0.3
LRRC9	FLJ46156	ENSG00000131951	"Leucine rich repeat containing 9"	Q6ZRR7	14	59919713-60063559	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 16.4;pituitary gland: 13.9;testis: 14.3"	"Group enriched"	"Detected in some"	9	"Early spermatids: 98.5;Late spermatids: 64.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"basal ganglia: 7.3;pons and medulla: 16.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.3;CACO-2: 2.0;GAMG: 1.1;NTERA-2: 4.2;SCLC-21H: 1.9;SH-SY5Y: 1.3;SuSa: 1.7;U-2 OS: 1.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA040965, HPA041381, HPA077675"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cell Junctions"		NA	NA			"Plasma membrane, Cell Junctions"	"Nucleoplasm, Nuclear bodies"	"HPA040965: AB_2677225, HPA041381: AB_2677444, HPA077675: "	"unprognostic (1.01e-2)"	"unprognostic (2.00e-1)"	"unprognostic (4.45e-2)"	"unprognostic (2.12e-3)"	"unprognostic (2.80e-1)"	"unprognostic (2.95e-3)"	"unprognostic (1.93e-1)"	"unprognostic (3.11e-2)"	"unprognostic (1.91e-2)"	"unprognostic (4.82e-2)"	"unprognostic (3.45e-3)"	"unprognostic (6.06e-2)"	"unprognostic (2.62e-3)"	"unprognostic (8.54e-3)"	"unprognostic (8.30e-2)"	"unprognostic (1.67e-2)"	"unprognostic (2.29e-2)"	0.6	0.4	0.6	0.1	7.3	0.2	0.1	0.2	1.1	0.3	0.1	3.2	0.0	0.1	0.2	1.4	0.1	3.4	0.1	0.1	1.4	1.2	0.2	0.2	0.1	0.1	0.5	1.3	1.0	0.2	4.8	13.9	0.1	16.4	1.3	0.1	0.0	0.1	0.2	0.1	0.1	0.7	0.1	0.9	0.1	0.2	14.3	2.2	0.0	0.1	0.0	0.1	0.2	0.1	0.6	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	4.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.9	1.3	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.4	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	7.3	0.2	1.1	1.4	1.2	0.5	1.3	16.4	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	98.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.6	0.0	0.0	0.0	64.1	0.9	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.7	0.0	0.1	0.0	0.0	8.8	0.9	0.0	0.1	0.0	0.0	0.0
MACF1	"ABP620, ACF7, FLJ45612, FLJ46776, KIAA0465, KIAA1251, MACF"	ENSG00000127603	"Microtubule-actin crosslinking factor 1"	Q9UPN3	1	39081316-39487177	"Predicted intracellular proteins, Predicted membrane proteins"	"Wnt signaling pathway"	Actin-binding	"Disease mutation, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Cone photoreceptor cells: 734.3;Rod photoreceptor cells: 425.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013713, HPA068064, HPA068103"	Approved		Supported	"Plasma membrane,Cell Junctions,Actin filaments"		NA	NA			"Plasma membrane, Cell Junctions, Actin filaments"		"HPA013713: AB_10600821, HPA068064: AB_2685946, HPA068103: AB_2685953"	"unprognostic (2.71e-1)"	"unprognostic (3.14e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.02e-2)"	"unprognostic (9.00e-2)"	"unprognostic (6.19e-3)"	"unprognostic (1.32e-1)"	"unprognostic (7.40e-3)"	"unprognostic (5.45e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.98e-1)"	"prognostic favorable (2.77e-5)"	"unprognostic (1.07e-1)"	"unprognostic (1.81e-1)"	"unprognostic (8.57e-2)"	"unprognostic (4.22e-2)"	24.1	22.6	41.4	21.4	44.0	21.2	25.2	62.6	54.0	37.1	42.2	35.3	22.7	11.9	66.5	33.6	20.3	28.0	31.5	39.0	35.9	32.7	27.2	24.4	53.5	21.2	41.1	28.6	41.5	25.0	46.2	37.1	22.8	40.5	26.3	18.2	23.3	26.0	32.0	40.8	59.2	18.4	56.7	37.0	29.7	22.9	17.7	39.0	13.3	34.5	17.9	16.0	28.0	34.8	4.8	2.6	4.9	2.8	6.4	13.7	2.0	12.6	15.4	19.0	8.6	16.8	17.4	8.2	17.4	23.6	10.8	10.8	9.2	15.3	6.6	18.4	24.7	18.1	8.4	3.4	12.5	15.1	12.7	9.4	11.7	11.5	14.9	19.2	10.8	5.0	11.8	12.9	29.9	16.1	24.8	38.2	23.1	17.2	9.0	42.4	4.2	6.1	14.1	26.2	5.3	9.1	11.5	29.1	1.2	56.4	13.7	10.5	10.7	6.9	4.7	16.6	23.9	2.0	10.7	43.0	17.7	14.2	8.4	30.4	5.4	5.2	7.9	29.0	10.3	16.2	4.9	1.5	3.8	13.7	2.7	6.7	2.3	6.8	8.6	1.9	4.8	5.4	6.8	1.3	6.4	2.8	2.6	2.9	2.0	41.4	44.0	62.6	54.0	35.9	32.7	41.1	28.6	40.5	39.0	140.0	115.4	34.3	51.5	137.1	376.9	222.7	76.5	60.2	85.3	76.8	734.3	41.1	0.0	105.2	8.2	146.8	21.9	0.0	98.3	49.9	58.2	60.0	73.1	41.2	44.1	111.2	34.7	127.1	56.4	6.8	40.6	41.9	67.4	45.1	23.8	104.0	136.1	16.9	105.7	7.9	425.5	103.5	69.7	34.4	25.0	167.4	58.5	78.3	17.8	61.3
MAGI1	"AIP3, BAIAP1, BAP1, MAGI-1, TNRC19, WWP3"	ENSG00000151276	"Membrane associated guanylate kinase, WW and PDZ domain containing 1"	Q96QZ7	3	65353525-66038834	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Horizontal cells: 219.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEL: 24.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031851, HPA031852, HPA031853, HPA077002"	Supported		Supported	"Nucleoplasm,Cell Junctions"		NA	NA			"Cell Junctions"	Nucleoplasm	"HPA031851: AB_10599289, HPA031852: AB_2674074, HPA031853: AB_10602095, HPA077002: "	"unprognostic (5.00e-2)"	"unprognostic (9.84e-2)"	"unprognostic (6.00e-3)"	"unprognostic (1.73e-3)"	"unprognostic (1.64e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.46e-3)"	"unprognostic (9.46e-3)"	"unprognostic (8.59e-2)"	"unprognostic (2.19e-1)"	"unprognostic (6.58e-2)"	"unprognostic (2.05e-3)"	"prognostic favorable (4.55e-8)"	"unprognostic (3.51e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.68e-2)"	"unprognostic (8.03e-2)"	18.0	6.0	10.1	6.4	9.8	1.0	16.5	38.6	16.8	6.9	11.2	10.1	25.7	10.7	11.6	7.6	9.4	12.6	19.7	11.1	9.4	11.8	14.3	17.6	13.3	2.9	8.8	10.4	4.3	16.7	18.7	13.1	11.1	9.6	9.2	9.5	7.7	17.4	37.9	7.7	13.0	11.6	7.9	8.3	13.9	19.8	10.7	7.7	0.6	23.2	5.8	4.4	6.9	13.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	2.8	1.5	8.8	0.9	1.8	1.3	3.9	4.9	4.2	1.9	2.9	10.5	2.5	0.0	0.7	5.8	1.5	0.9	2.4	1.7	3.0	0.0	1.4	24.8	3.0	7.0	1.1	0.0	0.8	1.9	1.5	6.4	1.3	4.9	4.2	3.3	10.5	0.0	1.9	2.1	0.0	0.0	11.8	8.4	1.5	0.0	2.5	0.6	2.3	9.4	2.8	7.7	1.9	2.3	0.0	6.0	4.5	0.0	1.1	6.0	4.4	1.5	2.0	0.0	0.0	0.0	3.5	0.0	0.7	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.1	9.8	38.6	15.5	9.4	11.8	8.8	10.4	9.6	7.7	71.5	24.3	2.2	16.9	19.8	93.8	31.3	91.7	37.5	30.7	22.7	70.7	11.8	3.3	33.9	112.5	42.5	30.4	0.0	28.1	2.1	7.3	19.7	1.1	50.5	3.7	219.3	35.1	72.4	7.8	11.8	6.1	1.9	5.0	1.0	37.8	13.0	33.5	25.1	8.1	12.4	23.8	32.3	13.0	16.9	9.7	16.4	4.2	1.0	22.1	10.8
MAGI3	MAGI-3	ENSG00000081026	"Membrane associated guanylate kinase, WW and PDZ domain containing 3"	Q5TCQ9	1	113390749-113685923	"Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 50.7"	"Cell type enhanced"	"Detected in many"	11	"Alveolar cells type 1: 247.1;Bipolar cells: 91.7;Club cells: 97.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008444			Supported	"Cell Junctions"		NA	NA			"Cell Junctions"		"HPA008444: AB_2668069"	"unprognostic (4.07e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.54e-3)"	"unprognostic (2.32e-2)"	"unprognostic (2.31e-2)"	"unprognostic (5.21e-3)"	"unprognostic (2.23e-1)"	"unprognostic (7.06e-2)"	"unprognostic (2.80e-2)"	"prognostic favorable (4.29e-4)"	"unprognostic (1.09e-2)"	"unprognostic (1.03e-1)"	"prognostic favorable (2.60e-8)"	"unprognostic (1.71e-2)"	"unprognostic (7.85e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.50e-2)"	4.4	4.3	9.5	9.0	6.2	0.4	11.6	11.3	11.9	4.9	15.3	1.3	1.7	7.4	6.2	8.7	10.0	4.8	6.3	4.2	6.6	9.5	9.6	8.0	50.7	2.6	8.0	7.9	8.0	13.3	7.1	8.2	9.2	5.2	5.5	10.5	5.9	7.8	3.6	2.4	3.1	25.1	5.9	5.4	3.6	14.6	4.9	3.9	3.9	16.5	9.1	9.0	4.5	9.8	0.1	0.7	1.1	0.2	0.8	1.8	0.2	8.1	9.4	9.0	4.0	4.2	6.1	2.7	5.8	2.7	4.4	5.0	8.3	2.4	0.3	4.3	5.1	3.7	3.6	8.1	4.3	5.5	8.8	8.7	3.5	8.2	3.8	1.0	2.8	5.3	3.2	2.2	4.6	10.3	5.3	6.0	3.7	4.4	7.8	5.9	5.3	4.6	0.7	3.3	13.8	5.9	6.6	14.4	1.0	5.2	3.6	8.3	8.6	6.7	11.3	2.0	11.9	5.8	1.5	10.6	7.3	9.2	6.6	7.9	3.1	2.5	0.0	3.8	1.4	5.8	0.4	0.2	0.0	0.5	0.0	0.5	0.0	1.3	0.2	0.7	0.1	1.8	0.1	1.1	0.8	0.2	0.2	0.0	0.2	9.5	6.2	11.3	11.9	6.6	9.5	8.0	7.9	5.2	3.9	247.1	72.0	0.0	7.8	9.6	91.7	7.5	15.3	21.4	97.8	12.2	47.1	12.8	6.6	8.8	20.1	12.0	41.6	0.0	9.3	1.7	11.3	11.7	5.8	12.2	3.3	38.1	13.2	9.8	1.8	21.6	9.5	2.8	11.8	0.0	19.0	36.6	11.9	26.6	10.6	4.3	46.3	12.9	6.9	15.9	10.1	6.6	4.6	1.8	25.9	8.9
MAP1S	"BPY2IP1, C19orf5, FLJ10669, MAP8, VCY2IP1"	ENSG00000130479	"Microtubule associated protein 1S"	Q66K74	19	17719242-17734516	"Predicted intracellular proteins"	Apoptosis	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	12	"Early spermatids: 78.9;Late spermatids: 220.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050934, HPA054637"	Approved		Supported	"Nucleoplasm,Nucleoli,Cell Junctions,Cytosol"		NA	NA			Cytosol	"Nucleoplasm, Nucleoli, Cell Junctions"	"HPA050934: AB_2681281, HPA054637: AB_2682552"	"unprognostic (8.47e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.72e-1)"	"unprognostic (3.70e-1)"	"unprognostic (8.23e-2)"	"prognostic unfavorable (5.29e-4)"	"unprognostic (2.53e-1)"	"unprognostic (6.17e-2)"	"unprognostic (4.39e-2)"	"prognostic favorable (2.65e-4)"	"unprognostic (6.33e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.09e-1)"	"unprognostic (8.65e-2)"	14.7	7.1	18.9	14.0	27.0	14.9	13.4	15.4	42.1	12.3	11.5	15.5	4.9	12.5	13.4	9.8	11.6	11.1	13.1	9.3	17.2	12.9	8.3	6.9	17.6	13.2	11.4	18.1	16.8	13.8	8.9	11.9	16.1	14.3	10.0	4.7	8.4	12.6	12.1	21.2	6.0	10.5	8.8	10.3	14.2	16.0	34.1	13.1	13.2	8.5	4.3	8.6	12.6	7.6	13.1	20.7	24.9	17.7	9.4	13.3	12.5	13.0	20.5	6.2	8.1	5.2	7.8	15.7	8.6	4.4	5.5	6.2	27.9	7.5	7.7	15.9	5.5	6.4	7.2	5.0	7.0	2.3	9.6	28.7	6.9	18.2	18.2	11.1	7.6	10.0	8.5	4.0	8.3	5.2	3.9	10.9	5.9	10.7	4.4	2.9	18.3	9.3	19.3	13.6	8.2	24.0	15.1	4.8	7.8	7.1	20.0	11.0	12.1	4.8	7.4	8.6	4.7	4.7	8.4	16.8	10.1	8.7	19.5	12.9	8.3	10.0	7.8	11.6	12.2	11.8	13.3	17.0	19.2	13.3	17.7	12.8	13.1	10.4	13.1	20.7	13.1	8.8	11.7	24.9	9.4	13.1	16.7	9.5	12.5	18.9	27.0	15.4	42.1	17.2	12.9	11.4	18.1	14.3	13.1	3.0	6.9	9.5	12.3	9.2	10.0	4.8	10.2	0.0	4.5	3.5	7.9	17.5	3.3	18.4	78.9	12.8	21.7	0.0	14.9	13.7	10.1	12.1	10.3	3.9	23.4	38.1	19.5	25.8	19.1	220.0	20.8	18.7	1.7	16.2	12.9	7.8	17.9	14.0	29.7	5.2	5.9	12.9	11.4	16.3	26.4	2.9	28.3	10.9	13.1	12.3
MAP2K4	"JNKK1, MEK4, MKK4, PRKMK4, SERK1"	ENSG00000065559	"Mitogen-activated protein kinase kinase 4"	P45985	17	12020824-12143830	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Stress response"	"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 13.2"	"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	5	"SuSa: 67.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007751, HPA060074"	Enhanced		Approved	"Nucleoplasm,Cell Junctions"		NA	NA			Nucleoplasm	"Cell Junctions"	"CAB007751: , HPA060074: AB_2684197"	"unprognostic (1.55e-1)"	"unprognostic (1.85e-1)"	"unprognostic (4.47e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.70e-1)"	"unprognostic (2.89e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.93e-3)"	"unprognostic (2.53e-1)"	"unprognostic (2.76e-3)"	"unprognostic (4.82e-2)"	"unprognostic (5.32e-3)"	"unprognostic (3.13e-1)"	"unprognostic (2.30e-1)"	"unprognostic (7.00e-2)"	"unprognostic (1.79e-1)"	10.7	13.2	23.7	9.4	21.0	3.1	14.4	25.0	42.7	12.5	11.5	7.9	8.5	9.6	12.1	17.8	18.5	11.5	10.7	14.9	31.7	29.3	15.8	20.6	11.4	14.6	24.5	27.1	13.0	11.1	19.6	16.7	15.1	23.4	14.5	13.1	6.5	9.8	13.2	20.6	14.4	9.9	13.5	16.3	10.7	10.7	10.3	9.8	10.3	16.5	11.6	13.4	11.1	11.2	2.8	1.8	13.2	4.3	3.5	3.3	2.3	10.6	9.2	12.1	6.2	6.7	8.7	7.7	7.3	9.6	8.3	8.0	5.4	3.7	4.4	5.9	11.3	5.4	7.1	10.5	10.1	12.5	7.8	12.3	4.9	5.4	10.2	7.9	4.7	7.4	7.2	10.0	9.7	10.2	8.6	7.5	6.3	5.2	2.6	10.4	3.9	5.6	4.4	7.0	11.5	4.5	7.0	13.6	3.0	11.4	6.9	2.4	7.2	8.4	4.5	7.0	67.1	5.7	3.4	6.8	4.1	6.3	5.6	8.6	5.1	5.7	3.5	7.7	3.7	5.9	0.6	2.7	2.0	3.0	1.5	2.7	2.8	2.4	2.4	1.8	2.7	2.0	3.3	13.2	3.5	4.3	1.8	2.6	2.3	23.7	21.0	25.0	42.7	31.7	29.3	24.5	27.1	23.4	9.8	8.9	14.2	10.8	26.3	36.9	14.2	21.2	10.2	2.7	21.6	14.0	7.9	10.7	21.6	11.2	6.3	8.7	11.8	0.0	12.4	8.6	12.9	32.3	1.1	16.3	10.2	17.5	11.5	10.4	17.7	5.8	10.9	11.7	11.8	19.0	13.8	10.3	14.7	11.5	12.0	17.7	9.7	12.9	12.0	7.9	8.1	34.4	21.2	9.5	10.6	40.3
MAPK15	"ERK7, ERK8"	ENSG00000181085	"Mitogen-activated protein kinase 15"	Q8TD08	8	143716259-143722458	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 26.9;epididymis: 27.6;fallopian tube: 29.5"	"Cell type enriched"	"Detected in some"	6	"Ciliated cells: 85.6"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"pons and medulla: 26.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 7.2;HaCaT: 5.4;HeLa: 14.3;MCF7: 13.9;T-47d: 12.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA002704			Approved	"Nucleoplasm,Cell Junctions,Cytosol"		NA	NA			"Nucleoplasm, Cytosol"	"Cell Junctions"	"HPA002704: AB_1079307"	"unprognostic (9.11e-2)"	"unprognostic (1.38e-1)"	"unprognostic (8.04e-3)"	"unprognostic (2.94e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.09e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.88e-1)"	"unprognostic (9.51e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.54e-2)"	"unprognostic (5.78e-1)"	"unprognostic (6.35e-2)"	"unprognostic (1.62e-2)"	0.6	0.1	3.6	0.3	8.1	0.1	1.1	0.2	2.1	4.5	0.4	8.7	5.2	0.5	2.2	27.6	1.3	29.5	0.4	1.1	5.4	4.6	3.9	0.2	7.4	0.5	0.2	1.5	4.7	2.0	9.1	4.2	0.6	26.9	0.9	0.4	1.6	3.0	2.4	0.2	4.9	0.7	0.5	0.4	0.5	0.9	7.3	2.4	0.1	8.4	0.5	0.4	0.5	0.9	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	1.7	0.0	0.0	0.0	0.6	1.3	0.0	0.0	0.0	0.2	7.2	0.0	1.3	0.0	0.0	5.4	0.1	0.2	0.0	1.1	1.6	0.0	14.3	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.3	2.7	0.0	0.0	13.9	0.0	0.0	2.0	1.2	1.1	0.0	3.0	0.4	0.9	1.3	4.0	4.0	0.0	2.8	0.0	0.2	12.5	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	8.1	0.2	2.1	5.4	4.6	0.2	1.5	26.9	2.4	0.0	8.3	0.0	0.2	0.3	0.0	0.8	0.0	85.6	13.6	0.0	0.0	0.0	0.0	0.6	12.6	0.0	0.0	0.0	0.0	0.6	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.5	0.0	0.5	0.0	0.0	0.8	0.0	0.0	0.0	2.7	0.7	0.3	0.1	0.0	0.1	0.0
MARVELD2	"DFNB49, FLJ30532, MRVLDC2, TRIC"	ENSG00000152939	"MARVEL domain containing 2"	Q8N4S9	5	69415065-69444330	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Hearing		"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 18.4;CAPAN-2: 15.9;HaCaT: 12.3;hTCEpi: 10.3;RT4: 14.2;SCLC-21H: 16.7;T-47d: 12.4"	"Region enriched"	"Detected in single"	8	"cerebellum: 8.8"	"Low region specificity"	"Detected in all"			"HPA018119, HPA061726"	Uncertain		Supported	"Cell Junctions"		NA	NA			"Cell Junctions"		"HPA018119: AB_2669771, HPA061726: AB_2684595"	"unprognostic (4.11e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.22e-2)"	"unprognostic (2.44e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.49e-1)"	"unprognostic (8.84e-2)"	"unprognostic (2.43e-1)"	"unprognostic (3.47e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.75e-1)"	"prognostic favorable (2.84e-13)"	"unprognostic (1.78e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.82e-1)"	0.6	0.7	1.1	2.3	1.4	0.2	4.5	0.7	1.3	2.6	13.2	1.6	9.5	9.4	1.6	6.4	9.1	4.4	9.2	0.9	1.4	1.2	12.2	24.2	11.2	0.4	1.7	0.8	1.0	18.9	3.9	8.0	9.9	2.1	5.0	7.3	5.2	10.9	7.4	0.4	5.4	21.8	1.4	1.3	0.6	8.9	2.7	0.7	1.1	25.7	6.4	7.3	4.7	4.1	1.4	0.4	1.5	0.8	1.1	2.3	1.0	6.6	2.5	0.0	0.0	0.0	0.0	18.4	0.1	0.0	0.1	0.4	8.6	15.9	0.0	1.8	1.1	0.0	12.3	0.0	9.2	0.3	0.1	3.5	0.0	0.8	4.6	1.1	0.0	0.0	0.3	10.3	0.1	1.4	0.4	0.7	0.1	0.0	0.1	0.0	6.6	0.0	0.0	1.3	3.9	0.2	0.0	0.0	0.4	6.9	14.2	16.7	0.0	1.7	1.7	0.2	3.2	12.4	0.0	1.0	0.0	0.0	0.0	0.0	0.1	2.2	0.0	0.0	0.1	0.0	1.5	0.8	0.2	0.4	0.2	1.1	1.2	2.3	0.2	0.3	1.4	0.7	0.5	0.9	1.1	0.1	0.4	0.1	1.0	1.1	1.4	0.7	1.3	1.4	1.2	1.7	0.8	2.1	0.7	20.8	21.6	0.8	16.8	4.4	0.1	2.5	25.5	30.8	20.5	15.7	2.0	19.2	14.9	19.8	4.6	3.1	25.7	0.0	22.9	7.1	0.8	23.1	1.1	33.9	1.6	0.0	16.1	3.7	0.6	1.6	0.0	0.8	1.7	13.6	23.4	0.8	23.3	31.9	0.0	5.3	0.2	0.0	1.0	3.8	1.9	5.6	10.1	0.0	24.5	33.8
MCMBP	"C10orf119, FLJ13081, MCM-BP"	ENSG00000197771	"Minichromosome maintenance complex binding protein"	Q9BTE3	10	119829404-119892556	"Predicted intracellular proteins"	"Cell cycle, Cell division, DNA replication, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013792, HPA038481"	Uncertain		Enhanced	"Nucleoplasm,Cell Junctions,Cytosol"		NA	NA			Nucleoplasm	"Cell Junctions, Cytosol"	"CAB013792: , HPA038481: AB_10794620"	"unprognostic (1.26e-1)"	"unprognostic (7.92e-2)"	"unprognostic (4.62e-2)"	"unprognostic (2.31e-2)"	"unprognostic (1.72e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.31e-3)"	"unprognostic (5.61e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (2.20e-4)"	"unprognostic (7.32e-2)"	"prognostic unfavorable (6.18e-4)"	"unprognostic (2.23e-2)"	"unprognostic (8.24e-2)"	"unprognostic (2.51e-1)"	"unprognostic (4.87e-2)"	33.6	15.3	11.7	23.2	13.8	14.6	35.5	17.2	13.8	27.0	26.3	16.9	11.4	15.5	28.0	14.9	26.4	23.0	18.7	26.3	12.0	10.2	18.7	23.7	28.5	38.6	17.4	8.5	29.2	18.2	23.2	17.6	35.4	14.2	22.5	21.4	15.7	21.0	17.4	30.1	23.8	20.7	26.0	16.8	26.0	20.7	15.4	15.5	38.0	24.5	28.2	24.7	32.5	28.6	4.5	6.9	12.1	9.7	4.1	5.1	2.4	31.0	22.1	31.0	21.4	15.7	19.3	18.2	28.8	31.6	36.7	38.0	28.8	25.5	36.2	13.3	23.0	16.7	29.0	37.0	29.0	43.0	26.5	27.3	18.6	17.6	22.0	24.4	34.3	45.0	15.8	16.4	33.2	43.8	20.2	25.1	23.7	17.1	27.3	24.0	23.0	43.0	20.7	15.6	23.1	16.0	27.2	60.0	18.4	15.7	21.4	13.4	17.2	21.0	17.5	24.0	24.3	11.9	24.5	19.4	18.1	17.8	18.3	34.3	19.7	21.9	40.1	21.6	23.1	11.1	12.1	5.3	3.6	4.2	9.7	5.1	4.5	3.9	4.4	6.9	1.8	4.2	3.8	6.4	4.1	6.1	3.5	3.9	2.4	11.7	13.8	17.2	13.8	12.0	10.2	17.4	8.5	14.2	15.5	14.9	13.9	20.1	27.2	38.0	10.0	16.2	12.7	10.7	18.2	19.2	3.9	30.7	11.6	9.6	3.3	32.4	15.1	0.0	11.5	42.5	26.3	18.7	17.4	23.1	33.4	30.2	10.4	30.1	35.7	4.9	27.9	31.3	21.9	8.2	18.5	16.9	12.8	7.0	21.2	17.5	17.1	19.4	29.9	27.6	61.5	37.4	33.2	27.4	26.9	24.5
MEF2B	RSRFR2	ENSG00000213999	"Myocyte enhancer factor 2B"	Q02080	19	19145568-19170289	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	22	"lymphoid tissue: 81.2"	"Cell type enriched"	"Detected in single"	16	"Sertoli cells: 6.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.1"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	12	"Daudi: 50.9;U-266/70: 51.2;U-698: 67.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA004734	Supported		Approved	"Nucleoplasm,Cell Junctions,Cytosol"		NA	NA			"Nucleoplasm, Cytosol"	"Cell Junctions"	"HPA004734: AB_10963939"	"unprognostic (7.31e-3)"	"unprognostic (4.06e-2)"	"unprognostic (9.44e-5)"	"unprognostic (5.07e-2)"	"unprognostic (2.01e-1)"	"unprognostic (7.19e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.98e-2)"	"unprognostic (8.66e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.56e-11)"	"unprognostic (2.40e-1)"	"unprognostic (1.92e-1)"	"unprognostic (3.68e-1)"	"unprognostic (8.98e-3)"	2.0	1.0	0.8	81.2	1.2	1.4	1.9	0.6	1.4	2.7	3.0	0.9	0.6	1.5	2.2	1.1	1.5	2.3	2.2	1.9	1.0	0.6	1.8	2.9	2.0	32.3	1.1	0.9	3.7	0.8	0.8	2.1	0.8	1.0	3.7	1.0	1.8	3.5	1.1	1.4	2.3	3.1	1.1	1.2	6.7	1.7	1.7	0.8	1.6	3.0	3.5	58.7	1.9	2.9	0.1	0.2	1.1	0.9	0.0	0.2	0.0	0.2	0.1	0.1	0.2	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.3	50.9	0.1	0.2	0.1	0.4	0.0	0.0	0.0	0.1	0.3	0.1	0.1	0.1	0.2	0.2	0.4	0.1	0.2	0.1	0.1	0.1	0.0	0.4	0.1	0.5	0.0	0.2	0.3	0.3	0.0	0.0	0.9	0.4	0.0	1.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.5	0.1	0.0	0.4	0.5	0.1	51.2	4.7	67.3	0.1	0.3	0.0	0.0	0.9	0.0	0.2	0.1	0.2	0.1	0.1	0.1	0.2	0.0	0.1	0.2	1.1	0.0	0.0	0.0	0.0	0.0	0.8	1.2	0.6	1.4	1.0	0.6	1.1	0.9	1.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MEIOC	"C17orf104, FLJ35848"	ENSG00000180336	"Meiosis specific with coiled-coil domain"	A2RUB1	17	44656404-44690308	"Predicted intracellular proteins"	Meiosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	24	"testis: 59.6"	"Group enriched"	"Detected in some"	5	"Early spermatids: 263.1;Late spermatids: 392.6;Spermatocytes: 236.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HAP1: 13.4;HMC-1: 20.5;NTERA-2: 7.1;SiHa: 7.5;SuSa: 10.2;THP-1: 10.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA027266	Enhanced		Uncertain	"Cell Junctions"		NA	NA			"Cell Junctions"		"HPA027266: AB_1848900"	"unprognostic (5.82e-2)"	"unprognostic (6.86e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.96e-2)"	"unprognostic (9.12e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.13e-1)"	"unprognostic (3.63e-2)"	"unprognostic (8.89e-2)"	"unprognostic (7.58e-2)"	"unprognostic (6.83e-4)"	"unprognostic (1.85e-1)"	"unprognostic (6.24e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.75e-1)"	"unprognostic (9.91e-3)"	"unprognostic (8.89e-3)"	0.2	0.2	0.4	0.2	0.8	0.6	0.2	2.5	0.9	0.2	0.2	0.2	0.2	0.1	0.2	0.3	0.2	0.0	0.2	0.3	0.7	0.6	1.4	0.3	0.2	0.3	0.4	0.2	0.2	0.2	0.0	0.4	0.2	0.3	0.2	0.0	0.2	0.2	0.2	1.5	0.7	0.2	0.2	0.3	0.2	0.1	59.6	0.2	0.2	0.3	0.2	0.3	0.2	0.2	1.8	1.9	2.2	0.8	0.8	1.0	0.1	0.2	6.2	0.9	1.0	0.2	0.0	0.5	0.8	0.0	0.5	1.7	0.4	0.2	0.7	1.5	0.3	0.2	0.2	13.4	0.0	0.2	0.6	5.4	0.5	0.8	0.3	0.0	0.5	20.5	0.0	0.0	0.8	0.0	1.4	0.0	1.3	0.4	0.6	0.1	1.2	0.4	1.2	7.1	0.2	0.6	0.3	0.7	0.4	0.0	0.2	1.5	2.0	7.5	0.2	0.1	10.2	0.9	10.2	0.2	0.4	0.2	1.5	0.7	0.5	0.8	0.3	0.5	0.7	1.2	1.9	0.8	0.7	0.9	0.5	0.5	0.9	0.8	0.5	0.2	1.8	1.0	0.9	2.2	0.8	0.6	1.9	0.5	0.1	0.4	0.8	2.5	0.9	0.7	0.6	0.4	0.2	0.3	0.2	0.0	0.6	0.0	1.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	2.0	0.2	3.3	0.2	263.1	0.0	0.0	0.0	0.2	0.4	0.0	0.4	0.0	0.5	0.3	0.0	0.0	0.0	1.0	392.6	4.4	0.5	0.0	0.0	0.0	1.0	0.3	0.0	3.5	1.1	2.2	19.4	0.0	236.7	55.3	0.0	0.2	0.0	0.0	0.5
MEPCE	"BCDIN3, FLJ20257, MePCE"	ENSG00000146834	"Methylphosphate capping enzyme"	Q7L2J0	7	100428790-100434126	"Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026384, HPA051587"	Supported		Approved	"Nucleoplasm,Cell Junctions"		NA	NA			Nucleoplasm	"Cell Junctions"	"CAB026384: , HPA051587: AB_2681544"	"unprognostic (8.59e-2)"	"unprognostic (1.23e-2)"	"unprognostic (3.77e-2)"	"prognostic unfavorable (6.01e-6)"	"unprognostic (1.09e-1)"	"unprognostic (1.53e-2)"	"unprognostic (3.83e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.69e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.65e-3)"	"unprognostic (1.09e-1)"	"prognostic favorable (1.01e-10)"	"unprognostic (9.66e-2)"	"unprognostic (9.31e-2)"	"unprognostic (4.57e-1)"	"unprognostic (9.50e-3)"	17.5	24.1	17.7	13.9	22.8	18.5	15.0	24.1	24.1	15.7	14.0	16.7	26.9	14.1	18.8	22.5	16.1	18.6	22.9	12.4	20.1	13.7	18.7	20.8	13.5	19.7	19.7	16.4	29.2	18.3	32.5	15.0	19.0	19.3	15.8	10.2	17.2	18.5	24.2	21.4	26.1	15.8	15.7	17.7	34.9	14.4	63.1	20.4	21.7	25.7	17.1	17.9	16.3	20.4	8.4	8.7	9.3	3.6	7.3	9.1	10.6	13.5	17.6	13.1	14.0	12.7	12.8	9.7	15.2	22.3	16.5	12.8	14.3	20.0	28.0	25.4	9.5	13.0	12.6	14.2	11.5	10.9	12.5	16.2	14.4	13.6	10.8	10.7	18.4	17.9	13.2	13.8	18.8	23.9	9.0	13.7	9.0	28.5	20.8	15.7	50.5	21.0	42.0	24.1	11.4	19.6	17.0	10.5	25.4	11.0	8.4	19.7	17.0	23.8	46.7	15.9	6.8	11.9	16.9	11.7	27.8	21.6	18.7	20.0	13.8	13.1	31.2	15.6	23.1	24.3	2.5	3.6	4.8	5.6	3.2	6.5	8.0	6.4	6.0	4.4	8.4	9.1	8.0	9.3	7.3	2.6	8.7	5.7	10.6	17.7	22.8	24.1	24.1	20.1	13.7	19.7	16.4	19.3	20.4	8.9	20.5	18.0	14.7	26.9	8.9	19.8	17.8	9.4	7.9	21.0	7.9	13.3	13.3	9.0	21.7	18.0	26.9	0.0	10.4	7.0	12.5	12.5	17.4	17.9	10.9	11.1	10.3	33.2	27.3	44.1	16.1	14.2	8.5	18.0	18.8	16.7	8.8	24.6	14.5	11.7	9.1	6.5	12.8	34.9	13.7	22.0	17.7	15.8	15.5	8.6
METTL9	DREV1	ENSG00000197006	"Methyltransferase like 9"	Q9H1A3	16	21597218-21657473	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Proximal tubular cells: 326.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA053588, HPA056347"	Uncertain		Approved	"Nucleoplasm,Cell Junctions,Cytosol"	"Secreted to blood"	NA	NA			"Nucleoplasm, Cell Junctions"	Cytosol	"HPA053588: AB_2682203, HPA056347: "	"unprognostic (1.55e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.98e-3)"	"unprognostic (5.43e-2)"	"unprognostic (5.81e-2)"	"unprognostic (3.13e-1)"	"prognostic unfavorable (8.71e-4)"	"unprognostic (3.44e-2)"	"unprognostic (1.11e-2)"	"unprognostic (7.57e-3)"	"unprognostic (1.73e-2)"	"unprognostic (3.18e-1)"	"unprognostic (1.49e-3)"	"unprognostic (2.14e-1)"	"unprognostic (3.28e-1)"	"unprognostic (5.17e-2)"	"unprognostic (1.65e-1)"	24.0	45.5	29.6	18.8	34.9	50.0	45.1	12.2	31.9	34.2	19.1	18.7	15.5	14.9	23.4	35.6	30.2	23.8	19.4	32.0	22.2	20.0	61.0	8.7	24.0	38.8	26.8	8.4	22.8	28.8	37.2	25.0	25.4	17.7	23.8	20.3	32.5	22.1	19.3	30.6	21.5	20.6	21.1	25.0	29.6	18.8	10.8	18.1	39.8	37.8	20.0	25.9	24.9	24.6	4.9	14.1	30.5	24.5	5.6	7.3	7.6	13.6	10.4	26.4	22.8	27.3	49.5	9.5	21.9	31.4	17.3	21.0	7.5	24.9	24.0	18.7	38.3	16.7	8.6	17.5	19.6	23.7	18.2	14.3	10.4	10.5	27.9	19.6	8.1	21.6	29.1	20.9	17.9	23.4	32.6	33.1	26.9	15.3	19.8	34.2	15.1	21.1	13.6	23.7	17.0	10.8	30.8	20.5	21.8	28.5	13.4	15.3	27.6	18.6	12.9	46.7	20.7	13.1	4.2	18.7	28.8	12.6	17.6	13.4	16.8	27.0	19.3	28.3	20.2	20.3	30.5	24.5	10.7	4.0	4.5	4.8	4.6	6.8	7.3	14.1	4.9	7.3	5.4	12.5	5.6	3.9	4.4	5.4	7.6	29.6	34.9	12.2	31.9	22.2	20.0	26.8	8.4	17.7	18.1	17.9	25.0	67.7	73.4	63.7	38.7	50.8	28.1	17.4	25.0	82.0	43.2	62.9	238.8	101.7	6.4	91.1	45.1	0.0	107.0	99.3	82.6	115.4	48.3	10.4	80.8	42.9	81.5	80.4	211.5	4.5	58.7	86.5	99.5	101.8	76.5	49.9	98.9	45.6	61.2	326.8	37.5	64.7	68.4	13.2	20.0	67.2	116.4	146.0	75.0	107.4
MFAP3L	"KIAA0626, NYD-sp9"	ENSG00000198948	"Microfibril associated protein 3 like"	O75121	4	169986597-170033031	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 32.9"	"Group enriched"	"Detected in many"	20	"Early spermatids: 409.5;Late spermatids: 1347.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"basophil: 7.9;eosinophil: 2.1;neutrophil: 4.9"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 7.9"	"Cell line enhanced"	"Detected in many"		"HMC-1: 14.4;RT4: 23.5;SK-BR-3: 21.6;SuSa: 12.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017986, HPA062306, HPA077490"	Enhanced		Supported	"Nucleoplasm,Cell Junctions"	"Intracellular and membrane"	NA	NA			Nucleoplasm	"Cell Junctions"	"HPA017986: AB_1853842, HPA062306: , HPA077490: AB_2686842"	"unprognostic (8.04e-3)"	"unprognostic (8.67e-3)"	"unprognostic (3.74e-1)"	"unprognostic (1.28e-2)"	"unprognostic (4.51e-2)"	"unprognostic (7.92e-2)"	"unprognostic (3.50e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.33e-1)"	"unprognostic (3.96e-1)"	"unprognostic (7.58e-2)"	"prognostic favorable (1.42e-8)"	"unprognostic (6.59e-3)"	"unprognostic (2.12e-1)"	"unprognostic (1.62e-4)"	"unprognostic (2.40e-3)"	2.1	3.4	15.0	1.3	19.6	2.7	10.2	4.9	19.4	11.4	2.1	21.1	4.2	1.0	4.9	32.9	1.2	4.0	2.6	1.9	15.4	11.1	25.6	29.5	2.7	1.2	21.8	10.0	1.1	1.6	5.7	3.3	5.5	21.1	2.9	2.2	17.5	2.0	11.7	4.2	19.7	1.1	3.9	16.4	1.7	1.3	30.6	20.8	0.0	2.8	0.2	1.0	11.9	1.5	0.0	0.7	7.9	0.8	0.0	0.8	6.9	0.2	3.5	1.9	2.0	1.6	0.8	0.7	3.8	0.5	1.8	1.6	1.2	0.2	0.0	0.1	5.9	3.4	1.8	6.9	0.8	0.8	0.0	2.6	0.0	3.7	1.4	0.9	0.0	14.4	1.2	2.1	0.2	0.6	1.0	0.2	2.2	0.5	0.7	3.6	2.0	0.6	0.5	2.0	0.4	3.0	0.0	1.1	0.0	5.2	23.5	1.6	3.5	3.2	21.6	6.9	12.8	1.2	0.0	0.1	1.9	7.1	3.5	7.3	0.3	0.0	0.0	4.8	0.7	7.1	7.9	0.2	2.1	0.8	0.8	0.4	0.0	0.7	0.2	0.3	0.0	0.3	0.1	4.9	0.0	0.0	0.7	0.1	6.9	15.0	19.6	4.9	15.4	15.4	11.1	21.8	10.0	21.1	20.8	0.0	6.4	0.0	0.2	2.3	9.2	2.5	0.0	0.0	0.0	34.9	19.6	2.9	5.0	0.4	409.5	2.3	0.4	23.3	1.0	0.9	0.5	0.5	4.6	43.3	0.9	3.2	2.4	4.9	1.0	1347.3	4.9	0.6	6.8	0.0	0.1	2.3	1.3	0.0	8.5	17.3	14.7	19.4	3.4	18.0	13.6	7.3	7.9	0.0	0.4	2.1
MICALL1	"KIAA1668, MICAL-L1, MIRAB13"	ENSG00000100139	"MICAL like 1"	Q8N3F8	22	37905657-37942822	"Plasma proteins, Predicted intracellular proteins"	"Endocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cytotrophoblasts: 26.6;Syncytiotrophoblasts: 33.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTCEpi: 47.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043480, HPA051956"	Approved		Supported	"Cell Junctions,Centriolar satellite,Cytosol"		NA	NA			"Cell Junctions, Centriolar satellite, Cytosol"		"HPA043480: AB_10793950, HPA051956: AB_2681671"	"unprognostic (2.13e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.94e-2)"	"unprognostic (4.90e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.37e-1)"	"prognostic unfavorable (3.08e-6)"	"unprognostic (3.46e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.68e-2)"	"unprognostic (2.42e-3)"	"unprognostic (1.57e-2)"	"unprognostic (6.96e-3)"	"unprognostic (6.61e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.92e-2)"	8.0	4.8	5.3	10.1	10.3	6.3	12.6	5.9	7.3	19.1	25.2	21.4	17.6	6.1	21.3	11.0	32.3	11.1	14.4	6.0	7.5	5.5	6.4	5.7	11.8	9.2	17.4	5.1	6.8	14.2	19.2	4.3	29.6	12.5	15.3	7.5	8.7	13.4	25.2	8.5	24.4	9.2	43.5	18.7	5.9	28.5	7.4	11.1	5.3	9.4	15.5	13.5	21.4	17.5	2.8	3.3	2.3	1.6	4.1	2.6	1.6	10.9	6.1	6.6	7.1	6.7	5.7	26.5	15.6	8.9	15.3	11.5	8.3	5.9	4.7	4.8	10.3	10.8	28.5	5.1	30.4	11.1	8.1	13.4	1.9	6.5	8.2	10.9	5.4	5.5	4.8	47.6	18.2	37.9	5.6	10.5	1.8	3.4	4.6	13.3	5.2	1.3	2.4	2.3	6.4	4.6	7.3	12.6	2.6	4.0	30.4	4.6	8.2	9.7	8.5	8.3	8.5	5.1	5.2	14.5	25.6	21.2	17.0	12.7	4.7	1.6	3.0	23.3	2.5	12.4	0.4	1.1	0.6	1.8	1.6	2.3	2.5	1.4	2.2	1.7	2.8	2.6	1.3	2.3	4.1	0.6	3.3	0.9	1.6	5.3	10.3	5.9	7.3	7.5	5.5	17.4	5.1	12.5	11.1	0.0	5.6	1.5	8.1	6.6	0.9	9.0	7.6	5.3	9.1	5.2	0.0	26.6	1.7	8.5	12.7	6.0	4.2	0.0	8.9	24.3	3.8	4.6	1.1	3.9	7.9	4.8	3.4	4.3	1.8	17.7	1.7	3.7	1.7	9.0	3.4	0.8	10.8	2.6	3.9	2.2	0.6	0.0	4.2	2.8	2.1	8.0	33.0	2.5	3.3	12.7
MIGA2	"C9orf54, FAM73B, FLJ00199, FLJ14596"	ENSG00000148343	"Mitoguardin 2"	Q7L4E1	9	129036621-129072082	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 2: 9.0;Club cells: 5.7;Collecting duct cells: 7.0;monocytes: 6.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041363	Approved		Approved	"Cell Junctions,Cytosol"		NA	NA			Cytosol	"Cell Junctions"	"HPA041363: AB_10794664"	"unprognostic (2.10e-1)"	"unprognostic (4.82e-3)"	"unprognostic (1.07e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.93e-2)"	"unprognostic (3.07e-3)"	"unprognostic (2.90e-2)"	"prognostic favorable (3.04e-6)"	"unprognostic (1.12e-2)"	"unprognostic (1.44e-3)"	"unprognostic (8.57e-3)"	"unprognostic (1.25e-1)"	"unprognostic (4.63e-2)"	"unprognostic (4.15e-3)"	10.1	14.3	7.7	11.5	10.2	17.3	6.8	17.6	16.0	5.6	17.2	8.9	14.6	23.7	7.6	8.7	11.5	7.1	13.3	24.4	7.9	11.6	7.6	7.4	5.2	7.5	9.0	10.9	8.4	6.8	7.5	8.5	3.1	9.4	9.3	5.5	8.7	11.1	12.3	13.0	9.8	21.6	9.0	7.6	7.1	9.9	7.0	7.2	8.0	9.6	5.3	10.8	10.0	9.8	2.8	3.9	8.5	3.1	1.2	6.5	2.2	4.0	8.3	2.6	13.0	7.1	3.7	5.8	7.3	5.5	8.4	5.3	7.2	8.5	6.1	3.3	5.6	7.3	19.3	3.5	5.4	1.3	5.6	5.1	4.4	16.2	5.3	7.9	5.0	10.1	5.2	4.3	7.6	3.9	2.7	5.8	5.8	6.4	2.6	4.5	10.6	5.0	10.3	6.0	9.7	12.1	10.3	7.6	10.1	4.4	7.8	8.2	5.8	8.1	12.9	4.5	1.6	9.3	5.4	5.7	5.5	6.3	9.1	5.5	3.5	5.1	5.7	7.8	4.0	6.4	8.5	2.6	2.4	3.0	3.1	6.5	2.3	2.2	3.9	2.9	2.8	2.2	1.3	4.8	1.2	1.7	3.9	1.9	2.2	7.7	10.2	17.6	16.0	7.9	11.6	9.0	10.9	9.4	7.2	3.0	9.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	5.7	7.0	0.0	2.5	1.7	4.7	0.0	0.0	0.0	0.0	4.0	1.9	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	6.4	0.0	0.0	4.5	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0
MLKL	FLJ34389	ENSG00000168404	"Mixed lineage kinase domain like pseudokinase"	Q8NB16	16	74671855-74700960	"Enzymes, Predicted intracellular proteins, Transporters"	Necrosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 50.4"	"Cell type enhanced"	"Detected in many"	6	"granulocytes: 27.8;Macrophages: 24.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA078638			Supported	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA			"Plasma membrane"	"Cell Junctions, Cytosol"	"HPA078638: "	"unprognostic (7.53e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.57e-1)"	"prognostic favorable (2.16e-4)"	"unprognostic (1.23e-1)"	"unprognostic (3.07e-1)"	"unprognostic (5.69e-2)"	"unprognostic (3.67e-3)"	"unprognostic (1.90e-1)"	"unprognostic (6.64e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.60e-3)"	"unprognostic (5.30e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.53e-3)"	18.5	4.7	5.2	15.1	8.9	21.6	13.2	2.9	7.9	6.4	8.0	3.2	5.3	8.5	7.5	3.8	11.5	5.2	9.1	6.8	6.4	3.5	7.4	6.7	17.3	14.8	10.5	1.8	2.8	8.2	1.6	3.0	7.1	8.1	6.3	9.2	6.5	12.6	4.3	2.3	3.6	10.0	6.0	11.2	26.2	8.2	1.9	8.4	4.3	6.5	4.9	10.4	9.2	50.4	4.2	9.2	25.2	17.7	1.7	8.1	7.1	6.5	12.2	0.1	0.1	3.2	6.7	0.1	8.5	7.4	8.0	11.9	7.0	13.2	0.1	9.8	7.2	6.9	10.5	2.2	12.2	3.0	4.1	0.3	9.2	9.1	8.0	2.3	6.0	9.6	4.5	1.2	8.5	3.0	4.7	19.3	10.7	1.3	1.3	6.2	10.9	3.4	12.0	1.1	14.3	15.0	6.7	0.9	11.7	11.4	4.8	0.5	0.4	6.7	4.5	3.7	0.0	3.2	6.3	21.0	4.0	2.4	3.6	5.8	5.7	19.2	1.6	7.3	21.2	1.9	8.3	17.7	21.7	5.8	10.6	7.9	4.2	6.5	6.0	9.2	2.8	3.6	5.5	25.2	1.7	10.2	0.5	8.1	7.1	5.2	8.9	2.9	7.9	6.4	3.5	10.5	1.8	8.1	8.4	3.0	15.4	8.1	4.8	3.1	0.0	1.6	2.5	2.7	7.9	1.8	0.0	0.2	1.7	4.0	2.6	17.9	5.8	0.0	4.6	0.5	3.8	2.0	27.8	0.9	14.2	1.6	1.2	14.7	15.5	3.8	0.9	24.1	6.8	1.0	5.6	0.0	4.1	9.1	0.4	0.3	0.4	0.0	3.3	0.0	0.2	2.5	0.2	10.0	6.4	5.1
MLST8	"GbetaL, GBL, Lst8, Pop3"	ENSG00000167965	"MTOR associated protein, LST8 homolog"	Q9BVC4	16	2204248-2209416	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019935, HPA041841"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cell Junctions"		NA	NA			Nucleoplasm	"Golgi apparatus, Cell Junctions"	"CAB019935: AB_561447, HPA041841: AB_2677701"	"unprognostic (2.19e-1)"	"unprognostic (7.68e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.35e-3)"	"unprognostic (1.74e-1)"	"unprognostic (8.17e-3)"	"unprognostic (1.52e-1)"	"unprognostic (5.77e-2)"	"unprognostic (5.70e-3)"	"unprognostic (4.62e-2)"	"unprognostic (1.65e-1)"	"prognostic favorable (7.60e-4)"	"unprognostic (8.74e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.29e-1)"	"unprognostic (5.48e-2)"	12.4	18.6	24.0	11.9	22.8	15.7	10.4	23.1	39.1	11.6	14.4	15.7	12.5	16.6	9.9	14.0	15.9	17.4	12.6	18.4	23.9	18.5	15.5	17.9	9.1	13.3	20.7	20.0	16.0	32.3	11.1	12.6	15.5	16.1	14.4	6.8	17.3	25.5	13.0	36.6	13.5	13.9	8.7	14.1	10.5	15.6	25.5	13.3	13.4	20.8	13.9	11.8	13.2	9.0	8.5	14.8	2.5	18.6	7.4	9.6	11.5	7.2	20.7	8.6	21.9	11.3	8.0	14.2	5.9	8.1	10.4	9.6	28.0	10.1	18.6	15.0	7.1	4.3	8.8	8.7	18.0	1.2	14.1	39.7	12.6	20.5	18.0	16.4	19.3	17.8	11.4	12.9	12.1	15.7	8.5	11.1	25.8	18.1	12.9	5.5	30.3	18.3	25.8	16.6	6.2	19.3	19.2	8.6	32.6	7.8	4.3	27.2	13.9	9.8	22.2	15.8	3.3	13.1	18.9	7.8	12.2	13.8	9.8	8.0	14.8	8.9	20.3	6.0	17.1	10.2	0.0	15.2	2.5	8.5	18.6	6.6	8.5	7.5	9.6	14.8	7.2	9.0	9.0	1.7	7.4	16.9	8.2	7.2	11.5	24.0	22.8	23.1	39.1	23.9	18.5	20.7	20.0	16.1	13.3	6.0	13.6	23.8	14.5	13.1	30.3	3.0	10.2	10.7	6.8	15.7	19.6	58.4	29.9	30.2	39.4	11.9	36.0	23.3	37.0	37.8	20.1	13.3	8.1	14.5	41.0	28.6	27.6	19.6	22.1	78.3	13.8	14.5	16.9	34.3	26.7	26.0	26.7	37.4	14.2	30.7	24.7	19.4	15.5	24.7	25.4	13.6	44.1	18.7	37.1	11.1
MOAP1	"MAP-1, PNMA4"	ENSG00000165943	"Modulator of apoptosis 1"	Q96BY2	14	93182196-93184928	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 69.5"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA000939, HPA076948"	Enhanced		Approved	"Nucleoplasm,Cell Junctions"		NA	NA			Nucleoplasm	"Cell Junctions"	"HPA000939: AB_1079402, HPA076948: "	"unprognostic (9.40e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.57e-1)"	"unprognostic (7.52e-2)"	"unprognostic (1.21e-1)"	"unprognostic (8.75e-2)"	"unprognostic (1.01e-1)"	"prognostic favorable (7.37e-9)"	"unprognostic (1.98e-1)"	"unprognostic (6.52e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.58e-2)"	"prognostic favorable (3.15e-6)"	"unprognostic (6.93e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.61e-1)"	"unprognostic (9.27e-2)"	6.9	14.5	21.9	5.7	30.0	15.9	8.6	30.5	69.5	12.8	10.1	7.1	7.7	7.1	9.3	12.0	8.0	11.1	8.2	23.9	24.2	35.9	14.2	9.0	9.7	7.9	22.9	27.8	8.6	9.0	25.0	12.0	7.1	27.8	15.0	7.4	10.1	8.2	14.9	13.9	5.2	7.0	10.1	11.2	7.8	8.3	4.4	7.8	5.9	10.6	3.6	7.5	8.4	3.8	6.3	4.2	16.4	4.4	8.8	14.3	7.5	3.8	3.0	7.3	9.8	6.3	2.4	4.9	4.5	5.2	4.7	5.3	3.2	3.8	11.6	8.3	5.2	3.3	6.0	5.2	4.5	5.2	5.3	6.6	6.5	6.1	4.3	8.2	5.8	11.8	4.3	6.8	2.8	5.7	11.2	5.7	14.1	2.3	7.1	5.3	15.9	9.1	5.5	3.4	7.7	3.9	5.6	9.9	7.0	11.9	10.9	16.9	14.6	4.6	6.5	18.4	6.1	10.0	4.3	6.2	1.8	2.9	4.2	2.2	13.4	13.7	7.0	4.8	3.7	3.2	16.4	4.0	10.3	11.3	4.4	12.6	6.0	10.5	11.5	4.2	6.3	14.3	12.2	3.7	8.8	4.4	4.0	9.8	7.5	21.9	30.0	30.5	69.5	24.2	35.9	22.9	27.8	27.8	7.8	29.8	27.2	31.3	16.6	14.3	94.0	64.3	12.7	6.7	12.5	19.2	47.1	23.2	34.9	26.8	3.8	15.8	10.7	0.0	13.3	4.8	12.5	23.4	26.6	6.4	14.5	79.4	46.6	11.6	10.8	0.9	16.4	10.1	11.8	18.0	18.8	76.4	16.9	10.2	25.8	13.9	85.3	19.4	26.1	9.6	21.3	13.6	39.9	31.9	13.1	18.6
MPP7	FLJ32798	ENSG00000150054	"Membrane palmitoylated protein 7"	Q5T2T1	10	28050993-28334486	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 33.2"	"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 55.2;Suprabasal keratinocytes: 53.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 11.0;CACO-2: 20.7;CAPAN-2: 12.9;T-47d: 41.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA037597, HPA037598"	Approved		Supported	"Nucleoplasm,Cell Junctions"		NA	NA			"Cell Junctions"	Nucleoplasm	"HPA037597: AB_2675569, HPA037598: AB_10696941"	"unprognostic (1.12e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.59e-3)"	"unprognostic (1.49e-1)"	"unprognostic (6.64e-2)"	"unprognostic (7.78e-2)"	"unprognostic (9.31e-3)"	"prognostic favorable (5.88e-4)"	"unprognostic (2.15e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.26e-1)"	"prognostic favorable (2.79e-14)"	"unprognostic (2.46e-1)"	"unprognostic (1.88e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.03e-2)"	1.9	1.2	1.9	3.2	1.9	2.6	3.7	3.2	3.0	2.3	6.3	1.9	1.9	1.8	1.9	3.7	16.3	4.6	2.0	2.0	1.9	0.6	4.9	1.9	3.7	4.6	1.9	1.9	1.9	11.3	1.8	7.8	4.2	2.2	2.8	3.5	2.6	5.0	1.9	4.7	11.2	3.3	3.0	1.9	2.4	5.9	33.2	1.9	1.9	5.7	1.9	3.0	3.4	5.4	0.7	8.1	9.0	8.2	4.9	9.2	5.3	2.6	0.0	0.2	0.0	0.0	0.0	11.0	0.5	0.4	2.2	3.5	20.7	12.9	0.0	0.1	1.5	1.6	4.8	1.8	3.4	5.2	0.0	3.5	0.0	0.6	1.2	0.0	0.0	0.0	0.1	5.5	0.3	0.2	0.0	0.0	1.0	0.5	0.0	2.9	4.9	1.0	0.0	0.6	4.0	1.0	0.5	6.2	0.0	0.2	8.7	0.5	0.0	1.1	5.3	0.0	1.8	41.8	0.5	0.0	0.8	6.0	0.0	0.4	0.1	0.0	0.0	0.0	4.9	0.0	0.0	8.2	9.0	4.3	2.7	6.3	0.7	4.7	2.9	8.1	0.6	9.2	6.4	3.3	4.9	1.4	0.1	1.1	5.3	1.9	1.9	3.2	3.0	1.9	0.6	1.9	1.9	2.2	1.9	41.7	38.7	0.0	9.3	20.5	1.2	9.0	12.7	16.0	23.9	14.0	15.7	38.9	8.3	3.5	55.2	2.8	10.9	0.0	10.9	2.0	2.1	11.1	1.1	2.6	4.7	3.2	6.4	1.8	5.6	13.5	0.9	2.5	6.8	0.0	8.9	22.1	7.6	7.0	0.4	7.3	7.0	0.0	4.7	2.5	9.3	53.3	38.9	8.7	10.7	12.8
MPZL2	"EVA, EVA1"	ENSG00000149573	"Myelin protein zero like 2"	O60487	11	118253403-118264536	"Predicted membrane proteins"	"Cell adhesion"		"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 103.8"	"Cell type enhanced"	"Detected in many"	8	"Basal glandular cells: 405.2;Basal keratinocytes: 295.4;Suprabasal keratinocytes: 408.6;Urothelial cells: 416.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"classical monocyte: 9.3;intermediate monocyte: 7.2;myeloid DC: 13.4;neutrophil: 10.9"	"Group enriched"	"Detected in many"	10	"dendritic cells: 13.4;granulocytes: 10.9;monocytes: 9.3"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 25.3;EFO-21: 27.9;HaCaT: 34.9;RT4: 66.3;TIME: 72.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA060740	Approved		Approved	"Cell Junctions"		NA	NA			"Cell Junctions"		"HPA060740: AB_2684352"	"unprognostic (1.74e-1)"	"unprognostic (6.02e-2)"	"unprognostic (8.23e-2)"	"unprognostic (3.28e-3)"	"unprognostic (9.95e-3)"	"unprognostic (1.56e-1)"	"unprognostic (2.11e-3)"	"unprognostic (3.58e-1)"	"unprognostic (7.39e-2)"	"unprognostic (5.45e-2)"	"prognostic unfavorable (1.14e-4)"	"unprognostic (1.91e-1)"	"unprognostic (3.91e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.80e-1)"	"prognostic favorable (1.62e-4)"	"unprognostic (2.08e-2)"	11.7	1.7	1.5	2.8	1.5	0.0	17.1	1.5	1.6	31.0	8.5	1.0	26.3	4.4	6.8	17.8	103.8	13.4	12.3	4.7	2.4	1.5	11.7	7.9	21.7	1.8	2.4	0.6	7.4	4.6	10.2	9.2	1.5	4.0	17.8	8.7	6.2	21.6	32.8	7.8	11.4	4.4	5.6	4.3	1.3	10.0	3.7	1.3	5.7	21.7	52.3	41.1	29.4	37.4	0.0	13.4	10.9	9.3	0.3	1.0	2.8	13.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	25.3	0.0	27.9	0.0	0.1	34.9	0.0	8.0	0.0	0.0	2.0	0.0	0.3	7.3	0.0	0.0	0.0	0.0	19.2	0.0	0.6	0.0	18.2	0.1	0.0	0.0	0.0	10.5	0.0	0.0	0.3	7.0	0.0	0.0	0.0	1.3	3.1	66.3	0.0	0.0	1.2	12.9	0.0	0.1	5.5	0.1	72.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	9.3	2.3	0.1	7.2	1.0	0.0	0.5	0.4	13.4	0.0	0.6	0.7	10.9	0.3	1.0	0.2	0.2	2.8	1.5	1.5	1.5	1.6	2.4	1.5	2.4	0.6	4.0	1.3	77.4	91.1	0.0	405.2	295.4	0.0	3.4	28.1	46.8	146.7	122.1	0.0	1.0	0.0	32.1	0.0	28.8	29.1	0.0	45.6	0.1	7.2	133.5	6.9	13.6	0.8	0.0	5.1	23.4	4.0	0.0	0.0	11.0	20.3	0.0	3.3	0.0	45.3	14.8	0.0	5.6	0.0	0.0	7.1	0.0	0.6	408.6	14.9	2.6	32.4	416.5
MRPL46	"C15orf4, LIECG2, P2ECSL"	ENSG00000259494	"Mitochondrial ribosomal protein L46"	Q9H2W6	15	88459476-88467419	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050166	Uncertain		Supported	"Nucleoplasm,Cell Junctions,Mitochondria"		NA	NA			Mitochondria	"Nucleoplasm, Cell Junctions"	"HPA050166: AB_2681039"	"unprognostic (1.42e-1)"	"unprognostic (6.94e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.21e-2)"	"unprognostic (3.28e-2)"	"unprognostic (5.16e-2)"	"unprognostic (6.22e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.79e-1)"	"unprognostic (4.64e-3)"	"unprognostic (7.78e-2)"	"unprognostic (5.65e-2)"	"prognostic favorable (2.09e-6)"	"unprognostic (7.73e-2)"	"unprognostic (9.18e-2)"	"unprognostic (6.96e-3)"	"unprognostic (1.63e-1)"	11.0	28.3	14.2	11.9	14.7	5.4	13.2	15.8	15.6	7.3	12.4	8.5	10.0	11.1	9.6	11.5	13.3	10.5	8.3	40.8	11.8	11.3	19.3	38.7	7.4	10.4	13.2	13.0	11.4	8.9	8.1	9.2	13.7	13.8	9.0	13.8	7.8	9.3	9.5	57.0	8.2	9.3	11.1	11.4	9.7	12.0	13.7	11.7	12.2	10.0	17.9	11.0	11.1	13.4	31.8	24.6	13.2	24.5	24.3	31.9	25.1	10.0	32.2	10.6	11.3	15.2	11.1	19.6	14.4	13.5	21.8	19.5	39.6	22.2	23.9	14.8	13.0	19.5	24.6	40.7	17.7	17.6	9.7	32.4	19.9	23.2	41.3	9.5	19.4	15.5	12.8	21.6	16.4	11.4	11.0	18.8	23.7	21.8	10.2	15.8	21.5	16.3	24.6	16.4	18.6	19.6	18.8	14.6	18.1	16.9	32.3	16.1	10.5	13.7	21.6	29.5	18.6	24.3	24.2	11.6	17.0	16.1	9.0	20.7	9.5	19.6	19.4	18.7	21.4	12.8	9.9	19.6	13.2	26.8	24.5	30.5	31.8	28.7	26.1	24.6	28.4	31.9	28.4	3.5	24.3	17.6	20.9	26.9	25.1	14.2	14.7	15.8	15.6	11.8	11.3	13.2	13.0	13.8	11.7	0.0	6.4	19.3	18.4	12.2	20.3	64.9	30.6	16.0	10.3	34.9	25.5	77.8	101.2	30.3	48.5	15.4	23.1	0.0	32.9	37.0	13.4	13.1	21.9	82.5	31.2	14.3	27.2	17.2	12.6	6.8	13.3	9.2	6.8	63.1	17.9	17.8	28.5	17.5	17.7	80.1	22.7	25.8	10.5	30.3	24.5	20.5	67.5	22.7	28.6	26.5
MRPS18B	"C6orf14, HSPC183, MRPS18-2, PTD017"	ENSG00000204568	"Mitochondrial ribosomal protein S18B"	Q9Y676	6	30617709-30626395	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043485, HPA050334"	Supported		Supported	"Cell Junctions,Mitochondria"		NA	NA			Mitochondria	"Cell Junctions"	"HPA043485: AB_2678506, HPA050334: AB_2681091"	"unprognostic (8.18e-3)"	"unprognostic (1.14e-1)"	"unprognostic (8.96e-2)"	"unprognostic (2.51e-2)"	"unprognostic (4.20e-2)"	"unprognostic (7.40e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.40e-2)"	"prognostic favorable (3.99e-5)"	"unprognostic (1.89e-1)"	"unprognostic (1.64e-1)"	"unprognostic (5.14e-2)"	"unprognostic (5.39e-2)"	17.1	18.9	9.9	10.3	10.7	5.4	16.0	8.5	13.1	11.6	13.4	12.8	11.9	12.8	9.3	15.5	15.5	16.5	12.3	26.6	9.0	8.0	22.4	49.1	10.5	17.3	13.1	9.3	16.4	21.8	17.4	10.2	11.8	9.1	10.9	16.4	10.1	17.1	18.0	55.4	13.7	14.0	10.4	12.4	14.4	13.5	10.2	11.2	13.5	21.5	31.1	15.6	11.2	9.3	15.7	8.9	6.3	10.2	12.4	15.2	11.2	9.7	5.9	4.7	6.7	7.2	9.7	8.7	3.6	8.4	11.5	7.1	9.2	4.6	10.0	8.4	5.7	8.6	7.8	10.9	10.2	11.3	6.0	11.6	9.7	4.6	10.7	6.3	9.1	4.2	8.4	12.8	9.4	26.1	7.8	6.4	9.5	14.7	9.6	10.4	7.4	6.0	5.6	3.4	7.8	7.6	8.0	6.4	19.1	10.7	4.1	10.3	3.3	3.2	13.6	13.7	4.6	17.6	4.8	3.7	7.5	7.3	4.3	6.2	8.2	9.8	8.5	3.6	13.8	11.0	6.3	8.0	4.0	9.1	10.1	12.3	15.7	12.1	9.8	8.9	14.7	15.2	12.2	0.6	12.4	10.2	8.1	11.4	11.2	9.9	10.7	8.5	13.1	9.0	8.0	13.1	9.3	9.1	11.2	56.6	44.3	53.6	61.6	32.6	43.2	135.7	101.9	53.5	46.6	45.4	60.9	106.9	164.2	89.2	46.6	63.4	48.4	23.3	80.0	101.6	52.1	46.2	36.9	95.6	72.2	41.3	30.1	49.1	44.0	26.6	65.0	42.1	57.3	93.8	55.1	39.2	65.0	59.6	42.1	161.2	51.1	51.8	67.0	22.6	60.7	39.3	80.7	41.7	80.3	30.1
MTFR1L	FAM54B	ENSG00000117640	"Mitochondrial fission regulator 1 like"	Q9H019	1	25818640-25832942	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Early spermatids: 175.3;Late spermatids: 418.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027124, HPA027130"	Approved		Approved	"Cell Junctions,Mitochondria"		NA	NA			Mitochondria	"Cell Junctions"	"HPA027124: AB_10600211, HPA027130: AB_10611251"	"unprognostic (9.90e-2)"	"unprognostic (6.86e-3)"	"unprognostic (9.29e-2)"	"prognostic favorable (6.81e-4)"	"unprognostic (1.16e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.43e-1)"	"unprognostic (4.52e-3)"	"unprognostic (2.12e-1)"	"unprognostic (2.24e-1)"	"unprognostic (9.89e-3)"	"unprognostic (5.33e-2)"	"prognostic favorable (5.89e-12)"	"unprognostic (1.41e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.33e-1)"	13.2	43.5	17.8	8.1	23.9	6.2	14.0	19.4	26.5	13.8	20.2	17.1	21.6	18.2	16.7	23.3	19.2	17.1	13.4	58.7	16.8	17.6	27.7	25.1	10.7	9.0	17.7	20.7	26.8	14.5	38.7	16.4	15.6	19.2	19.9	14.8	24.2	16.3	28.8	76.9	11.4	15.3	28.0	13.0	13.4	16.4	46.4	15.0	5.8	16.5	23.1	9.9	21.1	16.6	10.1	21.1	41.1	20.3	10.3	10.6	18.1	7.6	10.6	21.5	21.8	27.9	26.4	9.1	17.9	25.6	18.4	20.3	3.5	16.1	2.6	16.0	31.7	16.2	7.0	17.6	15.3	18.1	17.3	15.8	22.0	17.8	13.9	26.8	18.0	22.1	27.1	14.5	19.6	14.7	27.3	15.1	10.8	13.3	11.8	26.2	8.1	10.2	12.8	11.8	10.1	15.6	10.2	19.4	7.7	18.9	7.0	22.0	20.1	13.4	13.0	26.7	15.1	10.9	16.7	15.6	15.2	12.1	35.5	11.2	12.4	7.4	9.2	26.6	24.5	16.9	20.4	19.4	41.1	10.4	18.8	6.2	10.1	9.9	9.3	21.1	10.0	10.6	9.7	5.2	10.3	20.3	8.5	10.3	18.1	17.8	23.9	19.4	26.5	16.8	17.6	17.7	20.7	19.2	15.0	14.9	23.2	21.5	23.3	11.9	0.0	129.8	15.3	8.1	15.9	21.0	0.0	46.0	87.9	28.6	175.3	16.8	19.0	0.0	29.3	32.3	25.4	13.0	34.7	29.4	29.9	0.0	15.0	16.5	13.4	418.5	31.7	18.9	42.2	59.5	13.1	0.0	23.1	14.8	36.7	58.4	0.0	25.8	29.7	84.9	35.7	11.3	49.7	10.2	18.8	11.5
MTHFR		ENSG00000177000	"Methylenetetrahydrofolate reductase"	P42898	1	11785723-11806920	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Allosteric enzyme, Oxidoreductase"	"Disease mutation, Schizophrenia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 27.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063389, HPA076180, HPA077255"	Enhanced		Approved	"Cell Junctions"		NA	NA			"Cell Junctions"		"HPA063389: AB_2685001, HPA076180: , HPA077255: "	"unprognostic (3.25e-2)"	"unprognostic (8.19e-2)"	"unprognostic (4.48e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.34e-1)"	"prognostic favorable (3.97e-5)"	"prognostic unfavorable (1.19e-4)"	"unprognostic (1.75e-2)"	"unprognostic (2.85e-1)"	"unprognostic (8.69e-2)"	"prognostic favorable (4.81e-5)"	"unprognostic (3.10e-1)"	"prognostic favorable (2.12e-4)"	"unprognostic (2.35e-3)"	"unprognostic (2.94e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.80e-2)"	11.7	11.0	8.9	10.3	12.4	24.5	9.7	15.3	15.8	9.0	10.4	13.5	8.3	10.7	10.4	54.5	11.3	12.7	10.9	23.4	9.2	8.6	12.0	12.4	16.2	13.3	9.9	10.7	28.8	11.2	6.7	17.5	6.6	10.7	10.2	9.1	14.1	7.3	7.2	15.3	13.2	13.6	10.9	7.4	18.3	13.6	10.6	10.9	10.2	15.8	9.8	11.7	10.4	17.9	4.9	3.2	4.7	7.4	3.4	4.7	2.3	1.3	5.9	6.8	7.8	6.8	10.5	1.1	4.2	8.8	4.0	3.5	5.4	8.7	11.4	2.3	4.3	9.3	2.6	4.8	4.0	1.7	5.4	4.4	8.4	7.4	1.5	9.1	4.6	10.9	9.2	4.0	3.0	3.3	6.6	6.2	10.8	27.4	7.5	4.1	1.8	5.0	2.2	2.3	5.9	2.1	5.2	3.7	12.6	6.4	7.2	6.8	11.6	5.2	5.1	8.2	4.3	8.1	7.2	5.5	4.0	3.3	4.7	1.0	4.2	5.7	21.3	4.9	10.6	3.6	1.1	3.8	1.9	4.7	7.4	1.8	3.0	1.6	2.5	3.2	4.9	2.4	2.7	4.7	3.4	6.9	1.5	1.0	2.3	8.9	12.4	15.3	15.8	9.2	8.6	9.9	10.7	10.7	10.9	23.8	50.3	12.3	6.7	7.4	0.0	35.5	10.2	5.3	10.3	26.2	0.0	4.1	1.7	7.7	13.8	16.2	32.7	46.7	22.0	2.7	16.0	9.3	8.1	19.5	18.8	0.0	11.6	38.6	38.0	28.3	17.0	26.2	11.8	10.8	15.4	0.0	15.7	17.8	8.5	14.3	0.0	19.4	24.7	6.0	4.7	8.2	2.4	8.7	16.5	8.1
MVD	MPD	ENSG00000167508	"Mevalonate diphosphate decarboxylase"	P53602	16	88651935-88663161	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Lyase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041404, HPA048250"	Uncertain		Approved	"Cell Junctions,Cytosol"		NA	NA		30000	Cytosol	"Cell Junctions"	"HPA041404: AB_2677457, HPA048250: AB_2680329"	"unprognostic (1.67e-1)"	"unprognostic (3.05e-1)"	"unprognostic (2.42e-1)"	"prognostic favorable (2.17e-4)"	"unprognostic (1.89e-1)"	"unprognostic (9.56e-2)"	"unprognostic (9.26e-3)"	"unprognostic (8.33e-2)"	"unprognostic (6.68e-2)"	"unprognostic (5.47e-2)"	"unprognostic (2.51e-1)"	"unprognostic (6.22e-2)"	"unprognostic (1.19e-3)"	"unprognostic (4.12e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.11e-1)"	"unprognostic (5.00e-2)"	11.9	18.5	15.8	16.9	19.7	7.6	12.5	21.7	27.9	10.8	19.4	17.1	10.8	39.6	8.4	7.3	30.0	7.4	8.7	11.9	17.2	18.2	9.2	25.9	14.6	12.6	14.6	17.3	11.1	19.0	11.0	7.8	7.6	24.5	13.7	5.1	10.8	16.1	8.7	27.8	18.3	20.7	6.6	23.8	11.1	21.2	23.0	14.6	4.3	9.2	18.6	12.2	7.3	13.8	15.0	17.6	2.5	8.9	18.1	18.1	9.4	14.7	9.5	15.9	10.3	5.4	11.9	9.0	7.3	7.7	5.0	4.3	25.1	37.5	7.1	11.9	4.3	18.6	22.0	7.1	39.0	1.4	4.5	12.1	5.2	5.2	38.1	10.9	3.3	3.7	9.4	7.5	13.3	4.2	2.5	5.3	17.5	14.6	3.9	2.7	34.5	11.3	17.0	19.1	5.1	9.3	11.8	4.6	18.5	14.8	9.3	16.1	5.4	18.3	4.2	5.3	3.4	20.8	15.0	11.5	4.7	9.5	8.3	4.1	11.0	4.8	24.4	5.6	16.4	7.7	2.5	8.2	1.5	18.1	8.6	13.5	10.3	12.1	11.9	9.5	15.0	9.4	11.5	1.1	18.1	8.9	17.6	12.6	9.4	15.8	19.7	21.7	27.9	17.2	18.2	14.6	17.3	24.5	14.6	23.8	45.3	22.0	10.8	13.5	19.2	11.9	28.1	10.7	15.9	19.2	5.9	20.1	21.6	27.8	48.8	12.0	73.8	0.0	53.8	25.2	18.8	15.9	16.1	17.8	31.6	22.3	31.6	23.9	28.8	70.6	7.5	16.4	20.3	45.9	40.3	14.8	24.2	38.6	8.5	16.5	16.5	6.5	14.2	32.0	13.5	18.9	40.8	32.0	29.4	16.7
NAMPT	"PBEF, PBEF1"	ENSG00000105835	"Nicotinamide phosphoribosyltransferase"	P43490	7	106248285-106286326	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Biological rhythms, Pyridine nucleotide biosynthesis"	"Cytokine, Glycosyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Hepatocytes: 597.4;Macrophages: 479.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	18	"neutrophil: 143.5"	"Lineage enriched"	"Detected in many"	20	"granulocytes: 143.5"	"Cell line enhanced"	"Detected in all"		"U-87 MG: 110.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034349, HPA047776, HPA057722"	Approved		Approved	"Nuclear speckles,Cell Junctions"	"Secreted to blood"	NA	NA	2140000	410000	"Nuclear speckles"	"Cell Junctions"	"CAB034349: AB_2251220, HPA047776: AB_2680151, HPA057722: "	"unprognostic (2.87e-1)"	"prognostic unfavorable (4.78e-4)"	"unprognostic (5.90e-3)"	"unprognostic (1.63e-2)"	"unprognostic (1.50e-2)"	"prognostic unfavorable (8.81e-4)"	"unprognostic (2.15e-1)"	"unprognostic (2.74e-2)"	"unprognostic (2.74e-1)"	"unprognostic (3.30e-1)"	"prognostic unfavorable (1.51e-4)"	"unprognostic (3.02e-1)"	"prognostic unfavorable (2.49e-6)"	"unprognostic (6.83e-2)"	"unprognostic (6.96e-2)"	"unprognostic (7.76e-2)"	"unprognostic (6.44e-3)"	67.3	22.2	8.1	113.6	18.1	110.4	52.6	7.8	12.9	11.6	18.2	2.9	9.5	9.3	9.9	13.5	53.4	27.8	28.1	84.4	13.4	6.3	13.5	92.9	48.9	117.5	10.3	5.2	27.3	18.3	5.5	10.0	23.9	29.2	17.4	10.5	8.2	32.9	14.3	41.0	12.9	14.1	44.9	59.1	41.1	26.4	11.9	7.1	6.2	13.5	40.7	13.2	48.8	26.4	0.8	2.0	143.5	7.3	1.0	1.5	1.3	19.2	12.9	4.6	7.8	19.7	23.0	7.6	6.1	34.6	12.4	21.9	7.6	11.7	16.1	14.7	6.8	37.2	15.2	8.6	18.4	27.2	9.5	9.2	6.5	5.5	5.9	73.7	12.6	12.1	21.9	21.1	22.2	26.0	18.6	39.5	8.0	13.6	62.0	14.8	10.1	12.6	5.3	9.0	12.2	10.4	6.0	6.6	35.5	11.8	18.2	9.5	5.2	8.6	18.8	21.8	13.4	6.0	3.6	33.6	18.5	14.3	26.5	11.2	42.7	24.2	23.3	110.0	14.3	27.4	8.1	2.3	3.5	0.4	5.6	0.7	0.8	0.5	0.6	2.0	0.7	0.8	0.4	143.5	1.0	7.3	0.8	1.5	1.3	8.1	18.1	7.8	12.9	13.4	6.3	10.3	5.2	29.2	7.1	122.1	246.8	48.1	258.1	184.4	22.1	87.9	163.1	104.4	177.5	40.1	11.8	23.8	39.7	250.8	6.3	173.0	92.2	0.0	120.5	44.2	117.9	276.9	178.5	597.4	98.8	38.1	24.1	141.8	340.8	4.5	37.4	479.6	153.5	65.9	46.4	19.5	161.8	35.1	29.4	36.0	28.4	25.8	234.9	14.9	57.9	181.7	21.2	41.5	63.9	273.8
NECTIN2	"CD112, HVEB, PRR2, PVRL2, PVRR2"	ENSG00000130202	"Nectin cell adhesion molecule 2"	Q92692	19	44846175-44889228	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Ductal cells: 182.4;Exocrine glandular cells: 136.8;monocytes: 139.7;Pancreatic endocrine cells: 178.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"eosinophil: 11.5"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012759, CAB026138, HPA073459"	Enhanced		Approved	"Nucleoli fibrillar center,Cell Junctions"		NA	NA		3400000	"Nucleoli fibrillar center, Cell Junctions"		"CAB026138: , HPA012759: AB_1846227, HPA073459: "	"unprognostic (3.30e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.07e-1)"	"unprognostic (5.61e-3)"	"unprognostic (7.45e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.66e-2)"	"unprognostic (6.63e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.97e-1)"	"unprognostic (6.93e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.61e-1)"	"unprognostic (8.19e-2)"	"unprognostic (2.05e-1)"	29.5	28.2	7.9	15.6	7.7	5.6	38.0	4.5	9.0	24.2	34.0	9.3	22.3	24.2	23.2	27.4	33.6	16.7	54.1	21.9	10.5	8.1	29.0	53.7	39.6	23.0	8.2	6.8	25.5	20.6	22.5	15.9	45.8	11.2	25.8	14.8	22.9	24.4	28.9	14.6	18.3	42.9	13.8	8.4	31.4	26.2	38.7	5.8	3.8	32.2	19.2	24.1	21.6	31.4	0.0	3.3	11.5	2.6	0.0	0.3	0.7	16.9	20.3	26.2	31.0	13.3	8.1	30.5	14.5	18.0	25.7	29.7	41.9	37.3	0.1	19.6	16.7	13.5	23.2	23.2	12.0	20.5	0.7	12.1	10.3	7.0	27.0	31.9	0.1	27.5	14.1	4.8	12.2	10.0	27.4	33.2	0.6	16.7	0.1	12.8	30.8	0.1	1.2	21.8	53.0	6.1	0.9	8.9	0.6	30.4	20.9	1.2	3.5	18.0	27.4	6.2	49.0	21.4	10.0	33.1	7.1	24.9	5.2	10.7	2.1	6.0	0.1	12.9	2.2	18.3	1.5	2.6	11.5	0.0	0.9	0.3	0.0	0.1	0.0	3.3	0.0	0.0	0.0	2.4	0.0	0.5	0.3	0.0	0.7	7.9	7.7	4.5	9.0	10.5	8.1	8.2	6.8	11.2	5.8	32.8	33.2	0.0	0.0	0.0	0.0	0.0	0.0	6.7	12.5	55.8	0.0	82.4	3.3	182.4	0.0	0.0	0.0	0.0	136.8	82.2	0.0	0.0	3.5	0.0	47.7	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	139.7	0.0	0.0	178.3	0.0	0.0	25.8	0.0	0.0	0.0	0.0	0.0	0.0	85.1	0.0	0.0	0.0
NECTIN3	"CD113, CDw113, DKFZP566B0846, nectin-3, PPR3, PVRL3, PVRR3"	ENSG00000177707	"Nectin cell adhesion molecule 3"	Q9NQS3	3	111070071-111275563	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 94.2"	"Cell type enriched"	"Detected in some"	4	"Syncytiotrophoblasts: 98.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 1.7"	"Lineage enriched"	"Detected in single"	4	"T-cells: 1.7"	"Cell line enhanced"	"Detected in many"		"AF22: 33.5;TIME: 47.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009869, HPA011038"	Approved		Approved	"Cell Junctions,Cytosol"		NA	NA		20000000	Cytosol	"Cell Junctions"	"CAB009869: AB_2284699, HPA011038: AB_1079719"	"unprognostic (3.76e-2)"	"unprognostic (3.81e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.97e-2)"	"unprognostic (1.02e-1)"	"unprognostic (9.77e-2)"	"unprognostic (3.26e-3)"	"unprognostic (3.77e-1)"	"unprognostic (7.58e-2)"	"unprognostic (3.94e-2)"	"unprognostic (5.33e-2)"	"unprognostic (7.04e-2)"	"prognostic favorable (9.82e-7)"	"unprognostic (2.01e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.05e-1)"	5.6	4.0	5.4	4.4	6.0	0.0	4.5	1.3	8.9	4.6	12.6	6.5	2.8	17.8	5.0	2.2	3.5	5.4	4.4	4.8	6.3	5.0	6.9	16.4	5.6	1.9	6.0	4.1	9.2	4.7	1.9	1.9	94.2	5.5	6.9	12.6	10.7	3.4	4.8	2.3	1.8	18.9	7.2	8.9	1.8	13.2	27.6	4.5	0.4	24.1	2.0	1.4	5.4	7.7	0.1	0.0	0.3	0.0	0.2	1.7	0.7	0.0	10.1	33.5	2.2	13.6	25.2	2.0	22.0	23.3	13.7	11.7	9.3	4.7	0.0	7.3	31.3	7.6	0.1	9.3	3.2	25.2	0.2	2.5	0.0	3.6	0.7	23.0	1.6	0.3	12.7	1.4	9.0	8.7	12.3	11.5	0.4	0.0	8.8	29.5	0.0	2.2	0.0	9.4	3.1	3.6	0.0	16.6	0.0	8.5	5.3	0.8	6.1	0.4	0.0	4.6	11.7	0.3	0.1	47.5	17.4	7.2	3.1	13.1	4.9	0.0	0.0	11.0	0.0	16.0	0.0	0.0	0.3	0.1	0.0	1.2	0.0	1.7	1.0	0.0	0.1	0.3	0.4	0.0	0.2	0.0	0.0	0.1	0.7	5.4	6.0	1.3	8.9	6.3	5.0	6.0	4.1	5.5	4.5	23.8	7.3	0.0	0.0	0.0	0.0	0.0	0.0	1.4	5.7	12.2	0.0	3.3	0.0	3.9	0.0	0.0	0.0	0.0	16.4	7.6	0.0	0.0	1.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	13.3	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	98.1	0.0	0.0	0.0
NEU1	NEU	ENSG00000204386	"Neuraminidase 1"	Q99519	6	31857659-31862906	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Lipid degradation, Lipid metabolism"	"Glycosidase, Hydrolase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"GAMG: 38.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015634, HPA021506"	Approved		Supported	"Vesicles,Cell Junctions"		NA	NA		86000	Vesicles	"Cell Junctions"	"HPA015634: AB_1854386, HPA021506: AB_1854385"	"unprognostic (3.84e-2)"	"unprognostic (7.47e-2)"	"unprognostic (9.64e-2)"	"unprognostic (4.65e-2)"	"unprognostic (3.00e-1)"	"unprognostic (4.42e-3)"	"unprognostic (1.38e-3)"	"unprognostic (8.58e-3)"	"unprognostic (7.49e-2)"	"unprognostic (5.21e-2)"	"unprognostic (4.44e-3)"	"unprognostic (1.27e-1)"	"unprognostic (2.70e-2)"	"unprognostic (6.22e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.13e-3)"	10.5	30.2	8.6	9.4	11.1	5.2	10.5	15.5	14.6	13.4	14.1	7.4	16.1	14.1	9.8	13.9	9.0	8.3	16.1	9.8	8.0	9.5	29.7	24.2	16.1	7.2	9.4	6.6	12.7	20.6	13.6	16.5	19.8	10.3	15.1	9.1	14.7	18.1	13.8	10.0	9.1	23.5	9.8	4.7	13.4	12.7	6.5	10.0	5.8	22.7	7.0	9.6	13.6	9.5	4.2	7.7	15.2	13.4	3.0	5.1	7.4	2.4	2.4	2.4	5.6	8.2	3.1	4.8	2.2	7.5	6.5	9.6	14.1	2.6	0.8	5.7	2.9	38.4	1.3	5.1	2.0	2.5	2.0	3.4	1.2	1.4	16.5	14.7	1.5	6.9	5.1	3.8	7.9	4.1	3.9	5.8	1.6	2.6	5.8	3.3	4.3	1.2	2.3	1.9	4.3	1.9	1.7	1.3	8.5	10.8	5.2	1.8	1.1	2.4	3.3	5.8	3.2	6.2	7.1	2.4	4.3	2.5	6.0	3.9	7.2	11.5	1.7	3.1	3.9	3.0	6.4	13.4	8.7	5.1	10.3	4.2	3.9	3.9	4.1	7.7	4.2	4.0	3.9	15.2	3.0	9.2	4.3	4.8	7.4	8.6	11.1	15.5	14.6	8.0	9.5	9.4	6.6	10.3	10.0	23.8	47.7	44.6	42.4	30.5	24.5	18.7	38.2	10.7	17.0	45.4	23.6	52.4	8.3	82.1	0.8	27.6	80.5	0.0	51.5	49.0	63.2	112.7	66.9	21.3	139.8	9.5	108.9	26.4	42.3	0.7	25.6	53.4	67.4	25.2	37.4	48.4	45.4	80.7	21.9	55.3	29.8	25.8	42.2	5.0	7.5	36.4	164.8	28.7	38.6	31.8
NHS		ENSG00000188158	"NHS actin remodeling regulator"	Q6T4R5	X	17375420-17735994	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			Cataract	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 21.6;Peritubular cells: 29.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 1.1;neutrophil: 2.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"EFO-21: 11.0;RPTEC TERT1: 16.5;RT4: 10.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA031497, HPA076257"	Uncertain		Supported	"Cell Junctions"		NA	NA			"Cell Junctions"		"HPA031497: AB_10610144, HPA076257: AB_2686789"	"unprognostic (1.39e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.17e-1)"	"prognostic favorable (1.68e-4)"	"unprognostic (2.58e-1)"	"unprognostic (1.69e-1)"	"unprognostic (9.92e-3)"	"unprognostic (3.27e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.61e-3)"	"unprognostic (2.54e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.21e-1)"	"unprognostic (8.83e-3)"	"unprognostic (1.83e-3)"	5.1	6.7	3.6	6.0	3.6	0.6	14.2	5.9	6.3	10.2	5.9	1.3	10.0	1.9	10.7	7.1	3.7	5.3	10.4	3.5	2.2	3.1	11.8	0.7	3.7	2.6	1.5	1.1	7.8	0.9	0.7	5.1	5.5	4.7	7.0	3.5	9.4	3.2	8.8	1.1	4.2	2.5	11.2	5.3	2.1	3.6	12.4	1.3	0.8	4.5	2.2	1.3	8.1	16.0	0.1	0.6	2.0	1.1	0.0	0.2	0.3	6.5	2.7	4.7	0.0	0.1	0.2	7.6	2.9	2.0	1.3	0.7	0.2	1.3	0.4	11.0	2.0	6.5	5.8	3.0	3.7	1.9	0.1	1.0	0.0	4.4	0.0	0.0	0.0	0.0	0.6	2.6	0.0	5.9	5.8	0.0	0.0	0.0	0.0	0.6	3.1	0.0	0.0	5.7	2.9	1.7	0.0	0.0	0.2	16.5	10.1	1.1	2.4	8.2	0.0	0.0	2.7	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	7.0	0.1	7.1	0.0	1.1	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.6	0.1	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.3	3.6	3.6	5.9	6.3	2.2	3.1	1.5	1.1	4.7	1.3	3.0	0.0	0.0	9.8	7.3	8.1	1.6	0.0	9.4	20.5	1.8	21.6	4.2	5.0	0.6	0.5	1.0	0.5	0.0	2.0	4.1	6.4	5.5	0.0	0.0	1.3	3.2	4.1	0.6	4.1	0.7	15.5	1.8	3.3	0.0	2.0	12.4	4.2	3.1	29.4	5.9	19.3	6.5	12.2	0.4	0.4	3.3	2.2	0.0	3.4	10.1
NHSL2		ENSG00000204131	"NHS like 2"	Q5HYW2	X	71910818-72161750	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.1"	"Cell type enhanced"	"Detected in many"	7	"Basal glandular cells: 52.1;Glandular cells: 82.4;Ito cells: 55.3;Kupffer cells: 52.6;Urothelial cells: 89.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 13.5"	"Group enriched"	"Detected in many"	4	"dendritic cells: 3.5;granulocytes: 13.5;monocytes: 5.7"	"Cell line enhanced"	"Detected in some"		"AF22: 16.8;EFO-21: 19.9;HUVEC TERT2: 18.3;TIME: 10.6;U-937: 13.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049771	Uncertain		Approved	"Plasma membrane,Cell Junctions"		NA	NA			"Cell Junctions"	"Plasma membrane"	"HPA049771: AB_2680872"	"unprognostic (9.71e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.92e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.50e-2)"	"unprognostic (2.88e-2)"	"unprognostic (5.72e-4)"	"unprognostic (5.46e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.61e-2)"	"unprognostic (4.27e-3)"	"unprognostic (9.99e-2)"	"unprognostic (7.76e-2)"	"unprognostic (4.37e-4)"	7.8	2.3	11.0	4.8	22.5	3.4	5.2	27.1	9.4	6.6	5.5	1.5	0.9	1.3	8.7	2.7	5.5	3.8	7.4	3.6	4.9	3.2	2.0	1.6	5.5	1.3	2.2	4.9	3.1	1.6	3.1	6.1	3.7	4.3	6.4	3.3	6.2	2.6	8.7	2.8	2.3	2.6	11.7	2.4	4.5	3.4	9.6	2.7	0.3	5.3	4.6	1.6	6.3	4.4	0.0	3.5	13.5	5.7	0.9	1.8	1.7	0.2	0.4	16.8	0.1	0.2	0.7	0.1	0.5	3.1	0.1	0.2	0.1	0.0	0.1	19.9	1.7	0.0	0.0	1.0	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.9	0.3	0.0	0.6	0.0	0.0	18.3	0.0	0.0	2.7	0.1	0.1	0.1	1.3	3.2	0.0	0.0	0.0	1.0	0.0	0.1	1.9	0.4	3.8	0.0	0.0	0.0	4.9	0.0	1.1	10.6	0.0	1.1	1.3	0.0	0.0	0.0	0.1	0.8	13.3	0.0	4.1	5.7	11.8	1.8	3.9	1.7	0.0	1.0	1.6	3.5	0.0	0.1	0.2	13.5	0.9	3.0	0.0	0.1	1.7	11.0	22.5	27.1	9.4	4.9	3.2	2.2	4.9	4.3	2.7	0.0	3.4	0.0	52.1	0.5	0.6	16.3	10.2	0.0	0.0	1.8	0.0	15.3	0.0	0.2	3.0	21.8	2.4	23.3	0.6	18.6	11.2	82.4	7.0	14.3	16.2	0.0	1.2	55.3	52.6	4.9	29.4	3.4	1.7	0.0	4.5	1.2	0.3	0.0	20.1	1.4	0.3	25.8	2.2	2.5	1.7	0.3	20.8	27.7	4.9	89.4
NLGN3	"ASPGX1, AUTSX1, HNL3, KIAA1480"	ENSG00000196338	"Neuroligin 3"	Q9NZ94	X	71144831-71171201	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"Asperger syndrome, Autism, Autism spectrum disorder, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 45.9"	"Cell type enriched"	"Detected in some"	6	"Peritubular cells: 16.3"	"Cancer enriched"	"Detected in many"	19	"glioma: 37.4"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	6	"neutrophil: 3.3"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 3.3"	"Cell line enhanced"	"Detected in some"		"AF22: 11.1;NTERA-2: 8.1;SH-SY5Y: 4.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003183, HPA004066"	Enhanced		Supported	"Golgi apparatus,Cell Junctions"	"Intracellular and membrane"	NA	NA			"Golgi apparatus, Cell Junctions"		"HPA003183: AB_1079469, HPA004066: AB_2732397"	"unprognostic (4.06e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.59e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.87e-1)"	"unprognostic (6.52e-2)"	"unprognostic (1.63e-1)"	"unprognostic (7.10e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.94e-1)"	"unprognostic (6.18e-2)"	"unprognostic (4.27e-9)"	"unprognostic (4.28e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.22e-5)"	"unprognostic (9.01e-2)"	1.4	8.9	16.3	1.6	19.4	2.2	1.3	11.5	45.9	3.2	1.6	30.0	0.1	1.1	4.2	8.1	1.5	6.0	2.4	2.1	15.7	9.7	1.2	0.9	1.3	1.2	12.7	13.1	6.1	1.2	1.4	1.1	1.5	15.2	7.9	1.4	1.6	1.6	16.0	0.8	1.6	1.6	2.9	12.9	1.4	1.5	3.8	12.3	0.0	1.0	0.0	1.1	1.5	1.3	0.2	0.1	3.3	0.3	0.3	0.5	0.0	0.1	0.8	11.1	0.3	2.6	1.1	1.9	0.3	0.1	0.0	0.2	0.1	0.5	0.8	0.8	0.1	0.0	0.2	0.4	0.0	0.2	0.7	1.3	0.5	0.5	0.1	0.0	0.2	0.9	0.6	0.1	0.3	0.0	0.5	0.1	3.1	0.7	2.1	0.1	0.6	0.7	1.7	8.1	0.1	0.0	0.9	0.4	0.5	0.0	1.2	2.7	4.4	0.3	0.0	1.0	1.4	0.0	0.5	0.3	0.2	1.3	0.5	0.1	1.7	1.5	0.6	0.3	0.5	0.6	0.3	0.3	0.0	0.1	0.0	0.1	0.2	0.1	0.0	0.1	0.2	0.5	0.1	3.3	0.3	0.0	0.1	0.1	0.0	16.3	19.4	11.5	23.1	15.7	9.7	12.7	13.1	15.2	12.3	0.0	0.0	0.0	0.4	0.6	2.1	0.4	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	1.2	0.3	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	2.5	2.0	0.0	0.0	0.0	0.0	2.4	0.1	0.0	16.3	0.0	0.5	0.0	0.1	0.2	0.0	0.4	0.2	0.0	0.0	0.3
NLK		ENSG00000087095	"Nemo like kinase"	Q9UBE8	17	28041737-28196381	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation, Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Bipolar cells: 93.3;Cone photoreceptor cells: 145.3;Early spermatids: 243.8;Late spermatids: 250.1;Rod photoreceptor cells: 92.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	32	"basophil: 17.6"	"Lineage enriched"	"Detected in single"	32	"granulocytes: 17.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018192, HPA056511"	Approved		Approved	"Nucleoplasm,Nucleoli,Cell Junctions"		NA	NA			Nucleoplasm	"Nucleoli, Cell Junctions"	"HPA018192: AB_1854525, HPA056511: AB_2683160"	"unprognostic (7.19e-2)"	"unprognostic (1.98e-1)"	"unprognostic (5.54e-2)"	"unprognostic (5.64e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.67e-2)"	"unprognostic (2.59e-3)"	"unprognostic (2.72e-2)"	"unprognostic (4.23e-3)"	"unprognostic (1.07e-2)"	"unprognostic (1.09e-2)"	"unprognostic (5.29e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.92e-1)"	"unprognostic (5.27e-2)"	"unprognostic (6.57e-2)"	6.4	30.5	19.4	10.9	14.1	7.4	7.5	7.5	38.2	6.2	6.7	8.3	14.4	8.3	5.7	8.8	4.5	5.1	8.2	8.5	18.2	12.0	13.0	8.2	7.1	11.7	15.2	23.6	4.6	11.5	20.8	9.4	9.1	7.0	6.7	7.1	12.7	5.8	17.4	4.9	4.5	8.3	4.6	15.3	10.1	7.0	17.4	7.5	10.9	13.2	3.7	11.0	7.2	4.4	0.5	0.3	17.6	0.3	0.1	0.5	0.2	4.6	5.4	13.0	4.5	2.8	3.6	5.8	4.7	4.8	7.8	6.0	27.1	4.2	6.3	7.1	3.8	9.9	4.4	9.2	8.5	9.0	14.6	5.8	24.8	5.0	4.6	4.7	5.2	25.6	4.7	5.3	5.1	6.2	7.6	9.1	18.0	9.5	7.7	7.1	5.5	13.4	6.0	5.0	9.1	2.7	11.2	8.4	4.6	14.2	5.7	9.5	3.6	7.1	6.8	29.1	16.4	10.6	8.3	9.3	5.6	7.6	4.6	9.4	9.0	8.6	6.1	5.5	5.7	6.1	17.6	0.2	0.2	0.3	0.3	0.1	0.5	0.4	0.4	0.2	0.3	0.2	0.5	0.1	0.1	0.3	0.3	0.4	0.2	19.4	14.1	7.5	38.2	18.2	12.0	15.2	23.6	7.0	7.5	20.8	5.9	4.7	3.5	4.7	93.3	23.0	10.2	6.7	4.5	31.4	145.3	2.5	1.7	3.3	243.8	10.6	5.9	0.0	5.5	3.0	3.7	5.4	24.2	8.9	7.2	35.0	27.1	10.4	14.2	250.1	5.2	5.0	15.1	4.6	9.4	9.4	5.7	7.0	2.5	6.3	92.4	12.9	3.9	25.8	9.5	4.3	5.4	5.1	8.3	5.8
NLRX1	"CLR11.3, NOD9"	ENSG00000160703	"NLR family member X1"	Q86UT6	11	119166568-119184016	"Predicted intracellular proteins"	"Host-virus interaction, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 34.9;lymphoid tissue: 37.5;tongue: 38.9"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 14.3"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 14.3"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061516	Supported		Supported	"Plasma membrane,Cell Junctions,Mitochondria"		NA	NA		35000	Mitochondria	"Plasma membrane, Cell Junctions"	"HPA061516: AB_2684548"	"unprognostic (7.58e-2)"	"unprognostic (3.71e-1)"	"unprognostic (6.36e-2)"	"prognostic favorable (2.47e-5)"	"unprognostic (5.60e-3)"	"unprognostic (2.59e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.43e-2)"	"unprognostic (8.80e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.49e-1)"	"unprognostic (3.29e-1)"	"prognostic favorable (2.59e-6)"	"unprognostic (3.06e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.83e-2)"	"unprognostic (4.22e-2)"	4.8	6.1	1.9	3.3	3.7	3.6	3.6	2.5	4.9	8.9	5.1	2.9	8.0	2.9	5.6	5.3	34.9	6.7	4.9	8.7	2.9	1.6	4.3	4.4	3.4	3.4	1.8	2.7	2.9	6.2	5.6	2.5	3.3	3.0	4.4	2.0	5.4	5.6	4.8	14.3	11.6	3.2	4.6	2.4	4.5	4.0	3.2	1.3	3.8	4.3	38.9	37.5	5.3	8.5	0.6	2.0	14.3	3.3	1.3	1.3	1.9	4.1	12.2	1.3	9.7	4.2	4.8	1.9	5.5	6.4	2.8	4.8	0.7	10.2	7.4	16.9	7.0	4.1	10.3	3.7	3.1	0.9	9.5	4.0	9.7	4.2	6.6	6.4	3.4	5.7	5.4	13.2	3.6	7.0	5.6	5.6	9.9	0.1	4.9	2.8	10.9	5.7	8.2	6.0	5.3	6.8	11.2	1.7	2.4	6.6	5.3	1.8	6.4	8.1	4.3	3.5	2.0	14.0	10.1	6.5	5.5	4.9	4.9	2.8	1.8	1.9	2.5	0.8	10.4	3.9	2.8	3.3	14.3	0.9	1.5	1.0	0.6	0.8	1.3	2.0	0.4	1.0	1.1	8.1	1.3	1.3	0.9	1.3	1.9	1.9	3.7	2.5	4.9	2.9	1.6	1.8	2.7	3.0	1.3	0.0	6.4	1.7	1.6	2.3	1.2	10.8	5.1	6.7	2.3	7.0	2.0	3.0	1.7	6.0	1.5	3.0	4.2	0.0	3.4	1.7	2.5	1.8	0.0	9.6	5.7	0.0	2.4	4.3	5.3	2.7	1.1	1.9	1.7	5.4	4.1	5.6	5.1	7.0	1.1	4.3	3.2	0.0	2.1	1.9	1.9	4.1	0.5	0.5	4.5	0.9
NPNT	"EGFL6L, POEM"	ENSG00000168743	Nephronectin	Q6UXI9	4	105894775-106004027	"Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion, Differentiation"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 125.3"	"Cell type enhanced"	"Detected in many"	14	"Alveolar cells type 1: 172.7;Alveolar cells type 2: 69.4;Club cells: 97.8"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 104.1"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 15.2;CAPAN-2: 9.9;HeLa: 17.2;Hep G2: 13.7;MCF7: 12.2;RPTEC TERT1: 20.0;T-47d: 26.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA003711, HPA050203"	Supported		Approved	"Nucleoplasm,Cell Junctions,Cytosol"	"Secreted to extracellular matrix"	NA	NA			"Nucleoplasm, Cell Junctions, Cytosol"		"HPA003711: AB_1854591, HPA050203: AB_2681050"	"unprognostic (1.24e-1)"	"unprognostic (7.93e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.43e-2)"	"unprognostic (3.92e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.87e-1)"	"unprognostic (7.85e-3)"	"unprognostic (4.78e-4)"	"unprognostic (1.19e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.68e-1)"	"prognostic favorable (8.28e-8)"	"unprognostic (4.81e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.31e-2)"	5.4	1.6	3.4	2.4	4.4	0.0	8.3	0.7	2.5	13.3	11.0	1.9	4.2	16.4	8.7	11.4	5.7	5.9	19.0	2.5	2.5	2.7	22.7	1.3	34.9	0.9	7.5	2.4	4.1	11.6	0.0	14.6	3.0	2.2	26.3	7.6	16.9	2.8	5.7	2.6	2.1	37.7	4.0	0.9	4.4	4.0	3.0	2.8	3.4	125.3	3.7	2.3	3.7	6.2	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.0	15.2	0.1	0.0	0.0	0.0	7.6	9.9	0.1	0.4	0.1	0.0	0.9	3.8	0.0	0.0	0.0	3.9	0.4	17.2	13.7	0.0	0.0	0.1	1.7	1.3	0.0	0.0	0.2	0.0	0.2	0.0	0.2	0.0	12.2	0.2	0.7	0.1	0.0	6.2	0.0	0.0	0.1	20.0	0.8	0.9	0.3	0.9	7.4	0.0	2.3	26.8	0.6	0.0	0.3	0.2	0.2	0.6	0.1	0.5	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	4.4	0.7	2.5	2.5	2.7	7.5	2.4	2.2	2.8	172.7	69.4	0.0	4.6	1.6	0.2	2.0	33.1	10.7	97.8	31.4	0.0	2.2	1.7	19.0	11.6	8.0	8.0	0.0	2.1	0.1	0.9	29.6	0.0	0.0	0.3	0.0	15.0	3.1	0.0	11.8	2.3	1.3	5.0	0.0	9.2	0.0	6.3	3.1	0.0	3.0	0.1	0.0	33.5	0.5	1.5	1.0	1.3	0.0	6.9	2.8
NR2C1	"TR2, TR2-11"	ENSG00000120798	"Nuclear receptor subfamily 2 group C member 1"	P13056	12	95020229-95073703	"Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035040, HPA035041, HPA067767"	Supported		Supported	"Nucleoplasm,Cell Junctions,Cytosol"		NA	NA			Nucleoplasm	"Cell Junctions, Cytosol"	"HPA035040: AB_2674426, HPA035041: AB_2674427, HPA067767: AB_2685898"	"unprognostic (2.44e-1)"	"unprognostic (8.04e-3)"	"unprognostic (3.17e-2)"	"unprognostic (2.51e-1)"	"unprognostic (3.56e-3)"	"unprognostic (3.01e-2)"	"prognostic unfavorable (5.18e-5)"	"unprognostic (1.30e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.83e-2)"	"unprognostic (4.56e-2)"	"prognostic unfavorable (1.03e-6)"	"unprognostic (2.31e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.16e-1)"	"prognostic favorable (5.62e-5)"	11.6	15.8	15.9	11.8	14.7	15.5	12.4	38.3	23.9	12.5	11.2	12.5	12.9	11.2	17.6	20.2	8.3	15.5	11.1	14.8	14.6	9.3	10.3	14.0	14.2	9.9	11.7	15.2	16.3	12.5	16.4	15.4	11.2	13.7	10.7	12.7	14.6	8.0	17.4	19.6	11.0	11.2	15.7	14.2	14.3	10.5	22.2	14.9	12.3	18.0	9.0	10.2	12.3	10.7	4.5	6.2	3.5	4.2	3.5	9.0	3.9	8.1	10.1	16.1	7.6	3.7	6.7	22.9	8.0	5.8	8.0	7.5	8.9	4.6	9.9	2.9	5.3	5.1	8.7	7.9	6.2	6.1	4.3	16.8	12.0	8.2	10.6	8.5	8.0	5.2	7.7	5.1	5.5	6.8	8.9	8.5	12.4	9.1	3.9	9.3	5.4	8.7	18.6	10.9	6.6	17.8	8.4	11.3	5.9	9.0	9.4	8.3	6.6	12.8	5.5	5.9	9.3	9.6	5.1	8.0	6.5	6.4	7.9	4.5	5.7	9.3	9.5	1.6	9.4	3.0	0.5	4.1	3.5	7.1	4.2	9.0	3.7	5.7	6.0	6.2	4.5	7.2	5.0	2.6	3.5	3.7	6.2	3.7	3.9	15.9	14.7	38.3	23.9	14.6	9.3	11.7	15.2	13.7	14.9	32.8	12.5	7.0	12.2	7.3	39.9	16.1	10.2	22.7	1.2	10.4	17.7	12.6	3.3	10.1	14.3	14.6	8.5	0.0	8.2	10.9	11.3	8.0	9.3	10.6	8.3	23.8	6.9	12.9	10.5	3.8	40.6	10.2	13.5	10.8	10.9	14.6	14.3	11.5	28.3	6.8	50.7	6.5	9.8	54.9	23.8	6.5	6.5	10.9	10.9	17.1
NUDT9	MGC3037	ENSG00000170502	"Nudix hydrolase 9"	Q9BW91	4	87422582-87459454	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPTEC TERT1: 60.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036917, HPA044866, HPA078535"	Approved		Approved	"Nuclear membrane,Nuclear bodies,Cell Junctions,Mitochondria"	"Intracellular and membrane"	NA	NA		9000	"Nuclear bodies, Mitochondria"	"Nuclear membrane, Cell Junctions"	"HPA036917: AB_10696790, HPA044866: AB_2679120, HPA078535: AB_2686885"	"unprognostic (7.22e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.45e-2)"	"prognostic favorable (7.43e-5)"	"unprognostic (2.05e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.47e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.09e-2)"	"unprognostic (4.23e-1)"	"prognostic favorable (8.00e-11)"	"unprognostic (1.21e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.77e-3)"	14.2	25.6	19.5	10.0	22.7	4.0	31.1	22.5	22.3	17.9	19.6	11.8	18.0	27.0	17.3	24.5	12.8	16.2	11.4	18.0	21.8	19.4	28.1	30.9	15.8	12.2	22.9	16.5	18.4	64.1	35.4	33.1	17.5	20.0	22.5	18.3	11.3	20.2	18.7	23.8	10.2	30.0	16.0	17.0	9.9	14.1	14.1	22.6	7.6	22.7	16.0	9.7	13.6	35.9	13.9	13.8	3.7	13.9	9.3	18.3	10.6	10.6	11.6	12.9	6.5	25.6	16.2	10.4	20.7	13.5	8.0	8.0	8.1	18.5	15.7	21.2	16.7	14.6	7.4	11.9	14.5	12.8	11.7	9.1	5.1	13.5	14.3	16.1	9.4	8.5	15.5	19.3	9.5	9.0	16.5	15.9	5.1	14.4	10.6	15.0	14.1	13.1	10.2	10.4	25.1	4.7	15.4	11.5	9.2	60.2	9.9	15.7	10.7	13.3	23.6	10.5	17.5	13.5	13.6	16.3	12.9	12.5	9.4	10.1	8.1	6.3	12.8	18.5	8.9	16.3	0.9	11.7	3.7	13.4	13.8	12.4	13.9	13.4	13.2	13.8	12.0	15.9	18.3	1.3	9.3	13.9	13.0	12.3	10.6	19.5	22.7	22.5	22.3	21.8	19.4	22.9	16.5	20.0	22.6	62.5	31.4	15.2	36.7	8.9	13.8	35.3	43.3	45.5	60.3	22.7	25.5	27.4	34.9	42.5	19.0	27.0	24.4	0.0	31.7	28.2	26.6	34.7	19.7	42.0	28.9	6.4	16.1	17.8	11.6	7.6	23.6	17.1	10.1	22.6	15.4	21.8	28.5	25.8	25.1	47.3	15.3	25.8	26.7	29.8	21.7	8.3	31.5	7.2	22.2	26.3
NUMB	C14orf41	ENSG00000133961	"NUMB, endocytic adaptor protein"	P49757	14	73275107-73458617	"Cancer-related genes, Predicted intracellular proteins"	Neurogenesis	"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 64.9"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002874, CAB011478"	Approved		Enhanced	"Cell Junctions"		NA	NA			"Cell Junctions"		"CAB011478: AB_443023, HPA002874: "	"unprognostic (5.28e-2)"	"unprognostic (7.23e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.32e-3)"	"unprognostic (2.02e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.43e-1)"	"unprognostic (9.49e-2)"	"unprognostic (1.33e-2)"	"unprognostic (4.08e-3)"	"unprognostic (2.65e-3)"	"unprognostic (4.14e-2)"	"prognostic favorable (2.32e-6)"	"unprognostic (9.12e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.92e-2)"	"unprognostic (2.87e-1)"	27.3	21.5	26.2	24.5	23.5	21.3	26.4	37.1	27.0	24.2	35.9	17.3	26.1	31.3	30.8	23.9	30.1	28.8	28.8	23.3	23.3	14.1	30.3	35.5	40.5	23.0	18.9	20.7	29.2	26.8	31.8	28.3	29.9	23.4	23.7	29.4	22.3	34.2	23.9	16.4	24.6	45.3	38.0	26.1	32.9	25.1	19.0	19.8	20.1	27.7	17.0	26.2	30.5	26.9	5.2	15.2	64.9	20.9	2.7	3.8	11.6	21.4	14.7	10.6	9.6	21.5	32.9	14.5	20.3	27.5	16.4	17.5	17.7	27.0	9.8	12.8	25.1	12.0	14.2	12.5	20.9	25.0	15.0	7.0	7.8	9.6	11.4	22.9	7.2	18.5	18.3	22.6	40.4	24.2	18.1	35.4	15.5	14.2	11.8	20.7	19.3	13.1	10.0	4.9	24.3	15.8	8.4	14.8	6.6	22.7	32.8	4.4	11.4	25.4	17.2	10.3	18.8	25.8	10.7	33.9	24.7	13.9	15.8	8.7	9.9	11.4	8.9	49.6	8.5	10.8	16.3	19.8	20.8	3.0	17.1	3.1	5.2	3.0	3.3	15.2	5.1	3.1	2.8	64.9	2.7	20.9	2.8	3.8	11.6	26.2	23.5	37.1	27.0	23.3	14.1	18.9	20.7	23.4	19.8	59.6	43.5	56.4	25.1	38.0	28.9	18.3	35.7	45.5	52.4	52.4	76.6	21.2	21.6	24.4	10.3	58.3	51.2	0.0	22.8	25.9	40.1	33.7	23.1	45.1	40.4	14.3	39.1	52.2	90.4	4.6	41.7	93.0	43.9	27.9	35.0	49.3	36.8	39.1	34.6	33.5	48.7	25.8	30.8	38.4	29.8	40.7	28.7	24.9	30.2	40.8
OCLN	PPP1R115	ENSG00000197822	Occludin	Q16625	5	69492292-69558104	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 58.1"	"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 1: 101.3;Urothelial cells: 183.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 21.3;CAPAN-2: 28.4;HaCaT: 22.9;MCF7: 22.6;RPTEC TERT1: 17.7;RT4: 19.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005933, CAB013075, CAB068212, CAB068213, CAB068214"	Enhanced		Supported	"Plasma membrane,Cell Junctions"	"Intracellular and membrane"	NA	NA			"Plasma membrane, Cell Junctions"		"CAB013075: AB_2533101, CAB068212: AB_2665711, CAB068213: AB_2665712, CAB068214: AB_2665713, HPA005933: AB_1079520"	"unprognostic (2.28e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.50e-2)"	"unprognostic (9.94e-2)"	"unprognostic (3.65e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.08e-2)"	"unprognostic (8.25e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.58e-2)"	"unprognostic (3.48e-1)"	"prognostic favorable (6.59e-11)"	"unprognostic (2.83e-1)"	"unprognostic (4.01e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.35e-1)"	1.2	0.8	3.4	3.8	3.7	0.5	7.6	3.9	2.9	4.3	15.5	3.2	21.9	10.2	1.7	7.4	10.6	7.9	17.1	1.1	4.0	2.9	15.3	31.7	29.2	0.4	4.0	1.7	2.3	33.2	12.0	3.2	9.0	6.7	5.7	10.9	7.7	7.1	25.0	0.5	8.7	24.5	1.2	3.8	2.1	15.1	2.0	1.5	0.4	58.1	9.8	8.6	5.0	6.5	1.2	1.2	1.8	0.3	2.0	0.9	0.1	15.4	6.2	0.1	0.5	0.2	0.4	12.5	0.0	1.5	2.1	3.1	21.3	28.4	0.1	5.4	0.3	7.8	22.9	6.3	3.0	5.8	0.1	11.1	1.2	0.2	6.5	0.1	0.5	1.6	0.0	3.2	4.8	0.2	1.1	1.2	2.1	0.0	0.1	0.0	22.6	0.6	0.4	2.4	6.8	2.6	0.0	4.7	0.5	17.7	19.3	2.1	1.0	0.1	16.9	0.2	4.4	9.5	1.9	0.2	0.1	6.4	1.3	1.5	0.3	0.1	0.1	0.1	0.1	0.1	0.8	0.3	0.7	0.8	0.2	0.2	0.8	0.9	0.3	0.1	1.2	0.7	0.9	1.8	2.0	0.2	1.2	0.4	0.1	3.4	3.7	3.9	2.9	4.0	2.9	4.0	1.7	6.7	1.5	101.3	47.6	3.2	51.5	3.3	6.0	1.3	56.0	48.2	55.7	24.4	13.7	26.5	8.3	49.2	2.0	5.3	55.1	0.0	52.8	1.2	3.2	76.5	2.3	42.9	2.6	6.4	25.2	16.0	25.3	1.1	2.8	2.6	1.7	5.4	35.4	3.5	63.1	47.2	1.4	11.3	6.2	12.9	2.7	4.2	7.8	13.6	13.7	4.9	33.9	183.7
PAK4		ENSG00000130669	"P21 (RAC1) activated kinase 4"	O96013	19	39125770-39182816	"Enzymes, Predicted intracellular proteins, RAS pathway related proteins"	"Apoptosis, Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A549: 45.4;MCF7: 50.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025747, CAB044670, HPA070175, HPA072220"	Uncertain		Supported	"Plasma membrane,Cell Junctions"		NA	Yes			"Plasma membrane, Cell Junctions"		"CAB025747: , CAB044670: AB_1854940, HPA070175: AB_2686232, HPA072220: AB_2686497"	"unprognostic (1.71e-1)"	"unprognostic (2.84e-1)"	"unprognostic (5.86e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.93e-1)"	"unprognostic (8.51e-2)"	"unprognostic (3.56e-3)"	"unprognostic (1.13e-3)"	"unprognostic (3.90e-2)"	"unprognostic (4.04e-2)"	"unprognostic (7.29e-2)"	"prognostic unfavorable (9.85e-4)"	"prognostic favorable (5.29e-5)"	"unprognostic (2.39e-1)"	"unprognostic (7.05e-2)"	"unprognostic (2.02e-1)"	"unprognostic (4.85e-2)"	6.8	11.1	11.0	12.7	12.3	4.8	11.9	13.7	12.4	17.3	19.6	13.7	19.9	26.0	12.2	17.3	20.1	15.3	16.5	8.1	10.9	8.1	19.4	17.0	18.7	5.4	13.7	7.7	13.8	29.6	11.2	17.0	23.0	10.3	29.6	8.1	19.7	40.9	18.5	10.3	18.6	25.1	9.0	8.3	7.9	18.6	22.3	12.5	8.8	15.2	10.1	14.7	11.5	15.0	2.8	3.4	4.2	2.5	3.6	4.5	1.9	17.9	45.4	6.8	10.3	2.1	2.3	20.5	8.6	3.5	5.8	5.9	29.7	15.3	4.1	13.1	5.4	7.6	6.6	3.7	6.8	2.2	10.9	10.4	4.8	8.3	14.4	3.4	4.9	7.1	2.7	3.0	5.4	3.9	3.8	7.5	6.3	9.7	3.2	3.4	50.0	5.2	5.4	12.3	15.9	10.9	5.3	5.3	3.1	5.6	19.8	21.7	15.0	8.7	39.0	9.7	3.7	17.3	8.2	12.5	9.9	17.0	11.3	15.3	3.7	3.5	3.4	12.1	2.9	11.8	1.0	2.5	4.2	2.6	1.4	3.6	2.2	2.9	4.5	3.4	2.8	2.2	2.2	2.1	3.6	2.1	2.9	3.0	1.9	11.0	12.3	13.7	12.4	10.9	8.1	13.7	7.7	10.3	12.5	0.0	1.0	0.5	15.0	12.8	14.8	1.2	20.4	6.7	0.0	17.4	23.6	35.6	26.6	18.7	2.7	15.8	35.5	0.0	17.2	46.7	10.8	17.8	5.7	10.5	8.3	20.6	43.0	12.3	5.6	4.9	10.9	2.5	6.8	14.4	30.6	14.1	16.5	40.3	9.9	10.6	13.1	0.0	7.2	5.7	17.7	16.4	54.7	8.7	29.9	20.6
PAK6	PAK5	ENSG00000137843	"P21 (RAC1) activated kinase 6"	Q9NQU5	15	40238759-40277487	"Enzymes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 22.2"	"Cell type enhanced"	"Detected in many"	11	"Cytotrophoblasts: 38.8;Suprabasal keratinocytes: 16.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 14.8;HaCaT: 23.0;hTCEpi: 14.1;SK-BR-3: 7.8"									HPA031124	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cell Junctions"		NA	NA			"Nucleoplasm, Nucleoli fibrillar center"	"Cell Junctions"	"HPA031124: AB_10601044"	"unprognostic (1.85e-3)"	"unprognostic (2.15e-1)"	"unprognostic (3.33e-3)"	"unprognostic (7.79e-3)"	"unprognostic (7.08e-3)"	"unprognostic (9.57e-2)"		"unprognostic (2.71e-1)"	"unprognostic (7.73e-2)"	"unprognostic (1.34e-2)"	"unprognostic (7.13e-3)"	"unprognostic (4.04e-2)"	"unprognostic (8.87e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.79e-1)"	"unprognostic (7.37e-3)"	"unprognostic (3.34e-2)"	0.3	5.3	14.7	0.8	18.4	0.8	2.3	11.3	20.1	3.0	1.3	1.6	2.5	1.4	1.0	1.1	15.8	4.3	1.4	7.9	11.6	5.2	3.4	0.4	2.6	1.0	3.0	10.9	0.6	7.4	12.9	6.4	8.1	2.1	3.6	1.2	0.3	3.4	7.5	3.5	22.2	1.4	0.8	1.2	1.0	3.6	12.8	2.2	0.0	7.4	8.5	5.1	3.0	5.1	1.4	0.7	2.9	0.7	2.0	5.5	1.2	2.7	0.0	0.2	0.1	0.0	0.0	4.4	0.0	0.1	0.6	0.4	14.8	2.0	0.1	2.4	0.0	0.9	23.0	3.3	4.9	0.2	0.1	0.7	0.0	1.9	0.1	0.0	0.1	0.3	0.0	14.1	0.2	3.3	0.2	0.0	3.9	1.1	0.2	0.0	3.2	0.0	0.3	0.4	2.7	2.0	0.2	0.1	1.8	1.1	6.0	5.4	1.3	1.9	7.8	0.2	1.3	0.9	7.2	0.0	0.2	0.4	0.0	0.1	0.0	0.2	0.0	0.5	0.4	0.1	2.1	0.7	2.9	5.5	0.3	2.1	1.4	0.5	4.2	0.7	0.5	0.3	1.2	1.3	2.0	0.2	0.5	0.1	1.2	14.7	18.4	11.3	20.1	11.6	5.2	3.0	10.9	2.1	2.2	0.0	3.4	0.0	6.8	8.8	3.9	0.0	7.6	4.0	4.5	5.2	0.0	38.8	11.6	4.0	5.9	0.0	0.0	0.0	3.7	1.2	0.6	4.0	0.0	0.0	3.5	0.0	4.7	0.0	0.3	4.5	1.7	0.3	1.7	0.0	0.8	1.4	2.7	0.0	1.8	0.0	0.0	0.0	0.1	1.6	1.5	16.7	7.6	1.3	1.9	6.8
PARD3	"ASIP, Baz, Bazooka, PAR3, PARD3A, PPP1R118"	ENSG00000148498	"Par-3 family cell polarity regulator"	Q8TEW0	10	34109560-34815325	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	25	"basophil: 9.0"	"Lineage enriched"	"Detected in single"	73	"granulocytes: 9.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030443	Approved		Supported	"Plasma membrane,Cell Junctions"		NA	NA			"Plasma membrane, Cell Junctions"		"HPA030443: AB_10600926"	"unprognostic (9.49e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.81e-2)"	"unprognostic (3.52e-2)"	"prognostic unfavorable (1.73e-5)"	"unprognostic (3.48e-1)"	"unprognostic (3.49e-1)"	"unprognostic (8.07e-2)"	"unprognostic (5.82e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.20e-2)"	"unprognostic (3.54e-1)"	"unprognostic (9.20e-2)"	"prognostic unfavorable (4.41e-4)"	16.4	12.9	13.8	7.0	15.8	0.3	16.8	4.4	8.3	24.8	20.3	7.4	19.7	7.1	21.4	13.6	34.5	14.7	13.2	17.1	10.7	6.3	18.0	15.9	15.2	3.0	7.8	4.3	28.4	26.2	19.0	15.8	14.4	8.8	20.5	15.3	11.7	15.5	17.3	28.3	34.4	14.9	21.1	8.7	3.3	14.2	9.1	9.2	12.8	15.6	14.6	13.4	20.7	29.5	0.0	0.0	9.0	0.1	0.0	0.0	2.1	19.3	47.1	16.0	10.8	12.0	10.3	22.9	8.8	10.6	15.6	17.6	17.2	16.5	0.1	12.8	18.4	11.8	14.1	13.6	22.8	20.3	0.1	10.2	0.0	5.9	17.6	15.3	2.1	0.0	12.4	21.9	20.5	15.5	14.4	9.8	12.7	13.0	6.1	18.7	13.5	21.8	1.5	6.7	12.0	16.7	17.4	16.2	8.4	32.4	14.9	8.2	8.3	10.4	15.0	16.3	19.8	8.3	2.5	11.3	7.9	22.9	14.6	9.2	5.0	6.2	0.0	8.5	0.0	8.6	9.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	2.1	13.8	15.8	4.4	8.3	10.7	6.3	7.8	4.3	8.8	9.2	32.8	27.0	0.0	30.8	30.2	12.2	34.3	20.4	34.8	27.3	14.0	27.5	21.2	0.0	30.4	13.4	7.7	15.1	0.0	31.0	18.3	12.5	26.7	1.1	20.2	2.9	11.1	23.1	10.4	0.3	11.2	28.1	2.1	5.0	0.0	24.6	29.8	33.8	23.0	36.0	21.0	19.8	25.8	17.0	4.2	23.4	53.8	33.5	1.3	19.5	41.6
PARD3B	"ALS2CR19, PAR3beta, Par3L"	ENSG00000116117	"Par-3 family cell polarity regulator beta"	Q8TEW8	2	204545793-205620162	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 68.9;Peritubular cells: 54.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"memory CD4 T-cell: 1.0"	"Lineage enriched"	"Detected in single"	5	"T-cells: 1.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 17.1;BJ hTERT+: 10.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035283	Approved		Supported	"Cell Junctions"		NA	NA			"Cell Junctions"		"HPA035283: AB_10671102"	"unprognostic (6.18e-2)"	"unprognostic (3.86e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.41e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.38e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.43e-1)"	"prognostic favorable (2.67e-10)"	"unprognostic (1.74e-1)"	"unprognostic (8.13e-2)"	"unprognostic (1.23e-1)"	"unprognostic (8.09e-2)"	13.9	4.3	6.7	6.9	6.5	0.0	8.6	2.1	4.6	11.9	17.5	8.3	11.3	5.3	15.1	8.9	7.1	10.3	11.8	6.7	7.9	5.3	10.8	5.0	8.2	2.9	7.5	4.3	12.6	12.3	13.5	3.6	6.3	7.7	11.7	8.5	14.7	5.0	8.5	4.5	7.1	14.1	26.1	6.7	4.4	7.2	5.4	7.5	0.8	8.6	7.3	3.7	9.6	22.7	0.0	0.0	0.0	0.1	0.0	1.0	0.1	2.2	1.9	5.5	2.0	17.1	8.1	3.1	3.4	10.9	2.8	3.3	5.1	1.5	0.0	4.1	6.8	2.4	0.2	0.7	0.8	3.1	0.1	2.7	7.5	4.5	0.0	1.7	0.0	0.5	3.1	1.6	1.0	4.8	4.7	4.3	0.7	0.2	0.1	4.1	0.8	0.0	0.0	0.8	0.7	0.5	0.0	2.6	1.8	3.6	2.3	0.6	1.9	1.8	1.7	1.4	5.6	2.6	0.0	9.5	2.4	1.7	4.9	1.6	0.0	0.0	0.0	2.3	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.1	0.0	0.0	0.1	6.7	6.5	2.1	4.6	7.9	5.3	7.5	4.3	7.7	7.5	8.9	7.5	0.5	2.8	9.7	0.2	9.1	10.2	26.8	21.6	27.9	0.0	2.4	0.0	7.1	68.9	5.2	9.3	0.0	2.1	0.2	13.6	6.2	1.1	3.8	0.4	4.8	5.8	8.0	0.6	20.4	28.7	1.2	6.8	0.0	7.8	12.1	4.7	11.5	54.5	4.7	0.2	19.4	9.5	0.7	1.0	4.1	0.9	0.0	7.0	3.7
PARD6A	"PAR-6, PAR-6A, PAR6alpha, TAX40, TIP-40"	ENSG00000102981	"Par-6 family cell polarity regulator alpha"	Q9NPB6	16	67660946-67662778	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 26.8;pancreas: 31.0"	"Cell type enriched"	"Detected in many"	5	"Late spermatids: 203.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"REH: 17.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009733, HPA041551"	Approved		Supported	"Cell Junctions,Actin filaments,Cytosol"		No	No			"Cell Junctions, Actin filaments"	Cytosol	"CAB009733: AB_2159676, HPA041551: AB_2677545"	"prognostic favorable (5.40e-4)"	"unprognostic (6.18e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.33e-2)"	"unprognostic (7.63e-2)"	"unprognostic (4.08e-3)"	"unprognostic (1.23e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.59e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.98e-3)"	"unprognostic (9.13e-2)"	"prognostic favorable (3.08e-7)"	"unprognostic (9.22e-3)"	"unprognostic (6.69e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.39e-2)"	2.7	6.1	11.7	3.5	12.4	2.1	2.8	26.8	16.1	2.0	3.0	2.2	3.7	2.0	2.4	3.6	2.7	2.5	3.1	2.3	13.8	7.2	5.5	3.1	3.5	4.0	7.9	5.7	3.3	31.0	5.3	13.9	1.5	7.4	2.7	2.0	1.4	3.8	4.6	7.0	1.5	2.5	2.7	3.7	3.7	3.2	16.9	3.4	2.5	2.3	1.4	3.4	2.9	3.1	11.4	5.3	3.7	1.0	1.2	8.5	2.1	5.5	6.0	1.7	14.8	1.2	0.2	3.1	0.1	0.7	2.2	2.1	3.0	2.3	9.4	2.8	0.1	0.8	4.4	3.4	0.7	0.5	4.4	3.2	3.8	2.8	3.4	1.6	1.5	8.9	0.1	0.3	2.1	0.8	1.4	1.1	14.1	0.3	2.2	0.4	5.5	9.6	2.0	2.0	7.7	3.9	17.4	1.1	15.2	5.9	3.2	14.3	7.7	0.9	2.1	2.3	0.5	12.9	0.6	0.9	0.2	0.5	1.4	2.9	2.3	7.3	8.4	1.7	3.4	0.6	2.1	1.0	0.4	4.5	0.5	8.5	11.4	6.4	5.9	1.2	7.4	3.2	2.4	3.7	1.2	0.1	5.3	6.1	2.1	11.7	12.4	26.8	16.1	13.8	7.2	7.9	5.7	7.4	3.4	3.0	4.3	8.1	1.4	0.8	9.7	1.0	12.7	4.0	2.3	19.2	3.9	4.6	28.2	6.6	42.8	2.7	2.1	0.0	13.1	0.2	2.4	2.1	5.7	3.8	4.0	30.2	32.6	1.3	3.2	203.1	3.4	3.1	5.0	1.0	2.4	15.2	5.2	2.6	1.4	12.9	7.6	0.0	2.1	4.6	2.6	1.4	2.4	9.6	2.9	1.4
PATJ	"Cipp, INADL"	ENSG00000132849	"PATJ, crumbs cell polarity complex component"	Q8NI35	1	61742406-62178675	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 66.4"	"Group enriched"	"Detected in some"	9	"Alveolar cells type 1: 80.4;Alveolar cells type 2: 49.2;Ciliated cells: 49.5;Club cells: 71.7;Collecting duct cells: 54.1;Ductal cells: 30.3;Exocrine glandular cells: 23.0;Pancreatic endocrine cells: 38.8;Proximal tubular cells: 28.9;Syncytiotrophoblasts: 22.1"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 66.4"	"Cell type enhanced"	"Detected in many"		"eosinophil: 9.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 19.2;RPTEC TERT1: 16.9;RT4: 18.1"	"Low region specificity"	"Detected in many"							"HPA066352, HPA066960, HPA069079"	Approved		Supported	"Cell Junctions,Centriolar satellite,Cytosol"		NA	NA			"Cell Junctions"	"Centriolar satellite, Cytosol"	"HPA066352: AB_2685663, HPA066960: AB_2685755, HPA069079: AB_2686079"	"unprognostic (1.81e-1)"	"unprognostic (5.70e-3)"	"unprognostic (1.75e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.35e-1)"	"unprognostic (7.96e-2)"	"unprognostic (7.60e-2)"	"unprognostic (1.88e-1)"	"unprognostic (9.90e-2)"	"unprognostic (3.39e-3)"	"unprognostic (2.99e-2)"	"prognostic favorable (1.47e-5)"	"unprognostic (3.05e-3)"	"unprognostic (6.72e-3)"	"unprognostic (2.21e-2)"	"unprognostic (2.43e-1)"	2.6	4.6	3.4	6.3	4.4	1.9	11.6	66.4	3.2	5.7	9.6	2.0	17.9	5.5	4.4	17.7	11.6	5.3	10.3	27.8	2.3	5.1	19.8	7.7	12.5	6.1	4.6	2.0	4.7	17.9	15.2	21.4	2.8	14.2	8.4	7.0	4.4	24.8	24.3	25.4	13.9	15.7	5.2	15.8	2.2	6.3	2.7	3.0	1.3	17.0	11.1	9.6	7.4	7.5	1.8	0.3	9.9	0.2	3.2	4.1	0.8	19.2	3.9	1.3	1.7	0.7	1.9	16.3	1.1	1.5	1.2	1.6	6.7	7.3	0.1	5.2	2.4	10.5	11.6	2.8	10.2	2.1	1.9	4.8	0.1	5.6	5.9	1.6	0.0	0.1	0.7	10.9	2.0	4.6	3.0	0.6	0.0	0.0	0.0	1.0	6.7	0.0	0.0	6.7	8.7	1.0	0.0	1.4	2.7	16.9	18.1	3.3	1.1	4.9	16.0	4.2	13.8	12.7	0.2	0.1	1.0	2.4	0.1	2.2	0.8	1.4	2.5	0.9	0.0	0.2	0.4	0.1	9.9	1.9	0.1	3.5	1.8	3.1	2.6	0.1	1.5	4.1	2.6	0.9	3.2	0.2	0.3	2.7	0.8	3.4	4.4	66.4	3.2	2.3	5.1	4.6	2.0	14.2	3.0	80.4	49.2	0.0	0.0	0.0	0.0	0.0	0.0	49.5	71.7	54.1	0.0	2.5	5.0	30.3	0.0	0.0	0.0	0.0	23.0	0.6	0.0	0.0	1.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.8	0.0	0.0	28.9	0.0	0.0	0.0	0.0	0.0	0.0	22.1	0.0	0.0	0.0
PCDH1	pc42	ENSG00000156453	"Protocadherin 1"	Q08174	5	141853111-141879246	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Enterocytes: 37.9;Exocrine glandular cells: 40.1;Pancreatic endocrine cells: 44.8;Urothelial cells: 43.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 2.2;naive CD8 T-cell: 1.6"	"Lineage enriched"	"Detected in single"	6	"T-cells: 2.2"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 29.5;HaCaT: 36.8;HUVEC TERT2: 19.3;OE19: 26.1;RT4: 25.2;TIME: 25.1;WM-115: 17.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047720, HPA050538"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Cell Junctions"		NA	NA		270000	"Nucleoplasm, Cell Junctions"	Nucleoli	"HPA047720: AB_2680130, HPA050538: AB_2681162"	"unprognostic (4.67e-2)"	"unprognostic (1.79e-1)"	"unprognostic (5.30e-2)"	"unprognostic (4.61e-3)"	"unprognostic (5.03e-2)"	"unprognostic (4.16e-2)"	"prognostic unfavorable (4.96e-5)"	"unprognostic (1.98e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (3.61e-4)"	"unprognostic (2.43e-1)"	"prognostic favorable (7.55e-5)"	"unprognostic (2.05e-1)"	"unprognostic (4.16e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.91e-1)"	22.4	4.5	14.8	7.4	17.6	1.4	19.0	16.1	25.6	8.3	22.2	7.3	11.4	20.6	7.0	7.0	26.9	9.7	6.8	8.9	11.6	7.4	14.9	13.0	18.9	3.4	8.8	16.9	2.5	11.0	1.3	5.2	32.5	9.2	11.1	14.4	6.0	23.7	12.3	7.4	17.3	15.8	7.5	7.5	1.6	22.8	1.5	9.8	0.0	9.1	3.9	8.8	8.6	11.7	0.0	0.0	0.3	0.0	0.0	2.2	0.5	6.2	0.3	2.6	2.9	0.1	0.0	1.9	0.0	0.0	0.0	0.0	1.5	29.5	0.0	15.2	0.2	0.3	36.8	3.4	2.7	0.0	0.0	0.1	0.0	0.1	0.0	2.4	0.0	0.1	0.0	6.2	0.0	0.4	6.3	19.3	0.0	0.0	3.1	0.0	5.0	0.1	0.0	11.2	26.1	5.0	0.1	0.0	4.2	2.1	25.2	0.3	0.6	0.1	8.1	6.5	7.9	6.5	0.1	25.1	0.0	0.2	0.0	2.3	0.0	0.0	0.0	0.2	0.0	17.8	0.0	0.0	0.3	2.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.4	0.5	14.8	17.6	16.1	25.6	11.6	7.4	8.8	16.9	9.2	9.8	0.0	4.0	0.0	10.2	0.9	9.1	2.2	22.9	4.0	2.3	12.2	0.0	0.6	3.3	13.6	0.3	21.8	37.9	0.0	40.1	0.2	1.6	22.4	0.0	26.0	0.2	25.4	7.5	6.2	1.9	0.8	0.6	0.5	0.0	0.0	17.6	4.0	44.8	19.3	0.4	5.1	0.4	12.9	15.1	0.2	0.2	2.3	16.8	0.0	14.7	43.0
PCDH7	"BH-Pcdh, PPP1R120"	ENSG00000169851	"Protocadherin 7"	O60245	4	30720415-31146805	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Basal glandular cells: 66.6;Basal keratinocytes: 75.6;Cardiomyocytes: 73.6;Collecting duct cells: 61.1;Urothelial cells: 51.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEK 293: 16.7;RH-30: 47.0;RT4: 24.8"	"Low region specificity"	"Detected in all"							"HPA011866, HPA046521"	Uncertain		Enhanced	"Plasma membrane,Cell Junctions"		NA	NA			"Plasma membrane, Cell Junctions"		"HPA011866: AB_1855047, HPA046521: AB_2679682"	"unprognostic (1.87e-1)"	"unprognostic (8.88e-2)"	"unprognostic (4.48e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.04e-2)"	"prognostic unfavorable (6.46e-5)"	"unprognostic (1.96e-1)"	"unprognostic (8.39e-2)"	"unprognostic (1.02e-2)"	"unprognostic (9.91e-2)"	"unprognostic (2.09e-4)"	"prognostic unfavorable (6.42e-4)"	"unprognostic (1.55e-1)"	"unprognostic (7.65e-2)"	"unprognostic (1.56e-2)"	2.0	3.2	11.9	4.9	11.5	0.4	3.0	1.2	25.3	23.2	18.4	1.7	34.3	3.1	15.3	22.9	13.0	8.9	7.4	16.7	13.4	11.9	2.2	1.2	2.8	1.4	8.0	11.0	4.5	1.1	0.5	0.8	0.5	11.7	9.9	7.3	6.2	1.6	32.2	0.9	10.1	5.3	23.7	5.3	15.3	14.2	1.2	4.4	0.0	3.9	1.3	1.4	20.1	7.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.4	5.6	7.8	11.7	11.5	0.0	1.4	0.0	0.7	0.3	0.7	10.2	0.0	0.0	0.0	0.0	5.8	0.5	14.7	1.3	0.0	16.7	0.0	10.6	0.0	12.1	0.2	0.0	6.8	3.4	0.3	4.2	6.9	2.8	0.0	0.0	0.0	3.4	0.0	0.0	0.0	3.4	3.5	1.5	0.0	47.0	0.0	0.3	24.8	0.3	0.1	0.1	0.4	0.5	3.3	0.7	2.6	0.0	9.5	2.4	2.6	0.0	0.0	0.0	0.0	7.4	0.0	6.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.9	11.5	1.2	24.9	13.4	11.9	8.0	11.0	11.7	4.4	0.0	0.0	0.0	66.6	75.6	29.7	73.6	0.0	13.4	3.4	61.1	0.0	0.1	0.0	0.1	12.1	4.8	0.0	0.0	0.6	0.1	7.7	12.5	1.1	0.0	0.3	9.5	0.0	12.9	0.6	7.9	0.3	0.8	20.3	0.0	0.0	1.3	15.4	0.0	26.9	0.0	2.9	0.0	12.2	1.1	2.4	33.8	0.1	0.0	0.0	51.1
PCDHA11	"CNR7, CNRN7, CNRS7, CRNR7, PCDH-ALPHA11"	ENSG00000249158	"Protocadherin alpha 11"	Q9Y5I1	5	140868183-141012344	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 9.3;parathyroid gland: 4.7"	"Cell type enhanced"	"Detected in single"	20	"Bipolar cells: 1.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 16.8;EFO-21: 8.8;MCF7: 4.5;T-47d: 6.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA077160			Approved	"Vesicles,Cell Junctions,Cytoplasmic bodies"		NA	NA			"Vesicles, Cell Junctions"	"Cytoplasmic bodies"	"HPA077160: AB_2686827"	"unprognostic (1.54e-2)"	"unprognostic (1.83e-3)"	"unprognostic (2.75e-1)"	"unprognostic (2.59e-1)"	"unprognostic (6.98e-3)"		"unprognostic (1.36e-1)"	"unprognostic (9.28e-3)"	"unprognostic (2.40e-3)"	"unprognostic (2.53e-2)"	"unprognostic (1.53e-2)"	"unprognostic (2.27e-2)"	"unprognostic (3.13e-4)"	"unprognostic (9.91e-5)"	"unprognostic (1.05e-1)"	"unprognostic (3.85e-3)"	"unprognostic (3.26e-2)"	0.1	0.6	1.0	0.1	1.6	0.0	0.2	7.0	9.3	1.3	0.0			0.0	0.6	0.1	0.0	0.2	1.0	0.0	0.8	1.0	1.2	0.0	0.8	0.0	0.3		0.0	3.3	4.7	1.6	0.0		0.1	0.0		1.3	0.0	0.0	0.0	0.3	0.1	0.3	0.0	0.0	1.6			1.5		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	4.0	16.8	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.5	0.0	8.8	0.0	0.9	0.0	0.2	1.1	0.0	0.0	0.0	0.0	2.1	0.0	0.1	0.0	0.0	0.0	2.2	0.0	0.5	0.4	0.0	1.0	0.0	0.1	0.0	4.5	0.0	0.0	3.7	0.8	3.2	0.0	0.0	0.0	0.4	1.9	0.8	2.2	0.0	1.8	0.4	2.4	6.0	0.0	0.0	0.7	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	1.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0
PDGFRA	"CD140a, GAS9, PDGFR2"	ENSG00000134853	"Platelet derived growth factor receptor alpha"	P16234	4	54229097-54298247	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	"Chemotaxis, Host-virus interaction"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 81.5"	"Group enriched"	"Detected in many"	9	"Fibroblasts: 171.4;Leydig cells: 416.6;Peritubular cells: 384.4"	"Cancer enhanced"	"Detected in all"		"glioma: 30.8"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"ASC diff: 82.8;ASC TERT1: 38.8;BJ hTERT+: 48.0;fHDF/TERT166: 33.4;HHSteC: 28.0;HSkMC: 70.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004947, CAB018143"	Supported		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"	"Intracellular and membrane"	NA	NA		150000	"Nucleoplasm, Plasma membrane, Cell Junctions"		"CAB018143: AB_2162351, HPA004947: AB_2732399"	"unprognostic (1.67e-1)"	"unprognostic (9.35e-2)"	"unprognostic (4.59e-3)"	"unprognostic (1.60e-1)"	"unprognostic (8.92e-2)"	"prognostic favorable (9.33e-4)"	"unprognostic (1.24e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.18e-2)"	"unprognostic (2.18e-1)"	"unprognostic (7.01e-2)"	"prognostic unfavorable (9.79e-6)"	"unprognostic (9.58e-3)"	"unprognostic (9.87e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.72e-3)"	35.0	12.4	12.6	16.1	7.6	0.9	17.2	2.4	20.1	33.2	19.1	9.2	6.4	9.6	27.6	14.6	21.9	22.5	16.2	15.3	8.9	7.4	22.8	8.4	24.1	26.9	9.2	4.0	81.5	6.8	1.6	2.1	25.1	7.2	18.6	15.2	19.2	8.5	8.3	11.9	7.0	17.4	19.7	8.8	51.6	13.6	19.0	9.3	0.5	11.3	12.8	4.3	35.9	24.6	0.9	0.4	2.5	0.4	0.3	0.8	0.3	0.0	0.0	0.2	0.1	82.8	38.8	0.1	4.3	48.0	0.0	0.1	11.5	0.0	0.1	0.1	33.4	0.1	0.1	3.3	0.0	0.0	0.4	0.1	0.1	0.1	0.2	28.0	0.0	0.0	70.4	0.0	5.5	0.0	0.9	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.2	0.6	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.1	6.7	0.0	0.1	0.0	0.3	0.1	0.0	0.1	15.2	0.5	16.6	0.0	0.0	0.0	0.1	0.4	0.0	0.3	2.5	0.4	0.2	0.5	0.2	0.2	0.6	0.8	0.4	0.0	0.9	0.7	0.4	2.3	0.3	0.3	0.4	0.2	0.3	12.6	7.6	2.4	7.3	8.9	7.4	9.2	4.0	7.2	9.3	0.0	0.3	0.9	0.3	15.1	0.7	4.0	0.0	0.0	0.0	0.0	0.0	1.3	1.7	2.9	1.6	3.3	0.0	0.0	5.8	1.2	171.4	0.4	0.0	0.8	2.8	0.0	0.0	38.1	0.6	3.7	416.6	1.6	21.9	8.2	0.0	18.3	12.2	0.0	384.4	0.0	0.4	0.0	13.2	1.1	3.5	13.8	1.1	0.0	0.0	0.8
PDLIM1	"CLIM1, CLP-36, CLP36, hCLIM1"	ENSG00000107438	"PDZ and LIM domain 1"	O00151	10	95237572-95291024	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Basal glandular cells: 648.1;Enterocytes: 781.7;Paneth cells: 737.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"eosinophil: 39.1;memory B-cell: 49.1;naive B-cell: 44.9"	"Group enriched"	"Detected in many"	6	"B-cells: 49.1;granulocytes: 39.1"	"Cell line enhanced"	"Detected in many"		"HaCaT: 96.9;HHSteC: 94.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA017010, CAB072838, CAB072840"	Approved		Supported	"Plasma membrane,Cell Junctions,Actin filaments"		NA	NA		210000000	"Actin filaments"	"Plasma membrane, Cell Junctions"	"CAB072838: , CAB072840: , HPA017010: AB_1855147"	"unprognostic (1.61e-1)"	"unprognostic (2.87e-2)"	"unprognostic (2.58e-2)"	"prognostic favorable (1.14e-5)"	"unprognostic (3.18e-2)"	"unprognostic (7.54e-2)"	"unprognostic (2.07e-1)"	"unprognostic (8.99e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.82e-3)"	"unprognostic (5.77e-2)"	"unprognostic (6.56e-2)"	"unprognostic (1.27e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.21e-3)"	"unprognostic (1.11e-1)"	60.9	6.4	2.9	32.3	3.7	2.7	69.9	3.6	3.7	30.6	78.8	3.0	24.3	27.8	30.0	35.6	48.3	28.0	38.4	107.5	3.0	2.4	19.8	49.0	78.8	91.6	6.3	2.2	23.3	20.5	11.7	6.7	53.0	16.5	34.7	34.7	12.8	34.5	27.4	150.1	26.4	96.3	27.2	8.6	52.9	28.3	14.3	3.6	23.4	76.9	54.9	41.9	65.0	38.9	49.1	6.8	39.1	0.5	1.7	3.2	9.2	34.5	22.3	1.6	0.0	8.2	5.6	36.0	10.6	33.0	27.6	45.4	47.1	53.7	0.0	3.0	28.6	14.0	96.9	11.3	61.3	28.0	0.0	17.5	34.4	6.7	76.3	94.4	0.0	1.8	16.1	32.3	14.0	50.9	29.6	49.3	3.0	7.4	8.8	6.5	6.1	0.1	0.6	3.2	16.7	18.0	29.0	1.3	12.1	14.2	32.9	6.2	2.5	11.4	10.5	0.1	38.8	8.6	15.2	43.4	10.8	2.5	0.0	0.0	4.2	0.0	11.3	11.9	0.0	5.1	0.0	0.5	39.1	2.8	0.1	0.0	49.1	0.5	3.2	6.8	44.9	0.1	2.0	1.7	1.7	0.3	0.7	0.4	9.2	2.9	3.7	3.6	3.7	3.0	2.4	6.3	2.2	16.5	3.6	71.5	92.6	110.2	648.1	325.4	6.5	205.6	201.2	180.7	158.1	48.8	27.5	481.5	13.3	337.3	7.0	238.0	781.7	23.3	152.6	92.5	136.8	121.0	11.6	70.6	44.6	1.6	97.3	328.4	20.6	5.3	4.6	29.4	38.8	5.4	406.4	7.0	203.4	737.0	0.7	62.7	43.8	310.4	177.4	0.5	42.4	173.0	97.8	33.0	340.8	482.4
PDPN	"aggrus, Gp38, GP40, PA2.26, T1A-2"	ENSG00000162493	Podoplanin	Q86YL7	1	13583465-13617957	"Predicted membrane proteins"	"Cell shape"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 71.8"	"Cell type enhanced"	"Detected in many"	14	"Alveolar cells type 1: 98.3;Fibroblasts: 108.5;monocytes: 202.8;Muller glia cells: 85.7;Peritubular cells: 59.1"	"Cancer enhanced"	"Detected in many"		"testis cancer: 102.3"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 3.1"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 3.1"	"Cell line enhanced"	"Detected in some"		"AF22: 30.3;EFO-21: 72.6;HAP1: 50.4;HHSteC: 44.7;NTERA-2: 23.3;SuSa: 25.2;TIME: 48.3"									"HPA007534, HPA007949, CAB008376"	Enhanced		Supported	"Plasma membrane,Cell Junctions,Mitochondria"		NA	NA			"Plasma membrane"	"Cell Junctions, Mitochondria"	"CAB008376: AB_592530, HPA007534: AB_1857718, HPA007949: "	"unprognostic (1.75e-1)"	"unprognostic (3.19e-2)"	"unprognostic (6.03e-2)"	"unprognostic (3.61e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.85e-2)"	"unprognostic (5.23e-2)"	"unprognostic (9.21e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.92e-2)"	"unprognostic (5.62e-3)"	"unprognostic (9.20e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.29e-2)"	"unprognostic (2.78e-2)"	27.7	2.0	6.3	29.8	10.9	0.5	30.3	5.0	6.7	21.4	12.8	11.0	4.1	2.5	16.8	15.3	8.9	19.8	23.7	18.6	5.7	6.5	1.9	0.8	17.8	10.4	10.0	2.4	18.4	3.9	0.7	2.3	71.8	13.5	11.3	6.4	26.6	6.0	8.6	21.9	10.0	7.6	18.6	17.5	0.7	15.1	9.7	7.9	3.2	5.7	9.7	9.9	27.3	28.9	0.4	0.2	3.1	0.4	0.3	0.4	0.1	0.0	0.0	30.3	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	72.6	1.7	0.0	0.1	50.4	9.0	0.0	0.1	9.2	0.0	0.0	0.0	44.7	0.0	0.0	6.1	16.8	3.8	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.3	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	25.2	0.0	0.1	48.3	8.5	7.3	0.1	0.0	0.0	0.0	0.1	18.1	0.0	0.0	1.0	0.4	0.6	0.2	0.2	0.2	0.4	0.3	0.3	0.2	0.4	0.4	0.3	3.1	0.3	0.2	0.2	0.2	0.1	6.3	10.9	5.0	4.8	5.7	6.5	10.0	2.4	13.5	7.9	98.3	9.1	0.0	29.7	12.9	1.2	6.9	0.0	6.7	29.6	0.0	3.9	1.8	0.0	0.4	0.5	7.4	0.0	0.0	0.0	1.6	108.5	3.5	1.1	0.0	6.5	0.0	0.0	7.4	0.0	0.4	18.7	4.1	6.8	202.8	0.0	85.7	0.5	0.0	59.1	0.0	2.8	0.0	6.2	0.9	8.6	6.0	2.4	0.0	0.0	3.4
PEAR1	"FLJ00193, JEDI, MEGF12"	ENSG00000187800	"Platelet endothelial aggregation receptor 1"	Q5VY43	1	156893698-156916434	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Endothelial cells: 26.3;Erythroid cells: 23.3;Ito cells: 34.4;Leydig cells: 41.1;Peritubular cells: 33.6;Sertoli cells: 25.8;Smooth muscle cells: 14.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 9.1;HBEC3-KT: 13.8;HHSteC: 10.4;HUVEC TERT2: 24.4;TIME: 39.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035217	Approved		Approved	"Nucleoplasm,Cell Junctions,Centrosome"		NA	NA		35000000	"Nucleoplasm, Cell Junctions"	Centrosome	"HPA035217: AB_10669902"	"unprognostic (1.02e-1)"	"unprognostic (1.84e-5)"	"unprognostic (4.77e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.48e-1)"	"unprognostic (5.62e-2)"	"unprognostic (5.93e-2)"	"unprognostic (1.04e-2)"	"unprognostic (3.99e-1)"	"unprognostic (2.17e-1)"	"unprognostic (5.04e-1)"	"prognostic unfavorable (4.31e-4)"	"unprognostic (1.20e-2)"	"unprognostic (3.37e-3)"	"unprognostic (8.51e-2)"	"unprognostic (2.64e-2)"	18.5	7.1	1.8	3.0	5.1	2.8	29.2	1.2	2.9	16.5	5.8	2.7	6.3	2.3	15.9	10.5	6.6	8.9	10.3	11.1	2.7	1.8	6.8	3.8	12.0	10.1	3.2	2.1	10.6	3.2	1.7	3.9	15.5	3.7	9.6	1.4	15.5	4.1	5.5	11.4	4.4	4.1	9.6	3.1	12.2	4.1	8.1	1.5	0.6	10.5	5.8	2.1	6.7	11.5	0.0	0.0	0.4	0.0	0.0	0.0	2.4	0.2	1.3	0.4	0.0	0.0	1.8	0.0	5.4	9.1	2.2	1.3	0.1	0.2	0.0	0.2	4.0	0.2	0.1	0.0	13.8	0.6	0.0	0.0	6.7	0.2	0.3	10.4	0.0	0.0	5.4	0.0	3.1	0.7	0.5	24.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	3.4	0.0	0.0	39.2	0.0	3.0	1.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	2.4	1.8	5.1	1.2	2.9	2.7	1.8	3.2	2.1	3.7	1.5	0.0	5.6	0.0	0.0	0.8	1.3	5.6	2.5	0.0	0.0	0.0	0.0	0.1	0.0	0.6	1.1	26.3	0.0	23.3	0.3	0.1	5.1	0.1	1.1	0.0	0.4	0.0	1.7	34.4	1.3	1.9	41.1	0.4	5.0	0.0	1.0	0.3	0.9	0.0	33.6	0.0	0.2	25.8	14.6	0.7	1.1	1.0	0.2	0.0	0.0	0.1
PGLYRP2	"PGLYRPL, PGRP-L, PGRPL, tagL, tagL-alpha, tagl-beta, TAGL-like"	ENSG00000161031	"Peptidoglycan recognition protein 2"	Q96PD5	19	15468645-15498956	"Enzymes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	Immunity	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"liver: 95.8"	"Cell type enriched"	"Detected in some"	16	"Hepatocytes: 136.1"	"Cancer enriched"	"Detected in some"	16	"liver cancer: 42.9"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"granulocytes: 3.6;monocytes: 7.1;T-cells: 3.7"	"Group enriched"	"Detected in some"	6	"MCF7: 10.9;T-47d: 10.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB033468, HPA046311, HPA075237"	Supported		Approved	"Cell Junctions"	"Secreted to blood"	NA	NA		160000000000	"Cell Junctions"		"CAB033468: AB_1127187, HPA046311: AB_2679621, HPA075237: AB_2686739"	"unprognostic (7.39e-3)"	"unprognostic (1.52e-2)"	"unprognostic (5.22e-2)"	"unprognostic (8.79e-2)"	"unprognostic (3.97e-1)"	"unprognostic (4.88e-4)"	"unprognostic (5.93e-3)"	"unprognostic (6.48e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.18e-2)"	"unprognostic (3.15e-2)"	"unprognostic (2.40e-1)"	"unprognostic (6.66e-16)"	"unprognostic (6.35e-3)"	"unprognostic (2.80e-1)"	"unprognostic (2.45e-2)"	"unprognostic (2.81e-4)"	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	95.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	3.6	7.1	0.6	3.7	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	10.9	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.1	0.0	0.7	0.0	0.0	0.2	0.0	0.0	0.0	10.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	3.6	0.7	0.3	2.6	2.4	2.5	0.3	1.6	1.3	0.2	0.0	3.6	3.7	2.5	0.6	7.1	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.2	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	136.1	0.3	0.0	0.0	3.1	1.3	2.5	0.3	0.0	8.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	2.9	0.0	0.0
PKP2		ENSG00000057294	"Plakophilin 2"	Q99959	12	32790745-32896840	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"		"Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"heart muscle: 134.7"	"Cell type enhanced"	"Detected in many"	16	"Cardiomyocytes: 399.9;Extravillous trophoblasts: 148.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"eosinophil: 10.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 56.3;OE19: 20.4;SuSa: 45.7"	"Region enriched"	"Detected in many"	4	"hippocampal formation: 22.1"	"Low region specificity"	"Detected in all"			"HPA014314, CAB037336, HPA056908"	Enhanced		Enhanced	"Nucleoplasm,Cell Junctions"		NA	NA			"Cell Junctions"	Nucleoplasm	"CAB037336: , HPA014314: AB_1855451, HPA056908: AB_2683272"	"unprognostic (1.89e-1)"	"unprognostic (1.70e-2)"	"prognostic favorable (8.55e-4)"	"unprognostic (2.55e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.88e-2)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (6.79e-4)"	"unprognostic (2.90e-1)"	"unprognostic (1.83e-2)"	"unprognostic (5.94e-3)"	"unprognostic (2.22e-1)"	"unprognostic (4.94e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.41e-2)"	"unprognostic (3.76e-2)"	3.1	0.7	1.4	7.9	5.2	1.1	3.3	2.2	1.8	6.1	14.2	1.4	6.9	6.5	1.2	2.0	3.3	21.6	4.4	134.7	3.9	0.9	3.6	13.6	1.1	3.4	0.7	2.0	9.5	5.4	9.6	14.7	24.1	3.8	3.5	13.3	12.6	24.6	5.0	3.4	1.9	13.3	1.3	1.3	2.4	4.8	3.4	0.4	2.7	0.6	2.3	4.3	2.0	2.1	0.6	3.9	10.4	2.1	1.5	1.0	0.6	15.7	3.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	56.3	14.2	0.0	9.7	0.0	2.1	14.0	1.9	12.4	0.0	0.0	4.5	0.1	0.6	14.7	8.8	0.8	0.2	0.0	11.7	0.0	13.6	6.3	0.5	0.0	2.8	4.4	1.3	4.1	0.0	0.1	8.6	20.4	2.7	0.0	6.8	4.7	4.1	7.5	1.7	1.5	0.6	3.3	0.0	45.7	7.1	0.2	0.1	0.0	6.3	0.0	3.8	3.7	0.0	0.1	0.0	0.0	0.7	5.1	1.4	10.4	0.4	1.6	1.0	0.2	0.6	0.4	3.9	0.6	0.9	0.5	1.2	1.5	2.1	0.8	0.6	0.6	1.4	5.2	2.2	1.8	3.9	0.9	0.7	2.0	3.8	0.4	0.0	0.0	2.4	42.2	6.3	1.0	399.9	15.3	12.0	19.4	1.8	3.9	39.7	3.3	12.2	3.0	3.5	74.7	0.0	8.6	148.3	17.6	16.8	4.6	39.3	7.7	1.6	26.0	3.7	13.1	1.3	10.9	7.4	10.1	0.0	60.1	13.0	16.5	52.6	2.1	8.4	1.1	0.0	1.4	5.4	7.2	2.9	34.7	0.7	87.1	25.7
PKP3		ENSG00000184363	"Plakophilin 3"	Q9Y446	11	392614-404908	"Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 69.0;skin 1: 48.4;tongue: 59.0"	"Cell type enhanced"	"Detected in many"	7	"Enterocytes: 206.5;Extravillous trophoblasts: 144.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 1.6;NK-cell: 2.3"	"Group enriched"	"Detected in many"	5	"NK-cells: 2.3;T-cells: 1.6"	"Cell line enhanced"	"Detected in many"		"A-431: 37.6;CAPAN-2: 26.4;HaCaT: 50.7;hTCEpi: 33.2;MCF7: 23.7;SK-BR-3: 38.5"	"Region enriched"	"Detected in single"	37	"cerebellum: 10.0"	"Low region specificity"	"Detected in many"			"CAB012993, HPA062937"	Enhanced		Enhanced	"Nucleoplasm,Cell Junctions"		NA	NA			"Cell Junctions"	Nucleoplasm	"CAB012993: AB_2533221, HPA062937: AB_2684908"	"unprognostic (4.74e-2)"	"unprognostic (5.28e-2)"	"unprognostic (4.45e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.57e-1)"	"unprognostic (8.88e-3)"	"prognostic unfavorable (2.89e-5)"	"unprognostic (1.25e-1)"	"unprognostic (6.73e-3)"	"prognostic unfavorable (3.93e-4)"	"unprognostic (3.55e-2)"	"prognostic unfavorable (1.08e-4)"	"unprognostic (2.16e-2)"	"unprognostic (3.41e-1)"	"unprognostic (2.60e-1)"	"unprognostic (3.15e-2)"	0.6	0.0	0.2	3.7	0.3	0.0	3.3	0.2	0.3	14.5	14.6	0.3	5.0	11.2	1.9	6.2	69.0	2.6	8.9	0.5	0.3	0.1	0.6	0.2	4.3	0.2	0.2	0.2	1.1	10.2	3.9	3.8	23.2	0.2	4.5	3.6	0.2	12.5	2.5	0.6	48.4	25.4	1.0	0.2	0.3	10.4	0.5	0.2	2.2	5.8	59.0	29.9	2.8	21.5	0.3	0.0	0.0	0.0	2.3	1.6	0.1	37.6	7.3	0.0	0.1	0.0	0.0	15.8	0.3	0.2	0.8	0.4	15.0	26.4	0.0	1.5	0.3	1.7	50.7	0.0	19.2	0.1	0.0	9.5	0.0	4.3	10.4	0.1	0.0	0.0	0.1	33.2	0.1	8.1	0.1	0.1	0.0	11.2	0.2	0.1	23.7	0.1	0.0	0.0	19.0	12.7	0.2	0.0	0.1	0.4	7.6	10.8	0.1	10.9	38.5	0.0	0.5	13.9	0.1	1.3	0.2	1.4	0.7	0.2	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.2	0.8	0.0	0.3	0.0	0.7	0.0	2.3	0.0	0.0	0.0	0.1	0.2	0.3	0.2	0.3	0.3	0.1	0.2	0.2	0.2	0.2	14.9	15.4	0.0	43.7	64.1	0.0	1.1	7.6	9.4	12.5	12.2	0.0	112.3	0.0	83.2	0.0	0.4	206.5	0.0	54.5	144.7	3.5	34.6	13.8	0.0	11.6	0.0	20.8	0.0	0.0	0.0	0.9	1.8	1.7	3.6	76.4	0.5	96.8	93.0	0.0	0.7	0.1	0.0	1.6	0.0	0.4	77.5	91.8	0.0	83.6	52.6
PKP4	p0071	ENSG00000144283	"Plakophilin 4"	Q99569	2	158456964-158682879	"Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 111.7"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 5.3"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037334, HPA066647, HPA070648"	Approved		Enhanced	"Plasma membrane,Cell Junctions"		NA	NA			"Cell Junctions"	"Plasma membrane"	"CAB037334: , HPA066647: AB_2685696, HPA070648: AB_2686291"	"unprognostic (2.76e-1)"	"unprognostic (5.26e-2)"	"unprognostic (1.48e-2)"	"prognostic favorable (5.80e-4)"	"unprognostic (2.34e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.02e-3)"	"unprognostic (2.43e-1)"	"unprognostic (1.04e-2)"	"unprognostic (9.53e-2)"	"unprognostic (1.82e-2)"	"unprognostic (9.69e-2)"	"prognostic favorable (3.29e-7)"	"unprognostic (2.23e-1)"	"unprognostic (9.80e-2)"	"unprognostic (1.33e-3)"	"unprognostic (2.28e-3)"	7.3	3.9	42.7	3.7	42.1	4.2	15.5	14.5	26.6	19.8	7.1	49.9	6.9	7.1	8.3	8.9	10.7	11.8	8.9	12.1	47.7	31.2	34.2	9.7	7.3	3.0	66.9	14.7	8.3	8.7	12.2	6.6	3.4	28.4	7.8	8.1	10.4	19.3	13.1	4.0	9.4	6.4	8.5	111.7	3.2	7.7	5.6	31.6	3.3	18.2	2.4	5.5	9.1	6.9	0.1	0.7	1.0	5.3	0.0	2.1	0.5	16.7	9.3	12.9	14.6	5.9	6.5	12.3	14.0	7.5	21.1	18.3	31.3	15.9	10.7	10.4	16.2	7.7	13.6	16.6	13.9	35.3	16.1	8.5	10.1	10.5	25.5	10.0	16.0	2.2	2.8	13.5	14.5	22.1	12.8	10.6	13.8	13.7	17.1	16.0	18.5	7.0	6.8	13.7	23.4	7.1	9.3	19.2	9.2	31.1	12.1	22.4	4.0	9.7	14.6	11.4	12.4	17.3	14.7	4.9	12.6	14.2	9.3	17.5	9.8	8.2	7.9	7.4	8.8	12.2	0.0	1.0	0.0	0.4	0.3	0.7	0.0	1.5	0.6	0.4	0.1	1.2	0.4	1.0	0.0	5.3	0.7	2.1	0.5	42.7	42.1	14.5	26.6	47.7	31.2	66.9	14.7	28.4	31.6	38.7	17.6	4.9	19.0	24.0	32.4	44.7	50.9	33.5	34.2	45.4	27.5	0.3	19.9	20.4	10.2	56.2	10.3	23.3	15.9	0.3	10.4	28.3	9.3	23.7	2.6	4.8	8.6	20.3	8.1	7.0	10.0	6.7	6.8	1.8	17.6	8.1	14.4	10.5	15.9	25.9	18.6	12.9	13.4	10.7	5.9	26.6	0.2	3.5	19.5	18.6
PLEKHA6	"KIAA0969, PEPP3"	ENSG00000143850	"Pleckstrin homology domain containing A6"	Q9Y2H5	1	204218851-204377665	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 60.1"	"Cell type enhanced"	"Detected in many"	6	"Bipolar cells: 37.9;Cholangiocytes: 35.7;Enterocytes: 45.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"myeloid DC: 1.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"A-431: 20.3;BEWO: 33.0;CAPAN-2: 27.6;OE19: 27.6;RT4: 22.9;SK-BR-3: 20.4;T-47d: 19.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028152, HPA028157"	Enhanced		Approved	"Vesicles,Cell Junctions"		NA	NA			"Cell Junctions"	Vesicles	"HPA028152: AB_10601048, HPA028157: "	"unprognostic (9.81e-3)"	"unprognostic (3.05e-1)"	"unprognostic (1.59e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.38e-2)"	"unprognostic (9.01e-2)"	"unprognostic (3.32e-1)"	"unprognostic (9.60e-3)"	"unprognostic (1.53e-1)"	"unprognostic (5.02e-3)"	"unprognostic (1.23e-1)"	"unprognostic (8.22e-2)"	"unprognostic (5.17e-2)"	"prognostic favorable (3.57e-4)"	2.4	4.6	18.2	4.1	27.8	0.4	10.6	60.1	34.5	3.4	23.2	13.4	1.4	18.2	2.6	10.0	13.0	7.4	9.8	11.8	14.2	11.4	20.9	13.9	2.4	0.6	11.5	23.3	2.8	7.6	3.7	17.6	6.3	18.9	9.4	21.9	21.7	5.2	11.2	2.6	2.0	20.8	4.8	19.0	1.9	29.1	2.7	14.2	0.0	2.2	1.3	1.9	7.3	6.1	0.9	1.4	0.1	0.2	0.0	0.4	0.0	20.3	12.8	8.1	0.0	0.1	0.1	33.0	0.7	2.3	0.0	0.1	6.1	27.6	0.1	6.2	0.4	0.1	2.3	0.1	2.2	0.1	0.0	1.3	0.0	5.0	8.7	1.2	0.0	0.0	0.3	6.9	0.0	1.8	2.5	3.6	0.3	0.0	0.0	8.3	9.1	0.0	0.0	2.5	27.6	15.7	0.0	0.0	0.0	8.2	22.9	1.7	16.9	9.2	20.4	0.1	1.8	19.5	0.1	0.2	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.4	0.2	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	18.2	27.8	60.1	34.5	14.2	11.4	11.5	23.3	18.9	14.2	0.0	10.4	0.0	4.3	0.1	37.9	13.9	35.7	2.7	1.2	8.7	19.6	5.7	3.3	6.8	6.8	1.1	45.2	0.0	4.5	1.4	2.6	7.3	0.0	18.7	0.7	17.5	16.1	0.6	0.0	2.9	4.9	0.2	0.0	0.0	27.5	0.9	9.4	28.8	3.5	9.1	6.7	0.0	0.2	0.1	0.1	0.5	18.1	0.9	24.0	6.9
PLEKHA7	DKFZp686M22243	ENSG00000166689	"Pleckstrin homology domain containing A7"	Q6IQ23	11	16777317-17014443	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 23.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"eosinophil: 6.8;MAIT T-cell: 4.5"	"Group enriched"	"Detected in many"	6	"granulocytes: 6.8;T-cells: 4.5"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 43.4;HaCaT: 28.7;OE19: 23.8;RT4: 39.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038610, HPA066103"	Approved		Enhanced	"Nucleoplasm,Cell Junctions,Cytosol"		NA	NA			"Nucleoplasm, Cell Junctions"	Cytosol	"HPA038610: AB_10671746, HPA066103: AB_2732738"	"unprognostic (1.05e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.81e-2)"	"unprognostic (4.30e-2)"	"unprognostic (2.51e-2)"	"unprognostic (6.95e-3)"	"unprognostic (2.81e-2)"	"unprognostic (1.85e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.65e-3)"	"unprognostic (3.13e-2)"	"prognostic favorable (1.89e-15)"	"unprognostic (9.74e-2)"	"unprognostic (1.17e-2)"	"unprognostic (4.81e-1)"	"unprognostic (2.65e-2)"	6.8	1.2	5.3	6.6	8.0	0.1	10.7	2.9	4.9	7.7	18.1	10.9	10.0	17.7	4.7	6.0	30.6	6.0	15.1	13.6	7.5	4.2	18.1	9.0	6.4	1.2	7.2	4.6	8.1	18.9	19.1	3.2	18.7	14.5	6.0	11.5	18.2	15.0	16.3	2.7	8.9	32.0	2.7	8.1	1.7	15.2	7.4	7.9	1.4	7.2	1.9	5.5	10.7	12.4	0.5	0.9	6.8	0.3	0.2	4.5	0.3	5.1	4.6	4.9	2.2	0.2	0.0	8.1	0.0	0.1	1.7	3.2	7.9	43.4	0.0	2.0	0.6	0.2	28.7	6.5	0.0	1.2	1.5	6.3	13.3	3.7	5.4	0.1	0.0	0.1	0.2	2.5	0.0	0.1	4.0	0.0	5.6	0.5	0.1	0.7	3.3	3.0	0.1	2.7	23.8	4.5	4.1	0.0	1.0	4.2	39.3	3.1	0.3	5.9	16.9	0.2	9.3	4.3	1.5	1.1	0.0	1.6	1.2	1.0	2.9	0.9	5.8	0.0	0.2	0.0	0.2	0.3	6.8	0.6	0.1	4.5	0.5	0.8	0.6	0.3	0.2	0.2	0.4	0.6	0.2	0.1	0.9	0.1	0.3	5.3	8.0	2.9	4.9	7.5	4.2	7.2	4.6	14.5	7.9	3.0	13.4	0.0	1.2	0.6	1.2	8.7	5.1	6.7	12.5	10.4	23.6	5.4	3.3	4.7	11.7	2.3	8.4	0.0	5.3	0.8	0.6	0.8	2.3	2.4	1.7	0.0	0.0	0.6	1.0	4.5	0.6	2.4	0.0	1.0	4.6	3.9	7.6	3.5	0.4	8.1	10.6	0.0	0.3	0.2	0.5	0.4	5.0	0.5	2.6	4.6
PLEKHG4	"ARHGEF44, DKFZP434I216, SCA4"	ENSG00000196155	"Pleckstrin homology and RhoGEF domain containing G4"	Q58EX7	16	67277510-67289499	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 28.2"	"Cell type enhanced"	"Detected in many"	11	"Spermatocytes: 28.6;Spermatogonia: 22.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 4.0"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"cerebellum: 3.7"	"Not detected"	"Not detected"			HPA055696			Approved	"Cell Junctions"		NA	NA			"Cell Junctions"		"HPA055696: AB_2682889"	"unprognostic (2.63e-1)"	"unprognostic (1.98e-3)"	"unprognostic (1.16e-1)"	"unprognostic (9.90e-2)"	"unprognostic (3.40e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.50e-1)"	"unprognostic (7.88e-2)"	"unprognostic (6.88e-2)"	"unprognostic (4.06e-3)"	"unprognostic (4.48e-2)"	"unprognostic (7.92e-2)"	"prognostic unfavorable (6.72e-9)"	"unprognostic (1.85e-1)"	"unprognostic (6.78e-2)"	"unprognostic (9.35e-3)"	"unprognostic (5.01e-2)"	5.6	3.5	1.1	3.8	3.9	1.1	7.4	1.0	3.2	4.8	4.5	8.0	3.3	3.6	4.7	5.0	6.1	3.3	6.1	2.2	1.2	1.5	2.2	0.3	4.8	6.8	5.4	2.4	15.2	7.3	0.5	2.6	4.7	3.9	2.2	2.7	9.5	5.7	2.1	1.3	8.2	3.7	2.7	4.7	6.5	2.0	28.2	1.3	5.9	3.4	3.4	5.5	1.6	4.3	0.6	4.0	0.2	0.7	0.4	2.0	1.0	2.5	4.8	0.3	2.8	2.5	23.9	3.7	5.9	7.9	6.0	9.9	13.7	2.3	7.1	17.2	5.4	2.0	0.1	3.6	0.3	4.3	1.2	1.9	14.0	11.3	3.3	7.7	8.3	11.3	17.9	2.8	20.0	0.2	5.0	11.7	23.2	11.2	0.1	0.1	1.9	10.5	2.8	2.2	2.0	5.1	0.0	0.0	7.3	2.8	0.5	1.5	8.8	19.9	1.5	8.1	0.9	1.1	5.9	17.7	2.9	10.5	21.0	0.1	17.0	16.8	6.6	12.1	0.2	3.5	0.0	0.2	0.2	0.8	0.7	1.5	0.6	1.0	1.1	0.3	0.1	2.0	1.2	0.0	0.4	0.3	4.0	1.4	1.0	1.1	3.9	1.0	3.2	1.2	1.5	5.4	2.4	3.9	1.3	3.0	1.6	0.0	0.5	2.5	0.7	2.8	2.5	1.4	5.7	1.8	0.0	0.3	0.0	0.8	1.1	1.5	1.0	0.0	0.3	0.3	3.1	0.5	3.5	0.0	0.7	0.0	1.2	2.5	1.3	2.0	5.8	1.0	0.0	0.0	2.2	2.2	1.0	2.9	1.4	0.0	5.5	6.5	0.9	28.6	22.2	1.1	0.2	3.2	3.2	0.4
PLEKHG6	"FLJ10665, MYOGEF"	ENSG00000008323	"Pleckstrin homology and RhoGEF domain containing G6"	Q3KR16	12	6310436-6328506	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 43.4;placenta: 39.6"	"Cell type enhanced"	"Detected in many"	11	"Enterocytes: 64.9;Extravillous trophoblasts: 43.1;Paneth cells: 35.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"neutrophil: 2.5;plasmacytoid DC: 3.9"	"Group enriched"	"Detected in many"	7	"dendritic cells: 3.9;granulocytes: 2.5"	"Cell line enhanced"	"Detected in some"		"BEWO: 56.1;CACO-2: 17.8;CAPAN-2: 9.8;OE19: 16.9;RT4: 18.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA041459, HPA058230"	Uncertain		Supported	"Cell Junctions,Centrosome"		NA	NA			"Cell Junctions"	Centrosome	"HPA041459: AB_10794518, HPA058230: AB_2683645"	"unprognostic (1.67e-1)"	"unprognostic (9.93e-3)"	"unprognostic (1.44e-1)"	"unprognostic (8.03e-3)"	"unprognostic (5.84e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.30e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.13e-1)"	"unprognostic (3.68e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.95e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.44e-1)"	"unprognostic (4.18e-2)"	"unprognostic (5.73e-2)"	7.5	0.2	0.3	8.9	0.7	1.0	15.8	0.3	0.4	4.4	30.3	0.4	1.1	19.4	0.6	1.6	19.9	0.5	6.7	1.2	0.3	0.0	1.1	2.5	1.8	0.3	0.3	0.3	0.6	4.5	1.9	3.3	39.6	0.5	2.6	9.6	0.7	8.8	2.3	0.3	6.7	43.4	0.5	0.3	0.4	5.7	0.5	0.3	0.5	3.4	11.3	8.6	6.8	8.6	0.3	3.9	2.5	0.2	0.1	0.4	0.1	0.2	2.1	0.2	0.0	1.1	0.1	56.1	0.1	0.0	0.1	0.1	17.8	9.8	0.1	0.1	0.0	0.0	4.6	0.0	0.1	0.0	0.0	0.0	0.0	0.5	3.5	0.2	0.2	0.1	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	2.7	0.0	0.2	4.6	16.9	0.3	0.0	0.0	0.1	0.0	18.9	0.1	0.0	0.4	8.4	0.1	4.2	2.7	0.0	0.4	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.6	0.2	0.6	0.2	0.1	0.1	0.1	0.1	0.2	0.0	0.3	0.1	0.4	2.5	0.1	0.1	3.9	0.1	0.1	0.3	0.7	0.3	0.4	0.3	0.0	0.3	0.3	0.5	0.3	0.0	0.0	0.0	5.7	4.4	0.0	0.3	5.1	0.0	0.0	1.8	0.0	13.8	0.0	8.3	1.1	0.3	64.9	0.0	1.6	43.1	1.1	6.7	0.0	2.1	2.4	0.0	8.1	0.0	0.0	1.5	2.3	0.0	0.0	0.0	18.6	0.9	2.5	35.4	0.7	0.7	0.0	0.0	3.1	0.2	0.5	6.0	20.0	0.0	20.6	16.8
PROM2		ENSG00000155066	"Prominin 2"	Q8N271	2	95274453-95291308	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Cholangiocytes: 45.9;Collecting duct cells: 31.4;Urothelial cells: 37.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 23.8;CAPAN-2: 42.0;HaCaT: 22.6;hTCEpi: 24.6;MCF7: 18.6;RT4: 25.6;SK-BR-3: 36.7"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"CAB046005, HPA063728"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA			"Nucleoplasm, Plasma membrane"	"Cell Junctions"	"CAB046005: AB_2284371, HPA063728: AB_2685104"	"prognostic unfavorable (2.16e-4)"	"unprognostic (1.60e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.76e-1)"	"unprognostic (7.30e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (2.90e-4)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (1.55e-6)"	"unprognostic (1.46e-2)"	"unprognostic (4.59e-1)"	"unprognostic (5.24e-2)"	"unprognostic (2.50e-2)"	0.3	0.2	0.5	2.9	0.6	0.0	9.3	1.1	0.5	11.4	5.2	0.3	22.2	4.4	1.4	22.5	42.6	2.2	37.2	0.5	0.6	0.5	18.8	0.4	1.3	0.3	0.6	0.3	1.5	8.6	8.1	1.5	12.5	0.3	11.6	4.2	0.3	35.6	20.0	1.3	26.7	2.6	2.7	0.7	0.4	11.5	1.8	0.3	1.7	5.7	21.6	22.2	20.0	14.8	0.0	0.2	0.6	0.0	0.0	0.3	0.0	23.8	0.0	0.0	0.2	0.1	0.0	12.1	0.0	0.0	0.1	0.1	0.2	42.0	0.0	0.0	0.0	0.0	22.6	0.0	13.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	24.6	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	18.6	0.1	0.1	0.0	1.1	0.1	0.0	0.0	0.0	0.0	25.6	0.2	0.0	0.0	36.7	0.0	0.3	11.5	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.1	0.1	0.6	0.0	0.0	0.2	0.2	0.0	0.5	0.6	1.1	0.5	0.6	0.5	0.6	0.3	0.3	0.3	3.0	3.4	0.0	20.8	6.0	0.2	1.4	45.9	6.7	11.4	31.4	3.9	15.3	10.0	12.0	0.4	0.0	2.6	0.0	9.6	2.3	0.8	11.1	0.0	0.0	2.0	0.0	3.5	0.0	0.0	1.1	0.3	0.0	6.8	1.0	10.5	0.0	12.7	7.0	0.7	0.0	0.9	0.0	1.0	0.7	0.0	11.2	9.4	0.0	12.4	37.6
PRR15		ENSG00000176532	"Proline rich 15"	Q8IV56	7	29563811-29567295	"Predicted intracellular proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 66.1"	"Cell type enhanced"	"Detected in many"	11	"Ciliated cells: 66.9;Enterocytes: 108.9;Paneth cells: 46.5;Undifferentiated cells: 48.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.6"	"Lineage enhanced"	"Detected in single"		"B-cells: 1.6"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 15.5;HaCaT: 17.9;OE19: 38.3;RT4: 13.7;SK-BR-3: 30.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA040996, HPA048121"	Enhanced		Uncertain	"Vesicles,Cell Junctions"		NA	NA			Vesicles	"Cell Junctions"	"HPA040996: AB_2677241, HPA048121: AB_2680271"	"unprognostic (5.46e-2)"	"unprognostic (1.27e-1)"	"unprognostic (8.97e-2)"	"prognostic favorable (6.37e-4)"	"unprognostic (7.49e-2)"	"unprognostic (1.96e-2)"	"unprognostic (2.00e-1)"	"prognostic unfavorable (7.23e-4)"	"unprognostic (2.95e-1)"	"unprognostic (2.45e-2)"	"unprognostic (3.69e-3)"	"unprognostic (1.25e-1)"	"prognostic favorable (1.83e-6)"	"unprognostic (1.30e-2)"	"unprognostic (5.71e-2)"	"unprognostic (2.33e-3)"	"unprognostic (1.58e-2)"	3.8	0.5	0.7	14.4	0.4	0.0	3.1	0.4	0.8	22.8	58.9	0.8	2.6	24.8	6.8	13.3	0.7	2.9	12.1	1.0	0.6	0.5	12.7	0.5	3.7	0.6	0.4	0.4	4.0	2.0	0.0	2.7	19.0	0.5	2.7	18.5	0.3	4.6	0.9	0.5	0.3	66.1	1.1	1.1	0.4	16.6	1.4	0.4	0.3	1.0	1.0	1.9	7.0	1.9	1.6	0.0	0.0	0.5	0.0	0.0	0.6	6.5	9.3	0.0	0.0	3.6	4.5	11.9	0.3	0.4	0.1	0.1	8.1	15.5	0.0	1.7	2.2	0.2	17.9	1.9	0.0	0.0	0.0	1.3	0.5	1.7	8.8	1.2	0.0	0.0	0.0	3.0	0.0	0.7	0.0	0.0	0.6	0.0	0.0	0.0	1.5	0.2	1.2	1.4	38.3	7.4	0.0	0.0	8.2	10.7	13.7	0.2	0.1	0.9	30.2	0.0	5.5	2.2	0.0	7.9	0.2	0.0	0.0	0.3	0.7	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.7	0.4	0.4	0.8	0.6	0.5	0.4	0.4	0.5	0.4	0.0	0.3	0.0	1.1	0.1	0.0	0.3	10.2	66.9	6.8	36.6	0.0	12.5	24.9	6.1	0.6	0.3	108.9	0.0	19.6	8.7	0.3	2.1	0.0	0.0	2.5	0.0	8.1	0.0	0.0	0.0	1.4	2.7	0.0	1.0	37.6	0.0	10.9	46.5	2.1	9.2	0.0	0.0	0.4	0.0	0.4	0.0	5.3	0.0	48.1	19.0
PSEN1	"AD3, FAD, PS1, S182"	ENSG00000080815	"Presenilin 1"	P49768	14	73136418-73223691	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Cell adhesion, Notch signaling pathway"	"Hydrolase, Protease"	"Alzheimer disease, Amyloidosis, Cancer-related genes, Cardiomyopathy, Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006844, HPA030760, HPA067496"	Approved		Supported	"Nucleoplasm,Golgi apparatus,Cell Junctions"		Yes	No			"Golgi apparatus"	"Nucleoplasm, Cell Junctions"	"CAB006844: , HPA030760: AB_10696211, HPA067496: AB_2685853"	"unprognostic (1.67e-1)"	"unprognostic (4.79e-2)"	"unprognostic (7.39e-2)"	"unprognostic (8.68e-3)"	"unprognostic (3.84e-1)"	"unprognostic (5.48e-3)"	"prognostic unfavorable (1.99e-5)"	"unprognostic (1.65e-1)"	"unprognostic (8.99e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.76e-3)"	"unprognostic (2.74e-1)"	"prognostic favorable (1.52e-8)"	"unprognostic (2.29e-1)"	"unprognostic (2.32e-1)"	"unprognostic (7.12e-3)"	"unprognostic (1.85e-1)"	16.3	15.3	21.0	13.4	34.9	19.2	15.7	15.5	24.7	16.5	26.2	66.1	9.5	26.6	14.2	15.4	19.0	12.6	17.1	9.9	28.6	18.2	19.7	16.9	16.9	10.8	42.1	20.7	13.5	15.0	21.8	9.2	22.7	31.8	13.6	25.6	15.0	16.8	13.4	13.0	24.7	27.9	14.6	61.9	14.6	16.3	16.8	39.7	15.4	19.7	8.7	15.9	17.2	13.5	9.0	24.4	38.1	34.0	11.7	10.5	17.1	14.4	22.2	20.8	8.3	29.1	20.8	18.9	21.3	24.5	21.9	27.6	27.6	36.2	9.4	14.1	20.2	17.9	38.5	17.5	16.1	23.9	21.5	10.8	10.8	15.1	13.4	26.9	10.8	21.1	21.3	29.4	18.1	22.4	20.0	17.5	10.6	12.0	19.2	20.4	28.7	8.2	14.1	9.0	25.7	16.5	10.5	17.7	12.0	30.4	30.7	11.6	15.5	23.2	21.8	18.9	19.7	27.0	24.3	18.5	22.3	18.4	18.1	10.0	12.6	18.4	9.6	18.7	13.2	13.5	29.2	27.1	27.1	7.2	30.8	7.0	7.2	7.0	5.9	24.4	9.0	6.6	6.4	38.1	11.7	34.0	12.8	10.5	17.1	21.0	34.9	15.5	24.7	28.6	18.2	42.1	20.7	31.8	39.7	26.8	35.7	14.6	21.9	25.3	16.5	10.1	20.4	22.7	26.1	22.7	37.3	22.8	5.0	24.3	8.6	20.3	63.6	0.0	23.2	24.7	22.1	24.7	17.4	18.6	27.3	12.7	15.5	13.5	47.8	10.0	15.3	43.2	15.1	33.3	34.1	13.6	29.5	51.8	14.5	13.3	27.4	25.8	18.4	21.6	13.7	28.9	41.8	20.3	36.6	44.4
PTPRB	PTPB	ENSG00000127329	"Protein tyrosine phosphatase, receptor type B"	P23467	12	70515866-70637440	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Angiogenesis	"Hydrolase, Protein phosphatase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"Endothelial cells: 113.4;Ito cells: 448.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	7	"memory B-cell: 3.5"	"Lineage enriched"	"Detected in single"	7	"B-cells: 3.5"	"Cell line enhanced"	"Detected in some"		"EFO-21: 11.3;hTERT-RPE1: 9.1;HUVEC TERT2: 28.0;TIME: 40.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004782, HPA067868"	Uncertain		Approved	"Vesicles,Plasma membrane,Cell Junctions"		NA	NA		6700000	"Plasma membrane"	"Vesicles, Cell Junctions"	"CAB004782: , HPA067868: AB_2685911"	"unprognostic (3.18e-1)"	"unprognostic (2.99e-6)"	"unprognostic (1.56e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.55e-2)"	"unprognostic (1.77e-2)"	"prognostic favorable (6.05e-4)"	"unprognostic (4.59e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.40e-1)"	"prognostic favorable (1.02e-4)"	"unprognostic (2.91e-2)"	"unprognostic (7.18e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.38e-1)"	23.5	7.0	4.5	5.5	7.0	0.1	22.9	3.6	6.1	11.3	8.0	4.3	7.1	5.3	17.1	8.5	5.8	8.2	11.4	17.6	6.2	5.1	18.7	12.0	39.9	3.3	6.9	4.6	5.5	4.4	4.9	5.7	23.3	7.8	6.1	8.2	16.0	3.6	7.1	11.8	4.7	7.4	13.3	7.3	22.9	5.2	3.7	4.3	0.7	14.0	12.2	2.6	6.5	14.7	3.5	0.1	0.2	0.0	0.4	0.3	0.2	1.9	0.1	0.8	0.1	0.0	0.0	0.4	0.4	1.9	1.0	2.4	0.0	1.5	0.7	11.3	0.3	0.1	6.9	0.1	0.3	3.6	0.6	0.3	0.1	0.8	0.5	0.1	0.3	0.0	0.0	0.3	2.8	0.0	9.1	28.0	0.0	1.5	0.5	0.6	0.0	0.0	0.0	1.0	1.9	0.4	0.0	0.7	0.4	5.2	0.8	0.0	0.4	0.7	0.0	1.6	0.2	0.0	0.6	40.9	0.4	0.4	0.1	2.4	0.5	0.4	0.3	0.2	0.5	0.0	0.2	0.0	0.0	0.2	0.0	0.0	3.5	0.0	0.3	0.0	0.3	0.1	0.0	0.1	0.4	0.0	0.1	0.0	0.2	4.5	7.0	3.6	6.1	6.2	5.1	6.9	4.6	7.8	4.3	0.0	19.9	13.7	0.8	3.3	5.4	9.2	17.8	0.0	1.2	3.5	0.0	0.0	0.0	1.4	4.3	113.4	4.3	46.7	0.8	0.0	1.9	0.6	23.3	2.0	0.3	4.8	0.0	448.7	26.3	2.5	1.1	2.0	5.0	0.0	4.8	0.3	7.2	14.4	0.0	0.0	0.8	0.0	0.9	0.7	0.5	1.4	0.0	1.7	5.2	0.6
PTPRK	R-PTP-kappa	ENSG00000152894	"Protein tyrosine phosphatase, receptor type K"	Q15262	6	127968779-128520674	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"memory B-cell: 2.3;naive B-cell: 4.8;naive CD8 T-cell: 1.6"	"Group enriched"	"Detected in many"	7	"B-cells: 4.8;T-cells: 1.6"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054056, HPA054822"	Uncertain		Supported	"Vesicles,Plasma membrane,Cell Junctions"		NA	NA		13000000	"Cell Junctions"	"Vesicles, Plasma membrane"	"HPA054056: AB_2682359, HPA054822: AB_2682614"	"unprognostic (3.15e-2)"	"unprognostic (1.07e-2)"	"unprognostic (5.79e-3)"	"unprognostic (4.95e-3)"	"unprognostic (1.89e-2)"	"unprognostic (7.26e-2)"	"unprognostic (3.27e-1)"	"unprognostic (6.06e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (1.99e-4)"	"unprognostic (1.46e-1)"	"prognostic favorable (9.33e-5)"	"unprognostic (2.10e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.59e-1)"	"unprognostic (9.32e-2)"	12.0	5.2	18.6	10.7	20.3	1.2	20.9	4.7	24.4	12.2	21.9	25.6	11.2	25.7	12.1	10.3	9.1	13.2	29.6	11.4	17.2	12.6	13.3	23.6	17.4	5.7	20.5	19.3	15.6	25.7	11.4	12.2	17.4	14.9	16.3	23.4	3.9	18.3	17.5	9.1	13.5	27.4	14.6	17.1	6.4	24.6	2.7	23.7	15.3	10.1	6.5	7.6	18.4	15.1	4.8	0.0	0.0	0.0	0.4	1.6	0.2	4.5	4.9	2.9	0.2	6.2	8.3	3.0	12.3	23.8	5.1	4.6	8.1	3.8	0.0	3.7	11.3	14.8	12.9	3.1	9.7	7.2	13.6	4.9	0.1	7.5	11.2	7.6	0.0	0.4	6.1	9.0	10.6	14.5	13.3	13.8	4.4	0.0	0.2	12.4	9.1	6.9	0.0	3.1	8.3	6.3	24.8	6.3	0.8	12.6	9.3	15.5	0.0	12.7	14.2	0.7	3.5	3.9	0.3	23.4	8.0	5.6	15.5	11.1	0.1	1.6	0.0	10.2	0.0	8.4	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.1	0.1	0.0	4.8	0.4	1.6	0.0	0.4	0.0	0.0	0.1	0.2	18.6	20.3	4.7	24.4	17.2	12.6	20.5	19.3	14.9	23.7	23.8	27.4	9.7	78.6	56.3	3.1	19.3	76.5	18.7	33.0	17.4	3.9	21.8	0.0	51.8	3.4	46.7	63.1	0.0	53.2	4.5	30.5	99.0	1.1	36.5	5.1	9.5	42.2	8.0	1.0	2.1	15.8	1.8	16.9	2.8	41.3	7.0	84.8	57.5	17.0	11.2	0.6	58.2	35.8	3.6	5.8	33.2	22.4	1.0	48.9	100.5
PTPRR	"EC-PTP, PCPTP1, PTP-SL, PTPBR7, PTPRQ"	ENSG00000153233	"Protein tyrosine phosphatase, receptor type R"	Q15256	12	70638073-70920843	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 56.1"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 11.2;Club cells: 5.7;Enterocytes: 7.3;Horizontal cells: 15.9;Paneth cells: 11.4"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"cerebellum: 56.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HDLM-2: 14.3;RT4: 27.4"	"Region enriched"	"Detected in all"	5	"cerebellum: 100.5"	"Low region specificity"	"Detected in all"			"CAB011461, HPA011851, HPA071067"	Uncertain		Supported	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA			"Plasma membrane, Cell Junctions, Cytosol"		"CAB011461: AB_298890, HPA011851: AB_1855939, HPA071067: AB_2686340"	"unprognostic (4.98e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.63e-3)"	"unprognostic (3.48e-5)"	"unprognostic (5.44e-3)"	"unprognostic (1.77e-3)"	"unprognostic (1.13e-1)"	"unprognostic (9.01e-2)"	"unprognostic (1.37e-3)"	"unprognostic (8.06e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.92e-2)"	"unprognostic (4.78e-2)"	"unprognostic (2.72e-1)"	"prognostic favorable (1.40e-5)"	0.4	3.8	18.8	1.6	11.3	0.3	0.4	56.1	20.9	0.5	11.2	0.1	0.0	5.1	8.4	0.3	0.4	0.5	1.9	0.4	8.6	4.9	0.4	0.4	0.4	0.4	1.3	13.2	0.4	0.6	0.3	0.9	0.7	3.3	0.5	7.8	0.8	0.4	2.1	0.4	0.4	11.3	4.9	3.1	0.4	4.4	0.4	1.4	0.0	0.4	0.0	0.3	4.8	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.4	0.0	0.3	0.0	0.0	0.5	0.0	0.0	0.0	14.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.2	27.4	0.1	4.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	18.8	11.3	56.1	20.9	8.6	4.9	1.3	13.2	3.3	1.4	0.0	0.0	0.0	0.1	0.5	11.2	2.5	0.0	0.0	5.7	0.0	0.0	0.0	0.0	2.1	1.7	1.5	7.3	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	15.9	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.3	1.9	11.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.4	0.3
PVALB	D22S749	ENSG00000100362	Parvalbumin	P20472	22	36800684-36819479	"Predicted intracellular proteins"		"Muscle protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 125.0;parathyroid gland: 137.5"	"Group enriched"	"Detected in some"	10	"Distal tubular cells: 543.8;Horizontal cells: 1442.9"	"Group enriched"	"Detected in many"	10	"breast cancer: 14.2;renal cancer: 59.5;urothelial cancer: 12.3"	"Region enhanced"	"Detected in all"		"cerebellum: 125.0"	"Cell type enriched"	"Detected in single"	6	"neutrophil: 3.4"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 3.4"	"Cell line enriched"	"Detected in single"	198	"RPMI-8226: 134.1"	"Region enriched"	"Detected in many"	5	"cerebellum: 2377.5"	"Low region specificity"	"Detected in all"			"CAB002515, HPA048536"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Cell Junctions"		No	NA			Nucleoplasm	"Nucleoli, Cell Junctions"	"CAB002515: AB_563948, HPA048536: AB_2680433"	"unprognostic (4.41e-2)"	"unprognostic (1.60e-1)"	"unprognostic (9.75e-2)"	"unprognostic (1.79e-3)"	"unprognostic (7.80e-2)"	"unprognostic (2.49e-2)"	"unprognostic (2.52e-2)"	"unprognostic (6.53e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.13e-1)"	"unprognostic (5.21e-2)"	"unprognostic (6.92e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.65e-2)"	"unprognostic (8.99e-3)"	0.9	0.8	1.2	0.9	3.9	0.8	4.3	125.0	47.2	0.8	0.8	6.6	0.0	0.8	1.1	0.9	0.8	0.8	0.9	0.8	4.5	9.4	16.7	1.8	1.2	1.2	28.6	2.5	0.8	0.8	137.5	0.2	1.2	22.9	0.9	0.9	27.3	1.2	1.0	5.0	0.8	0.8	0.9	12.6	1.2	0.9	1.1	1.2	0.0	0.9	0.0	1.4	1.2	1.0	0.0	0.5	3.4	0.4	0.0	0.3	12.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	134.1	0.0	0.4	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	3.4	0.0	0.0	0.5	0.3	12.2	1.2	3.9	125.0	47.2	4.5	9.4	28.6	2.5	22.9	1.2	0.0	0.0	0.0	0.0	0.0	39.1	0.2	0.0	0.0	0.0	36.6	9.8	0.2	543.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	10.5	0.0	40.7	1442.9	0.0	40.5	3.7	0.0	0.6	0.9	0.0	0.0	0.0	41.2	0.0	0.0	0.0	0.8	104.1	0.0	0.0	0.0	0.6	0.0	0.3	1.0	0.0	0.0
PYM1	"PYM, WIBG"	ENSG00000170473	"PYM homolog 1, exon junction complex associated factor"	Q9BRP8	12	55901413-55932618	"Predicted intracellular proteins"	"Nonsense-mediated mRNA decay, Translation regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"monocytes: 146.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012803, HPA039717, HPA046200"	Supported		Supported	"Nucleoplasm,Nucleoli,Cell Junctions,Cytosol"		No	No			"Nucleoplasm, Nucleoli, Cytosol"	"Cell Junctions"	"CAB012803: AB_2269494, HPA039717: AB_2676644, HPA046200: AB_10965556"	"unprognostic (3.03e-2)"	"unprognostic (1.00e-1)"	"unprognostic (5.65e-2)"	"unprognostic (8.82e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.28e-1)"	"prognostic unfavorable (3.05e-4)"	"unprognostic (3.29e-1)"	"unprognostic (2.17e-3)"	"unprognostic (2.44e-2)"	"unprognostic (3.94e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.59e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.29e-1)"	"prognostic favorable (1.34e-4)"	17.5	21.4	16.2	21.2	14.8	13.2	20.3	16.3	17.1	15.2	21.2	14.2	27.1	21.8	16.1	30.8	46.7	16.3	21.5	13.6	14.0	14.7	19.4	31.3	14.4	28.6	14.7	14.0	13.3	24.8	15.3	19.8	21.5	12.8	20.7	21.5	18.3	22.9	24.5	18.2	27.2	29.9	16.3	13.2	25.5	15.8	21.1	14.1	26.3	22.5	31.2	39.1	16.5	19.9	29.5	35.9	21.6	27.2	14.4	53.6	24.1	17.5	14.1	20.6	11.4	12.5	16.3	33.8	13.0	15.7	12.3	10.4	20.5	21.0	22.1	19.8	12.5	5.7	13.9	15.8	27.8	9.9	17.0	11.8	18.0	12.0	25.2	15.3	20.8	16.5	14.7	17.9	13.8	20.8	15.6	13.0	9.9	15.3	24.6	14.4	26.5	13.3	37.2	35.9	20.1	7.3	12.0	8.2	25.3	25.2	25.0	13.9	16.0	16.6	22.3	11.6	20.0	27.1	44.1	10.1	7.4	10.5	11.5	9.4	13.0	19.7	34.1	12.7	14.5	11.6	3.9	24.5	21.6	18.7	27.2	22.9	29.5	34.0	26.1	35.9	25.2	22.6	22.6	5.8	14.4	18.5	19.6	53.6	24.1	16.2	14.8	16.3	17.1	14.0	14.7	14.7	14.0	12.8	14.1	17.9	15.9	15.9	26.4	0.0	13.6	0.0	28.1	30.8	26.1	22.7	7.9	72.4	66.3	34.7	9.6	12.4	38.3	23.3	44.0	61.6	11.5	34.5	17.4	32.7	48.8	6.4	7.0	19.0	44.8	7.4	21.6	40.2	0.0	146.1	41.7	34.7	43.4	37.0	22.3	44.1	10.6	12.9	0.0	18.1	24.3	0.0	51.8	37.4	37.7	28.0
RAB25	CATX-8	ENSG00000132698	"RAB25, member RAS oncogene family"	P57735	1	156061160-156070514	"Cancer-related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 98.3"	"Cell type enhanced"	"Detected in many"	5	"Paneth cells: 238.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 3.3;naive CD4 T-cell: 3.4"	"Lineage enriched"	"Detected in single"	24	"T-cells: 3.4"	"Cell line enhanced"	"Detected in some"		"BEWO: 24.3;CAPAN-2: 23.6;MCF7: 32.8;OE19: 75.9;RT4: 29.8;SK-BR-3: 48.5;T-47d: 45.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA010872, CAB033645"	Enhanced		Uncertain	"Cell Junctions,Cytosol"		NA	NA			"Cell Junctions, Cytosol"		"CAB033645: AB_1128883, HPA010872: AB_1079729"	"unprognostic (2.43e-1)"	"unprognostic (4.57e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.27e-2)"	"unprognostic (4.63e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.03e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.39e-1)"	"prognostic favorable (1.38e-6)"	"unprognostic (2.31e-2)"	"unprognostic (3.24e-2)"	"unprognostic (3.14e-2)"	"unprognostic (4.94e-2)"	0.4	0.3	0.3	10.9	0.3	0.0	10.8	0.5	0.4	23.6	28.4	0.3	28.1	14.8	4.0	15.9	98.3	9.7	33.3	0.3	0.3	0.3	18.2	1.0	19.1	0.6	0.3	0.2	2.3	27.4	8.6	9.5	19.1	0.3	13.3	16.2	0.4	44.1	26.8	0.4	48.0	43.0	2.1	0.4	0.3	16.2	1.1	0.2	3.7	36.1	74.6	60.9	13.0	31.8	0.1	0.0	0.0	0.0	0.0	3.4	0.8	17.8	0.0	0.0	0.0	0.0	0.0	24.3	0.0	0.0	0.0	0.0	17.5	23.6	0.0	0.0	0.0	0.0	21.5	0.0	10.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.8	0.0	0.0	0.9	75.9	0.0	0.0	0.0	0.0	0.0	29.8	2.6	0.0	0.0	48.5	0.0	4.4	45.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.1	2.8	0.8	0.0	0.0	3.4	2.9	0.0	0.0	0.0	0.0	0.9	0.8	0.3	0.3	0.5	0.4	0.3	0.3	0.3	0.2	0.3	0.2	26.8	27.6	0.0	90.6	48.9	0.0	0.1	79.0	53.5	27.3	82.0	0.0	84.0	140.9	146.8	0.0	0.1	182.7	0.0	132.5	23.0	3.7	95.3	5.7	0.0	6.1	0.0	82.1	0.0	0.0	0.0	0.3	2.5	20.3	6.4	160.3	0.0	154.4	238.4	0.0	16.8	0.0	0.0	2.1	0.2	0.7	135.3	67.2	1.5	195.0	192.0
RAB3B		ENSG00000169213	"RAB3B, member RAS oncogene family"	P20337	1	51907956-51990764	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 18.2;placenta: 37.6;prostate: 20.0"	"Cell type enhanced"	"Detected in many"	17	"Alveolar cells type 1: 137.0;Alveolar cells type 2: 101.3;Intestinal endocrine cells: 282.2"	"Group enriched"	"Detected in many"	6	"prostate cancer: 19.4;testis cancer: 6.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 44.6;BJ hTERT+: 17.3;fHDF/TERT166: 16.1;HBF TERT88: 15.3;TIME: 34.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003159, CAB023293"	Enhanced		Approved	"Cell Junctions"		NA	NA			"Cell Junctions"		"CAB023293: , HPA003159: AB_1856005"	"unprognostic (1.10e-1)"	"unprognostic (2.20e-3)"	"unprognostic (5.43e-3)"	"unprognostic (1.65e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.20e-2)"	"unprognostic (8.77e-3)"	"unprognostic (2.79e-1)"	"unprognostic (2.81e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.02e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.15e-2)"	0.4	5.8	16.6	1.4	8.5	0.8	1.8	2.0	13.8	0.4	3.1	0.9	0.0	1.6	0.5	0.8	0.5	0.7	2.7	0.4	9.9	15.8	1.4	1.3	0.5	0.5	4.5	9.3	3.2	2.1	0.4	13.7	37.6	18.2	20.0	4.4	0.1	0.8	0.6	1.0	3.7	1.9	0.9	1.4	0.5	2.7	0.8	1.3	0.0	0.5	0.0	0.6	0.6	0.4	1.1	0.8	2.1	0.5	0.5	0.4	0.0	0.6	3.0	0.4	0.5	0.1	0.8	0.0	44.6	17.3	9.0	4.4	3.6	1.3	0.2	0.7	16.1	1.3	0.0	5.5	4.6	15.3	0.0	0.4	0.0	0.2	1.2	0.7	0.0	0.0	0.4	0.1	14.9	3.4	5.6	2.8	0.4	0.1	0.1	9.9	0.1	0.0	0.0	7.2	0.8	0.4	0.1	0.0	0.0	1.4	0.2	1.5	0.4	0.0	0.1	0.0	9.3	0.0	0.1	34.6	8.8	3.2	0.1	14.5	0.0	0.2	0.1	8.0	0.0	0.3	1.1	0.5	0.3	0.4	0.3	0.3	0.6	0.3	0.4	0.1	1.1	0.4	0.4	2.1	0.5	0.5	0.8	0.2	0.0	16.6	8.5	2.0	13.8	9.9	15.8	4.5	9.3	18.2	1.3	137.0	101.3	0.9	5.2	2.2	2.4	0.6	15.3	52.2	51.2	0.0	2.0	0.6	3.3	4.0	1.9	0.5	1.3	0.0	15.3	0.2	0.9	19.1	7.0	0.4	0.3	0.0	282.2	0.0	2.6	1.0	0.6	0.9	1.7	1.0	6.1	24.2	59.3	0.3	1.1	0.0	3.5	0.0	0.4	1.9	4.8	1.3	3.3	0.7	1.5	2.6
RAD51C	"FANCO, RAD51L2"	ENSG00000108384	"RAD51 paralog C"	O43502	17	58692573-58735611	"Disease related genes, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"	DNA-binding	"Disease mutation, Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Spermatocytes: 113.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 79.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA045198			Supported	"Nucleoplasm,Vesicles,Cell Junctions,Mitochondria,Cytosol"		NA	NA			"Nucleoplasm, Mitochondria, Cytosol"	"Vesicles, Cell Junctions"	"HPA045198: AB_2679250"	"unprognostic (5.39e-3)"	"unprognostic (2.39e-2)"	"unprognostic (1.23e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.83e-1)"	"unprognostic (4.59e-2)"	"prognostic unfavorable (8.68e-5)"	"unprognostic (3.65e-2)"	"unprognostic (2.91e-2)"	"unprognostic (1.03e-2)"	"prognostic favorable (5.33e-4)"	"unprognostic (2.55e-1)"	"unprognostic (2.62e-2)"	"unprognostic (7.62e-2)"	"unprognostic (2.41e-1)"	"unprognostic (9.52e-2)"	"unprognostic (2.42e-2)"	11.1	22.7	22.1	10.1	20.8	19.4	15.4	20.8	31.0	12.3	13.7	16.0	11.1	7.3	14.3	23.1	13.2	11.8	10.9	24.9	20.2	17.4	13.7	13.9	8.9	19.6	17.2	21.4	13.4	11.2	20.0	18.3	15.1	28.9	18.3	15.0	13.2	10.6	12.7	15.5	10.3	9.6	14.4	14.0	14.4	13.2	18.9	12.7	23.8	12.6	11.7	18.6	12.6	11.8	14.4	13.0	18.8	11.3	11.2	21.7	9.2	15.7	18.3	11.3	12.4	6.2	5.3	25.8	8.6	4.0	11.6	14.8	7.8	10.2	9.3	12.8	5.9	15.3	6.0	15.1	12.2	21.6	22.6	31.3	13.1	20.6	29.4	6.1	16.8	11.7	3.2	11.0	12.9	10.5	6.2	12.9	15.6	20.3	12.8	9.9	79.0	23.8	23.4	3.0	10.5	17.0	15.3	17.9	17.5	7.0	9.9	14.0	13.0	6.9	3.4	13.0	3.0	10.2	17.8	4.1	9.8	26.0	8.8	10.5	12.0	44.5	27.2	9.9	16.6	11.2	18.8	7.5	9.8	13.7	11.3	13.3	14.1	15.0	14.9	13.0	14.4	16.4	15.4	4.6	11.2	9.8	11.7	21.7	9.2	22.1	20.8	20.8	31.0	20.2	17.4	17.2	21.4	28.9	12.7	17.9	11.5	15.2	17.6	10.5	14.6	54.1	10.2	10.7	13.6	15.7	5.9	46.3	49.7	22.6	78.9	14.9	4.2	70.0	16.3	78.6	13.4	14.4	23.0	12.5	29.2	15.9	6.4	14.1	13.4	51.1	16.1	22.9	23.6	22.6	13.1	21.7	12.0	10.5	14.5	19.5	23.0	32.3	22.1	113.9	80.6	9.4	30.3	21.3	12.5	8.4
RASA4	"CAPRI, GAPL, KIAA0538"	ENSG00000105808	"RAS p21 protein activator 4"	O43374	7	102573807-102616757	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		"GTPase activation"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	5	"skeletal muscle: 58.0"	"Cell type enhanced"	"Detected in many"	9	"Bipolar cells: 65.5;Intestinal endocrine cells: 69.0"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-138 MG: 27.6"									HPA043010	Uncertain		Approved	"Vesicles,Cell Junctions"		NA	NA			Vesicles	"Cell Junctions"	"HPA043010: AB_2678267"	"unprognostic (6.44e-2)"	"unprognostic (3.64e-2)"	"unprognostic (8.93e-3)"	"unprognostic (1.69e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.17e-2)"	"unprognostic (3.44e-1)"	"unprognostic (7.45e-2)"	"unprognostic (2.92e-1)"	"unprognostic (2.29e-1)"	"unprognostic (4.62e-3)"	"unprognostic (4.19e-2)"	"unprognostic (4.81e-2)"	"unprognostic (8.87e-3)"	"unprognostic (2.47e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.18e-2)"	5.5	2.3	4.2	2.5	2.6	1.6	4.4	2.7	4.7	4.9	4.0			3.6	6.3	1.8	1.9	3.6	1.9	1.5	3.6	3.0	3.3	0.2	2.7	3.6	1.9		4.1	2.1	6.8	3.7	4.0		3.3	1.6		2.0	5.6	58.0	5.4	4.3	3.2	1.2	4.1	2.2	0.6			2.2		2.4	3.9	4.7	3.6	11.3	2.2	9.4	1.5	3.7	3.1	0.7	1.2	9.2	1.9	1.7	4.7	0.3	9.4	4.8	3.2	3.3	3.8	2.7	7.2	7.0	14.3	0.3	9.2	0.4	0.1	2.4	1.3	2.4	2.0	3.7	0.9	1.8	1.3	2.7	4.4	1.1	0.8	0.4	12.3	1.6	4.9	3.2	10.6	0.7	3.7	7.2	5.0	0.7	5.0	4.8	9.9	2.0	10.3	0.3	3.5	9.0	18.8	1.7	2.2	1.2	6.1	1.9	3.6	2.3	27.6	13.4	3.1	2.4	16.8	10.3	6.2	3.4	3.0	3.4	0.4	8.4	0.3	1.9	9.4	3.7	2.8	3.2	2.2	11.3	3.6	3.4	2.4	2.2	1.5	1.2	9.8	3.5	3.1											11.9	10.4	6.0	4.5	3.4	65.5	0.6	2.5	6.7	7.9	3.5	15.7	0.2	11.6	1.1	0.4	10.8	6.2	0.0	0.6	0.1	2.3	0.9	1.1	0.8	5.8	27.0	69.0	3.7	8.0	0.0	7.8	16.2	1.7	2.8	12.1	5.8	1.4	2.9	7.4	7.5	11.0	12.9	7.2	2.1	2.3	3.0	0.3	5.0	1.9	2.7
RASA4B		ENSG00000170667	"RAS p21 protein activator 4B"	C9J798	7	102482445-102517781	"Predicted intracellular proteins, RAS pathway related proteins"		"GTPase activation"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	8	"skeletal muscle: 47.4"	"Cell type enhanced"	"Detected in some"	10	"Bipolar cells: 2.3;Cardiomyocytes: 4.0;Distal tubular cells: 1.7;Intestinal endocrine cells: 2.4"	"Not detected"	"Not detected"							"Group enriched"	"Detected in some"	7	"classical monocyte: 3.7;intermediate monocyte: 3.7;myeloid DC: 6.2;plasmacytoid DC: 3.9"	"Group enriched"	"Detected in many"	20	"dendritic cells: 6.2;monocytes: 3.7"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 9.1;SH-SY5Y: 11.8;U-138 MG: 16.5;U-2 OS: 14.2"									HPA043010	Uncertain		Approved	"Vesicles,Cell Junctions"		NA	NA			Vesicles	"Cell Junctions"	"HPA043010: AB_2678267"	"unprognostic (1.05e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.15e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.10e-1)"	"unprognostic (6.79e-2)"	"unprognostic (3.08e-3)"	"unprognostic (2.31e-1)"	"unprognostic (5.44e-4)"	"unprognostic (1.18e-2)"	"unprognostic (3.77e-2)"	"unprognostic (4.37e-3)"	"unprognostic (1.10e-1)"	2.9	1.1	2.3	1.4	1.2	0.0	2.1	0.5	4.4	3.2	2.4			2.5	4.1	0.0	0.6	1.5	1.3	0.5	1.8	2.0	0.9	0.1	0.8	1.3	1.1		2.2	0.9	0.0	1.1	1.7		1.5	0.0		0.7	3.7	47.4	1.8	3.0	0.5	0.5	1.9	0.8	0.2			0.3		0.2	1.4	2.3	0.1	6.2	0.0	3.7	0.0	0.2	1.8	0.2	0.9	3.2	0.2	0.5	1.9	0.1	5.7	3.1	1.2	2.9	0.2	0.4	2.2	6.4	6.6	0.5	7.7	0.0	0.0	0.0	0.2	0.7	0.3	1.7	0.5	0.0	0.0	0.2	2.1	0.3	0.0	0.0	9.1	0.8	0.1	0.6	8.1	0.7	2.2	0.0	1.1	0.0	0.3	0.9	2.3	1.1	3.6	0.0	0.8	2.2	11.8	0.9	0.2	0.2	2.2	0.2	1.6	1.0	16.5	14.2	1.3	0.5	2.7	1.9	0.2	1.9	0.4	2.6	0.0	3.7	0.0	0.2	3.7	0.1	0.1	0.0	0.0	6.2	0.1	0.0	0.0	0.0	0.0	0.6	3.9	0.0	1.8											0.0	1.1	0.5	0.2	0.3	2.3	4.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.6	0.4	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.3	0.0	2.4	0.0	0.3	0.0	0.3	0.7	0.0	0.0	1.2	0.3	0.1	0.0	0.0	0.1	0.4	0.0	0.9	0.2	0.0	1.0	0.1	0.5	0.0	0.1
RASAL1	RASAL	ENSG00000111344	"RAS protein activator like 1"	O95294	12	113098819-113136239	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	Differentiation	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 64.0"	"Cell type enriched"	"Detected in many"	9	"Collecting duct cells: 34.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"Daudi: 8.5;EFO-21: 11.1;REH: 12.3;RPMI-8226: 27.4;RPTEC TERT1: 10.9;U-698: 23.3"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"amygdala: 21.7;cerebral cortex: 20.9;hippocampal formation: 33.7"	HPA041650	Enhanced		Approved	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	"Cell Junctions"	"HPA041650: AB_2677598"	"unprognostic (9.95e-2)"	"unprognostic (1.11e-2)"	"unprognostic (5.44e-3)"	"prognostic unfavorable (3.26e-5)"	"unprognostic (1.27e-2)"	"unprognostic (7.73e-3)"	"unprognostic (1.57e-2)"	"unprognostic (1.43e-2)"	"unprognostic (2.65e-1)"	"unprognostic (3.02e-3)"	"unprognostic (3.16e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.74e-2)"	"unprognostic (2.85e-3)"	"unprognostic (1.15e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.64e-1)"	0.9	10.4	8.6	2.5	11.2	1.2	1.6	0.4	18.2	2.5	2.1	18.8	3.7	1.2	0.9	0.9	16.9	2.2	1.8	0.8	11.8	4.9	7.4	0.9	0.9	1.7	7.3	10.9	0.8	1.4	64.0	3.9	1.0	4.0	0.9	1.7	0.0	22.4	7.4	0.8	8.0	1.1	0.9	1.8	1.0	9.6	1.1	8.4	0.0	8.0	6.0	5.0	1.0	3.7	0.4	0.2	1.3	0.2	0.3	1.6	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	2.2	8.5	11.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	2.3	0.0	0.0	0.3	3.0	0.0	12.3	0.0	27.4	10.9	0.0	0.3	0.0	0.0	4.1	0.0	0.0	1.7	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	23.3	0.0	0.0	0.0	1.3	0.2	0.1	0.1	0.0	1.6	0.2	0.9	0.4	0.0	0.4	1.2	0.5	0.4	0.3	0.0	0.2	0.4	0.3	8.6	11.2	0.4	18.2	11.8	4.9	7.3	10.9	4.0	8.4	0.0	0.0	0.5	0.0	0.5	0.5	3.5	2.5	0.0	0.0	34.9	0.0	1.0	0.0	0.9	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	2.3	0.0	0.3	0.0	1.2	0.0	0.0	0.0	0.0	2.1	1.7	1.8	4.1	2.3	3.0	3.5	0.0	3.9	0.0	0.0	0.1	0.0	0.3	1.0	1.0	0.0	2.3	0.4
RASSF4	"AD037, MGC44914"	ENSG00000107551	"Ras association domain family member 4"	Q9H2L5	10	44959407-44995891	"Predicted intracellular proteins"	"Cell cycle"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	13	"Hofbauer cells: 128.5;monocytes: 389.5;Muller glia cells: 247.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"classical monocyte: 28.3;intermediate monocyte: 21.7;myeloid DC: 28.5;non-classical monocyte: 11.5"	"Group enriched"	"Detected in many"	9	"dendritic cells: 28.5;monocytes: 28.3"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 21.5;RH-30: 54.6;RPMI-8226: 17.8;U-937: 27.9;WM-115: 18.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA038834, HPA077069"	Approved		Approved	"Nucleoplasm,Nucleoli,Cell Junctions,Cytokinetic bridge,Mitotic spindle,Cytosol"		NA	NA			"Nucleoplasm, Nucleoli"	"Cell Junctions, Cytokinetic bridge, Mitotic spindle, Cytosol"	"HPA038834: AB_10795576, HPA077069: "	"unprognostic (1.83e-1)"	"unprognostic (8.21e-3)"	"unprognostic (1.21e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.25e-1)"	"unprognostic (5.14e-2)"	"unprognostic (3.15e-2)"	"unprognostic (2.18e-2)"	"unprognostic (8.81e-2)"	"unprognostic (4.83e-2)"	"unprognostic (8.75e-3)"	"unprognostic (4.20e-1)"	"unprognostic (4.11e-3)"	"unprognostic (4.02e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.20e-2)"	23.4	5.9	16.7	17.0	25.5	6.0	8.4	12.5	36.5	3.6	8.2	26.7	12.1	11.2	2.6	14.9	4.3	3.3	9.0	29.1	16.6	15.1	37.2	10.5	9.7	14.1	34.5	9.7	3.0	11.5	2.2	8.4	10.4	19.4	4.5	5.3	8.4	14.0	9.9	7.6	2.9	10.8	7.0	21.8	12.6	4.3	5.7	31.5	1.2	23.0	2.9	7.4	8.3	3.9	0.0	28.5	0.9	28.3	2.2	3.0	13.8	0.4	0.1	2.0	3.9	6.1	0.3	1.4	0.2	0.3	0.6	1.2	1.6	0.2	0.0	0.7	0.2	1.3	0.0	0.8	0.9	0.9	12.2	0.0	0.0	0.0	12.7	6.5	0.8	0.0	4.5	0.0	0.6	0.0	3.7	0.9	0.5	0.0	21.5	0.9	0.0	0.9	13.9	0.4	0.0	0.4	2.6	54.6	17.8	0.1	0.3	0.3	0.3	0.0	0.1	0.6	3.7	0.3	10.6	0.2	0.1	1.2	1.0	2.1	0.2	0.2	0.0	6.4	27.9	18.1	0.0	28.3	0.0	3.0	21.7	0.0	0.0	0.2	1.3	28.5	0.0	0.2	1.0	0.9	2.2	11.5	0.7	0.1	13.8	16.7	25.5	12.5	18.2	16.6	15.1	34.5	9.7	19.4	31.5	17.9	15.0	4.7	1.2	3.3	17.2	38.7	38.2	6.7	10.3	15.7	3.9	0.9	14.9	40.8	1.2	4.7	11.8	0.0	3.4	1.1	7.0	1.3	1.1	15.5	128.5	35.0	11.1	8.0	63.6	3.2	9.8	81.9	8.5	389.5	8.7	247.8	4.1	14.0	2.1	98.2	13.3	25.8	17.6	0.3	0.9	1.5	2.2	6.4	16.6	0.5
RD3L	"TDRD9-AS1, TDRD9AS1"	ENSG00000227729	"Retinal degeneration 3-like"	P0DJH9	14	103940426-103942308	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	16	"heart muscle: 32.6"	"Group enriched"	"Detected in some"	14	"Bipolar cells: 69.7;Cardiomyocytes: 39.9;Cone photoreceptor cells: 27.5;Horizontal cells: 25.4;Rod photoreceptor cells: 17.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HEK 293: 1.1"	"Region enhanced"	"Detected in single"		"olfactory region: 12.7"	"Low region specificity"	"Detected in all"			HPA067971	Enhanced		Approved	"Cell Junctions"		NA	NA			"Cell Junctions"		"HPA067971: AB_2685935"																		0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.6	0.1	0.2	0.0	1.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.2	0.0	0.2	0.3	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.2	0.1	0.1	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	69.7	39.9	0.0	0.0	0.0	0.0	27.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	17.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RGS19	"GAIP, RGSGAIP"	ENSG00000171700	"Regulator of G protein signaling 19"	P49795	20	64073181-64079988	"Predicted intracellular proteins"	Autophagy	"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 95.0;bone marrow: 36.7;lymphoid tissue: 43.1"	"Cell type enhanced"	"Detected in many"	9	"B-cells: 73.1;Hofbauer cells: 121.6;Kupffer cells: 93.5;Macrophages: 101.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 49.8;NB-4: 39.2;THP-1: 33.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056384, HPA069984"	Enhanced		Supported	"Nucleoli fibrillar center,Cell Junctions"		NA	NA			"Cell Junctions"	"Nucleoli fibrillar center"	"HPA056384: AB_2732602, HPA069984: AB_2732145"	"unprognostic (3.98e-2)"	"unprognostic (2.32e-1)"	"unprognostic (4.26e-3)"	"unprognostic (8.42e-2)"	"unprognostic (2.03e-1)"	"unprognostic (9.94e-2)"	"prognostic unfavorable (2.75e-4)"	"unprognostic (1.25e-2)"	"unprognostic (2.41e-2)"	"unprognostic (3.91e-1)"	"unprognostic (3.22e-1)"	"unprognostic (2.88e-1)"	"prognostic unfavorable (2.06e-9)"	"unprognostic (1.35e-1)"	"unprognostic (2.68e-2)"	"unprognostic (6.77e-2)"	"unprognostic (4.66e-3)"	7.0	4.8	6.0	19.0	7.5	36.7	12.7	2.5	5.0	3.3	3.5	6.8	1.9	5.5	2.9	2.9	4.4	4.1	4.5	5.1	5.4	4.9	4.0	7.2	10.4	27.2	9.1	2.6	2.7	3.9	0.8	2.6	5.6	5.7	3.9	1.8	2.2	6.1	2.2	1.6	4.3	10.6	3.2	7.1	43.1	5.7	2.8	7.2	15.2	3.7	1.2	19.5	6.1	3.6	17.3	29.9	95.0	55.5	9.1	13.8	22.0	4.9	7.5	2.1	3.9	0.9	1.6	3.7	3.1	2.2	6.5	2.7	11.1	6.8	8.7	8.7	1.9	6.9	4.8	2.2	4.0	1.5	4.2	4.1	12.4	3.8	4.5	1.3	25.2	49.8	1.1	2.4	2.7	0.9	1.3	4.2	5.8	4.7	4.6	1.9	8.8	18.6	39.2	2.2	4.2	9.6	15.7	1.3	6.2	1.8	2.4	4.1	3.9	3.2	2.0	4.1	1.1	2.6	33.3	4.4	6.1	3.1	1.0	3.0	2.9	2.2	10.5	3.4	19.3	4.0	33.1	35.5	95.0	13.4	50.4	13.8	17.3	12.7	12.7	29.9	17.1	8.9	9.2	79.6	9.1	55.5	17.1	13.5	22.0	6.0	7.5	2.5	5.0	5.4	4.9	9.1	2.6	5.7	7.2	3.0	5.5	73.1	4.9	8.7	0.0	2.2	0.0	2.7	4.5	1.8	0.0	2.6	0.0	10.2	0.3	15.2	0.0	23.3	12.7	7.2	6.4	7.3	47.4	0.6	121.6	0.0	0.0	12.3	93.5	0.4	4.0	101.1	5.0	24.4	0.5	0.5	12.8	3.4	1.1	1.7	0.0	12.9	7.2	0.2	6.8	7.9	1.5	48.0	0.8	7.5
RPUSD1	"C16orf40, MGC19600, RLUCL"	ENSG00000007376	"RNA pseudouridylate synthase domain containing 1"	Q9UJJ7	16	784974-788397	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041144, HPA041938"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cell Junctions,Cytosol"		NA	NA			"Golgi apparatus"	"Nucleoplasm, Cell Junctions, Cytosol"	"HPA041144: AB_10794265, HPA041938: AB_10795601"	"unprognostic (1.51e-2)"	"unprognostic (1.26e-3)"	"unprognostic (2.03e-1)"	"unprognostic (4.01e-1)"	"unprognostic (2.99e-1)"	"unprognostic (9.05e-3)"	"unprognostic (1.07e-3)"	"unprognostic (3.45e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.31e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.23e-1)"	"unprognostic (6.25e-2)"	"unprognostic (8.07e-3)"	"unprognostic (5.44e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.41e-1)"	9.5	9.7	12.0	16.5	14.8	20.9	10.4	15.3	23.8	7.4	11.2	9.4	6.2	17.6	10.5	14.0	13.9	8.6	11.2	8.1	12.7	10.4	10.7	13.4	8.2	18.2	9.5	11.3	10.0	15.3	9.9	8.9	8.2	11.2	11.3	5.1	10.9	19.8	10.5	11.1	16.8	12.8	8.3	7.0	17.4	15.1	6.2	9.2	15.5	8.5	15.1	15.6	10.8	10.7	17.3	23.1	17.7	19.9	18.0	20.4	15.8	10.6	12.6	3.1	14.0	2.7	3.2	14.4	8.9	5.1	11.7	8.5	29.3	10.1	14.9	9.7	4.2	8.2	18.3	7.1	9.0	2.1	13.5	29.0	7.3	19.3	10.5	4.4	13.5	12.4	4.8	8.7	10.1	2.7	3.4	8.0	8.8	17.1	6.7	4.0	33.8	16.8	14.1	15.8	4.9	21.8	30.0	8.3	30.6	4.2	6.6	16.3	11.7	10.2	16.8	9.8	1.9	8.6	16.9	9.0	11.7	15.2	12.2	12.8	10.8	10.8	17.1	5.6	10.6	9.5	17.5	19.9	17.7	18.3	18.0	18.1	14.9	15.5	20.4	23.1	17.3	16.2	16.3	12.7	18.0	17.4	21.2	18.7	15.8	12.0	14.8	15.3	23.8	12.7	10.4	9.5	11.3	11.2	9.2	3.0	3.5	18.7	3.5	14.2	38.1	3.3	2.5	2.7	0.0	8.7	2.0	17.7	6.6	13.7	0.4	6.8	18.6	0.0	23.3	22.4	8.9	4.4	0.0	4.0	17.2	1.6	12.7	10.4	1.6	1.4	6.4	7.9	13.5	23.4	11.0	7.8	22.5	14.0	6.0	8.1	3.3	12.9	5.6	4.2	12.0	14.6	12.2	10.2	16.7	4.7
RRP7A	"CGI-96, Rrp7"	ENSG00000189306	"Ribosomal RNA processing 7 homolog A"	Q9Y3A4	22	42509968-42519802	"Plasma proteins, Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001586, HPA046768"	Approved		Approved	"Nucleoplasm,Nucleoli,Cell Junctions"		NA	NA			"Nucleoplasm, Nucleoli"	"Cell Junctions"	"HPA001586: AB_1078506, HPA046768: AB_2679796"	"unprognostic (8.46e-2)"	"unprognostic (3.30e-3)"	"unprognostic (5.96e-2)"	"unprognostic (3.21e-3)"	"unprognostic (9.71e-3)"	"unprognostic (2.92e-1)"	"prognostic unfavorable (1.21e-5)"	"unprognostic (6.73e-2)"	"unprognostic (3.00e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.41e-1)"	"unprognostic (3.22e-2)"	"unprognostic (9.53e-3)"	"unprognostic (8.02e-2)"	"unprognostic (2.12e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.71e-2)"	10.4	12.9	19.9	15.4	26.6	16.5	13.5	18.5	20.9	12.8	12.2	15.1	9.4	10.2	12.0	47.3	15.1	18.9	12.0	11.1	17.5	14.8	14.0	18.1	11.3	21.5	14.8	9.3	21.2	12.0	16.6	10.3	17.7	17.4	17.8	10.8	12.6	15.2	14.6	13.5	14.9	13.3	11.9	11.7	15.6	12.0	11.2	18.6	17.4	11.6	8.7	16.4	10.7	11.0	26.2	30.5	17.4	27.5	15.2	18.4	20.3	13.0	18.4	10.1	11.9	6.5	4.3	20.5	11.1	6.7	14.4	12.2	23.4	7.5	21.8	5.7	7.9	8.0	14.5	11.6	15.5	6.2	5.5	23.7	11.8	12.8	12.6	6.2	28.3	10.2	5.5	7.8	19.5	9.9	5.2	8.7	11.7	16.6	6.3	8.5	26.5	27.2	11.6	8.4	10.4	13.4	47.4	10.4	9.6	7.5	16.0	5.5	3.9	8.2	23.6	10.8	5.4	9.6	12.8	6.5	11.0	14.2	8.4	11.3	9.7	7.2	25.6	9.2	10.9	15.8	10.0	23.5	17.4	18.4	26.4	17.7	20.5	16.1	16.8	18.1	26.2	17.7	16.5	4.7	15.2	27.5	30.5	13.5	20.3	19.9	26.6	18.5	20.9	17.5	14.8	14.8	9.3	17.4	18.6	20.8	35.8	52.9	72.3	38.9	26.5	14.2	25.5	34.8	33.0	21.0	15.7	80.7	14.9	65.2	48.5	37.9	36.0	23.3	23.4	117.3	32.9	62.0	46.2	29.2	83.7	25.4	25.3	31.3	37.8	94.1	20.4	49.8	32.1	146.1	29.9	22.2	58.6	42.1	17.3	34.2	28.7	6.5	26.9	30.9	22.8	33.1	100.7	41.5	40.0	87.7
RSC1A1	RS1	ENSG00000215695	"Regulator of solute carriers 1"	Q92681	1	15659869-15661722	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA027813, HPA028676"	Approved		Supported	"Nucleoplasm,Cell Junctions"		NA	NA			Nucleoplasm	"Cell Junctions"	"HPA027813: AB_10600308, HPA028676: AB_10600895"																		3.0	0.9	0.3	1.7	0.4	2.8	2.6	0.1	0.6	2.2	0.6			0.0	1.2	0.0	3.5	1.2	1.1	2.9	0.3	0.5	4.0	7.7	2.7	2.0	0.4		4.6	0.2	2.1	1.3	2.3		3.9	1.3		0.1	0.8	0.6	2.1	0.6	3.0	0.8	0.1	0.6	4.7			1.7		3.2	1.1	2.2	1.1	2.8	0.5	3.5	1.7	2.3	1.5	3.3	3.9	4.8	3.2	6.0	4.2	6.4	2.8	4.7	7.9	7.4	6.4	5.5	7.4	2.8	6.3	3.9	2.3	12.5	4.0	9.7	4.9	3.1	6.9	7.7	6.8	1.3	10.1	3.5	3.3	0.0	13.6	7.5	1.8	4.9	5.0	19.0	7.0	5.7	3.3	5.3	0.0	5.2	1.9	2.2	4.5	6.8	3.1	1.8	6.2	3.9	1.6	5.3	2.4	4.6	4.3	3.4	0.9	4.8	4.0	7.4	3.6	2.1	2.1	4.0	12.9	1.6	2.7	2.8	0.0	1.2	0.5	0.4	3.5	1.4	1.1	0.5	2.3	2.8	0.2	0.6	0.5	0.0	1.7	0.1	0.7	2.3	1.5											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
S100A14	"BCMP84, S100A15"	ENSG00000189334	"S100 calcium binding protein A14"	Q9HCY8	1	153614255-153616986	"Plasma proteins, Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 256.0;tongue: 189.3"	"Cell type enhanced"	"Detected in many"	15	"Basal keratinocytes: 2079.3;Enterocytes: 1153.1;Suprabasal keratinocytes: 3157.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	11	"plasmacytoid DC: 1.1"	"Lineage enriched"	"Detected in single"	11	"dendritic cells: 1.1"	"Cell line enhanced"	"Detected in some"		"A-431: 61.0;HaCaT: 84.7;HBEC3-KT: 120.1;hTCEpi: 179.0;OE19: 129.5;SK-BR-3: 126.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA027613	Enhanced		Approved	"Nuclear bodies,Plasma membrane,Cell Junctions,Cytosol"		NA	NA		110000	"Nuclear bodies, Plasma membrane, Cell Junctions, Cytosol"		"HPA027613: AB_10602298"	"unprognostic (1.73e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.75e-2)"	"unprognostic (6.27e-2)"	"unprognostic (2.30e-2)"	"unprognostic (9.48e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.75e-3)"	"unprognostic (2.89e-1)"	"unprognostic (3.16e-3)"	"unprognostic (8.41e-2)"	"unprognostic (1.80e-1)"	"unprognostic (4.81e-2)"	"unprognostic (9.53e-2)"	0.6	0.0	0.6	4.3	0.6	0.0	6.4	0.6	0.6	38.0	19.2	0.6	3.9	21.4	5.7	2.6	256.0	1.2	7.9	0.6	0.6	0.0	2.4	1.2	7.5	0.6	0.6	0.6	0.7	4.6	6.6	0.8	1.4	0.7	1.9	19.6	0.7	41.8	3.1	0.6	41.4	23.8	1.0	0.6	0.6	9.4	0.9	0.6	8.9	9.6	189.3	71.0	2.2	79.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	61.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	7.6	11.1	0.0	0.1	0.0	0.0	84.7	0.0	120.1	0.0	0.0	0.0	0.0	0.8	0.5	0.0	0.0	0.0	0.0	179.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	10.8	0.0	0.0	0.0	129.5	0.1	0.0	0.0	0.2	0.6	4.0	0.0	0.0	0.1	126.4	0.1	3.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.6	0.6	0.6	0.6	0.6	0.0	0.6	0.6	0.7	0.6	56.6	133.0	0.5	298.4	2079.3	0.0	4.4	214.0	18.7	91.0	33.2	0.0	0.6	41.4	164.9	0.0	0.2	1153.1	0.0	59.6	1.7	22.4	341.3	28.7	5.8	0.3	0.0	147.3	1.3	0.0	0.0	0.0	5.3	229.5	3.6	470.4	0.0	202.6	775.0	0.0	3.1	0.0	0.0	33.3	0.0	0.0	3157.3	0.2	0.7	410.3	819.7
S100A9	"60B8AG, CAGB, CFAG, CGLB, LIAG, MAC387, MIF, MRP14, NIF, P14"	ENSG00000163220	"S100 calcium binding protein A9"	P06702	1	153357854-153361027	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Apoptosis, Autophagy, Chemotaxis, Immunity, Inflammatory response, Innate immunity"	"Antimicrobial, Antioxidant"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 638.3;bone marrow: 820.1;esophagus: 642.6;tongue: 477.6"	"Cell type enriched"	"Detected in many"	7	"Kupffer cells: 11072.0"	"Cancer enhanced"	"Detected in all"		"cervical cancer: 5468.0;head and neck cancer: 6692.8"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"classical monocyte: 381.5;neutrophil: 638.3"	"Group enriched"	"Detected in many"	6	"granulocytes: 638.3;monocytes: 381.5"	"Cell line enriched"	"Detected in some"	6	"SK-BR-3: 233.1"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA004193, CAB009441"	Enhanced		Supported	"Nucleoplasm,Cell Junctions,Cytosol"	"Secreted to blood"	NA	NA	10600000	1400000000	"Nucleoplasm, Cell Junctions, Cytosol"		"CAB009441: AB_2184420, HPA004193: AB_1856537"	"unprognostic (1.72e-1)"	"unprognostic (3.33e-2)"	"unprognostic (2.40e-1)"	"unprognostic (3.94e-3)"	"unprognostic (1.36e-2)"	"unprognostic (5.45e-3)"	"prognostic unfavorable (1.13e-6)"	"unprognostic (1.10e-2)"	"unprognostic (4.31e-1)"	"unprognostic (3.06e-1)"	"unprognostic (1.35e-2)"	"unprognostic (5.59e-2)"	"prognostic unfavorable (8.10e-4)"	"unprognostic (1.48e-1)"	"unprognostic (7.52e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.75e-2)"	19.5	2.1	1.3	41.9	4.2	820.1	4.1	0.9	2.1	143.6	4.4	0.7	0.4	0.7	4.9	4.0	642.6	9.9	4.4	51.2	2.5	0.4	2.8	4.8	29.2	169.0	5.3	0.6	3.4	4.4	0.1	0.9	10.4	5.2	2.2	0.7	2.0	109.6	0.5	3.4	7.5	1.4	13.1	2.1	103.2	3.5	2.9	1.4	3.8	6.7	477.6	228.0	24.3	237.0	0.5	87.5	638.3	381.5	0.3	1.0	323.2	2.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.8	36.6	0.0	0.0	2.2	0.0	15.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.7	0.0	0.0	12.7	0.0	0.8	0.0	0.0	0.0	0.7	0.3	0.0	2.9	0.0	0.3	0.0	0.2	0.0	0.0	0.5	7.7	0.0	9.5	0.1	0.0	0.3	233.1	0.1	0.1	3.6	29.6	0.6	0.0	0.3	0.0	0.0	0.0	0.1	0.2	0.0	6.7	0.0	5.3	381.5	46.4	0.5	31.6	1.0	0.4	0.4	0.3	87.5	0.5	0.3	0.3	638.3	0.3	15.0	2.9	0.5	323.2	1.3	4.2	0.9	2.1	2.5	0.4	5.3	0.6	5.2	1.4	214.4	574.2	57.1	52.5	17.7	0.0	2.5	66.2	112.4	185.4	34.9	0.0	111.0	5.0	49.4	1.3	7.0	0.5	23.3	32.9	44.2	7.1	19.6	151.1	16.4	1627.6	0.0	0.0	71.2	11072.0	2.2	5.5	1162.8	0.0	4.6	2.1	0.0	10.3	0.8	0.0	16.3	0.2	0.0	2.5	0.3	1.3	29.1	1033.7	24.9	1.9	291.7
SAMD4A	"DKFZP434H0350, hSmaug1, KIAA1053, SAMD4, Smaug, SMG, SMGA"	ENSG00000020577	"Sterile alpha motif domain containing 4A"	Q9UPU9	14	54567097-54793315	"Predicted intracellular proteins"	"Translation regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 48.7;testis: 44.6"	"Group enriched"	"Detected in many"	6	"Early spermatids: 1164.1;Late spermatids: 1577.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 3.9;non-classical monocyte: 3.6"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043061, HPA065309"	Approved		Approved	"Cell Junctions,Cytosol"		NA	NA			"Cell Junctions"	Cytosol	"HPA043061: AB_2678299, HPA065309: AB_2685462"	"unprognostic (1.46e-1)"	"unprognostic (8.10e-3)"	"unprognostic (9.66e-3)"	"unprognostic (1.18e-4)"	"unprognostic (2.79e-1)"	"unprognostic (6.37e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.98e-1)"	"unprognostic (7.74e-2)"	"unprognostic (1.09e-2)"	"unprognostic (2.83e-2)"	"unprognostic (8.27e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.51e-1)"	7.5	2.9	7.8	9.0	6.0	0.5	4.0	5.6	7.0	8.9	10.1	8.0	3.0	2.3	11.1	5.5	5.4	4.2	6.5	28.2	5.5	7.3	2.5	7.6	6.4	2.9	10.6	5.2	2.1	4.1	4.8	2.0	6.0	10.8	7.7	3.3	3.4	2.4	6.3	48.7	2.6	3.3	23.8	26.5	4.6	3.9	44.6	6.1	0.7	2.4	1.3	4.8	15.9	5.8	0.9	2.6	0.0	3.9	0.0	0.4	0.8	17.0	1.7	3.4	1.7	7.2	11.4	6.3	14.9	21.3	11.8	12.0	17.5	4.1	1.0	7.6	20.6	5.2	11.8	3.3	7.4	16.6	9.7	1.6	0.0	2.0	3.6	4.1	0.0	0.1	6.4	2.5	8.5	12.6	3.3	9.2	0.0	1.3	0.0	5.5	1.1	0.2	0.0	1.7	0.1	4.1	0.5	6.8	0.0	5.5	5.5	0.5	5.6	2.3	2.9	7.7	7.2	11.2	0.2	18.6	14.0	23.1	3.4	4.6	0.1	0.0	0.0	4.0	0.3	4.5	0.0	2.3	0.0	0.0	3.9	0.0	0.3	0.0	0.0	2.6	0.9	0.0	0.0	0.0	0.0	3.6	0.0	0.4	0.8	7.8	6.0	5.6	5.7	5.5	7.3	10.6	5.2	10.8	6.1	23.8	1.0	3.2	34.8	35.1	0.5	244.5	12.7	0.0	5.7	17.4	7.9	7.5	3.3	8.2	1164.1	32.1	4.2	0.0	6.7	1.7	65.1	37.0	22.0	48.2	10.0	9.5	5.8	12.3	13.0	1577.3	13.6	11.7	23.6	0.0	1.3	1.0	14.6	5.8	22.3	19.2	4.2	12.9	48.5	12.7	7.2	21.2	1.6	1.0	1.3	37.6
SAPCD1	"C6orf26, NG23"	ENSG00000228727	"Suppressor APC domain containing 1"	Q5SSQ6	6	31762799-31764851	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"retina: 8.8;skin 1: 14.7"	"Cell type enriched"	"Detected in single"	27	"Ciliated cells: 2.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 7.3;JURKAT: 6.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA071699			Approved	"Vesicles,Cell Junctions"		NA	NA			Vesicles	"Cell Junctions"	"HPA071699: AB_2686433"	"unprognostic (9.25e-4)"	"unprognostic (1.32e-1)"	"unprognostic (3.41e-2)"	"unprognostic (3.28e-1)"	"unprognostic (9.34e-2)"	"unprognostic (8.02e-4)"	"unprognostic (1.63e-2)"	"unprognostic (3.80e-2)"	"unprognostic (2.01e-1)"	"unprognostic (8.16e-3)"	"unprognostic (1.56e-2)"	"unprognostic (2.25e-1)"	"unprognostic (8.15e-10)"	"unprognostic (2.65e-2)"	"unprognostic (4.45e-1)"	"unprognostic (3.57e-1)"	"unprognostic (7.98e-5)"	0.8	0.3	0.7	1.6	1.0	4.8	1.8	0.7	1.3	2.0	1.0	1.3	0.7	0.2	1.2	0.8	0.7	1.8	2.5	0.7	0.7	0.8	3.2	0.9	1.4	2.5	1.9	0.7	1.6	0.7	0.2	2.9	3.3	3.9	2.6	1.1	8.8	0.7	1.6	0.7	14.7	1.5	0.7	3.1	2.1	0.8	1.2	0.7	0.7	0.7	0.7	0.7	0.8	0.7	0.0	0.5	0.2	0.1	0.0	0.7	0.0	0.5	0.0	0.0	0.5	0.4	0.8	0.8	0.4	0.2	0.2	0.0	2.8	1.0	0.8	0.1	0.2	0.0	1.6	0.0	0.7	0.1	0.0	3.1	3.8	7.3	1.0	0.2	0.3	0.1	0.2	0.0	1.1	1.4	0.3	0.5	6.4	0.4	1.1	0.0	3.7	2.8	2.3	0.0	0.3	0.8	0.4	0.9	0.0	0.6	0.7	1.2	0.6	0.3	0.7	0.4	0.9	0.3	0.0	0.2	0.1	2.9	0.0	0.3	2.1	2.0	2.0	0.2	2.7	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.5	0.0	0.0	0.7	1.0	0.7	1.3	0.7	0.8	1.9	0.7	3.9	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SCAMP1	SCAMP37	ENSG00000085365	"Secretory carrier membrane protein 1"	O15126	5	78360583-78479071	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044753, CAB079009"		Supported	Approved	"Nucleoplasm,Vesicles,Cell Junctions"		NA	NA			"Nucleoplasm, Vesicles, Cell Junctions"		"CAB079009: , HPA044753: "	"unprognostic (8.25e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.40e-3)"	"unprognostic (5.34e-3)"	"unprognostic (2.60e-1)"	"unprognostic (2.57e-3)"	"unprognostic (5.51e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.31e-1)"	"unprognostic (8.23e-3)"	"unprognostic (2.35e-2)"	"unprognostic (2.56e-1)"	"prognostic favorable (1.92e-4)"	"unprognostic (8.44e-3)"	"unprognostic (7.56e-2)"	"unprognostic (3.12e-2)"	"unprognostic (4.99e-2)"	7.5	8.3	9.2	4.0	19.3	2.4	10.0	12.8	19.5	8.4	6.4	5.4	9.9	5.3	8.7	9.3	8.6	10.7	6.4	8.0	15.8		10.4	6.2	5.9	3.9	6.5	15.8	8.8	8.8	17.5	14.6	7.6	14.6	12.2	7.3	7.6	10.6	11.0	4.7	5.8	5.3	9.1	9.0	3.9	9.6	4.5	7.1	4.1	14.2	3.8	3.7	8.8	6.3	7.9	14.9	15.3	15.8	10.0	9.9	7.4	12.5	9.9	9.9	30.6	13.7	17.7	15.6	11.6	16.9	9.6	21.9	3.7	23.5	18.5	13.1	16.9	27.5	10.2	14.0	21.8	17.2	6.5	13.3	8.5	7.9	7.6	8.8	5.4	6.6	11.6	20.2	10.9	17.3	24.2	14.6	10.4	3.2	13.3	18.2	14.7	9.3	11.5	8.0	5.4	10.2	11.4	16.3	21.1	17.5	14.9	28.1	17.1	10.7	15.2	10.9	10.5	21.1	9.8	14.9	10.6	7.9	11.7	9.7	9.3	11.2	11.5	20.7	20.3	8.8	15.3	11.4	12.8	8.2	12.6	9.9	7.9	9.4	9.8	14.9	6.6	7.8	6.8	7.0	10.0	15.8	4.6	9.1	7.4											23.8	19.0	6.7	28.6	34.8	72.3	33.0	20.4	71.0	26.1	38.4	66.8	10.4	11.6	22.7	31.3	27.8	11.7	23.3	26.3	21.3	31.0	36.1	11.5	13.9	16.8	30.2	34.0	22.1	30.5	12.1	18.7	22.7	28.7	6.4	33.6	43.2	26.4	11.5	26.9	20.5	63.0	12.9	25.0	17.0	20.4	39.5	8.8	13.8	17.0	25.0
SCHIP1	SCHIP-1	ENSG00000151967	"Schwannomin interacting protein 1"	P0DPB3	3	159839861-159897360	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	6	"brain: 55.0;heart muscle: 65.9;skeletal muscle: 54.5"	"Cell type enhanced"	"Detected in many"	9	"Cardiomyocytes: 11.3;Horizontal cells: 14.3"	"Cancer enriched"	"Detected in single"	7	"glioma: 2.9"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 9.7"	"Group enriched"	"Detected in many"	58	"dendritic cells: 9.7;granulocytes: 3.1"	"Cell line enhanced"	"Detected in some"		"AF22: 9.5;AN3-CA: 17.3;HUVEC TERT2: 20.5;NTERA-2: 10.5;SH-SY5Y: 59.6"									"HPA003243, HPA069824"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cell Junctions,Cytosol"		NA	NA			"Plasma membrane, Cell Junctions, Cytosol"	"Nucleoplasm, Nuclear bodies"	"HPA003243: AB_1079877, HPA069824: AB_2732142"	"unprognostic (1.07e-1)"	"unprognostic (3.27e-2)"	"unprognostic (1.37e-2)"	"unprognostic (2.36e-5)"	"prognostic favorable (2.80e-4)"	"unprognostic (6.25e-2)"	"unprognostic (4.56e-3)"	"unprognostic (1.11e-1)"	"unprognostic (7.81e-2)"	"unprognostic (1.38e-1)"	"unprognostic (6.45e-3)"	"unprognostic (4.67e-2)"	"unprognostic (2.12e-1)"	"unprognostic (4.66e-4)"	"unprognostic (2.30e-1)"	"unprognostic (4.52e-2)"	"unprognostic (4.96e-1)"	6.1	3.9	30.1	1.5	22.0	2.0	1.9	23.9	55.0	3.7	3.6	21.1	0.0	2.2	4.7	2.0	4.2	3.4	3.0	65.9	29.6	17.9	3.5	1.9	3.1	1.7	22.8	24.1	1.8	1.6	1.4	6.0	10.3	15.6	6.2	2.3	0.7	2.9	2.6	54.5	1.4	1.9	5.9	28.9	5.1	2.0	2.7	24.3	0.0	2.0	7.6	1.6	1.9	0.6	0.0	9.7	3.1	0.0	0.1	0.0	0.1	0.0	0.0	9.5	17.3	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.6	0.0	0.4	0.0	0.0	0.8	0.0	0.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.0	0.4	0.1	4.0	0.1	20.5	0.0	0.0	0.0	1.2	0.0	0.0	0.0	10.5	0.0	0.0	0.0	1.9	0.0	0.4	0.0	0.0	59.6	0.0	0.0	0.0	2.6	0.0	1.0	3.7	0.2	0.5	0.1	0.8	0.7	0.0	0.0	0.2	0.7	0.4	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.1	0.0	9.7	0.0	0.1	30.1	22.0	23.9	28.9	29.6	17.9	22.8	24.1	15.6	24.3	6.0	1.7	0.0	4.6	0.3	4.2	11.3	0.0	4.0	3.4	3.5	2.0	1.0	0.0	0.2	0.0	4.6	0.0	0.0	0.2	0.4	0.6	0.5	0.0	0.5	0.2	14.3	0.0	1.8	0.0	0.0	0.0	0.0	3.3	0.0	0.0	4.9	0.9	0.0	0.0	0.7	0.5	0.0	1.8	0.0	0.4	0.5	0.7	0.0	0.0	1.4
SCN8A	"CerIII, CIAT, MED, NaCh6, Nav1.6, PN4"	ENSG00000196876	"Sodium voltage-gated channel alpha subunit 8"	Q9UQD0	12	51590266-51812864	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"Disease mutation, Epilepsy, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 27.6;pituitary gland: 9.7"	"Cell type enhanced"	"Detected in some"	9	"Bipolar cells: 13.7;Cone photoreceptor cells: 9.8;Intestinal endocrine cells: 10.9;Rod photoreceptor cells: 10.5;Spermatogonia: 10.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"memory CD8 T-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"AF22: 12.0;ASC TERT1: 12.7;BJ hTERT+: 11.2;WM-115: 11.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022169, HPA043937, HPA073590"			Approved	"Vesicles,Plasma membrane,Cell Junctions"		NA	NA			"Plasma membrane"	"Vesicles, Cell Junctions"	"CAB022169: , HPA043937: , HPA073590: "	"unprognostic (2.96e-2)"	"unprognostic (8.49e-2)"	"unprognostic (6.93e-2)"	"unprognostic (3.52e-6)"	"unprognostic (8.13e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.77e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.73e-4)"	"unprognostic (1.69e-2)"	"unprognostic (1.29e-5)"	"unprognostic (4.38e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.37e-1)"	"unprognostic (4.75e-2)"	1.1	3.0	9.1	1.5	18.1	1.9	1.9	16.7	27.6	1.0	2.0	1.6	0.0	1.1	1.5	2.0	0.9	1.1	2.5	0.9	12.6	4.5	1.9	4.3	1.0	1.3	3.2	13.7	1.8	3.2	1.5	9.7	0.9	14.8	1.8	2.5	0.9	1.7	1.2	1.0	1.1	1.2	1.0	2.2	1.7	2.7	3.8	1.6	0.0	1.7	0.0	1.2	1.0	0.6	0.4	0.2	0.0	0.0	0.0	1.0	0.0	1.4	1.0	12.0	0.1	1.6	12.7	0.2	6.8	11.2	7.9	7.3	2.0	1.4	0.3	1.6	8.9	3.5	0.0	1.9	0.0	9.3	1.2	0.6	0.1	0.1	0.2	0.1	0.2	0.9	1.7	0.0	5.2	1.1	3.1	8.4	2.8	0.1	0.1	4.9	0.8	2.0	0.1	4.1	0.7	3.8	0.0	0.6	0.0	0.0	0.4	4.8	2.0	3.5	1.8	0.2	1.8	0.3	0.1	2.2	7.7	5.1	2.8	4.3	0.1	0.1	0.0	1.5	1.6	11.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.7	1.0	0.0	0.4	0.4	0.2	0.0	0.0	0.0	0.2	0.0	0.0	9.1	18.1	16.7	25.0	12.6	4.5	3.2	13.7	14.8	1.6	0.0	0.0	0.0	0.4	0.0	13.7	1.2	0.0	0.0	0.0	0.0	9.8	0.0	0.0	0.2	0.4	0.4	0.0	0.0	0.5	0.0	0.0	0.2	0.0	3.4	0.0	4.8	10.9	1.3	0.0	0.2	0.0	0.0	0.0	0.0	1.3	5.3	0.5	0.0	0.7	0.5	10.5	0.0	0.3	1.9	10.0	0.0	0.0	0.0	0.6	0.1
SCRIB	"KIAA0147, SCRB1, Vartul"	ENSG00000180900	"Scribbled planar cell polarity protein"	Q14160	8	143790920-143815379	"Disease related genes, Predicted intracellular proteins"	"Differentiation, Host-virus interaction, Inhibition of host innate immune response by virus, Inhibition of host interferon signaling pathway by virus, Inhibition of host STAT1 by virus, Inhibition of host STAT2 by virus, Viral immunoevasion"	"Developmental protein"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015463, CAB022081, HPA023557, HPA064312"	Supported		Enhanced	"Nucleoplasm,Plasma membrane,Cell Junctions,Rods & Rings"		NA	NA			"Plasma membrane, Cell Junctions"	"Nucleoplasm, Rods & Rings"	"CAB015463: AB_2238926, CAB022081: , HPA023557: AB_2671238, HPA064312: AB_2685242"	"unprognostic (1.24e-1)"	"unprognostic (1.94e-2)"	"unprognostic (7.78e-2)"	"unprognostic (8.95e-2)"	"unprognostic (3.77e-1)"	"unprognostic (3.96e-2)"	"unprognostic (1.14e-3)"	"unprognostic (1.86e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.56e-1)"	"unprognostic (8.22e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.16e-3)"	"unprognostic (3.46e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.83e-1)"	13.0	6.1	15.1	10.8	12.2	9.4	15.9	10.1	13.9	15.1	18.4	17.5	9.8	14.8	9.4	5.9	36.6	11.6	11.9	8.0	12.2	7.7	10.2	13.6	11.5	12.9	13.5	12.8	10.9	17.2	11.2	9.6	9.5	11.8	10.9	7.6	7.5	22.9	11.2	36.8	33.3	16.3	11.2	9.7	11.2	17.0	10.1	16.4	14.0	9.1	11.9	9.6	11.6	17.8	0.6	0.5	0.2	0.4	0.2	1.5	0.6	18.6	15.1	6.9	8.8	2.5	3.3	11.7	10.5	3.0	4.9	4.1	6.6	12.2	7.4	12.8	3.1	2.8	19.5	3.7	14.1	0.9	8.2	20.8	10.3	13.0	11.6	5.7	4.3	5.8	2.8	13.7	4.7	4.1	2.2	5.3	8.1	13.0	2.6	3.7	37.2	11.1	9.2	5.2	11.6	19.2	13.4	6.4	8.2	2.5	18.8	15.1	11.1	11.9	13.1	11.1	2.2	16.5	10.3	10.2	5.4	22.4	9.5	14.7	9.3	9.1	7.5	5.5	4.3	8.4	0.1	0.1	0.1	0.6	0.4	1.5	0.6	0.4	1.2	0.5	0.4	0.4	0.4	0.2	0.2	0.1	0.2	0.4	0.6	15.1	12.2	10.1	13.9	12.2	7.7	13.5	12.8	11.8	16.4	0.0	6.9	6.9	4.2	7.6	11.1	10.8	15.3	1.4	1.2	14.0	13.7	8.9	3.3	7.5	1.2	6.0	18.4	23.3	8.1	5.3	5.1	8.0	0.0	7.5	5.5	4.8	13.3	4.3	6.3	0.4	8.3	4.6	8.5	4.6	19.5	11.9	9.9	20.1	9.2	4.3	14.0	12.9	4.2	7.9	9.2	9.4	4.2	5.1	19.5	5.9
SEMA4B	"KIAA1745, MGC131831, SEMAC, SemC"	ENSG00000185033	"Semaphorin 4B"		15	90160604-90229679	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Extravillous trophoblasts: 69.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"memory B-cell: 14.7;naive B-cell: 11.8;neutrophil: 4.0"	"Group enriched"	"Detected in many"	5	"B-cells: 14.7;granulocytes: 4.0"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 52.8;RPTEC TERT1: 32.7;RT4: 35.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013372	Approved		Approved	"Nucleoplasm,Vesicles,Cell Junctions"		NA	NA			"Cell Junctions"	"Nucleoplasm, Vesicles"	"HPA013372: AB_1856670"	"unprognostic (3.33e-2)"	"unprognostic (5.96e-2)"	"unprognostic (2.23e-2)"	"unprognostic (2.50e-2)"	"unprognostic (7.78e-2)"	"unprognostic (4.48e-2)"	"unprognostic (6.34e-3)"	"prognostic unfavorable (1.25e-4)"	"unprognostic (2.04e-1)"	"unprognostic (9.31e-2)"	"unprognostic (1.58e-3)"	"unprognostic (4.67e-2)"	"prognostic unfavorable (3.33e-8)"	"unprognostic (1.66e-1)"	"unprognostic (1.23e-2)"	"unprognostic (3.57e-2)"	"unprognostic (7.09e-2)"	7.0	19.8	13.1	13.7	16.7	7.1	13.6	9.1	13.1	16.2	21.7	9.4	18.2	24.0	9.0	12.3	56.7	16.3	20.3	13.8	13.3	7.6	18.6	32.1	11.6	10.0	13.4	11.1	17.0	19.8	9.4	10.8	14.6	15.4	18.1	10.0	15.4	21.3	15.7	4.0	29.0	22.2	13.5	18.8	16.3	22.4	8.3	14.8	12.8	32.7	15.5	27.2	31.6	24.6	14.7	0.9	4.0	2.0	0.3	0.7	1.0	5.9	16.2	1.2	3.8	1.1	0.8	8.9	1.8	4.0	2.3	2.4	1.9	52.8	4.2	20.4	1.3	13.3	28.3	1.0	26.3	1.9	24.0	3.4	5.5	4.0	2.6	4.5	0.6	2.5	3.2	11.5	2.5	5.2	9.6	2.5	1.2	2.6	6.7	1.2	4.4	1.5	2.3	5.5	13.2	14.9	1.8	0.9	9.2	32.7	35.5	3.9	3.9	6.4	10.4	2.4	2.8	7.2	1.7	5.7	1.8	3.4	3.8	4.1	9.7	11.8	2.1	17.4	4.5	1.8	0.0	2.0	0.3	0.7	1.2	0.5	14.7	0.5	0.4	0.9	11.8	0.4	0.5	4.0	0.3	2.0	0.1	0.1	1.0	13.1	16.7	9.1	13.1	13.3	7.6	13.4	11.1	15.4	14.8	14.9	22.7	19.3	32.9	57.8	2.9	5.5	10.2	17.4	40.9	15.7	23.6	11.3	3.3	21.9	0.9	4.5	26.4	0.0	31.3	69.5	4.8	31.7	0.0	11.5	10.7	15.9	4.1	4.3	5.1	0.7	12.0	6.0	5.0	1.0	13.0	31.5	34.3	19.0	11.3	3.3	45.7	19.4	15.5	0.3	3.2	49.9	10.4	4.4	14.9	45.4
SHKBP1	"PP203, Sb1"	ENSG00000160410	"SH3KBP1 binding protein 1"	Q8TBC3	19	40576851-40591399	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 81.8"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041887	Uncertain		Approved	"Cell Junctions"		NA	NA			"Cell Junctions"		"HPA041887: AB_10794639"	"unprognostic (1.26e-1)"	"unprognostic (7.55e-2)"	"unprognostic (1.38e-1)"	"unprognostic (4.52e-2)"	"unprognostic (8.24e-2)"	"unprognostic (9.14e-2)"	"unprognostic (1.66e-3)"	"unprognostic (3.53e-2)"	"unprognostic (6.98e-2)"	"unprognostic (6.69e-3)"	"unprognostic (1.42e-1)"	"unprognostic (6.87e-2)"	"unprognostic (5.29e-2)"	"unprognostic (6.15e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.65e-1)"	"unprognostic (8.64e-2)"	12.1	13.0	9.8	25.4	15.2	40.1	19.5	2.7	11.3	12.1	10.7	11.7	9.0	12.7	14.1	12.1	17.8	13.4	12.2	10.7	7.5	5.2	16.5	14.7	20.0	53.5	17.8	5.9	11.4	14.6	9.9	9.2	11.7	11.0	13.6	7.4	9.0	12.7	10.3	5.8	12.1	17.0	11.8	11.1	51.8	15.2	7.5	15.1	33.9	14.0	11.1	25.3	14.4	13.5	14.9	28.4	81.8	40.7	12.2	19.3	30.6	23.1	36.0	7.2	10.2	6.3	7.1	13.7	9.1	13.6	14.2	19.6	15.7	16.0	24.5	18.0	14.2	12.1	10.2	9.3	17.2	6.7	37.7	22.2	17.8	9.8	10.5	13.7	16.6	51.0	11.6	12.5	13.0	8.2	10.4	20.6	28.0	9.9	20.6	10.8	20.4	17.0	23.4	5.2	21.0	13.4	30.7	9.4	18.3	11.7	19.1	6.0	14.0	13.9	7.7	8.1	7.3	12.1	27.5	15.5	14.3	18.9	22.3	17.9	19.4	9.2	16.5	23.0	19.6	12.7	35.8	37.1	37.0	14.3	36.0	11.6	14.9	13.8	14.6	28.4	13.1	8.2	9.4	81.8	12.2	40.7	8.5	19.3	30.6	9.8	15.2	2.7	11.3	7.5	5.2	17.8	5.9	11.0	15.1	11.9	24.0	64.1	17.4	7.6	2.2	3.5	2.5	8.1	14.8	27.9	5.9	20.8	24.9	36.5	7.3	22.4	28.0	0.0	34.0	44.6	14.1	13.1	51.8	11.3	69.2	3.2	21.9	22.7	78.8	12.5	13.6	55.0	21.9	80.2	16.2	6.0	31.1	31.6	11.7	23.2	1.5	0.0	12.3	1.8	18.8	8.5	24.7	51.1	18.9	18.8
SHROOM2	APXL	ENSG00000146950	"Shroom family member 2"	Q13796	X	9786456-9949443	"Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	17	"Cone photoreceptor cells: 45.2;Peritubular cells: 78.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"RT4: 12.8;SuSa: 13.4;WM-115: 15.6"	"Low region specificity"	"Detected in many"							HPA051646	Approved		Approved	"Plasma membrane,Cell Junctions,Cytosol"		No	No			"Plasma membrane, Cell Junctions"	Cytosol	"HPA051646: AB_2681562"	"unprognostic (8.65e-3)"	"unprognostic (1.36e-3)"	"unprognostic (4.68e-2)"	"unprognostic (4.06e-2)"	"unprognostic (6.99e-3)"	"unprognostic (8.05e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.51e-1)"	"unprognostic (6.54e-2)"	"unprognostic (2.82e-2)"	"unprognostic (9.73e-2)"	"prognostic favorable (1.35e-7)"	"unprognostic (1.56e-1)"	"unprognostic (3.34e-1)"	"unprognostic (1.93e-1)"	"unprognostic (7.67e-3)"	1.3	3.6	6.8	1.3	7.7	0.5	2.5	2.8	17.0	4.7	3.2	3.7	4.6	1.8	3.3	5.8	7.2	3.6	6.3	1.5	7.4	5.5	5.3	7.6	8.1	1.0	5.7	9.1	13.8	7.2	5.5	6.1	14.3	5.8	10.6	3.0	3.6	6.0	5.8	0.7	7.9	1.4	2.1	7.9	1.7	2.6	5.8	2.5	1.8	3.1	3.4	3.4	6.4	4.3	0.0	0.9	1.1	0.0	0.0	0.2	0.0	4.0	0.5	7.5	1.0	0.4	1.2	4.2	0.4	1.3	1.6	2.6	4.9	0.0	0.0	1.4	1.0	0.3	3.2	3.8	10.7	1.9	0.0	2.9	0.0	0.0	0.8	2.5	0.0	5.1	0.2	7.5	12.3	0.5	2.7	9.2	0.0	0.0	0.0	2.6	4.3	0.0	0.0	6.6	0.0	0.0	0.0	8.3	0.0	7.0	12.8	1.1	0.6	0.3	0.1	12.0	13.4	4.4	0.2	4.3	12.0	1.5	0.0	0.4	0.0	0.0	0.0	7.9	0.0	15.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.9	0.0	0.0	6.8	7.7	2.8	17.0	7.4	5.5	5.7	9.1	5.8	2.5	0.0	1.0	0.0	2.7	1.6	5.1	3.1	5.1	1.4	2.3	3.5	45.2	7.7	3.3	2.7	0.5	5.8	0.3	0.0	0.0	1.0	0.5	5.4	0.0	4.9	0.5	1.6	1.2	11.6	0.6	0.0	3.4	0.0	0.0	0.0	0.5	1.8	1.5	0.0	78.1	0.9	17.7	0.0	0.9	0.0	1.3	1.8	1.7	0.5	0.4	4.8
SLC16A1	"MCT, MCT1"	ENSG00000155380	"Solute carrier family 16 member 1"	P53985	1	112911847-112957013	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Symport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Cone photoreceptor cells: 149.2;Muller glia cells: 221.8;Rod photoreceptor cells: 246.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003324, CAB017489, HPA071055, CAB079035"	Enhanced	Supported	Enhanced	"Plasma membrane,Cell Junctions"		NA	NA			"Plasma membrane, Cell Junctions"		"CAB017489: AB_2189197, CAB079035: , HPA003324: AB_1856982, HPA071055: AB_2686337"	"unprognostic (1.19e-1)"	"unprognostic (1.61e-2)"	"unprognostic (2.97e-1)"	"prognostic unfavorable (8.37e-6)"	"unprognostic (1.53e-1)"	"unprognostic (2.89e-2)"	"unprognostic (2.15e-3)"	"prognostic unfavorable (4.05e-4)"	"unprognostic (6.92e-2)"	"unprognostic (6.31e-3)"	"prognostic unfavorable (2.10e-4)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (6.78e-8)"	"unprognostic (1.30e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.53e-3)"	11.6	7.2	17.4	8.7	19.5	3.1	4.4	10.0	24.0	4.6	23.4	12.7	3.3	18.4	19.3	15.1	10.4	8.7	8.3	39.0	19.5	12.3	6.5	26.9	3.2	5.8	19.2	6.5	6.0	1.9	5.6	3.7	18.8	16.6	8.3	18.1	22.8	2.5	6.5	31.4	7.5	9.5	20.0	16.1	4.8	14.5	17.9	22.5	4.9	5.4	17.7	6.2	9.6	6.2	3.0	5.9	0.6	3.2	2.0	11.4	2.4	20.2	4.7	14.6	12.4	10.1	8.6	48.0	10.9	8.3	8.6	13.9	16.0	11.8	22.2	15.3	9.9	6.4	19.4	20.4	20.3	16.3	13.9	20.7	18.2	12.9	18.6	17.9	23.2	1.9	12.0	24.9	12.7	25.0	13.9	20.8	11.6	23.0	14.8	9.6	3.9	13.6	11.7	47.2	5.6	15.2	12.2	23.0	15.3	10.6	0.4	16.2	8.5	21.2	0.6	16.2	21.9	0.9	8.8	14.0	8.3	14.6	16.3	16.1	7.8	6.8	22.4	24.1	14.7	10.2	0.6	3.2	0.0	4.1	2.6	6.3	3.0	4.1	4.4	5.9	2.1	4.4	3.8	0.3	2.0	0.7	1.0	11.4	2.4	17.4	19.5	10.0	24.0	19.5	12.3	19.2	6.5	16.6	22.5	0.0	1.6	15.2	6.7	79.3	17.1	109.7	5.1	0.0	1.2	0.0	149.2	57.9	0.0	2.0	102.1	20.4	27.6	0.0	2.9	62.5	30.5	13.5	9.2	34.7	13.7	19.1	3.4	8.0	9.1	75.6	10.9	4.8	37.1	1.8	14.9	221.8	5.1	5.7	7.1	10.2	246.9	0.0	20.6	35.1	10.2	34.5	38.4	6.9	13.6	0.9
SLC16A10	"MCT10, TAT1"	ENSG00000112394	"Solute carrier family 16 member 10"	Q8TF71	6	111087503-111231194	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 25.1;skeletal muscle: 33.4"	"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 2: 26.2;Melanocytes: 42.2"	"Cancer enriched"	"Detected in many"	6	"testis cancer: 4.5"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 4.7"	"Lineage enriched"	"Detected in single"	5	"T-cells: 4.7"	"Cell line enhanced"	"Detected in many"		"HAP1: 29.4;HEK 293: 12.7;RPMI-8226: 24.2"	"Low region specificity"	"Detected in many"							HPA016860	Approved		Supported	"Vesicles,Cell Junctions"		NA	NA			"Vesicles, Cell Junctions"		"HPA016860: AB_2189211"	"unprognostic (2.03e-1)"	"unprognostic (2.08e-1)"	"unprognostic (6.11e-2)"	"unprognostic (3.56e-4)"	"unprognostic (2.24e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.86e-3)"	"unprognostic (5.22e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.10e-3)"	"unprognostic (2.73e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.91e-1)"	7.6	4.9	1.8	2.4	5.4	0.4	1.1	9.5	2.0	0.8	4.8	1.7	1.7	7.6	0.7	1.6	0.7	1.1	1.0	2.8	1.8	1.0	8.1	9.8	6.1	1.8	0.8	0.5	1.2	25.1	8.9	1.5	17.4	5.6	1.2	1.3	3.6	3.5	6.0	33.4	12.1	6.0	0.8	1.0	2.7	3.9	3.5	0.8	19.6	2.2	1.5	0.9	4.4	1.4	0.5	0.3	0.8	0.2	0.3	4.7	0.3	0.6	0.6	0.2	1.3	0.0	0.0	2.4	0.0	0.1	0.5	0.8	5.1	0.2	4.1	0.9	0.1	1.4	0.0	29.4	0.0	0.5	0.1	12.7	4.7	0.3	4.8	0.0	5.0	4.9	0.0	0.0	0.0	0.0	0.1	0.0	6.8	0.8	0.1	0.0	2.0	6.2	0.7	9.0	0.1	1.9	3.5	4.3	24.2	0.0	0.4	6.8	2.1	0.1	0.6	1.1	2.3	1.2	0.8	0.0	0.1	1.1	0.3	1.6	2.0	0.0	1.1	0.2	3.8	0.5	0.8	0.2	0.1	0.2	0.2	0.2	0.2	1.1	0.3	0.0	0.5	4.7	4.0	0.8	0.3	0.1	0.3	4.0	0.3	1.8	5.4	9.5	2.0	1.8	1.0	0.8	0.5	5.6	0.8	8.9	26.2	0.9	10.0	8.7	6.2	7.7	0.0	1.4	5.7	5.2	2.0	1.1	1.7	0.1	7.2	0.7	3.9	0.0	11.1	1.7	2.5	2.8	1.1	19.7	20.5	1.6	6.3	5.5	13.5	5.2	0.0	14.3	42.2	1.0	2.8	1.7	3.1	0.0	0.0	15.2	0.6	0.0	1.0	9.8	9.8	12.9	1.0	0.5	5.0	0.9
SLC16A9	"C10orf36, FLJ43803, MCT9"	ENSG00000165449	"Solute carrier family 16 member 9"	Q7RTY1	10	59650761-59736002	"Predicted membrane proteins, Transporters"	"Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adrenal gland: 58.0;kidney: 70.9"	"Cell type enriched"	"Detected in many"	7	"Proximal tubular cells: 218.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HAP1: 8.7;NTERA-2: 16.4;SH-SY5Y: 7.9;SuSa: 8.8;U-251 MG: 8.3;U-937: 14.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049286	Approved		Approved	"Nucleoplasm,Cell Junctions"		NA	NA			Nucleoplasm	"Cell Junctions"	"HPA049286: AB_2680699"	"unprognostic (3.39e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.60e-3)"	"unprognostic (1.76e-2)"	"unprognostic (5.96e-2)"	"unprognostic (3.50e-3)"	"unprognostic (5.01e-2)"	"unprognostic (2.11e-3)"	"unprognostic (5.99e-2)"	"unprognostic (4.60e-2)"	"prognostic favorable (2.56e-6)"	"unprognostic (7.57e-3)"	"unprognostic (1.27e-2)"	"unprognostic (3.72e-1)"	"unprognostic (1.94e-1)"	0.7	58.0	5.7	2.0	4.6	0.7	0.9	9.9	4.4	8.2	4.6	9.6	1.6	0.3	12.6	2.2	5.3	8.6	3.3	1.4	10.0	2.6	70.9	1.1	0.6	0.8	6.7	5.5	13.4	1.3	11.8	6.4	0.2	8.2	3.2	6.4	5.2	1.6	4.2	9.2	0.5	0.8	3.0	6.0	14.3	2.4	3.4	6.5	0.0	11.2	4.4	3.1	0.9	4.8	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.2	4.2	5.6	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.2	0.0	0.6	0.0	0.0	0.7	8.7	0.0	0.0	0.0	1.4	0.1	0.2	0.0	0.1	1.8	0.0	0.4	0.1	0.0	2.3	0.1	0.3	4.4	6.1	0.1	0.4	3.3	2.3	0.0	16.4	1.6	7.5	2.7	0.2	5.7	0.0	0.2	2.8	7.9	0.1	0.3	0.0	8.8	2.8	3.6	2.6	0.4	0.9	0.1	8.3	0.0	0.0	0.0	0.0	14.8	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	5.7	4.6	9.9	4.3	10.0	2.6	6.7	5.5	8.2	6.5	0.0	0.0	0.0	1.1	0.1	4.7	2.8	0.0	4.0	9.1	7.0	0.0	0.0	21.6	0.7	0.1	0.0	17.7	0.0	0.0	0.8	1.2	12.7	0.0	0.0	0.1	3.2	19.3	0.0	10.5	0.4	12.7	0.0	3.3	1.0	15.5	11.2	0.2	30.3	11.3	218.2	0.8	0.0	2.8	0.3	0.1	0.1	0.0	0.0	12.8	5.7
SLC23A3	"FLJ31168, SVCT3, Yspl1"	ENSG00000213901	"Solute carrier family 23 member 3"	Q6PIS1	2	219161465-219170095	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	11	"intestine: 36.5;kidney: 32.4"	"Cell type enhanced"	"Detected in many"	9	"Enterocytes: 6.7;Proximal tubular cells: 8.9"	"Cancer enriched"	"Detected in some"	9	"renal cancer: 5.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 9.0;U-266/70: 6.6"	"Region enhanced"	"Detected in some"		"cerebral cortex: 1.3"	"Not detected"	"Not detected"			HPA019059			Approved	"Nucleoplasm,Cell Junctions"		NA	NA			Nucleoplasm	"Cell Junctions"	"HPA019059: AB_1857017"	"unprognostic (2.49e-2)"	"unprognostic (6.65e-2)"	"unprognostic (2.05e-4)"	"unprognostic (6.97e-2)"	"unprognostic (8.41e-2)"	"unprognostic (1.22e-2)"	"unprognostic (9.07e-2)"	"unprognostic (1.93e-1)"	"unprognostic (4.01e-2)"	"unprognostic (4.35e-2)"	"unprognostic (3.10e-1)"	"unprognostic (6.12e-4)"	"unprognostic (9.42e-2)"	"unprognostic (6.48e-2)"	"unprognostic (2.41e-2)"	"unprognostic (3.34e-1)"	"unprognostic (6.52e-5)"	0.4	0.0	0.3	2.3	0.3	0.0	0.5	0.3	0.5	0.8	14.9	0.3	0.3	5.3	1.1	0.3	0.9	0.5	0.3	0.3	0.3	0.0	32.4	3.1	0.7	0.3	0.3	0.3	1.0	0.4	0.5	0.3	0.5	0.3	1.4	0.8	0.3	0.4	0.3	0.3	1.1	36.5	0.3	0.3	0.4	0.5	0.3	0.3	0.3	1.3	0.3	0.4	0.6	1.3	0.8	0.0	0.0	0.8	0.0	0.5	0.0	0.9	0.4	0.2	1.1	4.0	2.2	0.8	2.2	0.6	0.4	1.3	2.4	1.6	0.5	0.8	1.5	0.1	3.2	0.7	0.3	0.6	1.9	1.8	2.1	1.9	0.2	0.7	0.2	0.9	0.7	9.0	0.9	2.9	3.6	1.2	1.2	0.3	0.9	0.6	0.3	0.1	1.0	0.0	0.8	0.2	0.5	0.6	0.8	3.1	3.7	0.5	1.0	0.2	0.0	2.4	1.1	0.9	1.1	2.6	2.1	1.4	2.2	0.7	6.6	0.3	2.9	0.6	0.7	0.1	0.0	0.2	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.0	0.3	0.1	0.5	0.0	0.0	0.8	0.0	0.2	0.0	0.3	0.3	0.3	0.5	0.3	0.0	0.3	0.3	0.3	0.3	0.0	0.3	2.0	1.1	1.3	0.8	0.3	2.5	0.0	0.0	1.8	0.0	0.2	1.7	0.2	0.0	0.7	6.7	0.0	0.0	0.1	0.6	1.4	0.0	0.5	0.2	0.0	1.7	0.6	0.3	0.0	1.4	0.4	1.7	1.0	2.8	1.9	0.2	3.1	1.1	8.9	0.1	0.0	0.8	0.0	0.1	1.4	0.3	0.0	1.6	0.7
SLC26A9		ENSG00000174502	"Solute carrier family 26 member 9"	Q7LBE3	1	205913048-205943460	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"salivary gland: 108.4"	"Cell type enhanced"	"Detected in some"	23	"Alveolar cells type 2: 51.6;Cardiomyocytes: 25.8;Proximal tubular cells: 10.5"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 9.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 12.6;Hep G2: 4.7;OE19: 20.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA051485	Enhanced		Approved	"Cell Junctions"		NA	NA			"Cell Junctions"		"HPA051485: AB_2681503"	"unprognostic (1.55e-2)"	"unprognostic (2.70e-2)"	"unprognostic (8.77e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.83e-2)"	"prognostic favorable (8.55e-5)"	"unprognostic (1.26e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.49e-1)"	"unprognostic (8.07e-2)"	"unprognostic (8.85e-2)"	"unprognostic (3.41e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.05e-1)"	"unprognostic (7.45e-3)"	"unprognostic (2.01e-1)"	0.1	0.0	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	1.3	0.1	6.4	0.1	0.1	0.0	0.1	0.1	5.5	0.1	0.1	0.1	0.1	0.5	0.0	0.3	0.1	0.1	0.1	0.0	0.1	108.4	0.1	0.1	1.9	0.1	0.1	0.1	0.1	17.8	0.1	0.1	0.2	0.4	1.1	2.7	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.6	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	20.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	3.0	51.6	0.0	0.0	0.0	0.0	25.8	0.0	4.0	4.5	1.8	0.0	0.0	1.7	2.9	0.4	0.0	0.0	0.0	2.1	0.0	0.0	0.1	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6
SLC2A11	"GLUT10, GLUT11"	ENSG00000133460	"Solute carrier family 2 member 11"	Q9BYW1	22	23856703-23886309	"Predicted membrane proteins, Transporters"	"Sugar transport, Transport"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Cone photoreceptor cells: 280.8;Rod photoreceptor cells: 194.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 12.0"									"HPA042960, HPA071184"	Uncertain		Uncertain	"Nucleoplasm,Cell Junctions"		NA	NA			"Cell Junctions"	Nucleoplasm	"HPA042960: AB_2678241, HPA071184: AB_2686355"	"unprognostic (1.31e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.69e-2)"	"unprognostic (6.97e-2)"	"unprognostic (7.93e-2)"	"unprognostic (1.32e-1)"	"unprognostic (4.24e-2)"	"unprognostic (1.60e-3)"	"unprognostic (3.53e-1)"	"unprognostic (4.89e-2)"	"prognostic favorable (3.83e-4)"	"unprognostic (2.32e-1)"	"prognostic favorable (5.77e-7)"	"unprognostic (1.25e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.85e-1)"	"unprognostic (6.29e-2)"	4.3	7.8	8.5	6.1	15.3	3.5	6.2	22.9	17.0	4.1	4.9	6.4	17.2	3.9	7.7	9.0	2.8	5.0	5.2	8.5	11.0	13.4	19.5	4.9	4.5	7.1	9.5	10.9	6.6	28.8	18.6	14.0	21.0	9.7	7.6	6.0	10.4	6.1	11.4	13.6	4.2	4.8	10.4	9.6	5.3	6.1	4.5	6.2	1.6	9.2	2.4	6.4	4.5	5.3	2.2	4.6	1.5	1.1	1.2	1.6	0.3	2.6	1.3	1.7	7.6	1.6	3.4	0.7	1.6	2.0	1.8	1.3	1.8	1.8	3.4	0.9	2.2	1.6	2.2	3.2	0.9	0.9	2.3	2.9	1.7	2.8	2.6	2.5	1.6	1.8	1.3	3.2	2.7	2.3	8.4	0.7	2.7	0.7	7.6	1.0	2.8	0.3	0.7	2.5	1.7	2.1	4.6	0.2	3.8	5.6	0.7	4.1	2.3	0.8	12.0	2.7	2.1	6.2	0.8	0.5	0.7	1.2	0.7	0.8	7.1	1.9	3.3	1.5	1.2	1.8	1.5	0.4	0.9	0.9	1.1	0.7	2.1	0.8	0.8	0.2	2.2	1.6	1.1	1.2	1.2	0.7	4.6	0.2	0.3	8.5	15.3	22.9	17.0	11.0	13.4	9.5	10.9	9.7	6.2	17.9	12.9	16.6	8.2	2.9	57.0	29.0	7.6	8.1	4.5	24.4	280.8	7.0	11.6	4.7	5.9	3.3	3.4	0.0	4.9	7.6	4.5	8.0	2.3	5.8	5.2	35.0	10.4	4.9	3.1	8.5	8.6	4.2	3.3	2.8	4.9	15.4	3.5	2.9	9.2	20.7	194.1	0.0	6.2	3.9	5.1	2.8	16.7	7.5	7.3	5.4
SLC2A12	"GLUT12, GLUT8"	ENSG00000146411	"Solute carrier family 2 member 12"	Q8TD20	6	133988697-134052636	"Predicted membrane proteins, Transporters"	"Sugar transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 46.6"	"Cell type enhanced"	"Detected in many"	15	"Ciliated cells: 9.4;Glandular cells: 11.7;Muller glia cells: 11.4;Syncytiotrophoblasts: 30.7"	"Cancer enriched"	"Detected in many"	6	"prostate cancer: 18.2"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 1.3;myeloid DC: 1.0"	"Group enriched"	"Detected in many"	6	"dendritic cells: 1.0;monocytes: 1.3"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 7.4;hTERT-RPE1: 13.5;SuSa: 22.1;U-2 OS: 8.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA031593, HPA031594"	Approved		Supported	"Plasma membrane,Cell Junctions"		NA	NA			"Plasma membrane"	"Cell Junctions"	"HPA031593: AB_10600810, HPA031594: AB_2673948"	"unprognostic (2.06e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.69e-2)"	"unprognostic (5.55e-3)"	"unprognostic (2.18e-1)"	"unprognostic (6.02e-2)"	"unprognostic (2.24e-3)"	"unprognostic (2.54e-2)"	"unprognostic (2.08e-2)"	"unprognostic (3.69e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.33e-3)"	"unprognostic (3.04e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.55e-3)"	0.9	1.2	5.2	0.4	6.7	0.1	1.5	14.6	5.5	4.8	3.0	7.1	4.9	8.1	9.7	2.6	7.0	3.4	3.0	11.4	6.5	2.8	6.7	7.9	3.4	0.2	3.4	5.2	1.5	1.3	1.2	2.5	1.9	19.7	27.0	1.4	46.6	5.2	11.2	4.2	3.9	11.9	14.8	1.6	0.3	14.4	0.5	3.3	0.6	0.6	1.9	2.7	6.7	2.0	0.0	1.0	0.0	1.3	0.0	0.1	0.1	2.1	0.7	1.8	0.0	1.4	0.7	0.1	1.3	5.4	0.7	3.0	0.0	7.4	0.2	1.1	0.1	5.5	5.6	0.0	0.5	1.0	0.0	4.7	0.0	0.6	0.1	0.2	0.0	0.0	1.0	0.5	0.6	0.1	13.5	0.4	0.3	0.4	0.6	0.1	0.6	0.1	0.1	1.6	0.0	0.5	0.0	0.9	2.0	1.6	0.7	0.2	0.5	0.0	1.7	0.0	22.1	0.0	0.0	0.0	0.2	8.0	0.2	0.7	2.8	2.1	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.0	1.3	0.1	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.1	0.1	5.2	6.7	14.6	5.5	6.5	2.8	3.4	5.2	19.7	3.3	0.0	4.8	0.0	0.8	1.8	0.1	5.7	0.0	9.4	2.3	0.0	0.0	1.9	3.3	1.2	0.0	0.4	0.0	0.0	0.2	0.5	0.3	11.7	0.0	0.9	0.2	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	0.8	2.9	1.4	0.3	0.5	0.0	0.1	0.0	0.0	1.6	30.7	0.0	0.3	1.4
SLC38A6	NAT-1	ENSG00000139974	"Solute carrier family 38 member 6"	Q8IZM9	14	60981114-61083733	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Early spermatids: 130.6;Hofbauer cells: 89.9;Late spermatids: 97.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 33.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018508	Approved		Approved	"Plasma membrane,Cell Junctions,Microtubules"		NA	NA			"Cell Junctions"	"Plasma membrane, Microtubules"	"HPA018508: AB_2190518"	"unprognostic (7.08e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.75e-1)"	"unprognostic (3.49e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.74e-2)"	"prognostic unfavorable (9.47e-6)"	"unprognostic (9.89e-3)"	"unprognostic (2.38e-1)"	"unprognostic (2.18e-2)"	"unprognostic (2.20e-1)"	"unprognostic (5.13e-2)"	"prognostic unfavorable (1.37e-5)"	"unprognostic (1.73e-1)"	"unprognostic (4.63e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.90e-1)"	26.1	16.9	8.3	6.7	16.6	4.0	11.4	9.7	14.0	8.1	7.1	5.2	5.5	4.5	10.0	20.5	5.0	8.4	14.4	5.4	8.8	8.6	16.9	9.2	12.2	9.6	8.6	10.9	9.9	6.1	23.8	21.5	13.7	14.3	8.1	10.1	10.9	11.7	6.4	4.1	4.6	5.6	8.0	7.6	10.8	6.4	10.9	6.5	8.8	9.7	7.1	7.2	11.6	8.1	2.4	5.2	0.2	8.6	0.7	5.2	3.4	7.1	10.0	3.2	5.9	33.9	12.3	2.2	5.4	16.2	5.1	4.8	2.5	19.6	1.7	9.3	4.9	10.8	6.3	3.1	5.5	4.8	2.4	1.4	3.0	4.1	6.5	11.1	1.5	5.8	9.7	2.3	5.0	5.9	21.1	6.8	2.7	4.1	3.7	17.9	4.0	2.7	3.9	2.0	4.3	6.6	0.5	9.5	5.5	15.0	4.0	1.5	1.2	4.5	3.3	8.7	4.7	4.7	2.6	7.2	8.0	3.4	9.3	3.0	0.7	2.1	0.6	16.4	1.3	6.3	0.0	8.4	0.1	2.2	8.6	2.6	2.4	4.0	2.9	4.4	2.2	3.3	4.3	0.2	0.7	5.4	5.2	5.2	3.4	8.3	16.6	9.7	14.0	8.8	8.6	8.6	10.9	14.3	6.5	20.8	4.1	2.7	10.8	4.6	18.5	2.8	5.1	34.8	5.7	5.2	21.6	5.0	1.7	4.1	130.6	6.7	2.2	0.0	2.5	7.9	8.5	6.5	5.8	4.0	89.9	4.8	4.1	3.7	20.7	97.9	10.0	19.2	5.0	1.8	2.3	14.2	6.0	2.0	5.6	16.8	25.0	0.0	6.6	15.1	10.6	2.5	5.6	4.4	2.8	5.9
SLC44A2	CTL2	ENSG00000129353	"Solute carrier family 44 member 2"	Q8IWA5	19	10602457-10644559	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Extravillous trophoblasts: 210.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A-431: 62.3;SK-BR-3: 60.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003228, HPA070799"	Approved		Approved	"Vesicles,Cell Junctions"		NA	NA		78000	"Vesicles, Cell Junctions"		"HPA003228: AB_1080009, HPA070799: AB_2686314"	"unprognostic (6.35e-3)"	"unprognostic (5.75e-2)"	"unprognostic (4.34e-1)"	"unprognostic (3.06e-3)"	"unprognostic (4.38e-2)"	"unprognostic (8.41e-3)"	"unprognostic (1.64e-1)"	"unprognostic (2.52e-1)"	"unprognostic (2.66e-2)"	"unprognostic (4.32e-1)"	"prognostic unfavorable (6.01e-4)"	"unprognostic (8.63e-2)"	"prognostic favorable (1.71e-5)"	"unprognostic (1.28e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.21e-3)"	"unprognostic (3.61e-2)"	29.3	14.2	25.1	21.4	28.3	23.4	31.6	24.2	33.9	24.7	23.0	40.7	21.7	10.5	21.0	17.3	31.8	24.8	24.9	29.1	21.2	17.9	29.4	9.1	39.4	46.7	26.1	18.4	14.2	16.5	21.6	8.6	114.9	31.8	19.9	20.3	36.6	22.1	28.8	51.6	29.0	19.1	19.3	37.5	49.4	44.0	51.6	21.2	30.4	26.9	26.4	39.2	29.0	26.3	19.0	17.8	86.0	45.9	13.1	21.8	22.8	62.3	1.5	14.0	8.3	21.2	13.1	39.9	13.6	33.4	22.4	26.5	14.0	29.9	12.6	18.2	37.6	2.7	48.3	2.1	10.4	14.5	0.3	1.8	8.0	7.9	0.5	23.5	0.1	6.8	14.1	13.9	8.4	7.4	18.3	17.1	5.9	3.8	2.1	34.0	45.9	6.6	6.1	4.9	18.5	5.6	14.2	19.9	0.5	7.3	33.2	1.3	8.4	10.7	60.1	1.5	15.2	23.4	0.6	15.6	10.1	3.6	12.0	3.4	0.8	1.4	12.4	2.5	5.6	11.2	22.9	7.2	39.3	21.8	19.6	17.2	17.7	15.1	16.5	3.7	19.0	16.5	16.8	86.0	13.1	45.9	17.8	16.5	22.8	25.1	28.3	24.2	33.9	21.2	17.9	26.1	18.4	31.8	21.2	50.6	29.0	40.2	16.9	8.7	11.9	32.2	20.4	16.0	39.8	87.2	13.7	107.9	1.7	38.7	130.7	26.0	27.4	46.7	39.5	210.6	15.5	11.6	19.7	0.9	32.0	3.2	9.2	66.9	28.0	20.6	35.9	7.7	5.0	4.6	17.2	33.6	29.3	37.4	53.0	3.8	2.9	58.2	18.6	3.0	2.7	7.4	78.1	41.7	20.9	16.5
SLC5A7	"CHT1, hCHT"	ENSG00000115665	"Solute carrier family 5 member 7"	Q9GZV3	2	107986523-108013994	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Neurotransmitter biosynthesis, Sodium transport, Symport, Transport"		"Congenital myasthenic syndrome, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	9	"brain: 45.1"	"Group enriched"	"Detected in some"	13	"Alveolar cells type 1: 3.0;Ciliated cells: 2.7;Club cells: 5.7"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.8"	"Group enriched"	"Detected in some"	13	"basal ganglia: 13.8;pons and medulla: 45.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	19	"RT4: 8.9;SCLC-21H: 2.6"	"Group enriched"	"Detected in many"	4	"basal ganglia: 21.3;hypothalamus: 10.1;midbrain: 12.2;pons and medulla: 16.6;thalamus: 7.1"	"Region enhanced"	"Detected in some"		"pons and medulla: 26.3"	HPA046105			Approved	"Nuclear bodies,Cell Junctions,Intermediate filaments"		NA	NA			"Cell Junctions, Intermediate filaments"	"Nuclear bodies"	"HPA046105: "	"unprognostic (2.98e-1)"		"unprognostic (1.01e-1)"					"unprognostic (1.29e-3)"			"unprognostic (7.10e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.39e-4)"	"unprognostic (1.05e-2)"	"unprognostic (9.78e-3)"	"unprognostic (6.42e-2)"	"unprognostic (1.61e-2)"	0.3	2.4	0.1	1.6	13.8	0.0	0.3	0.1	0.4	3.3	5.2	0.1	0.3	2.3	1.6	0.7	1.0	0.2	0.5	1.2	0.2	2.2	0.9	0.2	0.9	0.0	0.3	0.5	0.8	0.5	0.0	0.1	0.0	45.1	0.8	2.5	1.0	0.9	4.2	0.1	0.1	2.5	3.1	10.0	0.1	1.7	0.3	0.8	0.0	4.0	0.3	0.1	4.4	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	2.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	13.8	0.1	0.4	0.2	2.2	0.3	0.5	45.1	0.8	3.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.7	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3
SLC6A6	TAUT	ENSG00000131389	"Solute carrier family 6 member 6"	P31641	3	14402576-14489349	"Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 76.4"	"Group enriched"	"Detected in many"	4	"Cone photoreceptor cells: 538.0;Rod photoreceptor cells: 502.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"neutrophil: 33.2"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 33.2"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 45.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015028, HPA016488"	Enhanced		Approved	"Cell Junctions,Cytosol"		NA	NA			"Cell Junctions, Cytosol"		"HPA015028: AB_1857200, HPA016488: AB_1857202"	"unprognostic (8.25e-2)"	"unprognostic (7.29e-3)"	"unprognostic (2.63e-2)"	"prognostic favorable (5.22e-5)"	"prognostic unfavorable (5.75e-8)"	"unprognostic (4.14e-2)"	"prognostic unfavorable (8.78e-4)"	"unprognostic (2.58e-1)"	"unprognostic (2.56e-1)"	"unprognostic (3.81e-1)"	"unprognostic (6.96e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.78e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.01e-2)"	"unprognostic (9.65e-2)"	"unprognostic (1.90e-1)"	10.2	25.9	5.7	18.0	16.5	46.4	8.1	11.1	12.2	11.3	9.5	8.7	3.6	8.5	14.5	4.4	7.0	7.0	14.5	23.2	5.6	4.6	16.6	2.3	18.6	12.9	18.0	7.6	31.3	2.8	3.8	9.6	18.0	13.3	5.0	4.1	76.4	15.7	7.7	26.6	16.8	22.2	8.2	11.1	20.3	14.0	4.0	12.6	6.2	10.4	11.3	11.2	8.8	6.1	1.6	1.9	33.2	6.9	0.7	3.9	2.3	4.6	17.3	6.2	4.7	8.1	2.5	12.8	7.0	27.8	8.3	6.1	6.3	8.0	13.5	6.4	11.0	12.0	3.7	4.2	5.7	7.4	1.5	5.2	12.8	22.7	9.4	0.2	3.5	27.8	1.3	1.7	7.6	2.0	7.2	9.0	6.3	7.1	2.7	7.3	4.9	9.8	6.8	9.6	6.5	5.0	7.0	7.4	21.1	45.5	9.7	11.5	4.1	5.2	2.8	1.5	24.4	10.7	1.9	22.7	10.6	5.7	2.6	5.0	3.0	3.4	5.0	24.7	6.9	32.4	2.5	5.1	5.0	1.3	4.2	0.7	1.6	1.4	1.7	1.9	0.9	0.2	0.3	33.2	0.7	6.9	0.7	3.9	2.3	5.7	16.5	11.1	12.2	5.6	4.6	18.0	7.6	13.3	12.6	6.0	22.1	4.7	11.2	43.8	102.1	3.6	2.5	12.0	12.5	19.2	538.0	2.2	0.0	9.6	17.0	16.1	0.7	0.0	7.1	12.8	16.4	5.5	12.7	0.4	26.7	9.5	13.8	11.6	62.5	13.3	16.1	47.4	16.9	129.0	2.9	28.2	21.5	2.9	16.3	26.3	502.9	0.0	8.2	0.5	1.5	20.8	4.2	22.4	1.2	10.6
SLC7A2	"ATRC2, CAT-2, HCAT2"	ENSG00000003989	"Solute carrier family 7 member 2"	P52569	8	17497088-17570573	"Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 68.1;parathyroid gland: 78.2;skeletal muscle: 57.8"	"Cell type enhanced"	"Detected in many"	11	"Hepatocytes: 230.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HHSteC: 67.7;RT4: 17.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA009277			Supported	"Plasma membrane,Cell Junctions"		NA	NA			"Plasma membrane"	"Cell Junctions"	"HPA009277: AB_2668229"	"unprognostic (1.31e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.20e-2)"	"unprognostic (7.24e-3)"	"unprognostic (3.11e-1)"	"unprognostic (1.76e-1)"	"unprognostic (4.49e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.11e-2)"	"prognostic unfavorable (2.65e-7)"	"prognostic unfavorable (3.08e-4)"	"unprognostic (1.46e-2)"	"unprognostic (8.98e-2)"	"unprognostic (1.79e-1)"	10.6	3.8	8.6	1.4	3.4	0.1	18.0	2.5	8.3	11.5	2.5	2.4	2.9	0.8	6.4	11.8	3.7	13.6	5.1	9.7	6.8	0.9	3.8	68.1	3.3	2.8	4.4	3.5	35.1	32.2	78.2	3.0	29.0	9.1	4.9	1.5	13.0	2.4	3.3	57.8	3.3	2.0	4.3	10.9	1.8	3.3	7.7	3.5	0.0	14.3	10.4	1.2	3.4	6.4	0.0	0.0	0.8	0.0	0.3	0.0	0.0	0.0	0.9	0.3	10.4	0.0	0.1	11.3	0.0	7.0	0.5	0.6	3.3	0.0	0.0	2.4	0.0	1.5	0.0	7.5	1.7	2.4	0.0	3.9	0.0	8.1	7.2	67.7	3.1	0.0	9.1	1.4	8.8	8.4	0.0	3.2	0.0	0.0	0.0	7.9	11.0	0.4	3.6	3.8	2.3	0.9	0.0	5.2	5.4	0.8	17.4	0.1	1.4	0.5	0.2	3.1	8.0	0.0	0.3	7.2	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	8.6	3.4	2.5	8.3	6.8	0.9	4.4	3.5	9.1	3.5	11.9	63.8	0.0	6.1	7.3	1.8	14.3	33.1	84.3	27.3	7.0	33.4	17.0	0.0	4.5	10.8	5.2	0.1	0.0	79.6	13.8	18.2	28.5	2.3	230.6	4.7	0.0	84.5	6.7	6.9	17.4	35.1	1.5	3.3	1.0	2.2	15.0	29.6	0.0	26.2	1.8	38.5	58.2	52.8	0.4	0.4	3.3	21.7	2.5	2.6	1.8
SLC9A2	NHE2	ENSG00000115616	"Solute carrier family 9 member A2"	Q9UBY0	2	102619707-102711318	"Plasma proteins, Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 16.8;intestine: 16.1;stomach 1: 19.8"	"Cell type enhanced"	"Detected in some"	10	"Early spermatids: 19.1;Enterocytes: 23.6;Late spermatids: 22.4;Mucus-secreting cells: 26.9;Paneth cells: 40.3;Undifferentiated cells: 31.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 6.8;OE19: 25.9;RT4: 11.9;SK-BR-3: 10.5;T-47d: 13.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA035121, HPA035122"	Approved		Supported	"Cell Junctions"		NA	NA			"Cell Junctions"		"HPA035121: AB_10602894, HPA035122: AB_2674477"	"unprognostic (1.53e-2)"	"unprognostic (8.05e-3)"	"unprognostic (6.00e-2)"	"unprognostic (3.00e-3)"	"unprognostic (3.12e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.40e-3)"	"unprognostic (1.60e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.70e-1)"	0.2	0.4	0.9	10.8	1.4	0.0	1.0	0.5	1.9	1.0	15.0	0.6	8.4	4.6	0.2	5.8	0.5	0.2	16.8	0.2	1.5	1.0	4.6	0.2	0.2	0.0	0.9	0.7	0.2	0.2	0.1	1.7	0.0	1.8	4.5	16.1	0.9	3.7	11.7	4.4	1.3	9.5	0.4	1.3	0.2	19.8	5.3	0.6	1.0	0.6	1.8	3.1	2.8	0.2	0.0	0.0	0.3	0.0	0.3	0.1	0.0	6.8	4.3	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.7	0.1	0.0	2.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	2.3	2.1	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	5.3	0.0	0.0	0.1	25.9	3.6	0.0	0.0	0.0	0.8	11.9	0.0	0.0	0.0	10.5	0.0	0.0	13.2	0.0	0.0	0.0	0.5	0.0	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.9	1.4	0.5	1.9	1.5	1.0	0.9	0.7	1.8	0.6	0.0	0.0	0.0	0.2	0.3	0.0	0.4	0.0	0.0	0.0	8.7	0.0	0.4	0.0	0.2	19.1	0.0	23.6	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.1	0.0	9.4	0.0	0.0	22.4	0.6	0.0	0.0	0.0	26.9	0.5	4.9	40.3	0.0	1.0	0.0	0.0	0.3	0.7	0.1	0.5	0.2	0.0	31.4	0.7
SLC9B2	"FLJ23984, NHA2, NHEDC2"	ENSG00000164038	"Solute carrier family 9 member B2"	Q86UD5	4	103019868-103085829	"Predicted membrane proteins, Transporters"	"Antiport, Hydrogen ion transport, Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 45.6"	"Group enriched"	"Detected in many"	4	"Cone photoreceptor cells: 25.5;Exocrine glandular cells: 60.7;Hepatocytes: 33.1;Pancreatic endocrine cells: 60.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 5.6;NK-cells: 12.2;T-cells: 6.3"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA047008	Uncertain		Approved	"Nucleoplasm,Cell Junctions"		NA	NA			"Nucleoplasm, Cell Junctions"		"HPA047008: AB_2679901"	"unprognostic (1.85e-1)"	"unprognostic (5.43e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.11e-1)"	"unprognostic (8.83e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.43e-2)"	"unprognostic (3.78e-2)"	"unprognostic (3.26e-1)"	"unprognostic (2.53e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.51e-5)"	"unprognostic (2.23e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.90e-2)"	"unprognostic (2.35e-5)"	7.3	7.9	8.8	6.3	13.3	5.3	5.5	16.5	24.5	5.6	5.0	5.2	0.4	2.0	8.5	4.2	4.7	5.9	9.8	5.5	8.9	12.5	1.9	45.6	3.3	7.2	10.3	13.4	8.0	2.4	1.2	8.8	5.2	20.8	5.6	3.9	8.3	2.1	6.7	4.5	3.7	3.0	9.8	9.8	4.6	5.7	4.8	4.7	2.5	2.6	1.8	6.9	5.5	8.5	5.6	1.7	0.0	0.1	12.2	6.3	1.8	2.6	1.3	3.1	6.5	15.7	13.1	0.0	12.0	4.8	2.0	1.9	1.3	1.7	16.9	2.1	13.9	2.7	0.8	7.1	5.0	2.8	14.8	4.9	16.9	4.2	12.2	8.4	11.8	5.3	11.5	6.8	4.2	14.7	6.7	8.6	4.8	5.7	12.4	6.2	1.0	9.5	7.3	2.4	0.0	3.8	0.0	3.4	7.4	5.8	1.0	10.8	9.7	5.4	1.4	3.5	0.9	1.5	7.9	10.5	4.5	2.7	7.0	4.1	10.6	7.6	12.3	5.3	10.4	1.7	0.0	0.1	0.0	5.1	0.0	6.3	5.6	5.6	4.5	0.9	3.6	3.4	4.2	0.0	12.2	0.1	1.7	2.4	1.8	8.8	13.3	16.5	21.2	8.9	12.5	10.3	13.4	20.8	4.7	0.0	0.3	6.5	2.6	4.2	8.9	2.4	7.6	0.0	1.2	0.0	25.5	0.3	0.0	5.5	10.6	8.7	0.0	0.0	60.7	2.0	8.8	2.0	1.1	33.1	1.3	7.9	2.9	4.3	1.5	5.0	5.2	2.3	10.1	6.4	0.6	0.6	60.5	0.0	4.9	1.0	2.0	6.5	10.5	1.8	4.3	3.3	0.2	4.6	0.0	0.9
SLCO4A1	"OATP-E, OATP4A1, SLC21A12"	ENSG00000101187	"Solute carrier organic anion transporter family member 4A1"	Q96BD0	20	62642445-62685785	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	17	"Extravillous trophoblasts: 195.5;Melanocytes: 57.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"T-reg: 4.3"	"Group enriched"	"Detected in many"	5	"B-cells: 2.3;dendritic cells: 2.6;T-cells: 4.3"	"Cell line enhanced"	"Detected in many"		"PC-3: 56.2;RPTEC TERT1: 53.9"	"Region enriched"	"Detected in single"	5	"cerebellum: 7.5"	"Low region specificity"	"Detected in some"			"HPA030669, HPA030670"	Uncertain		Supported	"Cell Junctions"		NA	NA			"Cell Junctions"		"HPA030669: AB_10601163, HPA030670: AB_10670033"	"unprognostic (8.94e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.41e-1)"	"unprognostic (2.46e-3)"	"unprognostic (3.34e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.84e-3)"	"prognostic unfavorable (4.74e-4)"	"unprognostic (4.94e-2)"	"unprognostic (1.21e-2)"	"unprognostic (3.49e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.84e-3)"	"unprognostic (9.27e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.25e-1)"	25.0	5.2	16.4	5.3	22.4	3.9	27.2	11.3	23.8	5.0	6.4	1.6	4.3	4.2	5.5	2.3	24.1	5.2	5.6	18.1	19.0	9.2	16.6	3.1	29.4	5.7	18.1	2.3	3.1	5.4	13.8	1.2	11.9	24.8	2.8	5.5	7.1	20.1	4.1	19.2	16.5	4.4	3.6	9.8	4.5	14.9	3.3	16.5	0.5	4.5	4.0	8.7	7.4	18.5	2.3	2.6	0.0	0.5	0.0	4.3	0.7	4.1	5.3	0.2	3.1	0.7	0.6	7.6	1.3	4.7	4.1	1.4	8.9	4.2	4.9	12.9	0.1	2.8	6.1	4.7	0.3	1.5	0.5	2.7	5.9	6.0	6.5	0.0	4.5	1.9	0.0	1.8	0.0	1.8	1.2	0.7	3.0	4.6	1.3	0.0	4.1	4.6	17.6	1.4	20.5	56.2	8.4	0.3	7.2	53.9	3.9	5.0	7.2	1.1	1.2	4.5	2.0	0.2	2.1	0.8	0.1	3.0	2.0	7.6	2.6	4.2	3.0	11.2	6.5	0.7	0.0	0.0	0.0	0.2	0.5	0.0	2.3	0.5	0.1	2.6	2.0	0.7	0.3	0.0	0.0	0.1	0.0	4.3	0.7	16.4	22.4	11.3	23.8	19.0	9.2	18.1	2.3	24.8	16.5	3.0	2.2	5.7	0.7	24.3	13.2	3.6	2.5	1.4	1.2	24.4	29.5	1.6	0.0	4.0	0.3	26.3	2.1	0.0	2.2	195.5	4.1	2.1	0.0	0.0	5.0	0.0	0.0	17.8	9.9	0.4	0.3	8.4	57.3	0.0	5.1	4.2	7.7	2.3	0.7	4.2	43.2	0.0	6.6	0.2	4.2	14.1	19.7	3.2	6.8	6.3
SLIT3	"MEGF5, SLIL2, Slit-3, SLIT1, slit2"	ENSG00000184347	"Slit guidance ligand 3"	O75094	5	168661733-169301129	"Predicted intracellular proteins, Predicted secreted proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	13	"Fibroblasts: 32.9;Melanocytes: 33.7;Sertoli cells: 84.1;Smooth muscle cells: 67.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	7	"NK-cell: 4.1"	"Lineage enriched"	"Detected in single"	7	"NK-cells: 4.1"	"Cell line enhanced"	"Detected in some"		"ASC diff: 81.4;fHDF/TERT166: 28.9;RT4: 25.2;SH-SY5Y: 18.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA051630	Approved		Supported	"Cell Junctions"	"Secreted in other tissues"	NA	NA			"Cell Junctions"		"HPA051630: AB_2681557"	"unprognostic (2.86e-2)"	"unprognostic (2.64e-1)"	"unprognostic (4.43e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.50e-2)"	"unprognostic (3.53e-2)"	"unprognostic (9.21e-3)"	"unprognostic (3.06e-2)"	"unprognostic (1.71e-1)"	"unprognostic (9.50e-3)"	"unprognostic (1.57e-1)"	"unprognostic (2.08e-1)"	"prognostic unfavorable (2.45e-5)"	"unprognostic (5.90e-3)"	"unprognostic (8.56e-2)"	"unprognostic (4.27e-1)"	"unprognostic (3.53e-1)"	38.5	12.5	6.7	6.3	7.9	0.2	31.8	20.3	10.8	28.0	13.2	1.8	13.0	3.2	21.6	22.4	18.2	14.8	32.5	28.3	6.2	4.6	12.0	1.5	24.9	6.7	2.2	7.1	29.4	4.6	37.6	3.8	12.4	10.7	28.5	5.9	7.7	10.7	9.8	4.9	17.5	7.1	44.4	2.0	7.7	8.2	6.3	0.3	11.8	16.6	10.8	6.2	36.8	32.1	0.1	0.0	0.5	0.1	4.1	0.0	0.0	0.0	2.7	0.0	0.0	81.4	1.5	0.0	4.5	0.7	1.0	2.1	0.0	0.0	0.0	1.1	28.9	3.3	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	1.0	0.1	1.0	11.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	25.2	0.3	18.9	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.7	0.5	6.5	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	4.1	0.0	0.0	0.0	0.0	6.7	7.9	20.3	10.8	6.2	4.6	2.2	7.1	10.7	0.3	0.0	2.9	0.0	1.6	23.7	2.4	22.8	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.2	9.7	3.1	0.0	0.0	0.0	0.4	32.9	0.6	1.1	0.0	1.1	0.0	0.0	2.5	0.0	6.2	0.9	1.5	33.7	0.0	0.0	12.3	0.0	0.0	0.4	1.7	0.2	84.1	67.6	0.5	1.6	15.4	0.9	0.0	0.0	0.7
SLX4	"BTBD12, FANCP, KIAA1784, KIAA1987"	ENSG00000188827	"SLX4 structure-specific endonuclease subunit"	Q8IY92	16	3581181-3611598	"Disease related genes, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"		"Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 19.9;testis: 25.0"	"Cell type enhanced"	"Detected in many"	8	"Rod photoreceptor cells: 10.9;Spermatocytes: 18.6;Spermatogonia: 10.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 3.0"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049421, HPA066238"	Approved		Supported	"Nucleoplasm,Cell Junctions,Cytosol"		NA	NA			Nucleoplasm	"Cell Junctions, Cytosol"	"HPA049421: AB_2680759, HPA066238: AB_2685642"	"unprognostic (1.04e-1)"	"unprognostic (1.23e-1)"	"unprognostic (4.06e-2)"	"unprognostic (2.65e-2)"	"unprognostic (4.62e-1)"	"unprognostic (6.08e-3)"	"unprognostic (8.28e-5)"	"unprognostic (6.52e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.97e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.32e-2)"	"unprognostic (8.39e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.43e-3)"	"unprognostic (5.74e-2)"	2.9	3.1	5.3	6.1	8.5	6.0	2.4	19.9	11.8	2.5	2.9	9.8	2.5	4.9	6.5	3.3	3.4	3.0	2.8	2.2	7.4	4.3	2.9	2.7	3.0	8.6	3.8	8.1	2.7	3.1	3.7	8.6	2.6	7.4	3.3	2.2	5.4	3.0	2.6	5.5	4.2	4.0	3.1	3.3	4.8	3.7	25.0	3.2	5.8	2.6	1.0	6.5	3.1	2.7	0.6	0.2	3.0	1.1	0.6	0.6	0.7	3.0	9.3	6.1	7.5	2.3	2.4	6.3	4.8	2.4	5.6	6.2	4.6	3.7	10.9	4.8	2.4	4.3	6.7	4.1	3.4	3.3	9.1	5.1	7.5	6.7	2.9	2.0	7.2	10.6	1.8	2.5	5.2	2.9	1.4	4.0	6.2	7.1	6.0	4.4	5.1	4.4	6.3	5.0	1.8	3.5	8.9	10.0	3.0	2.2	2.1	5.2	4.6	4.2	3.0	1.5	3.3	7.3	5.7	4.7	6.5	9.0	5.5	5.6	5.4	4.2	12.8	2.1	7.4	6.3	3.0	0.4	0.0	0.6	0.5	0.4	0.3	0.3	0.3	0.2	0.6	0.3	0.5	0.5	0.6	1.1	0.2	0.3	0.7	5.3	8.5	19.9	11.8	7.4	4.3	3.8	8.1	7.4	3.2	0.0	2.9	4.5	0.8	0.7	7.7	1.4	2.5	2.7	4.5	0.0	2.0	1.3	0.0	1.4	3.5	1.1	1.5	0.0	2.1	1.5	1.5	0.4	0.0	0.9	2.3	0.0	0.0	1.8	1.6	1.6	2.0	3.2	0.0	1.0	2.2	1.7	1.6	0.0	1.8	0.4	10.9	0.0	1.8	18.6	10.0	0.5	0.8	3.5	1.7	0.5
SMAGP	"hSMAGP, MGC149453, MGC149454"	ENSG00000170545	"Small cell adhesion glycoprotein"	Q0VAQ4	12	51244558-51270890	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 53.4"	"Group enriched"	"Detected in many"	9	"Cytotrophoblasts: 1087.3;Syncytiotrophoblasts: 704.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 39.4;OE19: 47.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039711	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA			"Plasma membrane"	"Nucleoplasm, Cell Junctions"	"HPA039711: AB_10674985"	"unprognostic (2.55e-3)"	"unprognostic (2.63e-1)"	"unprognostic (3.96e-2)"	"unprognostic (3.63e-3)"	"prognostic unfavorable (5.36e-4)"	"unprognostic (3.01e-1)"	"unprognostic (1.63e-3)"	"unprognostic (6.26e-2)"	"unprognostic (7.48e-2)"	"unprognostic (9.11e-2)"	"prognostic unfavorable (4.38e-4)"	"unprognostic (1.46e-1)"	"prognostic favorable (2.24e-4)"	"unprognostic (4.32e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.52e-1)"	7.5	6.9	0.9	11.3	1.7	0.9	26.3	1.1	1.3	13.1	22.6	0.9	5.3	6.9	8.0	13.6	53.4	3.2	21.8	6.0	1.0	1.0	10.9	4.3	17.6	14.2	1.5	0.4	5.2	14.9	4.6	1.9	50.0	3.0	4.8	24.3	2.6	10.2	6.9	3.6	12.6	8.5	3.4	4.3	11.5	14.1	4.8	0.7	1.2	4.2	28.7	33.1	7.9	24.6	22.5	2.6	8.6	3.7	12.3	9.5	3.5	23.3	7.2	0.8	0.8	3.2	12.7	39.4	18.0	18.1	9.2	5.7	14.2	24.6	0.2	3.2	11.1	3.4	8.3	5.1	6.9	12.9	1.1	4.1	3.1	0.9	4.7	8.9	0.7	3.0	8.2	5.3	19.9	18.0	21.1	22.1	6.0	2.4	1.3	14.8	20.6	3.8	2.8	3.6	47.5	27.9	0.2	0.3	0.8	13.3	5.4	0.9	1.1	3.9	15.8	2.8	9.9	13.6	1.2	7.7	10.3	9.8	0.5	10.9	0.4	0.6	0.4	15.1	7.7	5.5	1.9	3.7	6.4	9.5	2.4	6.1	22.5	4.2	6.9	2.6	17.6	3.9	7.0	8.6	12.3	2.6	1.5	2.7	3.5	0.9	1.7	1.1	1.3	1.0	1.0	1.5	0.4	3.0	0.7	0.0	18.8	28.2	46.4	19.3	1.2	1.1	53.5	8.1	12.5	15.7	0.0	1087.3	41.4	27.1	6.5	53.4	61.6	0.0	95.9	65.5	13.8	46.6	12.7	5.8	83.3	1.6	19.7	38.1	5.4	2.1	12.0	6.7	13.5	5.4	100.2	2.5	97.3	73.7	9.2	15.3	1.2	25.8	8.1	5.2	28.8	26.0	704.6	15.2	97.4	72.3
SMPD2	"ISC1, nSMase"	ENSG00000135587	"Sphingomyelin phosphodiesterase 2"	O60906	6	109440763-109443919	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Sphingolipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	14	"Early spermatids: 151.6;Late spermatids: 248.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA018110, HPA018125"	Uncertain		Approved	"Vesicles,Plasma membrane,Cell Junctions"		NA	NA			"Vesicles, Plasma membrane"	"Cell Junctions"	"HPA018110: AB_1857292, HPA018125: AB_1857293"	"unprognostic (1.61e-1)"	"unprognostic (8.01e-2)"	"unprognostic (1.97e-1)"	"unprognostic (8.79e-3)"	"unprognostic (3.88e-2)"	"unprognostic (2.38e-1)"	"prognostic unfavorable (1.17e-4)"	"unprognostic (7.08e-2)"	"unprognostic (7.59e-2)"	"unprognostic (1.41e-1)"	"prognostic favorable (1.00e-3)"	"unprognostic (3.60e-2)"	"unprognostic (2.14e-3)"	"unprognostic (7.94e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.45e-2)"	"prognostic favorable (1.70e-4)"	6.0	6.8	4.2	20.2	4.9	8.5	8.5	5.4	6.4	9.0	12.6	9.8	16.4	10.5	6.1	16.0	17.2	17.4	12.6	5.1	4.9	3.7	10.2	7.8	8.4	9.4	4.7	4.2	6.7	15.5	17.9	8.8	19.5	4.8	10.1	10.2	8.4	16.6	11.9	3.3	16.9	15.4	7.8	4.3	10.1	11.1	35.1	4.7	18.3	10.5	13.5	23.0	6.3	10.1	18.3	13.4	9.3	7.8	6.2	8.0	5.3	8.9	10.4	5.5	8.6	9.7	5.3	18.3	3.0	11.2	7.6	7.2	9.8	7.3	4.9	6.4	6.4	16.0	11.5	5.5	13.2	4.6	6.2	14.2	5.7	10.7	6.0	8.1	6.2	6.7	5.6	15.3	6.7	13.3	8.5	6.9	8.7	11.0	8.7	3.7	12.9	10.0	13.5	1.5	11.9	5.0	7.1	2.6	5.3	13.7	15.3	7.2	6.0	5.7	17.9	13.5	4.6	5.7	12.0	4.4	3.4	4.9	2.7	11.2	5.9	1.5	3.1	6.6	6.0	6.0	5.7	7.8	9.3	6.6	7.5	7.3	12.8	7.4	8.0	10.2	18.3	5.6	5.7	2.3	6.2	6.6	13.4	7.2	5.3	4.2	4.9	5.4	6.4	4.9	3.7	4.7	4.2	4.8	4.7	11.9	7.4	4.2	8.5	8.8	1.3	2.0	12.7	58.9	7.9	12.2	3.9	8.2	1.7	14.7	151.6	3.8	27.2	0.0	17.1	16.1	6.0	12.7	0.0	3.2	8.5	0.0	8.1	4.3	6.6	248.2	8.6	10.8	8.5	11.8	21.2	2.3	13.7	24.6	8.5	7.9	5.2	12.9	2.8	36.6	10.6	16.3	14.2	4.9	13.8	13.7
SNRK	"FLJ20224, HSNFRK, KIAA0096"	ENSG00000163788	"SNF related kinase"	Q9NRH2	3	43286512-43424764	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Ito cells: 86.5;Sertoli cells: 122.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HUVEC TERT2: 51.9;TIME: 30.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042163	Uncertain		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cell Junctions"		NA	NA			"Vesicles, Plasma membrane, Cell Junctions"	Nucleoplasm	"HPA042163: AB_10794645"	"prognostic favorable (9.28e-4)"	"unprognostic (8.46e-2)"	"unprognostic (2.79e-3)"	"unprognostic (6.41e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.16e-3)"	"unprognostic (2.00e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.63e-3)"	"unprognostic (4.25e-1)"	"unprognostic (2.32e-1)"	"unprognostic (4.68e-2)"	"prognostic favorable (9.41e-5)"	"unprognostic (9.21e-3)"	"unprognostic (2.04e-1)"	"unprognostic (7.06e-3)"	"unprognostic (7.38e-2)"	31.5	8.8	9.8	13.1	14.4	41.0	22.6	34.5	21.1	17.6	14.4	7.9	5.9	12.8	20.9	10.5	16.2	11.5	16.4	13.9	11.0	11.0	16.8	20.3	24.7	19.8	11.4	10.6	15.1	18.0	18.4	16.2	26.2	22.5	12.1	9.9	14.7	10.7	9.4	12.5	24.5	17.0	18.7	9.8	25.4	11.2	13.9	7.2	48.4	24.8	13.5	14.4	15.8	19.3	3.2	3.0	20.9	5.5	8.1	10.7	6.5	3.3	2.0	3.8	3.6	11.3	4.0	3.6	3.6	6.1	3.9	3.8	2.8	4.8	5.3	2.8	4.5	2.6	2.1	4.4	7.7	4.1	6.0	3.6	6.0	3.8	3.2	5.9	6.7	6.7	4.5	5.3	4.4	7.5	4.0	51.9	6.1	2.6	6.1	3.5	1.7	6.8	5.9	4.2	1.8	9.3	4.7	2.8	5.5	10.1	5.7	2.7	5.6	3.1	3.3	4.3	3.4	2.3	8.6	30.2	3.4	3.5	3.9	4.1	9.9	7.1	4.5	2.4	8.1	4.9	4.8	2.8	5.4	7.6	5.5	10.7	2.8	6.7	7.6	3.0	3.2	10.1	10.1	20.9	8.1	5.0	0.9	7.1	6.5	9.8	14.4	34.5	21.1	11.0	11.0	11.4	10.6	22.5	7.2	29.8	30.3	12.9	9.7	46.9	49.8	14.5	22.9	16.0	18.2	15.7	15.7	6.3	10.0	9.2	40.0	52.3	28.4	0.0	7.8	2.7	11.8	9.9	13.9	21.3	11.3	28.6	10.4	86.5	27.6	4.9	11.5	16.6	21.9	4.6	8.9	15.6	8.4	8.2	11.0	10.4	17.2	122.9	26.4	10.7	15.7	44.8	6.9	41.7	8.5	15.4
SNX32	"FLJ30934, SNX6B"	ENSG00000172803	"Sorting nexin 32"	Q86XE0	11	65833641-65856896	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 16.6"	"Cell type enhanced"	"Detected in some"	12	"Early spermatids: 10.4;Late spermatids: 8.2;Spermatocytes: 4.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 1.0;dendritic cells: 1.2;T-cells: 3.0"	"Cell line enhanced"	"Detected in some"		"HHSteC: 6.1;HSkMC: 8.0;REH: 2.6;SH-SY5Y: 3.1;U-266/70: 9.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041775	Uncertain		Uncertain	"Cell Junctions,Focal adhesion sites"		NA	NA			"Cell Junctions, Focal adhesion sites"		"HPA041775: AB_10797268"	"unprognostic (6.74e-4)"	"unprognostic (1.06e-1)"	"unprognostic (1.67e-2)"	"unprognostic (4.50e-5)"	"unprognostic (1.00e-1)"	"unprognostic (9.28e-2)"	"unprognostic (7.30e-2)"	"unprognostic (9.17e-3)"	"unprognostic (2.70e-1)"	"unprognostic (2.87e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.64e-4)"	"unprognostic (2.14e-1)"	"unprognostic (1.14e-1)"	"unprognostic (9.80e-2)"	"unprognostic (5.36e-2)"	0.8	1.0	9.0	1.1	16.6	1.3	1.3	3.5	16.1	1.6	2.2	1.6	0.0	3.4	2.0	1.3	0.9	2.5	2.8	0.9	10.2	5.0	0.9	0.7	0.8	1.0	3.6	10.9	1.3	0.8	0.8	0.3	0.9	3.4	0.8	1.9	0.1	0.7	0.9	0.6	1.1	1.5	2.0	1.8	0.9	0.9	3.5	3.7	0.0	0.7	0.0	1.3	1.0	0.2	1.0	1.2	0.2	0.3	0.1	3.0	0.4	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.1	0.0	0.7	8.0	0.1	0.0	0.0	0.4	0.0	1.2	0.0	0.0	0.4	0.0	0.5	0.3	0.1	0.0	0.0	2.6	0.0	2.3	0.1	0.0	0.0	3.1	0.0	0.0	1.7	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	9.3	1.6	0.0	0.7	0.0	0.3	0.0	0.1	0.0	1.2	0.3	3.0	0.3	1.6	1.2	1.2	1.0	1.4	0.6	0.2	0.1	0.0	0.7	1.2	0.4	9.0	16.6	3.5	15.4	10.2	5.0	3.6	10.9	3.4	3.7	0.0	1.1	0.0	0.3	0.3	1.7	0.8	0.0	1.4	1.2	0.0	0.0	0.0	0.0	0.0	10.4	0.5	0.8	0.0	0.0	0.1	0.6	0.1	3.5	0.0	0.3	0.0	0.0	0.6	0.0	8.2	0.3	0.0	1.7	0.0	0.3	0.8	0.1	0.0	1.1	0.2	0.5	0.0	0.3	4.4	1.3	0.4	0.0	0.0	1.2	0.1
SPERT	"CBY2, NURIT"	ENSG00000174015	"Spermatid associated"	Q8NA61	13	45702311-45714559	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	21	"testis: 66.5"	"Group enriched"	"Detected in some"	81	"Early spermatids: 730.0;Late spermatids: 1376.0"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"T-reg: 3.2"	"Lineage enriched"	"Detected in single"	32	"T-cells: 3.2"	"Cell line enhanced"	"Detected in some"		"EFO-21: 1.8;HDLM-2: 3.5;hTCEpi: 1.2;JURKAT: 1.1;MCF7: 1.3;SCLC-21H: 1.2;SK-BR-3: 2.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA039359, HPA040046"	Enhanced		Approved	"Plasma membrane,Cell Junctions"		NA	NA			"Plasma membrane, Cell Junctions"		"HPA039359: AB_10794088, HPA040046: AB_10796117"	"unprognostic (2.86e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.76e-2)"	"unprognostic (4.19e-4)"		"unprognostic (8.52e-2)"	"unprognostic (8.87e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.38e-1)"		"unprognostic (2.38e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.97e-2)"	"unprognostic (4.15e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	66.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	1.8	0.8	0.0	0.0	0.1	0.0	0.0	3.5	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	1.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.2	0.0	2.5	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.7	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	3.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	730.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1376.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	12.9	0.0	7.4	5.3	0.0	0.0	0.0	0.0	0.0
SPTBN2	SCA5	ENSG00000173898	"Spectrin beta, non-erythrocytic 2"	O15020	11	66685248-66729226	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Actin capping, Actin-binding"	"Disease mutation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 46.7;skin 1: 36.9"	"Cell type enhanced"	"Detected in many"	13	"Collecting duct cells: 82.0;Cone photoreceptor cells: 98.2;Late spermatids: 50.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 20.3;NTERA-2: 23.5;SCLC-21H: 23.9;SK-BR-3: 16.7;T-47d: 19.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009844, HPA039293, HPA043529"	Enhanced		Approved	"Plasma membrane,Cell Junctions"		NA	NA		4800000	"Plasma membrane"	"Cell Junctions"	"CAB009844: AB_2194521, HPA039293: AB_2676430, HPA043529: AB_2678531"	"unprognostic (9.34e-2)"	"unprognostic (5.71e-2)"	"unprognostic (4.89e-2)"	"unprognostic (3.41e-3)"	"unprognostic (4.91e-1)"	"unprognostic (6.05e-3)"	"unprognostic (4.45e-2)"	"unprognostic (1.38e-2)"	"unprognostic (7.25e-2)"	"unprognostic (1.67e-2)"	"prognostic unfavorable (3.14e-5)"	"unprognostic (1.64e-1)"	"unprognostic (1.05e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.00e-3)"	0.8	4.9	26.2	1.0	38.3	1.7	4.5	29.6	46.7	9.6	0.9	2.0	0.0	1.0	1.1	1.2	12.7	2.6	1.2	0.7	19.7	8.2	12.7	7.1	0.9	0.5	6.5	24.7	0.8	8.3	12.2	3.9	0.7	14.4	6.8	0.7	1.7	13.4	3.1	0.7	36.9	0.9	1.2	1.9	0.9	1.2	18.9	6.2	0.0	0.5	0.1	3.3	1.1	3.6	0.1	0.0	0.4	0.0	0.0	0.0	0.0	6.5	3.4	1.6	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.0	2.2	8.1	0.0	1.8	0.0	0.3	7.8	11.9	1.1	0.0	0.0	4.7	0.0	20.3	1.1	0.3	3.3	0.3	0.1	5.5	0.0	3.5	1.9	2.9	2.4	3.3	0.0	0.0	12.8	2.6	1.5	23.5	9.2	10.5	10.9	1.3	6.7	4.5	1.1	23.9	14.1	6.6	16.7	1.5	1.3	19.1	0.9	0.6	0.0	4.2	0.6	5.2	0.3	1.2	7.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	26.2	38.3	29.6	46.7	19.7	8.2	6.5	24.7	14.4	6.2	3.0	0.6	0.0	1.7	3.3	7.4	1.6	2.5	1.4	2.3	82.0	98.2	0.8	0.0	2.4	24.4	0.6	0.0	0.0	8.7	0.3	0.5	3.1	0.0	20.2	0.1	0.0	2.9	1.3	0.0	50.4	1.7	0.0	0.0	1.0	1.6	1.4	6.9	0.0	1.4	1.2	21.0	0.0	0.0	2.7	8.6	10.9	0.2	0.0	0.6	1.4
SRC	"ASV, c-src, SRC1"	ENSG00000197122	"SRC proto-oncogene, non-receptor tyrosine kinase"	P12931	20	37344685-37406050	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Transporters"	"Cell adhesion, Cell cycle, Host-virus interaction, Immunity"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 5.3;non-classical monocyte: 4.4"	"Group enriched"	"Detected in many"	6	"dendritic cells: 3.0;monocytes: 5.3"	"Cell line enhanced"	"Detected in many"		"A549: 35.9;HBEC3-KT: 33.4;RT4: 34.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004023, HPA030875"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cell Junctions,Cytosol"		NA	NA		20000000	"Plasma membrane, Cell Junctions"	"Nucleoplasm, Cytosol"	"CAB004023: AB_2106059, HPA030875: AB_2673640"	"unprognostic (5.58e-2)"	"unprognostic (9.83e-2)"	"unprognostic (3.56e-1)"	"unprognostic (4.54e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.54e-2)"	"prognostic unfavorable (4.90e-5)"	"unprognostic (3.89e-2)"	"unprognostic (7.04e-2)"	"unprognostic (8.13e-2)"	"unprognostic (1.54e-2)"	"prognostic unfavorable (1.63e-4)"	"prognostic unfavorable (1.22e-4)"	"unprognostic (2.33e-2)"	"unprognostic (4.72e-2)"	"unprognostic (3.65e-2)"	"prognostic favorable (5.22e-5)"	6.9	17.5	12.8	11.1	12.0	5.4	9.9	6.4	16.0	16.0	16.4	3.5	15.1	29.5	20.3	9.7	16.2	14.2	42.1	5.8	11.3	6.6	13.4	2.9	10.4	7.0	3.3	9.9	15.8	19.1	6.6	11.3	6.3	5.1	19.9	13.1	13.1	7.5	22.5	3.4	7.7	28.1	27.2	3.6	12.2	29.8	27.3	4.8	4.0	6.6	10.5	10.4	26.4	20.0	0.3	3.0	0.1	5.3	0.6	0.1	1.6	7.7	35.9	8.3	7.4	3.1	5.0	17.2	7.2	6.2	8.8	5.6	13.5	7.0	0.2	4.5	13.0	10.0	14.2	4.9	33.4	3.4	0.0	4.5	2.0	1.3	20.9	7.5	0.1	3.1	5.3	11.4	5.7	7.7	9.8	8.0	4.6	0.2	0.0	1.4	5.3	1.9	0.2	3.9	21.5	32.6	8.4	2.2	0.2	3.7	34.4	7.7	27.9	8.1	11.4	8.9	6.6	10.2	2.8	11.6	10.5	7.1	3.8	6.4	0.1	0.2	0.1	7.4	0.0	7.8	0.0	2.6	0.0	0.0	5.3	0.0	0.3	0.0	0.1	1.1	0.3	0.0	0.0	0.1	0.6	4.4	3.0	0.1	1.6	12.8	12.0	6.4	16.0	11.3	6.6	3.3	9.9	5.1	4.8	3.0	1.7	4.4	10.8	7.2	5.4	1.6	15.3	1.4	0.0	12.2	2.0	1.6	1.7	9.7	1.3	1.4	30.0	0.0	16.2	7.0	8.2	11.2	0.0	0.9	5.8	3.2	16.1	1.3	6.9	1.5	10.0	12.1	1.7	7.2	25.9	4.1	29.0	18.1	16.3	9.5	4.7	12.9	6.4	0.2	0.7	8.0	1.9	0.0	14.9	27.7
SRCIN1	"KIAA1684, p140Cap, SNIP"	ENSG00000277363	"SRC kinase signaling inhibitor 1"	Q9C0H9	17	38530016-38605930	"Predicted intracellular proteins"	Exocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 21.2;salivary gland: 11.7;skin 1: 6.1"	"Cell type enhanced"	"Detected in many"	25	"Bipolar cells: 30.8;Cholangiocytes: 20.4;Horizontal cells: 96.9"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in single"		"basophil: 1.3"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 1.3"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 5.3;SCLC-21H: 16.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009701, HPA063795"	Enhanced		Approved	"Cell Junctions"		NA	NA			"Cell Junctions"		"HPA009701: AB_1857324, HPA063795: AB_2685124"	"unprognostic (4.53e-1)"	"unprognostic (4.05e-1)"	"unprognostic (2.45e-2)"	"unprognostic (3.24e-4)"	"unprognostic (4.10e-2)"	"unprognostic (3.72e-3)"	"unprognostic (1.53e-1)"	"unprognostic (2.84e-2)"	"unprognostic (9.95e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.16e-4)"	"unprognostic (1.00e-1)"	"unprognostic (5.07e-3)"	"unprognostic (9.51e-2)"	"unprognostic (6.50e-2)"	"unprognostic (2.67e-2)"	"prognostic favorable (1.76e-4)"	1.3	2.6	7.9	0.5	9.5	0.6	1.7	16.3	21.2	1.3	0.8	18.4	0.0	1.2	1.0	1.3	0.5	2.1	0.4	0.6	7.0		0.5	1.8	0.8	0.6	9.0	10.5	0.4	1.6	2.2	0.0	0.6	10.2	0.8	0.7	0.5	11.7	1.7	0.9	6.1	0.9	0.5	5.5	0.6	0.9	0.8	10.7	0.0	0.8	0.0	0.4	0.9	0.0	0.3	0.3	1.3	0.2	0.2	0.2	0.0	0.5	0.6	1.2	3.5	0.2	0.0	0.1	0.0	0.1	0.2	0.1	0.7	0.6	1.0	1.1	0.0	0.9	1.3	1.6	0.2	0.1	1.2	1.4	0.0	0.5	1.4	0.2	0.0	0.0	0.1	0.2	0.0	0.5	0.1	0.0	0.6	0.1	5.3	0.0	3.2	0.0	0.0	1.7	0.7	0.1	0.1	0.0	0.1	0.5	2.6	16.5	2.4	0.0	1.4	1.0	0.9	2.6	0.5	0.0	0.0	1.6	0.0	0.0	1.1	0.2	0.1	0.1	0.7	0.7	1.3	0.2	0.2	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.3	0.2	0.2	0.6	0.2	0.0	0.3	0.0	0.0											0.0	0.6	0.0	0.9	0.7	30.8	2.4	20.4	4.0	0.0	3.5	0.0	0.0	0.0	1.9	0.1	0.1	0.3	0.0	0.2	0.1	0.8	1.4	0.0	9.6	0.3	96.9	9.4	0.6	0.0	0.2	0.6	0.0	0.0	0.0	2.1	1.7	0.5	0.0	0.4	0.0	2.8	0.0	0.3	0.7	2.0	0.6	0.1	0.0	1.1	1.7
SSX2IP	hMsd1	ENSG00000117155	"SSX family member 2 interacting protein"	Q9Y2D8	1	84643707-84690803	"Predicted intracellular proteins"	"Cell adhesion, Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 51.4"	"Cell type enhanced"	"Detected in many"	16	"Cone photoreceptor cells: 245.4;Early spermatids: 718.3;Late spermatids: 850.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA075946	Supported		Approved	"Cell Junctions"		NA	NA			"Cell Junctions"		"HPA075946: "	"unprognostic (5.18e-3)"	"unprognostic (2.13e-1)"	"prognostic favorable (1.45e-4)"	"unprognostic (2.83e-2)"	"unprognostic (2.75e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.28e-3)"	"unprognostic (7.73e-2)"	"unprognostic (2.38e-1)"	"unprognostic (3.37e-2)"	"unprognostic (9.49e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.96e-2)"	"unprognostic (7.23e-3)"	"unprognostic (2.08e-2)"	"unprognostic (2.45e-2)"	"unprognostic (3.46e-2)"	1.8	2.0	10.6	2.8	25.2	6.5	2.7	17.7	25.7	3.9	7.9	1.6	3.0	22.2	5.1	12.4	3.8	3.8	4.6	4.9	9.8	5.0	9.0	7.5	2.2	3.1	3.8	12.4	1.6	3.7	5.6	10.2	3.2	6.9	7.0	4.2	5.2	3.8	6.6	3.1	3.3	13.3	5.6	3.1	2.7	3.7	51.4	5.1	4.8	4.4	1.7	3.2	3.1	3.0	1.5	5.8	4.8	3.2	5.4	11.0	5.0	16.2	8.1	6.5	11.9	2.2	7.0	8.0	27.9	14.3	12.3	10.0	5.7	3.6	16.1	4.9	23.5	15.9	9.1	11.5	9.0	17.4	3.2	9.7	15.2	9.8	4.9	4.6	13.2	1.2	3.0	14.8	13.9	8.8	8.3	4.1	6.2	31.3	6.1	7.8	6.2	9.2	5.2	9.6	3.1	12.7	6.2	28.6	7.1	12.9	9.4	12.8	16.0	7.8	12.8	14.0	4.3	7.4	6.9	1.2	11.8	17.3	16.0	27.5	6.4	7.5	17.6	9.8	11.9	7.2	1.1	1.1	4.8	11.0	2.4	6.2	1.4	3.7	4.5	4.4	1.5	4.6	6.9	1.5	5.4	3.2	5.8	2.0	5.0	10.6	25.2	17.7	25.7	9.8	5.0	3.8	12.4	6.9	5.1	3.0	4.0	3.7	6.9	9.3	28.4	19.4	17.8	17.4	10.3	10.4	245.4	3.2	6.6	5.7	718.3	3.6	10.2	46.7	10.4	1.7	6.6	5.7	4.6	12.5	2.3	19.1	8.1	3.7	1.3	850.2	14.7	4.7	5.0	2.8	7.3	174.8	7.0	3.5	10.6	33.8	147.0	0.0	4.1	42.7	52.8	8.5	0.5	5.3	7.4	2.5
SYNPO2L	FLJ12921	ENSG00000166317	"Synaptopodin 2 like"	Q9H987	10	73644881-73663803	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	15	"heart muscle: 69.3;skeletal muscle: 72.8;tongue: 29.3"	"Cell type enriched"	"Detected in some"	220	"Cardiomyocytes: 650.0"	"Group enriched"	"Detected in some"	6	"breast cancer: 1.5;head and neck cancer: 1.4;prostate cancer: 0.5"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"CACO-2: 7.7;HSkMC: 6.2;RH-30: 5.9;SK-BR-3: 6.3"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA055192, HPA057142"	Enhanced		Supported	"Nuclear speckles,Cell Junctions,Cytosol"		NA	NA			"Nuclear speckles"	"Cell Junctions, Cytosol"	"HPA055192: AB_2682732, HPA057142: AB_2683348"	"unprognostic (2.75e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.20e-3)"	"unprognostic (3.65e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.54e-2)"	"unprognostic (3.30e-1)"	"unprognostic (2.49e-2)"	"unprognostic (4.50e-2)"	"unprognostic (2.32e-1)"	"unprognostic (7.44e-4)"	"unprognostic (1.09e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.34e-1)"	3.8	0.1	0.0	0.0	0.1	0.1	1.1	0.0	0.2	0.1	0.0	0.3	0.0	0.0	0.0	3.2	3.3	0.0	0.0	69.3	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.1	0.8	0.0	0.0	1.6	0.0	72.8	0.1	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	1.3	29.3	3.4	0.0	0.3	0.7	1.0	3.0	0.7	0.7	0.7	0.1	0.5	0.1	0.8	0.3	0.1	0.0	1.1	0.9	1.2	0.2	0.0	7.7	0.7	0.4	0.5	0.9	0.1	0.1	0.1	0.0	0.4	0.2	0.2	0.3	0.6	0.4	0.6	0.2	0.3	6.2	0.1	1.2	0.1	0.3	0.0	0.5	0.3	0.3	0.3	0.3	0.2	1.9	0.2	0.0	0.7	0.2	5.9	0.3	0.0	0.6	0.3	0.4	0.1	6.3	0.1	0.3	0.4	0.7	0.0	0.6	1.0	0.2	0.3	1.0	0.3	0.3	0.2	0.6	0.0	2.9	0.7	0.7	0.7	0.4	0.3	0.5	0.3	0.3	0.2	0.7	0.4	0.4	3.0	0.7	0.4	1.0	0.2	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	3.0	0.0	0.0	1.4	1.3	1.4	650.0	0.0	1.4	1.2	0.0	2.0	0.1	0.0	0.0	1.0	1.0	0.0	0.0	0.0	0.1	0.9	0.7	1.1	0.2	0.2	0.0	0.0	0.0	0.3	1.0	0.9	0.8	1.7	0.0	0.0	0.8	0.0	0.0	0.4	0.0	1.3	0.0	0.5	0.7	0.6	0.4	0.0	0.7	0.0	0.9
TBC1D24	"DFNA65, DFNB86, KIAA1171, TLDC6"	ENSG00000162065	"TBC1 domain family member 24"	Q9ULP9	16	2475051-2509560	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		"GTPase activation"	"Deafness, Disease mutation, Epilepsy, Mental retardation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 33.4"	"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 41.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"SCLC-21H: 26.8"									"HPA044712, HPA068080"	Uncertain		Supported	"Plasma membrane,Cell Junctions"		NA	NA			"Plasma membrane, Cell Junctions"		"HPA044712: AB_10795619, HPA068080: AB_2685948"	"prognostic unfavorable (3.22e-4)"	"unprognostic (5.23e-2)"	"unprognostic (4.02e-2)"	"unprognostic (6.41e-2)"	"unprognostic (3.52e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.03e-2)"	"unprognostic (1.68e-1)"	"unprognostic (7.37e-2)"	"unprognostic (4.37e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.66e-3)"	"unprognostic (2.02e-2)"	"unprognostic (8.19e-2)"	"unprognostic (7.78e-3)"	"unprognostic (1.61e-1)"	6.0	5.8	11.0	2.9	9.6	3.7	4.9	15.8	17.7	4.2	3.5	2.8	6.7	3.8	3.3	5.0	2.2	4.3	3.5	4.9	9.0	5.4	7.6	6.6	6.4	3.0	3.8	12.2	2.1	16.6	5.2	5.6	3.6	7.5	4.5	1.9	5.4	33.4	6.4	6.1	3.5	2.8	3.1	3.7	3.4	3.8	2.4	4.5	0.8	5.5	1.0	2.3	4.0	2.9	0.2	1.3	0.0	0.9	0.2	2.2	1.0	2.6	5.0	3.4	6.9	4.0	4.0	2.9	4.7	2.5	3.1	2.7	4.7	2.2	6.6	4.3	3.6	1.5	4.7	5.3	1.5	2.3	7.1	6.3	5.9	6.6	4.0	2.4	4.3	2.6	1.5	2.1	2.7	1.1	2.1	3.9	2.4	7.2	3.7	2.9	4.6	2.9	8.6	3.0	2.3	3.3	15.3	6.5	4.6	2.2	1.7	26.8	6.5	3.2	11.8	1.9	1.3	3.8	3.9	4.0	6.1	6.7	6.0	4.6	2.4	2.2	8.2	2.6	6.3	5.5	0.0	0.7	0.0	2.2	0.8	0.7	0.2	0.5	0.7	1.3	0.1	0.5	0.3	0.0	0.2	0.9	0.6	0.0	1.0	11.0	9.6	15.8	12.4	9.0	5.4	3.8	12.2	7.5	4.5	26.8	22.4	2.7	2.7	0.5	15.4	4.7	15.3	4.0	10.3	5.2	41.2	1.3	28.2	4.8	0.2	3.6	1.7	23.3	5.3	0.7	8.4	3.5	3.5	15.1	3.0	25.4	10.9	12.3	5.4	0.7	8.3	2.3	1.7	1.8	2.6	11.1	4.8	3.5	5.6	3.3	25.0	0.0	3.7	2.7	3.8	1.3	0.2	2.6	4.4	1.4
TCAF2	"FAM115C, FAM139A, FLJ40722, GATD9"	ENSG00000170379	"TRPM8 channel associated factor 2"	A6NFQ2	7	143620952-143730409	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Cytotrophoblasts: 12.2;Hepatocytes: 10.9;Syncytiotrophoblasts: 13.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 9.2;HUVEC TERT2: 9.8;TIME: 15.5;U-87 MG: 13.4"									"HPA038756, HPA038758"	Uncertain		Supported	"Plasma membrane,Cell Junctions"		NA	NA			"Plasma membrane, Cell Junctions"		"HPA038756: AB_10960427, HPA038758: AB_10960353"	"unprognostic (6.59e-2)"	"unprognostic (4.99e-2)"	"unprognostic (2.34e-2)"	"unprognostic (8.86e-3)"	"prognostic unfavorable (9.53e-5)"	"unprognostic (1.89e-1)"	"unprognostic (3.11e-2)"	"unprognostic (4.47e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.04e-2)"	"unprognostic (3.98e-2)"	"unprognostic (2.21e-2)"	"prognostic unfavorable (4.17e-6)"	"unprognostic (7.19e-2)"	"unprognostic (4.02e-2)"	"unprognostic (5.41e-3)"	"unprognostic (2.85e-2)"	3.1	2.7	1.5	5.8	2.7	5.8	8.4	2.0	4.0	5.2	1.8	0.6	2.0	1.8	6.1	2.1	13.1	2.2	3.5	3.5	2.3	1.9	3.1	6.4	7.1	12.4	1.6	1.2	4.2	3.2	2.1	3.8	8.1	2.8	5.5	1.6	1.7	5.7	9.2	2.1	6.7	3.5	5.0	4.7	4.0	3.1	2.2	2.0	7.3	2.3	7.6	7.0	8.0	12.1	2.6	1.0	7.0	0.4	3.5	6.5	1.3	4.8	0.3	0.3	0.3	1.0	1.0	1.9	1.5	2.6	0.7	1.9	0.2	0.5	0.3	2.1	1.2	0.6	0.9	0.1	2.5	2.2	9.2	0.5	0.8	0.7	0.3	1.1	0.3	0.6	2.6	1.1	0.3	0.9	2.0	9.8	0.7	2.7	4.8	4.1	0.9	0.7	0.9	0.4	4.7	2.4	0.4	2.0	2.2	0.0	1.9	0.3	0.2	0.5	3.5	0.3	0.9	1.8	0.3	15.5	1.4	1.0	5.2	0.4	7.7	2.4	0.2	13.4	0.5	2.8	7.0	0.4	0.4	4.0	0.4	4.2	2.6	6.5	4.1	0.3	2.5	5.8	4.6	1.6	3.5	0.3	1.0	6.2	1.3	1.5	2.7	2.0	4.0	2.3	1.9	1.6	1.2	2.8	2.0	0.0	2.6	0.0	1.1	0.0	0.2	0.4	0.0	0.0	3.4	0.0	0.0	12.2	0.0	0.4	0.9	2.1	0.0	0.0	0.3	4.3	0.5	2.7	2.3	10.9	1.8	0.0	0.0	0.6	1.6	0.4	1.7	0.7	0.0	0.0	0.1	1.7	1.3	0.0	0.7	0.3	0.0	0.0	0.6	3.2	0.2	0.0	13.2	2.9	0.0	1.0
TCAF2C		ENSG00000283528	"TRPM8 channel associated factor 2C"		7	143639230-143647646	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Group enriched"	"Detected in some"	4	"blood: 2.2;parathyroid gland: 1.9;placenta: 1.3"	"Not detected"	"Not detected"											"Cell type enhanced"	"Detected in some"		"basophil: 2.2;T-reg: 1.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A-431: 1.1;OE19: 1.5;U-266/70: 3.9;U-266/84: 1.8"									"HPA038756, HPA038758"	Uncertain		Supported	"Plasma membrane,Cell Junctions"		NA	NA			"Plasma membrane, Cell Junctions"		"HPA038756: AB_10960427, HPA038758: AB_10960353"																		0.0	0.0		0.2		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.4	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	1.9		1.3		0.0	0.0		0.0	0.0	0.0	0.1	0.0	0.1		0.0	0.1	0.0			0.0		0.0	0.0		0.6	0.0	2.2	0.0	0.0	1.8	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	3.9	1.8	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.6	0.0	0.4	0.0	0.0	0.0	0.0	1.8	0.1											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TEDC2	"C16orf59, FLJ13909"	ENSG00000162062	"Tubulin epsilon and delta complex 2"	Q7L2K0	16	2460080-2464963	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 15.3;testis: 12.5"	"Cell type enhanced"	"Detected in some"	16	"Cytotrophoblasts: 7.9;Extravillous trophoblasts: 12.0;Hofbauer cells: 3.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051394, HPA055389"	Approved		Approved	"Nucleoplasm,Cell Junctions"		NA	NA			"Nucleoplasm, Cell Junctions"		"HPA051394: AB_2681465, HPA055389: AB_2732595"	"unprognostic (3.23e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.14e-2)"	"unprognostic (7.46e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.38e-3)"	"prognostic unfavorable (2.43e-5)"	"prognostic unfavorable (7.58e-4)"	"unprognostic (4.04e-3)"	"unprognostic (8.85e-2)"	"unprognostic (3.74e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.16e-4)"	"unprognostic (1.28e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.03e-1)"	0.8	1.8	2.3	6.2	4.1	9.3	1.1	2.8	4.6	1.2	2.6	0.8	0.0	4.3	1.2	1.4	4.5	1.2	1.4	1.3	2.3	2.7	2.2	1.7	1.0	5.6	2.1	1.9	1.0	1.9	0.3	2.4	3.8	2.0	1.3	2.2	1.0	1.3	0.8	1.0	2.6	3.8	1.1	1.4	2.5	2.2	12.5	0.8	15.3	0.9	4.2	3.9	0.6	2.2	1.2	1.4	0.0	1.0	0.0	2.1	0.7	5.2	16.7	9.6	11.2	0.1	0.6	9.7	4.2	2.5	6.8	6.6	11.5	4.4	7.3	7.0	1.8	3.7	8.1	6.9	4.2	1.6	8.1	9.2	6.6	11.8	11.8	0.2	6.4	8.9	0.6	0.5	6.0	1.6	0.5	3.1	12.3	11.3	2.8	2.3	10.1	11.2	11.9	21.3	5.1	6.1	27.4	8.3	16.6	1.4	2.3	9.1	14.9	4.9	5.2	3.6	2.6	7.6	7.4	1.1	7.3	10.6	6.9	9.5	6.2	10.2	14.7	3.7	6.4	9.9	0.0	0.0	0.0	0.1	0.1	0.0	0.6	2.1	0.0	0.3	1.2	0.7	1.3	0.0	0.0	1.0	1.4	1.9	0.7	2.3	4.1	2.8	4.6	2.3	2.7	2.1	1.9	2.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	7.9	1.7	2.8	0.0	0.0	0.0	0.0	1.1	12.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	1.6	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0
TES	"DKFZP586B2022, TESS-2, TESTIN"	ENSG00000135269	"Testin LIM domain protein"	Q9UGI8	7	116210493-116258783	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 1: 226.3;Early spermatids: 327.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"EFO-21: 51.4;hTCEpi: 58.1;SK-BR-3: 58.3"					"Low region specificity"	"Detected in single"			"HPA015269, HPA018123"	Approved		Supported	"Plasma membrane,Cell Junctions,Focal adhesion sites,Cytosol"		NA	NA			"Focal adhesion sites, Cytosol"	"Plasma membrane, Cell Junctions"	"HPA015269: AB_1857899, HPA018123: AB_1857900"	"unprognostic (9.81e-2)"	"unprognostic (5.53e-3)"	"unprognostic (4.79e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.01e-1)"	"unprognostic (6.08e-3)"	"unprognostic (1.84e-3)"	"unprognostic (4.81e-3)"	"unprognostic (8.81e-3)"	"unprognostic (6.19e-3)"	"prognostic unfavorable (1.20e-5)"	"unprognostic (1.60e-2)"	"prognostic favorable (8.71e-5)"	"unprognostic (1.50e-1)"	"unprognostic (5.47e-2)"	"unprognostic (2.36e-2)"	"unprognostic (3.86e-1)"	12.1	2.9	1.2	36.4	1.5	8.6	22.1	0.8	1.2	42.4	53.1	1.5	43.9	9.3	47.6	21.2	22.6	19.5	15.3	7.9	1.6	1.4	14.3	4.6	16.8	20.3	1.9	0.7	17.1	12.3	3.1	4.2	21.2	3.3	26.1	16.8	5.0	19.0	50.9	5.2	9.1	27.4	84.5	3.0	19.1	25.2	18.4	0.7	17.1	26.3	11.2	18.4	71.6	33.9	26.8	21.9	56.8	39.6	49.0	40.5	34.7	24.4	5.2	5.9	0.0	2.6	6.7	13.8	12.8	6.2	2.4	2.3	12.9	27.3	0.0	51.4	8.9	0.3	25.2	3.1	18.8	5.9	12.1	10.1	2.4	12.1	6.3	15.7	11.1	0.0	14.9	58.1	8.3	21.1	16.6	6.7	0.0	2.5	8.6	0.6	5.0	0.0	0.1	3.9	28.4	14.9	0.0	0.0	9.6	24.2	9.4	2.7	25.5	18.7	58.3	14.1	17.9	0.0	4.5	11.3	0.1	0.3	18.9	0.1	20.5	9.9	0.2	1.6	5.7	19.4	56.8	20.2	53.4	40.5	32.6	39.0	26.8	31.0	36.6	21.9	23.8	31.0	35.0	10.5	49.0	39.6	5.4	31.5	34.7	1.2	1.5	0.8	1.2	1.6	1.4	1.9	0.7	3.3	0.7	226.3	36.4	52.3	147.2	177.9	2.3	14.5	38.2	84.3	97.8	34.9	11.8	16.7	18.3	104.8	327.4	24.0	101.5	0.0	97.9	69.1	27.0	83.0	17.4	9.9	14.9	1.6	48.4	15.4	52.9	82.2	1.7	62.3	27.0	36.1	57.8	23.0	142.2	58.6	0.4	10.3	12.6	6.5	20.6	18.2	9.7	107.3	24.4	57.4	44.4	125.3
TIAM1		ENSG00000156299	"T cell lymphoma invasion and metastasis 1"	Q13009	21	31118416-31559977	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 110.1"	"Cell type enhanced"	"Detected in many"	7	"Basal keratinocytes: 74.4;Horizontal cells: 69.9;Suprabasal keratinocytes: 125.3;Urothelial cells: 72.7"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	8	"cerebellum: 110.1"	"Group enriched"	"Detected in many"	5	"classical monocyte: 10.7;intermediate monocyte: 9.6;memory CD4 T-cell: 8.3;myeloid DC: 5.9;naive CD4 T-cell: 10.9;NK-cell: 6.9;non-classical monocyte: 12.4;T-reg: 16.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 19.4;HEL: 18.7;HMC-1: 16.4;RT4: 19.4;SCLC-21H: 18.3"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 574.6"	"CAB010416, HPA034853"	Enhanced		Supported	"Nucleoplasm,Nuclear membrane,Cell Junctions,Cytokinetic bridge,Cytosol"		NA	NA			"Nucleoplasm, Cell Junctions"	"Nuclear membrane, Cytokinetic bridge, Cytosol"	"CAB010416: AB_2240410, HPA034853: "	"unprognostic (9.59e-2)"	"unprognostic (7.44e-3)"	"unprognostic (5.64e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.81e-3)"	"unprognostic (2.84e-2)"	"unprognostic (3.73e-1)"	"unprognostic (8.08e-2)"	"unprognostic (2.70e-3)"	"unprognostic (7.97e-3)"	"unprognostic (9.52e-2)"	"unprognostic (1.20e-3)"	"unprognostic (2.38e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.21e-1)"	3.3	11.4	13.4	5.3	12.4	2.1	4.4	110.1	15.1	10.1	2.2	9.7	0.5	1.5	7.9	3.0	18.9	9.4	4.0	2.1	11.6	7.0	1.7	3.7	4.1	8.8	6.2	7.9	1.5	1.9	0.3	4.2	4.4	8.9	3.7	2.8	7.0	2.2	3.1	0.7	20.4	1.7	10.0	6.4	4.2	2.1	5.9	7.1	6.2	1.3	5.3	9.3	8.1	5.0	0.1	5.9	0.6	12.4	6.9	16.8	3.6	1.5	0.5	12.1	0.7	0.2	2.8	19.4	0.0	0.0	1.5	0.5	0.1	2.2	4.1	0.8	0.3	2.2	2.8	1.4	2.4	2.4	0.3	6.7	18.7	0.3	0.1	0.3	0.0	16.4	1.2	0.8	8.2	3.3	1.4	0.0	6.2	0.0	6.1	6.1	7.9	2.8	0.1	3.9	2.9	5.2	3.7	3.8	0.0	1.8	19.4	18.3	4.5	0.8	6.3	0.7	4.4	2.6	0.0	0.1	1.7	7.1	0.0	0.8	6.9	5.1	3.7	4.0	1.4	13.4	0.6	10.7	0.0	0.3	9.6	2.1	0.1	8.3	1.6	5.9	0.0	10.9	0.6	0.6	6.9	12.4	0.3	16.8	3.6	13.4	12.4	110.1	14.4	11.6	7.0	6.2	7.9	8.9	7.1	3.0	2.9	0.8	40.5	74.4	1.2	1.1	2.5	0.0	18.2	0.0	2.0	7.6	0.0	1.5	10.0	15.8	0.0	0.0	0.6	25.1	7.6	16.1	23.1	3.6	8.2	69.9	5.2	50.3	22.7	9.0	31.9	28.4	10.1	18.0	0.3	39.3	1.1	10.7	54.8	0.0	4.4	6.5	2.1	1.4	6.1	125.3	8.9	6.9	0.9	72.7
TJP1	"DKFZp686M05161, MGC133289, ZO-1"	ENSG00000104067	"Tight junction protein 1"	Q07157	15	29699367-29968865	"Predicted intracellular proteins, Transporters"		Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA001636, HPA001637, CAB010822"	Enhanced		Enhanced	"Cell Junctions"		NA	NA			"Cell Junctions"		"CAB010822: , HPA001636: AB_1080762, HPA001637: AB_1080760"	"unprognostic (2.11e-2)"	"unprognostic (6.83e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.81e-2)"	"unprognostic (9.43e-2)"	"unprognostic (1.21e-1)"	"unprognostic (4.54e-2)"	"unprognostic (6.71e-3)"	"unprognostic (1.98e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.86e-3)"	"unprognostic (3.54e-1)"	"prognostic favorable (1.72e-4)"	"unprognostic (2.85e-3)"	"unprognostic (3.02e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.20e-1)"	22.1	11.7	27.5	9.2	32.8	2.2	18.0	12.0	36.3	24.8	16.9	37.5	10.7	10.9	29.5	27.6	45.7	22.9	18.2	26.0	28.3	19.1	20.4	20.8	31.1	7.8	29.3	21.3	23.6	19.4	30.1	17.7	38.3	23.4	17.8	15.5	15.2	18.5	15.4	16.4	17.8	14.4	29.4	31.7	10.1	16.7	25.9	32.6	1.2	23.1	17.9	13.2	18.5	27.3	0.7	0.2	0.3	0.4	1.0	0.2	0.1	26.1	19.3	10.6	8.7	9.4	13.1	12.0	8.1	7.2	6.8	7.7	26.6	10.5	0.1	11.0	10.8	9.0	19.7	6.5	9.1	8.7	0.2	7.2	0.1	10.4	11.2	25.3	0.0	0.3	7.2	6.6	8.4	16.3	10.4	15.1	0.0	9.7	5.4	5.2	14.5	0.1	0.2	9.7	11.9	6.1	0.0	15.0	0.0	13.6	16.1	5.2	7.4	16.7	7.3	6.9	21.9	5.0	0.3	23.6	7.0	10.7	4.8	11.1	1.9	1.8	0.1	7.9	0.1	3.9	0.0	0.2	0.1	0.0	0.1	0.0	0.4	0.1	0.1	0.0	0.7	0.2	0.2	0.3	1.0	0.4	0.2	0.2	0.1	27.5	32.8	12.0	26.1	28.3	19.1	29.3	21.3	23.4	32.6	157.8	42.2	2.2	89.8	31.8	36.2	95.8	38.2	29.4	43.3	55.8	9.8	24.8	21.6	107.0	12.1	131.3	49.5	0.0	72.9	11.2	45.0	132.7	5.7	41.4	3.3	119.2	44.1	93.3	8.4	9.4	31.4	5.7	60.8	2.8	31.6	34.9	126.3	31.5	60.1	20.9	49.7	77.6	86.8	53.9	47.9	52.6	28.1	4.4	19.1	142.6
TJP2	"DFNA51, X104, ZO-2, ZO2"	ENSG00000119139	"Tight junction protein 2"	Q9UDY2	9	69121264-69255208	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Disease mutation, Intrahepatic cholestasis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Bipolar cells: 241.2;Rod photoreceptor cells: 273.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"non-classical monocyte: 4.0"	"Lineage enriched"	"Detected in single"	8	"monocytes: 4.0"	"Cell line enhanced"	"Detected in many"		"A-431: 53.3"									"HPA001813, CAB009228, HPA070714"	Supported		Enhanced	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA		790000	"Plasma membrane, Cell Junctions"	Nucleoplasm	"CAB009228: AB_2203583, HPA001813: AB_1080764, HPA070714: AB_2732161"	"unprognostic (1.30e-1)"	"unprognostic (7.69e-2)"	"unprognostic (1.23e-3)"	"unprognostic (7.68e-2)"	"unprognostic (2.01e-1)"	"unprognostic (8.83e-3)"	"unprognostic (1.94e-2)"	"unprognostic (1.86e-1)"	"unprognostic (4.82e-2)"	"unprognostic (3.30e-2)"	"unprognostic (2.93e-3)"	"unprognostic (3.60e-1)"	"prognostic favorable (1.78e-14)"	"unprognostic (3.29e-2)"	"unprognostic (6.42e-2)"	"unprognostic (8.15e-3)"	"unprognostic (5.85e-2)"	25.2	9.5	23.7	8.0	29.7	5.7	20.7	35.6	24.9	9.0	20.0	50.3	20.6	27.2	11.9	7.3	28.9	12.6	13.2	19.8	35.1	12.7	23.3	34.5	23.9	5.8	39.7	20.5	20.9	13.2	43.2	3.6	18.0	32.0	13.5	16.7	19.1	18.0	23.1	8.3	18.6	25.7	15.3	39.7	3.5	30.4	17.8	41.1	11.1	22.5	9.0	10.8	26.5	26.6	0.0	0.2	0.4	4.0	0.0	0.5	0.5	53.3	1.7	4.3	4.8	20.1	19.7	23.3	8.1	6.0	13.0	7.1	6.5	19.5	7.7	8.1	4.5	7.0	32.9	6.9	17.1	14.8	27.3	5.0	7.4	4.6	32.9	5.7	3.0	14.1	15.3	12.3	10.1	6.1	3.7	27.2	2.1	4.5	5.2	6.8	7.5	1.1	0.4	10.4	33.4	11.7	3.9	6.1	0.8	33.4	35.6	1.9	3.3	2.9	20.8	0.6	9.9	6.7	1.6	39.0	9.7	10.5	7.5	8.3	5.4	1.1	0.1	11.2	4.3	3.6	0.0	0.7	0.0	0.0	1.5	0.4	0.0	0.2	0.0	0.2	0.0	0.0	0.1	0.4	0.0	4.0	0.1	0.5	0.5	23.7	29.7	35.6	17.5	35.1	12.7	39.7	20.5	32.0	41.1	41.7	21.4	1.4	65.1	57.9	241.2	34.6	50.9	9.4	5.7	3.5	33.4	24.0	0.0	27.8	2.7	42.7	67.5	0.0	20.8	23.1	14.7	83.3	5.7	92.7	4.9	17.5	11.1	25.2	17.0	3.6	27.0	2.8	27.0	4.6	41.5	123.0	32.6	42.5	13.1	1.4	273.3	0.0	10.3	21.3	11.1	56.0	36.2	3.1	36.2	146.9
TJP3	ZO-3	ENSG00000105289	"Tight junction protein 3"	O95049	19	3708109-3750813	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 47.0"	"Cell type enhanced"	"Detected in many"	14	"Early spermatids: 259.3;Enterocytes: 138.3;Paneth cells: 101.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	4	"gdT-cell: 2.0;MAIT T-cell: 6.2;memory CD4 T-cell: 4.8;memory CD8 T-cell: 3.8;naive CD4 T-cell: 5.3;naive CD8 T-cell: 1.9;T-reg: 5.5"	"Lineage enriched"	"Detected in many"	6	"T-cells: 6.2"	"Cell line enhanced"	"Detected in some"		"BEWO: 22.2;CAPAN-2: 22.3;MCF7: 9.8;OE19: 17.4;SK-BR-3: 13.0;T-47d: 27.4"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"CAB013244, HPA046863, HPA053337"	Enhanced		Enhanced	"Nucleoplasm,Cell Junctions"		NA	NA			"Nucleoplasm, Cell Junctions"		"CAB013244: AB_2533257, HPA046863: AB_2679845, HPA053337: AB_2682118"	"unprognostic (2.22e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.80e-1)"	"prognostic favorable (1.83e-6)"	"unprognostic (2.78e-1)"	"prognostic favorable (9.52e-4)"	"unprognostic (1.30e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.52e-1)"	"unprognostic (6.52e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.78e-1)"	"prognostic favorable (9.36e-8)"	"unprognostic (8.58e-3)"	"unprognostic (5.03e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.62e-3)"	0.2	0.0	0.3	8.4	0.4	0.0	3.6	0.2	0.3	3.3	34.9	0.7	15.0	23.0	0.7	5.0	16.0	7.9	22.8	0.6	0.5	0.1	4.4	8.0	10.1	0.6	0.2	0.2	2.2	5.9	2.0	1.6	2.7	1.1	2.6	7.7	1.6	26.1	20.5	0.4	4.3	47.0	0.6	0.2	0.4	15.2	1.4	0.2	0.6	5.5	2.6	8.3	4.5	3.4	1.0	0.0	0.0	0.0	0.0	6.2	1.7	0.1	3.3	0.0	0.0	0.0	0.0	22.2	0.0	0.0	0.0	0.0	6.5	22.3	4.0	0.6	0.0	0.0	5.2	0.3	0.0	0.0	0.2	0.1	0.0	0.5	1.6	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.1	0.0	9.8	0.0	0.1	0.4	17.4	0.1	0.0	0.0	2.9	0.7	3.4	0.1	0.1	0.8	13.0	0.0	1.7	27.4	0.1	0.0	0.0	0.5	0.0	0.0	0.8	1.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.0	0.0	6.2	0.7	4.8	3.8	0.0	1.0	5.3	1.9	0.0	0.0	0.0	0.0	5.5	1.7	0.3	0.4	0.2	0.3	0.5	0.1	0.2	0.2	1.1	0.2	8.9	10.7	0.0	6.7	0.0	0.0	0.8	30.6	34.8	12.5	29.6	0.0	26.9	16.6	16.8	259.3	0.0	138.3	0.0	21.0	3.5	0.2	4.8	4.6	4.9	2.4	0.0	12.0	0.0	0.0	10.7	1.7	0.1	3.3	0.0	40.6	0.0	16.7	101.7	1.1	5.1	0.0	0.0	0.2	2.1	3.3	0.1	33.6	1.5	46.1	23.1
TM4SF5		ENSG00000142484	"Transmembrane 4 L six family member 5"	O14894	17	4771884-4783213	"Predicted membrane proteins"	"Cell cycle"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	9	"intestine: 80.9;liver: 69.8"	"Cell type enhanced"	"Detected in many"	14	"Enterocytes: 55.9;Hepatocytes: 125.4;Intestinal endocrine cells: 110.5;Mucus-secreting cells: 76.1;Paneth cells: 190.0"	"Cancer enriched"	"Detected in many"	9	"liver cancer: 219.6"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	5	"non-classical monocyte: 1.1"	"Lineage enriched"	"Detected in single"	5	"monocytes: 1.1"	"Group enriched"	"Detected in some"	13	"CACO-2: 23.4;Hep G2: 40.5;OE19: 25.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA055674			Uncertain	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA			"Plasma membrane, Cell Junctions"	Nucleoplasm	"HPA055674: "		"unprognostic (1.81e-1)"	"unprognostic (1.61e-1)"				"unprognostic (1.31e-1)"				"unprognostic (4.44e-2)"		"unprognostic (9.33e-2)"	"unprognostic (3.57e-2)"	"unprognostic (1.95e-1)"		"unprognostic (5.21e-3)"	0.1	0.1	0.1	0.6	0.1	0.0	0.1	0.1	0.1	0.1	45.1	0.1	0.1	50.5	0.1	0.2	0.1	0.1	7.0	0.1	0.1	0.1	3.1	69.8	0.1	0.1	0.1	0.1	0.1	0.9	4.1	0.1	0.6	0.1	0.1	1.6	0.1	0.1	0.1	0.1	0.1	80.9	0.1	0.1	0.1	8.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	1.1	0.0	0.2	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	23.4	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	40.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.3	0.0	25.7	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.0	0.0	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	25.5	0.0	0.0	1.8	0.0	0.0	5.0	1.1	1.5	0.0	55.9	0.0	8.1	1.2	0.0	0.0	4.6	125.4	0.1	0.0	110.5	6.2	3.2	1.3	0.0	0.0	0.0	0.0	76.1	0.0	4.9	190.0	0.0	47.6	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.9	34.5	0.0
TMEM141	MGC14141	ENSG00000244187	"Transmembrane protein 141"	Q96I45	9	136791355-136793257	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Distal tubular cells: 530.6;Enterocytes: 541.1;Paneth cells: 627.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 64.4;T-47d: 62.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014615, HPA050244"	Approved		Supported	"Cell Junctions,Mitochondria"		NA	NA			Mitochondria	"Cell Junctions"	"HPA014615: AB_2204756, HPA050244: AB_2681061"	"unprognostic (2.05e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.00e-1)"	"unprognostic (8.53e-3)"	"unprognostic (1.52e-2)"	"unprognostic (3.15e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.94e-2)"	"unprognostic (2.24e-1)"	"unprognostic (8.45e-2)"	"prognostic favorable (6.63e-4)"	"unprognostic (1.49e-1)"	"unprognostic (2.77e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.70e-1)"	10.0	15.5	15.7	23.4	15.3	15.5	22.9	11.6	28.3	17.2	54.4	21.0	22.4	21.9	9.4	31.1	35.5	22.6	27.9	22.8	15.2	12.2	38.5	43.4	14.4	23.0	19.9	19.3	13.8	46.3	20.6	23.1	31.7	22.0	49.0	51.4	12.5	32.5	27.5	13.5	22.0	25.6	10.5	19.1	14.1	23.3	16.5	13.8	16.3	28.6	26.0	15.2	16.4	16.3	11.1	42.7	9.0	19.4	12.4	11.3	12.2	15.0	11.0	9.8	6.1	12.4	10.0	21.2	8.5	13.4	10.6	8.5	14.5	13.7	14.5	13.3	9.2	9.6	22.6	4.2	25.0	3.4	10.5	7.6	8.1	6.1	16.1	18.1	8.4	10.1	9.6	42.9	8.1	23.0	12.1	15.7	19.3	8.0	7.8	13.8	30.8	11.5	6.5	4.7	64.4	12.4	9.6	10.3	42.7	24.0	8.5	16.5	7.4	9.2	35.1	9.6	8.8	62.6	8.2	10.7	7.6	6.0	13.8	5.5	5.1	7.9	7.7	11.4	12.2	10.8	6.5	13.8	9.0	11.3	19.4	10.2	8.7	7.9	8.1	11.2	11.1	10.9	10.0	3.3	12.4	16.0	42.7	7.5	12.2	15.7	15.3	11.6	28.3	15.2	12.2	19.9	19.3	22.0	13.8	53.6	66.5	48.0	79.9	36.1	13.8	38.7	140.1	40.2	47.8	111.7	7.9	153.9	530.6	139.6	35.4	42.8	541.1	0.0	69.3	125.8	30.6	159.7	40.5	149.9	127.7	4.8	198.8	60.2	56.6	92.7	34.8	37.5	81.0	99.2	409.6	43.5	87.4	627.8	28.0	354.2	22.0	45.3	28.3	48.3	42.6	54.8	229.4	48.4	378.9	92.2
TMEM164	"FLJ22679, RP13-360B22.2"	ENSG00000157600	"Transmembrane protein 164"	Q5U3C3	X	110002631-110182734	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"seminal vesicle: 69.7"	"Cell type enhanced"	"Detected in many"	5	"Enterocytes: 32.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"basophil: 25.9;eosinophil: 7.2;neutrophil: 8.8"	"Lineage enriched"	"Detected in many"	15	"granulocytes: 25.9"	"Cell line enhanced"	"Detected in all"		"HMC-1: 37.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038784	Approved		Approved	"Vesicles,Cell Junctions"		NA	NA			Vesicles	"Cell Junctions"	"HPA038784: AB_10670790"	"unprognostic (2.14e-3)"	"unprognostic (3.35e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.65e-3)"	"unprognostic (7.94e-2)"	"unprognostic (3.97e-2)"	"prognostic unfavorable (8.17e-6)"	"unprognostic (9.85e-3)"	"unprognostic (5.68e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.95e-1)"	"unprognostic (7.66e-2)"	"prognostic favorable (3.14e-4)"	"unprognostic (1.76e-1)"	"unprognostic (1.81e-2)"	"unprognostic (4.19e-3)"	15.0	8.6	9.2	6.1	10.9	11.1	9.2	2.6	6.8	3.9	17.0	6.0	36.3	14.5	4.5	4.1	10.5	5.5	8.8	14.7	6.6	5.9	8.4	1.7	35.8	7.6	4.6	3.5	11.9	17.2	11.1	8.7	6.6	7.0	6.2	14.8	18.7	7.6	69.7	32.0	15.2	33.1	4.6	2.9	6.9	9.9	2.2	5.1	4.5	11.4	6.0	5.8	5.0	5.1	0.4	1.4	25.9	1.7	1.1	0.9	0.8	4.8	11.1	9.1	5.9	11.3	8.3	5.5	2.4	5.7	5.2	3.3	8.6	7.6	3.8	16.5	3.7	12.7	7.1	7.9	12.8	5.1	10.6	5.4	26.3	6.0	3.6	6.7	11.5	37.6	11.5	22.6	9.3	12.9	14.2	10.0	7.0	8.1	4.7	9.1	9.7	12.0	14.7	8.1	16.6	8.0	5.5	7.0	3.2	8.2	5.1	8.5	9.5	15.5	15.3	7.1	8.8	4.4	11.5	22.3	4.4	3.2	5.1	3.4	2.8	3.4	3.1	11.5	14.5	11.6	25.9	1.7	7.2	0.3	1.5	0.9	0.1	0.4	0.3	1.4	0.4	0.2	0.3	8.8	1.1	0.9	0.2	0.5	0.8	9.2	10.9	2.6	6.8	6.6	5.9	4.6	3.5	7.0	5.1	3.0	26.0	3.2	3.3	4.2	0.2	19.7	10.2	1.4	6.8	15.7	2.0	1.9	3.3	4.0	0.3	5.2	32.2	0.0	9.9	4.7	3.4	7.9	3.5	1.5	12.0	0.0	26.6	6.2	25.0	0.5	1.7	5.8	1.7	21.6	12.9	0.8	9.8	14.4	1.4	3.0	0.9	0.0	3.1	0.2	0.0	6.9	2.3	4.3	17.8	6.4
TMEM183A	C1orf37	ENSG00000163444	"Transmembrane protein 183A"	Q8IXX5	1	203007386-203024848	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA072607			Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA			"Plasma membrane"	"Nucleoplasm, Cell Junctions"	"HPA072607: AB_2686539"	"unprognostic (2.94e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.41e-2)"	"unprognostic (5.99e-2)"	"prognostic unfavorable (2.62e-4)"	"unprognostic (6.46e-2)"	"unprognostic (3.21e-2)"	"unprognostic (4.82e-3)"	"unprognostic (5.28e-2)"	"unprognostic (7.84e-2)"	"unprognostic (4.83e-2)"	"unprognostic (6.01e-3)"	"unprognostic (9.55e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.32e-1)"	12.2	12.6	22.4	13.5	20.8	50.1	17.2	31.9	30.4	14.4	21.1	12.4	6.7	20.0	13.6	15.2	19.3	12.0	15.0	11.5	19.8	21.0	16.0	21.1	13.4	20.2	19.3	14.8	15.0	29.9	12.0	8.2	10.9	20.8	15.0	23.6	11.1	22.2	13.6	8.8	16.1	18.8	17.6	12.4	14.5	15.8	27.7	12.3	23.3	20.5	14.8	17.7	15.3	20.7	17.4	27.2	35.6	24.4	26.4	23.7	24.3	12.7	12.4	15.9	26.1	21.1	15.9	26.3	12.8	12.7	14.9	13.1	15.0	13.5	31.9	9.3	16.5	6.0	16.2	21.3	18.0	12.4	10.3	25.9	15.7	14.5	16.5	15.3	28.1	13.9	15.6	20.1	12.2	24.8	15.1	18.7	25.8	32.2	11.6	13.8	28.4	22.9	28.9	43.8	17.3	19.8	17.7	27.2	25.6	23.0	12.5	20.5	25.7	19.2	32.1	18.4	26.5	22.9	22.2	13.8	10.1	14.1	17.2	14.0	11.8	18.9	24.7	11.1	21.9	10.6	21.1	24.4	35.6	18.1	20.4	17.9	16.6	20.5	20.5	27.2	17.4	23.7	19.3	21.3	26.4	18.5	19.5	21.2	24.3	22.4	20.8	31.9	30.4	19.8	21.0	19.3	14.8	20.8	12.3	14.9	15.6	44.9	49.0	65.3	20.7	10.9	48.4	28.1	28.4	33.2	9.8	46.3	59.7	71.4	117.2	35.8	68.3	23.3	66.2	74.0	37.9	74.7	17.3	45.7	54.3	17.5	50.6	32.5	53.2	96.3	25.0	47.0	37.1	59.5	68.9	18.9	55.2	56.1	27.6	74.5	26.2	19.4	47.6	72.3	76.8	71.8	43.1	44.7	83.1	77.4
TMEM186	"C16orf51, DKFZP564K2062"	ENSG00000184857	"Transmembrane protein 186"	Q96B77	16	8780384-8797648	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Late spermatids: 62.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018226, HPA063559"	Uncertain		Approved	"Cell Junctions"		NA	NA			"Cell Junctions"		"HPA018226: AB_1845579, HPA063559: AB_2685041"	"unprognostic (3.49e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.98e-2)"	"unprognostic (4.81e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.32e-2)"	"unprognostic (2.08e-2)"	"unprognostic (8.06e-2)"	"unprognostic (9.35e-2)"	"unprognostic (2.45e-1)"	"unprognostic (3.99e-2)"	"prognostic favorable (1.93e-8)"	"unprognostic (1.06e-1)"	"unprognostic (3.73e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.89e-2)"	6.6	12.0	8.2	6.2	10.4	1.9	11.0	5.4	13.2	7.4	10.6	8.2	9.4	10.1	11.0	14.2	9.6	10.4	9.7	11.5	7.4	7.6	9.6	15.9	6.2	8.2	9.1	12.6	9.7	11.8	16.3	11.8	8.4	7.8	8.4	12.5	10.4	14.0	8.4	16.9	8.8	9.2	15.1	10.3	10.1	9.1	11.7	6.2	7.0	11.9	7.7	11.0	10.4	6.2	14.3	10.4	11.8	13.8	9.5	17.2	8.4	6.8	10.7	8.0	10.1	13.7	7.3	7.6	7.8	8.1	10.4	8.6	10.3	11.4	20.7	6.7	5.7	7.1	13.1	14.1	11.1	11.9	12.0	13.6	8.7	13.8	21.9	15.4	9.6	7.1	8.7	18.9	11.3	16.7	8.5	9.3	17.3	14.8	11.4	6.0	18.3	7.4	9.4	10.1	14.6	9.4	15.7	10.4	22.7	11.0	5.8	12.3	11.7	10.7	15.2	9.2	8.5	18.2	7.8	5.9	7.4	10.4	18.1	6.4	10.5	11.1	10.0	11.5	17.8	5.9	11.8	10.0	7.5	9.4	9.6	12.5	14.3	10.0	10.6	10.4	12.7	17.2	13.2	4.8	9.5	13.8	8.1	13.0	8.4	8.2	10.4	5.4	13.2	7.4	7.6	9.1	12.6	7.8	6.2	6.0	7.0	11.3	6.9	7.2	5.8	2.5	5.1	8.1	11.4	10.4	0.0	19.8	18.3	12.1	34.1	4.4	8.5	0.0	9.7	10.0	4.3	6.0	6.9	11.6	11.6	12.7	13.2	4.3	3.3	62.1	8.6	3.7	6.8	10.0	8.6	8.9	8.9	7.0	6.0	16.1	5.3	12.9	4.7	13.2	10.0	8.3	12.6	6.4	15.3	5.5
TMEM222	"C1orf160, DKFZP564D0478"	ENSG00000186501	"Transmembrane protein 222"	Q9H0R3	1	27322145-27336400	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016579, HPA059374"	Approved		Approved	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	"Cell Junctions"	"HPA016579: AB_2669392, HPA059374: AB_2683995"	"unprognostic (3.65e-1)"	"unprognostic (5.27e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.39e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.11e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.51e-2)"	"unprognostic (1.96e-2)"	"unprognostic (2.62e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.29e-3)"	"unprognostic (5.28e-2)"	"unprognostic (1.56e-1)"	"unprognostic (3.83e-2)"	"unprognostic (7.80e-2)"	18.4	22.0	28.0	12.0	31.4	19.5	17.8	23.2	45.4	18.1	17.1	32.1	13.2	14.4	16.5	25.0	22.8	29.8	21.3	27.5	28.9	30.8	20.6	35.0	18.8	15.0	26.0	20.8	22.3	24.6	19.9	22.4	20.0	26.7	22.9	14.3	26.4	21.7	25.2	19.9	15.6	21.3	18.6	21.5	15.2	16.7	20.7	16.4	19.4	24.0	14.9	19.1	17.8	13.3	22.8	19.9	36.5	21.0	19.2	23.2	15.7	12.2	14.9	12.5	20.5	19.6	14.2	10.1	19.0	21.9	26.0	22.2	6.1	25.8	7.8	14.9	20.2	12.1	17.0	13.7	18.5	10.9	10.3	26.3	13.0	12.4	14.0	29.1	12.9	13.0	24.8	10.5	24.9	14.2	12.0	17.3	15.6	9.8	18.1	16.2	10.9	18.5	13.6	23.5	12.7	18.7	15.4	8.7	15.7	25.2	7.2	27.0	23.8	14.7	20.8	18.3	4.7	20.5	20.9	15.8	15.4	13.0	24.7	17.9	19.5	17.3	8.1	23.3	25.1	22.1	19.3	13.7	17.0	22.3	20.3	17.0	22.8	20.7	17.0	12.0	18.9	20.9	21.4	36.5	19.2	21.0	19.9	23.2	15.7	28.0	31.4	23.2	45.4	28.9	30.8	26.0	20.8	26.7	16.4	8.9	15.7	15.7	11.9	10.4	39.6	7.7	10.2	5.3	5.7	12.2	13.7	26.0	33.2	33.2	19.8	15.4	22.2	23.3	35.0	28.5	23.5	15.6	16.2	11.3	24.4	41.3	28.7	9.2	9.1	60.6	18.7	11.4	25.3	29.7	17.4	52.7	36.4	17.5	18.7	17.0	17.1	12.9	14.6	18.9	17.7	11.8	25.7	22.3	19.1	10.1
TMEM251	"C14orf109, DKFZP564F1123"	ENSG00000153485	"Transmembrane protein 251"	Q8N6I4	14	93184951-93187089	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Distal tubular cells: 96.2;Hofbauer cells: 100.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048559	Uncertain		Approved	"Golgi apparatus,Cell Junctions"		NA	NA			"Cell Junctions"	"Golgi apparatus"	"HPA048559: AB_2680441"	"unprognostic (1.21e-2)"	"unprognostic (4.56e-2)"	"unprognostic (4.61e-3)"	"unprognostic (3.37e-2)"	"unprognostic (2.14e-1)"	"unprognostic (4.03e-2)"	"prognostic unfavorable (6.14e-7)"	"unprognostic (1.67e-2)"	"unprognostic (1.88e-1)"	"unprognostic (9.99e-3)"	"unprognostic (5.80e-3)"	"unprognostic (1.58e-1)"	"prognostic favorable (1.10e-4)"	"unprognostic (5.17e-2)"	"unprognostic (1.61e-1)"	"unprognostic (7.47e-2)"	"unprognostic (6.17e-2)"	15.8	19.5	12.2	10.7	14.3	3.9	23.1	11.5	14.2	21.9	19.6	11.4	19.6	15.5	13.0	26.2	10.8	15.8	11.5	23.2	12.2	12.8	25.0	14.4	24.1	19.1	19.0	11.1	12.4	23.6	16.4	17.2	12.5	15.8	26.1	19.5	18.3	18.7	18.5	22.6	10.4	17.9	11.5	17.3	13.3	16.5	8.7	15.1	14.2	19.4	11.0	11.7	13.3	11.8	6.0	8.7	13.7	12.7	5.4	6.6	4.4	7.1	7.5	10.1	10.7	11.8	4.6	6.8	4.9	5.8	8.6	11.2	5.3	7.4	8.1	10.1	4.7	11.4	9.5	11.0	8.1	11.8	7.3	8.6	6.9	5.6	10.6	11.2	9.5	11.0	6.1	9.3	6.9	11.1	4.5	8.7	9.0	5.6	7.9	6.9	33.9	6.9	7.8	5.9	18.1	8.1	4.1	10.2	7.1	10.7	14.3	9.8	9.2	7.5	4.1	29.1	9.0	11.3	7.0	3.8	4.3	7.0	9.1	6.3	10.5	12.6	8.2	8.1	4.0	6.5	4.8	10.8	13.7	4.7	9.7	3.1	5.3	5.5	5.3	8.7	6.0	6.1	6.6	10.7	5.4	12.7	7.6	4.4	4.4	12.2	14.3	11.5	14.2	12.2	12.8	19.0	11.1	15.8	15.1	3.0	11.8	14.9	29.1	20.6	14.3	17.3	22.9	10.7	9.1	29.6	25.5	33.6	96.2	24.2	1.6	10.0	23.3	0.0	23.1	15.7	13.9	37.4	17.3	14.7	100.3	12.7	14.5	8.0	21.1	1.5	10.9	26.7	30.4	10.0	33.3	20.5	15.7	17.5	10.3	58.4	25.2	38.8	15.6	3.3	14.3	27.1	22.9	10.7	30.8	29.7
TNK1		ENSG00000174292	"Tyrosine kinase non receptor 1"	Q13470	17	7380534-7389774	"Enzymes, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Enterocytes: 10.4"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"basal ganglia: 6.4;cerebellum: 11.4;cerebral cortex: 4.0;pons and medulla: 4.3"	"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"B-cells: 1.6;T-cells: 3.8"	"Cell line enhanced"	"Detected in many"		"HaCaT: 10.5;HBEC3-KT: 7.0;hTCEpi: 7.9;T-47d: 8.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA012065, HPA056452"	Uncertain		Approved	"Cell Junctions"		NA	NA			"Cell Junctions"		"HPA012065: AB_1858165, HPA056452: "	"unprognostic (4.90e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.95e-1)"	"prognostic favorable (4.28e-4)"	"unprognostic (2.84e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.41e-2)"	"unprognostic (3.65e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.52e-2)"	"unprognostic (2.43e-1)"	"unprognostic (3.10e-1)"	"prognostic favorable (6.40e-4)"	"unprognostic (1.77e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.38e-1)"	"prognostic favorable (1.52e-4)"	3.4	0.6	1.1	2.2	6.4	0.4	7.9	11.4	4.0	5.4	11.7	0.4	7.7	7.1	5.1	5.3	7.2	3.5	6.3	2.0	1.0	0.4	4.6	6.9	3.2	2.7	1.5	0.8	4.4	6.8	5.4	2.7	2.5	4.3	8.9	4.5	7.7	10.5	4.8	1.8	8.3	11.3	5.1	0.7	2.4	9.6	2.2	0.6	0.6	11.6	5.7	5.2	4.5	4.4	1.6	0.1	0.4	0.0	0.0	3.8	0.6	6.4	1.0	0.2	0.4	0.0	0.0	4.4	0.2	0.0	0.4	0.4	3.3	3.0	0.0	2.6	0.3	0.1	10.5	0.0	7.0	0.1	0.7	1.5	0.0	3.7	1.9	0.4	0.0	0.3	0.1	7.9	0.0	1.2	0.2	0.0	2.8	0.8	0.0	0.0	4.9	0.6	0.0	0.9	5.6	0.9	0.2	0.2	0.7	4.9	3.0	0.2	0.5	3.6	5.3	1.0	0.3	8.7	0.1	1.7	0.2	0.8	0.2	0.0	0.5	1.0	0.1	0.1	0.4	0.5	0.0	0.0	0.0	1.0	0.0	1.9	1.6	1.8	1.2	0.1	1.5	3.3	3.8	0.4	0.0	0.0	0.0	0.8	0.6	1.1	6.4	11.4	4.0	1.0	0.4	1.5	0.8	4.3	0.6	6.0	4.3	0.5	2.1	2.3	1.2	0.8	2.5	0.0	2.3	1.8	0.0	0.2	0.0	4.4	1.1	0.7	10.4	0.0	5.9	0.4	1.0	4.0	0.0	2.5	0.1	0.0	2.9	1.3	0.0	0.6	1.1	0.1	0.0	0.0	6.3	0.2	6.4	6.5	0.4	1.4	2.4	0.0	0.9	0.6	0.9	2.0	0.6	1.0	6.4	1.8
TP53BP2	"53BP2, ASPP2, PPP1R13A"	ENSG00000143514	"Tumor protein p53 binding protein 2"	Q13625	1	223779899-223845972	"Cancer-related genes, Predicted intracellular proteins"	"Apoptosis, Cell cycle"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021603, HPA050429"	Supported		Enhanced	"Cell Junctions,Cytosol"		NA	NA			"Cell Junctions, Cytosol"		"HPA021603: AB_1844384, HPA050429: AB_2681124"	"unprognostic (1.29e-1)"	"unprognostic (5.11e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.38e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.03e-1)"	"unprognostic (7.65e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.48e-2)"	"unprognostic (7.37e-2)"	"unprognostic (2.67e-1)"	"unprognostic (7.99e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.83e-1)"	10.0	8.3	26.5	17.2	28.7	38.8	20.8	9.3	17.9	10.9	12.0	12.6	8.1	7.9	11.9	9.8	15.9	9.4	17.4	10.9	17.3	14.7	10.1	13.9	21.4	18.6	18.7	8.6	15.5	13.0	16.4	8.3	8.2	12.9	9.6	9.5	17.7	10.2	8.1	12.0	9.9	9.5	12.2	13.0	10.6	9.7	10.2	14.9	17.3	22.1	7.4	11.7	11.8	14.8	2.2	2.9	6.7	2.7	7.2	4.0	2.0	15.6	7.9	21.4	13.5	7.6	7.5	13.7	10.1	14.4	14.8	12.7	16.3	9.5	0.0	8.9	8.4	10.7	10.7	16.7	6.0	19.9	30.2	16.4	20.8	7.6	5.5	15.5	17.1	14.6	8.9	6.7	13.6	14.0	11.1	8.7	11.6	26.3	15.8	12.2	4.5	12.9	10.6	18.5	9.5	7.7	17.2	22.3	1.7	13.3	9.9	18.6	24.0	11.1	13.9	14.6	14.7	7.8	23.5	10.1	15.2	10.8	16.3	18.9	7.8	8.1	13.0	9.2	11.5	17.3	6.7	2.7	1.6	2.3	2.6	2.8	2.2	2.6	4.0	2.9	1.9	2.7	1.9	3.2	7.2	2.0	1.7	1.6	2.0	26.5	28.7	9.3	17.9	17.3	14.7	18.7	8.6	12.9	14.9	44.7	24.3	6.5	41.6	15.2	4.4	15.4	12.7	17.4	42.1	7.0	49.1	9.1	1.7	18.3	0.9	10.9	9.1	23.3	9.3	5.0	17.9	31.4	47.4	9.7	8.6	0.0	14.3	10.4	14.8	1.4	9.8	15.0	8.5	6.4	7.9	6.9	17.8	5.8	8.1	4.4	45.8	0.0	20.8	11.4	22.2	10.2	4.0	10.9	9.8	38.8
TPD52L1	"D53, hD53"	ENSG00000111907	"Tumor protein D52 like 1"	Q16890	6	125119049-125264407	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 95.2;salivary gland: 104.6"	"Cell type enhanced"	"Detected in many"	6	"Collecting duct cells: 118.7;Distal tubular cells: 149.2;Exocrine glandular cells: 97.5;Extravillous trophoblasts: 106.8;Melanocytes: 124.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 52.5;hTCEpi: 46.2;MCF7: 68.6;RPTEC TERT1: 53.2;SK-BR-3: 37.1;T-47d: 31.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027915, HPA027916"	Enhanced		Approved	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA			"Plasma membrane, Cell Junctions, Cytosol"		"HPA027915: AB_10602074, HPA027916: AB_10601860"	"unprognostic (1.44e-1)"	"unprognostic (2.01e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.87e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.14e-1)"	"unprognostic (7.85e-2)"	"unprognostic (7.80e-2)"	"unprognostic (9.42e-3)"	"unprognostic (1.76e-1)"	"prognostic favorable (3.26e-4)"	"unprognostic (1.06e-1)"	"unprognostic (6.83e-2)"	"prognostic favorable (3.97e-4)"	"prognostic unfavorable (5.34e-4)"	10.3	95.2	31.5	4.3	47.5	1.0	25.7	2.6	32.9	10.5	8.5	9.2	31.0	4.3	6.2	27.6	43.3	13.9	10.8	26.0	21.4	9.5	11.7	22.0	4.7	2.9	15.4	12.8	9.0	18.0	10.3	8.7	4.0	16.1	16.6	5.8	13.0	104.6	32.7	34.4	11.8	4.6	27.1	5.5	1.4	10.3	2.6	18.2	0.0	23.5	20.1	11.0	18.1	14.6	1.1	0.9	5.9	1.2	5.3	1.7	1.0	7.0	8.0	0.0	52.5	0.4	0.1	12.5	1.2	1.1	0.0	0.1	12.8	9.0	0.0	27.0	5.9	1.7	16.2	1.6	11.2	0.0	0.1	11.2	0.1	11.3	0.1	1.1	0.0	0.0	1.4	46.2	0.0	6.1	16.4	0.0	0.0	5.6	0.1	0.9	68.6	0.0	0.1	0.8	6.9	4.4	0.0	0.0	0.0	53.2	1.8	1.7	0.0	13.5	37.1	0.8	2.0	31.6	0.1	0.0	0.3	1.1	0.1	0.3	0.0	0.0	0.0	0.2	0.0	0.1	2.7	1.2	0.8	0.8	0.6	0.8	0.8	1.3	0.6	0.5	1.1	1.7	1.2	5.9	5.3	0.3	0.9	0.4	1.0	31.5	47.5	2.6	32.9	21.4	9.5	15.4	12.8	16.1	18.2	0.0	21.2	0.5	40.2	17.4	1.7	40.6	17.8	13.4	13.6	118.7	3.9	27.1	149.2	28.9	5.4	30.1	4.6	0.0	97.5	106.8	3.1	35.2	2.3	56.3	9.5	0.0	15.5	4.3	1.9	3.4	16.1	4.1	124.9	1.0	9.1	3.2	37.3	0.0	34.3	26.2	1.3	0.0	15.6	2.8	5.3	32.5	12.0	2.9	9.7	17.9
TRIM38	"RNF15, RORET"	ENSG00000112343	"Tripartite motif containing 38"	O00635	6	25962802-25991226	"Enzymes, Predicted intracellular proteins"	"Immunity, Innate immunity, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"B-cells: 100.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA031685	Approved		Approved	"Plasma membrane,Cell Junctions,Centrosome"		NA	NA			Centrosome	"Plasma membrane, Cell Junctions"	"HPA031685: AB_10603218"	"unprognostic (6.62e-2)"	"unprognostic (1.65e-3)"	"unprognostic (3.34e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.51e-2)"	"unprognostic (7.79e-2)"	"unprognostic (3.27e-2)"	"unprognostic (2.78e-2)"	"prognostic favorable (8.95e-5)"	"unprognostic (2.81e-2)"	"unprognostic (6.28e-2)"	"unprognostic (2.73e-1)"	"unprognostic (3.36e-1)"	"unprognostic (4.49e-2)"	"prognostic favorable (8.20e-5)"	"prognostic favorable (4.94e-9)"	13.3	8.4	2.5	15.7	2.3	12.0	7.9	1.1	3.4	17.2	12.1	3.1	20.5	6.7	26.2	22.3	15.7	8.9	9.2	5.8	2.8	2.3	26.1	8.8	14.0	14.4	3.7	1.8	11.5	4.3	1.0	4.3	10.3	3.5	15.5	7.8	9.2	9.8	16.5	9.0	5.3	14.6	13.1	4.5	17.6	6.6	5.3	2.9	16.6	13.7	9.5	20.1	18.0	15.4	16.5	10.1	12.1	12.9	6.7	7.9	6.3	3.5	2.0	0.3	4.3	10.4	13.9	3.6	4.5	9.0	8.8	14.6	1.6	3.8	7.9	7.4	5.5	8.5	5.6	2.7	4.4	5.2	8.0	1.8	3.6	3.3	1.4	13.8	4.2	7.4	13.9	3.3	5.4	1.9	7.3	7.6	3.9	2.3	4.4	10.4	1.7	4.0	4.8	1.4	0.0	2.7	6.2	4.3	8.2	10.4	7.1	0.1	0.1	3.4	7.1	12.0	0.5	1.0	5.5	7.7	1.6	2.7	2.7	3.0	5.1	3.7	8.9	4.3	5.2	9.7	10.1	10.6	4.7	7.6	12.9	7.4	14.3	6.5	6.8	10.1	16.5	6.2	6.7	12.1	6.7	11.4	9.5	7.9	6.3	2.5	2.3	1.1	3.4	2.8	2.3	3.7	1.8	3.5	2.9	23.8	43.9	100.5	47.4	13.3	0.6	3.5	22.9	17.4	29.6	43.6	0.0	19.8	14.9	19.1	0.9	42.0	39.9	0.0	13.0	17.5	17.0	35.9	34.6	14.8	28.8	0.0	17.4	27.0	84.3	2.2	18.4	61.3	10.1	49.5	29.9	0.3	17.8	40.3	17.7	62.8	0.7	6.5	18.9	0.2	0.2	8.2	17.7	36.2	23.3	78.5
TRMT6	"CGI-09, GCD10, Gcd10p, MGC5029"	ENSG00000089195	"TRNA methyltransferase 6"	Q9UJA5	20	5937235-5950558	"Predicted intracellular proteins"	"tRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Spermatogonia: 110.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047032, HPA050408"	Approved		Enhanced	"Nucleoplasm,Cell Junctions"		NA	NA			Nucleoplasm	"Cell Junctions"	"HPA047032: AB_2679911, HPA050408: AB_2681117"	"unprognostic (1.78e-1)"	"unprognostic (4.51e-2)"	"unprognostic (1.65e-1)"	"unprognostic (4.26e-2)"	"unprognostic (2.11e-1)"	"unprognostic (6.81e-2)"	"prognostic unfavorable (4.70e-12)"	"unprognostic (5.37e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.14e-1)"	"unprognostic (6.27e-2)"	"unprognostic (1.22e-1)"	"unprognostic (7.65e-3)"	"unprognostic (2.52e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.87e-3)"	"unprognostic (4.96e-2)"	10.5	12.9	10.5	11.3	12.1	20.6	8.5	15.0	10.5	7.3	7.4	5.7	47.8	5.1	9.1	7.9	11.9	7.9	5.6	13.2	8.4	9.5	10.2	10.1	7.2	13.2	8.3	11.8	9.6	9.6	9.8	13.9	9.4	13.6	7.2	8.2	5.1	8.2	33.9	24.4	9.9	8.6	8.0	8.2	12.2	7.5	15.5	7.9	10.3	8.7	10.6	12.7	8.8	7.9	9.2	17.8	5.9	8.7	13.9	11.6	7.1	25.5	12.6	8.5	13.0	4.8	6.2	11.9	12.3	6.3	12.1	10.1	16.6	11.3	30.5	6.4	6.8	15.8	19.6	17.0	19.6	20.2	6.3	11.9	25.1	5.8	14.8	9.5	23.0	6.6	6.2	10.3	21.5	16.2	4.1	5.1	11.9	15.1	9.5	13.8	7.1	23.9	12.5	19.2	16.5	15.9	15.9	16.9	16.7	8.2	16.3	16.6	25.7	15.0	19.4	19.7	8.5	10.3	11.2	5.0	14.3	13.4	13.2	24.7	15.5	29.9	35.7	6.3	19.0	14.0	2.0	7.9	5.9	9.6	8.7	11.0	9.2	10.8	11.6	17.8	8.2	11.2	11.6	0.8	13.9	7.6	8.1	11.3	7.1	10.5	12.1	15.0	10.5	8.4	9.5	8.3	11.8	13.6	7.9	6.0	16.9	15.9	15.9	19.1	17.7	21.3	12.7	34.8	34.2	27.9	9.8	23.4	29.9	18.1	3.0	15.3	3.9	0.0	26.5	20.1	12.3	14.0	34.6	16.3	15.9	25.4	13.2	3.7	13.2	6.3	10.6	27.0	16.9	9.0	8.2	12.2	17.8	7.0	6.7	17.9	9.8	12.9	20.5	59.7	110.3	21.0	24.5	17.5	9.9	14.2
TSPAN6	"T245, TM4SF6, TSPAN-6"	ENSG00000000003	"Tetraspanin 6"	O43657	X	100627109-100639991	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 88.4"	"Group enriched"	"Detected in many"	6	"Early spermatids: 313.3;Late spermatids: 1149.4"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"pons and medulla: 34.2"	"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 6.6"	"Lineage enriched"	"Detected in single"	8	"T-cells: 6.6"	"Cell line enhanced"	"Detected in many"		"NTERA-2: 43.2;RT4: 65.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004109	Approved		Approved	"Nucleoli fibrillar center,Cell Junctions,Cytosol"		NA	NA			"Cell Junctions, Cytosol"	"Nucleoli fibrillar center"	"HPA004109: AB_1080301"	"unprognostic (7.71e-2)"	"unprognostic (8.97e-2)"	"unprognostic (3.56e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.71e-3)"	"unprognostic (5.93e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.80e-3)"	"unprognostic (2.04e-3)"	"unprognostic (8.76e-2)"	"unprognostic (3.83e-3)"	"unprognostic (4.28e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.24e-1)"	"unprognostic (9.54e-3)"	27.0	9.8	7.0	4.4	6.6	0.1	33.0	2.9	4.9	15.9	17.8	12.6	6.4	9.7	11.1	10.4	27.1	24.2	10.0	5.7	7.4	7.3	26.7	68.2	8.3	3.6	6.9	4.1	27.6	25.1	19.6	17.7	23.6	34.2	15.5	20.3	16.7	88.4	6.7	3.5	4.7	11.6	4.7	10.4	8.6	8.0	17.5	6.6	2.9	24.6	11.0	19.8	17.2	11.5	0.3	0.2	0.8	0.2	0.3	6.6	1.4	7.9	10.6	28.7	14.5	12.6	6.8	11.6	4.5	7.1	9.0	21.1	23.8	13.9	0.0	19.1	4.6	6.2	6.5	0.1	8.6	10.6	0.0	15.4	1.4	6.9	26.5	7.0	0.0	1.1	13.3	4.2	7.9	3.1	13.1	19.1	0.0	0.0	0.0	9.2	8.2	0.0	0.1	43.2	12.0	8.0	0.0	13.6	0.0	14.1	65.2	1.8	7.8	4.5	3.9	6.0	24.1	5.7	1.0	5.3	5.6	8.6	9.2	2.9	0.0	0.0	0.0	5.0	0.0	4.0	0.5	0.1	0.2	1.0	0.1	3.5	0.3	2.4	0.8	0.0	0.2	6.6	3.8	0.8	0.3	0.2	0.2	0.1	1.4	7.0	6.6	2.9	4.9	7.4	7.3	6.9	4.1	34.2	6.6	3.0	8.5	7.8	36.0	6.4	0.7	7.3	61.1	115.1	21.6	89.0	0.0	26.5	19.9	64.9	313.3	22.2	51.9	0.0	11.1	33.5	17.7	46.5	0.0	94.2	3.8	0.0	32.3	58.9	11.8	1149.4	30.5	2.9	10.1	1.8	42.7	38.6	20.9	46.0	33.6	37.7	1.5	19.4	7.5	19.0	32.2	4.6	11.3	3.5	78.3	78.2
TSR2	"DT1P1A10, RP1-112K5.2, WGG1"	ENSG00000158526	"TSR2, ribosome maturation factor"	Q969E8	X	54440401-54445487	"Disease related genes, Predicted intracellular proteins"	"rRNA processing"		"Diamond-Blackfan anemia, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030514	Approved		Approved	"Nucleoplasm,Nucleoli,Cell Junctions,Cytosol"		NA	NA			"Nucleoplasm, Nucleoli"	"Cell Junctions, Cytosol"	"HPA030514: AB_10603457"	"unprognostic (1.05e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.58e-2)"	"unprognostic (2.64e-2)"	"unprognostic (5.91e-2)"	"unprognostic (7.15e-3)"	"unprognostic (8.29e-2)"	"unprognostic (4.39e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.94e-2)"	"unprognostic (6.19e-2)"	"prognostic favorable (1.21e-6)"	"unprognostic (2.27e-1)"	"unprognostic (1.13e-1)"	"unprognostic (7.93e-3)"	"unprognostic (1.80e-3)"	20.8	25.0	52.9	13.8	53.1	15.3	19.2	27.6	44.3	18.2	17.2	30.8	16.9	13.9	18.4	33.9	16.2	21.1	14.8	22.2	45.3	46.2	26.5	23.7	17.5	14.9	53.8	34.4	22.9	17.2	30.7	19.0	19.8	31.0	20.8	20.6	19.0	16.6	25.4	35.5	17.2	14.7	19.7	54.3	18.1	16.5	8.4	27.5	10.2	23.9	10.8	22.0	17.7	16.8	39.6	15.4	28.7	21.2	24.7	41.4	21.1	20.3	26.1	19.1	17.4	17.3	12.5	17.1	20.2	16.5	18.9	16.2	24.6	22.3	22.3	14.0	17.7	33.7	21.1	46.7	28.0	25.2	29.0	23.1	18.2	19.5	19.2	10.7	31.4	19.0	11.6	15.4	26.3	27.2	14.9	13.1	18.8	18.5	16.7	19.2	37.4	23.9	24.8	30.4	18.4	29.7	21.5	35.6	18.9	20.1	18.1	24.2	16.8	38.5	19.3	21.4	34.7	39.2	11.0	17.9	13.9	24.5	29.1	17.2	17.9	27.0	26.7	20.4	25.0	20.8	24.5	15.3	28.7	35.1	20.5	28.8	38.7	33.3	31.8	13.9	39.6	41.4	31.7	9.4	24.7	21.2	15.4	35.5	21.1	52.9	53.1	27.6	44.3	45.3	46.2	53.8	34.4	31.0	27.5	23.8	23.8	40.1	37.8	29.1	55.8	44.8	22.9	45.5	39.8	33.2	25.5	86.7	106.1	35.8	0.8	36.5	26.0	0.0	28.8	60.7	42.6	34.1	43.9	22.9	39.7	54.0	17.4	23.4	12.3	2.1	32.2	27.9	38.8	70.3	30.8	56.3	30.9	28.6	42.5	51.9	48.8	45.3	43.4	12.2	43.7	27.7	63.5	41.1	28.8	29.1
TSSK4	"C14orf20, STK22E"	ENSG00000139908	"Testis specific serine kinase 4"	Q6SA08	14	24205697-24208362	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Spermatogenesis"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"testis: 46.1"	"Cell type enriched"	"Detected in some"	15	"Early spermatids: 178.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA060660, HPA077103"	Approved		Approved	"Cell Junctions"		NA	NA			"Cell Junctions"		"HPA060660: AB_2684339, HPA077103: AB_2732332"	"unprognostic (1.95e-1)"	"unprognostic (4.30e-2)"	"unprognostic (1.52e-1)"	"unprognostic (5.69e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.38e-5)"	"unprognostic (1.06e-1)"	"unprognostic (6.25e-3)"	"unprognostic (1.64e-1)"	"unprognostic (3.39e-1)"	"unprognostic (7.03e-3)"	"unprognostic (1.27e-3)"	"unprognostic (3.42e-1)"	"unprognostic (4.30e-2)"	"unprognostic (6.28e-2)"	"unprognostic (8.98e-2)"	"unprognostic (7.26e-2)"	0.6	0.9	0.6	1.7	0.6	3.1	0.6	1.5	1.8	0.6	0.6	0.6	0.6	1.5	0.8	0.9	1.4	0.8	1.7	0.6	0.6	0.4	0.6	0.6	0.8	2.8	0.6	0.6	0.8	0.9	0.0	0.6	0.6	0.6	0.6	0.0	0.6	1.4	0.6	1.0	4.7	1.6	0.6	0.6	1.5	0.6	46.1	0.6	0.6	1.4	0.6	0.6	1.0	0.6	2.1	1.7	2.0	1.0	1.8	2.0	0.7	1.0	4.1	4.0	1.5	0.1	0.0	4.3	1.6	0.1	0.0	0.0	2.1	3.7	3.1	0.9	0.1	0.8	3.8	0.0	0.1	0.0	1.6	3.1	3.5	4.8	3.0	0.0	1.5	3.8	0.0	0.0	0.0	0.6	3.6	0.1	3.7	1.3	2.0	0.0	3.8	3.6	1.7	0.7	0.9	3.2	3.0	1.6	2.7	0.0	5.3	2.2	2.1	2.7	2.5	0.8	1.8	1.6	1.8	1.4	2.9	1.8	3.8	1.3	4.3	4.8	4.8	1.0	2.8	0.9	0.0	1.0	2.0	2.0	1.0	0.7	2.0	1.6	1.6	0.6	2.1	1.6	1.7	2.0	1.8	0.9	1.7	0.7	0.7	0.6	0.6	1.5	0.6	0.6	0.4	0.6	0.6	0.6	0.6	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	178.8	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	11.8	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	1.2	0.7	0.0	0.1	0.0	0.0	0.0
UBALD1	FAM100A	ENSG00000153443	"UBA like domain containing 1"	Q8TB05	16	4608883-4615027	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA066771	Approved		Approved	"Nucleoplasm,Cell Junctions,Cytosol"		NA	NA			"Nucleoplasm, Cytosol"	"Cell Junctions"	"HPA066771: AB_2685717"	"unprognostic (7.09e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.55e-1)"	"unprognostic (7.67e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.54e-1)"	"unprognostic (4.37e-3)"	"unprognostic (2.63e-3)"	"unprognostic (8.06e-2)"	"unprognostic (1.95e-3)"	"unprognostic (2.35e-1)"	"unprognostic (3.99e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.35e-2)"	23.0	16.7	20.5	17.9	25.0	37.5	11.9	32.4	39.2	12.1	19.3	15.1	11.7	23.7	20.4	11.0	15.0	13.9	12.4	14.8	20.9	14.2	19.6	32.9	15.7	13.8	12.0	22.2	14.8	27.2	9.0	12.1	27.9	16.9	18.9	5.3	13.6	19.4	18.1	38.3	16.7	19.5	14.2	11.5	23.9	25.9	13.2	13.0	9.9	17.3	11.3	11.6	17.8	12.8	1.9	2.8	11.3	4.5	1.5	2.6	1.5	5.4	15.9	3.8	5.9	2.5	3.3	17.0	8.3	3.4	3.2	4.6	7.8	6.5	8.2	9.3	2.6	2.4	15.2	2.4	8.4	0.9	17.1	24.2	7.6	16.6	12.0	5.2	4.7	13.1	4.7	6.3	4.9	2.4	3.7	3.4	6.3	11.5	8.6	1.2	27.1	7.9	26.0	14.2	4.9	14.1	11.4	4.7	26.4	2.8	8.0	11.0	10.1	9.8	15.2	13.0	2.3	9.7	7.8	10.1	6.5	7.4	26.1	5.3	16.8	13.5	9.2	2.6	6.5	3.4	1.3	2.3	11.3	2.5	3.5	1.6	1.9	2.0	2.6	2.8	1.8	2.1	2.2	3.9	1.5	4.5	1.8	2.4	1.5	20.5	25.0	32.4	39.2	20.9	14.2	12.0	22.2	16.9	13.0	8.9	8.0	9.8	49.6	97.9	8.9	3.6	7.6	2.7	7.9	17.4	3.9	58.7	26.6	19.0	30.4	15.8	17.3	0.0	20.4	54.1	23.1	30.9	10.4	31.6	20.8	9.5	81.1	15.4	16.8	89.2	15.0	18.1	20.3	17.2	21.3	12.0	21.6	17.5	18.7	33.8	8.7	45.3	30.6	11.5	17.7	89.8	90.2	15.3	12.8	32.8
VASP		ENSG00000125753	"Vasodilator stimulated phosphoprotein"	P50552	19	45506579-45526983	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Extravillous trophoblasts: 388.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"eosinophil: 23.6"	"Group enriched"	"Detected in all"	6	"granulocytes: 23.6;monocytes: 10.4"	"Cell line enhanced"	"Detected in all"		"HMC-1: 65.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004612, HPA005724"	Enhanced		Supported	"Plasma membrane,Cell Junctions,Focal adhesion sites"		NA	NA		110000000	"Plasma membrane, Cell Junctions, Focal adhesion sites"		"CAB004612: AB_2213431, HPA005724: AB_1858721"	"unprognostic (3.07e-2)"	"unprognostic (1.07e-2)"	"unprognostic (4.70e-2)"	"unprognostic (7.85e-3)"	"unprognostic (8.31e-2)"	"unprognostic (1.90e-2)"	"prognostic unfavorable (3.49e-5)"	"unprognostic (1.66e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.30e-2)"	"unprognostic (3.64e-3)"	"unprognostic (4.39e-1)"	"prognostic unfavorable (5.91e-7)"	"unprognostic (1.15e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.08e-2)"	29.1	10.3	4.9	33.3	5.9	40.3	19.0	3.9	4.7	22.6	38.2	5.3	15.4	28.8	37.5	13.3	34.3	23.8	32.2	21.1	5.2	4.3	17.9	21.1	30.5	44.5	7.7	2.2	22.5	10.5	2.9	7.5	31.5	6.2	26.8	9.8	8.9	12.9	20.3	10.4	13.0	43.7	36.7	4.8	69.2	33.4	14.4	6.6	28.3	11.7	12.8	33.2	39.2	17.5	1.8	2.6	23.6	10.4	2.0	2.1	2.2	15.5	16.4	4.8	8.2	2.4	4.2	12.3	16.1	12.4	11.1	9.7	7.4	32.8	7.2	13.7	12.8	7.4	14.5	1.4	15.9	3.7	21.2	3.7	41.4	8.1	12.5	13.6	15.1	65.0	6.4	9.0	10.4	6.7	9.0	16.5	6.1	24.7	15.7	6.8	13.0	6.9	13.1	8.4	14.6	11.3	5.2	3.0	2.7	9.5	50.0	5.7	4.0	19.1	9.8	11.3	3.2	10.6	26.0	24.6	17.8	18.0	5.7	25.3	8.4	10.1	12.4	12.4	18.5	21.3	5.6	4.0	23.6	2.1	6.5	1.5	1.8	1.7	2.0	2.6	1.7	1.1	1.3	17.1	2.0	10.4	1.0	1.2	2.2	4.9	5.9	3.9	4.7	5.2	4.3	7.7	2.2	6.2	6.6	14.9	24.5	57.0	75.3	87.2	7.9	14.6	30.6	10.7	34.2	31.4	25.5	54.0	14.9	140.2	2.8	53.3	134.7	0.0	86.8	388.2	29.9	56.5	81.9	13.5	148.4	6.4	110.1	45.4	113.3	3.6	24.2	183.9	47.2	67.7	118.7	13.1	143.6	173.9	46.3	13.6	13.6	129.4	84.5	7.5	10.0	68.0	117.9	82.0	102.2	112.6
VCAM1	CD106	ENSG00000162692	"Vascular cell adhesion molecule 1"	P19320	1	100719742-100739045	"Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins"	"Cell adhesion"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"kidney: 69.6;lymphoid tissue: 129.2"	"Cell type enhanced"	"Detected in many"	21	"Ductal cells: 130.8;Ito cells: 82.3;Kupffer cells: 410.3;Proximal tubular cells: 200.7"	"Cancer enriched"	"Detected in all"	8	"renal cancer: 89.5"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	10	"gdT-cell: 1.3;memory CD8 T-cell: 2.9;naive CD8 T-cell: 1.1"	"Lineage enriched"	"Detected in single"	17	"T-cells: 2.9"	"Group enriched"	"Detected in some"	5	"HHSteC: 58.3;HSkMC: 38.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000154, HPA034796, HPA069867"	Enhanced		Supported	"Cell Junctions"		NA	NA	624000000	960000000	"Cell Junctions"		"CAB000154: , HPA034796: AB_2674333, HPA069867: AB_2686215"	"unprognostic (2.96e-1)"	"prognostic favorable (3.82e-4)"	"unprognostic (1.31e-1)"	"unprognostic (7.49e-3)"	"unprognostic (1.04e-1)"	"prognostic favorable (7.19e-5)"	"unprognostic (1.60e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.95e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.80e-1)"	"unprognostic (5.47e-2)"	"unprognostic (1.68e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.55e-2)"	10.9	18.1	1.5	20.2	3.2	1.3	5.2	0.9	1.1	3.7	5.0	3.3	1.4	3.3	4.9	4.5	5.3	4.9	6.8	7.2	1.7	2.3	69.6	11.8	9.8	26.8	2.8	1.7	11.1	6.6	10.6	3.5	10.9	4.2	8.3	5.5	15.3	4.9	1.1	4.7	1.8	6.3	4.2	3.7	129.2	3.0	2.5	1.6	13.3	3.5	2.8	20.9	8.2	2.8	0.0	0.1	0.0	0.0	0.0	2.9	0.1	0.0	0.0	0.3	0.1	0.2	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	8.4	0.0	0.0	0.0	0.0	58.3	0.0	0.0	38.9	0.0	10.2	0.1	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.1	2.9	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	1.5	3.2	0.9	1.1	1.7	2.3	2.8	1.7	4.2	1.6	0.0	6.4	2.4	0.1	8.9	0.0	2.0	0.0	2.7	0.0	3.5	0.0	0.9	8.3	130.8	0.1	16.1	0.0	0.0	2.7	0.8	67.5	0.6	1.1	2.5	3.0	0.0	0.0	82.3	410.3	0.0	15.8	1.9	1.7	0.0	0.0	3.0	2.6	0.0	7.1	200.7	0.0	0.0	14.0	0.0	0.0	6.5	2.3	1.5	0.0	0.0
VPS13B	"CHS1, COH1"	ENSG00000132549	"Vacuolar protein sorting 13 homolog B"	Q7Z7G8	8	99013266-99877580	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"		"Disease mutation, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043865			Approved	"Cell Junctions"		NA	NA			"Cell Junctions"		"HPA043865: AB_2678704"	"unprognostic (4.23e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.60e-3)"	"unprognostic (5.72e-2)"	"unprognostic (6.08e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.65e-3)"	"unprognostic (8.60e-2)"	"unprognostic (5.95e-2)"	"unprognostic (6.52e-2)"	"unprognostic (5.19e-2)"	"unprognostic (1.59e-1)"	"unprognostic (8.93e-3)"	"unprognostic (2.90e-1)"	11.3	10.5	9.6	13.8	10.4	22.1	10.3	13.4	11.8	12.4	9.3	6.6	10.8	4.8	22.4	8.0	10.4	11.6	8.8	7.9	8.7	4.7	7.9	6.2	12.3	12.5	9.9	7.4	16.5	8.1	18.3	21.2	7.9	8.5	10.0	7.5	6.5	9.9	9.6	8.4	11.0	9.6	18.4	11.0	9.8	8.8	10.7	8.4	15.6	9.5	4.9	10.7	12.5	11.8	5.0	1.0	9.8	3.3	1.0	2.9	0.8	8.1	5.9	7.2	5.3	13.5	16.3	3.5	5.3	9.7	5.3	7.1	3.5	4.2	4.5	6.9	8.9	3.9	3.8	4.9	4.9	9.6	7.3	4.5	9.9	6.2	2.7	4.3	4.7	7.3	10.5	4.6	8.5	12.2	7.4	7.5	7.7	7.4	12.2	6.0	5.0	9.8	2.7	2.3	8.5	2.2	7.9	5.1	8.6	3.5	7.7	2.1	5.9	8.2	3.9	4.0	6.7	7.1	5.4	10.4	8.0	7.5	7.0	4.5	5.0	5.7	12.4	6.0	7.7	5.5	3.5	1.9	4.3	2.1	1.7	1.9	5.0	1.8	1.6	0.8	2.9	2.9	1.9	9.8	1.0	3.3	1.0	2.1	0.8	9.6	10.4	13.4	11.8	8.7	4.7	9.9	7.4	8.5	8.4	17.9	9.8	10.0	7.2	7.8	14.3	10.9	7.6	4.0	13.6	3.5	35.3	4.1	0.0	4.4	6.3	7.4	7.4	0.0	4.0	3.2	11.0	9.0	3.5	4.5	5.9	11.1	8.6	6.2	17.3	6.5	25.6	9.3	6.8	6.4	10.6	9.7	3.6	10.5	19.4	3.1	14.0	0.0	9.2	20.0	6.1	8.4	3.5	12.9	8.0	5.8
VPS36	"C13orf9, CGI-145, Eap45"	ENSG00000136100	"Vacuolar protein sorting 36 homolog"	Q86VN1	13	52412602-52450628	"Predicted intracellular proteins"	"Protein transport, Transcription, Transcription regulation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Rod photoreceptor cells: 249.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA039734, HPA043947"	Approved		Supported	"Vesicles,Lysosomes,Plasma membrane,Cell Junctions"		NA	NA			"Vesicles, Lysosomes"	"Plasma membrane, Cell Junctions"	"HPA039734: AB_2676652, HPA043947: AB_2678744"	"unprognostic (2.43e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.80e-1)"	"unprognostic (2.94e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.32e-1)"	"unprognostic (6.57e-2)"	"unprognostic (7.84e-2)"	"unprognostic (3.96e-3)"	"unprognostic (1.19e-2)"	"unprognostic (9.37e-2)"	"unprognostic (5.57e-2)"	"prognostic favorable (9.91e-6)"	"unprognostic (6.47e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.94e-1)"	"unprognostic (9.83e-2)"	16.4	14.5	16.5	15.9	22.3	7.0	23.5	36.8	27.7	17.1	21.1	13.6	12.8	23.8	22.4	12.9	24.6	16.6	18.0	20.3	15.4	13.0	22.6	20.2	17.5	15.6	16.2	18.5	20.0	19.0	14.4	20.1	21.7	25.9	20.1	24.7	18.2	21.6	18.3	23.4	44.6	27.9	23.7	13.8	22.3	15.7	4.2	13.8	18.1	20.0	16.8	18.1	20.3	21.7	14.4	14.9	13.9	19.2	19.4	19.3	11.8	3.8	6.4	11.3	7.4	11.8	16.5	9.7	8.8	6.8	8.9	5.4	7.5	12.7	13.5	4.7	12.6	5.7	10.8	8.9	10.6	10.0	10.0	8.6	15.8	10.1	6.7	14.0	21.2	17.2	11.5	20.9	6.1	10.0	10.0	9.0	17.6	11.6	11.9	17.2	4.9	15.4	21.3	10.7	15.1	3.3	16.2	6.4	8.2	15.7	10.0	5.8	12.2	6.2	14.9	13.4	13.8	8.7	35.4	14.0	5.8	6.9	5.7	9.9	8.9	11.1	14.3	5.9	15.0	13.3	13.9	13.5	10.9	12.1	14.8	19.3	14.4	13.3	15.1	14.3	12.3	12.4	13.2	3.7	19.4	19.2	14.9	14.3	11.8	16.5	22.3	36.8	27.7	15.4	13.0	16.2	18.5	25.9	13.8	77.4	38.5	35.3	43.5	38.0	114.4	71.9	38.2	33.5	47.8	31.4	113.9	51.3	58.0	31.0	1.2	57.1	58.8	0.0	25.7	34.0	26.8	47.9	42.8	49.9	37.6	49.3	47.8	33.7	36.4	1.9	46.1	34.1	27.0	27.9	56.5	33.0	27.4	59.4	49.1	58.0	249.2	45.3	28.3	8.4	18.5	50.8	31.9	37.6	49.4	40.0
VTCN1	"B7-H4, B7H4, B7S1, B7X, FLJ22418"	ENSG00000134258	"V-set domain containing T cell activation inhibitor 1"	Q7Z7D3	1	117143587-117210960	"Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 46.4;epididymis: 29.9;kidney: 27.0;pancreas: 35.9"	"Group enriched"	"Detected in some"	5	"Collecting duct cells: 52.4;Ductal cells: 73.6;Exocrine glandular cells: 31.1"	"Group enriched"	"Detected in many"	6	"breast cancer: 55.8;endometrial cancer: 45.2;ovarian cancer: 49.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"SK-BR-3: 74.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA054200	Approved		Approved	"Plasma membrane,Cell Junctions,Focal adhesion sites"		No	NA			"Plasma membrane"	"Cell Junctions, Focal adhesion sites"	"HPA054200: AB_2682415"	"unprognostic (4.13e-1)"	"unprognostic (1.71e-3)"	"unprognostic (2.95e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.56e-1)"	"unprognostic (7.94e-2)"	"unprognostic (4.86e-2)"	"unprognostic (3.53e-1)"	"unprognostic (1.17e-2)"	"unprognostic (4.54e-2)"	"unprognostic (5.47e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.42e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.45e-2)"	0.1	0.0	0.1	0.1	0.1	0.0	46.4	0.1	0.1	6.7	0.1	0.1	7.0	0.0	2.6	29.9	0.4	14.2	1.9	0.2	0.1	0.1	27.0	0.9	0.3	0.1	0.1	0.1	4.5	35.9	0.0	1.4	3.0	0.1	1.5	0.0	0.1	17.5	3.6	0.2	2.2	0.1	0.8	0.1	0.1	1.5	2.5	0.1	0.2	0.1	0.5	1.5	2.1	0.7	0.4	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.5	0.0	0.0	0.0	13.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.3	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.3	0.0	0.0	74.4	0.0	9.6	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	2.4	0.0	0.0	1.2	0.0	4.0	10.3	52.4	0.0	1.7	0.0	73.6	1.6	0.0	0.0	0.0	31.1	1.1	0.0	1.5	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	3.9
WDPCP	"BBS15, C2orf86, fritz, hFrtz"	ENSG00000143951	"WD repeat containing planar cell polarity effector"	O95876	2	63121383-63827843	"Disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Bardet-Biedl syndrome, Ciliopathy, Disease mutation, Mental retardation, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Alveolar cells type 1: 157.8;Alveolar cells type 2: 91.0;Ciliated cells: 161.9;Club cells: 104.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044144	Uncertain		Approved	"Cell Junctions"		Yes	No			"Cell Junctions"		"HPA044144: AB_10969458"	"unprognostic (3.36e-1)"	"unprognostic (3.22e-2)"	"unprognostic (1.95e-1)"	"unprognostic (7.07e-2)"	"unprognostic (2.95e-1)"	"unprognostic (6.88e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.59e-3)"	"unprognostic (7.22e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.93e-1)"	"unprognostic (4.87e-2)"	"unprognostic (2.34e-3)"	"unprognostic (6.02e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.25e-3)"	"unprognostic (2.00e-1)"	7.2	7.6	7.9	5.4	13.8	15.6	6.6	10.7	14.2	6.4	4.6	7.8	5.6	3.7	8.1	9.3	4.9	8.6	5.3	10.8	7.8	7.5	8.1	5.1	5.5	6.7	7.0	10.1	9.5	5.0	6.9	17.1	5.7	9.8	5.8	4.5	10.4	4.8	4.5	9.3	6.7	3.9	8.7	9.4	6.2	6.3	13.1	8.5	7.5	7.8	4.5	6.3	5.1	4.9	5.6	4.6	8.7	4.3	6.3	7.0	1.6	6.0	5.8	4.8	5.5	5.4	5.6	5.0	6.1	2.9	3.6	3.3	4.7	3.5	6.0	5.0	3.6	4.5	4.9	2.7	2.7	4.6	8.0	4.5	7.7	5.5	3.7	2.8	6.2	5.9	3.3	2.7	3.9	2.3	5.2	3.3	9.6	3.4	9.2	4.0	7.0	8.0	6.7	5.9	3.0	2.4	7.5	5.1	6.1	2.4	4.0	6.4	8.0	4.0	5.6	7.3	7.5	5.7	5.4	6.8	7.0	10.7	5.9	5.4	7.1	4.9	11.6	7.6	6.7	6.8	8.7	4.3	2.8	3.6	2.3	7.0	3.7	3.1	4.6	3.2	5.6	4.1	6.1	3.7	6.3	1.9	4.6	2.7	1.6	7.9	13.8	10.7	14.2	7.8	7.5	7.0	10.1	9.8	8.5	157.8	91.0	3.7	3.2	3.7	15.6	7.6	2.5	161.9	104.6	1.8	21.6	2.3	1.7	1.8	31.9	3.6	0.4	0.0	1.9	2.3	4.2	1.8	60.4	0.9	3.4	11.1	0.0	4.3	2.4	11.0	4.0	3.9	5.0	1.0	0.9	8.5	1.9	0.9	3.5	3.5	24.3	0.0	4.2	12.7	7.0	3.0	1.6	5.3	0.6	1.7
WDR1		ENSG00000071127	"WD repeat domain 1"	O75083	4	10074339-10116949	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Late spermatids: 926.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020804, HPA036434, HPA070293"	Approved		Supported	"Plasma membrane,Cell Junctions"		NA	NA		280000000	"Plasma membrane, Cell Junctions"		"CAB020804: , HPA036434: AB_2675121, HPA070293: AB_2732152"	"unprognostic (1.35e-1)"	"unprognostic (6.64e-2)"	"unprognostic (5.31e-2)"	"unprognostic (1.32e-3)"	"unprognostic (2.65e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.63e-3)"	"unprognostic (6.83e-3)"	"unprognostic (1.69e-1)"	"unprognostic (9.00e-3)"	"unprognostic (2.52e-2)"	"unprognostic (2.61e-1)"	"prognostic favorable (1.73e-5)"	"unprognostic (1.11e-1)"	"unprognostic (3.56e-1)"	"unprognostic (3.46e-2)"	"unprognostic (4.83e-3)"	40.2	23.7	19.0	49.4	18.1	33.5	35.0	8.1	22.6	53.5	53.3	25.8	38.4	39.2	80.9	54.2	59.6	54.9	57.6	49.5	19.6	20.5	55.4	41.3	41.7	57.4	22.1	17.1	51.5	22.2	19.5	18.6	40.4	26.8	47.1	38.3	37.6	38.5	49.1	32.1	31.6	54.5	88.0	19.5	46.9	41.1	38.0	16.0	74.5	49.9	36.4	50.2	69.6	41.5	22.9	40.2	54.2	61.2	32.5	55.6	64.1	30.5	30.7	27.5	23.1	20.9	34.7	43.4	77.3	71.4	69.9	55.0	36.7	38.7	21.3	25.2	92.2	76.0	20.0	29.9	56.5	74.8	33.2	10.2	60.7	31.4	26.0	48.9	19.2	70.4	33.3	29.0	70.9	35.5	53.5	75.1	38.0	18.1	35.4	67.7	17.5	84.8	27.1	32.6	24.6	30.8	40.0	25.2	18.0	43.6	48.8	9.3	10.2	33.0	18.3	31.8	37.7	15.3	20.9	112.9	53.9	22.6	44.6	67.6	22.4	35.8	27.9	57.0	29.3	66.8	37.1	29.0	54.2	48.3	51.7	37.4	22.9	40.6	48.2	37.8	16.9	41.7	44.4	54.1	32.5	61.2	40.2	55.6	64.1	19.0	18.1	8.1	22.6	19.6	20.5	22.1	17.1	26.8	16.0	32.8	48.2	70.0	155.9	129.0	22.1	55.6	73.9	62.9	60.3	99.5	39.3	147.9	72.9	294.0	462.5	69.7	206.5	0.0	185.6	249.1	66.7	101.7	80.8	62.3	224.0	31.8	104.6	84.7	141.3	926.6	43.4	122.8	75.9	402.2	113.7	74.5	238.9	137.2	86.7	88.0	24.9	97.0	170.5	94.8	67.2	119.7	193.7	125.0	117.8	177.3
ZNF236		ENSG00000130856	"Zinc finger protein 236"	Q9UL36	18	76822607-76970727	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008600	Uncertain		Approved	"Nucleoplasm,Cell Junctions,Cytosol"		NA	NA			"Nucleoplasm, Cell Junctions"	Cytosol	"HPA008600: AB_1080696"	"unprognostic (1.38e-1)"	"unprognostic (7.24e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.20e-1)"	"unprognostic (9.88e-3)"	"unprognostic (5.51e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.83e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.95e-2)"	"unprognostic (9.40e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.37e-1)"	5.7	5.2	7.0	9.1	11.2	10.8	10.0	15.3	11.0	7.2	5.8	7.3	6.7	5.0	7.6	7.1	5.6	7.6	6.3	5.1	8.3	5.7	4.7	4.3	6.4	6.2	8.3	3.5	11.3	7.1	12.2	8.9	5.6	7.3	6.2	4.1	5.4	6.6	12.6	5.7	9.9	5.5	5.8	6.5	5.5	5.8	16.6	10.6	10.4	6.5	1.9	10.0	6.2	12.7	9.0	4.6	5.9	3.4	3.0	5.4	1.2	4.2	5.7	8.0	5.9	6.2	6.0	3.6	3.3	4.6	5.3	4.2	4.0	4.0	6.0	1.6	4.3	5.6	7.8	5.5	4.6	4.4	6.4	5.6	5.7	6.6	4.7	3.8	9.1	6.6	5.9	5.1	5.0	7.7	5.7	5.3	9.6	5.4	5.1	5.3	4.0	11.2	5.1	4.4	1.3	4.5	7.1	8.3	4.0	3.9	6.7	4.6	4.8	5.9	3.6	4.1	3.9	4.3	6.4	5.4	9.1	3.7	2.4	4.9	3.5	4.7	7.8	6.0	5.0	6.8	1.1	3.4	5.9	5.4	2.9	5.2	9.0	4.0	3.7	2.2	8.1	4.6	4.8	3.7	3.0	2.7	4.6	3.9	1.2	7.0	11.2	15.3	11.0	8.3	5.7	8.3	3.5	7.3	10.6	8.9	6.4	3.7	7.4	6.4	14.6	6.9	10.2	14.7	6.8	7.0	9.8	6.9	1.7	4.3	6.0	7.5	4.3	23.3	3.4	6.0	7.7	6.0	1.1	5.7	5.3	23.8	5.8	7.4	8.7	3.3	9.8	5.3	6.8	5.4	4.7	10.8	3.9	2.9	6.7	2.2	14.3	6.5	8.2	27.0	18.5	7.3	5.0	5.1	5.2	5.8
ZNF497	FLJ44773	ENSG00000174586	"Zinc finger protein 497"	Q6ZNH5	19	58354357-58362848	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	9	"Alveolar cells type 1: 6.0;Ciliated cells: 5.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 17.5"									HPA047872	Uncertain		Approved	"Nucleoplasm,Cell Junctions"		NA	NA			Nucleoplasm	"Cell Junctions"	"HPA047872: AB_2680196"	"unprognostic (8.24e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.09e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.42e-2)"	"unprognostic (2.30e-2)"	"unprognostic (8.53e-2)"	"unprognostic (9.45e-2)"	"unprognostic (9.29e-2)"	"unprognostic (4.16e-3)"	"unprognostic (7.03e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.58e-2)"	"unprognostic (7.28e-2)"	"unprognostic (1.24e-1)"	0.8	2.3	3.3	2.8	5.5	2.3	5.0	7.5	6.2	3.3	1.7	3.1	3.0	2.0	4.1	3.7	3.6	9.1	3.1	2.0	7.2	3.3	3.7	5.0	3.2	3.8	2.0	4.5	4.5	6.0	3.8	5.9	1.8	5.8	3.2	1.2	1.4	7.7	1.9	0.8	4.6	3.1	0.6	3.5	3.6	2.8	2.3	0.6	2.5	4.9	2.0	1.5	1.4	2.1	4.7	4.8	2.3	2.8	2.1	4.8	1.9	1.7	5.9	5.3	5.1	0.2	0.1	7.1	3.2	0.0	0.0	0.0	0.4	1.9	3.4	1.7	0.0	3.0	0.8	0.6	0.4	0.0	3.6	17.5	3.1	1.6	1.0	0.3	1.2	8.2	0.4	0.8	0.1	0.6	5.9	0.0	8.6	2.5	0.5	0.1	6.0	4.3	4.4	3.3	1.4	1.8	10.7	3.9	1.8	0.5	1.4	4.1	5.9	1.7	5.2	2.9	2.8	7.1	3.5	0.5	5.9	3.1	0.5	1.0	7.7	9.1	3.0	1.6	3.5	3.2	2.3	2.8	0.9	2.4	1.1	2.6	3.8	2.8	2.9	2.7	4.7	2.9	4.8	1.0	2.1	0.9	4.8	3.1	1.9	3.3	5.5	7.5	4.2	7.2	3.3	2.0	4.5	5.8	0.6	6.0	0.3	0.0	0.4	0.2	1.4	0.6	0.0	5.3	1.2	0.0	0.0	1.7	1.7	1.1	1.0	0.3	0.4	0.0	0.2	0.4	0.2	0.2	0.0	1.5	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.1	1.1	0.4	0.3	0.0	0.7	1.5	0.0	0.0	0.0	1.1	0.3	0.2	0.0	1.2	0.0
ZNF536	KIAA0390	ENSG00000198597	"Zinc finger protein 536"	O15090	19	30228290-30713538	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 44.5"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 29.2;Horizontal cells: 66.7;Muller glia cells: 58.4"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 4.0;HAP1: 8.9;SH-SY5Y: 24.4;U-937: 5.9;WM-115: 10.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077341			Approved	"Nucleoplasm,Cell Junctions"		NA	NA			"Nucleoplasm, Cell Junctions"		"HPA077341: AB_2732340"	"unprognostic (1.98e-1)"	"unprognostic (4.11e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.03e-1)"		"unprognostic (4.70e-2)"	"unprognostic (4.68e-1)"	"unprognostic (5.50e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.25e-2)"	"unprognostic (4.46e-4)"	"unprognostic (1.58e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.55e-2)"	"unprognostic (3.45e-1)"	1.1	6.0	9.9	2.0	21.0	0.6	0.8	14.3	24.1	4.2	4.0	44.5	0.0	2.7	1.7	1.3	6.9	1.0	1.3	2.9	13.3	7.7	0.8	0.7	1.0	0.7	20.9	9.6	0.9	0.9	0.7	3.4	0.7	18.3	3.7	4.1	4.8	1.6	2.4	1.4	1.2	4.2	1.2	23.1	1.5	2.1	5.0	18.4	0.0	6.9	0.0	0.7	2.9	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	8.9	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	24.4	0.0	0.0	1.6	0.0	0.0	1.2	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	5.9	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	9.9	21.0	14.3	15.1	13.3	7.7	20.9	9.6	18.3	18.4	0.0	0.0	0.0	0.1	0.3	29.2	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.7	0.4	0.0	0.0	0.5	66.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	58.4	0.0	0.0	0.0	0.0	9.5	0.0	1.9	0.3	0.4	0.3	0.0	0.0	0.0	0.1
ZNF688		ENSG00000229809	"Zinc finger protein 688"	P0C7X2	16	30569346-30572734	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"Early spermatids: 132.4;Late spermatids: 434.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048922	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA			Nucleoplasm	"Plasma membrane, Cell Junctions"	"HPA048922: AB_2680557"	"prognostic favorable (5.90e-4)"	"prognostic favorable (7.74e-4)"	"unprognostic (1.68e-1)"	"prognostic favorable (4.58e-5)"	"unprognostic (1.37e-1)"	"unprognostic (1.76e-2)"	"unprognostic (4.01e-1)"	"prognostic favorable (3.24e-4)"	"unprognostic (1.11e-1)"	"unprognostic (3.26e-2)"	"prognostic favorable (6.61e-4)"	"unprognostic (7.75e-2)"	"unprognostic (5.14e-2)"	"unprognostic (7.08e-2)"	"unprognostic (2.48e-1)"	"unprognostic (4.12e-2)"	"unprognostic (4.03e-2)"	10.7	11.9	14.2	11.8	11.8	13.7	8.0	13.8	16.7	8.8	15.3	15.5	12.1	20.5	11.5	9.6	12.0	13.5	14.5	17.2	13.1	10.6	11.2	12.4	10.3	19.9	12.1	11.5	12.9	14.7	8.4	14.0	7.8	11.2	11.8	9.0	11.0	13.8	10.1	32.5	9.5	14.4	14.2	11.0	13.9	13.0	24.6	8.3	21.6	13.7	8.3	10.0	10.4	13.3	6.1	5.4	12.6	5.4	15.1	6.8	2.8	7.8	5.9	6.0	6.3	11.4	2.9	2.5	4.5	6.2	3.8	3.0	1.8	11.9	4.1	9.1	5.6	5.2	5.8	1.7	2.8	4.1	12.2	3.6	2.8	2.3	1.4	3.0	3.9	12.7	5.9	6.3	4.0	4.9	6.5	3.8	5.6	2.9	9.6	4.2	4.7	11.1	4.3	2.2	7.7	1.9	9.5	2.4	6.2	6.6	2.5	8.6	9.6	1.6	11.8	9.9	1.8	12.9	6.5	2.9	3.3	3.6	3.8	3.5	13.8	9.6	4.4	10.1	3.4	5.6	12.6	3.9	8.3	4.8	3.9	5.8	5.5	5.6	5.4	3.9	6.1	4.8	4.4	6.0	15.1	5.4	5.4	6.8	2.8	14.2	11.8	13.8	16.7	13.1	10.6	12.1	11.5	11.2	8.3	6.0	1.9	17.1	10.5	5.7	19.5	8.5	17.8	20.1	6.8	15.7	17.7	6.3	41.4	19.2	132.4	11.1	34.5	0.0	27.4	7.9	13.1	9.8	4.7	18.7	21.4	20.6	19.5	14.1	22.9	434.2	18.4	15.6	16.9	28.9	25.1	28.0	19.6	32.3	18.7	38.4	25.5	6.5	12.5	25.3	7.9	6.1	3.9	20.3	22.1	5.7